Citrus Sinensis ID: 000659
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 1368 | 2.2.26 [Sep-21-2011] | |||||||
| Q8RWW0 | 744 | Receptor-like serine/thre | no | no | 0.392 | 0.721 | 0.593 | 0.0 | |
| Q9SX31 | 708 | Proline-rich receptor-lik | no | no | 0.313 | 0.605 | 0.429 | 2e-88 | |
| Q9SGY7 | 718 | Putative proline-rich rec | no | no | 0.238 | 0.454 | 0.479 | 3e-87 | |
| Q9FE20 | 456 | Serine/threonine-protein | no | no | 0.214 | 0.644 | 0.541 | 9e-86 | |
| Q9FFW5 | 681 | Proline-rich receptor-lik | no | no | 0.210 | 0.422 | 0.513 | 7e-85 | |
| Q9C660 | 762 | Proline-rich receptor-lik | no | no | 0.244 | 0.439 | 0.476 | 4e-84 | |
| Q9LV48 | 652 | Proline-rich receptor-lik | no | no | 0.210 | 0.441 | 0.513 | 1e-83 | |
| Q9ZUE0 | 720 | Proline-rich receptor-lik | no | no | 0.212 | 0.404 | 0.518 | 5e-83 | |
| Q9C821 | 509 | Proline-rich receptor-lik | no | no | 0.257 | 0.691 | 0.434 | 7e-83 | |
| P43293 | 389 | Probable serine/threonine | no | no | 0.254 | 0.894 | 0.439 | 4e-82 |
| >sp|Q8RWW0|ALE2_ARATH Receptor-like serine/threonine-protein kinase ALE2 OS=Arabidopsis thaliana GN=ALE2 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 636 bits (1641), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 337/568 (59%), Positives = 407/568 (71%), Gaps = 31/568 (5%)
Query: 704 PPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFM 763
P + DC T C EP T+TP GSPCGCV+PM+V L LSVA ++ FP+ +EL E+AAG ++
Sbjct: 93 PSSHDCQQT-CVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTYL 151
Query: 764 KQSQVRIIGANA-AEQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDY 822
+QSQV+I+GA+A +E KTVV +LVPLGEKFDNTTA L YQRF HK+V + + FGDY
Sbjct: 152 EQSQVKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGDY 211
Query: 823 EVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNGRATKPEGVDVPKRRQKY-----GLSG 877
EV ++ YPG+P S P +G +G+ P G+ +P + G+
Sbjct: 212 EVTHISYPGIPSSSP----------NGDVTGD-----APGGLPIPINATTFANKSQGIGF 256
Query: 878 GMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSG 937
IAI+ LS FV ++L A ++ K+K + V +L S K GA + S
Sbjct: 257 RTIAIIALSGFV-LILVLVGAISIIVKWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSA 315
Query: 938 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVA 997
S S S SS+AT S KTF+ SE+EKAT F A R+LGEGGFG VY G ++DGT+VA
Sbjct: 316 RSSGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVA 375
Query: 998 VKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH 1057
VK+L R +Q REF+AEVEMLSRLHHRNLVKLIGICIE + RCL+YEL+ NGSVESHLH
Sbjct: 376 VKLLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH 435
Query: 1058 GVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117
L WDARLKIALGAAR LAYLHEDS+PRVIHRDFK+SN+LLE DFTPKVSDFG
Sbjct: 436 -----EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFG 490
Query: 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 1177
LAR A E S+HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR+PVDM+
Sbjct: 491 LAREAT-EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMS 549
Query: 1178 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237
QP G+ENLV WARPLL +REGLE+++DP+L FD +AKVAAIASMCV EV HRPFM
Sbjct: 550 QPSGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFM 609
Query: 1238 GEVVQALKLVCNECDEAKEVGSASSSQD 1265
GEVVQALKL+ N+ DE G S +D
Sbjct: 610 GEVVQALKLIYNDADET--CGDYCSQKD 635
|
Required during the differentiation of the protoderm into shoots epidermis and cuticle. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SX31|PERK9_ARATH Proline-rich receptor-like protein kinase PERK9 OS=Arabidopsis thaliana GN=PERK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 191/445 (42%), Positives = 252/445 (56%), Gaps = 16/445 (3%)
Query: 864 VDVPKRRQKYGL-SGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS-HACQAEEVPQSLQT 921
+D P G+ +G ++ I V A V L W L + K A +V S +
Sbjct: 265 LDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSGGDVTPSPMS 324
Query: 922 SHVKPSGAAGLMVGS---GLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILG 978
S + A M S G S S+ S S FS E+ KAT F +LG
Sbjct: 325 STARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATNGFSQENLLG 384
Query: 979 EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 1038
EGGFG VY G+L DG VAVK LK QG REF AEVE LSR+HHR+LV ++G CI
Sbjct: 385 EGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVSIVGHCISGD 444
Query: 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1098
R L+Y+ + N + HLHG E + L W R+KIA GAAR LAYLHED PR+IHRD
Sbjct: 445 RRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDCHPRIIHRDI 501
Query: 1099 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVY 1158
KSSNILLE +F +VSDFGLAR A+D + HI+TRV+GTFGY+APEYA +G L KSDV+
Sbjct: 502 KSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSGKLTEKSDVF 560
Query: 1159 SYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---SREGLERIIDPSLGNDVPFDS 1215
S+GVV+LEL++GRKPVD +QP G E+LV WARPL++ E + + DP LG +
Sbjct: 561 SFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPKLGGNYVESE 620
Query: 1216 VAKVAAIASMCVQPEVQHRPFMGEVVQALK-LVCNECDEAKEVGSA---SSSQDDMSIDL 1271
+ ++ A CV+ RP MG++V+A + L + +G + +S+Q I L
Sbjct: 621 MFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNSAQQSAEIRL 680
Query: 1272 DSKVSTGSGQLPDPLQRHYSVPNYD 1296
+++ GS H S + D
Sbjct: 681 FRRMAFGSQNYSTDFFSHSSYNSRD 705
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 324 bits (831), Expect = 3e-87, Method: Compositional matrix adjust.
Identities = 174/363 (47%), Positives = 234/363 (64%), Gaps = 37/363 (10%)
Query: 954 GSAKT-FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF 1012
G++K F+ E+ + T F S ++GEGGFG VY G+L +G VA+K LK V +G REF
Sbjct: 352 GTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVSAEGYREF 411
Query: 1013 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL 1072
AEVE++SR+HHR+LV L+G CI EQ R L+YE +PN +++ HLHG K L W R+
Sbjct: 412 KAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHG--KNLPVLEWSRRV 469
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+IA+GAA+ LAYLHED P++IHRD KSSNILL+ +F +V+DFGLAR D HIST
Sbjct: 470 RIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLAR-LNDTAQSHIST 528
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
RVMGTFGY+APEYA +G L +SDV+S+GVV+LEL++GRKPVD +QP G+E+LV WARP
Sbjct: 529 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLVEWARPR 588
Query: 1193 LTSREGLER-----IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247
L E +E+ ++DP L ND V K+ A+ CV+ RP M +VV+AL
Sbjct: 589 LI--EAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRAL--- 643
Query: 1248 CNECDEAKEVGSASSSQDDMSIDLDSKVSTG------SGQLPDPLQ--RHYSVPNYDLGL 1299
++DD+S DL + V G SGQ + ++ R S + DLG
Sbjct: 644 --------------DTRDDLS-DLTNGVKVGQSRVYDSGQYSNEIRIFRRASEDSSDLGT 688
Query: 1300 DTG 1302
+TG
Sbjct: 689 NTG 691
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FE20|PBS1_ARATH Serine/threonine-protein kinase PBS1 OS=Arabidopsis thaliana GN=PBS1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 319 bits (818), Expect = 9e-86, Method: Compositional matrix adjust.
Identities = 162/299 (54%), Positives = 202/299 (67%), Gaps = 5/299 (1%)
Query: 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFL 1013
+A TF+ E+ AT NF LGEGGFG VY G LD G VAVK L R QG REFL
Sbjct: 70 AAHTFAFRELAAATMNFHPDTFLGEGGFGRVYKGRLDSTGQVVAVKQLDRNGLQGNREFL 129
Query: 1014 AEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDAR 1071
EV MLS LHH NLV LIG C + R LVYE +P GS+E HLH + DKE+ L W+ R
Sbjct: 130 VEVLMLSLLHHPNLVNLIGYCADGDQRLLVYEFMPLGSLEDHLHDLPPDKEA--LDWNMR 187
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
+KIA GAA+ L +LH+ ++P VI+RDFKSSNILL+ F PK+SDFGLA+ + H+S
Sbjct: 188 MKIAAGAAKGLEFLHDKANPPVIYRDFKSSNILLDEGFHPKLSDFGLAKLGPTGDKSHVS 247
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191
TRVMGT+GY APEYAMTG L VKSDVYS+GVV LEL++GRK +D P G++NLVAWARP
Sbjct: 248 TRVMGTYGYCAPEYAMTGQLTVKSDVYSFGVVFLELITGRKAIDSEMPHGEQNLVAWARP 307
Query: 1192 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250
L R ++ DP L P ++ + A+ASMC+Q + RP + +VV AL + N+
Sbjct: 308 LFNDRRKFIKLADPRLKGRFPTRALYQALAVASMCIQEQAATRPLIADVVTALSYLANQ 366
|
Protein kinase required for plant defense mechanism mediated by the disease resistance (R) protein RPS5. In case of infection by Pseudomonas syringae, RPS5 specifically recognizes the avrPphB type III effector avirulence protein and triggers a defense reaction. AvrPphB may trigger RPS5-mediated defense mechanism via the cleavage of PBS1. Both kinase activity and cleavage by avrPphB are independently required to trigger the RPS5-mediated resistance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 316 bits (810), Expect = 7e-85, Method: Compositional matrix adjust.
Identities = 155/302 (51%), Positives = 204/302 (67%), Gaps = 14/302 (4%)
Query: 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 1018
FS E+ + T F +LGEGGFG VY GVL DG +VAVK LK QG REF AEVE+
Sbjct: 327 FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEI 386
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP----LGWDARLKI 1074
+SR+HHR+LV L+G CI EQ R LVY+ +PN ++ HLH AP + W+ R+++
Sbjct: 387 ISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLH------APGRPVMTWETRVRV 440
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD-EESRHISTR 1133
A GAAR +AYLHED PR+IHRD KSSNILL++ F V+DFGLA+ A + + + H+STR
Sbjct: 441 AAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTR 500
Query: 1134 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193
VMGTFGY+APEYA +G L K+DVYSYGV++LEL++GRKPVD +QP G E+LV WARPLL
Sbjct: 501 VMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLL 560
Query: 1194 ---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250
E + ++DP LG + + ++ A+ CV+ RP M +VV+AL +
Sbjct: 561 GQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRALDTLEEA 620
Query: 1251 CD 1252
D
Sbjct: 621 TD 622
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 314 bits (804), Expect = 4e-84, Method: Compositional matrix adjust.
Identities = 165/346 (47%), Positives = 218/346 (63%), Gaps = 11/346 (3%)
Query: 952 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE 1011
+ S + FS E+ AT F +LGEGGFG VY GVL D VAVK LK QG RE
Sbjct: 411 FGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDRE 470
Query: 1012 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1071
F AEV+ +SR+HHRNL+ ++G CI E R L+Y+ +PN ++ HLH + L W R
Sbjct: 471 FKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHAAG--TPGLDWATR 528
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
+KIA GAAR LAYLHED PR+IHRD KSSNILLE++F VSDFGLA+ A+D + HI+
Sbjct: 529 VKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNT-HIT 587
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191
TRVMGTFGY+APEYA +G L KSDV+S+GVV+LEL++GRKPVD +QP G E+LV WARP
Sbjct: 588 TRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARP 647
Query: 1192 LL---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248
LL T E + DP LG + + ++ A+ C++ RP M ++V+A +
Sbjct: 648 LLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIVRAFDSLA 707
Query: 1249 NE-CDEAKEVGSA---SSSQDDMSIDLDSKVSTGSGQL-PDPLQRH 1289
E +G + +S+Q I L +++ GS D L R+
Sbjct: 708 EEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNYSTDSLTRN 753
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 312 bits (800), Expect = 1e-83, Method: Compositional matrix adjust.
Identities = 151/294 (51%), Positives = 206/294 (70%), Gaps = 6/294 (2%)
Query: 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 1014
S TF+ E+ +AT F + +LG+GGFG V+ G+L G +VAVK LK QG REF A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 1015 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1074
EVE++SR+HHR+LV LIG C+ R LVYE +PN ++E HLHG K + W RLKI
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKI 381
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
ALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRV 440
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 1195 --SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
S EG E + D +GN+ + +A++ A A+ CV+ + RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 310 bits (794), Expect = 5e-83, Method: Compositional matrix adjust.
Identities = 157/303 (51%), Positives = 202/303 (66%), Gaps = 12/303 (3%)
Query: 954 GSAKT-FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF 1012
GS +T FS E+ + T F ILGEGGFG VY G L DG VAVK LK QG REF
Sbjct: 353 GSGQTHFSYEELAEITQGFARKNILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREF 412
Query: 1013 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL 1072
AEVE++SR+HHR+LV L+G CI +Q R L+YE + N ++E HLHG K L W R+
Sbjct: 413 KAEVEIISRVHHRHLVSLVGYCISDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRV 470
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+IA+G+A+ LAYLHED P++IHRD KS+NILL+ ++ +V+DFGLAR D H+ST
Sbjct: 471 RIAIGSAKGLAYLHEDCHPKIIHRDIKSANILLDDEYEAQVADFGLAR-LNDTTQTHVST 529
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
RVMGTFGY+APEYA +G L +SDV+S+GVV+LEL++GRKPVD TQP G+E+LV WARPL
Sbjct: 530 RVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPL 589
Query: 1193 L---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249
L L +ID L V ++ A+ CV+ RP M +VV+AL
Sbjct: 590 LLKAIETGDLSELIDTRLEKRYVEHEVFRMIETAAACVRHSGPKRPRMVQVVRAL----- 644
Query: 1250 ECD 1252
+CD
Sbjct: 645 DCD 647
|
Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9C821|PEK15_ARATH Proline-rich receptor-like protein kinase PERK15 OS=Arabidopsis thaliana GN=PERK15 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 310 bits (793), Expect = 7e-83, Method: Compositional matrix adjust.
Identities = 162/373 (43%), Positives = 236/373 (63%), Gaps = 21/373 (5%)
Query: 878 GMIAIVVLSA-FVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGS 936
G+I VVL A FV + +C + K K + E++ S+ + P
Sbjct: 62 GLITGVVLGATFVLLGVCIFVCFYKRKKRKLKKKKKEDIEASINRDSLDPKD-------- 113
Query: 937 GLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKV 996
DS +L SS F+ ++ KAT NF + +LG+GGFG V+ GVL DGT V
Sbjct: 114 --DSNNLQQWSSSEI---GQNLFTYEDLSKATSNFSNTNLLGQGGFGYVHRGVLVDGTLV 168
Query: 997 AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL 1056
A+K LK QG REF AE++ +SR+HHR+LV L+G CI R LVYE +PN ++E HL
Sbjct: 169 AIKQLKSGSGQGEREFQAEIQTISRVHHRHLVSLLGYCITGAQRLLVYEFVPNKTLEFHL 228
Query: 1057 HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116
H +KE + W R+KIALGAA+ LAYLHED +P+ IHRD K++NIL++ + K++DF
Sbjct: 229 H--EKERPVMEWSKRMKIALGAAKGLAYLHEDCNPKTIHRDVKAANILIDDSYEAKLADF 286
Query: 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1176
GLARS++D ++ H+STR+MGTFGY+APEYA +G L KSDV+S GVV+LEL++GR+PVD
Sbjct: 287 GLARSSLDTDT-HVSTRIMGTFGYLAPEYASSGKLTEKSDVFSIGVVLLELITGRRPVDK 345
Query: 1177 TQPPGQEN-LVAWARPLLTS--REG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQ 1232
+QP ++ +V WA+PL+ +G + ++DP L ND + + ++ A A+ V+ +
Sbjct: 346 SQPFADDDSIVDWAKPLMIQALNDGNFDGLVDPRLENDFDINEMTRMVACAAASVRHSAK 405
Query: 1233 HRPFMGEVVQALK 1245
RP M ++V+A +
Sbjct: 406 RRPKMSQIVRAFE 418
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2 | Back alignment and function description |
|---|
Score = 307 bits (787), Expect = 4e-82, Method: Compositional matrix adjust.
Identities = 166/378 (43%), Positives = 232/378 (61%), Gaps = 30/378 (7%)
Query: 921 TSHVKPSGAAGLMVGSGLDSASLSFGSSIATYT------------GSAKTFSASEIEKAT 968
++ +K A+ + S S S GSS A+++ + K FS SE++ AT
Sbjct: 6 SNRIKTDIASSTWLSSKFLSRDGSKGSSTASFSYMPRTEGEILQNANLKNFSLSELKSAT 65
Query: 969 GNFDASRILGEGGFGLVYSGVLDD----------GTKVAVKVLKRVDQQGGREFLAEVEM 1018
NF ++GEGGFG V+ G +D+ G +AVK L + QG RE+LAE+
Sbjct: 66 RNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQGHREWLAEINY 125
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
L +L H NLVKLIG C+EE+ R LVYE + GS+E+HL PL W+ R+++ALGA
Sbjct: 126 LGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSWNTRVRMALGA 185
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
AR LA+LH ++ P+VI+RDFK+SNILL+ ++ K+SDFGLAR ++ H+STRVMGT
Sbjct: 186 ARGLAFLH-NAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSHVSTRVMGTQ 244
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198
GY APEY TGHL VKSDVYS+GVV+LELLSGR+ +D QP G+ NLV WARP LT++
Sbjct: 245 GYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWARPYLTNKRR 304
Query: 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 1258
L R++DP L K+A +A C+ + + RP M E+V+ ++ E KE
Sbjct: 305 LLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTME----ELHIQKE-- 358
Query: 1259 SASSSQDDMSIDLDSKVS 1276
AS Q + I +D+ ++
Sbjct: 359 -ASKEQQNPQISIDNIIN 375
|
May play a role in the regulation of plant growth and development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1368 | ||||||
| 359484309 | 992 | PREDICTED: receptor-like serine/threonin | 0.679 | 0.937 | 0.648 | 0.0 | |
| 255546109 | 1282 | conserved hypothetical protein [Ricinus | 0.685 | 0.731 | 0.635 | 0.0 | |
| 124360779 | 986 | Protein kinase [Medicago truncatula] | 0.662 | 0.918 | 0.622 | 0.0 | |
| 357449795 | 1478 | Serine/threonine protein kinase PBS1 [Me | 0.619 | 0.573 | 0.649 | 0.0 | |
| 224122486 | 1156 | predicted protein [Populus trichocarpa] | 0.695 | 0.823 | 0.614 | 0.0 | |
| 356558353 | 1255 | PREDICTED: receptor-like serine/threonin | 0.665 | 0.725 | 0.626 | 0.0 | |
| 297738662 | 1046 | unnamed protein product [Vitis vinifera] | 0.641 | 0.839 | 0.616 | 0.0 | |
| 356545725 | 1270 | PREDICTED: uncharacterized protein LOC10 | 0.896 | 0.966 | 0.502 | 0.0 | |
| 449436078 | 1050 | PREDICTED: receptor-like serine/threonin | 0.635 | 0.828 | 0.613 | 0.0 | |
| 359482516 | 873 | PREDICTED: receptor-like serine/threonin | 0.577 | 0.904 | 0.631 | 0.0 |
| >gi|359484309|ref|XP_003633096.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1135 bits (2937), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 662/1021 (64%), Positives = 743/1021 (72%), Gaps = 91/1021 (8%)
Query: 400 PSNTALTPASHPSNIAPPPLFVPVL-----PSALPGKAPVSQSPISLPDAPAA----TPR 450
PSN ++P P PP L VP+ PSA KAP +++P+ P AP A P
Sbjct: 11 PSNPRMSP---PHYKTPPHLKVPITLPSVPPSASQRKAPDNKAPVWAPVAPIAPVAPVPD 67
Query: 451 GNFHRHSPAI------HPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPV 504
G R P HP MPG LPP A RN + +API+ PIAP
Sbjct: 68 GPPQRKWPQNPPSMHPHPVMPGLLPPSAHNRNKPDNKAPISTPIAP-------------- 113
Query: 505 ARPIIPGGTPTASPDPDVPP-STPPLSVDGKRVGKPVAEPSYDIPMP-PPVNHSPSKAPS 562
DPDV P STPPL+ +R PVA P P P PVNHSP+KAPS
Sbjct: 114 --------------DPDVTPISTPPLASHWRRKQMPVAAPPNRTPDPLSPVNHSPAKAPS 159
Query: 563 THKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIAS-SPAPSYFIS 621
H MRHSN +P S+P+ P N G+ +P SSP SF KH RNKI +PA SY I
Sbjct: 160 IHNAMRHSN-AP-ASLSTPQSPTNKGSQSPASSPSMSFSKHHRGRNKITGPAPASSYLIP 217
Query: 622 PTTSIHQGPVV------PPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPS 672
P + HQGPV+ PP +P + H+ P PLN +SP+HSP P+ ++ +PS
Sbjct: 218 PPSPRHQGPVISPAPSHPPKSLPNRTRTHHAPLPLNPGSRISPAHSPSPSSLTYPSPAPS 277
Query: 673 PSPTSASGQT-----ELPLLPPKSSPSEPIRAFPP---------------PPPNADCSTT 712
PSPT ++P L PK SPS PP PPPN DCS
Sbjct: 278 PSPTLIYCHVCICTLQVPFLSPKISPSR----LPPSSKMPAPPPVQALPPPPPNQDCSAI 333
Query: 713 ICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIG 772
+CTEP TNTPPGSPCGCV PMQV LRL+VALYTFFPLVSELA EIAAGVFM+QSQVRI+G
Sbjct: 334 VCTEPNTNTPPGSPCGCVLPMQVQLRLNVALYTFFPLVSELAEEIAAGVFMRQSQVRIMG 393
Query: 773 ANAAE-QPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPG 831
ANAA + +KT+VL DLVPLGEKFDNTTAFLTYQRFW KQVVIK+ +FGDYEV+YV YPG
Sbjct: 394 ANAASPEAEKTIVLIDLVPLGEKFDNTTAFLTYQRFWGKQVVIKNLFFGDYEVIYVNYPG 453
Query: 832 LPPSPPSASSSIGIIDDGPYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFV 889
LPPSPPSA SSI +ID+GPYSG NNGR P GVDV K R K+GLSG +IAI+VLSA V
Sbjct: 454 LPPSPPSAPSSITMIDNGPYSGQGNNGRTIHPLGVDVHKNRHKHGLSGSVIAIIVLSASV 513
Query: 890 AVVLCSAAAWVLLFKYKSHACQAEEVPQ--SLQTSHVKPSGAAGLMVGSGLDSASLSFGS 947
AVVLCSA AWV LFK C + VP +L S +P GAAG +VGS SASLSFGS
Sbjct: 514 AVVLCSAVAWVFLFKKTD--CIGQPVPTQAALVPSLARPPGAAGSVVGSAPSSASLSFGS 571
Query: 948 SIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ 1007
SIATYTGSAKTFSA++IE+AT NFD SRILGEGGFG VYSGVL+DGTKVAVKVLKR D Q
Sbjct: 572 SIATYTGSAKTFSAADIERATDNFDDSRILGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQ 631
Query: 1008 GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLG 1067
GGREFLAEVEMLSRLHHRNLVKLIGIC EE+ RCLVYELIPNGSVESHLHG DKE+APL
Sbjct: 632 GGREFLAEVEMLSRLHHRNLVKLIGICTEERTRCLVYELIPNGSVESHLHGADKETAPLD 691
Query: 1068 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127
W AR+K+ALGAAR LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR+AMDEE+
Sbjct: 692 WGARIKVALGAARGLAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARTAMDEEN 751
Query: 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 1187
RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQENLVA
Sbjct: 752 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVA 811
Query: 1188 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247
WARPLLTS+EGL+ +ID SLG+DVPFDSVAKVAAIASMCVQPEV HRPFMGEVVQALKLV
Sbjct: 812 WARPLLTSKEGLQTMIDLSLGSDVPFDSVAKVAAIASMCVQPEVSHRPFMGEVVQALKLV 871
Query: 1248 CNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSL 1307
CNECDE KE GS S SQ+D+S+DLD+ VS+ SGQLPDP H+ V Y GLD LS+
Sbjct: 872 CNECDETKEAGSKSGSQEDLSLDLDTGVSSASGQLPDPSHAHFPVSTYGSGLDAETGLSV 931
Query: 1308 SYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGS 1367
S LFS+SAR G++ S FRRYSSSGPLRTGR R FWQR+RR GGS SEHG +F L PGS
Sbjct: 932 SELFSTSARFGRQPSGSFRRYSSSGPLRTGRARHFWQRMRRNSGGSVSEHGIMFRLRPGS 991
Query: 1368 Y 1368
+
Sbjct: 992 H 992
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255546109|ref|XP_002514114.1| conserved hypothetical protein [Ricinus communis] gi|223546570|gb|EEF48068.1| conserved hypothetical protein [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1135 bits (2935), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/1012 (63%), Positives = 728/1012 (71%), Gaps = 74/1012 (7%)
Query: 421 VPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVA-------- 472
+P+ P+A KA Q+P+ +P A P N SP + P P P +
Sbjct: 147 LPMPPNASQRKALGRQTPVPVP---VAAPSNNLSYDSPMLPPIAPETSPIINPSPPEISP 203
Query: 473 ----QKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPP---- 524
+N S PI + IAP PP RQ P + I P P SP P V P
Sbjct: 204 PSAHHNKNMSVTGTPITKSIAPVASPPRELRQNQPSSHLIAPTKMPFVSPVPVVSPTREL 263
Query: 525 ------------------------STPPLSVDGKRVGKPVAEPSYDIP-MPPPVNHSPSK 559
S+PP S+D K+ P+A P + P P +HSP+K
Sbjct: 264 PRHSPSVLPGEPPAILPVPDVSHASSPPTSIDRKKDRSPIAAPPDETPSHLPSADHSPTK 323
Query: 560 ------APSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIASS 613
APSTH+ ++++ +P S P + GN T SSP F K R SS
Sbjct: 324 GSFSAVAPSTHEPTGYTSYGLVPSSSPPNHSLSKGNHTSASSPSIPFHKQNHSRTDF-SS 382
Query: 614 PAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTS 670
PAP+Y SP S QGPV PSF+PTSR+ HY PPP++ S SPSH P PV V +
Sbjct: 383 PAPAY--SPP-SKQQGPVASPSFLPTSRRTHYAPPPISPGSSASPSHFHFPKPVINVSPA 439
Query: 671 PSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPP------------NADCSTTICTEPY 718
PSPSPT+ASG T++P+L P+ SPS P PP N DCS+T+C EPY
Sbjct: 440 PSPSPTAASGWTKMPILSPEVSPSGSSPRSPKMPPRPPVHALPPPPPNEDCSSTVCVEPY 499
Query: 719 TNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-E 777
TNTPPGSPCGCV PMQVGLRLSVALYTFFPLVSELA EIA GVFMKQSQVRI+GANAA +
Sbjct: 500 TNTPPGSPCGCVLPMQVGLRLSVALYTFFPLVSELAQEIATGVFMKQSQVRIMGANAASQ 559
Query: 778 QPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPP 837
QP+KTVVL DLVPLGE+FDNTTA LT+ RFWHKQVVIK+S+FGDYEVLYVRYPGLPPSP
Sbjct: 560 QPEKTVVLIDLVPLGERFDNTTAVLTFHRFWHKQVVIKASFFGDYEVLYVRYPGLPPSP- 618
Query: 838 SASSSIGIIDDGPYSGNN--GRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCS 895
+ S I IIDDGPYSGNN R KP GVDV KR +K GL GMIAI+ LSA +A++LCS
Sbjct: 619 PSPSGITIIDDGPYSGNNNNARTIKPLGVDVHKRHRKDGLGAGMIAIISLSASLALILCS 678
Query: 896 AAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGS 955
A AWVLL +++ Q PQ L S KPSG G ++GSGL SASLSFGSSIA YTGS
Sbjct: 679 AVAWVLLVRHRGRMSQPTPTPQPLPPSGAKPSGTTGSVIGSGLSSASLSFGSSIAPYTGS 738
Query: 956 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAE 1015
AKTFS S+IE+AT NF+ASRILGEGGFG VYSGVL+DGTKVAVKVLKR D QGGREFLAE
Sbjct: 739 AKTFSISDIERATNNFNASRILGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQGGREFLAE 798
Query: 1016 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1075
VEMLSRLHHRNLVKLIGIC EE+ARCLVYELIPNGSVESHLHG DKESAPL WDAR++IA
Sbjct: 799 VEMLSRLHHRNLVKLIGICTEERARCLVYELIPNGSVESHLHGADKESAPLDWDARIRIA 858
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
LGAAR LAYLHEDSSP VIHRDFKSSNILLEHDFTPKVSDFGLAR+AMDE++RHISTRVM
Sbjct: 859 LGAARGLAYLHEDSSPHVIHRDFKSSNILLEHDFTPKVSDFGLARTAMDEDNRHISTRVM 918
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195
GTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM QPPGQENLVAWARPLLTS
Sbjct: 919 GTFGYVAPEYAMTGHLLVKSDVYSYGVVVLELLTGRKPVDMLQPPGQENLVAWARPLLTS 978
Query: 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 1255
+EGLE I DPSLG DVPFDSVAKVAAIASMCVQPEV +RPFMGEVVQALKLVCNECDEAK
Sbjct: 979 KEGLEIITDPSLGPDVPFDSVAKVAAIASMCVQPEVSNRPFMGEVVQALKLVCNECDEAK 1038
Query: 1256 EVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSA 1315
EVGS S S D+S+D+D++ S GSG + DP Q VPNYD D R LS+S LFS+S
Sbjct: 1039 EVGSRSPSW-DISVDMDAEASAGSGHMRDPFQNRTIVPNYDSEPDIERGLSMSDLFSTSV 1097
Query: 1316 RSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGS 1367
R G++ S FRRYSSSGPLRTGRG+Q WQR+RRL G S SEHG +F +WP +
Sbjct: 1098 RYGRQASGSFRRYSSSGPLRTGRGKQLWQRMRRLTGESVSEHGGIFRIWPAA 1149
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|124360779|gb|ABN08751.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1078 bits (2789), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 593/952 (62%), Positives = 692/952 (72%), Gaps = 46/952 (4%)
Query: 433 PVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGP 492
PVSQ AP A P NF ++S PS G +PP EP+ P P
Sbjct: 51 PVSQ-------APVAEPPANFPKNSSVSQPSQHGSVPPNVHNTTIHKGHIHTPEPVMPPP 103
Query: 493 ---FPPGNSRQKSPVARPIIPGGTPTASPDPDVPPS-TPPLSVDGKRVGKPVAEPSYDIP 548
FP P+ P+IP P P P + P+ TP S +GK G+PV+ P P
Sbjct: 104 ISTFP-----VDPPLIHPVIPAAPPNEVPAPVISPTLTPSRSFNGKNGGEPVSAPLNKKP 158
Query: 549 M-PPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVR 607
PP + +SP++APS +K R +H+P P S PK P N + +P SSP +F KH+ R
Sbjct: 159 KSPPAIVNSPAQAPSVNK-ARPFHHAPEPLTSPPKSPFNKEDHSPASSPSTTFHKHQHTR 217
Query: 608 NKIAS-SPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTP 663
N I S +PA SYF+SP TS HQ +PPSF+PT+R+RH P P+N + SP P+ +P
Sbjct: 218 NTITSPAPASSYFVSPPTSKHQDKPIPPSFLPTNRRRHNAPAPMNRGSADSPFTFPIQSP 277
Query: 664 VSRVPTSPSPSPTSASGQTELPLLPPK--------SSPSEPI----RAFPPPPPNADCST 711
VS+V +PSPS + T++P PPK SP +PI +A PPPPPN DC +
Sbjct: 278 VSQVSPAPSPSFKTFPHSTKIPFHPPKISPQRSFSKSPKKPILPRVQALPPPPPNEDCLS 337
Query: 712 TICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRII 771
+C+EPYTN+PPG PC C+WPM+VGLRL+V LYTFFPLVSELA EI++GVFMKQSQVRI+
Sbjct: 338 FVCSEPYTNSPPGVPCMCIWPMRVGLRLNVPLYTFFPLVSELASEISSGVFMKQSQVRIM 397
Query: 772 GANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYP 830
GANAA +QPDKT L DLVPLGE+FDNTTAFLT RFWHK+VVIKSSYFGDYEVLY+ YP
Sbjct: 398 GANAATDQPDKTDALIDLVPLGEQFDNTTAFLTSDRFWHKKVVIKSSYFGDYEVLYISYP 457
Query: 831 GLPPSPPSASSSIGIIDDGPYS--GNNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAF 888
GLPPSPP SS+ +ID GPYS GNNGR KP GVD+ KR+ + GLS G+IAI+ LS+F
Sbjct: 458 GLPPSPPLPPSSVNMIDGGPYSNNGNNGRTIKPLGVDIQKRQHRSGLSKGIIAIIALSSF 517
Query: 889 VAVVLCSAAAWVLLFKYKSHACQAE--EVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFG 946
+A+VLCSAA + L+ K++ H +++ P+ S K G AG SAS SF
Sbjct: 518 LAIVLCSAAVFALI-KFRDHVSESQPTSTPRVFPPSLTKTPGTAGPSNAGA--SASTSFR 574
Query: 947 SSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ 1006
SSIA Y GSAKTFS +EIEKAT NF SRILGEGGFGLVYSG L+DG+KVA KVLKR D
Sbjct: 575 SSIAAYAGSAKTFSMNEIEKATDNFHPSRILGEGGFGLVYSGNLEDGSKVAFKVLKREDH 634
Query: 1007 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPL 1066
G REFL+EVEMLSRLHHRNLVKLIGIC E RCLVYELIPNGSVESHLHGVD+E +PL
Sbjct: 635 HGDREFLSEVEMLSRLHHRNLVKLIGICTELSFRCLVYELIPNGSVESHLHGVDREKSPL 694
Query: 1067 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126
W AR+KIALGAAR LAYLHEDSSP VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE+
Sbjct: 695 DWSARIKIALGAARGLAYLHEDSSPHVIHRDFKSSNILLENDFTPKVSDFGLARTAADED 754
Query: 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1186
+RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVD +QPPGQENLV
Sbjct: 755 NRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDFSQPPGQENLV 814
Query: 1187 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246
AWARPLLTSREGLE IIDPSLG++VPFDSVAKVAAIASMCVQPEV RPFMGEVVQALKL
Sbjct: 815 AWARPLLTSREGLEVIIDPSLGSNVPFDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKL 874
Query: 1247 VCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLS 1306
VCNECDEAKE GS SS++D S D T + QLPD Q H + NYD G+D LS
Sbjct: 875 VCNECDEAKEAGSTSSNKDGSSSDF----YTVTEQLPDNFQSHSAAANYDFGVDIENGLS 930
Query: 1307 LSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHG 1358
S +FSSSAR ++ S FRR+S SGPLRTGR ++ W IR+L GGS SEHG
Sbjct: 931 TSEIFSSSARFERQVSGSFRRHSYSGPLRTGRSKRLWHIIRKLSGGSVSEHG 982
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449795|ref|XP_003595174.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] gi|355484222|gb|AES65425.1| Serine/threonine protein kinase PBS1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1073 bits (2775), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 571/879 (64%), Positives = 666/879 (75%), Gaps = 31/879 (3%)
Query: 503 PVARPIIPGGTPTASPDPDVPPS-TPPLSVDGKRVGKPVAEPSYDIPM-PPPVNHSPSKA 560
P+ P+IP P P P + P+ TP S +GK G+PV+ P P PP + +SP++A
Sbjct: 604 PLIHPVIPAAPPNEVPAPVISPTLTPSRSFNGKNGGEPVSAPLNKKPKSPPAIVNSPAQA 663
Query: 561 PSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIAS-SPAPSYF 619
PS +K R +H+P P S PK P N + +P SSP +F KH+ RN I S +PA SYF
Sbjct: 664 PSVNK-ARPFHHAPEPLTSPPKSPFNKEDHSPASSPSTTFHKHQHTRNTITSPAPASSYF 722
Query: 620 ISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPSPSPT 676
+SP TS HQ +PPSF+PT+R+RH P P+N + SP P+ +PVS+V +PSPS
Sbjct: 723 VSPPTSKHQDKPIPPSFLPTNRRRHNAPAPMNRGSADSPFTFPIQSPVSQVSPAPSPSFK 782
Query: 677 SASGQTELPLLPPK--------SSPSEPI----RAFPPPPPNADCSTTICTEPYTNTPPG 724
+ T++P PPK SP +PI +A PPPPPN DC + +C+EPYTN+PPG
Sbjct: 783 TFPHSTKIPFHPPKISPQRSFSKSPKKPILPRVQALPPPPPNEDCLSFVCSEPYTNSPPG 842
Query: 725 SPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTV 783
PC C+WPM+VGLRL+V LYTFFPLVSELA EI++GVFMKQSQVRI+GANAA +QPDKT
Sbjct: 843 VPCMCIWPMRVGLRLNVPLYTFFPLVSELASEISSGVFMKQSQVRIMGANAATDQPDKTD 902
Query: 784 VLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSI 843
L DLVPLGE+FDNTTAFLT RFWHK+VVIKSSYFGDYEVLY+ YPGLPPSPP SS+
Sbjct: 903 ALIDLVPLGEQFDNTTAFLTSDRFWHKKVVIKSSYFGDYEVLYISYPGLPPSPPLPPSSV 962
Query: 844 GIIDDGPYS--GNNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVL 901
+ID GPYS GNNGR KP GVD+ KR+ + GLS G+IAI+ LS+F+A+VLCSAA + L
Sbjct: 963 NMIDGGPYSNNGNNGRTIKPLGVDIQKRQHRSGLSKGIIAIIALSSFLAIVLCSAAVFAL 1022
Query: 902 LFKYKSHACQAE--EVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTF 959
+ K++ H +++ P+ S K G AG SAS SF SSIA Y GSAKTF
Sbjct: 1023 I-KFRDHVSESQPTSTPRVFPPSLTKTPGTAGPSNAGA--SASTSFRSSIAAYAGSAKTF 1079
Query: 960 SASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEML 1019
S +EIEKAT NF SRILGEGGFGLVYSG L+DG+KVA KVLKR D G REFL+EVEML
Sbjct: 1080 SMNEIEKATDNFHPSRILGEGGFGLVYSGNLEDGSKVAFKVLKREDHHGDREFLSEVEML 1139
Query: 1020 SRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
SRLHHRNLVKLIGIC E RCLVYELIPNGSVESHLHGVD+E +PL W AR+KIALGAA
Sbjct: 1140 SRLHHRNLVKLIGICTELSFRCLVYELIPNGSVESHLHGVDREKSPLDWSARIKIALGAA 1199
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
R LAYLHEDSSP VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE++RHISTRVMGTFG
Sbjct: 1200 RGLAYLHEDSSPHVIHRDFKSSNILLENDFTPKVSDFGLARTAADEDNRHISTRVMGTFG 1259
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199
YVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVD +QPPGQENLVAWARPLLTSREGL
Sbjct: 1260 YVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDFSQPPGQENLVAWARPLLTSREGL 1319
Query: 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGS 1259
E IIDPSLG++VPFDSVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNECDEAKE GS
Sbjct: 1320 EVIIDPSLGSNVPFDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNECDEAKEAGS 1379
Query: 1260 ASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGK 1319
SS++D S D T + QLPD Q H + NYD G+D LS S +FSSSAR +
Sbjct: 1380 TSSNKDGSSSDF----YTVTEQLPDNFQSHSAAANYDFGVDIENGLSTSEIFSSSARFER 1435
Query: 1320 EESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHG 1358
+ S FRR+S SGPLRTGR ++ W IR+L GGS SEHG
Sbjct: 1436 QVSGSFRRHSYSGPLRTGRSKRLWHIIRKLSGGSVSEHG 1474
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122486|ref|XP_002330493.1| predicted protein [Populus trichocarpa] gi|222872427|gb|EEF09558.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1067 bits (2759), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 629/1024 (61%), Positives = 719/1024 (70%), Gaps = 72/1024 (7%)
Query: 413 NIAPPPLFV-----PVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGP 467
N APPP P P+A +A V Q+P+S APAA P +SP + P
Sbjct: 137 NTAPPPTLNQGHEPPKPPNAHRREAAVRQTPVSASSAPAAAPSRQSPENSPVSQSNAPEA 196
Query: 468 LPPVAQKRNASNREAPI---AEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVP- 523
K++ S AP+ P P P G Q S P++PG P P+VP
Sbjct: 197 SSLSTHKKDVSFSGAPVPNSVSPAVPVVSPMGAMPQNSSATHPVMPGEPPAILSGPNVPH 256
Query: 524 PSTPPLSVDGKRVGKPVAEPSYDIPMP-PPVNHSPSK------APSTHKYMRHSNHSPLP 576
PS P S+D K+ PV+ P + P P P++H P+K APSTH MRHSN SP+
Sbjct: 257 PSAPTPSIDDKKDEIPVSAPPNETPTPLSPMSHFPAKGSFSGIAPSTHNAMRHSNDSPIS 316
Query: 577 PFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIA-SSPAPSYFISPTTSIHQGPVVPPS 635
P S PK P + + SP F K ++I+ S+PA S P +S QGPV+PPS
Sbjct: 317 PSSLPKTPLAKQHHSSAPSPSIPFHKQNHESSRISDSAPASSNPTFPPSSKQQGPVMPPS 376
Query: 636 FIPTSRKRHYGPPPL----NSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKS 691
F+PTSR + Y PL +S + SH P PV V +PSP+ T+ASG T++P L PK+
Sbjct: 377 FLPTSRHKQYAFSPLGTPDSSNNASHYRYPKPVIIVSPTPSPTQTAASGWTKMPALSPKA 436
Query: 692 SPSEPIRAFPP------------PPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRL 739
SPS P PPPN DCSTT+CTEPYTNTPPGSPC CV PMQVGL +
Sbjct: 437 SPSGFSSRTPKMPPLPPLHTLPPPPPNEDCSTTVCTEPYTNTPPGSPCRCVLPMQVGLGV 496
Query: 740 SVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANA-AEQPDKTVVLTDLVPLGEKFDNT 798
SVALYTFFPLVSELA EIAAGVFMKQ QVRIIGANA ++Q +KT+VL DLVPLGE+FDN+
Sbjct: 497 SVALYTFFPLVSELAQEIAAGVFMKQGQVRIIGANAPSQQLEKTIVLIDLVPLGERFDNS 556
Query: 799 TAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSGN--NG 856
TA LTY RFW KQVVI S+FGDYEVLYVRY GLPP PP A I IIDDGPYSGN N
Sbjct: 557 TALLTYLRFWKKQVVINPSFFGDYEVLYVRYLGLPPPPPMAPFGIAIIDDGPYSGNDNNA 616
Query: 857 RATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVP 916
R KP GVDV KR++K GL+GG+IAI+ +S FVA+VL SA A LLFK++ HA Q V
Sbjct: 617 RMIKPLGVDVHKRKRKDGLAGGIIAIIAVSGFVALVLFSAVALALLFKHRDHASQPASVL 676
Query: 917 QSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRI 976
Q L S VKPSG AG ++GSGL SASLSF SSI YTGSAKTFS S+IE+AT +FDASRI
Sbjct: 677 QPLPPSVVKPSGIAGSLIGSGLSSASLSFASSIPAYTGSAKTFSKSDIERATSSFDASRI 736
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
LGEGGFGLVYSGVL+DGTKVAVKVLKR DQQGGREFLAEVEMLSRLHHRNLVKLIGIC E
Sbjct: 737 LGEGGFGLVYSGVLEDGTKVAVKVLKRNDQQGGREFLAEVEMLSRLHHRNLVKLIGICTE 796
Query: 1037 EQARCLVYELIPNGSVESHLHG--------------------------------VDKESA 1064
E +R LVYELI NGSVESHLHG VDKESA
Sbjct: 797 ECSRSLVYELIANGSVESHLHGSRLALSEFSYLDQESYLLDKESMFYNMNMLVWVDKESA 856
Query: 1065 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124
L WDAR+KIALGAAR LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR+A+D
Sbjct: 857 -LNWDARIKIALGAARGLAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARTALD 915
Query: 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1184
EE+RHIST+VMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQEN
Sbjct: 916 EENRHISTQVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQEN 975
Query: 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
LVAWARP LT++EGLE IIDP+L DVPFDSVAKVAAIASMCVQPEV HRPFM EVVQAL
Sbjct: 976 LVAWARPFLTTKEGLEVIIDPTLATDVPFDSVAKVAAIASMCVQPEVSHRPFMSEVVQAL 1035
Query: 1245 KLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRR 1304
KLV NECDEAKE+ S SSSQ D+SI +D++VS SGQL D L+ V NYD D R
Sbjct: 1036 KLVSNECDEAKELDSRSSSQ-DLSIYMDAEVSAVSGQLRDSLRSQALVHNYDSEPDIERG 1094
Query: 1305 LSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLW 1364
L SY FS+S G++ S RR SSGPL+TGRGR+ +QR+ RL G S SE G +F +W
Sbjct: 1095 LVDSYFFSTSDGCGRQGSGSLRR-CSSGPLKTGRGRELFQRM-RLTGESVSERGTIFKMW 1152
Query: 1365 PGSY 1368
PGS+
Sbjct: 1153 PGSH 1156
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558353|ref|XP_003547471.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1062 bits (2747), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 597/953 (62%), Positives = 693/953 (72%), Gaps = 42/953 (4%)
Query: 433 PVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEP-IAPG 491
PVSQ+P+++P A N ++S P+ G PP Q R A+N + P + P
Sbjct: 323 PVSQAPVAMPPA-------NLPKYSSVSQPTHHGNSPPDVQNRTANNGHSHTPAPEMPPS 375
Query: 492 PFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPS-TPPLSVDGKRVGKPVAEPSYDIPMP 550
PP P+A +IP +P SP P V P+ TP S + + G+PV+ P Y IP P
Sbjct: 376 VTPPSPFPVDPPLAHHVIPAASPPKSPAPVVSPALTPSRSFNWTKGGEPVSAPPYKIPKP 435
Query: 551 -PPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNK 609
P + HSP++APS R +H+P P SSPK P N + P SSP +F KH RN
Sbjct: 436 LPAIVHSPAQAPSCAHKERQFHHAPEPLISSPKSPFNK-DHPPASSPSTTFYKHHYTRNT 494
Query: 610 IAS-SPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVS 665
+ S +PA S+F+SP+TS HQ PPS +PTS +RH+ PPP+N SVSPS + +PV+
Sbjct: 495 VTSPAPASSHFVSPSTSKHQDGSNPPSPLPTSGQRHHAPPPMNTGSSVSPSSLHIQSPVN 554
Query: 666 RVPTSPSPSPTSASGQTELPLLPPKSSPSEP------------IRAFPPPPPNADCSTTI 713
+V +PSP + T++PL PPK SPS P +A PPPPPN DC + +
Sbjct: 555 QVSPAPSPIFNISPHSTKIPLHPPKVSPSRPSSKIPKKPVRPRFQALPPPPPNEDCISVV 614
Query: 714 CTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGA 773
C+EPYT+TPPG+PC CVWPM+VGLRLSV+LYTFFPLVSE A EIA GVFMKQSQVRI+GA
Sbjct: 615 CSEPYTSTPPGAPCKCVWPMKVGLRLSVSLYTFFPLVSEFASEIATGVFMKQSQVRIMGA 674
Query: 774 NAA-EQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGL 832
+AA +QPDKT+V DLVPLGE+FDNTTAFLT +RFWHKQVVIK+SYFGDY VLYV YPGL
Sbjct: 675 DAANQQPDKTIVFIDLVPLGEEFDNTTAFLTSERFWHKQVVIKTSYFGDYVVLYVTYPGL 734
Query: 833 PPSPPSASSSIGIIDDGPYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVA 890
PPSPP SSI IID GPYSG NNGR KP GVD+ KR+ + GLS G+IA++ LS F+
Sbjct: 735 PPSPPLPPSSISIIDGGPYSGGGNNGRTIKPLGVDISKRQHRGGLSKGIIAVIALSVFLV 794
Query: 891 VVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIA 950
V LC AAA + FKY+ H Q P+ L P A ++ G L SAS SF SSIA
Sbjct: 795 VALCFAAA-LASFKYRDHVSQTPSTPRILPPLTKAPGAAGSVVGGG-LASASTSFRSSIA 852
Query: 951 TYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR 1010
YTGSAKT S ++IEKAT NF ASR+LGEGGFGLVYSG+L+DGTKVAVKVLKR D QG R
Sbjct: 853 AYTGSAKTLSMNDIEKATDNFHASRVLGEGGFGLVYSGILEDGTKVAVKVLKREDHQGNR 912
Query: 1011 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 1070
EFL+EVEMLSRLHHRNLVKLIGIC E RCLVYELIPNGSVESHLHG DKE++PL W A
Sbjct: 913 EFLSEVEMLSRLHHRNLVKLIGICAEVSFRCLVYELIPNGSVESHLHGADKENSPLDWSA 972
Query: 1071 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130
RLKIALG+AR LAYLHEDSSP VIHRDFKSSNILLE+DFTPKVSDFGLAR+A DE +RHI
Sbjct: 973 RLKIALGSARGLAYLHEDSSPHVIHRDFKSSNILLENDFTPKVSDFGLARTAADEGNRHI 1032
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1190
STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQENLVAWAR
Sbjct: 1033 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVAWAR 1092
Query: 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250
PLL+S EGLE +IDPSLG DVP DSVAKVAAIASMCVQPEV RPFMGEVVQALKLVCNE
Sbjct: 1093 PLLSSEEGLEAMIDPSLGPDVPSDSVAKVAAIASMCVQPEVSDRPFMGEVVQALKLVCNE 1152
Query: 1251 CDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYL 1310
CDEA+E GS+SSS D QL D LQ +S NYD G+D L S L
Sbjct: 1153 CDEARETGSSSSSVDLSHSR----------QLSDNLQGQFSATNYDSGVDIENGLLASEL 1202
Query: 1311 FSSSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSL 1363
FSSSAR G+ S FRR+S SGPL TGR ++ WQ IR+L GGS SEHG +F L
Sbjct: 1203 FSSSARYGRRVSGSFRRHSYSGPLNTGRSKRLWQIIRKLSGGSVSEHGTMFKL 1255
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297738662|emb|CBI27907.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1038 bits (2685), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 626/1016 (61%), Positives = 700/1016 (68%), Gaps = 138/1016 (13%)
Query: 400 PSNTALTPASHPSNIAPPPLFVPVL-----PSALPGKAPVSQSPISLPDAPAA----TPR 450
PSN ++P P PP L VP+ PSA KAP +++P+ P AP A P
Sbjct: 122 PSNPRMSP---PHYKTPPHLKVPITLPSVPPSASQRKAPDNKAPVWAPVAPIAPVAPVPD 178
Query: 451 GNFHRHSPAI------HPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPV 504
G R P HP MPG LPP A RN + +API+ PIAP
Sbjct: 179 GPPQRKWPQNPPSMHPHPVMPGLLPPSAHNRNKPDNKAPISTPIAP-------------- 224
Query: 505 ARPIIPGGTPTASPDPDVPP-STPPLSVDGKRVGKPVAEPSYDIPMP-PPVNHSPSKAPS 562
DPDV P STPPL+ +R PVA P P P PVNHSP+KAPS
Sbjct: 225 --------------DPDVTPISTPPLASHWRRKQMPVAAPPNRTPDPLSPVNHSPAKAPS 270
Query: 563 THKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIAS-SPAPSYFIS 621
H MRHSN +P S+P+ P N G+ +P SSP SF KH RNKI +PA SY I
Sbjct: 271 IHNAMRHSN-AP-ASLSTPQSPTNKGSQSPASSPSMSFSKHHRGRNKITGPAPASSYLIP 328
Query: 622 PTTSIHQGPVV------PPSFIPTSRKRHYGPPPLN---SVSPSHSPLPTPVSRVPTSPS 672
P + HQGPV+ PP +P + H+ P PLN +SP+HSP P+ ++ +PS
Sbjct: 329 PPSPRHQGPVISPAPSHPPKSLPNRTRTHHAPLPLNPGSRISPAHSPSPSSLTYPSPAPS 388
Query: 673 PSPTSASGQTELPLLPPKSSPSEPIRAFPP---------------PPPNADCSTTICTEP 717
PSPT+ SGQT +P L PK SPS PP PPPN DCS +CTEP
Sbjct: 389 PSPTARSGQTMIPFLSPKISPSR----LPPSSKMPAPPPVQALPPPPPNQDCSAIVCTEP 444
Query: 718 YTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAAE 777
TNTPPGSPCGCV PMQV LRL+VALYTFFPLVSELA EIAAGVFM+QSQVRI+GANAA
Sbjct: 445 NTNTPPGSPCGCVLPMQVQLRLNVALYTFFPLVSELAEEIAAGVFMRQSQVRIMGANAAS 504
Query: 778 -QPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSP 836
+ +KT+VL DLVPLGEKFDNTTAFLTYQRFW KQVVIK+ +FGDYEV+YV YPGLPPSP
Sbjct: 505 PEAEKTIVLIDLVPLGEKFDNTTAFLTYQRFWGKQVVIKNLFFGDYEVIYVNYPGLPPSP 564
Query: 837 PSASSSIGIIDDGPYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLC 894
PSA SSI +ID+GPYSG NNGR P GVDV K R K+GLSG +IAI+VLSA VAVVLC
Sbjct: 565 PSAPSSITMIDNGPYSGQGNNGRTIHPLGVDVHKNRHKHGLSGSVIAIIVLSASVAVVLC 624
Query: 895 SAAAWVLLFKYKSHACQAEEVPQ--SLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATY 952
SA AWV LFK C + VP +L S +P GAAG +VGS SASLSFGSSIATY
Sbjct: 625 SAVAWVFLFKKTD--CIGQPVPTQAALVPSLARPPGAAGSVVGSAPSSASLSFGSSIATY 682
Query: 953 TGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF 1012
TGSAKTFSA++IE+AT NFD SRILGEGGFG VYSGVL+DGTKVAVKVLKR D QGGREF
Sbjct: 683 TGSAKTFSAADIERATDNFDDSRILGEGGFGRVYSGVLEDGTKVAVKVLKRDDHQGGREF 742
Query: 1013 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL 1072
LAEVEMLSRLHHRNLVKLIGIC EE+ RCLVYELIPNGSVESHLHG DKE+APL W AR+
Sbjct: 743 LAEVEMLSRLHHRNLVKLIGICTEERTRCLVYELIPNGSVESHLHGADKETAPLDWGARI 802
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
K+ALGAAR LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR+AMDEE+RHIST
Sbjct: 803 KVALGAARGLAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARTAMDEENRHIST 862
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
RVMGTFGYVAPEYAMTGHLL ENLVAWARPL
Sbjct: 863 RVMGTFGYVAPEYAMTGHLL------------------------------ENLVAWARPL 892
Query: 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252
LTS+EGL+ +ID SLG+DVPFDSVAKVAAIASMCVQPEV HRPFMGEVVQALKLVCNECD
Sbjct: 893 LTSKEGLQTMIDLSLGSDVPFDSVAKVAAIASMCVQPEVSHRPFMGEVVQALKLVCNECD 952
Query: 1253 EAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFS 1312
E KE +GQLPDP H+ V Y GLD LS+S LFS
Sbjct: 953 ETKE----------------------AGQLPDPSHAHFPVSTYGSGLDAETGLSVSELFS 990
Query: 1313 SSARSGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGSY 1368
+SAR G++ S FRRYSSSGPLRTGR R FWQR+RR GGS SEHG +F L PGS+
Sbjct: 991 TSARFGRQPSGSFRRYSSSGPLRTGRARHFWQRMRRNSGGSVSEHGIMFRLRPGSH 1046
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356545725|ref|XP_003541286.1| PREDICTED: uncharacterized protein LOC100816296 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1033 bits (2672), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 707/1406 (50%), Positives = 840/1406 (59%), Gaps = 179/1406 (12%)
Query: 1 MGLVMPVILQLVKLCVIGFAFTVQGSAGYGIPPSPAIIGGHFLLPRLP-VTFTLKP--HL 57
MG+V+ ++LQL C+I FA T Q G I PSPA LP +P TL P H
Sbjct: 1 MGVVLALMLQL---CIIAFAVTAQEFKGSIISPSPA------FLPVVPPGEETLGPIYHG 51
Query: 58 LGGHAPSPIELPTHS-----APPPVNIPSF-SPSTPAVSAPFDMAPPPSLIPTNPVASPP 111
G AP+ LP+ +P P N+ + SPS+PAV P P PP
Sbjct: 52 EGSKAPN---LPSDGDGFVISPSPANLHVYHSPSSPAV-------------PNGPFYKPP 95
Query: 112 SITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPA 171
PP TAP SP K P+
Sbjct: 96 KTF---------------------PPSTTAP------------------SPQKIKDIEPS 116
Query: 172 SPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
PS PS A P P P P++ N P KT+P P T PP
Sbjct: 117 KSPS---------PSTIALSP---PYAVVPLPSAVQGNKPPPVKTSPPQREAP--TVRPP 162
Query: 232 ASLPSKTAPPPASHLSNTAPPPASHPYKTSPL--PASHPSKTAPPPASHPSNTAPPPASH 289
S P TAP P + S+ +P K SP+ P H T + +N+ +
Sbjct: 163 FSTP--TAPAPVAISSDRSP-------KISPVSQPIEHGHLTPDVDNRNANNSHLAESFS 213
Query: 290 PSKTAPPPASHPSNTAPPPASHPSN--TAPPPASHPSNTAPPPASHPSNTAPPPASHSSK 347
P+ A P A+ P N++ AS P+ T PP + P S P P + +
Sbjct: 214 PAPGAVPSANLPKNSS---ASQPTENGTFPPKEGTNNGHGLEPIS------PAPVAVNLP 264
Query: 348 TAPPPASHPSNTALPPASHPSNPA----IPPASHPSNTAIPPASHP--SNTAPPHASHPS 401
P + P + +LPP H N + P S P++ AIPP ++ S + P H S
Sbjct: 265 KESPVSQPPEHASLPPIVHQRNANMGHNLKPVS-PASVAIPPTTYKITSMDSEPTTQHGS 323
Query: 402 NTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIH 461
+ P H N + G + SP P A+P P H
Sbjct: 324 ---IPPNVHKRN-------------SNKGHTSETVSP-----EPVASPPWKVENSPPETH 362
Query: 462 PSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPD 521
P +P P S AP+ P P FP K P+ PI+P +P+ P P
Sbjct: 363 PIVPTITP--------STLTAPVTSP--PSAFP-----LKPPLVHPIVPVASPSKLPAPV 407
Query: 522 VPPSTPPLSVDGKRVGKPVAEPSYDIPMP-PPVNHSPSKAPSTHKYMRHSNHSPLPPFSS 580
P TP S + K+ G PV P P P P V HSP++AP K R +H+P P SS
Sbjct: 408 SSP-TPLRSFNWKKGGAPVVAPLSRNPKPLPAVIHSPAQAPVAQK-ARQLHHAPEPLISS 465
Query: 581 PKPPQNNGNDTPVSSPLASFPKHRDVRNKIAS-SPAPSYFISPTTSIHQGPVVPPSFIPT 639
PK N P SP +SF KH R I S SPA S +SP TS HQ +PP P
Sbjct: 466 PKSSSNKEYHYPPLSPTSSFYKHPHTREIIGSPSPASSSMVSPPTSKHQEAAIPPLLPPR 525
Query: 640 SRKRHYGPPPLNSVSPSHSP---LPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEP 696
S +RH+ PP+NS S + + +V +PSPS AS T + PPK +PSE
Sbjct: 526 SGQRHHVSPPINSSSSVSPFSSPIHSNTGQVSPAPSPSIKFASHPTGSTIFPPKVAPSES 585
Query: 697 IRAFPP------------PPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALY 744
P PPPN DC +T+CTEPYTN+PPG PC CVWPM+VGLRLSV+LY
Sbjct: 586 SSKRPKMPLLPQVQVLPPPPPNEDCISTVCTEPYTNSPPGEPCRCVWPMRVGLRLSVSLY 645
Query: 745 TFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLT 803
TFFPLVSELA EIA GVFMKQSQVRI+GANAA +QP+KTVVL DLVPLGE+FDNTTAF T
Sbjct: 646 TFFPLVSELASEIATGVFMKQSQVRIMGANAADQQPEKTVVLIDLVPLGEEFDNTTAFFT 705
Query: 804 YQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYS--GNNGRATKP 861
RFWHK V+IK+ YFGDY+VLYV YPGLPPSPP SS+ + + GPYS GNNGR KP
Sbjct: 706 SDRFWHKMVIIKAFYFGDYDVLYVSYPGLPPSPPLPPSSLNMFNGGPYSTDGNNGRTIKP 765
Query: 862 EGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQT 921
GVD+ KR+QK GLS G+I+ + +S +AVVLC+AAAWV+ FK++ H Q+ P+ L
Sbjct: 766 IGVDILKRQQKVGLSRGIISTIAVSVSLAVVLCAAAAWVM-FKFRDHVSQSASTPRQLSP 824
Query: 922 -SHVKPSGAAGLM--VGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILG 978
S K G AG + G+G+ S S SF SSIA YTGSAKTFS ++I+KAT +F ASRILG
Sbjct: 825 PSLTKEPGTAGSLRGAGAGVGSVSTSFRSSIAAYTGSAKTFSTNDIKKATDDFHASRILG 884
Query: 979 EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 1038
EGGFGLVYSG+L+DGTKVAVKVLKR D G REFLAEVEMLSRLHHRNLVKLIGICIE
Sbjct: 885 EGGFGLVYSGILEDGTKVAVKVLKREDHHGDREFLAEVEMLSRLHHRNLVKLIGICIENS 944
Query: 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1098
R LVYEL+PNGSVES+LHGVD+ ++PL W AR+KIALGAAR LAYLHEDSSPRVIHRDF
Sbjct: 945 FRSLVYELVPNGSVESYLHGVDRGNSPLDWGARMKIALGAARGLAYLHEDSSPRVIHRDF 1004
Query: 1099 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVY 1158
KSSNILLE DFTPKVSDFGLAR+A DEE++HISTRVMGTFGYVAPEYAMTGHLLVKSDVY
Sbjct: 1005 KSSNILLEDDFTPKVSDFGLARTATDEENKHISTRVMGTFGYVAPEYAMTGHLLVKSDVY 1064
Query: 1159 SYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 1218
SYGVV+LELL+GRKPVDM+Q PGQENLVAWARPLLTS+EG E +ID SLG DVPFDSVAK
Sbjct: 1065 SYGVVLLELLTGRKPVDMSQAPGQENLVAWARPLLTSKEGCEAMIDQSLGTDVPFDSVAK 1124
Query: 1219 VAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEV-GSASSSQDDMSIDLDSKVST 1277
VAAIASMCVQPEV +RPFM EVVQALKLVC+ECDEAKE GS+S S +D+S+DL +ST
Sbjct: 1125 VAAIASMCVQPEVSNRPFMSEVVQALKLVCSECDEAKEESGSSSFSLEDLSVDLALGIST 1184
Query: 1278 GSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTG 1337
SGQL D Q S N+D G+D R L+ S +FSSSAR G+ ES FRR S SGPLRTG
Sbjct: 1185 VSGQLSDNFQSQLSGTNFDSGVDIERGLAASEIFSSSARFGRAESGSFRRNSYSGPLRTG 1244
Query: 1338 RGRQFWQRIRRLVGGSDSEHGAVFSL 1363
R RQ WQ IR L GS SEHG + L
Sbjct: 1245 RSRQLWQIIRSLSSGSVSEHGTMLKL 1270
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436078|ref|XP_004135821.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] gi|449489947|ref|XP_004158466.1| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1029 bits (2660), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 570/929 (61%), Positives = 665/929 (71%), Gaps = 59/929 (6%)
Query: 473 QKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP--PLS 530
++ N S+ AP EPI+P P + SPV+ P+ P P+ P+P++ P+ P +
Sbjct: 146 EQTNTSSNVAPTPEPISPASKLP----KDSPVSHPVFPVRPPSILPEPNISPAIAISPKA 201
Query: 531 VDGKRVGKPVAEPSYDIP-MPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGN 589
D KR+ P A P +P PVNHS +APS+H + R + LPP K P + N
Sbjct: 202 GDKKRLEAPAATPYNTLPKYMSPVNHSSEEAPSSHNHSRDTQPPILPP---QKAPFHRVN 258
Query: 590 DTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRH----- 644
+P S PL S KH +N I+ +PAPSY IS T+ GPV+ + R+ H
Sbjct: 259 LSPTSPPLPSNYKHHRSKNHISHAPAPSYPISSHTTKAPGPVISTAQHSPGRRHHSPPPK 318
Query: 645 ----------YGPPPLNSVSPSHSPLPTPVSRVPTSPSPSP-TSASGQTELPLLPPKSSP 693
Y PPPL V SPSPSP SG T PPK+SP
Sbjct: 319 SEPSPISPLHYAPPPL---------------VVHVSPSPSPHQKISGHTRRHFYPPKASP 363
Query: 694 SEP---------IRAFPPPPPNADCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALY 744
S+P I PPPPPN DC TT C EPYTNTPPGSPCGCVWPMQ+GLRLSV+LY
Sbjct: 364 SKPSAKSPKMSPIHTLPPPPPNEDCLTTQCIEPYTNTPPGSPCGCVWPMQIGLRLSVSLY 423
Query: 745 TFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLVPLGEKFDNTTAFLT 803
TFFPLVSELA EIA GVF+KQSQVRIIGANAA +QPDKTV+L DLVPLGEKFDNTTAFLT
Sbjct: 424 TFFPLVSELAAEIAVGVFVKQSQVRIIGANAANQQPDKTVILIDLVPLGEKFDNTTAFLT 483
Query: 804 YQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPY--SGNNGRATKP 861
YQRFWHK+V IK+SYFG+YEVLYVRYPGLP SPPS S I ++ PY + N+ RA KP
Sbjct: 484 YQRFWHKKVSIKASYFGNYEVLYVRYPGLPQSPPSGDSGI---ENEPYFSNSNDARAVKP 540
Query: 862 EGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQT 921
GVDV R+ K LSGG+IAIV LS VAVVLC A AW+LLFK CQ + P +
Sbjct: 541 IGVDVQNRQHKNKLSGGIIAIVALSTTVAVVLCVATAWILLFKRNDGLCQPKPTPHVSLS 600
Query: 922 SHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGG 981
S KPSGA G ++ + SASLS GSSIA Y+GSAKTFSA +IE+AT NFD SRILGEGG
Sbjct: 601 SLNKPSGAGGSVMATMPSSASLSIGSSIAPYSGSAKTFSAPDIERATNNFDPSRILGEGG 660
Query: 982 FGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041
FG VY G+L+DGT+VAVKVLKR D QGGREFLAEVEMLSRLHHRNLVKLIGIC EE++R
Sbjct: 661 FGRVYRGILEDGTEVAVKVLKRDDLQGGREFLAEVEMLSRLHHRNLVKLIGICTEERSRS 720
Query: 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSS 1101
LVYELIPNGSVESHLHGVDKE+APL W++R+KIALGAAR L+YLHEDSSPRVIHRDFKSS
Sbjct: 721 LVYELIPNGSVESHLHGVDKETAPLDWESRVKIALGAARGLSYLHEDSSPRVIHRDFKSS 780
Query: 1102 NILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG 1161
NILLEHDFTPKVSDFGLAR+AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG
Sbjct: 781 NILLEHDFTPKVSDFGLARTAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYG 840
Query: 1162 VVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 1221
VV+LELL+GRKPVDM+QPPG+ENLV+WARPLLTS+EGL+ IID S+ ++VPF+++AKVAA
Sbjct: 841 VVLLELLTGRKPVDMSQPPGEENLVSWARPLLTSKEGLDVIIDKSIDSNVPFENIAKVAA 900
Query: 1222 IASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGS-ASSSQDDMSIDLDSKVSTGSG 1280
IASMCVQPEV HRPFMGEVVQALKLVCN+C+ +E S A SS + +ID + ++ S
Sbjct: 901 IASMCVQPEVSHRPFMGEVVQALKLVCNQCNTTRETSSHAGSSPESSTIDTNDDEASSSR 960
Query: 1281 QLPDPLQRHYSVPNYDLGLDT-GRRLSLSYLFSSSARSGKEESELFRRYSSSGPLRTGRG 1339
+ D Y VPN GLD+ LS+S L ++S +GK+ES R SS P R G+G
Sbjct: 961 YMLDSFHSEYLVPNSFPGLDSIDTHLSISDLLNTSIGNGKQESRSLERCFSSSPHRIGKG 1020
Query: 1340 -RQFWQRIRRLVGGSDSEHGAVFSLWPGS 1367
R FW+R+RR G S SEHG W GS
Sbjct: 1021 KRNFWERMRRYSGNSISEHGMPTKTWSGS 1049
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359482516|ref|XP_002275886.2| PREDICTED: receptor-like serine/threonine-protein kinase ALE2-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 977 bits (2525), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 523/828 (63%), Positives = 612/828 (73%), Gaps = 38/828 (4%)
Query: 562 STHKYMRHSNHSPLPPFSSPKPPQNNGNDTPV----SSPLASFPKHRDVRNKIA-SSPAP 616
ST KY S SP PPQ+ V SSP SF +H RNK S+PAP
Sbjct: 61 STLKYAFFSWCSP------SSPPQSEAAKKHVHGSASSPTTSFYRHHHARNKFRNSAPAP 114
Query: 617 SYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNS------------VSPSHSPLPTPV 664
S+ +SP QGP V P +G P ++ H+ + V
Sbjct: 115 SHLLSPHPYSQQGPSVSSFHSPVPSSTSWGSPSPAPSPAPLSRQINMIINKYHAVIMFCV 174
Query: 665 SRVPTSP-SPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTPP 723
+V P + +P +S L K+ P + PPPPPN DC++ CTEP T TPP
Sbjct: 175 CKVHFHPPAVAPLGSS------LKNMKTPPPPLVWTLPPPPPNEDCASLTCTEPLTYTPP 228
Query: 724 GSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKT 782
GSPCGCVWP+QV LRLSVALYTFFPLVSELA EIAAGV + SQVRI+GANAA +Q DKT
Sbjct: 229 GSPCGCVWPIQVKLRLSVALYTFFPLVSELADEIAAGVSLNHSQVRIMGANAANQQLDKT 288
Query: 783 VVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSS 842
++L DLVPLGEKF++TTAF Y++FW K+ IK+S +G YE LYVRYPGLPPSPPS+ S+
Sbjct: 289 IILIDLVPLGEKFNHTTAFSIYEKFWLKKFFIKTSLYGGYEALYVRYPGLPPSPPSSISN 348
Query: 843 IGIIDDGPYSG--NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWV 900
I DDG YSG NNGR KP GVDVP++ QK+GL G MI ++VLS+ V+C A AWV
Sbjct: 349 I---DDGSYSGHGNNGRVMKPLGVDVPQK-QKHGLGGSMITVIVLSSVTGFVICIAVAWV 404
Query: 901 LLFKYKSHACQAEEVPQSLQTSHVKPSGAAG-LMVGSGLDSASLSFGSSIATYTGSAKTF 959
L+ K + H QAE++P SL +S KPSGAAG +M+GS S S+SF S + TYTGSAKTF
Sbjct: 405 LVLKCRGHVHQAEDIPHSLISSFAKPSGAAGSMMLGSRTSSTSVSFSSGVVTYTGSAKTF 464
Query: 960 SASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEML 1019
S ++IE+AT NFDASR+LGEGGFGLVY G+LDDG +VAVKVLKR DQQGGREFLAEVEML
Sbjct: 465 SLNDIERATDNFDASRVLGEGGFGLVYRGILDDGVEVAVKVLKRDDQQGGREFLAEVEML 524
Query: 1020 SRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
SRLHHRNLVKLIGIC EE RCLVYEL+PNGSVESHLHGVDKE++PL W AR+KIALGAA
Sbjct: 525 SRLHHRNLVKLIGICTEEHTRCLVYELVPNGSVESHLHGVDKEASPLDWGARMKIALGAA 584
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
R LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR+A+DE ++HISTRVMGTFG
Sbjct: 585 RGLAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARTALDEGNKHISTRVMGTFG 644
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199
Y+APEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVD++QPPGQENLVAWARPLLT++EGL
Sbjct: 645 YLAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDLSQPPGQENLVAWARPLLTTKEGL 704
Query: 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGS 1259
E IIDP+L + PFDS AKVAAIASMCVQPEV HRPFMGEVVQALKLVC+E DE K++ S
Sbjct: 705 ETIIDPALKSSSPFDSAAKVAAIASMCVQPEVSHRPFMGEVVQALKLVCSEYDETKDLAS 764
Query: 1260 ASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSSARSGK 1319
S SQ+++SID+ K S G+L + Q H+ V +D DT LS+S L S+S
Sbjct: 765 KSFSQENLSIDVIRKSSRVLGELLEVSQVHHPVAGHDSSFDTKMALSVSDLVSTSMGFEG 824
Query: 1320 EESELFRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHGAVFSLWPGS 1367
++S FRRYSSSGPL TGR R+FWQR+RR GGS SEHG F LWP S
Sbjct: 825 QDSGSFRRYSSSGPLSTGRRREFWQRLRRSSGGSASEHGFSFKLWPRS 872
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 1368 | ||||||
| TAIR|locus:504954886 | 1113 | AT5G56890 [Arabidopsis thalian | 0.759 | 0.933 | 0.499 | 3.3e-250 | |
| TAIR|locus:2038992 | 744 | ALE2 "Abnormal Leaf Shape 2" [ | 0.459 | 0.844 | 0.523 | 6.6e-162 | |
| TAIR|locus:2026925 | 708 | PERK9 "proline-rich extensin-l | 0.319 | 0.617 | 0.429 | 5e-119 | |
| TAIR|locus:2028756 | 762 | PERK10 "proline-rich extensin- | 0.299 | 0.538 | 0.429 | 4.4e-114 | |
| TAIR|locus:2159873 | 681 | PERK8 "proline-rich extensin-l | 0.278 | 0.559 | 0.446 | 1.1e-109 | |
| TAIR|locus:2028911 | 720 | PERK12 "proline-rich extensin- | 0.288 | 0.547 | 0.430 | 9.2e-105 | |
| TAIR|locus:2125692 | 731 | PERK14 "proline-rich extensin- | 0.225 | 0.422 | 0.481 | 1.7e-104 | |
| TAIR|locus:2132168 | 725 | AT4G02010 [Arabidopsis thalian | 0.256 | 0.484 | 0.540 | 6.3e-104 | |
| TAIR|locus:2091722 | 652 | PERK1 "proline-rich extensin-l | 0.210 | 0.441 | 0.513 | 5.6e-101 | |
| TAIR|locus:2026846 | 710 | PERK13 "proline-rich extensin- | 0.259 | 0.5 | 0.452 | 1.1e-99 |
| TAIR|locus:504954886 AT5G56890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2358 (835.1 bits), Expect = 3.3e-250, Sum P(2) = 3.3e-250
Identities = 556/1114 (49%), Positives = 662/1114 (59%)
Query: 280 SNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 339
S + PP+ P +T+ PSN+ P SH S+ PP + + PP A AP
Sbjct: 29 SPLSSPPSPLP-ETSKGFGQAPSNS---PESHKSDNVPPSKASSQPSLPPLADL---AAP 81
Query: 340 PPASHSSKTAPP--PASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
PP+ AP P N A PA+ P +P AS P I P + P P A
Sbjct: 82 PPSDSVGGKAPAGVPVVFVPN-APAPATIPVKD-LPVASPPVLQPITPIASPPRFIPGDA 139
Query: 398 SH--PSNTALTPASHPSNIAP-PPLFVPVLPSALPGKAPVSQS-------PISLPDAPAA 447
P + +TPA S ++ PP+ LP P P + PI AP A
Sbjct: 140 PKEPPFSGRVTPAPVSSPVSDIPPIPSVALPPPTPSNVPPRNASNNHKPPPIEKSIAPVA 199
Query: 448 TPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNRXXXXXXXXXXXXXXXXNSRQKSPVARP 507
+P P I + P+ PV K S+ + R+ P P
Sbjct: 200 SP--------PTISIDIAPPVHPVIPKLTPSS------SPVPTSTPTKGSPRRNPPTTHP 245
Query: 508 IIP-GGXXXXXXXXXXXXXXXXXXXXGKRVGKPVAEPSYDIPMPPPV-NHS---PSKAPS 562
+ P G P A P+ + P PV H PS APS
Sbjct: 246 VFPIESPAVSPDHAANPVKHPPPSDNGDDSKSPGAAPANETAKPLPVFPHKASPPSIAPS 305
Query: 563 THKYMRHSNHXXXXXXXXXXXXQNNGNDTPVSS---PLASFPKHRDVRNKIASSPAPS-- 617
K+ RHS+H +N + P S PL+S +H R KIA SPAPS
Sbjct: 306 APKFNRHSHHTSPSTTPPPDSTPSNVHHHPSSPSPPPLSSHHQHHQERKKIADSPAPSPL 365
Query: 618 --YFISPTTSIHQGPVVPPSFIPTSRKRHYGP-PPL--NSVSPSHXXXXXXXXXXXXXXX 672
+ ISP S +G + PP P S H+ P PP+ + +SP+H
Sbjct: 366 PPHLISPKKSNRKGSMTPP---PQS---HHAPSPPIPDSLISPAHAPVSFSMKRISPALA 419
Query: 673 XXXXXXXGQTXXXXXXXXXXXXXX--IRAFXXXXXNADCSTTICTEPYTNTPPGSPCGCV 730
++AF N+DCS+TIC EPYTNTPPGSPCGCV
Sbjct: 420 PSPTQVFPLRSSSRPSKSRKFPLGPPLQAFPPPPPNSDCSSTICLEPYTNTPPGSPCGCV 479
Query: 731 WPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQVRIIGANAA-EQPDKTVVLTDLV 789
WP+QV LRLS+ALY FFP+VSE A EI+AGVFMKQSQVRI+GANAA EQP+K++VL DLV
Sbjct: 480 WPIQVELRLSMALYDFFPMVSEFAREISAGVFMKQSQVRIMGANAASEQPEKSIVLIDLV 539
Query: 790 PLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRXXXXXXXXXXXXXXXXXXXXX 849
PLG+KFDN TA LTYQRFW K+V I FG Y+V+YVR
Sbjct: 540 PLGDKFDNMTAMLTYQRFWSKKVYIDEPIFGGYDVIYVRYPGLPASPPTSGMTIIDQGPY 599
Query: 850 XXXXNNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFK-YKSH 908
NNGRA KP GVDVP++ +K L+GG IA++VLSA + LC W L+F+ +
Sbjct: 600 SGN-NNGRAVKPLGVDVPRKPRKKELNGGSIAVIVLSAAAFIGLCFVIVWFLVFRRQRDR 658
Query: 909 ACQAEEVPQSLQT--SHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEK 966
++ P + + S KPSG+A + GS S SLSF SSIA +T SAKTF+ASEI K
Sbjct: 659 RRLSKRTPLARPSLPSLSKPSGSARSLTGSRFSSTSLSFESSIAPFTLSAKTFTASEIMK 718
Query: 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 1026
AT NFD SR+LGEGGFG VY GV DDGTKVAVKVLKR DQQG REFLAEVEMLSRLHHRN
Sbjct: 719 ATNNFDESRVLGEGGFGRVYEGVFDDGTKVAVKVLKRDDQQGSREFLAEVEMLSRLHHRN 778
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
LV LIGICIE++ R LVYELIPNGSVESHLHG+DK S+PL WDARLKIALGAAR LAYLH
Sbjct: 779 LVNLIGICIEDRNRSLVYELIPNGSVESHLHGIDKASSPLDWDARLKIALGAARGLAYLH 838
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEY 1145
EDSSPRVIHRDFKSSNILLE+DFTPKVSDFGLAR+A+D+E +RHISTRVMGTFGYVAPEY
Sbjct: 839 EDSSPRVIHRDFKSSNILLENDFTPKVSDFGLARNALDDEDNRHISTRVMGTFGYVAPEY 898
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
AMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QPPGQENLV+W RP LTS EGL IID
Sbjct: 899 AMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQPPGQENLVSWTRPFLTSAEGLAAIIDQ 958
Query: 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASS-SQ 1264
SLG ++ FDS+AKVAAIASMCVQPEV HRPFMGEVVQALKLV NECDEAKE+ S +S S+
Sbjct: 959 SLGPEISFDSIAKVAAIASMCVQPEVSHRPFMGEVVQALKLVSNECDEAKELNSLTSISK 1018
Query: 1265 DDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGXXXXXXXXXXXXXXXGKEESEL 1324
DD D ++ S G + R+ +PNYD DT G+
Sbjct: 1019 DDFRDDTQAESSCGDSSAR--MARYPLLPNYDSEPDT---ERGLSTSEMYTGSGR----- 1068
Query: 1325 FRRYSSSGPLRTGRGRQFWQRIRRLVGGSDSEHG 1358
F R S+SGPL +GRG+ FWQ++RRL GS SEHG
Sbjct: 1069 FERQSNSGPLTSGRGKSFWQKMRRLSTGSLSEHG 1102
|
|
| TAIR|locus:2038992 ALE2 "Abnormal Leaf Shape 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1544 (548.6 bits), Expect = 6.6e-162, Sum P(2) = 6.6e-162
Identities = 354/676 (52%), Positives = 434/676 (64%)
Query: 708 DCSTTICTEPYTNTPPGSPCGCVWPMQVGLRLSVALYTFFPLVSELAGEIAAGVFMKQSQ 767
DC T C EP T+TP GSPCGCV+PM+V L LSVA ++ FP+ +EL E+AAG +++QSQ
Sbjct: 97 DCQQT-CVEPLTSTPFGSPCGCVFPMKVQLLLSVAPFSIFPVTNELEIEVAAGTYLEQSQ 155
Query: 768 VRIIGANA-AEQPDKTVVLTDLVPLGEKFDNTTAFLTYQRFWHKQVVIKSSYFGDYEVLY 826
V+I+GA+A +E KTVV +LVPLGEKFDNTTA L YQRF HK+V + + FGDYEV +
Sbjct: 156 VKIMGASADSENQGKTVVDINLVPLGEKFDNTTATLIYQRFRHKKVPLNETVFGDYEVTH 215
Query: 827 VRXXXXXXXXXXXXXXXXXXXXXXXXXNNGRAT--KPEGVDVPKRRQKY-----GLSGGM 879
+ NG T P G+ +P + G+
Sbjct: 216 I-----------------SYPGIPSSSPNGDVTGDAPGGLPIPINATTFANKSQGIGFRT 258
Query: 880 IAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLD 939
IAI+ LS FV +++ A +++ K+K + V +L S K GA + S
Sbjct: 259 IAIIALSGFVLILVLVGAISIIV-KWKKIGKSSNAVGPALAPSINKRPGAGSMFSSSARS 317
Query: 940 SASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVK 999
S S S SS+AT S KTF+ SE+EKAT F A R+LGEGGFG VY G ++DGT+VAVK
Sbjct: 318 SGSDSLMSSMATCALSVKTFTLSELEKATDRFSAKRVLGEGGFGRVYQGSMEDGTEVAVK 377
Query: 1000 VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV 1059
+L R +Q REF+AEVEMLSRLHHRNLVKLIGICIE + RCL+YEL+ NGSVESHLH
Sbjct: 378 LLTRDNQNRDREFIAEVEMLSRLHHRNLVKLIGICIEGRTRCLIYELVHNGSVESHLH-- 435
Query: 1060 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119
L WDARLKIALGAAR LAYLHEDS+PRVIHRDFK+SN+LLE DFTPKVSDFGLA
Sbjct: 436 ---EGTLDWDARLKIALGAARGLAYLHEDSNPRVIHRDFKASNVLLEDDFTPKVSDFGLA 492
Query: 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1179
R A E S+HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GR+PVDM+QP
Sbjct: 493 REAT-EGSQHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRRPVDMSQP 551
Query: 1180 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1239
G+ENLV WARPLL +REGLE+++DP+L FD +AKVAAIASMCV EV HRPFMGE
Sbjct: 552 SGEENLVTWARPLLANREGLEQLVDPALAGTYNFDDMAKVAAIASMCVHQEVSHRPFMGE 611
Query: 1240 VVQALKLVCNECDEA-KEVGSASSSQDDMSIDL--DSKVSTGSGQLPDPLQRHYSVPNY- 1295
VVQALKL+ N+ DE + S S S D D S S P R+ ++
Sbjct: 612 VVQALKLIYNDADETCGDYCSQKDSSVPDSADFKGDLAPSDSSWWNLTPRLRYGQASSFI 671
Query: 1296 DLGLDTGXXXXXXXXXXXXXXXGKEESELFRRYSSSGPLRTGRGRQFWQRIRRLV---GG 1352
+ +G + + + SGPLR R R+ + R+R + GG
Sbjct: 672 TMDYSSGPLEDMENRPHSASSIPRVGGLILP--NRSGPLRPMRSRRNFFRLRGSMSEHGG 729
Query: 1353 -SDSEHGAVFSLWPGS 1367
S S H LW G+
Sbjct: 730 PSSSRH-----LWSGN 740
|
|
| TAIR|locus:2026925 PERK9 "proline-rich extensin-like receptor kinase 9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 826 (295.8 bits), Expect = 5.0e-119, Sum P(3) = 5.0e-119
Identities = 195/454 (42%), Positives = 259/454 (57%)
Query: 855 NGRATKPEGVDVPKRRQKYGL-SGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKS-HACQA 912
N +P +D P G+ +G ++ I V A V L W L + K A
Sbjct: 257 NNPTLRPP-LDAPNSTNNSGIGTGAVVGISVAVALVVFTLFGIFVWCLRKREKRLSAVSG 315
Query: 913 EEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGS--SIATYTGSAKT-FSASEIEKATG 969
+V S +S + A M S AS GS S + G++K FS E+ KAT
Sbjct: 316 GDVTPSPMSSTARSDSAFFRMQSSAPVGASKRSGSYQSQSGGLGNSKALFSYEELVKATN 375
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
F +LGEGGFG VY G+L DG VAVK LK QG REF AEVE LSR+HHR+LV
Sbjct: 376 GFSQENLLGEGGFGCVYKGILPDGRVVAVKQLKIGGGQGDREFKAEVETLSRIHHRHLVS 435
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
++G CI R L+Y+ + N + HLHG E + L W R+KIA GAAR LAYLHED
Sbjct: 436 IVGHCISGDRRLLIYDYVSNNDLYFHLHG---EKSVLDWATRVKIAAGAARGLAYLHEDC 492
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
PR+IHRD KSSNILLE +F +VSDFGLAR A+D + HI+TRV+GTFGY+APEYA +G
Sbjct: 493 HPRIIHRDIKSSNILLEDNFDARVSDFGLARLALDCNT-HITTRVIGTFGYMAPEYASSG 551
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT---SREGLERIIDPS 1206
L KSDV+S+GVV+LEL++GRKPVD +QP G E+LV WARPL++ E + + DP
Sbjct: 552 KLTEKSDVFSFGVVLLELITGRKPVDTSQPLGDESLVEWARPLISHAIETEEFDSLADPK 611
Query: 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK-LVCNECDEAKEVGSA---SS 1262
LG + + ++ A CV+ RP MG++V+A + L + +G + +S
Sbjct: 612 LGGNYVESEMFRMIEAAGACVRHLATKRPRMGQIVRAFESLAAEDLTNGMRLGESEVFNS 671
Query: 1263 SQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYD 1296
+Q I L +++ GS H S + D
Sbjct: 672 AQQSAEIRLFRRMAFGSQNYSTDFFSHSSYNSRD 705
|
|
| TAIR|locus:2028756 PERK10 "proline-rich extensin-like receptor kinase 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 770 (276.1 bits), Expect = 4.4e-114, Sum P(3) = 4.4e-114
Identities = 184/428 (42%), Positives = 249/428 (58%)
Query: 874 GLSGGMIAIVVLSAFVAVVLCSAAAWVLLFK----YKSHACQAEEVPQSLQTSHVKPSGA 929
G+S G +A+V+L+ VV C L Y P+S ++ +K +
Sbjct: 332 GVSIG-VALVLLTLIGVVVCCLKKRKKRLSTIGGGYVMPTPMESSSPRS-DSALLKTQSS 389
Query: 930 AGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV 989
A L VG+ + + S + S + FS E+ AT F +LGEGGFG VY GV
Sbjct: 390 APL-VGNRSSNRTYLSQSEPGGFGQSRELFSYEELVIATNGFSDENLLGEGGFGRVYKGV 448
Query: 990 LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049
L D VAVK LK QG REF AEV+ +SR+HHRNL+ ++G CI E R L+Y+ +PN
Sbjct: 449 LPDERVVAVKQLKIGGGQGDREFKAEVDTISRVHHRNLLSMVGYCISENRRLLIYDYVPN 508
Query: 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1109
++ HLH L W R+KIA GAAR LAYLHED PR+IHRD KSSNILLE++F
Sbjct: 509 NNLYFHLHAAGTPG--LDWATRVKIAAGAARGLAYLHEDCHPRIIHRDIKSSNILLENNF 566
Query: 1110 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
VSDFGLA+ A+D + HI+TRVMGTFGY+APEYA +G L KSDV+S+GVV+LEL++
Sbjct: 567 HALVSDFGLAKLALDCNT-HITTRVMGTFGYMAPEYASSGKLTEKSDVFSFGVVLLELIT 625
Query: 1170 GRKPVDMTQPPGQENLVAWARPLL---TSREGLERIIDPSLGNDVPFDSVAKVAAIASMC 1226
GRKPVD +QP G E+LV WARPLL T E + DP LG + + ++ A+ C
Sbjct: 626 GRKPVDASQPLGDESLVEWARPLLSNATETEEFTALADPKLGRNYVGVEMFRMIEAAAAC 685
Query: 1227 VQPEVQHRPFMGEVVQALKLVCNE-CDEAKEVGSA---SSSQDDMSIDLDSKVSTGSGQL 1282
++ RP M ++V+A + E +G + +S+Q I L +++ GS
Sbjct: 686 IRHSATKRPRMSQIVRAFDSLAEEDLTNGMRLGESEIINSAQQSAEIRLFRRMAFGSQNY 745
Query: 1283 P-DPLQRH 1289
D L R+
Sbjct: 746 STDSLTRN 753
|
|
| TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 787 (282.1 bits), Expect = 1.1e-109, Sum P(3) = 1.1e-109
Identities = 182/408 (44%), Positives = 249/408 (61%)
Query: 854 NNGRATKPEGVDVPKRRQKYGLSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSH--ACQ 911
NNG T P P + + G +GG++AI V+ V + L W + +
Sbjct: 217 NNGNNTLPSSS--PGKSE-VG-TGGIVAIGVIVGLVFLSLFVMGVWFTRKRKRKDPGTFV 272
Query: 912 AEEVPQSLQTSHVKPSGAAGLMVGSG------LDSASLS---FGSSIATYTGSAKT-FSA 961
+P S +S P G+ ++ S + S S S + SS + + ++ FS
Sbjct: 273 GYTMPPSAYSS---PQGSDVVLFNSRSSAPPKMRSHSGSDYMYASSDSGMVSNQRSWFSY 329
Query: 962 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 1021
E+ + T F +LGEGGFG VY GVL DG +VAVK LK QG REF AEVE++SR
Sbjct: 330 DELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGEREFKAEVEIISR 389
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+HHR+LV L+G CI EQ R LVY+ +PN ++ HLH + + W+ R+++A GAAR
Sbjct: 390 VHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAPGRPV--MTWETRVRVAAGAARG 447
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGY 1140
+AYLHED PR+IHRD KSSNILL++ F V+DFGLA+ A + + + H+STRVMGTFGY
Sbjct: 448 IAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHVSTRVMGTFGY 507
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL---TSRE 1197
+APEYA +G L K+DVYSYGV++LEL++GRKPVD +QP G E+LV WARPLL E
Sbjct: 508 MAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWARPLLGQAIENE 567
Query: 1198 GLERIIDPSLG-NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
+ ++DP LG N +P + V A A+ CV+ RP M +VV+AL
Sbjct: 568 EFDELVDPRLGKNFIPGEMFRMVEAAAA-CVRHSAAKRPKMSQVVRAL 614
|
|
| TAIR|locus:2028911 PERK12 "proline-rich extensin-like receptor kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 752 (269.8 bits), Expect = 9.2e-105, Sum P(2) = 9.2e-105
Identities = 181/420 (43%), Positives = 242/420 (57%)
Query: 917 QSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKT-FSASEIEKATGNFDASR 975
Q Q+S G AG G S G+ + GS +T FS E+ + T F
Sbjct: 319 QQQQSSMGNSYGTAG---GGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKN 375
Query: 976 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
ILGEGGFG VY G L DG VAVK LK QG REF AEVE++SR+HHR+LV L+G CI
Sbjct: 376 ILGEGGFGCVYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCI 435
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
+Q R L+YE + N ++E HLHG K L W R++IA+G+A+ LAYLHED P++IH
Sbjct: 436 SDQHRLLIYEYVSNQTLEHHLHG--KGLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIH 493
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1155
RD KS+NILL+ ++ +V+DFGLAR D H+STRVMGTFGY+APEYA +G L +S
Sbjct: 494 RDIKSANILLDDEYEAQVADFGLAR-LNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRS 552
Query: 1156 DVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REG-LERIIDPSLGNDVP 1212
DV+S+GVV+LEL++GRKPVD TQP G+E+LV WARPLL G L +ID L
Sbjct: 553 DVFSFGVVLLELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYV 612
Query: 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLD 1272
V ++ A+ CV+ RP M +VV+AL +CD + G S+ I +
Sbjct: 613 EHEVFRMIETAAACVRHSGPKRPRMVQVVRAL-----DCDG--DSGDISNG-----IKIG 660
Query: 1273 SKVSTGSGQLPDPLQRHYSVP-NYDLGLDTGXXXXXXXXXXXXXXXGKE-ESELF--RRY 1328
+ SGQ + + + + D +++G G E E+ F RR+
Sbjct: 661 QSTTYDSGQYNEDIMKFRKMAFGGDNSVESGLYSGNYSAKSSSDFSGNESETRPFNNRRF 720
|
|
| TAIR|locus:2125692 PERK14 "proline-rich extensin-like receptor kinase 14" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 729 (261.7 bits), Expect = 1.7e-104, Sum P(2) = 1.7e-104
Identities = 153/318 (48%), Positives = 208/318 (65%)
Query: 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 1018
FS E+ KATG F +LGEGGFG V+ GVL +GT+VAVK LK QG REF AEV+
Sbjct: 377 FSYEELSKATGGFSEENLLGEGGFGYVHKGVLKNGTEVAVKQLKIGSYQGEREFQAEVDT 436
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
+SR+HH++LV L+G C+ R LVYE +P ++E HLH + + L W+ RL+IA+GA
Sbjct: 437 ISRVHHKHLVSLVGYCVNGDKRLLVYEFVPKDTLEFHLH--ENRGSVLEWEMRLRIAVGA 494
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR--HISTRVMG 1136
A+ LAYLHED SP +IHRD K++NILL+ F KVSDFGLA+ D S HISTRV+G
Sbjct: 495 AKGLAYLHEDCSPTIIHRDIKAANILLDSKFEAKVSDFGLAKFFSDTNSSFTHISTRVVG 554
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT-- 1194
TFGY+APEYA +G + KSDVYS+GVV+LEL++GR + ++LV WARPLLT
Sbjct: 555 TFGYMAPEYASSGKVTDKSDVYSFGVVLLELITGRPSIFAKDSSTNQSLVDWARPLLTKA 614
Query: 1195 -SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK--LVCNEC 1251
S E + ++D L + +A +AA A+ C++ RP M +VV+AL+ + +
Sbjct: 615 ISGESFDFLVDSRLEKNYDTTQMANMAACAAACIRQSAWLRPRMSQVVRALEGEVALRKV 674
Query: 1252 DEAKEVGSASSSQDDMSI 1269
+E + SSS++ I
Sbjct: 675 EETGNSVTYSSSENPNDI 692
|
|
| TAIR|locus:2132168 AT4G02010 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 944 (337.4 bits), Expect = 6.3e-104, Sum P(3) = 6.3e-104
Identities = 199/368 (54%), Positives = 251/368 (68%)
Query: 882 IVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSA 941
++++ + A VL A VL+ S A + E+ P + + VKP LD+
Sbjct: 306 LILIFSIAAGVLILAIITVLVIC--SRALREEKAPDPHKEA-VKPRN---------LDAG 353
Query: 942 SLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVL 1001
S FG S+ + S + S E+++AT NF+++ ILGEGGFG VY G+L DGT VA+K L
Sbjct: 354 S--FGGSLP-HPASTRFLSYEELKEATSNFESASILGEGGFGKVYRGILADGTAVAIKKL 410
Query: 1002 KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--RCLVYELIPNGSVESHLHGV 1059
QG +EF E++MLSRLHHRNLVKL+G + L YEL+PNGS+E+ LHG
Sbjct: 411 TSGGPQGDKEFQVEIDMLSRLHHRNLVKLVGYYSSRDSSQHLLCYELVPNGSLEAWLHGP 470
Query: 1060 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119
+ PL WD R+KIAL AAR LAYLHEDS P VIHRDFK+SNILLE++F KV+DFGLA
Sbjct: 471 LGLNCPLDWDTRMKIALDAARGLAYLHEDSQPSVIHRDFKASNILLENNFNAKVADFGLA 530
Query: 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1179
+ A + H+STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV+LELL+GRKPVDM+QP
Sbjct: 531 KQAPEGRGNHLSTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVLLELLTGRKPVDMSQP 590
Query: 1180 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1239
GQENLV W RP+L ++ LE ++D L P + +V IA+ CV PE RP MGE
Sbjct: 591 SGQENLVTWTRPVLRDKDRLEELVDSRLEGKYPKEDFIRVCTIAAACVAPEASQRPTMGE 650
Query: 1240 VVQALKLV 1247
VVQ+LK+V
Sbjct: 651 VVQSLKMV 658
|
|
| TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 765 (274.4 bits), Expect = 5.6e-101, Sum P(3) = 5.6e-101
Identities = 151/294 (51%), Positives = 206/294 (70%)
Query: 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA 1014
S TF+ E+ +AT F + +LG+GGFG V+ G+L G +VAVK LK QG REF A
Sbjct: 264 SKSTFTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQA 323
Query: 1015 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1074
EVE++SR+HHR+LV LIG C+ R LVYE +PN ++E HLHG K + W RLKI
Sbjct: 324 EVEIISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHG--KGRPTMEWSTRLKI 381
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
ALG+A+ L+YLHED +P++IHRD K+SNIL++ F KV+DFGLA+ A D + H+STRV
Sbjct: 382 ALGSAKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNT-HVSTRV 440
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194
MGTFGY+APEYA +G L KSDV+S+GVV+LEL++GR+PVD ++LV WARPLL
Sbjct: 441 MGTFGYLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLN 500
Query: 1195 --SREG-LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
S EG E + D +GN+ + +A++ A A+ CV+ + RP M ++V+AL+
Sbjct: 501 RASEEGDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALE 554
|
|
| TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 734 (263.4 bits), Expect = 1.1e-99, Sum P(3) = 1.1e-99
Identities = 166/367 (45%), Positives = 222/367 (60%)
Query: 903 FKYKSHACQAEEVPQSLQTSHVKPSGAA-GLMVGSGLDSASLSFGSSIATYTGSAKT-FS 960
F Y + + P + SG + G G G + S S S GS +T F+
Sbjct: 285 FLYGQNPTKGYSGPGGYNSQQQSNSGNSFGSQRGGGGYTRSGSAPDSAVM--GSGQTHFT 342
Query: 961 ASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 1020
E+ T F ILGEGGFG VY G L+DG VAVK LK QG REF AEVE++S
Sbjct: 343 YEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEIIS 402
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
R+HHR+LV L+G CI + R L+YE +PN ++E HLHG K L W R++IA+G+A+
Sbjct: 403 RVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHG--KGRPVLEWARRVRIAIGSAK 460
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
LAYLHED P++IHRD KS+NILL+ +F +V+DFGLA+ D H+STRVMGTFGY
Sbjct: 461 GLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAK-LNDSTQTHVSTRVMGTFGY 519
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--REG 1198
+APEYA +G L +SDV+S+GVV+LEL++GRKPVD QP G+E+LV WARPLL G
Sbjct: 520 LAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIETG 579
Query: 1199 -LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV--CNECDEAK 1255
++D L + V ++ A+ CV+ RP M +VV+AL +
Sbjct: 580 DFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNGN 639
Query: 1256 EVGSASS 1262
+VG +S+
Sbjct: 640 KVGQSSA 646
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.1 | LOW CONFIDENCE prediction! |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh4_pg.C_scaffold_145000043 | hypothetical protein (1156 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 1368 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-56 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 8e-56 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-53 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-50 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-36 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-34 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-33 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-32 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-32 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 4e-31 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-29 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-29 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-29 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 5e-29 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 6e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-28 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-27 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-27 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-26 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-26 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-26 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-26 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-25 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-25 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 6e-25 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 8e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-24 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-24 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 6e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-23 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-23 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-23 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-23 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-23 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-23 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-23 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-22 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-22 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-22 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 9e-22 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-21 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-21 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-21 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-21 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-21 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 5e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-20 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-20 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-20 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 3e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 8e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 1e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-19 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-19 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-19 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-19 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-19 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 4e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-19 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 5e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 6e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-18 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-18 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-18 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-18 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-18 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-17 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 4e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-17 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 9e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-16 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 2e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-16 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-16 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-16 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-16 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-16 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-16 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-16 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 5e-16 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 6e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-16 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 8e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-16 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-15 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-15 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-15 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 8e-15 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 9e-15 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-14 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-14 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-14 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-14 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-14 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 6e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 8e-14 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-13 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 2e-13 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-13 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-13 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-13 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 7e-13 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 7e-13 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-13 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-13 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 9e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-12 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-12 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-12 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 2e-12 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-12 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-12 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-12 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-12 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 5e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-12 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 5e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 5e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-12 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 8e-12 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-11 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-11 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-11 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 1e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-11 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-11 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-11 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-11 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-11 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-11 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 7e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-11 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-11 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 8e-11 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 9e-11 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 1e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-10 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-10 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-10 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 3e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 3e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-10 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 4e-10 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-10 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 5e-10 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-10 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-10 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-10 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 7e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-10 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-10 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-10 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-09 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 1e-09 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-09 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 2e-09 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-09 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-09 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-09 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 4e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 4e-09 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 5e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 6e-09 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 9e-09 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 1e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 1e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 1e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-08 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-08 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-08 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-08 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-08 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-08 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-08 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-08 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 6e-08 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 6e-08 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 7e-08 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 7e-08 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 8e-08 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 8e-08 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-08 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-07 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 1e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-07 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-07 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 2e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-07 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 2e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-07 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-07 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-07 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-07 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 3e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-07 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 3e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 4e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 4e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 4e-07 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-07 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 5e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 5e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 5e-07 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-07 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-07 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-07 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 7e-07 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 8e-07 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 9e-07 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 1e-06 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-06 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 2e-06 | |
| PRK10263 | 1355 | PRK10263, PRK10263, DNA translocase FtsK; Provisio | 2e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-06 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 2e-06 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-06 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 3e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 3e-06 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-06 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-06 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 4e-06 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 4e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 4e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-06 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 5e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 6e-06 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 6e-06 | |
| PHA03378 | 991 | PHA03378, PHA03378, EBNA-3B; Provisional | 6e-06 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-06 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 7e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 7e-06 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 8e-06 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 8e-06 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 8e-06 | |
| pfam11725 | 1771 | pfam11725, AvrE, Pathogenicity factor | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-06 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 1e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 1e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 1e-05 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-05 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-05 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 1e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-05 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 2e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 2e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 2e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-05 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-05 | |
| pfam08580 | 626 | pfam08580, KAR9, Yeast cortical protein KAR9 | 2e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-05 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 3e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 3e-05 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-05 | |
| PHA03377 | 1000 | PHA03377, PHA03377, EBNA-3C; Provisional | 3e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 4e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 4e-05 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 4e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 4e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-05 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-05 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 4e-05 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 5e-05 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 5e-05 | |
| pfam03153 | 332 | pfam03153, TFIIA, Transcription factor IIA, alpha/ | 5e-05 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 5e-05 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 6e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 6e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-05 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 7e-05 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 7e-05 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 7e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 8e-05 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 8e-05 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 8e-05 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 9e-05 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-05 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 9e-05 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 9e-05 | |
| PRK07994 | 647 | PRK07994, PRK07994, DNA polymerase III subunits ga | 1e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 1e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 1e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 1e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 1e-04 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-04 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 2e-04 | |
| pfam09770 | 804 | pfam09770, PAT1, Topoisomerase II-associated prote | 2e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 2e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 2e-04 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 2e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 2e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 2e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 2e-04 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 2e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 2e-04 | |
| PRK14954 | 620 | PRK14954, PRK14954, DNA polymerase III subunits ga | 2e-04 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 2e-04 | |
| pfam03154 | 979 | pfam03154, Atrophin-1, Atrophin-1 family | 3e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-04 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 3e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 3e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 3e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 3e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 3e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 3e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 3e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-04 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-04 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 4e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 4e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 4e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 4e-04 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 4e-04 | |
| PRK12323 | 700 | PRK12323, PRK12323, DNA polymerase III subunits ga | 5e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 5e-04 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 5e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-04 | |
| PRK10856 | 331 | PRK10856, PRK10856, cytoskeletal protein RodZ; Pro | 5e-04 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-04 | |
| PHA03307 | 1352 | PHA03307, PHA03307, transcriptional regulator ICP4 | 6e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-04 | |
| pfam05109 | 830 | pfam05109, Herpes_BLLF1, Herpes virus major outer | 6e-04 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 6e-04 | |
| PTZ00395 | 1560 | PTZ00395, PTZ00395, Sec24-related protein; Provisi | 6e-04 | |
| PRK08691 | 709 | PRK08691, PRK08691, DNA polymerase III subunits ga | 6e-04 | |
| pfam05539 | 408 | pfam05539, Pneumo_att_G, Pneumovirinae attachment | 6e-04 | |
| pfam03999 | 619 | pfam03999, MAP65_ASE1, Microtubule associated prot | 6e-04 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 7e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 7e-04 | |
| PRK12727 | 559 | PRK12727, PRK12727, flagellar biosynthesis regulat | 7e-04 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 8e-04 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 8e-04 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 8e-04 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-04 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 9e-04 | |
| PRK07003 | 830 | PRK07003, PRK07003, DNA polymerase III subunits ga | 0.001 | |
| PRK07764 | 824 | PRK07764, PRK07764, DNA polymerase III subunits ga | 0.001 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.001 | |
| PRK14086 | 617 | PRK14086, dnaA, chromosomal replication initiation | 0.001 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.001 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.001 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 0.001 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.001 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.001 | |
| pfam04388 | 667 | pfam04388, Hamartin, Hamartin protein | 0.001 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.001 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.001 | |
| PHA03132 | 580 | PHA03132, PHA03132, thymidine kinase; Provisional | 0.001 | |
| PHA03247 | 3151 | PHA03247, PHA03247, large tegument protein UL36; P | 0.002 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 0.002 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.002 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.002 | |
| PRK06995 | 484 | PRK06995, flhF, flagellar biosynthesis regulator F | 0.002 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.002 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.002 | |
| PRK14971 | 614 | PRK14971, PRK14971, DNA polymerase III subunits ga | 0.002 | |
| pfam13388 | 422 | pfam13388, DUF4106, Protein of unknown function (D | 0.002 | |
| pfam03251 | 458 | pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd prote | 0.002 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.002 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.002 | |
| pfam04484 | 313 | pfam04484, DUF566, Family of unknown function (DUF | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| PRK12372 | 413 | PRK12372, PRK12372, ribonuclease III; Reviewed | 0.002 | |
| pfam07174 | 297 | pfam07174, FAP, Fibronectin-attachment protein (FA | 0.002 | |
| pfam05044 | 908 | pfam05044, Prox1, Homeobox prospero-like protein ( | 0.002 | |
| PHA03269 | 566 | PHA03269, PHA03269, envelope glycoprotein C; Provi | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.003 | |
| PLN03209 | 576 | PLN03209, PLN03209, translocon at the inner envelo | 0.003 | |
| PRK12270 | 1228 | PRK12270, kgd, alpha-ketoglutarate decarboxylase; | 0.003 | |
| pfam07223 | 357 | pfam07223, DUF1421, Protein of unknown function (D | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.003 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.003 | |
| PTZ00436 | 357 | PTZ00436, PTZ00436, 60S ribosomal protein L19-like | 0.003 | |
| PTZ00449 | 943 | PTZ00449, PTZ00449, 104 kDa microneme/rhoptry anti | 0.003 | |
| PRK14959 | 624 | PRK14959, PRK14959, DNA polymerase III subunits ga | 0.003 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 0.003 | |
| PRK10811 | 1068 | PRK10811, rne, ribonuclease E; Reviewed | 0.003 | |
| PRK12799 | 421 | PRK12799, motB, flagellar motor protein MotB; Revi | 0.003 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.003 | |
| PRK03427 | 333 | PRK03427, PRK03427, cell division protein ZipA; Pr | 0.003 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.003 | |
| PHA03369 | 663 | PHA03369, PHA03369, capsid maturational protease; | 0.003 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 0.003 | |
| PRK14951 | 618 | PRK14951, PRK14951, DNA polymerase III subunits ga | 0.004 | |
| pfam04652 | 315 | pfam04652, DUF605, Vta1 like | 0.004 | |
| PRK14950 | 585 | PRK14950, PRK14950, DNA polymerase III subunits ga | 0.004 | |
| PRK14948 | 620 | PRK14948, PRK14948, DNA polymerase III subunits ga | 0.004 | |
| PRK14949 | 944 | PRK14949, PRK14949, DNA polymerase III subunits ga | 0.004 | |
| PRK14965 | 576 | PRK14965, PRK14965, DNA polymerase III subunits ga | 0.004 | |
| COG3170 | 755 | COG3170, FimV, Tfp pilus assembly protein FimV [Ce | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 | |
| PRK11901 | 327 | PRK11901, PRK11901, hypothetical protein; Reviewed | 0.004 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 3e-56
Identities = 88/283 (31%), Positives = 129/283 (45%), Gaps = 41/283 (14%)
Query: 974 SRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNL 1027
+ LGEG FG VY G L +VAVK LK +Q EFL E ++ +L H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
VKL+G+C EE+ +V E + G + S+L K L L AL AR + YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLR---KNRPKLSLSDLLSFALQIARGMEYLE- 119
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES-RHISTRV----MGTFGYVA 1142
S IHRD + N L+ + K+SDFGL+R D++ R ++ M A
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWM------A 171
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201
PE G KSDV+S+GV++ E+ + G +P PG N L + L +
Sbjct: 172 PESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-----YPGMSNEEVLEY--LKNGYRLPQ 224
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
P + ++ + C + + RP E+V+ L
Sbjct: 225 ----------PPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 194 bits (495), Expect = 8e-56
Identities = 84/277 (30%), Positives = 126/277 (45%), Gaps = 30/277 (10%)
Query: 975 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
+ LGEG FG VY G L +VAVK LK +Q EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
KL+G+C EE+ +V E +P G + +L L L AL AR + YL
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
S IHRD + N L+ + K+SDFGL+R + ++ + ++APE
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207
G KSDV+S+GV++ E+ + G +P PG N L L +
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEP-----YPGMSNAEVLEY--LKKGYRLPK------ 225
Query: 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
P + ++ + C + + RP E+V+ L
Sbjct: 226 ----PPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 3e-53
Identities = 73/195 (37%), Positives = 104/195 (53%), Gaps = 12/195 (6%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIGIC 1034
LGEGGFG VY G KVA+K++K+ D E L E+E+L +L+H N+VKL G+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E LV E GS++ L + L D L+I L L YLH S +I
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH---SNGII 114
Query: 1095 HRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1152
HRD K NILL + K++DFGL++ + + ++GT Y+APE +
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLL--TSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172
Query: 1153 VKSDVYSYGVVILEL 1167
KSD++S GV++ EL
Sbjct: 173 EKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 186 bits (476), Expect = 4e-53
Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 44/284 (15%)
Query: 975 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
+ LGEG FG VY G L TKVAVK LK ++ EFL E ++ +L H N+V
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+G+C + + +V E +P G + L K L L++AL A+ + YL
Sbjct: 65 RLLGVCTQGEPLYIVTEYMPGGDLLDFLR---KHGEKLTLKDLLQMALQIAKGMEYLE-- 119
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV-----AP 1143
S +HRD + N L+ + K+SDFGL+R +++ G + AP
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD-----YYRKRGGGKLPIKWMAP 173
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
E G KSDV+S+GV++ E+ + G +P P +++ E LE +
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPY----------------PGMSNEEVLELL 217
Query: 1203 IDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
D G P + ++ + C + + RP E+V+ L
Sbjct: 218 ED---GYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 3e-50
Identities = 76/203 (37%), Positives = 104/203 (51%), Gaps = 13/203 (6%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLI 1031
R LG G FG VY G VAVK+LK+ + + + E+ +L RL H N+V+LI
Sbjct: 5 RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1091
++ LV E G L PL D KIAL R L YLH +
Sbjct: 65 DAFEDKDHLYLVMEYCEGGD----LFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN--- 117
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE-YAMTGH 1150
+IHRD K NILL+ + K++DFGLA+ + + S ++T V GT Y+APE
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAK-KLLKSSSSLTTFV-GTPWYMAPEVLLGGNG 175
Query: 1151 LLVKSDVYSYGVVILELLSGRKP 1173
K DV+S GV++ ELL+G+ P
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPP 198
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 8e-50
Identities = 88/288 (30%), Positives = 130/288 (45%), Gaps = 43/288 (14%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 1029
+ LGEG FG VY G L T+VAVK LK + R +FL E ++ +L H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHL-----HGVDKESAPLGWDARLKIALGAARALAY 1084
L+G+C EE+ LV E + G + +L E + L L A+ A+ + Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST------RVMGTF 1138
L S + +HRD + N L+ D K+SDFGL+R D++ T R M
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM--- 174
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSRE 1197
APE G KSDV+S+GV++ E+ + G P PG N L
Sbjct: 175 ---APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY-----PGLSN--EEVLEYLRKGY 224
Query: 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
L + P D ++ + C Q + + RP E+V+ L+
Sbjct: 225 RLPK---PEYCPD-------ELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-46
Identities = 72/201 (35%), Positives = 103/201 (51%), Gaps = 12/201 (5%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIG 1032
LGEG FG VY G VA+KV+K+ + RE L E+++L +L H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ +E LV E G + L + S +AR AL YLH S
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSED---EAR-FYLRQILSALEYLH---SKG 117
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
++HRD K NILL+ D K++DFGLAR + ++T V GT Y+APE +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQL--DPGEKLTTFV-GTPEYMAPEVLLGKGYG 174
Query: 1153 VKSDVYSYGVVILELLSGRKP 1173
D++S GV++ ELL+G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-36
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 18/207 (8%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+LG G FG VY + D G +AVK L ++ E+ +LS L H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 1032 GICIEEQARCL-VY-ELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLH 1086
G +E+ L ++ E + GS+ S L K P+ R +I G LAYLH
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV---IRKYTRQILEG----LAYLH 118
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
S ++HRD K +NIL++ D K++DFG A+ D E+ + V GT ++APE
Sbjct: 119 ---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI 175
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
+D++S G ++E+ +G+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 21/217 (9%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNL 1027
R LGEG FG V+ G +D VAVK LK R+ F E E+L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVD--------KESAPLGWDARLKIALG 1077
VK G+C E +V+E + +G + L HG D L L+IA+
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
A + YL +S +HRD + N L+ +D K+ DFG++R + + M
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187
Query: 1138 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
++ PE M +SDV+S+GVV+ E+ + G++P
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 87/293 (29%), Positives = 134/293 (45%), Gaps = 37/293 (12%)
Query: 974 SRILGEGGFGLVYSGVLD---DGT--KVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 1027
+ LGEG FG V D D T +VAVK L ++Q +F E+E+L L H N+
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENI 68
Query: 1028 VKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
VK G+C + R L+ E +P+GS+ +L + + L + + + YL
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDYL 125
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVA 1142
S R IHRD + NIL+E + K+SDFGLA+ + E+ + + G F Y A
Sbjct: 126 G---SQRYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIFWY-A 180
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLS-GRK-------PVDMTQPPGQENLVAWARPLLT 1194
PE T SDV+S+GV + EL + G + M + +V LL
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 1195 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247
E L R PS ++V +D + +C + E Q RP +++ + +
Sbjct: 241 EGERLPR--PPSCPDEV-YD-------LMKLCWEAEPQDRPSFADLILIVDRL 283
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 68/199 (34%), Positives = 108/199 (54%), Gaps = 7/199 (3%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 1030
F R LG G FG V+ G+ + +VA+K+LK D ++F EV+ L RL H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
+C + ++ EL+ GS+ + L E L + + +A A +AYL E
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLR--SPEGQVLPVASLIDMACQVAEGMAYLEEQ-- 123
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1150
IHRD + NIL+ D KV+DFGLAR + +E ++S+ + + APE A G
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLAR--LIKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 1151 LLVKSDVYSYGVVILELLS 1169
KSDV+S+G+++ E+ +
Sbjct: 181 FSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 67/198 (33%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
+G+G FG V G G KVAVK LK D + FLAE +++ L H NLV+L+G+ ++
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71
Query: 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096
+V E + GS+ +L + A + +L AL + YL E +HR
Sbjct: 72 GNPLYIVTEYMAKGSLVDYLR--SRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126
Query: 1097 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 1156
D + N+L+ D KVSDFGLA+ + S ++ + APE KSD
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAK---EASQGQDSGKL--PVKWTAPEALREKKFSTKSD 181
Query: 1157 VYSYGVVILELLS-GRKP 1173
V+S+G+++ E+ S GR P
Sbjct: 182 VWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 16/201 (7%)
Query: 977 LGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G+GGFG VY G +VA+KV+K ++ + + E+++L + H N+VK G +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 1036 EEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
++ +V E GS++ + ES A + + L YLH +
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTES----QIA--YVCKELLKGLEYLHSN---G 118
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
+IHRD K++NILL D K+ DFGL+ D ++R+ ++GT ++APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGKPYD 175
Query: 1153 VKSDVYSYGVVILELLSGRKP 1173
K+D++S G+ +EL G+ P
Sbjct: 176 YKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 73/201 (36%), Positives = 106/201 (52%), Gaps = 15/201 (7%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKLIGI 1033
+G+G FG VY GVL T+VAVK + + FL E E+L + H N+VKLIG+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
C+++Q +V EL+P GS+ + L K+ L L+++L AA + YL S
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLR---KKKNRLTVKKLLQMSLDAAAGMEYLE---SKNC 114
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT----FGYVAPEYAMTG 1149
IHRD + N L+ + K+SDFG++R EE I T G + APE G
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYG 170
Query: 1150 HLLVKSDVYSYGVVILELLSG 1170
+SDV+SYG+++ E S
Sbjct: 171 RYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 2e-29
Identities = 148/643 (23%), Positives = 209/643 (32%), Gaps = 69/643 (10%)
Query: 62 APSPIELPTHSAPP-PVNIPSFSPSTPAV--SAPFDMAPPPSLIP----TNPVASPPSIT 114
A P PP P P+ S PA+ P P ++ +AS +
Sbjct: 2491 AAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEPVGEPVHPRMLTWIRGLEELASDDAGD 2550
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPP 174
PPP+ A PP + PPP AP PA + P A P S++ P
Sbjct: 2551 PPPPLPPAAPP---AAPDRSVPPPRPAPRPSE--PAVTSRARRPDAPPQSARPRAPVDDR 2605
Query: 175 SNAARPPASHPSNTARPPASHPSRTAPP-PASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ P P PP +H PP P+ + P P + P
Sbjct: 2606 GDPRGPAPPSPL----PPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRV 2661
Query: 234 LPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKT 293
+ A ++PP P S S PPP AP +
Sbjct: 2662 SRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATPL 2721
Query: 294 APPPAS----HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP--PASHSSK 347
P PA+ P+ A P P PP + P APP PA+ +
Sbjct: 2722 PPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAAGPPR 2781
Query: 348 TAPPPASHPSNTALPPASHPSNPAIPPAS-HPSNTAIPPASHPSNTAPPHASHPSNTALT 406
PA + + P +PA PPA+ A+PPA+ P+ PP T+
Sbjct: 2782 RLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPP------PTSAQ 2835
Query: 407 PASHPSNIAPPPLFVPVLPSALPG----KAPVSQSPISLPDAPAATPRGNFHRHSPAIHP 462
P + P PPP +P+ S PG + P S+SP + P APA P R + +
Sbjct: 2836 PTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVS-RS 2894
Query: 463 SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDV 522
+ LPP +R P P PP Q P +P P P P P +
Sbjct: 2895 TESFALPPDQPER----------PPQPQAPPPPQPQPQPPPPPQPQPPPPPP-PRPQPPL 2943
Query: 523 PPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPK 582
P+T P EPS +P P P + ++ +S
Sbjct: 2944 APTTDP---------AGAGEPSGAVPQPWLGALVPGRVAVP-RFRVPQPAPSREAPASST 2993
Query: 583 PPQNNGNDTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRK 642
PP + + VSS +S H + + P P S+ Q P +
Sbjct: 2994 PPLTGHSLSRVSSWASSLALHEE------TDPPP-------VSLKQTLWPPDDTEDSDAD 3040
Query: 643 RHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELP 685
+ S + PLP T +G E P
Sbjct: 3041 SLFDSDSERSDLEALDPLPPEPHDPFAHEPDPATPEAGARESP 3083
|
Length = 3151 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-29
Identities = 68/202 (33%), Positives = 108/202 (53%), Gaps = 12/202 (5%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
R LG G FG V+ G+ ++ T VAVK LK ++FLAE +++ +L H L++L +C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
E+ +V EL+ GS+ +L G L + +A A +AYL + I
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQG--GAGRALKLPQLIDMAAQVASGMAYLEAQN---YI 125
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 1152
HRD + N+L+ + KV+DFGLAR ++ R F + APE A+
Sbjct: 126 HRDLAARNVLVGENNICKVADFGLARVIKEDI---YEAREGAKFPIKWTAPEAALYNRFS 182
Query: 1153 VKSDVYSYGVVILELLS-GRKP 1173
+KSDV+S+G+++ E+++ GR P
Sbjct: 183 IKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 73/205 (35%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLI 1031
R LG G FG V+ G + TKVAVK LK G FL E +++ +L H LV+L
Sbjct: 12 RKLGAGQFGEVWMGTWNGTTKVAVKTLK----PGTMSPEAFLQEAQIMKKLRHDKLVQLY 67
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1091
+C EE+ +V E + GS+ L E L + +A A +AYL
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLK--SGEGKKLRLPQLVDMAAQIAEGMAYLESR--- 122
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTG 1149
IHRD + NIL+ + K++DFGLAR D+E + R F + APE A G
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDE---YTAREGAKFPIKWTAPEAANYG 179
Query: 1150 HLLVKSDVYSYGVVILELLS-GRKP 1173
+KSDV+S+G+++ E+++ GR P
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 76/213 (35%), Positives = 106/213 (49%), Gaps = 20/213 (9%)
Query: 977 LGEGGFGLVYSGV--LDDGT--KVAVKVLKRVDQQGG-REFLAEVEMLSRLHHRNLVKLI 1031
LG G FG V GV + G +VAVK LK+ G +EFL E ++++L H +V+LI
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI-ALGAARALAYLHEDSS 1090
G+C E LV EL P G + +L + P + LK A A +AYL
Sbjct: 63 GVCKGEPL-MLVMELAPLGPLLKYL--KKRREIP---VSDLKELAHQVAMGMAYLESK-- 114
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMT 1148
+HRD + N+LL + K+SDFG++R A+ S + G + + APE
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSR-ALGAGSDYYRATTAGRWPLKWYAPECINY 172
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKPV-DMTQP 1179
G KSDV+SYGV + E S G KP +M
Sbjct: 173 GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA 205
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 5e-29
Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 20/211 (9%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRN 1026
N+ ++G G FG+VY G+ L+ G VA+K L+++ ++ + + E+++L L H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD--ARL--KIALGAARAL 1082
+VK IG + ++ E NGS L + K+ P A ++ G L
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGS----LRQIIKKFGPFPESLVAVYVYQVLQG----L 112
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
AYLHE VIHRD K++NIL D K++DFG+A + +++ S+ ++ V+GT ++A
Sbjct: 113 AYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDAS-VVGTPYWMA 167
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
PE SD++S G ++ELL+G P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-29
Identities = 65/211 (30%), Positives = 112/211 (53%), Gaps = 20/211 (9%)
Query: 975 RILGEGGFGLVYSGV---LDDGTK--VAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
++LG G FG VY GV + K VA+KVL+ + +E L E +++ + H ++V
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+GIC+ Q L+ +L+P G + ++ +G L + A+ ++YL E
Sbjct: 73 RLLGICLSSQV-QLITQLMPLGCLLDYVR---NHKDNIGSQYLLNWCVQIAKGMSYLEEK 128
Query: 1089 SSPRVIHRDFKSSNILLEHDFTP---KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
R++HRD + N+L++ TP K++DFGLA+ +E + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVK---TPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182
Query: 1146 AMTGHLLVKSDVYSYGVVILELLS-GRKPVD 1175
+ KSDV+SYGV + EL++ G KP +
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWELMTFGAKPYE 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 2e-28
Identities = 84/358 (23%), Positives = 128/358 (35%), Gaps = 24/358 (6%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL-HHR 1025
++ R LGEG FG VY D VA+KVL + + FL E+++L+ L H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N+VKL +E + LV E + GS+E L PL L I AL YL
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117
Query: 1086 HEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTR----VMGTFGY 1140
H +IHRD K NILL K+ DFGLA+ D S +GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174
Query: 1141 VAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1197
+APE + + SD++S G+ + ELL+G P + + + L E
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-----LKIILE 229
Query: 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV-QALKLVCNECDEAKE 1256
+ L P + + + + ++R + L +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 1257 VGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDLGLDTGRRLSLSYLFSSS 1314
+ + L + L + D + +
Sbjct: 290 DLLKPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHN 347
|
Length = 384 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 6e-28
Identities = 63/200 (31%), Positives = 102/200 (51%), Gaps = 9/200 (4%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
+G G FGLV+ G + KVA+K + R +F+ E +++ +L H LV+L G+C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096
CLV+E + +G + +L + + L + L +AYL + VIHR
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESSN---VIHR 124
Query: 1097 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSD 1156
D + N L+ + KVSDFG+ R +D++ ST + +PE KSD
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS-STGTKFPVKWSSPEVFSFSKYSSKSD 183
Query: 1157 VYSYGVVILELLS-GRKPVD 1175
V+S+GV++ E+ S G+ P +
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE 203
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 8e-28
Identities = 61/211 (28%), Positives = 97/211 (45%), Gaps = 26/211 (12%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
+ +G+G FG VY L DG +K L + ++ + L EV++L +L+H N++
Sbjct: 6 KQIGKGSFGKVY---LVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNII 62
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
K E+ C+V E G + + KE P + L + AL YLH
Sbjct: 63 KYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR 122
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE---- 1144
+++HRD K NI L + K+ DFG+++ + T V GT Y++PE
Sbjct: 123 ---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLSPELCQN 177
Query: 1145 --YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y KSD++S G V+ EL + + P
Sbjct: 178 KPYN------YKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-27
Identities = 89/270 (32%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 976 ILGEGGFGLVYSGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+LG+G FG V+ G L D T VAVK K + Q+ +FL+E +L + H N+VKLIG+C
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+ Q +V EL+P G S L K+ L +K AL AA +AYL S I
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLR---KKKDELKTKQLVKFALDAAAGMAYLE---SKNCI 115
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
HRD + N L+ + K+SDFG++R D+ S + APE G +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQE-DDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174
Query: 1155 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 1214
SDV+SYG+++ E S + + PG N A RE +E+ S P D
Sbjct: 175 SDVWSYGILLWETFS----LGVCPYPGMTNQQA--------REQVEKGYRMSCPQKCPDD 222
Query: 1215 SVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
V + C + ++RP E+ + L
Sbjct: 223 ----VYKVMQRCWDYKPENRPKFSELQKEL 248
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 14/206 (6%)
Query: 974 SRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLV 1028
R +GEG FG VY GV ++ VAVK K RE FL E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
KLIG+ E +V EL P G + S+L V+K S L + + + + ALAYL
Sbjct: 71 KLIGVI-TENPVWIVMELAPLGELRSYLQ-VNKYSLDLA--SLILYSYQLSTALAYLE-- 124
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
S R +HRD + N+L+ K+ DFGL+R +++ES + +++ ++APE
Sbjct: 125 -SKRFVHRDIAARNVLVSSPDCVKLGDFGLSR-YLEDESYYKASKGKLPIKWMAPESINF 182
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKP 1173
SDV+ +GV + E+L G KP
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 73/223 (32%), Positives = 111/223 (49%), Gaps = 34/223 (15%)
Query: 975 RILGEGGFGLVYSG----VLDDGT---KVAVKVLKR--VDQQGGREFLAEVEMLSRLHHR 1025
LG G FG VY G +L G+ +VAVK L++ DQ+ +EFL E ++S +H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHP 59
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP---LGWDARLKIALGAARAL 1082
N+VKL+G+C+ + + ++ EL+ G + S+L E L L I L A+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 1083 AYLHEDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMD------EESRHIS 1131
YL + IHRD + N L+ + D K+ DFGLAR E +
Sbjct: 120 VYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
R M APE + G +SDV+S+GV++ E+L+ G++P
Sbjct: 177 VRWM------APESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 67/208 (32%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 977 LGEGGFGLVYSGVLDDGT----KVAVKVLKRVDQQGG-REFLAEVEMLSRLHHRNLVKLI 1031
LG+G FG+V G VAVK LK +FL E ++ L H NL++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLG--WDARLKIALGAARALAYLHEDS 1089
G+ + +V EL P GS+ L + D ++IA G + YL
Sbjct: 63 GVVLTHPLM-MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANG----MRYLE--- 114
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST---RVMGTFGYVAPEYA 1146
S R IHRD + NILL D K+ DFGL R+ E ++ +V F + APE
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESL 172
Query: 1147 MTGHLLVKSDVYSYGVVILELLS-GRKP 1173
T SDV+ +GV + E+ + G +P
Sbjct: 173 RTRTFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 64/202 (31%), Positives = 103/202 (50%), Gaps = 20/202 (9%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLIGI 1033
LG G FG+V+ G VA+K+++ +G +F+ E +++ +L H NLV+L G+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIR----EGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
C +++ +V E + NG + ++L + LG + L + A+ YL +
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLR---ERKGKLGTEWLLDMCSDVCEAMEYLESNG---F 121
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPEYAMTGH 1150
IHRD + N L+ D KVSDFGLAR +D++ T GT + PE
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVFDYSR 177
Query: 1151 LLVKSDVYSYGVVILELLSGRK 1172
KSDV+S+GV++ E+ S K
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 71/219 (32%), Positives = 109/219 (49%), Gaps = 27/219 (12%)
Query: 977 LGEGGFGLVYSGVL------DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 1027
LGEG FG VY G L T VA+K LK Q +EF E E++S L H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQ--QEFRQEAELMSDLQHPNI 70
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARLKIA 1075
V L+G+C +EQ C+++E + +G + L G + + L L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
+ A + YL SS +HRD + N L+ T K+SDFGL+R + + ++ +
Sbjct: 131 IQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
++ PE + G +SD++S+GVV+ E+ S G +P
Sbjct: 188 LPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 3e-26
Identities = 123/501 (24%), Positives = 158/501 (31%), Gaps = 62/501 (12%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDM--APPPSLIPTNPVASPPS 112
P L AP P S PPP P PS PAV++ APP S P PV
Sbjct: 2552 PPPLPPAAPPAA--PDRSVPPPRPAPR--PSEPAVTSRARRPDAPPQSARPRAPVDDRGD 2607
Query: 113 ITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPAS 172
P P + PP T PPP + P N P P A S
Sbjct: 2608 PRGPAPPSPLPP-----DTHAPDPPPPSPSPAANEPDPHPPPTVPPPERPRDDPAPGRVS 2662
Query: 173 PPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHP----SNTA 228
P A R + + PP R A P ++ A P P+P P S T
Sbjct: 2663 RPRRARRL--GRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAPHALVSATP 2720
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS 288
LPP ++ A P PA P + P TA PPA P
Sbjct: 2721 LPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPA---- 2776
Query: 289 HPSKTAPPPASHPSNTAPPPASHPSNTAPP-PASHPS-----NTAPPPASHPSNTAPPPA 342
PP A S S +P PA P+ A PPA+ P+ PPP
Sbjct: 2777 ----AGPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPT 2832
Query: 343 SHSSKTAPPPASHPSNTALP-------------------PASHPSNPAIPPASHPSNTAI 383
S + TAPPP P +LP PA+ P+ PA PP + A+
Sbjct: 2833 S-AQPTAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAV 2891
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPD 443
++ P P P + P P P P P P Q P++
Sbjct: 2892 SRSTESFALPPDQPERPP----QPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTT 2947
Query: 444 APAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSP 503
PA + P + +PG + P P P
Sbjct: 2948 DPAGAGEPSGAVPQPWLGALVPGRVA-------VPRFRVPQPAPSREAPASSTPPLTGHS 3000
Query: 504 VARPIIPGGTPTASPDPDVPP 524
++R + + D PP
Sbjct: 3001 LSRVSSWASSLALHEETDPPP 3021
|
Length = 3151 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-26
Identities = 78/284 (27%), Positives = 131/284 (46%), Gaps = 42/284 (14%)
Query: 977 LGEGGFGLVY----SGVLDDGTK--VAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 1030
LGEG FG V+ +L + K VAVK LK + ++F E E+L+ L H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL--HGVDKE---------SAPLGWDARLKIALGAA 1079
G+C E + +V+E + +G + L HG D + L L IA A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
+ YL +S +HRD + N L+ K+ DFG++R + + R M
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREG 1198
++ PE + +SD++S+GVV+ E+ + G++P W + L++ E
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP--------------WYQ--LSNTEA 233
Query: 1199 LERIIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEV 1240
+E I + G ++ P +V AI C Q E Q R + ++
Sbjct: 234 IECI---TQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDI 274
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 79/287 (27%), Positives = 131/287 (45%), Gaps = 38/287 (13%)
Query: 975 RILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNL 1027
R LG+G FG+VY G+ T+VA+K + R EFL E ++ + ++
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHV 71
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES------APLGWDARLKIALGAARA 1081
V+L+G+ Q +V EL+ G ++S+L E+ P +++A A
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+AYL + +HRD + N ++ D T K+ DFG+ R + + + + ++
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200
APE G KSDV+S+GVV+ E+ + +P G N E L+
Sbjct: 189 APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPY-----QGLSN-----------EEVLK 232
Query: 1201 RIIDPSLGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ID G D+P + K+ + MC Q + RP E+V +LK
Sbjct: 233 FVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 83/262 (31%), Positives = 125/262 (47%), Gaps = 34/262 (12%)
Query: 976 ILGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
I+GEG FG V G G KVAVK +K V Q FL E ++++LHH+NLV+L+G+
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGV- 67
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
I +V EL+ G++ + L + + L+ +L A + YL S +++
Sbjct: 68 ILHNGLYIVMELMSKGNLVNFLRTRGRALVSVI--QLLQFSLDVAEGMEYLE---SKKLV 122
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
HRD + NIL+ D KVSDFGLAR S + + + APE K
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARV----GSMGVDNSKL-PVKWTAPEALKHKKFSSK 177
Query: 1155 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 1213
SDV+SYGV++ E+ S GR P P ++ +E E ++ + P
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPY----------------PKMSLKEVKEC-VEKGYRMEPPE 220
Query: 1214 DSVAKVAAIASMCVQPEVQHRP 1235
A V + + C + E + RP
Sbjct: 221 GCPADVYVLMTSCWETEPKKRP 242
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-25
Identities = 72/214 (33%), Positives = 100/214 (46%), Gaps = 29/214 (13%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+ +G G +G+V S V G KVA+K + V D + L E+++L L H N++ L+
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLL 65
Query: 1032 GICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
I +V EL+ E+ LH V K PL D R L YLH
Sbjct: 66 DILRPPSPEDFNDVYIVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLH 120
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR------HISTRVMGTFGY 1140
S VIHRD K SNIL+ + K+ DFGLAR +E ++ TR Y
Sbjct: 121 ---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW-----Y 172
Query: 1141 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
APE ++ K+ D++S G + ELL RKP
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELL-TRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-25
Identities = 93/295 (31%), Positives = 131/295 (44%), Gaps = 41/295 (13%)
Query: 975 RILGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLV 1028
R+LGEG FG V Y D G VAVK LKR Q + E+ +L L+H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 1029 KLIGICIE--EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
K G C E + L+ E +P GS+ +L K L L A +AYLH
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHK--LNLAQLLLFAQQICEGMAYLH 124
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAP 1143
S IHRD + N+LL++D K+ DFGLA+ A+ E + R G F Y A
Sbjct: 125 ---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWY-AV 179
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSG--------RKPVDMTQPP-GQENLVAWARPLLT 1194
E SDV+S+GV + ELL+ +K +M P GQ +V L+
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV----RLIE 235
Query: 1195 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249
E R+ P + P + V + C + E + RP ++ LK + +
Sbjct: 236 LLERGMRLPCP---KNCPQE----VYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 66/274 (24%), Positives = 118/274 (43%), Gaps = 37/274 (13%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGG-----REFLAEVEMLSRLH 1023
+F+ +G+G FG+V+ V D V +K++D E + E +L++L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKLD 57
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP--LGWDARLKIALGAARA 1081
+++ +++ +V E NG + L P W ++I LG
Sbjct: 58 SSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLG---- 113
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
LA+LH S +++HRD KS N+ L+ K+ D G+A+ D + + + ++GT Y+
Sbjct: 114 LAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD--NTNFANTIVGTPYYL 168
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201
+PE KSDV++ GVV+ E +G+ P D N A ++
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA------NNQGALILKIIRGV----- 217
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1235
P V ++A + C+ + + RP
Sbjct: 218 -FPP-----VSQMYSQQLAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 8e-25
Identities = 71/203 (34%), Positives = 109/203 (53%), Gaps = 19/203 (9%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ +G+G FG V G G KVAVK +K + + FLAE ++++L H NLV+L+G+
Sbjct: 12 QTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 1035 IEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL ++
Sbjct: 69 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHL 1151
+HRD + N+L+ D KVSDFGL + A ST+ G + APE
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKF 176
Query: 1152 LVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+G+++ E+ S GR P
Sbjct: 177 STKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/216 (30%), Positives = 105/216 (48%), Gaps = 25/216 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 1029
+++G G FG V G L K VA+K LK R +FL E ++ + H N+++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+ + + ++ E + NGS++ L D + + + G A + YL E +
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGK---FTVGQLVGMLRGIASGMKYLSEMN 126
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH------ISTRVMGTFGYVAP 1143
+HRD + NIL+ + KVSDFGL+R D E+ + I R + AP
Sbjct: 127 Y---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIR------WTAP 177
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPV-DMT 1177
E SDV+S+G+V+ E++S G +P DM+
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (263), Expect = 1e-24
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 36/214 (16%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNLV 1028
+GEG +G VY G VA LK++ + +E + E+++L +L H N+V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVA---LKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 1029 KLIGICIEEQARC--LVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALAY 1084
+L I + +V+E + + L G+ D ++++K L Y
Sbjct: 62 RLKEIVTSKGKGSIYMVFEYMDH-----DLTGLLDSPEVKFT-ESQIKCYMKQLLEGLQY 115
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH S ++HRD K SNIL+ +D K++DFGLAR S + RV+ T Y PE
Sbjct: 116 LH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPE 171
Query: 1145 YAMTGHLLV-------KSDVYSYGVVILELLSGR 1171
LL+ + D++S G ++ EL G+
Sbjct: 172 ------LLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 74/275 (26%), Positives = 126/275 (45%), Gaps = 44/275 (16%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
LG G FG+V G VA+K++K EF+ E +++ +L H LV+L G+C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096
++ +V E + NG + ++L K P L++ +AYL S + IHR
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRFQPS---QLLEMCKDVCEGMAYLE---SKQFIHR 124
Query: 1097 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPEYAMTGHLLV 1153
D + N L++ KVSDFGL+R +D+E T +G+ + PE +
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDE----YTSSVGSKFPVRWSPPEVLLYSKFSS 180
Query: 1154 KSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID------PS 1206
KSDV+++GV++ E+ S G+ P + + E +E++ P
Sbjct: 181 KSDVWAFGVLMWEVYSLGKMPYE----------------RFNNSETVEKVSQGLRLYRPH 224
Query: 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV 1241
L ++ KV AI C + + RP +++
Sbjct: 225 LASE-------KVYAIMYSCWHEKAEERPTFQQLL 252
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 17/206 (8%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ-QGGREFLA----EVEMLSRLHHRNLV 1028
+LG G FG VY G+ LDDG AVK + D Q G+E + E+ +LS+L H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+ +G EE + EL+P GS+ L P+ +I LG L YLH
Sbjct: 66 QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLG----LEYLH-- 119
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 1147
+HRD K +NIL++ + K++DFG+A+ + E + G+ ++APE
Sbjct: 120 -DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKS-FKGSPYWMAPEVIAQ 175
Query: 1148 TGHLLVKSDVYSYGVVILELLSGRKP 1173
G + +D++S G +LE+ +G+ P
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-24
Identities = 63/208 (30%), Positives = 98/208 (47%), Gaps = 21/208 (10%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+G G FG VY+ V LD G +AVK ++ D + +E E+++L L H NLVK G+
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSSP 1091
+ + + E G++E L D + L LAYLH
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRIL------DEHVIRVYTLQLLEGLAYLHSH--- 118
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV---MGTFGYVAPE---Y 1145
++HRD K +NI L+H+ K+ DFG A + + + V GT Y+APE
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCA-VKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+D++S G V+LE+ +G++P
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 73/216 (33%), Positives = 111/216 (51%), Gaps = 20/216 (9%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLIGI 1033
LG G FG V+ G + TKVA+K LK QG FLAE ++ +L H LV+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLK----QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+E ++ E + NGS+ L E L + + +A A +A++ +
Sbjct: 70 VTQEPIY-IITEYMENGSLVDFLK--TPEGIKLTINKLIDMAAQIAEGMAFIERKNY--- 123
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHL 1151
IHRD +++NIL+ K++DFGLAR D E + R F + APE G
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGTF 180
Query: 1152 LVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENL 1185
+KSDV+S+G+++ E+++ GR P MT P +NL
Sbjct: 181 TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 83/262 (31%), Positives = 125/262 (47%), Gaps = 30/262 (11%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
LG G FG V+ G + TKVAVK LK FL E +++ +L H LV+L + +
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTMSPESFLEEAQIMKKLRHDKLVQLYAV-VS 71
Query: 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096
E+ +V E + GS+ L D E L + +A A +AY+ + IHR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLK--DGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126
Query: 1097 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 1154
D +S+NIL+ K++DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1155 SDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 1213
SDV+S+G+++ EL++ GR P PG N RE LE+ ++ P
Sbjct: 184 SDVWSFGILLTELVTKGRVPY-----PGMNN-----------REVLEQ-VERGYRMPCPQ 226
Query: 1214 DSVAKVAAIASMCVQPEVQHRP 1235
D + + C + + + RP
Sbjct: 227 DCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/202 (32%), Positives = 103/202 (50%), Gaps = 12/202 (5%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 1029
R++G+G FG VY G L D AVK L R+ D + +FL E ++ H N++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L+GIC+ + LV ++P + + E+ + L A+ + YL +
Sbjct: 61 LLGICLPSEGSPLV--VLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYL---A 115
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTFGYVAPEYAM 1147
S + +HRD + N +L+ FT KV+DFGLAR D+E S H T ++A E
Sbjct: 116 SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 1148 TGHLLVKSDVYSYGVVILELLS 1169
T KSDV+S+GV++ EL++
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 79/209 (37%), Positives = 109/209 (52%), Gaps = 29/209 (13%)
Query: 977 LGEGGFGLVYSGV--LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
LG+G FG V V D G A+KVLK+ + ++ L E +LSR++H +VKL
Sbjct: 1 LGKGSFGKVL-LVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH 59
Query: 1032 GICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIALGAARALAYLH 1086
E+ LV E P G + SHL G E AR +I L AL YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE-----ERARFYAAEIVL----ALEYLH 110
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
S +I+RD K NILL+ D K++DFGLA+ E SR +T GT Y+APE
Sbjct: 111 ---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFC-GTPEYLAPEVL 165
Query: 1147 M-TGHLLVKS-DVYSYGVVILELLSGRKP 1173
+ G+ K+ D +S GV++ E+L+G+ P
Sbjct: 166 LGKGY--GKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 977 LGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
LG G +G VY GV VAVK LK D EFL E ++ + H NLV+L+G+C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
E ++ E + G++ +L +++ L +A + A+ YL + + IH
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQEVNA--VVLLYMATQISSAMEYLEKKN---FIH 127
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1155
RD + N L+ + KV+DFGL+R M ++ + APE +KS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186
Query: 1156 DVYSYGVVILELLS-GRKP---VDMTQ 1178
DV+++GV++ E+ + G P +D++Q
Sbjct: 187 DVWAFGVLLWEIATYGMSPYPGIDLSQ 213
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 975 RILGEGGFGLVYSGVL--DDGT--KVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNL 1027
+ILGEG FG V G L DDG+ KVAVK +K +D E FL+E + H N+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMK-LDIHTYSEIEEFLSEAACMKDFDHPNV 63
Query: 1028 VKLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAP--LGWDARLKIALGAA 1079
+KLIG+C E + ++ + +G + S L P L LK + A
Sbjct: 64 MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE---SRHISTRVMG 1136
+ YL S+ IHRD + N +L D T V+DFGL++ + I+ +
Sbjct: 124 LGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV- 179
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196
++A E KSDV+++GV + E+ + T PG EN
Sbjct: 180 --KWIAIESLADRVYTSKSDVWAFGVTMWEIAT----RGQTPYPGVEN-----------H 222
Query: 1197 EGLERIIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
E + + GN + P D + ++ + C + + + RP ++ + L
Sbjct: 223 EIYDYLRH---GNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 4e-23
Identities = 79/273 (28%), Positives = 132/273 (48%), Gaps = 23/273 (8%)
Query: 976 ILGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
++ G G Y G + +G + VK + V+ +E+ + +L H N+VKLIG+C
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLC 752
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
E+ L++E I ++ L L W+ R KIA+G A+AL +LH SP V+
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
+ I+++ P + L + IS+ YVAPE T + K
Sbjct: 806 VGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------AYVAPETRETKDITEK 858
Query: 1155 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFD 1214
SD+Y +G++++ELL+G+ P D + ++V WAR S L+ IDPS+ DV +
Sbjct: 859 SDIYGFGLILIELLTGKSPADA-EFGVHGSIVEWAR-YCYSDCHLDMWIDPSIRGDVSVN 916
Query: 1215 S--VAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ +V +A C + RP +V++ L+
Sbjct: 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 5e-23
Identities = 58/219 (26%), Positives = 93/219 (42%), Gaps = 25/219 (11%)
Query: 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 1034
LG+G G+VY G A+K + + R+ L E++ L +VK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E +V E + GS L + K+ + IA + L YLH +I
Sbjct: 69 YKEGEISIVLEYMDGGS----LADLLKKVGKIPEPVLAYIARQILKGLDYLHTKR--HII 122
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV------MGTFGYVAPEYAMT 1148
HRD K SN+L+ K++DFG+ S+ + + +GT Y++PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGI--------SKVLENTLDQCNTFVGTVTYMSPERIQG 174
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 1187
+D++S G+ +LE G+ P PPGQ +
Sbjct: 175 ESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFE 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 6e-23
Identities = 68/206 (33%), Positives = 108/206 (52%), Gaps = 19/206 (9%)
Query: 975 RILGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGR---EFLAEVEMLSRLHHRN 1026
R LGEG FG V Y D+ G +VAVK LK + GG + E+E+L L+H N
Sbjct: 10 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHEN 67
Query: 1027 LVKLIGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+VK GIC E+ L+ E +P+GS++ +L + + +LK A+ + + Y
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDY 124
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAP 1143
L S + +HRD + N+L+E + K+ DFGL ++ D+E + + + AP
Sbjct: 125 L---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLS 1169
E + + SDV+S+GV + ELL+
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 70/224 (31%), Positives = 105/224 (46%), Gaps = 20/224 (8%)
Query: 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HH 1024
TG F+ ++GEG +G VY G VA+K++ + + E E +L + +H
Sbjct: 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD-IIEDEEEEIKEEYNILRKYSNH 62
Query: 1025 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
N+ G I++ LV EL GSV + G+ K+ L + I
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
R LAYLHE+ +VIHRD K NILL + K+ DFG+ SA + + +GT
Sbjct: 123 LRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV--SAQLDSTLGRRNTFIGTP 177
Query: 1139 GYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKPV-DM 1176
++APE +SDV+S G+ +EL G+ P+ DM
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM 221
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 2e-22
Identities = 67/220 (30%), Positives = 101/220 (45%), Gaps = 19/220 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH 1023
N R LGEG FG V+ D VAVK LK ++F E E+L+ L
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDK----ESAP---LGWDARLKI 1074
H ++VK G+C+E +V+E + +G + L HG D E L L I
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHI 125
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
A A + YL +S +HRD + N L+ + K+ DFG++R + +
Sbjct: 126 AQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHT 182
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
M ++ PE M +SDV+S GVV+ E+ + G++P
Sbjct: 183 MLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 98.4 bits (246), Expect = 2e-22
Identities = 62/229 (27%), Positives = 102/229 (44%), Gaps = 34/229 (14%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRL-HH 1024
+F +I+GEG F V + + A+K+L +++ ++ ++ E E+L+RL H
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 1025 RNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
++KL +++ V E PNG + ++ R A AL
Sbjct: 62 PGIIKLYY-TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK---CTRFYAAE-ILLALE 116
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-------- 1135
YLH S +IHRD K NILL+ D K++DFG A+ +D S S +
Sbjct: 117 YLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAK-VLDPNSSPESNKGDATNIDSQI 172
Query: 1136 -----------GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT YV+PE SD+++ G +I ++L+G+ P
Sbjct: 173 EKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 22/218 (10%)
Query: 975 RILGEGGFGLVYSG------VLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
R LGEG FG V+ D VAVK LK ++F E E+L+ L H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHL--HGVD----------KESAPLGWDARLKIAL 1076
K G+C + +V+E + +G + L HG D + LG L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1136
A + YL +S +HRD + N L+ + K+ DFG++R + + M
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
++ PE M +SDV+S+GV++ E+ + G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.2 bits (243), Expect = 6e-22
Identities = 68/209 (32%), Positives = 100/209 (47%), Gaps = 31/209 (14%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIG 1032
LGEG +G+VY G VA+K ++ +++ G L E+ +L L H N+VKL+
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHG-VDKESAPLGWDARL--KIALGAARALAYLHEDS 1089
+ E+ LV+E + L +DK PL L I R LAY H
Sbjct: 66 VIHTERKLYLVFEYC-----DMDLKKYLDKRPGPL--SPNLIKSIMYQLLRGLAYCH--- 115
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S R++HRD K NIL+ D K++DFGLAR+ R + V+ T Y APE
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLARAFG-IPLRTYTHEVV-TLWYRAPE----- 168
Query: 1150 HLLVKSDVYSYGV-------VILELLSGR 1171
+L+ S YS V + E+++G+
Sbjct: 169 -ILLGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 64/223 (28%), Positives = 97/223 (43%), Gaps = 47/223 (21%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+GEG G VY G +VA+K + R+ +Q + E+ ++ H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNIVDYYDSYL 85
Query: 1036 EEQARCLVYELIPNGS------------VESHLHGVDKESAPLGWDARLKIALGAARALA 1083
+V E + GS E + V +E + L
Sbjct: 86 VGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVL---------------QGLE 130
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
YLH S VIHRD KS NILL D + K++DFG A E+S+ S V+GT ++AP
Sbjct: 131 YLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAP 185
Query: 1144 E------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1180
E Y K D++S G++ +E+ G P + +PP
Sbjct: 186 EVIKRKDYGP------KVDIWSLGIMCIEMAEGEPPY-LREPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 9e-22
Identities = 84/290 (28%), Positives = 129/290 (44%), Gaps = 44/290 (15%)
Query: 975 RILGEGGFGLVYSGVL----DDGTK--VAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNL 1027
R LG G FG VY G+ D + VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 12 RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL-HGVDKESAP--LGWDARLKIALGAARALAY 1084
V+LIG+ E R ++ EL+ G ++S L + P L L A A+ Y
Sbjct: 72 VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131
Query: 1085 LHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L E+ IHRD + N LL K++DFG+AR R M ++
Sbjct: 132 LEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWM 188
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200
PE + G K+DV+S+GV++ E+ S G P PG+ N +E +E
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY-----PGRTN-----------QEVME 232
Query: 1201 RI-----IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ +DP G P V I + C Q + RP +++ ++
Sbjct: 233 FVTGGGRLDPPKGCPGP------VYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-21
Identities = 118/539 (21%), Positives = 147/539 (27%), Gaps = 65/539 (12%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA----SH 245
R PA A A P P AP S + LP + P
Sbjct: 2481 RRPAEARFPFAAGAAPDPGGGGPPDPDAPPAPSRLAPAILPDEP-VGEPVHPRMLTWIRG 2539
Query: 246 LSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTA 305
L A A P PLP + APP A P + PPP P + P S
Sbjct: 2540 LEELASDDAGDP--PPPLPPA-----APPAA--PDRSVPPPRPAPRPSEPAVTSRARRPD 2590
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
PP S P APP P AP P S A +PP
Sbjct: 2591 APPQSARPRAPVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSPAANEPDPHPPPTVPPPE 2650
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
P + P A ++PP T S S PPP
Sbjct: 2651 RPRDDPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPP------- 2703
Query: 426 SALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPG-PLPPVAQKRNASNREAPI 484
P P PA H + PLPP ++ P
Sbjct: 2704 ---PPPTP-----------------------EPAPHALVSATPLPPGPAAARQASPALPA 2737
Query: 485 AEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGK-PVAEP 543
A P P + ARP G P +P P P + PP + V +
Sbjct: 2738 APAPPAVPAGPATPGGPARPARPPTTAGPPAPAP-PAAPAAGPPRRLTRPAVASLSESRE 2796
Query: 544 SYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKH 603
S P P + AP+ S PLPP +S P + P P
Sbjct: 2797 SLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPPTSA---------QPTAPPPPPGPPP 2847
Query: 604 RDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTP 663
+ + +P P + + P P+ R P VS S P
Sbjct: 2848 PSLPLGGSVAPGGDVRRRPPS---RSPAAKPAAPARPPVRRLARPA---VSRSTESFALP 2901
Query: 664 VSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTNTP 722
+ P P P PP+ P P P PP EP P
Sbjct: 2902 PDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQPPLAPTTDPAGAGEPSGAVP 2960
|
Length = 3151 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 72/285 (25%), Positives = 137/285 (48%), Gaps = 32/285 (11%)
Query: 974 SRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRN 1026
SR LG+G FG+VY G+ + T+VA+K + R EFL E ++ + +
Sbjct: 11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES------APLGWDARLKIALGAAR 1080
+V+L+G+ + Q ++ EL+ G ++S+L + E AP +++A A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
+AYL+ + + +HRD + N ++ DFT K+ DFG+ R + + + + +
Sbjct: 131 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRW 187
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200
++PE G SDV+S+GVV+ E+ + + + P Q +++ + L
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQG---------MSNEQVLR 232
Query: 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+++ L D P + + + MC Q + RP E++ ++K
Sbjct: 233 FVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 95.7 bits (238), Expect = 1e-21
Identities = 79/280 (28%), Positives = 127/280 (45%), Gaps = 36/280 (12%)
Query: 976 ILGEGGFGLVYSGVLDDGTK----VAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 1029
++G G FG V G L K VA+K LK ++Q R+FL+E ++ + H N++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQR-RDFLSEASIMGQFDHPNIIH 69
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+ + + ++ E + NG+++S L D + + L+ G A + YL E +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLR---GIAAGMKYLSEMN 126
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAPEYA 1146
+HRD + NIL+ + KVSDFGL+R D+ S T +G + APE
Sbjct: 127 ---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183
Query: 1147 MTGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIID 1204
SDV+SYG+V+ E++S G +P DM S + + I+
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDM------------------SNQDVINAIE 225
Query: 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
P D + + C Q + RP G++V L
Sbjct: 226 QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTL 265
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 80/284 (28%), Positives = 137/284 (48%), Gaps = 32/284 (11%)
Query: 975 RILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNL 1027
R LG+G FG+VY G D T+VAVK + R EFL E ++ ++
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLK----IALGAARA 1081
V+L+G+ + Q +V EL+ +G ++S+L + + E+ P L+ +A A
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+AYL ++ + +HRD + N ++ HDFT K+ DFG+ R + + + + ++
Sbjct: 132 MAYL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201
APE G SD++S+GVV+ E+ S + + P Q L++ + L+
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQG---------LSNEQVLKF 233
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
++D D P + +V + MC Q + RP E+V LK
Sbjct: 234 VMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 3e-21
Identities = 67/200 (33%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAV-VS 71
Query: 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096
E+ +V E + GS+ L G + L + +A A +AY+ + +HR
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKG--EMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 1097 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 1154
D +++NIL+ + KV+DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1155 SDVYSYGVVILELLS-GRKP 1173
SDV+S+G+++ EL + GR P
Sbjct: 184 SDVWSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 73/282 (25%), Positives = 126/282 (44%), Gaps = 33/282 (11%)
Query: 976 ILGEGGFGLVY----SGVLDDGTK--VAVKVL-KRVDQQGGREFLAEVEMLSRLHHRNLV 1028
LG G FG V+ G+ ++G + V VK L K D+ EF E++M +L H+N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHL----HGVDK-ESAPLGWDARLKIALGAARALA 1083
+L+G+C E + ++ E G ++ L +K + PL ++ + A +
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
+L S+ R +HRD + N L+ KVS L++ + E + ++ ++AP
Sbjct: 132 HL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PLRWLAP 187
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
E KSDV+S+GV++ E+ + G P L+ E L R+
Sbjct: 188 EAVQEDDFSTKSDVWSFGVLMWEVFTQGELP----------------FYGLSDEEVLNRL 231
Query: 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
L VP +++ + + C + RP E+V AL
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 4e-21
Identities = 59/211 (27%), Positives = 104/211 (49%), Gaps = 20/211 (9%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVK---VLKRVDQQGGREFL-------AEVEMLSRLHH 1024
++G+G +G VY + + G +AVK + + + +E+E L L H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
N+V+ +G E+ + E +P GS+ S L + L ++ G LAY
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEG----LAY 123
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH S ++HRD K+ N+L++ D K+SDFG+++ + D + + G+ ++APE
Sbjct: 124 LH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPE 180
Query: 1145 YAMTGH--LLVKSDVYSYGVVILELLSGRKP 1173
+ K D++S G V+LE+ +GR+P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 65/213 (30%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ LG G FG V+ G ++ TKVAVK LK + FL E ++ L H LV+L +
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E+ ++ E + GS+ L E + + + A +AY+ + I
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLK--SDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YI 125
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 1152
HRD +++N+L+ K++DFGLAR D E + R F + APE G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGSFT 182
Query: 1153 VKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1184
+KSDV+S+G+++ E+++ G+ P PG N
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPY-----PGMSN 210
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 5e-21
Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 43/278 (15%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
R+LG+G FG L +D + V K L R+ ++ R+ L E+ +LS L H N++
Sbjct: 6 RVLGKGAFG---EATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62
Query: 1029 KLIGICIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+++ + E G++ G E + W A++Y+
Sbjct: 63 AYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW-----YLFQIVSAVSYI 117
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H+ ++HRD K+ NI L K+ DFG+++ + E T V+GT Y++PE
Sbjct: 118 HKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISK-ILGSEYSMAET-VVGTPYYMSPEL 172
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
KSD+++ G V+ ELL+ ++ D T P NLV +I+
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL---NLVV-------------KIVQ- 215
Query: 1206 SLGNDVPFDSV--AKVAAIASMCVQPEVQHRPFMGEVV 1241
GN P SV +++ ++ +Q + + RP EV+
Sbjct: 216 --GNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 9e-21
Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 40/236 (16%)
Query: 965 EKATGNFDASRILGEGGFGLVYS----GVL--DDGTKVAVKVLKR-VDQQGGREFLAEVE 1017
E N + R +G+G FG V+ G+L + T VAVK+LK +F E
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60
Query: 1018 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNG------------SVESHLHGVDKESA- 1064
+++ H N+VKL+G+C + CL++E + G + S H
Sbjct: 61 LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 1065 -----PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119
PL +L IA A +AYL E + +HRD + N L+ + K++DFGL+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 1120 RS--AMD----EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
R+ + D E+ I R M PE +SDV++YGVV+ E+ S
Sbjct: 178 RNIYSADYYKASENDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-20
Identities = 81/283 (28%), Positives = 136/283 (48%), Gaps = 35/283 (12%)
Query: 975 RILGEGGFGLVYSGVLDDGTK----VAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLV 1028
+++G G FG V SG L K VA+K LK ++Q R+FL+E ++ + H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIMGQFDHPNII 68
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L G+ + + +V E + NGS+++ L D + + L+ G A + YL
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR---GIASGMKYL--- 122
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE-ESRHISTRVMGTFGYVAPEYAM 1147
S +HRD + NIL+ + KVSDFGL+R D+ E+ + + + APE
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 1148 TGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
SDV+SYG+V+ E++S G +P +M+ + ++ + E R+ P
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-----------QDVIKAIEEGYRL--P 229
Query: 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL-KLV 1247
+ P D A + + C Q + RP ++V L KL+
Sbjct: 230 A-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 74/278 (26%), Positives = 128/278 (46%), Gaps = 32/278 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVK 1029
+++G G FG V+ G+L + VA+K LK + R +FL+E ++ + H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+ + + ++ E + NG+++ +L D E + L+ G A + YL S
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYL---S 124
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE-ESRHISTRVMGTFGYVAPEYAMT 1148
+HRD + NIL+ + KVSDFGL+R D+ E + ++ + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKPV-DMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206
SDV+S+G+V+ E++S G +P DM S + + I+
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERPYWDM------------------SNHEVMKAINDG 226
Query: 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
P D + V + C Q + RP ++V L
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLL 264
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-20
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 19/206 (9%)
Query: 977 LGEGGFGLVYSGVLDDGTK---VAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIG 1032
LG G FG V GV K VA+KVLK +++ R E + E E++ +L + +V++IG
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 1090
+C E +A LV E+ G + L G K+ + L ++++G + YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMG----MKYLEGKN- 115
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMT 1148
+HRD + N+LL + K+SDFGL++ A+ + + R G + + APE
Sbjct: 116 --FVHRDLAARNVLLVNQHYAKISDFGLSK-ALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKP 1173
+SDV+SYG+ + E S G+KP
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 67/242 (27%), Positives = 110/242 (45%), Gaps = 29/242 (11%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
LG G G+V + G +AVK ++ +++ ++ L E+++L + + +V G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAF 68
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKE--SAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ E + GS++ L V LG KIA+ + L YLHE
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK-- 121
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
+IHRD K SNIL+ K+ DFG++ ++ ++ +GT Y+APE
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYS 177
Query: 1153 VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID---PSLGN 1209
VKSD++S G+ ++EL +GR P PP P E L+ I++ P L +
Sbjct: 178 VKSDIWSLGLSLIELATGRFPY----PP-------ENDPPDGIFELLQYIVNEPPPRLPS 226
Query: 1210 DV 1211
Sbjct: 227 GK 228
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 976 ILGEGGFGLVYSGVLDDGTKVAVK--VLKRVDQQGG----REFLAEVEMLSRLHHRNLVK 1029
+LG+G +G VY G+ + G +AVK L + + EV++L L H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+G C+++ + E +P GS+ S L PL K +AYLH +
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLAR----SAMDEESRHISTRVMGTFGYVAPEY 1145
V+HRD K +N++L + K+ DFG AR + ++ + GT ++APE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
KSD++S G + E+ +G+ P
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-20
Identities = 59/217 (27%), Positives = 108/217 (49%), Gaps = 27/217 (12%)
Query: 977 LGEGGFGLVY----SGVL-----------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLS 1020
LGEG FG V+ G+ VAVK+L+ V + +FL E++++S
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESA--------PLGWDARL 1072
RL + N+++L+G+C+ + C++ E + NG + L + ES + L
Sbjct: 73 RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+A+ A + YL +S +HRD + N L+ + +T K++DFG++R+ + I
Sbjct: 133 YMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
R + ++A E + G SDV+++GV + E+ +
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 2e-20
Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 23/282 (8%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLH 1023
GNF + +G+G F +VY + L DG VA+K ++ +D + ++ L E+++L +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
H N++K + IE +V EL G + + K+ + K + AL
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
++H S R++HRD K +N+ + K+ D GL R + + S ++GT Y++P
Sbjct: 121 HMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSP 175
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203
E KSD++S G ++ E+ + + P + NL + + +E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD----KMNLYSLCKK-------IEKCD 224
Query: 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P L D ++ + S C+ P+ + RP + V+Q K
Sbjct: 225 YPPLPADH---YSEELRDLVSRCINPDPEKRPDISYVLQVAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 68/200 (34%), Positives = 106/200 (53%), Gaps = 13/200 (6%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036
LG+G FG V+ G + TKVA+K LK FL E +++ +L H LV L + +
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKP-GTMMPEAFLQEAQIMKKLRHDKLVPLYAV-VS 71
Query: 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096
E+ +V E + GS+ L D + L + +A A +AY+ + IHR
Sbjct: 72 EEPIYIVTEFMGKGSLLDFLKEGDGKYLKL--PQLVDMAAQIADGMAYIERMN---YIHR 126
Query: 1097 DFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLLVK 1154
D +++NIL+ + K++DFGLAR D E + R F + APE A+ G +K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 1155 SDVYSYGVVILELLS-GRKP 1173
SDV+S+G+++ EL++ GR P
Sbjct: 184 SDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLI 1031
+ LG G FG+V+ G KVA+K + +G +F+ E +++ +L H LV+L
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKAIN----EGAMSEEDFIEEAKVMMKLSHPKLVQLY 65
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1091
G+C +++ +V E + NG + L+ + + L D L + + YL +S
Sbjct: 66 GVCTQQKPLYIVTEFMENGCL---LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS-- 120
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG------YVAPEY 1145
IHRD + N L+ KVSDFG+ R +D+E + S + G + PE
Sbjct: 121 -FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE--YTS-----SSGAKFPVKWSPPEV 172
Query: 1146 AMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+GV++ E+ + G+ P
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 4e-20
Identities = 66/211 (31%), Positives = 104/211 (49%), Gaps = 19/211 (9%)
Query: 970 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRL 1022
N + LG G FG V D KVAVK+LK RE L +E++++S L
Sbjct: 36 NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHL 95
Query: 1023 -HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+H N+V L+G C ++ E G + + L K + L + L + A+
Sbjct: 96 GNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKG 153
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI---STRVMGTF 1138
+A+L +S IHRD + N+LL H K+ DFGLAR M+ +S ++ + R+
Sbjct: 154 MAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN-DSNYVVKGNARL--PV 207
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
++APE +SDV+SYG+++ E+ S
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 7e-20
Identities = 71/203 (34%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 977 LGEGGFGLV----YSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
LG+G FG V Y + D+ G VAVK L+ + R+F E+E+L L H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 1032 GICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
G+C R LV E +P GS+ +L K L L A + + YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYL---QKHRERLDHRKLLLYASQICKGMEYL---G 125
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG---TFGYVAPEYA 1146
S R +HRD + NIL+E + K+ DFGL + + ++ + R G F Y APE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTK-VLPQDKEYYKVREPGESPIFWY-APESL 183
Query: 1147 MTGHLLVKSDVYSYGVVILELLS 1169
V SDV+S+GVV+ EL +
Sbjct: 184 TESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 8e-20
Identities = 59/206 (28%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 976 ILGEGGFGLVYSGVLD--DGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+G+G FG V V DG + K + + ++ ++ ++EV +L L H N+V+
Sbjct: 7 TIGKGSFGTVRK-VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 1032 GICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH--E 1087
I+ + L V E G + + KE + + +I AL H
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRS 125
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1147
D V+HRD K +NI L+ + K+ DFGLA+ + +S T V GT Y++PE
Sbjct: 126 DPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYV-GTPYYMSPEQLN 183
Query: 1148 TGHLLVKSDVYSYGVVILELLSGRKP 1173
KSD++S G +I EL + P
Sbjct: 184 HMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 60/218 (27%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 977 LGEGGFGLVY----SGVLDDGTK-------------VAVKVLKRVDQQGGR-EFLAEVEM 1018
LGEG FG V+ G+ K VAVK+L+ + R +FL E+++
Sbjct: 13 LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR------- 1071
+SRL N+++L+ +CI C++ E + NG + L + + A D
Sbjct: 73 MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
+ +A A + YL SS +HRD + N L+ ++T K++DFG++R+ + I
Sbjct: 133 IFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
R + +++ E + G SDV+++GV + E+L+
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 67/239 (28%), Positives = 115/239 (48%), Gaps = 40/239 (16%)
Query: 977 LGEGGFGLVYSGVLDDGTK-----------------VAVKVLKRVDQQGGR-EFLAEVEM 1018
LGEG FG V+ + + VAVK+L+ + R +FL EV++
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKI 72
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAP----------- 1065
LSRL N+++L+G+C++E C++ E + NG + L H +D +
Sbjct: 73 LSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCL 132
Query: 1066 --LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123
+ + + L +AL A + YL SS +HRD + N L+ + T K++DFG++R+
Sbjct: 133 PAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189
Query: 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
+ I R + ++A E + G SDV+++GV + E+L + QP G+
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM----LCKEQPYGE 244
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 90.4 bits (224), Expect = 1e-19
Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 977 LGEGGFGLVYSGVL-----DDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKL 1030
LGE FG +Y G L D VA+K LK ++ Q EF E +++ LHH N+V L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 1075
+G+ +EQ C+++E + G + L G K S G L IA
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHG--DFLHIA 130
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
+ A + YL SS +H+D + NIL+ K+SD GL+R + + + +
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
++ PE M G SD++S+GVV+ E+ S G +P
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 90.3 bits (224), Expect = 1e-19
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 18/204 (8%)
Query: 977 LGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 1032
LG+GGFG V + V G A K L KR+ ++ G + L E ++L ++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHEDS 1089
+ CLV L+ G ++ H++ V + P A +I G L +LH+
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA-RAIFYAAQIICG----LEHLHQR- 114
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
R+++RD K N+LL+ ++SD GLA + GT GY+APE
Sbjct: 115 --RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQGE 169
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D ++ G + E+++GR P
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 64/210 (30%), Positives = 94/210 (44%), Gaps = 18/210 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVD---QQGGREFLAEVEMLSRLHHR 1025
+F+ R++G+G FG V D K+ A+K + + + R L E +L L+H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALA 1083
LV L +E+ LV +L+ G + HL E + I AL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ-----VKFWIC-EIVLALE 114
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
YLH S +IHRD K NILL+ ++DF +A + ++T GT GY+AP
Sbjct: 115 YLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGTPGYMAP 168
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
E V D +S GV E L G++P
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 2e-19
Identities = 65/232 (28%), Positives = 117/232 (50%), Gaps = 21/232 (9%)
Query: 956 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-LKRVDQQGGREFL 1013
A+ +E+ K ++LG G FG V+ G+ + +G + + V +K + + GR+
Sbjct: 1 ARILKETELRKL-------KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTF 53
Query: 1014 AEV--EMLS--RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 1069
E+ ML+ L H +V+L+GIC + LV +L P GS+ H+ + L
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGASLQ-LVTQLSPLGSLLDHVR---QHRDSLDPQ 109
Query: 1070 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129
L + A+ + YL E R++HR+ + NILL+ D +++DFG+A ++ ++
Sbjct: 110 RLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKY 166
Query: 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPP 1180
+ ++A E + G +SDV+SYGV + E++S G +P +P
Sbjct: 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-19
Identities = 65/197 (32%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+G G FG V+SG L D T VAVK + + +FL E +L + H N+V+LIG+C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
++Q +V EL+ G + L E L +++ AA + YL S I
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR---TEGPRLKVKELIQMVENAAAGMEYLE---SKHCI 116
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGHLL 1152
HRD + N L+ K+SDFG++R +E+ + ST M + APE G
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 1153 VKSDVYSYGVVILELLS 1169
+SDV+S+G+++ E S
Sbjct: 175 SESDVWSFGILLWEAFS 191
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGI 1033
+GEG +G+VY G VA+K +K + G + L E+++L L+H N++KL+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 1034 CIEEQARCLVYELIPNGSVESHL-HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ LV+E + ++ L + L + LA+ H S
Sbjct: 67 FRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHG 118
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR----HISTRVMGTFGYVAPE--YA 1146
++HRD K N+L+ + K++DFGLARS R ++ TR Y APE
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF-GSPVRPYTHYVVTR-----WYRAPELLLG 172
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGR 1171
G+ D++S G + ELLS R
Sbjct: 173 DKGY-STPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 2e-19
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 28/216 (12%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHH 1024
+ +GEG +G+V S G KVA+K + + Q F L E+++L R H
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ---TFCQRTLREIKILRRFKH 62
Query: 1025 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
N++ ++ I I + +V EL+ E+ L+ + K + L D
Sbjct: 63 ENIIGILDI-IRPPSFESFNDVYIVQELM-----ETDLYKLIK-TQHLSNDHIQYFLYQI 115
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS--TRVMG 1136
R L Y+H S V+HRD K SN+LL + K+ DFGLAR A D E H T +
Sbjct: 116 LRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIA-DPEHDHTGFLTEYVA 171
Query: 1137 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
T Y APE + K+ D++S G ++ E+LS R
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 63/205 (30%), Positives = 90/205 (43%), Gaps = 24/205 (11%)
Query: 977 LGEGGFGLVYSG-VLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+GEG +G+V G VA+K K D+ + L EV++L +L H N+V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+ LV+E + + L ++ L DA +A+AY H S +
Sbjct: 69 FRRKGRLYLVFEYVER----TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNI 121
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1153
IHRD K NIL+ K+ DFG AR A+ T + T Y APE LLV
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFAR-ALRARPASPLTDYVATRWYRAPE------LLV 174
Query: 1154 KS-------DVYSYGVVILELLSGR 1171
DV++ G ++ ELL G
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 28/218 (12%)
Query: 977 LGEGGFGLVY-----------------SGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEM 1018
LGEG FG V+ + D VAVKVL+ +FL EV++
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH-------GVDKESAPLGWDAR 1071
LSRL N+ +L+G+C + C++ E + NG + L G+ S L +
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
L +A A + YL S +HRD + N L+ ++T K++DFG++R+ + +
Sbjct: 133 LYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
R ++A E + G KSDV+++GV + E+L+
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 5e-19
Identities = 64/211 (30%), Positives = 107/211 (50%), Gaps = 31/211 (14%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 1030
LGEG + +VY + G VA+K +K +++ ++ + E+++L L H N++ L
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDS 1089
+ + + LV+E + E+ L V K+ + + A +K L R L YLH +
Sbjct: 68 LDVFGHKSNINLVFEFM-----ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
++HRD K +N+L+ D K++DFGLARS +R ++ +V+ T Y APE
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARS-FGSPNRKMTHQVV-TRWYRAPE----- 172
Query: 1150 HLLVKS-------DVYSYGVVILELLSGRKP 1173
LL + D++S G + ELL R P
Sbjct: 173 -LLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 5e-19
Identities = 63/224 (28%), Positives = 94/224 (41%), Gaps = 23/224 (10%)
Query: 969 GNFDASRILGEGGFGLVYSGVLDDGTK--VAVK-VLKRVDQQGGREFLAEVEMLSRLHHR 1025
LGEG G V + T A+K + + ++ L E+E+
Sbjct: 1 EKIVELSRLGEGAGGSV-TKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 1026 NLVKLIGICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
+VK G ++E + + E GS++S V K +G KIA + L+
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG---- 1139
YLH ++IHRD K SNILL K+ DFG+ S + + GTF
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGV--------SGELVNSLAGTFTGTSF 168
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV--DMTQPPG 1181
Y+APE + SDV+S G+ +LE+ R P + P G
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG 212
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 6e-19
Identities = 64/208 (30%), Positives = 111/208 (53%), Gaps = 14/208 (6%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKV----AVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLV 1028
++LG G FG VY G+ + +G V A+K+L + EF+ E +++ + H +LV
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+G+C+ + LV +L+P+G + ++H + +G L + A+ + YL E
Sbjct: 73 RLLGVCLSPTIQ-LVTQLMPHGCLLDYVH---EHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
R++HRD + N+L++ K++DFGLAR +E + + ++A E
Sbjct: 129 ---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKPVD 1175
+SDV+SYGV I EL++ G KP D
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 31/277 (11%)
Query: 975 RILGEGGFGLVYSGV-LDDGTK----VAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
++LG G FG VY G+ + DG VA+KVL+ + +E L E +++ + +
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+GIC+ + LV +L+P G + + V + +G L + A+ ++YL E
Sbjct: 73 RLLGICLTSTVQ-LVTQLMPYGCLLDY---VRENKDRIGSQDLLNWCVQIAKGMSYLEE- 127
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
R++HRD + N+L++ K++DFGLAR +E+ + + ++A E +
Sbjct: 128 --VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207
+SDV+SYGV + EL++ G KP D AR + E ER+ P +
Sbjct: 186 RRFTHQSDVWSYGVTVWELMTFGAKPYDGIP----------AREIPDLLEKGERLPQPPI 235
Query: 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
V I C + + RP E+V
Sbjct: 236 -------CTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 2e-18
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 16/221 (7%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL 1022
EI + + + + LG G FG V+ + TKVAVK +K FLAE ++ L
Sbjct: 2 EIPRESLKLE--KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTL 58
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
H LVKL + +E ++ E + GS+ L + PL + + A +
Sbjct: 59 QHDKLVKLHAVVTKEPIY-IITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGM 115
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GY 1140
A++ + + IHRD +++NIL+ K++DFGLAR D E + R F +
Sbjct: 116 AFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKW 169
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPV-DMTQP 1179
APE G +KSDV+S+G++++E+++ GR P M+ P
Sbjct: 170 TAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP 210
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-18
Identities = 63/206 (30%), Positives = 98/206 (47%), Gaps = 26/206 (12%)
Query: 977 LGEGGFGLVYS-GVLDDGTKVAVK--VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+GEG G+V+ + G VA+K L+R++ + L E++ L H +VKL+ +
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
LV E +P S L V + E PL + +AY+H +
Sbjct: 68 FPHGSGFVLVMEYMP-----SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
++HRD K +N+L+ D K++DFGLAR +EE R S +V T Y APE LL
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE------LL 172
Query: 1153 VKS-------DVYSYGVVILELLSGR 1171
+ D+++ G + ELL+G
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-18
Identities = 62/227 (27%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 970 NFDASRILGEGGFGLVYSGV------LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL 1022
N + LGEG FG V T VAVK+LK R+ L+E +L ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDAR---------- 1071
+H +++KL G C ++ L+ E GS+ S L K + LG D
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 1072 ---------LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122
+ A +R + YL E ++HRD + N+L+ K+SDFGL+R
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
+E+S ++ ++A E +SDV+S+GV++ E+++
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-18
Identities = 62/213 (29%), Positives = 103/213 (48%), Gaps = 27/213 (12%)
Query: 976 ILGEGGFGLVYSG-VLDDGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 1030
++GEG FG V + DG ++ A+K +K + R+F E+E+L +L HH N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHG------------VDKESAPLGWDARLKIALGA 1078
+G C L E P+G++ L + ++ L L A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
AR + YL S + IHRD + NIL+ ++ K++DFGL+R + ++ + MG
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK-KTMGRL 185
Query: 1139 G--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
++A E SDV+SYGV++ E++S
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-18
Identities = 54/203 (26%), Positives = 93/203 (45%), Gaps = 14/203 (6%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
LG+G FG VY + G A K+++ ++ +F+ E+++LS H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
E ++ E G+++S + + L + AL +LH +VIH
Sbjct: 73 YENKLWILIEFCDGGALDSI---MLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIH 126
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL--- 1152
RD K+ NILL D K++DFG++ + + +GT ++APE
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 1153 --VKSDVYSYGVVILELLSGRKP 1173
K+D++S G+ ++EL P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-17
Identities = 76/229 (33%), Positives = 108/229 (47%), Gaps = 55/229 (24%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTK--VAVKVLK-------RVDQQGGREFLAEVEMLSR 1021
++ + LG+G +G+V+ + D TK VA+K K D Q R F E+ L
Sbjct: 9 YEILQKLGKGAYGIVWKAI-DRRTKEVVALK--KIFDAFRNATDAQ--RTF-REIMFLQE 62
Query: 1022 L-HHRNLVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLK----- 1073
L H N+VKL+ + E + LV+E + E+ LH V + A + L+
Sbjct: 63 LGDHPNIVKLLNVIKAENDKDIYLVFEYM-----ETDLHAVIR--ANI-----LEDVHKR 110
Query: 1074 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM---DEESRH 1129
I +AL Y+H S VIHRD K SNILL D K++DFGLARS +
Sbjct: 111 YIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167
Query: 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV------VIL-ELLSGR 1171
+ T + T Y APE +L+ S Y+ GV IL E+L G+
Sbjct: 168 VLTDYVATRWYRAPE------ILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 66/214 (30%), Positives = 98/214 (45%), Gaps = 37/214 (17%)
Query: 980 GGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHRNLVKLIGICI 1035
G +G V+ G A+KV+K+ D + L E ++LS+ +VKL
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 1036 EEQARCLVYELIPNGSVESHLHGV---DKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
++ LV E +P G + S L V D++ A R+ IA AL YLH S
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLENVGSLDEDVA------RIYIAEIVL-ALEYLH---SNG 113
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI--------STRVMGTFGYVAPE 1144
+IHRD K NIL++ + K++DFGL S + R I R++GT Y+APE
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGL--SKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 1145 YAMTGHLLVKS-----DVYSYGVVILELLSGRKP 1173
+L + D +S G ++ E L G P
Sbjct: 172 V-----ILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-17
Identities = 60/216 (27%), Positives = 109/216 (50%), Gaps = 14/216 (6%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHR 1025
++ R++G G FG+V+ D V +K + V+Q E LA E ++L L H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIP-VEQMTKDERLAAQNECQVLKLLSHP 59
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N+++ +E++A +V E P G++ ++ + ++ L D L + AL ++
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLALHHV 117
Query: 1086 HEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
H + ++HRD K+ NILL+ H K+ DFG+++ S+ + V+GT Y++PE
Sbjct: 118 H---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPE 171
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1180
KSD+++ G V+ EL S ++ + P
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-17
Identities = 64/216 (29%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 976 ILGEGGFGLVYSGVLD-DGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 1030
++GEG FG V ++ DG K+ A+K+LK + R+F E+E+L +L HH N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 1075
+G C + E P G++ L HG ++ L L+ A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT---ASTLTSQQLLQFA 125
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
A + YL S + IHRD + N+L+ + K++DFGL+R E ++ + M
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG----EEVYVK-KTM 177
Query: 1136 GTFG--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
G ++A E KSDV+S+GV++ E++S
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-17
Identities = 75/263 (28%), Positives = 120/263 (45%), Gaps = 31/263 (11%)
Query: 971 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 1026
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+V L + A CLV L+ G ++ H++ + + G + AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG-----RAVFYAAEICCGLE 116
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ R+++RD K NILL+ ++SD GLA E + I RV GT GY+APE
Sbjct: 117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGRV-GTVGYMAPEVV 173
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206
D ++ G ++ E+++G Q P Q+ R RE +ER++
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIAG-------QSPFQQ------RKKKIKREEVERLV--- 217
Query: 1207 LGNDVPFDSVAKVAAIA-SMCVQ 1228
+V + K + A S+C
Sbjct: 218 --KEVQEEYSEKFSPDARSLCKM 238
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-17
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 975 RILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKL 1030
R +G G FG+V+S V D DG +VA+K + V Q + E++ML H N++
Sbjct: 6 RPIGYGAFGVVWS-VTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDS 1089
+ I + ++S LH + PL D +K+ L R L YLH
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSD-HVKVFLYQILRGLKYLH--- 120
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-T 1148
S ++HRD K N+L+ + K+ DFGLAR +ES+H++ V+ + Y APE M +
Sbjct: 121 SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAPEILMGS 179
Query: 1149 GHLLVKSDVYSYGVVILELLSGR 1171
H D++S G + ELL R
Sbjct: 180 RHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLA---EVEMLSRLH 1023
N+ ++LG+G FG VY +D G ++AVK + + +E A E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
H +V+ G +++ + E +P GSV+ L K L K +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVE 118
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFGYVA 1142
YLH S ++HRD K +NIL + K+ DFG ++ S + V GT +++
Sbjct: 119 YLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMS 175
Query: 1143 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKP 1173
PE ++G K+DV+S G ++E+L+ + P
Sbjct: 176 PE-VISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (204), Expect = 7e-17
Identities = 63/208 (30%), Positives = 99/208 (47%), Gaps = 31/208 (14%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKV-LKRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 1032
++GEG +G+V + G VA+K L+ D + ++ + E+ ML +L H NLV LI
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 1090
+ ++ LV+E + + ++ D E P G D K R + + H S
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD------DLEKYPNGLDESRVRKYLFQILRGIEFCH---S 118
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAPEYAMTG 1149
+IHRD K NIL+ K+ DFG AR+ A E + T + T Y APE
Sbjct: 119 HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE---VYTDYVATRWYRAPE----- 170
Query: 1150 HLLVKS-------DVYSYGVVILELLSG 1170
LLV D+++ G ++ E+L+G
Sbjct: 171 -LLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 9e-17
Identities = 85/354 (24%), Positives = 132/354 (37%), Gaps = 14/354 (3%)
Query: 74 PPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPV 133
P P P T A A + P + T ASP +P P + P PT P
Sbjct: 65 FEPPTGPPPGPGTEA-PANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPTPPP 123
Query: 134 ASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPA 193
ASPPP AP L +L P ASP ++ A P A A+ A+ P ++ A
Sbjct: 124 ASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETA 183
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHP--SNTALPPASLPSKTA---PPPASHLSN 248
PS PPA P +T + + P S +A PA P ++A +S S+
Sbjct: 184 RAPS---SPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSS 240
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPP---ASHPSNTAPPPASHPSKTAPPPASHPSNTA 305
++ + P P+ P + N S ++ P PS +
Sbjct: 241 SSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRERSPSPSP 300
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
P S P+ ++P +S S++ +S S+++ + P P+ PS + PP +
Sbjct: 301 SSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPA 360
Query: 366 HPSNP--AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
PS+P P+ PS+ A A + + P+ P
Sbjct: 361 DPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPRP 414
|
Length = 1352 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 9e-17
Identities = 62/212 (29%), Positives = 111/212 (52%), Gaps = 14/212 (6%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTK----VAVKVLKRVDQ-QGGREFLAEVEMLSRLHH 1024
F ++LG G FG VY G+ + +G K VA+K L+ + +E L E +++ + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
++ +L+GIC+ + L+ +L+P G + L V + +G L + A+ + Y
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCL---LDYVREHKDNIGSQYLLNWCVQIAKGMNY 124
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
L E R++HRD + N+L++ K++DFGLA+ +E + + ++A E
Sbjct: 125 LEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALE 181
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVD 1175
+ +SDV+SYGV + EL++ G KP D
Sbjct: 182 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-16
Identities = 57/213 (26%), Positives = 101/213 (47%), Gaps = 25/213 (11%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG------REFLAEVEMLSRLHHRNL 1027
+ LG G F Y + GT +AVK + V E+ +++RL+H ++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAARALAYL 1085
++++G E+ L E + GSV L G KE+ + + +L R L+YL
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYL 119
Query: 1086 HEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESR--HISTRVMGTFGY 1140
HE+ ++IHRD K +N+L++ +++DFG A + + +++GT +
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRL--RIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+APE DV+S G VI+E+ + + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 1e-16
Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 976 ILGEGGFGLVYSGVLD-DGTKV--AVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKL 1030
++GEG FG V + DG ++ A+K +K + R+F E+E+L +L HH N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL---------------HGVDKESAPLGWDARLKIA 1075
+G C L E P+G++ L + ++ L L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST---ASTLSSQQLLHFA 118
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
AR + YL + + IHRD + NIL+ ++ K++DFGL+R + ++ + M
Sbjct: 119 ADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG----QEVYVK-KTM 170
Query: 1136 GTFG--YVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
G ++A E SDV+SYGV++ E++S
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 66/209 (31%), Positives = 103/209 (49%), Gaps = 25/209 (11%)
Query: 977 LGEGGFGLVYSGVLD--DGTK-VAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLI 1031
LG G FG V G+ K VAVK+LK + E L E ++ +L + +V++I
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 1032 GICIEEQARCLVYELIPNGSVESHL----HGVDKESAPLGWDARLKIALGAARALAYLHE 1087
GIC E ++ LV EL G + L H +K L ++++G + YL E
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKHVTEKNITEL----VHQVSMG----MKYLEE 113
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1145
+ +HRD + N+LL K+SDFGL++ A+ + + + G + + APE
Sbjct: 114 TN---FVHRDLAARNVLLVTQHYAKISDFGLSK-ALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 1146 AMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+GV++ E S G+KP
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-16
Identities = 91/455 (20%), Positives = 133/455 (29%), Gaps = 30/455 (6%)
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPS--ITAPPPV--NMAPPPSLIPTTPVASP 136
P A A L + S + A V A PT P P
Sbjct: 16 EGGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPPGP 75
Query: 137 PPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHP 196
P SL P ASP + P S PP P
Sbjct: 76 GTEAPANESRSTPTWSLSTLAP------------ASPAREGSPTPPGPSSPDPPPPTPPP 123
Query: 197 SRTAPPPAS-HPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPAS 255
+ P PA P PA+ P PA++ S A + L ++P +
Sbjct: 124 ASPPPSPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETA 183
Query: 256 HPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNT 315
S PA P T P AS P S + + P + +S S++
Sbjct: 184 RA--PSSPPAEPPPSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSS 241
Query: 316 APPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPA 375
+ P P+ P + N S+ + P
Sbjct: 242 SESSGCGWGPENECPLPRPAPITLPT--------RIWEASGWNGPSSRPGPASSSSSPRE 293
Query: 376 SHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVS 435
PS + P S P+ ++P +S S++ + +S S+ + V P P ++P
Sbjct: 294 RSPSPSPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSP 353
Query: 436 QSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQK---RNASNREAPIAEPIAPGP 492
P D + R R + S P A+ A R+A P
Sbjct: 354 SRPPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPR 413
Query: 493 FPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP 527
P ++ S P TP+ P P PP P
Sbjct: 414 PSPLDAGAASGAFYARYPLLTPSGEPWPGSPPPPP 448
|
Length = 1352 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 67/214 (31%), Positives = 107/214 (50%), Gaps = 26/214 (12%)
Query: 971 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 1026
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+V L + A CLV L+ G ++ H++ + G+D + AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNM----GNPGFDEE-RAVFYAAEITCGLE 116
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ R+++RD K NILL+ ++SD GLA + E+ I RV GT GY+APE
Sbjct: 117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYMAPE-- 171
Query: 1147 MTGHLLVKSDVYSY-------GVVILELLSGRKP 1173
+VK++ Y++ G +I E++ G+ P
Sbjct: 172 -----VVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 3e-16
Identities = 75/292 (25%), Positives = 125/292 (42%), Gaps = 35/292 (11%)
Query: 971 FDASRILGEGGFGLVYSGVL--DDGT--KVAVKVLKR--VDQQGGREFLAEVEMLSRLHH 1024
F R+LG+G FG V L +DG+ KVAVK+LK EFL E + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 1025 RNLVKLIGICIEEQAR------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL 1076
N++KLIG+ + +A+ ++ + +G + + L + +E L ++ +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI 120
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1136
A + YL SS IHRD + N +L + T V+DFGL++ +
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1195
++A E SDV+++GV + E+++ G+ P G EN + L
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY-----AGVEN--SEIYNYLIK 230
Query: 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247
L++ P D + V + C PE + RP + L+L+
Sbjct: 231 GNRLKQ----------PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 977 LGEGGFGLVY------SGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 1030
LG+GGFG V +G L K+ K LK+ ++G + E +L+++H R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKK--RKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
+ CLV ++ G + H++ VD+E+ L +LH+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-- 116
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1150
R+I+RD K N+LL++D ++SD GLA D +S+ + GT G++APE
Sbjct: 117 -RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEE 173
Query: 1151 LLVKSDVYSYGVVILELLSGRKP 1173
D ++ GV + E+++ R P
Sbjct: 174 YDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 80.1 bits (198), Expect = 3e-16
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGI 1033
+G G +VY+ + L + KVA+K + +++ E EV+ +S+ +H N+VK
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRID-LEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDSS 1090
+ LV + GS L + K S P G IA + L YLH S
Sbjct: 68 FVVGDELWLVMPYLSGGS----LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---S 120
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYA 1146
IHRD K+ NILL D + K++DFG+ SA + + +V +GT ++APE
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGV--SASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 1147 MTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPP 1180
H K+D++S+G+ +EL +G P PP
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYS-KYPP 212
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-16
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 23/217 (10%)
Query: 977 LGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVK 1029
LGE FG VY G L + VA+K LK + + EF E M SRL H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 1030 LIGICIEEQARCLVYELIPNG---------SVESHLHGVDKE---SAPLGWDARLKIALG 1077
L+G+ +EQ +++ + S S + D + + L + I
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
A + +L SS V+H+D + N+L+ K+SD GL R + + +
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 1138 FGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+++PE M G + SD++SYGVV+ E+ S G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 3e-16
Identities = 66/221 (29%), Positives = 101/221 (45%), Gaps = 42/221 (19%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVL--------KRVDQQGGREFLAEVEMLS 1020
+F+ + LG G FG V K A+K+L K+V+ L E +L
Sbjct: 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEH-----VLNEKRILQ 56
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1077
+ H LV L G ++ LV E +P G + SHL + P AR ++ L
Sbjct: 57 SIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEP---VARFYAAQVVL- 112
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-- 1135
AL YLH +++RD K N+LL+ D K++DFG A + + R
Sbjct: 113 ---ALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFA--------KRVKGRTYTL 158
Query: 1136 -GTFGYVAPEYAM-TGHLLVKS-DVYSYGVVILELLSGRKP 1173
GT Y+APE + G+ K+ D ++ G++I E+L+G P
Sbjct: 159 CGTPEYLAPEIILSKGY--GKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 28/221 (12%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVK--VLKRVDQQG---GREFLA----EVEMLSRLHHR 1025
++G G FG VY G+ G +AVK L V R L E+ +L L H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N+V+ +G ++ + E +P GSV + L+ L + +I G L YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKG----LNYL 122
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-------VMGTF 1138
H + +IHRD K +NIL+++ K+SDFG+++ E+ +ST+ + G+
Sbjct: 123 H---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL---EANSLSTKTNGARPSLQGSV 176
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV-DMTQ 1178
++APE K+D++S G +++E+L+G+ P D TQ
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQ 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
FD LGEG +G VY + + G VA+KV+ V++ +E + E+ +L + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEE-DLQEIIKEISILKQCDSPYIVK 62
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
G + +V E GSV + +K L + I + L YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK---TLTEEEIAAILYQTLKGLEYLH--- 116
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S + IHRD K+ NILL + K++DFG++ + + +T V+GT ++APE
Sbjct: 117 SNKKIHRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNT-VIGTPFWMAPEVIQEI 174
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
K+D++S G+ +E+ G+ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 83.6 bits (206), Expect = 5e-16
Identities = 86/334 (25%), Positives = 113/334 (33%), Gaps = 15/334 (4%)
Query: 74 PPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPP---PSLIPT 130
P P S P++ +P P L P P AP + P
Sbjct: 217 QPQQPSPLSLISAPSLHPQRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMP 276
Query: 131 TPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPAS-PPSNAARPPASHPSNTA 189
+ P P N L + PL S+A P + PPS +A P P
Sbjct: 277 HALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQP 336
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
PPA PPP + S P PS P++LP A P S L T
Sbjct: 337 LPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLP-T 395
Query: 250 APPPASHPYKTSPLPASHPSKTAP--PPASHPSNTAPPPASHPSKTAPP--PASHPSNTA 305
PP++HP +P S P ++ P PP S + PP AS + P P
Sbjct: 396 HHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQH 455
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP-----PPASHSSKTAPPPASHPSNTA 360
P + PPP+ S A PP + + P + P P
Sbjct: 456 PFTSGGLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEP 515
Query: 361 LPPASHPSNPAIPPAS-HPSNTAIPPASHPSNTA 393
L A P +P PP S P T + SH S +A
Sbjct: 516 LDEAEEPESPPPPPRSPSPEPTVVNTPSHASQSA 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-16
Identities = 68/216 (31%), Positives = 99/216 (45%), Gaps = 38/216 (17%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVL-----KRVDQQGGREFLAEVEMLSRLHHRNLVKL 1030
+G G +G+V S + KVA+K + R+D + L E+++L L H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRID---AKRTLREIKLLRHLDHENVIAI 69
Query: 1031 IGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
I +VYEL+ ++ LH + + S L D R L Y+
Sbjct: 70 KDIMPPPHREAFNDVYIVYELM-----DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S V+HRD K SN+LL + K+ DFGLAR+ E T + T Y APE
Sbjct: 125 H---SANVLHRDLKPSNLLLNANCDLKICDFGLARTT--SEKGDFMTEYVVTRWYRAPE- 178
Query: 1146 AMTGHLLVKS-------DVYSYGVVILELLSGRKPV 1174
LL+ DV+S G + ELL GRKP+
Sbjct: 179 -----LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 7e-16
Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 25/208 (12%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKR------VDQQGGREFLAEVEMLSRLHHRNLVKL 1030
+G G FG V G G A V+K D+Q FL EV+ L+H N+++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQ--LLFLQEVQPYRELNHPNVLQC 60
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHG----VDKESAPLGWDARLKIALGAARALAYLH 1086
+G CIE LV E P G ++++L V + + D ++A A L +LH
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLH 117
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ IH D N L D + K+ D+GLA E+ ++APE
Sbjct: 118 QAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 1147 MTGH--LLV-----KSDVYSYGVVILEL 1167
LL KS+++S GV + EL
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 8e-16
Identities = 93/391 (23%), Positives = 123/391 (31%), Gaps = 43/391 (10%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
+ P +P A AP P P + + P P + +P P
Sbjct: 186 GAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQ 245
Query: 122 APPPSLIPTTPVASPPPITAPPLVNVLPA-PSLIPTTPLASPLSSKAFPPASPPSNAARP 180
S P A P P + P+ P SN +P
Sbjct: 246 PQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQ---------HPSSNPPQP 296
Query: 181 PASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAP 240
S P P + P + PS++A P P LPPA P
Sbjct: 297 FGLAQSQVPPLPL--------PSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKP 348
Query: 241 PPASHLSNTAPPPASHP-YKTSPLP-ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
PP + + HP + P P PS PPPA P ++ P +H +A PP
Sbjct: 349 PPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSLP---THHPPSAHPP- 404
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN 358
P P S A PP S + PP AS P HS P A HP
Sbjct: 405 --PLQLMPQSQPLQSVPAQPPVLTQSQSLPPKAST----HPHSGLHSGPPQSPFAQHPFT 458
Query: 359 TALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPP 418
+ PA P PP+ S A PP + + P A S P PP
Sbjct: 459 SGGLPAIGP-----PPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGP--------GPP 505
Query: 419 LFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
L + +A +SP P +P+ P
Sbjct: 506 LPPIQIKEEPLDEAEEPESPPPPPRSPSPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 71/221 (32%), Positives = 112/221 (50%), Gaps = 29/221 (13%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 1027
FD +GEG +G VY D G VA+K ++ +++ G A E+++L +L+HRN+
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNI 68
Query: 1028 VKLIGICIEEQ----------ARCLVYELIPN---GSVESHLHGVDKESAPLGWDARLKI 1074
V L I ++Q A LV+E + + G +ES L ++ + +K
Sbjct: 69 VNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK----SFMKQ 124
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
L L Y H+ + +HRD K SNILL + K++DFGLAR EESR + +V
Sbjct: 125 LL---EGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 1135 MGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 1174
+ T Y PE + + DV+S G ++ EL + +KP+
Sbjct: 179 I-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 8e-16
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 12/207 (5%)
Query: 971 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 1026
F R+LG+GGFG V + V G A K L KR+ ++ G L E ++L +++ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+V L + A CLV ++ G ++ H++ + G++ + AA L L
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFEEE-RALFYAAEILCGLE 116
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ ++RD K NILL+ ++SD GLA + ES I RV GT GY+APE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYMAPEVL 173
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ D + G +I E++ G+ P
Sbjct: 174 NNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 8e-16
Identities = 63/203 (31%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 977 LGEGGFGLVYSGV--LDDGTKVAVK-VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
LG G G V S V + GT +A K V ++ L E++++ +V G
Sbjct: 13 LGAGNGGSV-SKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGA 71
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+ E C+ E + GS L + K+ P+ + KIA+ L YL+ R+
Sbjct: 72 FLNENNICMCMEFMDCGS----LDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH--RI 125
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1153
+HRD K SNIL+ K+ DFG++ E I+ +GT Y++PE G V
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 1154 KSDVYSYGVVILELLSGRKPVDM 1176
KSDV+S G+ I+EL G+ P
Sbjct: 182 KSDVWSLGISIIELALGKFPFAF 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-15
Identities = 60/222 (27%), Positives = 82/222 (36%), Gaps = 15/222 (6%)
Query: 167 AFPPASPPSNAA-RPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPS 225
AF P A A+ P P A+ P+ AP PA+ P A P+ + A+ +
Sbjct: 362 AFRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPP---AAPAAAPAAAAAARA 418
Query: 226 NTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPP 285
A P P+ A A S P A P +P PA+ P+ A P A+ P A
Sbjct: 419 VAAAPARRSPAPEALAAARQASARGPGGAPAP---APAPAAAPAAAARPAAAGPRPVAAA 475
Query: 286 PASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA-----SHPSNTAPP 340
A+ P++ AP A P++ PPP PA + AP P+ P
Sbjct: 476 AAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPD 535
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTA 382
A + AP A P A P PP + S
Sbjct: 536 DAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLP 574
|
Length = 700 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 1e-15
Identities = 58/204 (28%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
LG+G FG VY + G A KV++ ++ +++ E+E+L+ +H +VKL+G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDSSPRVI 1094
+ ++ E P G+V++ + +D+ + +++ I AL YLH S ++I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLT----EPQIQVICRQMLEALQYLH---SMKII 132
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL-- 1152
HRD K+ N+LL D K++DFG+ SA + ++ +GT ++APE M +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGV--SAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190
Query: 1153 ---VKSDVYSYGVVILELLSGRKP 1173
K+D++S G+ ++E+ P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 31/218 (14%)
Query: 976 ILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRNL 1027
LGEG FG V ++ + VAVK+LK ++ + ++E+EM+ + H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI------------- 1074
+ L+G+C +E +V E +G++ L + P G A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFL----RARRPPGEYASPDDPRPPEETLTQKDL 134
Query: 1075 ---ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
A AR + +L +S + IHRD + N+L+ D K++DFGLAR + +
Sbjct: 135 VSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKT 191
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
T ++APE +SDV+S+GV++ E+ +
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 12/207 (5%)
Query: 971 FDASRILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRN 1026
F R+LG+GGFG V + V G A K L KR+ ++ G L E +L +++ R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+V L + A CLV ++ G ++ H++ + G+D + I AA L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNP----GFDEQRAI-FYAAELCCGLE 116
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ R+++RD K NILL+ ++SD GLA E + RV GT GY+APE
Sbjct: 117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQI--PEGETVRGRV-GTVGYMAPEVI 173
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
D + G +I E++ G+ P
Sbjct: 174 NNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 29/213 (13%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G G +G VY + G VA+KV+K E+ ML H N+V G +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDSSPR 1092
+V E GS++ PL + L+IA + LAYLHE
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQ---VTRGPL---SELQIAYVCRETLKGLAYLHET---G 121
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR--VMGTFGYVAPEYA---M 1147
IHRD K +NILL D K++DFG++ + + I+ R +GT ++APE A
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSA----QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 1148 TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1180
G K D+++ G+ +EL QPP
Sbjct: 178 KGGYDGKCDIWALGITAIELAEL-------QPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 2e-15
Identities = 88/393 (22%), Positives = 109/393 (27%), Gaps = 21/393 (5%)
Query: 30 GIPPSPAIIGGHFLLPRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAV 89
P P P LP G P P P+ PA
Sbjct: 2718 ATPLPPGPAAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAPAPPAAPAA 2777
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLP 149
P + P + S PS P A P ASP PP + P
Sbjct: 2778 GPPRRLTRPAVASLSESRESLPSPWDPADPPAAVLAPAAALPPAASPAGPLPPP-TSAQP 2836
Query: 150 APSLIPTTPLASPLSSK-AFPPASPPSN--AARPPASHPSNTARPPASHPSRTAPPPASH 206
P P L + P +R PA+ P+ ARPP +R A ++
Sbjct: 2837 TAPPPPPGPPPPSLPLGGSVAPGGDVRRRPPSRSPAAKPAAPARPPVRRLARPAVSRSTE 2896
Query: 207 PSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPAS 266
ALP P P PP P PPP PPP P +P
Sbjct: 2897 S--FALP----PDQPERPPQPQAPPPPQPQPQPPPPPQPQPPPPPPPRPQP-PLAPTTDP 2949
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 326
+ P A P P PS AP ++ P S+
Sbjct: 2950 AGAGEPSGAVPQPWLGALVPGRVAVPRFRVPQPAPSREAPASSTPPLTGHSLSRV--SSW 3007
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
A A H T PPP S PP + S+ S + P
Sbjct: 3008 ASSLALH-EETDPPPVSLKQTLWPPDDTEDSDADSLFDSDSERSDLEALDPLPPEPHDPF 3066
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPPL 419
+H + A P A S S PPPL
Sbjct: 3067 AHEPDPATPEAGA-------RESPSSQFGPPPL 3092
|
Length = 3151 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-15
Identities = 70/280 (25%), Positives = 126/280 (45%), Gaps = 23/280 (8%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK---VLKRVDQQGGREFLAEVEMLSRLHHR 1025
NF + +G G F VY L D VA+K + + +D + ++ + E+++L +L+H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N++K + IE+ +V EL G + + K+ + K + A+ ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S RV+HRD K +N+ + K+ D GL R + + S ++GT Y++PE
Sbjct: 123 H---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
KSD++S G ++ E+ + + P L + + +E+ P
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSP-----------FYGDKMNLFSLCQKIEQCDYP 226
Query: 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
L + K+ + SMC+ P+ RP +G V Q K
Sbjct: 227 PLPTE---HYSEKLRELVSMCIYPDPDQRPDIGYVHQIAK 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 3e-15
Identities = 90/349 (25%), Positives = 122/349 (34%), Gaps = 37/349 (10%)
Query: 110 PPSITAPPPVNMA----PPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSS 165
PPSI PP +A PP P P P P+P + + P P
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQRL 237
Query: 166 KAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPS 225
+ P P A++ P+ ++R P S PP +P P
Sbjct: 238 PSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPP---------MPHALQQGPVFLQH 288
Query: 226 NTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP-PPASHPSNTAP 284
++ PP + P L + A P + P S L P + P PPA + P
Sbjct: 289 PSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKP 348
Query: 285 PPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 344
PP + + HP + P P PSN PPPA P ++ P
Sbjct: 349 PPTTPIPQLPNQSHKHPPHLQGP---------SPFPQMPSNLPPPPALKPLSSLP----- 394
Query: 345 SSKTAPPPASHPSNTALPPASHP--SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSN 402
T PP++HP L P S P S PA PP S + P AS ++ S
Sbjct: 395 ---THHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSP 451
Query: 403 TA---LTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
A T P+ I PPP P+A P + SQ P S +
Sbjct: 452 FAQHPFTSGGLPA-IGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGC 499
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 78/225 (34%), Positives = 107/225 (47%), Gaps = 24/225 (10%)
Query: 956 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG---RE 1011
A+ FS + EK F R +G G FG VY + VA+K + +Q ++
Sbjct: 5 AELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD 61
Query: 1012 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1071
+ EV L +L H N ++ G + E LV E GS S + V K+ PL
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA-SDILEVHKK--PLQEVEI 117
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
I GA + LAYLH S IHRD K+ NILL T K++DFG A S + + +
Sbjct: 118 AAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSA-SLVSPANSFV- 172
Query: 1132 TRVMGTFGYVAPE--YAM-TGHLLVKSDVYSYGVVILELLSGRKP 1173
GT ++APE AM G K DV+S G+ +E L+ RKP
Sbjct: 173 ----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 64/217 (29%), Positives = 96/217 (44%), Gaps = 51/217 (23%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVK---------VLKRVDQQGGREFLAEVEMLSRLHHRN 1026
+GEG +G+V+ + G VA+K V+K++ L E+ ML +L H N
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA-------LREIRMLKQLKHPN 61
Query: 1027 LVKLIGICIEEQARCLVYELIPN---GSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
LV LI + ++ LV+E + +E + GV + KI +A+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLI-------KKIIWQTLQAVN 114
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR---SAMDEESRHISTRVMGTFGY 1140
+ H IHRD K NIL+ K+ DFG AR D+ + +++TR Y
Sbjct: 115 FCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR-----WY 166
Query: 1141 VAPEYAMTGHLLVKS-------DVYSYGVVILELLSG 1170
APE LLV DV++ G V ELL+G
Sbjct: 167 RAPE------LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 4e-15
Identities = 61/232 (26%), Positives = 108/232 (46%), Gaps = 31/232 (13%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 1021
E E +LG+G +G+VY+ L ++A+K + D + + E+ + S
Sbjct: 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSY 61
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG-----VDKESAPLGWDARLKIAL 1076
L HRN+V+ +G E + E +P GS+ + L D E + + ++
Sbjct: 62 LKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQI---- 117
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFG----LARSAMDEESRHIS 1131
L YLH++ +++HRD K N+L+ + K+SDFG LA E+
Sbjct: 118 --LEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET---- 168
Query: 1132 TRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQP 1179
GT Y+APE G+ +D++S G I+E+ +G+ P +++ +P
Sbjct: 169 --FTGTLQYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEP 217
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 71/213 (33%), Positives = 108/213 (50%), Gaps = 31/213 (14%)
Query: 975 RILGEGGFGLVY-----SGVLDDGTKVAVKVLK--------RVDQQGGREFLAEVEMLSR 1021
++LG+G FG V+ +G D G A+KVLK RV + R+ LAEV
Sbjct: 2 KVLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV----- 55
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+H +VKL E L+ + + G + + L KE D + +A A A
Sbjct: 56 -NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRL---SKEVMFTEEDVKFYLA-ELALA 110
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L +LH S +I+RD K NILL+ + K++DFGL++ ++D E + S GT Y+
Sbjct: 111 LDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYM 165
Query: 1142 APEYA-MTGHLLVKSDVYSYGVVILELLSGRKP 1173
APE GH +D +S+GV++ E+L+G P
Sbjct: 166 APEVVNRRGHTQ-SADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 5e-15
Identities = 64/219 (29%), Positives = 97/219 (44%), Gaps = 53/219 (24%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--------LAEVEMLSRL-HHRN 1026
LG+G FG VY + G VA+K +K+ +F L EV+ L +L H N
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKK-------KFYSWEECMNLREVKSLRKLNEHPN 59
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLKIALGAARALAY 1084
+VKL + E V+E +E +L+ + D++ P I + LA+
Sbjct: 60 IVKLKEVFRENDELYFVFEY-----MEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR-----HISTRVMGTFG 1139
+H+ HRD K N+L+ K++DFGLAR SR ++STR
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREI---RSRPPYTDYVSTR-----W 163
Query: 1140 YVAPEYAMTGHLLVKSDVYS-------YGVVILELLSGR 1171
Y APE +L++S YS G ++ EL + R
Sbjct: 164 YRAPE------ILLRSTSYSSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 68/271 (25%), Positives = 125/271 (46%), Gaps = 23/271 (8%)
Query: 969 GNFDASRILGEGGFGLVY-SGVLDDGTKVAVK---VLKRVDQQGGREFLAEVEMLSRLHH 1024
NF + +G G F VY + L DG VA+K + +D + + + E+++L +L+H
Sbjct: 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 61
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
N++K IE+ +V EL G + + K+ + K + AL +
Sbjct: 62 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
+H S RV+HRD K +N+ + K+ D GL R + + S ++GT Y++PE
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 176
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204
KSD++S G ++ E+ + + P + NL + + +E+
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF----YGDKMNLYSLCKK-------IEQCDY 225
Query: 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1235
P L +D + + + + +MC+ P+ + RP
Sbjct: 226 PPLPSDHYSEELRQ---LVNMCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 8e-15
Identities = 68/217 (31%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 975 RILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL--- 1030
R LG G GLV+S V D +VAVK + D Q + L E++++ RL H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 1031 -----------IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGA 1078
+G E + +V E +E+ L V E PL + ARL
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEY-----METDLANV-LEQGPLSEEHARL-FMYQL 123
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMG- 1136
R L Y+H S V+HRD K +N+ + D K+ DFGLAR +D H G
Sbjct: 124 LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGL 179
Query: 1137 -TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
T Y +P ++ + K+ D+++ G + E+L+G+
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 9e-15
Identities = 65/211 (30%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 977 LGEGGFGLVYSGVLDDG---TKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
+G G FG V G ++ G +V VK L+ Q +FL E + L H NL++ +G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSS 1090
C E LV E P G ++ +L K + D ++A A L +LH+++
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAEL-MTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA--MT 1148
IH D N LL D T K+ D+GL+ + E+ ++ ++APE +
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 1149 GHLLV-----KSDVYSYGVVILELLS-GRKP 1173
G+LLV +S+V+S GV I EL G +P
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQP 209
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-14
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 24/219 (10%)
Query: 970 NFDASRILGEGGFGLVYSGV---LDDGTKVAVKVLKRVDQQG--GREFLAEVEMLSRLH- 1023
++ + LG+G +G+V S + VA+K + V + + L E+++L
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 1024 HRNLVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GA 1078
H+N+ L + I L EL+ E+ LH + + PL DA + +
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLT-DAHFQSFIYQI 114
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMG 1136
L Y+H S V+HRD K N+L+ D K+ DFGLAR S E+ T +
Sbjct: 115 LCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVA 171
Query: 1137 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 1174
T Y APE ++ K+ DV+S G ++ ELL GRKPV
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 1e-14
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 16/202 (7%)
Query: 977 LGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
LG GGFG V V A+K +K+ V+ +E E+L +H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+++ ++ E G + + L + AR IA A YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE---YTARFYIA-CVVLAFEYLHNRG--- 113
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHL 1151
+I+RD K N+LL+ + K+ DFG A+ +S + GT YVAPE + G+
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKL---KSGQKTWTFCGTPEYVAPEIILNKGYD 170
Query: 1152 LVKSDVYSYGVVILELLSGRKP 1173
D +S G+++ ELL+GR P
Sbjct: 171 FS-VDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-14
Identities = 54/226 (23%), Positives = 84/226 (37%), Gaps = 11/226 (4%)
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
+ A+ P P A+ P+ AP PA+ + A PA+ + A+ P++ +P P +
Sbjct: 375 ATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAA--AARAVAAAPARRSPAPEA 432
Query: 278 HPSNTAPPPASHPSKTAPP--PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
+ AP PA+ P+ A P A+ P A A+ P+ AP A P+
Sbjct: 433 LAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPA 492
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPS--NPAIPPASHPSNTAIPPASHPSNTA 393
+ PPP PA + A S +PA T P +
Sbjct: 493 DDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPAPR 552
Query: 394 PPHASHPSNTALTPASHPSNIAPPPLFV---PVLPSALPGKAPVSQ 436
A+ P P + S + P +F P L + LP + Q
Sbjct: 553 AAAATEPVVAPRPPRASASGL--PDMFDGDWPALAARLPVRGLAQQ 596
|
Length = 700 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 2e-14
Identities = 67/337 (19%), Positives = 95/337 (28%), Gaps = 33/337 (9%)
Query: 129 PTTPVASPPPITAPPLV-NVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSN 187
P P P V +PAP + + A P A+ +
Sbjct: 360 PAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAA 419
Query: 188 TARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLS 247
R A P PPA+ AP PA + + PP S +
Sbjct: 420 ATRAEA--PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPPADSGSA 477
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
+ A P P + A PA+ + AP A+ P+ A P
Sbjct: 478 SAPASDAPPDAAFEPAP---RAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARP 534
Query: 308 PASHPSNTAPPPASH----------------PSNTAPPPASHPSNTAPPPASHSSKTAPP 351
P P+ AP + S+ A+ A P A + K A P
Sbjct: 535 PT--PAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAA--APKPAAP 590
Query: 352 PASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHP 411
+ T A+ P A A+ PP P + + ++
Sbjct: 591 RVAVQVPTPRARAATGDAPPNGAAR------AEQAAESRGAPPPWEDIPPDDYVPLSADE 644
Query: 412 SNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
P FVPV S P V+ P P P T
Sbjct: 645 GFGGPDDGFVPVFDSG-PDDVRVAPKPADAPAPPVDT 680
|
Length = 830 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 2e-14
Identities = 63/227 (27%), Positives = 100/227 (44%), Gaps = 28/227 (12%)
Query: 975 RILGEGGFGLVYSGVL---DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLHHRN 1026
+ LGEG FG V G L D KVAVK +K R + + +FL+E + H N
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCMKEFDHPN 61
Query: 1027 LVKLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGA 1078
+++LIG+C++ ++ + +G + S L P ++ K
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
A + YL SS IHRD + N +L + V+DFGL++ + +
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1184
++A E KSDV+S+GV + E+ + G+ P PG EN
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY-----PGVEN 220
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 10/207 (4%)
Query: 970 NFDASRILGEGGFGLVYS-GVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 1026
+F + LG+G +G VY L D A+K L + Q+ + + E+ +L+ ++H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
++ ++ C+V E P G + + K+ + +I + R L LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
E +++HRD KS+NILL + K+ D G+++ ++++ +GT Y+APE
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAKTQIGTPHYMAPEVW 173
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
KSD++S G ++ E+ + P
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 3e-14
Identities = 56/199 (28%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 1034
+G+G FG VY + VA+KV+ + + E + E++ LS+ + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSF 68
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
++ ++ E GS L + L I L YLHE+ I
Sbjct: 69 LKGSKLWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEE---GKI 120
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
HRD K++NILL + K++DFG++ S+ +T V GT ++APE K
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKR-NTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 1155 SDVYSYGVVILELLSGRKP 1173
+D++S G+ +EL G P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 4e-14
Identities = 74/282 (26%), Positives = 122/282 (43%), Gaps = 57/282 (20%)
Query: 977 LGEGGFGLVYSGVLDD-GTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH-RNLVKLIG- 1032
+G G FG V + GT +AVK ++ VD++ + L +++++ R +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 1033 --------ICIEEQARCL--VYELIPNGSVESHLHGVDKESAP---LGWDARLKIALGAA 1079
IC+E L Y+ + + V K P LG KIA+
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYV---------YEVLKSVIPEEILG-----KIAVATV 117
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
+AL YL E+ ++IHRD K SNILL+ + K+ DFG++ +D ++ TR G
Sbjct: 118 KALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRP 172
Query: 1140 YVAPEYAMTGHLL---VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196
Y+APE V+SDV+S G+ + E+ +G+ P W
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYP-----------KWNSVF---- 217
Query: 1197 EGLERIID---PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1235
+ L +++ P L N + ++C+ + RP
Sbjct: 218 DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP 259
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 5e-14
Identities = 53/215 (24%), Positives = 82/215 (38%), Gaps = 4/215 (1%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPS 219
A P ++ A P A P AA P A+ P+ A P A P+ A+ + A P++ +P+
Sbjct: 372 AGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAA--PAAAPAAAAAARAVAAAPARRSPA 429
Query: 220 PASHPSNTALPPASLPSKTAPP--PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P + + AP PA+ + A P A+ P + A+ P++ AP A
Sbjct: 430 PEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAP 489
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 337
P++ PPP PA + AP S P A + +
Sbjct: 490 APADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAP 549
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAI 372
AP A+ + P S + LP PA+
Sbjct: 550 APRAAAATEPVVAPRPPRASASGLPDMFDGDWPAL 584
|
Length = 700 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 23/216 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--QQGGREFLA---EVEMLSRLHH 1024
++ + +GEG FG +Y + + V+K +D + +E A EV +L+++ H
Sbjct: 1 RYEIIKKIGEGSFGKIY--LAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKH 58
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHL---HGVD-KESAPLGWDARLKIALGAAR 1080
N+V E +V E G + + GV E L W ++I+LG
Sbjct: 59 PNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG--- 113
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
L ++H+ +++HRD KS NI L + K+ DFG+AR D S ++ +GT
Sbjct: 114 -LKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SMELAYTCVGTPY 167
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
Y++PE K+D++S G V+ EL + + P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 61/207 (29%), Positives = 102/207 (49%), Gaps = 22/207 (10%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH---RNLVKL 1030
++G G +G VY G + G VA+K++ + EV +LS+L N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHE 1087
G ++ ++ E GSV + + ++ P+ A I++ AL Y+H+
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLM-----KAGPI---AEKYISVIIREVLVALKYIHK 119
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1147
VIHRD K++NIL+ + K+ DFG+A +++ S ST V GT ++APE
Sbjct: 120 VG---VIHRDIKAANILVTNTGNVKLCDFGVAAL-LNQNSSKRSTFV-GTPYWMAPEVIT 174
Query: 1148 TGHLL-VKSDVYSYGVVILELLSGRKP 1173
G K+D++S G+ I E+ +G P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 7e-14
Identities = 60/217 (27%), Positives = 98/217 (45%), Gaps = 23/217 (10%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRN 1026
+ +G G +G+V S + G KVA+K + + L E+++L H N
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65
Query: 1027 LVKLIGICIEEQARC----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA-RA 1081
++ + I A +V +L+ ES LH + PL + ++ L R
Sbjct: 66 IIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLT-EEHIRYFLYQLLRG 119
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS--TRVMGTFG 1139
L Y+H S VIHRD K SN+L+ D ++ DFG+AR + H T + T
Sbjct: 120 LKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW 176
Query: 1140 YVAPE--YAMTGHLLVKSDVYSYGVVILELLSGRKPV 1174
Y APE ++ + D++S G + E+L GR+ +
Sbjct: 177 YRAPELLLSLPEYTT-AIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 8e-14
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 20/218 (9%)
Query: 970 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRLHHRNL 1027
D +GEG G+V + G +VAVK + QQ RE L EV ++ H N+
Sbjct: 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR-RELLFNEVVIMRDYQHPNI 78
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAY 1084
V++ + +V E + G++ +H +++ A + L +AL++
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLAVLKALSF 130
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH + VIHRD KS +ILL D K+SDFG E R S ++GT ++APE
Sbjct: 131 LH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPE 185
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
+ D++S G++++E++ G P +PP Q
Sbjct: 186 VISRLPYGTEVDIWSLGIMVIEMVDGEPPY-FNEPPLQ 222
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 12/201 (5%)
Query: 977 LGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLIG 1032
LG+GGFG V + V + G A K L KR+ ++ G + L E E+L +++ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ CLV L+ G ++ H++ V + G + I A LH S
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGER----GLEMERVIHYSAQITCGILHLHSM-D 115
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
+++RD K N+LL+ ++SD GLA D ++ T+ GT GY+APE
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMAPEILKEEPYS 172
Query: 1153 VKSDVYSYGVVILELLSGRKP 1173
D ++ G I E+++GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-13
Identities = 64/213 (30%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 975 RILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQG--GREFLAEVEMLSRLHHRNLVKLI 1031
+G G +G V S G KVA+K L R Q + E+ +L + H N++ L+
Sbjct: 21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 1032 GICIEEQARCLVYELIPNGSVE--------SHLHGVD----KESAPLGWDARLKIALGAA 1079
+ P S+E +HL G D + L D +
Sbjct: 81 DV------------FTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQIL 128
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
R L Y+H S +IHRD K SNI + D K+ DFGLAR DE + +++TR
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATR-----W 180
Query: 1140 YVAPEYAMT-GHLLVKSDVYSYGVVILELLSGR 1171
Y APE + H D++S G ++ ELL+G+
Sbjct: 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 21/211 (9%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLHHRN 1026
F+ +GEG +G+VY G VA+K ++ +++ G L E+ +L L H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 1027 LVKLIGICIEEQARC--LVYELIPNGSVESHLHG-VDKESAPLGWDARLK-IALGAARAL 1082
+V+L + + + LV E E L +D P ++++K + L R L
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFS-ESQVKCLMLQLLRGL 121
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
YLHE+ +IHRD K SN+LL K++DFGLAR ++ ++ +V+ T Y A
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR-TYGLPAKPMTPKVV-TLWYRA 176
Query: 1143 PE--YAMTGHLLVKSDVYSYGVVILELLSGR 1171
PE T + D+++ G ++ ELL+ +
Sbjct: 177 PELLLGCTTYTT-AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 1e-13
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 975 RILGEGGFGLVYSGVLDDGTK----VAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 1028
RILG G FG + G L +K VA+ L+ D+Q R FLAE L + H N+V
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQR-RGFLAEALTLGQFDHSNIV 69
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L G+ +V E + NG+++S L K L + + G A + YL E
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR---KHEGQLVAGQLMGMLPGLASGMKYLSEM 126
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFG-LARSAMDEESRHISTRVMGTFGYVAPEYAM 1147
+H+ + +L+ D K+S F L E+ + + + APE
Sbjct: 127 G---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS--EAIYTTMSGKSPVLWAAPEAIQ 181
Query: 1148 TGHLLVKSDVYSYGVVILELLS-GRKPV-DMT 1177
H SDV+S+G+V+ E++S G +P DM+
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 2e-13
Identities = 105/408 (25%), Positives = 136/408 (33%), Gaps = 32/408 (7%)
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
PP P AL P S + P + P+ HP +
Sbjct: 178 PPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHPQR- 236
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKT---APPPASHPSNTAPPPASHPSNTAP 317
LP+ HP + P + HP + PP H P HPS+ P
Sbjct: 237 --LPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPP 294
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
P + PP PS P + S++A P P LPPA PS P I P
Sbjct: 295 QPFGLAQSQVPPLPL-PSQAQPHSHTPPSQSALQPQQPPREQPLPPA--PSMPHIKP--- 348
Query: 378 PSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQS 437
P T IP + S+ PPH PS PSN+ PPP P+ S+LP P S
Sbjct: 349 PPTTPIPQLPNQSHKHPPHLQGPSPF----PQMPSNLPPPPALKPL--SSLPTHHPPSAH 402
Query: 438 PISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGN 497
P L P + P + P + S P P + ++ P P A PF G
Sbjct: 403 PPPLQLMPQSQPLQSVPAQPPVLTQSQSLP-PKASTHPHSGLHSGPPQSPFAQHPFTSG- 460
Query: 498 SRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSP 557
+P P S P + P S + G + PP+
Sbjct: 461 ----------GLPAIGPPPSLPTSTPAAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQ 510
Query: 558 SKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRD 605
K + SP PP SP P N +S A F KH D
Sbjct: 511 IKEEPLDEA--EEPESPPPPPRSPSPEPTVVNTPSHASQSARFYKHLD 556
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-13
Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 14/203 (6%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
LG+G FG VY + G A KV+ ++ +++ E+++L+ H N+VKL+
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
E ++ E G+V++ + +++ PL + AL YLHE+ ++IH
Sbjct: 73 YENNLWILIEFCAGGAVDAVMLELER---PLTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH----- 1150
RD K+ NIL D K++DFG+ SA + + +GT ++APE M
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 1151 LLVKSDVYSYGVVILELLSGRKP 1173
K+DV+S G+ ++E+ P
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 67/223 (30%), Positives = 103/223 (46%), Gaps = 31/223 (13%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSR-LHHRNLVKLIG- 1032
LG G +G+V + GT +AVK ++ V+ Q + L ++++ R + V G
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 1033 --------ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
IC+E L + + G+ LG KIA+ +AL Y
Sbjct: 69 LFREGDVWICMEVMDTSL-DKFYKK----VYDKGLTIPEDILG-----KIAVSIVKALEY 118
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH S VIHRD K SN+L+ + K+ DFG++ +D ++ T G Y+APE
Sbjct: 119 LHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK---TIDAGCKPYMAPE 173
Query: 1145 Y----AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 1183
VKSDV+S G+ ++EL +GR P D + P Q+
Sbjct: 174 RINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (177), Expect = 3e-13
Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 46/219 (21%)
Query: 977 LGEGGFGLVYSG-VLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHH-RNLVKLIG- 1032
+G G G VY G +AVK ++R ++ + L +++++ + H +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 1033 --------ICIEEQARCL------VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
IC+E + CL + IP LG K+ +
Sbjct: 83 FITDSDVFICMELMSTCLDKLLKRIQGPIP--------------EDILG-----KMTVAI 123
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
+AL YL E VIHRD K SNILL+ K+ DFG++ +D +++ TR G
Sbjct: 124 VKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCA 178
Query: 1139 GYVAPEY----AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y+APE +++DV+S G+ ++EL +G+ P
Sbjct: 179 AYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 3e-13
Identities = 62/215 (28%), Positives = 105/215 (48%), Gaps = 25/215 (11%)
Query: 977 LGEGGFGLVYSGV---LDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 1026
LGEG FG V LD TKVAVK+LK ++ + ++E+EM+ + H+N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLH-----GVDKESAP-------LGWDARLKI 1074
++ L+G C ++ ++ E G++ +L G++ P L + +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + +T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
++APE +SDV+S+GV++ E+ +
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 4e-13
Identities = 36/136 (26%), Positives = 54/136 (39%), Gaps = 9/136 (6%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
P A+ + + A PA+ P A+ P+ A P A+ + APP A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
P+ A P A+ P + + P+ AP + P AP PA S+ A
Sbjct: 423 PAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASA--A 476
Query: 350 PPPASHPSNTALPPAS 365
P PA+ P+ L P
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 5e-13
Identities = 58/217 (26%), Positives = 74/217 (34%), Gaps = 12/217 (5%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P A A + PP AARP A P+ A P A P+ A PA + A
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAA--PAAPAAPAAPAPAGAAAAPAEASAAPA--- 644
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
+P HP + A+P AS P A + APPPA P A A P
Sbjct: 645 PGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAP------AAPAAPAGAAP 698
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH-PSNTAPPPASH 333
P+ A PPA A P + P + PP P + A PA
Sbjct: 699 AQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
P AP PA+ + PP + +
Sbjct: 759 PPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMDD 795
|
Length = 824 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 57/215 (26%), Positives = 97/215 (45%), Gaps = 25/215 (11%)
Query: 977 LGEGGFGLVYSGVL--------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 1026
LGEG FG V D VAVK+LK + + ++E+E++ + H+N
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLH------------GVDKESAPLGWDARLKI 1074
++ L+G+C +E ++ E G++ L L + +
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
A AR + YL S R IHRD + N+L+ D K++DFGLAR D + ++
Sbjct: 140 AYQVARGMEYL---ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
++APE +SDV+S+G+++ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-13
Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGI 1033
+G G +G V + G +VAVK L R Q + E+ +L + H N++ L+ +
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKES----APLGWDARLKIALGAARALAYLHEDS 1089
++ E + + +HL G D + L D + R L Y+H
Sbjct: 85 FTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 137
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S +IHRD K SN+ + D K+ DFGLAR DE + +++TR Y APE +
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNW 192
Query: 1150 -HLLVKSDVYSYGVVILELLSGR 1171
H D++S G ++ ELL+GR
Sbjct: 193 MHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 7e-13
Identities = 43/206 (20%), Positives = 60/206 (29%), Gaps = 8/206 (3%)
Query: 170 PASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
PA + PPA S A P + P+ A P+ + A ++ A
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAA------RPAAPAAPAAPAAPAPAGAAAAPAEASAAP 643
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
P + P + + PA+ P P A A P
Sbjct: 644 APGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPA 702
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
P+ A PPA + A P + P + + P P P A
Sbjct: 703 PAPAATPPAGQADDPAAQPPQAAQGASAPSPA-ADDPVPLPPEPDDPPDPAGAPAQPPPP 761
Query: 350 PPPASHPSNTALPPASHPSNPAIPPA 375
P PA + A PP S PS
Sbjct: 762 PAPAPAAAPAAAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 7e-13
Identities = 67/214 (31%), Positives = 97/214 (45%), Gaps = 31/214 (14%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRL---HHRN 1026
+GEG +G VY L+ G VA LK+V E L E+ +L +L H N
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVA---LKKVRVPLSEEGIPLSTLREIALLKQLESFEHPN 62
Query: 1027 LVKLIGIC-IEEQARC----LVYELIPNGSVESHLHG-VDKESAP-LGWDARLKIALGAA 1079
+V+L+ +C R LV+E V+ L + K P L + +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEH-----VDQDLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
R + +LH S R++HRD K NIL+ D K++DFGLAR E + T V+ T
Sbjct: 118 RGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSVVVTLW 171
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y APE + D++S G + EL R+P
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 7e-13
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G+G G VY+ + + G +VA+K + Q + E+ ++ H N+V + +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVIH 138
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1155
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1156 DVYSYGVVILELLSGRKP 1173
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 7e-13
Identities = 68/279 (24%), Positives = 122/279 (43%), Gaps = 38/279 (13%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRV------DQQGGRE-------FLAEVEML-SRL 1022
LG G FG VY V + LK + + RE ++EV ++ +L
Sbjct: 8 LGSGAFGCVYK-VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQL 66
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
H N+V+ +E +V +LI + H + + ++ + I + AL
Sbjct: 67 RHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
YLH++ R++HRD +NI+L D ++DFGLA+ E T V+GT Y
Sbjct: 127 RYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTILYSC 181
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSREGLER 1201
PE K+DV+++G ++ ++ QPP N+++ A + +E
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMC-------TLQPPFYSTNMLSLATKI------VEA 228
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1240
+ +P L + + V + + C+ P+ + RP + +V
Sbjct: 229 VYEP-LPEGMYSE---DVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 8e-13
Identities = 62/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 977 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+GEG G+V + G +VAVK + QQ EV ++ HH N+V + +
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 1036 EEQARCLVYELIPNGS---VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+V E + G+ + +H +++ A + L RAL+YLH
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------TVCLSVLRALSYLHNQG--- 138
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
VIHRD KS +ILL D K+SDFG E + S ++GT ++APE
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS--LVGTPYWMAPEVISRLPYG 196
Query: 1153 VKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
+ D++S G++++E++ G P +PP Q
Sbjct: 197 TEVDIWSLGIMVIEMIDGEPPY-FNEPPLQ 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 9e-13
Identities = 58/224 (25%), Positives = 77/224 (34%), Gaps = 19/224 (8%)
Query: 94 DMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSL 153
P + PVA P A P AP P+ P P A+P A V PA
Sbjct: 371 GAGPATAAAA--PVAQPAPAAAAPAA-AAPAPAAPPAAPAAAPAAAAAARAVAAAPARRS 427
Query: 154 IPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALP 213
LA+ + A P P+ A P A+ P+ ARP A+ P A A+ P+ A
Sbjct: 428 PAPEALAAARQASARGPGGAPAPAPAPAAA-PAAAARPAAAGPRPVAAAAAAAPARAAPA 486
Query: 214 SKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
+ AP+ P LPP + + PA ++ P PA+ P
Sbjct: 487 AAPAPADDDPPPWEELPPE--------FASPAPAQPDAAPAGWVAESIPDPATAD----P 534
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
A AP A P A P PP + S
Sbjct: 535 DDAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 1e-12
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLHHRNLVKL 1030
LGEG FG VY + G VA LK++ ++ F L E+++L +L H N+V L
Sbjct: 16 LGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKILKKLKHPNVVPL 72
Query: 1031 IGICIEE-----QARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALA 1083
I + +E + R VY + P ++ L G+ + S L ++++K L +
Sbjct: 73 IDMAVERPDKSKRKRGSVYMVTP--YMDHDLSGLLENPSVKLT-ESQIKCYMLQLLEGIN 129
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE---------ESRHISTRV 1134
YLHE+ ++HRD K++NIL+++ K++DFGLAR T +
Sbjct: 130 YLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNL 186
Query: 1135 MGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGR 1171
+ T Y PE + T + D++ G V E+ + R
Sbjct: 187 VVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 57/200 (28%), Positives = 96/200 (48%), Gaps = 17/200 (8%)
Query: 976 ILGEGGFGLVYSG-VLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
ILG G G VY L +AVKV+ + + ++ ++E+E+L + ++ G
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
E + E + GS++ ++ E LG +IA+ + L YL S ++
Sbjct: 68 FFVENRISICTEFMDGGSLD--VYRKIPEHV-LG-----RIAVAVVKGLTYLW---SLKI 116
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1153
+HRD K SN+L+ K+ DFG++ ++ I+ +GT Y+APE +
Sbjct: 117 LHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGI 172
Query: 1154 KSDVYSYGVVILELLSGRKP 1173
SDV+S G+ +EL GR P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-12
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 18/208 (8%)
Query: 977 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+GEG G+V + V G VAVK + QQ EV ++ H N+V++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 1036 EEQARCLVYELIPNGS---VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+V E + G+ + +H +++ A + L +AL+ LH +
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--------AVCLAVLKALSVLH---AQG 136
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
VIHRD KS +ILL HD K+SDFG E R S ++GT ++APE
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKS--LVGTPYWMAPELISRLPYG 194
Query: 1153 VKSDVYSYGVVILELLSGRKPVDMTQPP 1180
+ D++S G++++E++ G P +PP
Sbjct: 195 PEVDIWSLGIMVIEMVDGEPPY-FNEPP 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 2e-12
Identities = 46/195 (23%), Positives = 68/195 (34%), Gaps = 6/195 (3%)
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
A+ P P A+ P+ AP PA+ P+ A PA+ A A+ ++ +P P +
Sbjct: 375 ATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAA--AARAVAAAPARRSPAPEA 432
Query: 355 HPSNTALPPASHPSNPAIP--PASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPS 412
+ PA PA+ P+ A P A+ P A A+ P+ A A P+
Sbjct: 433 LAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAPAPA 492
Query: 413 NIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVA 472
+ PPP LP AP + P A P P A
Sbjct: 493 DDDPPPW--EELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAPA 550
Query: 473 QKRNASNREAPIAEP 487
+ A+ P
Sbjct: 551 PRAAAATEPVVAPRP 565
|
Length = 700 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-12
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 977 LGEGGFGLVYS----GVLDDGTK----VAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 1026
LGEG FG V G+ D K VAVK+LK ++ + ++E+EM+ + H+N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA----------- 1075
++ L+G C ++ ++ E G++ +L + P G + IA
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYL----RARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 1076 -----LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130
AR + YL +S + IHRD + N+L+ + K++DFGLAR + +
Sbjct: 139 LVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKK 195
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
+T ++APE +SDV+S+GV++ E+ +
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 76/287 (26%), Positives = 128/287 (44%), Gaps = 50/287 (17%)
Query: 977 LGEGGFGLVYSGVL-------DDGTKVAVKVLKRVDQQGGREFLAEVE---MLSRLHHRN 1026
LG+G F +Y GVL G V V+ +V R+ LA E ++S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
LVKL G+C+ +V E + G ++ LH +K + L W +L +A A AL YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH-REKNNVSLHW--KLDVAKQLASALHYLE 118
Query: 1087 EDSSPRVIHRDFKSSNILL-----EHDFTP--KVSDFGLARSAMDEESRHISTRVMGTFG 1139
+ +++H + NIL+ + P K+SD G+ + + E R +
Sbjct: 119 DK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREER------VERIP 169
Query: 1140 YVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1197
++APE G L + +D +S+G +LE+ S G+E L L+S E
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSN----------GEEPLST-----LSSSE 214
Query: 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244
D + +P A++A + + C + RP +++ L
Sbjct: 215 KERFYQD---QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 66/209 (31%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIG 1032
++G+G +G+V S + G KVA+K + V + L E+++L L H ++V++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 1033 ICIEEQAR-----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
I + R +V+EL+ ES LH V K + L + RAL Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM-----ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH- 120
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPEYA 1146
+ V HRD K NIL D K+ DFGLAR A ++ I T + T Y APE
Sbjct: 121 --TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPE-- 176
Query: 1147 MTGHLLVKS----DVYSYGVVILELLSGR 1171
+ G K D++S G + E+L+G+
Sbjct: 177 LCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 65/203 (32%), Positives = 94/203 (46%), Gaps = 20/203 (9%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+G G FGLV S G VA+K + + + E+++L L H N++ L I
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDI 77
Query: 1034 CIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
I V EL+ + LH + S PL R L Y+H S
Sbjct: 78 FISPLEDIYFVTELL-----GTDLHRL-LTSRPLEKQFIQYFLYQILRGLKYVH---SAG 128
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
V+HRD K SNIL+ + K+ DFGLAR + + ++STR Y APE +T
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY-----YRAPEIMLTWQKY 183
Query: 1153 -VKSDVYSYGVVILELLSGRKPV 1174
V+ D++S G + E+L G KP+
Sbjct: 184 DVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 69/225 (30%), Positives = 100/225 (44%), Gaps = 20/225 (8%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHR 1025
T ++ +G+G +G VY DG+ AVK+L + E AE +L L +H
Sbjct: 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNILQSLPNHP 79
Query: 1026 NLVKLIGI------CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
N+VK G+ + Q LV EL GSV + G+ L I GA
Sbjct: 80 NVVKFYGMFYKADKLVGGQL-WLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
L +LH + R+IHRD K +NILL + K+ DFG+ SA +R +GT
Sbjct: 139 LGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTSTRLRRNTSVGTPF 193
Query: 1140 YVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQP 1179
++APE + DV+S G+ +EL G P+ P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 24/203 (11%)
Query: 977 LGEGGFGLVYSGVLDDGTKVA---VKVLKRV---DQQGGREFLAEVE--MLSRLHHRNLV 1028
LG+G FG VY ++ D VA +KVLK + + A E +LS+L H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 1029 KLIGICIEEQARCLVYELIP----NGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
K +E A C++ E + +E H S + +++ LG + Y
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG----VHY 121
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
+H+ R++HRD K+ NI L+++ K+ DFG++R M S ++T GT Y++PE
Sbjct: 122 MHQR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMG--SCDLATTFTGTPYYMSPE 175
Query: 1145 YAMTGHLLVKSDVYSYGVVILEL 1167
KSD++S G ++ E+
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-12
Identities = 57/206 (27%), Positives = 95/206 (46%), Gaps = 14/206 (6%)
Query: 975 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR--VDQQGGRE-FLAEVEMLSRLHHRNLVKL 1030
R+LG+G FG V + + + G AVKVLK+ + Q E + E +LS + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 1031 IGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+ C + R V E + G + H+ + AR A AL +LH+
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARF-YAAEITSALMFLHDKG 116
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
+I+RD K N+LL+H+ K++DFG+ + + ++ GT Y+APE
Sbjct: 117 ---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTPDYIAPEILQEM 171
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVD 1175
D ++ GV++ E+L G P +
Sbjct: 172 LYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 57/205 (27%), Positives = 85/205 (41%), Gaps = 18/205 (8%)
Query: 980 GGFGLVY-SGVLDDGTKVAVKVLKRVDQQGGRE---FLAE-VEMLSRLHHRNLVKLIGIC 1034
G FG VY + G A+KVLK+ D + AE M+ + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+ LV E + G S + K L D + + LH+ +I
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI----KTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
HRD K N+L++ K++DFGL+R+ + + + +GT Y+APE +
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGL------ENKKFVGTPDYLAPETILGVGDDKM 173
Query: 1155 SDVYSYGVVILELLSGRKPVDMTQP 1179
SD +S G VI E L G P P
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-12
Identities = 88/450 (19%), Positives = 133/450 (29%), Gaps = 31/450 (6%)
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
P P + P A S ++ + + + PP P P +
Sbjct: 22 PRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPP--GPGTEA 79
Query: 344 HSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNT 403
++++ P S A + +P P S P PP P++ P A S
Sbjct: 80 PANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPD--PPPPTPPPASPPPSPAPDLSEM 137
Query: 404 ALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPS 463
S A P P+A+ A S+ +P T R PS
Sbjct: 138 LRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARA----------PS 187
Query: 464 MPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVP 523
P PP + A P P P ++ SP P + D
Sbjct: 188 SPPAEPPP-------STPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSS 240
Query: 524 PSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKP 583
S G P+ P+ S PS+ S+ SP SP P
Sbjct: 241 SSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSP--RERSPSP 298
Query: 584 PQNNGNDTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKR 643
++ P S + R +SS + S S ++ GP S P+
Sbjct: 299 SPSSPGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSR--- 355
Query: 644 HYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTS-ASGQTELPLLPPKSSPSEPIRAFPP 702
PPP + SP P P+ P + + PT + + + P
Sbjct: 356 --PPPPADPSSPRKRPRPSRAPSSPAASAGRPTRRRARAAVAGRARRRDATGRFPAGRPR 413
Query: 703 PPPNADCSTTICTEPYTNTPPGSPCGCVWP 732
P P + + Y P +P G WP
Sbjct: 414 PSPLDAGAAS--GAFYARYPLLTPSGEPWP 441
|
Length = 1352 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-12
Identities = 78/270 (28%), Positives = 115/270 (42%), Gaps = 28/270 (10%)
Query: 956 AKTFSASEIEKATGNFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLKRVDQQGG---RE 1011
A+ F + EK F R +G G FG VY + + + VA+K + +Q ++
Sbjct: 5 AELFFKDDPEKL---FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 1012 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1071
+ EV L +L H N ++ G + E LV E + S L V K+ PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEI 117
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
+ GA + LAYLH S +IHRD K+ NILL K+ DFG A
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANX---- 170
Query: 1132 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPV-DMTQPPGQENLVA 1187
+GT ++APE + G K DV+S G+ +EL + P+ +M ++
Sbjct: 171 --FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 1188 WARPLLTSR---EGLERIIDPSLGNDVPFD 1214
P L S E +D L +P D
Sbjct: 229 NESPALQSGHWSEYFRNFVDSCL-QKIPQD 257
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 5e-12
Identities = 73/237 (30%), Positives = 104/237 (43%), Gaps = 25/237 (10%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRLHH 1024
F R +G G FG VY D V +K++ G + + + EV+ L R+ H
Sbjct: 27 FTDLREIGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
N ++ G + E LV E + S L V K+ PL I GA + LAY
Sbjct: 85 PNSIEYKGCYLREHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEIAAITHGALQGLAY 140
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH S +IHRD K+ NILL K++DFG A A S +GT ++APE
Sbjct: 141 LH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS------FVGTPYWMAPE 191
Query: 1145 YAMT---GHLLVKSDVYSYGVVILELLSGRKPV-DMTQPPGQENLVAWARPLLTSRE 1197
+ G K DV+S G+ +EL + P+ +M ++ P L S E
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNE 248
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 72/261 (27%), Positives = 111/261 (42%), Gaps = 32/261 (12%)
Query: 962 SEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 1020
S + G F+ ++G G +G VY G + G A+KV+ V + E E+ ML
Sbjct: 9 SALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTEDEEEEIKLEINMLK 67
Query: 1021 RL-HHRNLVKLIGICIE------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK 1073
+ HHRN+ G I+ + LV E GSV + + W A
Sbjct: 68 KYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-- 125
Query: 1074 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1133
I R LA+LH + +VIHRD K N+LL + K+ DFG+ SA + +
Sbjct: 126 ICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNT 180
Query: 1134 VMGTFGYVAPEYAMTGH-----LLVKSDVYSYGVVILELLSGRKPV-DM----------T 1177
+GT ++APE +SD++S G+ +E+ G P+ DM
Sbjct: 181 FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 240
Query: 1178 QPPGQENLVAWARPLLTSREG 1198
PP + W++ + EG
Sbjct: 241 NPPPKLKSKKWSKKFIDFIEG 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 68/204 (33%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 977 LGEGGFGLVYSGVLDDGTK-VAVKVLKRVDQQGG---REFLAEVEMLSRLHHRNLVKLIG 1032
+G G FG VY + VAVK + +Q ++ + EV+ L +L H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
++E LV E + S L V K+ PL I GA + LAYLH S
Sbjct: 89 CYLKEHTAWLVMEYCLGSA--SDLLEVHKK--PLQEVEIAAITHGALQGLAYLH---SHN 141
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT---G 1149
+IHRD K+ NILL K++DFG A + S +GT ++APE + G
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASKSSPANS------FVGTPYWMAPEVILAMDEG 195
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
K DV+S G+ +E L+ RKP
Sbjct: 196 QYDGKVDVWSLGITCIE-LAERKP 218
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-12
Identities = 58/226 (25%), Positives = 93/226 (41%), Gaps = 57/226 (25%)
Query: 978 GEGGFGLVYSGVL---DDGTKVAVKVLK-RVDQQGGREFLA--EVEMLSRLHHRNLVKLI 1031
G G +G VY DG + A+K K +Q G A E+ +L L H N+V L+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68
Query: 1032 GICIEEQARC--LVYE-------------------LIPNGSVESHLHGVDKESAPLGWDA 1070
+ +E + L+++ IP V+S L
Sbjct: 69 EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW------------- 115
Query: 1071 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEE 1126
+I G + YLH + V+HRD K +NIL+ + K+ D GLAR +
Sbjct: 116 --QILNG----VHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLAR-LFNAP 165
Query: 1127 SRHIST--RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLS 1169
+ ++ V+ T Y APE + K+ D+++ G + ELL+
Sbjct: 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 8e-12
Identities = 44/220 (20%), Positives = 66/220 (30%), Gaps = 3/220 (1%)
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
P A+ P PA+ A P + P + + A A+ P+ +P
Sbjct: 371 GAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPA-AAAAARAVAAAPARRSPA 429
Query: 308 PASHPSNTAPPPASHPSNTAPP--PASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
P + + AP PA+ P+ A P A+ A A+ P+ A A
Sbjct: 430 PEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAAAP 489
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
P++ PP PA + AP S A P
Sbjct: 490 APADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPAPAAAP 549
Query: 426 SALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMP 465
+ A P A A+ F PA+ +P
Sbjct: 550 APRAAAATEPVVAPRPPRASASGLPDMFDGDWPALAARLP 589
|
Length = 700 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 69.2 bits (170), Expect = 1e-11
Identities = 41/192 (21%), Positives = 56/192 (29%), Gaps = 2/192 (1%)
Query: 199 TAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA-PPPASHLSNTAPPPASHP 257
AP A A S P A+ P+ A P A A A ++ AP P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 258 YKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
+ P + P + PA+ P P A A P P+ A
Sbjct: 650 PEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAPAAT 708
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
PPA + A P + P + PP + P P P +
Sbjct: 709 PPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAA 768
Query: 378 PSNTAIPPASHP 389
A PP+
Sbjct: 769 APAAAPPPSPPS 780
|
Length = 824 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 61/204 (29%), Positives = 103/204 (50%), Gaps = 19/204 (9%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
+GEG +G+VY G VA+K ++ + G A E+ +L L+H N+V+L+ +
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARL--KIALGAARALAYLHEDSS 1090
E LV+E + + ++ ++ +S+P G D L + +AY H S
Sbjct: 67 VHSENKLYLVFEFL-DLDLKKYM-----DSSPLTGLDPPLIKSYLYQLLQGIAYCH---S 117
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG- 1149
RV+HRD K N+L++ + K++DFGLAR A R + V+ T Y APE +
Sbjct: 118 HRVLHRDLKPQNLLIDREGALKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEILLGSR 175
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D++S G + E+++ R+P
Sbjct: 176 QYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 70/238 (29%), Positives = 106/238 (44%), Gaps = 20/238 (8%)
Query: 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVDQQGGREF 1012
S KT + ++ +G+G +G V+ VL+ +G+K AVK+L + E
Sbjct: 4 SGKTIIFDSFPDPSDTWEIIETIGKGTYGKVFK-VLNKKNGSKAAVKILDPI-HDIDEEI 61
Query: 1013 LAEVEMLSRLH-HRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPL 1066
AE +L L H N+VK G+ ++ + LV EL GSV + G K +
Sbjct: 62 EAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERM 121
Query: 1067 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126
I A L +LH + + IHRD K +NILL + K+ DFG+ SA
Sbjct: 122 EEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTS 176
Query: 1127 SRHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQP 1179
+R +GT ++APE L + DV+S G+ +EL G P+ P
Sbjct: 177 TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-11
Identities = 56/194 (28%), Positives = 85/194 (43%), Gaps = 44/194 (22%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLHHRNLVK 1029
+G+G FG V+ VA LK+V + +E F L E+++L L H N+V
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVA---LKKVLMENEKEGFPITALREIKILQLLKHENVVN 75
Query: 1030 LIGICIEE---QARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
LI IC + R LV+E + + A L + +K L +
Sbjct: 76 LIEICRTKATPYNRYKGSFYLVFEF------------CEHDLAGLLSNKNVKFTLSEIKK 123
Query: 1082 --------LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRH-I 1130
L Y+H +++HRD K++NIL+ D K++DFGLAR S +
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRY 180
Query: 1131 STRVMGTFGYVAPE 1144
+ RV+ T Y PE
Sbjct: 181 TNRVV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 1e-11
Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 23/208 (11%)
Query: 976 ILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREF-LAEVEMLSRLHHRNLVKLI 1031
I+G GGFG VY D G A+K L KR+ + G L E MLS + + ++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 1032 GICIEEQAR---CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLH 1086
+ + +L+ G + HL HGV E+ + A +I LG L ++H
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAA--EIILG----LEHMH 114
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
V++RD K +NILL+ ++SD GLA ++ H S +GT GY+APE
Sbjct: 115 NRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHGYMAPEVL 167
Query: 1147 MTGHLLVKS-DVYSYGVVILELLSGRKP 1173
G S D +S G ++ +LL G P
Sbjct: 168 QKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 34/213 (15%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
+GEG +G+VY G G VA+K ++ ++ G A E+ +L L H N+V L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED----- 1088
++E L++E + + ++ +L +S P G + A +YL++
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYL-----DSLPKGQ------YMDAELVKSYLYQILQGIL 115
Query: 1089 --SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVA 1142
S RV+HRD K N+L+++ K++DFGLAR+ I RV + T Y A
Sbjct: 116 FCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAF------GIPVRVYTHEVVTLWYRA 169
Query: 1143 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKPV 1174
PE + D++S G + E+ + +KP+
Sbjct: 170 PEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 69/219 (31%), Positives = 101/219 (46%), Gaps = 45/219 (20%)
Query: 976 ILGEGGFGLVYS-GVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
I+G GGFG VY D G A+K L KR+ + G E LA L+ R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQG-ETLA-------LNERIMLSLVS 52
Query: 1033 -------ICIE-----EQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIA 1075
+C+ C + +L+ G + HL HGV E + R +I
Sbjct: 53 TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEK-----EMRFYATEII 107
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
LG L ++H V++RD K +NILL+ ++SD GLA ++ H S +
Sbjct: 108 LG----LEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---V 156
Query: 1136 GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
GT GY+APE G S D +S G ++ +LL G P
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 1e-11
Identities = 60/221 (27%), Positives = 107/221 (48%), Gaps = 30/221 (13%)
Query: 977 LGEGGFGLVYSG----VLDDG----TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
LG+G F ++ G V D G T+V +KVL + + F M+S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
G+C+ +V E + GS++++L +K + W +L++A A AL +L +
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKK-NKNLINISW--KLEVAKQLAWALHFLEDK 119
Query: 1089 SSPRVIHRDFKSSNILL--EHDF---TP---KVSDFGLARSAMDEESRHISTRVMGTFGY 1140
+ H + + N+LL E D P K+SD G++ + + +E + R+ +
Sbjct: 120 G---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI--LLERI----PW 170
Query: 1141 VAPE-YAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQP 1179
V PE +L + +D +S+G + E+ SG KP+
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-11
Identities = 64/281 (22%), Positives = 89/281 (31%), Gaps = 15/281 (5%)
Query: 104 TNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL 163
T PVA + T AP + T PVAS A P V P P P+ +P
Sbjct: 317 TEPVAVAAAATTATQSWAAPVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAP- 375
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+ + +P S + A +P + + A PA P P + A P
Sbjct: 376 APEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYA 435
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLP-ASHPSKTAPPPASHPSNT 282
P+ P + + A S AP +T P A P P P
Sbjct: 436 PAPE--QPVAGNAWQAEEQQSTF---APQSTYQTEQTYQQPAAQEPLYQQPQPVEQQPVV 490
Query: 283 APPPASHPSKTAPPPASHPSNTAPPPASHPSNTA------PPPASHPSNTAPPPASHPSN 336
P P +K A PP + A A P P P PS
Sbjct: 491 EPEPVVEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPE-PIKSSLKAPSV 549
Query: 337 TAPPPASHSSKTAPPPASHPSNT-ALPPASHPSNPAIPPAS 376
A PP ++ +P + T A A+ + P A+
Sbjct: 550 AAVPPVEAAAAVSPLASGVKKATLATGAAATVAAPVFSLAN 590
|
Length = 1355 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 70/220 (31%), Positives = 104/220 (47%), Gaps = 29/220 (13%)
Query: 970 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREF-LAEVEMLSR 1021
NF+ R+LG G +G V+ G D G A+KVLK+ V + E E ++L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 1022 LHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALG 1077
+ R LV L + L+ + + G + +HL+ + ES R+ IA
Sbjct: 61 VR-RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE-----VRVYIA-E 113
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMG 1136
AL +LH+ +I+RD K NILL+ + ++DFGL++ +EE R S G
Sbjct: 114 IVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS--FCG 168
Query: 1137 TFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKP 1173
T Y+APE GH D +S GV+ ELL+G P
Sbjct: 169 TIEYMAPEVIRGGSGGHDKA-VDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-11
Identities = 53/212 (25%), Positives = 72/212 (33%), Gaps = 7/212 (3%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
P P + P PAS + P+ A P A P+ A PA + AP A
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVA 648
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN 358
+ P + P + PA+ P P A + A P P+
Sbjct: 649 APE--HHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 359 TALPPASHPSNPAIPPASHP-SNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
A PPA +PA P +A PA+ PP P + A PA P AP
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 418 PLFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
P P+A P +P S+ D +
Sbjct: 766 P---AAAPAAAPPPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-11
Identities = 39/193 (20%), Positives = 57/193 (29%), Gaps = 7/193 (3%)
Query: 216 TAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
AP A A + P + A P A AP + P A + AP P
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAP----AAPAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
P + P + PA+ P P A A P P+
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPA 704
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
A PPA + A P + P + ++ +P P + P + PP
Sbjct: 705 PAATPPAGQADDPAAQPPQAAQGASAPSPA--ADDPVPLPPEPDDPPDPAGAPAQPPPPP 762
Query: 396 HASHPSNTALTPA 408
+ + A P
Sbjct: 763 APAPAAAPAAAPP 775
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-11
Identities = 50/211 (23%), Positives = 67/211 (31%), Gaps = 11/211 (5%)
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
V P P A PA S P A P + P+ A P + +
Sbjct: 587 VVGPAPGAAGGEGPPAPASSG-PPEEAARP------AAPAAPAAPAAPAPAGAAAAPAEA 639
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
++ P+ P HP + A+P + PA+ P P A A P
Sbjct: 640 SAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAP 698
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH-PSNTAPPPASH 311
P + PA A P + P + PP P + A PA
Sbjct: 699 AQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
P AP PA+ P+ A PP S PS
Sbjct: 759 PPPPAPAPAAAPA--AAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-11
Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 25/215 (11%)
Query: 977 LGEGGFGLVYS----GVLDD----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 1026
LGEG FG V G+ D VAVK+LK + + ++E+EM+ + H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA------------RLKI 1074
++ L+G C ++ ++ E G++ +L +D +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + + +T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
++APE +SDV+S+GV++ E+ +
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 59/215 (27%), Positives = 93/215 (43%), Gaps = 39/215 (18%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRV----DQQGGREF-LAEVEMLSRLHHRNLVKL 1030
+GEG +G V+ + VA LKRV D +G L E+ +L L H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVA---LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRL 64
Query: 1031 IGICIEEQARCLVYELIP----------NGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
+ ++ LV+E NG ++ + + +
Sbjct: 65 YDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEI-------------VKS-FMFQLLK 110
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
LA+ H S V+HRD K N+L+ + K++DFGLAR A R S V+ T Y
Sbjct: 111 GLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLAR-AFGIPVRCYSAEVV-TLWY 165
Query: 1141 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPV 1174
P+ L S D++S G + EL + +P+
Sbjct: 166 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-11
Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 12/205 (5%)
Query: 977 LGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGIC 1034
+G+G FG V+ G+ + KV A+K++ + + E + E+ +LS+ + K G
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+++ ++ E + GS L E PL I + L YLH S + I
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLH---SEKKI 123
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
HRD K++N+LL K++DFG+A D + + +GT ++APE K
Sbjct: 124 HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDSK 181
Query: 1155 SDVYSYGVVILELLSGRKPVDMTQP 1179
+D++S G+ +EL G P P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 14/206 (6%)
Query: 977 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 1033
+G+G FG VY G+ D+ TK VA+K++ + + E + E+ +LS+ + + G
Sbjct: 12 IGKGSFGEVYKGI-DNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGS 70
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
++ ++ E + GS L + PL I + L YLH S R
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLH---SERK 122
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1153
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIKQSAYDF 180
Query: 1154 KSDVYSYGVVILELLSGRKPVDMTQP 1179
K+D++S G+ +EL G P P
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHP 206
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 56/219 (25%), Positives = 98/219 (44%), Gaps = 38/219 (17%)
Query: 974 SRILGEGGFGLVYSGVLDDGT-----KVAVKVLKRVDQQGGRE-----FLAEVEMLSRLH 1023
S +L EG FG ++ G+L D +V VK +K E L E +L L
Sbjct: 11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVK----DHASEIQVTLLLQESCLLYGLS 66
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPN-GSVESHL----HGVDKESAPLGWDARLKIALGA 1078
H+N++ ++ +CIE+ V N G+++ L G L + +A+
Sbjct: 67 HQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQI 126
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM--------DEESRHI 1130
A ++YLH VIH+D + N +++ + K++D L+R D E+R +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
++A E + SDV+S+GV++ EL++
Sbjct: 184 K--------WMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-11
Identities = 54/197 (27%), Positives = 89/197 (45%), Gaps = 21/197 (10%)
Query: 991 DDGTKVAVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLI--GICIEEQARCLVYE 1045
G +VA+K+L+ + + F E + +RL+H N+V L+ G V+E
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFE 59
Query: 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105
+P ++ L L ++ L ALA H ++HRD K NI++
Sbjct: 60 YVPGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMV 112
Query: 1106 -EHDFTP--KVSDFGLAR-----SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDV 1157
+ P KV DFG+ D + +T V+GT Y APE + SD+
Sbjct: 113 SQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172
Query: 1158 YSYGVVILELLSGRKPV 1174
Y++G++ LE L+G++ V
Sbjct: 173 YAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 2e-11
Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 21/224 (9%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRN 1026
G F+ ++G G +G VY G + G A+KV+ V E E+ ML + HHRN
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRN 64
Query: 1027 LVKLIGICIE------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
+ G I+ + LV E GSV + + W A I R
Sbjct: 65 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILR 122
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L++LH+ +VIHRD K N+LL + K+ DFG+ SA + + +GT +
Sbjct: 123 GLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYW 177
Query: 1141 VAPEYAMTGH-----LLVKSDVYSYGVVILELLSGRKPVDMTQP 1179
+APE KSD++S G+ +E+ G P+ P
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-11
Identities = 46/134 (34%), Positives = 73/134 (54%), Gaps = 10/134 (7%)
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
K+++ R LAYL E +++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 107 KVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA-WARP 1191
+GT Y++PE H V+SD++S G+ ++EL GR P+ PP + L A + RP
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI---PPPDAKELEAIFGRP 217
Query: 1192 LLTSREGLERIIDP 1205
++ EG I P
Sbjct: 218 VVDGEEGEPHSISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 34/211 (16%)
Query: 979 EGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHHRNLVKLIGI 1033
EG +G+VY G VA+K LK ++ G F L E+ +L +L H N+V + +
Sbjct: 15 EGTYGVVYRARDKKTGEIVALKKLKMEKEKEG--FPITSLREINILLKLQHPNIVTVKEV 72
Query: 1034 CIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHEDSS 1090
+ +V E VE L + + + +K + L +A+LH++
Sbjct: 73 VVGSNLDKIYMVMEY-----VEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW- 126
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1150
++HRD K+SN+LL + K+ DFGLAR T+++ T Y APE
Sbjct: 127 --ILHRDLKTSNLLLNNRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPE------ 176
Query: 1151 LLV-------KSDVYSYGVVILELLSGRKPV 1174
LL+ D++S G + ELL+ +KP+
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 8/140 (5%)
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
KI++ R L YL E ++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 156
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
+GT Y++PE H V+SD++S G+ ++E+ GR P+ E +
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216
Query: 1193 LTSREGLERIIDPSLGNDVP 1212
++E + D P
Sbjct: 217 GEAKESHRPV--SGHPPDSP 234
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 3e-11
Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 12/228 (5%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G+G G VY+ + + G +VA++ + Q + E+ ++ + N+V + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLH---SNQVIH 139
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1155
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 197
Query: 1156 DVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-ARPLLTSREGLERI 1202
D++S G++ +E++ G P P L+A P L + E L I
Sbjct: 198 DIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 1026
NF +GEG +G+VY G VA+K ++ + G A E+ +L L+H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYL 1085
+VKL+ + E LV+E + + ++ + PL +K L + LA+
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL---PLIKSYLFQLLQGLAFC 116
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S RV+HRD K N+L+ + K++DFGLAR A R + V+ T Y APE
Sbjct: 117 H---SHRVLHRDLKPQNLLINTEGAIKLADFGLAR-AFGVPVRTYTHEVV-TLWYRAPEI 171
Query: 1146 AM-TGHLLVKSDVYSYGVVILELLSGR 1171
+ + D++S G + E+++ R
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 975 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGREF-LAEVEMLSRL-HHRNLVK 1029
++LG+G FG V L ++ AVKVLK+ + Q E + E +L+ H L +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 1030 LIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L C + + R V E + G + H+ + P +I LG L +LHE
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLG----LQFLHER 115
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
+I+RD K N+LL+ + K++DFG+ + + ++ GT Y+APE ++
Sbjct: 116 G---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPE-ILS 169
Query: 1149 GHLLVKS-DVYSYGVVILELLSGRKPVD 1175
+ D ++ GV++ E+L+G+ P +
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 4e-11
Identities = 39/136 (28%), Positives = 54/136 (39%), Gaps = 8/136 (5%)
Query: 276 ASHPSNTAPPPASHPSKT-APPPASHPSNT-APPPASHPSNTAPPPASHPSNTAPPPASH 333
A P+ A A KT A P A+ P+ A+ P+ A P A+ + APP A+
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
P+ A P A AP A + A+ A P A P P ++ A
Sbjct: 423 PAPVAAPAA-----AAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPE-PAVASAA 476
Query: 394 PPHASHPSNTALTPAS 409
P A+ P+ LTP
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHR 1025
+F+ +LG+G FG V ++ A+K+LK+ V Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 1026 NLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+ + C + R V E + G + H+ V K P +I++G L +
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVG----LFF 116
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 1143
LH +I+RD K N++L+ + K++DFG+ + M + ++TR GT Y+AP
Sbjct: 117 LHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---GVTTRTFCGTPDYIAP 170
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
E D ++YGV++ E+L+G+ P D
Sbjct: 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-11
Identities = 84/332 (25%), Positives = 143/332 (43%), Gaps = 57/332 (17%)
Query: 913 EEVPQSLQTSHVKPSGAAG--LMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATG- 969
E++ + +H G +G M LD S ++ A + ++I ++
Sbjct: 8 EDINIYEEKNHKANKGGSGKFEMNDKKLDEEERS-HNNNAGEDEDEEKMIDNDINRSPNK 66
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
++ I+G G FG+VY + +D KVA+K + + Q RE L ++ L+H N++
Sbjct: 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL----IMKNLNHINII 122
Query: 1029 KLIGICIEEQAR--------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGA 1078
L E + +V E IP +V ++ + + + PL L
Sbjct: 123 FLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL-- 179
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAM--DEESRHISTRVM 1135
RALAY+H S + HRD K N+L++ + T K+ DFG A++ + +I +R
Sbjct: 180 CRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF- 235
Query: 1136 GTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILE------LLSGRKPVDMTQPPGQEN 1184
Y APE + T H+ D++S G +I E + SG+ VD
Sbjct: 236 ----YRAPELMLGATNYTTHI----DLWSLGCIIAEMILGYPIFSGQSSVD--------Q 279
Query: 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSV 1216
LV + L T E + ++P+ D+ F V
Sbjct: 280 LVRIIQVLGTPTEDQLKEMNPNYA-DIKFPDV 310
|
Length = 440 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 61/220 (27%), Positives = 103/220 (46%), Gaps = 24/220 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLK-----RVDQQGGREFLAEVEMLSRL 1022
+ + + +G G FG V+ V D ++ A+KV+ R+ Q+ + E +L +
Sbjct: 2 DLERIKTVGTGTFGRVHL-VRDRISEHYYALKVMAIPEVIRLKQE--QHVHNEKRVLKEV 58
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
H +++L +++ ++ E +P G + S+L + S G L A AL
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG----LFYASEIVCAL 114
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
YLH S +++RD K NILL+ + K++DFG A+ D + + GT Y+A
Sbjct: 115 EYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLA 166
Query: 1143 PE-YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 1181
PE GH D ++ G++I E+L G P P G
Sbjct: 167 PEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFG 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-11
Identities = 63/212 (29%), Positives = 94/212 (44%), Gaps = 38/212 (17%)
Query: 977 LGEGGFGLVYSGVLDDGT--KVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIG 1032
+G G +G V S D KVAVK L R Q R E+ +L + H N++ L+
Sbjct: 23 VGSGAYGSVCSA-YDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 1033 ICIEEQARCLVYELIPNGSVE--------SHLHGVDKES----APLGWDARLKIALGAAR 1080
+ P S+E ++L G D + L + + R
Sbjct: 82 V------------FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L Y+H S +IHRD K SN+ + D ++ DFGLAR A DE + +++TR Y
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WY 181
Query: 1141 VAPEYAMTG-HLLVKSDVYSYGVVILELLSGR 1171
APE + H D++S G ++ ELL G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 5e-11
Identities = 34/140 (24%), Positives = 52/140 (37%), Gaps = 10/140 (7%)
Query: 204 ASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPL 263
A P+ A + A A P A+ ++ A PA A P A+ +P
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPA----AAPAAAASAPAAPP 418
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
A+ P+ A P A+ P + + P+ AP + P AP PA
Sbjct: 419 AAAPPAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA--V 472
Query: 324 SNTAPPPASHPSNTAPPPAS 343
++ AP PA+ P+ P
Sbjct: 473 ASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 5e-11
Identities = 43/202 (21%), Positives = 62/202 (30%), Gaps = 9/202 (4%)
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
P+ A P+ + P + A P+ A A P+ A PA + AP A+
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAA 649
Query: 245 HLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNT 304
P + P + PA+ P P A A P P+
Sbjct: 650 --PEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAPA 706
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPA 364
A PPA + A P + P + PP PP + PP
Sbjct: 707 ATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPD-----DPPDPAGAPAQPPPP 761
Query: 365 SHPSNPAIPPASHPSNTAIPPA 386
P+ A PA+ P +
Sbjct: 762 PAPAPAA-APAAAPPPSPPSEE 782
|
Length = 824 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 5e-11
Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G+G G VY+ + + G +VA+K + Q + E+ ++ + N+V + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
+V E + GS+ + + + R +AL +LH S +VIH
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALDFLH---SNQVIH 138
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1155
RD KS NILL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1156 DVYSYGVVILELLSGRKP 1173
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-11
Identities = 54/235 (22%), Positives = 73/235 (31%), Gaps = 25/235 (10%)
Query: 53 LKPHLLGGHA--PSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASP 110
+P GG A + P P P+ + PA A P + VA+
Sbjct: 363 FRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAA 422
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP 170
P+ +P P +A P +P P AP PA + A P
Sbjct: 423 PARRSPAPEALAAARQASARGPGGAPAPAPAPAAA---PAAA--------------ARPA 465
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASH-PSNTALPSKTAPSPASHPSNTAL 229
A+ P A A+ P+ A A P+ PPP P A P+ P A
Sbjct: 466 AAGPRPVAAAAAAAPARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAES 525
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P P+ P A AP A P + P PP + S
Sbjct: 526 IPD--PATADPDDAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 7e-11
Identities = 56/210 (26%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKR----VDQQGGREFLAEVEMLSR------LH 1023
++LG+G FG V+ L A+K LK+ +D E M+ +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDD------VECTMVEKRVLSLAWE 54
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
H L L ++ V E + G + H+ K P +I G L
Sbjct: 55 HPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICG----LQ 110
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
+LH S +++RD K NILL+ D K++DFG+ + M +++ + GT Y+AP
Sbjct: 111 FLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIAP 165
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
E + D +S+GV++ E+L G+ P
Sbjct: 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 7e-11
Identities = 67/215 (31%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 976 ILGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEML----------SRLHH 1024
+LG G FG V ++ A+K LK+ D R+ EVE L + H
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIA-RD---EVESLMCEKRIFETANSERH 61
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
LV L C + + C V E G + H+H D S P + LG L
Sbjct: 62 PFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLG----LQ 115
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
YLHE+ ++++RD K N+LL+ + K++DFGL + M R ST GT ++AP
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR-TST-FCGTPEFLAP 170
Query: 1144 EYAMTGHLLVKS-----DVYSYGVVILELLSGRKP 1173
E L S D + GV+I E+L G P
Sbjct: 171 EV-----LTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-11
Identities = 47/263 (17%), Positives = 58/263 (22%), Gaps = 31/263 (11%)
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
A + + P + AS P PS K P P P +
Sbjct: 84 APSVGPDSDLSQKTSTFSPCQS-GYEASTDPEYIPDLQPDPSLWGTAPKPEPQPPQAPES 142
Query: 227 TALPPA------------------SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHP 268
P + PP L PP + + P P
Sbjct: 143 QPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQ--P 200
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
PP HP P AP P P P P P
Sbjct: 201 PGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLP---PQLPQQPPPLQQPQFPGLSQQMPP 257
Query: 329 PPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASH 388
PP P PP A PP + T P N +PP P +
Sbjct: 258 PPPQPPQQQQQPPQP----QAQPPPQNQ-PTPHPGLPQGQNAPLPPPQQPQLLPLVQQPQ 312
Query: 389 PSNTAPPHASHPSNTALTPASHP 411
P L+
Sbjct: 313 GQQRGPQF--REQLVQLSQQQRE 333
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 9e-11
Identities = 59/226 (26%), Positives = 94/226 (41%), Gaps = 39/226 (17%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE--------------FLAEVEMLSR 1021
LGEG +G V G VA+K +K ++ L E+++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAAR 1080
+ H N++ L+ + +E LV +++ S L V L ++++K I L
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-----ASDLKKVVDRKIRLT-ESQVKCILLQILN 130
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-----AMDEESRHI---ST 1132
L LH+ +HRD +NI + K++DFGLAR D S+
Sbjct: 131 GLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 1133 RVMG----TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
M T Y APE M + D++S G + ELL+G KP
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KP 232
|
Length = 335 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-10
Identities = 73/371 (19%), Positives = 116/371 (31%), Gaps = 13/371 (3%)
Query: 159 LASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAP 218
L + + A P A P + + S +A A A
Sbjct: 7 LYDLIEAAAEGGEFFPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFE 66
Query: 219 SP-ASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P P PA+ T S L+ +P P P P T PPPAS
Sbjct: 67 PPTGPPPGPGTEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPT-PPPAS 125
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 337
P + P S + P P+ + P + P+ A AS P + +
Sbjct: 126 PPP-SPAPDLSEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETAR 184
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
AP + PPA+ P S+P AS P+ A+ + + +
Sbjct: 185 APSSPPAEPPPSTPPAAAS-----PRPPRRSSPISASASSPAPAPGRSAADDAGASSSDS 239
Query: 398 SHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHS 457
S ++ P P + + S P + +++PR S
Sbjct: 240 SSSESSGCGWGPENECPLPRPAPITLPTRIWEASGWNGPSSRPGPASSSSSPRER----S 295
Query: 458 PAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTAS 517
P+ PS PG P + R +S+ E + S + + V+ P +P+ S
Sbjct: 296 PSPSPSSPGSGPAPSSPRASSSSS-SSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPS 354
Query: 518 PDPDVPPSTPP 528
P + P
Sbjct: 355 RPPPPADPSSP 365
|
Length = 1352 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-10
Identities = 31/136 (22%), Positives = 51/136 (37%), Gaps = 9/136 (6%)
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
P A+ + A PA+ P A+ P+ A P A+ + APP A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
P+ A P A+ P + + ++ AP + P A PA ++ A
Sbjct: 423 PAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA--VASAA 476
Query: 372 IPPASHPSNTAIPPAS 387
PA+ P+ + P
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-10
Identities = 40/227 (17%), Positives = 54/227 (23%), Gaps = 22/227 (9%)
Query: 104 TNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL 163
P A+ P + P + P P A P P A
Sbjct: 590 PAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAP-----------AGAAAAPAE 638
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+S A P + P + PA+ P A
Sbjct: 639 ASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-------PPPAPAPAAPA 691
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
A P P+ A PPA + A P S + PP
Sbjct: 692 APAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDD---- 747
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
PP + PPP + AP A PS + +
Sbjct: 748 PPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPSMD 794
|
Length = 824 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-10
Identities = 43/221 (19%), Positives = 59/221 (26%), Gaps = 17/221 (7%)
Query: 272 APPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 331
P P + P PAS + P+ A P A P+ A PA + AP A
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVA 648
Query: 332 SHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
+ P + + PA+ P P A A P P+
Sbjct: 649 APE--HHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 392 TAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG 451
A P A + A P + P P + P+ LP P P
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPS--------------PAADDPVPLPPEPDDPPDP 751
Query: 452 NFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGP 492
P P+ P A + E
Sbjct: 752 AGAPAQPPPPPAPAPAAAPAAAPPPSPPSEEEEMAEDDAPS 792
|
Length = 824 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-10
Identities = 37/115 (32%), Positives = 61/115 (53%), Gaps = 4/115 (3%)
Query: 1060 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119
++S PL D L+ + A+ + +L +S IHRD + N+LL K+ DFGLA
Sbjct: 203 TEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
R M++ + + ++APE V+SDV+SYG+++ E+ S G+ P
Sbjct: 260 RDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 67/248 (27%), Positives = 108/248 (43%), Gaps = 41/248 (16%)
Query: 969 GNFDASRILGEGGFGLVY-SGVLDDGTKVAVKVLKR-----VDQQGGREFLAEVEMLSRL 1022
+F +G+GG+G V+ + D G VA+K +K+ +++ R L E ++L+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEV--RHVLTERDILTTT 58
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAAR 1080
LVKL+ +++ L E +P G + L+ GV E + A + A+ A
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L Y IHRD K N L++ K++DFGL++ + + V+G+ Y
Sbjct: 119 ELGY---------IHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDY 164
Query: 1141 VAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWA---- 1189
+APE Y T D +S G ++ E L G P + P ENL W
Sbjct: 165 MAPEVLRGKGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQ 218
Query: 1190 RPLLTSRE 1197
RP+
Sbjct: 219 RPVYDDPR 226
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 977 LGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+GEG G+V + G +VAVK++ QQ EV ++ H+N+V++ +
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
+ ++ E + G++ + L + + +AL YLH S VIH
Sbjct: 89 VGEELWVLMEFLQGGALTDIVSQTR-----LNEEQIATVCESVLQALCYLH---SQGVIH 140
Query: 1096 RDFKSSNILLEHDFTPKVSDFGL-ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK 1154
RD KS +ILL D K+SDFG A+ + D R ++GT ++APE +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK---SLVGTPYWMAPEVISRTPYGTE 197
Query: 1155 SDVYSYGVVILELLSGRKP 1173
D++S G++++E++ G P
Sbjct: 198 VDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-10
Identities = 40/145 (27%), Positives = 62/145 (42%), Gaps = 15/145 (10%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A +P A+ + + A PA+ P A+ P+ A P A+ +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAP---------VAQAAAAPAPAAAPAAAASA 413
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
APP A+ + A P A+ P + PA+ P+ A PA P+ AP + P + AP
Sbjct: 414 PAAPPAAAPPAPVAAPAAAAP---AAAPAAAPAAVALAPAP-PAQAAPETVAIPVRVAPE 469
Query: 297 PASHPSNTAPPPASHPSNTAPPPAS 321
PA ++ AP PA+ P+ P
Sbjct: 470 PA--VASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-10
Identities = 52/198 (26%), Positives = 97/198 (48%), Gaps = 11/198 (5%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G+G G V++ + + G +VA+K + Q + E+ ++ L + N+V + +
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL 86
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095
+V E + GS+ + + A + R +AL +LH + +VIH
Sbjct: 87 VGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHAN---QVIH 138
Query: 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS 1155
RD KS N+LL D + K++DFG E+S+ + ++GT ++APE K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196
Query: 1156 DVYSYGVVILELLSGRKP 1173
D++S G++ +E++ G P
Sbjct: 197 DIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-10
Identities = 58/206 (28%), Positives = 94/206 (45%), Gaps = 26/206 (12%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 1030
+G G +G V S + G KVA+K L R Q E A E+ +L + H N++ L
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQS---ELFAKRAYRELRLLKHMKHENVIGL 79
Query: 1031 IGICIEEQAR---CLVYELIP-NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+ + + + Y ++P G+ L +K L D + + L Y+H
Sbjct: 80 LDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEK----LSEDRIQFLVYQMLKGLKYIH 135
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ +IHRD K N+ + D K+ DFGLAR E + ++ TR Y APE
Sbjct: 136 ---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WYRAPEVI 187
Query: 1147 MTG-HLLVKSDVYSYGVVILELLSGR 1171
+ H D++S G ++ E+L+G+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 2e-10
Identities = 66/237 (27%), Positives = 103/237 (43%), Gaps = 40/237 (16%)
Query: 969 GNFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLH 1023
+F+ +++G G FG V+ V D T A+KVL++ D + AE ++L+
Sbjct: 1 DDFEVIKVIGRGAFGEVWL-VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD 59
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
+VKL +E+ LV E +P G + + L + K+ P AR IA AL
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLL--IRKDVFPEET-ARFYIAELVL-ALD 115
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 1119
+H IHRD K NIL++ D K++DFGL
Sbjct: 116 SVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172
Query: 1120 ---RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
R ++ R + +GT Y+APE ++ D +S GV++ E+L G P
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-10
Identities = 66/220 (30%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 974 SRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNL 1027
SR+LG G G V + + DG AVKV VD +G E AEV L ++
Sbjct: 37 SRVLGSGATGTVLCAKRVSDGEPFAVKV---VDMEGMSEADKNRAQAEVCCLLNCDFFSI 93
Query: 1028 VKLIGICIEEQAR------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1075
VK C E+ A+ LV + G + + K + +
Sbjct: 94 VK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTF---REHEAG 146
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
L + L +H S +IHRD KS+NILL + K+ DFG ++ S +
Sbjct: 147 LLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFC 206
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
GT YVAPE K+D++S GV++ ELL+ ++P D
Sbjct: 207 GTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246
|
Length = 496 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-10
Identities = 76/375 (20%), Positives = 117/375 (31%), Gaps = 19/375 (5%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
P A S L S +A A A T PPP
Sbjct: 21 FPRPPATPGDAADDLLSGSQGQLVSDSAELAAVTVVAGAAACDRFEPPTGPPP----GPG 76
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
PA+ T S + +P P+ P P T PPPAS P + P
Sbjct: 77 TEAPANESRSTPTWSLSTLAPASPAREGSPTPPGPSSPDPPPPT-PPPASPPP-SPAPDL 134
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
S P P+ + P + P+ A AS P + + A
Sbjct: 135 SEMLRPVGSPGPPPAASPPAAGASPAAVASDAASSRQAALPLSSPEETARAPSSPPAEPP 194
Query: 370 PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALP 429
P+ PPA+ + ++ + P + + A + S+ + S+
Sbjct: 195 PSTPPAAASPRPPRRSSPISASASSPAPAPGRSAADDAGASSSDSSSS-------ESSGC 247
Query: 430 GKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIA 489
G P ++ P+ P AP P R A + P P A ++ +P P +
Sbjct: 248 GWGPENECPLPRP-APITLPT----RIWEASGWNGPSSRPGPASSSSSPRERSPSPSPSS 302
Query: 490 PGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVP-PSTPPLSVDGKRVGKPVAEPSYDIP 548
PG P +S + S + + + S + + R P P P
Sbjct: 303 PGSGPAPSSPRASSSSSSSRESSSSSTSSSSESSRGAAVSPGPSPSRSPSPSRPPPPADP 362
Query: 549 MPPPVNHSPSKAPST 563
P PS+APS+
Sbjct: 363 SSPRKRPRPSRAPSS 377
|
Length = 1352 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 3e-10
Identities = 34/143 (23%), Positives = 55/143 (38%), Gaps = 15/143 (10%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
+P A+ + A P A +PA+ P A+ P+ A P A+ +
Sbjct: 365 KPAAAAEA--AAPAEKKTPARP----EAAAPAAAP---VAQAAAAPAPAAAPAAAASAPA 415
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
APP A+ P + A+ P + + P++ AP + P AP PA
Sbjct: 416 APPAAAPPAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA 471
Query: 310 SHPSNTAPPPASHPSNTAPPPAS 332
++ AP PA+ P+ P
Sbjct: 472 --VASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 58/212 (27%), Positives = 91/212 (42%), Gaps = 43/212 (20%)
Query: 977 LGEGGFGLVYSG-VLDDGTKVAVKVLKR----VDQQGGREFLAEVEMLSRL-HHRNLVKL 1030
+GEG F V G A+K +K+ ++Q L E++ L RL H N+++L
Sbjct: 7 IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNN---LREIQALRRLSPHPNILRL 63
Query: 1031 IGICIEEQARCL----------VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
I + + + L +YELI PL +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG-----RKR-------PLPEKRVKSYMYQLLK 111
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVMGTF 1138
+L ++H + + HRD K NIL+ D K++DFG R + + +ISTR
Sbjct: 112 SLDHMHRNG---IFHRDIKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTR----- 162
Query: 1139 GYVAPEYAMT-GHLLVKSDVYSYGVVILELLS 1169
Y APE +T G+ K D+++ G V E+LS
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 56/205 (27%), Positives = 98/205 (47%), Gaps = 28/205 (13%)
Query: 977 LGEGGFG---LVYSGVLDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+GEG FG LV S +DG + +K + ++ + E EV +LS + H N+V+
Sbjct: 8 IGEGSFGKAILVKSK--EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHG----VDKESAPLGWDARLKIALGAARALAYLHE 1087
E +V + G + ++ + E L W ++ + AL ++H+
Sbjct: 66 ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICL------ALKHVHD 119
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPE 1144
+++HRD KS NI L D T K+ DFG+AR S ++ ++ +GT Y++PE
Sbjct: 120 R---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-----LARTCIGTPYYLSPE 171
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS 1169
KSD+++ G V+ E+ +
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 60/221 (27%), Positives = 101/221 (45%), Gaps = 32/221 (14%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLA---EVEMLSRLH 1023
N+ ++LG+G FG VY D G ++AVK ++ + + +E A E+++L L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 1024 HRNLVKLIGICIEEQARCL--VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
H +V+ G + R L E +P GS++ L K L + K
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL----KSYGALTENVTRKYTRQILEG 118
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST--------- 1132
++YLH S ++HRD K +NIL + K+ DFG S+ + T
Sbjct: 119 VSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFG--------ASKRLQTICLSGTGMK 167
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
V GT +++PE K+D++S G ++E+L+ + P
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 64.2 bits (157), Expect = 4e-10
Identities = 41/202 (20%), Positives = 57/202 (28%), Gaps = 4/202 (1%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
P P + + P PAS + P+ A P A P+ A ++ AP P
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPA--GAAAAPAEASAAPAPG 646
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
P + P + PA+ P A A P P+
Sbjct: 647 VAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAA-PPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 370 PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV-LPSAL 428
A PPA + A P + P + L P P P+
Sbjct: 706 AATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPA 765
Query: 429 PGKAPVSQSPISLPDAPAATPR 450
P AP + P S P
Sbjct: 766 PAAAPAAAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 4e-10
Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 977 LGEGGFGLVYSGVLDDGTK--VAVKVLKRVDQQGGREFLA-EVEMLSRLHHRNLVKLIGI 1033
+G+G FG V+ G+ D+ T+ VA+K++ + + E + E+ +LS+ + K G
Sbjct: 12 IGKGSFGEVFKGI-DNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGS 70
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
++ ++ E + GS L + + LK L + L YLH S +
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA--TMLKEIL---KGLDYLH---SEKK 122
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1153
IHRD K++N+LL K++DFG+A D + + +GT ++APE
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFVGTPFWMAPEVIQQSAYDS 180
Query: 1154 KSDVYSYGVVILELLSGRKPVDMTQP 1179
K+D++S G+ +EL G P P
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHP 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 50/212 (23%), Positives = 100/212 (47%), Gaps = 33/212 (15%)
Query: 977 LGEGGFGLVYSGVLDD---------GTKVAVKVLKRVDQQGGRE----FLAEVEMLSRLH 1023
LG G +Y+G+L+ + +KV+ +V R+ F M+ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
H+++V L G+C+ + +V E + G ++ +H ++S L + K+A A AL+
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH---RKSDVLTTPWKFKVAKQLASALS 119
Query: 1084 YLHEDSSPRVIHRDFKSSNILL-----EHDFTP--KVSDFGLARSAMDEESRHISTRVMG 1136
YL ED ++H + + NILL + + P K+SD G+ + + + +
Sbjct: 120 YL-EDK--DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQEC------VE 170
Query: 1137 TFGYVAPEYAM-TGHLLVKSDVYSYGVVILEL 1167
++APE + +L + +D +S+G + E+
Sbjct: 171 RIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 5e-10
Identities = 51/281 (18%), Positives = 78/281 (27%), Gaps = 19/281 (6%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A P + + + P P + + S A + +
Sbjct: 357 AFEPAVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAV-----TGAAGAALA 411
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
A A+ APP A P T+ AP PA + + PP
Sbjct: 412 PKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPP 471
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
S ++ A + P P + A PA+ S + AP A+ P
Sbjct: 472 ADSGSASAPASDAPPDAAFEPAP---RAAAPSAATPAAVPDARAPAAASREDAPAAAAPP 528
Query: 357 SNTALPPASHPSNPAIPPASHPS------NTAIPPASHPSNTAPPHASHPSNTALTPASH 410
+ A PP + PA + N + +S A A + A P
Sbjct: 529 APEARPPTPAAAAPAARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKP- 587
Query: 411 PSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG 451
A P + V V + + AA RG
Sbjct: 588 ----AAPRVAVQVPTPRARAATGDAPPNGAARAEQAAESRG 624
|
Length = 830 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-10
Identities = 60/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLA---EVEMLSRLH 1023
N+ ++LG+G FG VY +D G ++A K ++ + +E A E+++L L
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 1024 HRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
H +V+ G C+ ++A + E +P GSV+ L K L K
Sbjct: 63 HERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL----KAYGALTESVTRKYTRQILE 117
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFG 1139
++YLH S ++HRD K +NIL + K+ DFG ++ R V GT
Sbjct: 118 GMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+++PE K+DV+S G ++E+L+ + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 6e-10
Identities = 85/439 (19%), Positives = 121/439 (27%), Gaps = 52/439 (11%)
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
P A+ PS A PA+ P+ A PA+ AP PA+ AP PA P+ PP
Sbjct: 391 AGAPAAAAPSAAAAAPAAAPAPAAAAPAAAA---APAPAA-----APQPAPAPAPAPAPP 442
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
+ + A S AP P+ A P + PA P A PA+ P+
Sbjct: 443 SPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAP-------APAAAPA 495
Query: 391 NTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPR 450
A P A ++ A T I A K I LP+A R
Sbjct: 496 APAAPAAPAGADDAATLRERWPEI-----------LAAVPKRSRKTWAILLPEATVLGVR 544
Query: 451 GN----FHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEP----------IAPGPFPPG 496
G+ A NA +AE + P P G
Sbjct: 545 GDTLVLGFSTGGLAR--------RFASPGNAEVLVTALAEELGGDWQVEAVVGPAPGAAG 596
Query: 497 NSRQKSPVAR-PIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNH 555
+P + P P A P P + P A H
Sbjct: 597 GEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVAAPEHHPKH 656
Query: 556 SPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIASSPA 615
S + P + P P P + A +
Sbjct: 657 VAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAATPPAGQADD 716
Query: 616 PSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSP 675
P+ + QG P P + + + P P + P + +
Sbjct: 717 PA---AQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAA 773
Query: 676 TSASGQTELPLLPPKSSPS 694
S +E + +PS
Sbjct: 774 PPPSPPSEEEEMAEDDAPS 792
|
Length = 824 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-10
Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 22/215 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDD--GTK--VAVKVLKR--VDQQGGRE-FLAEVEMLSRL 1022
+F+ +LG+G FG V +L + GT A+K+LK+ + Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 1023 HHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+ + C + R V E + G + H+ V K P +IA+G
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIG---- 113
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1140
L +LH S +I+RD K N++L+ + K++DFG+ + + +TR GT Y
Sbjct: 114 LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDY 167
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
+APE D +++GV++ E+L+G+ P D
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 45/208 (21%), Positives = 95/208 (45%), Gaps = 37/208 (17%)
Query: 985 VYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKLIGICIEEQAR 1040
+Y G+ ++ +V ++ K+ +G E++ L R+ N++K+ G I+
Sbjct: 36 IYKGIFNN-KEVIIRTFKK-FHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIID---- 89
Query: 1041 CLVYELIPNGSVE------SHLHGV-DKESAPLGWDARLKIALGAARALAYLHE-DSSPR 1092
+ + +P S+ +L V DKE L + +L +A+ + L L++ + P
Sbjct: 90 --IVDDLPRLSLILEYCTRGYLREVLDKEKD-LSFKTKLDMAIDCCKGLYNLYKYTNKP- 145
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY-----VAPEYAM 1147
+++ S + L+ ++ K+ GL + ++++ M F Y + EY
Sbjct: 146 --YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF--MVYFSYKMLNDIFSEY-- 199
Query: 1148 TGHLLVKSDVYSYGVVILELLSGRKPVD 1175
+K D+YS GVV+ E+ +G+ P +
Sbjct: 200 ----TIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 7e-10
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 21/204 (10%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQGG---REFLAEVEMLSRLHHRNLVKLIG 1032
+GEG +G+VY D T + + K R++Q+ + E+ +L + H N+V+L
Sbjct: 10 IGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAP-LGWDARL-KIAL-GAARALAYLHEDS 1089
+ E+ LV+E + + ++ H+ +S+P + RL K L R +AY H
Sbjct: 69 VVHSEKRLYLVFEYL-DLDLKKHM-----DSSPDFAKNPRLIKTYLYQILRGIAYCH--- 119
Query: 1090 SPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM- 1147
S RV+HRD K N+L++ K++DFGLAR A R + V+ T Y APE +
Sbjct: 120 SHRVLHRDLKPQNLLIDRRTNALKLADFGLAR-AFGIPVRTFTHEVV-TLWYRAPEILLG 177
Query: 1148 TGHLLVKSDVYSYGVVILELLSGR 1171
+ H D++S G + E+++ +
Sbjct: 178 SRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.2 bits (149), Expect = 8e-10
Identities = 62/206 (30%), Positives = 94/206 (45%), Gaps = 28/206 (13%)
Query: 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
LGEG + VY G G VA+K + R++ + G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEI-RLEHEEGAPFTAIREASLLKDLKHANIVTLHDI 71
Query: 1034 CIEEQARCLVYELIPNG---SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
++ LV+E + ++ G+ + L L R LAY H+
Sbjct: 72 IHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL-------RGLAYCHQR-- 122
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM--- 1147
RV+HRD K N+L+ K++DFGLAR A S+ S V+ T Y P+ +
Sbjct: 123 -RVLHRDLKPQNLLISERGELKLADFGLAR-AKSVPSKTYSNEVV-TLWYRPPDVLLGST 179
Query: 1148 --TGHLLVKSDVYSYGVVILELLSGR 1171
+ L D++ G + E+ +GR
Sbjct: 180 EYSTSL----DMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 8e-10
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLA---EVEMLSRLH 1023
N+ ++LG G FG VY D G ++AVK + Q+ +E A E+++L L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 1024 HRNLVKLIGICI---EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
H +V+ G C+ EE+ + E +P GS++ L K L + + +
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL----KAYGALTENVTRRYTRQILQ 117
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-------- 1132
++YLH S ++HRD K +NIL + K+ DFG S+ I T
Sbjct: 118 GVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFG--------ASKRIQTICMSGTGI 166
Query: 1133 -RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
V GT +++PE K+DV+S ++E+L+ + P
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 9e-10
Identities = 60/208 (28%), Positives = 97/208 (46%), Gaps = 16/208 (7%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 1026
NF LGEG + VY G G VA+K + +D + G A E+ ++ L H N
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEI-HLDAEEGTPSTAIREISLMKELKHEN 59
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAY 1084
+V+L + E LV+E + + ++ ++ D D + +A+
Sbjct: 60 IVRLHDVIHTENKLMLVFEYM-DKDLKKYM---DTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
HE+ RV+HRD K N+L+ K++DFGLAR A S V+ T Y AP+
Sbjct: 116 CHEN---RVLHRDLKPQNLLINKRGELKLADFGLAR-AFGIPVNTFSNEVV-TLWYRAPD 170
Query: 1145 YAMTGHLLVKS-DVYSYGVVILELLSGR 1171
+ S D++S G ++ E+++GR
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-09
Identities = 32/132 (24%), Positives = 51/132 (38%), Gaps = 8/132 (6%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASH--PSNTAPPPASHPSKTAPPPASHPSNT 304
+ A A KT P + AP + P+ A P A+ + APP A+ P+
Sbjct: 367 AAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPV 426
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPA 364
A P A+ P + + P+ AP + + AP PA ++ A PA
Sbjct: 427 AAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPA--VASAAPAPA 480
Query: 365 SHPSNPAIPPAS 376
+ P+ + P
Sbjct: 481 AAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 53/208 (25%), Positives = 88/208 (42%), Gaps = 24/208 (11%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKLIG 1032
+G G FG V + T VA V+K + EFL + + L H N+++ +G
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62
Query: 1033 ICIEEQARCLVYELIPNGSVESHL-----HGVDKESAPLGWDARLKIALGAARALAYLHE 1087
C+E LV+E G ++S+L H + + L ++A A + ++H+
Sbjct: 63 QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ-----RMACEIAAGVTHMHK 117
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY-- 1145
+ +H D N L D T KV D+G+ S E+ ++APE
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVG 174
Query: 1146 AMTGHLLVK-----SDVYSYGVVILELL 1168
G L+ S+V++ GV + EL
Sbjct: 175 EFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 61/211 (28%), Positives = 103/211 (48%), Gaps = 25/211 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTK----VAVKVLKRV----DQQGGREFLAEVEMLSRLHHRN 1026
++LG+GG+G V+ G A+KVLK+ +Q+ AE +L + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLH--GVDKESAPLGWDARLKIALGAARALAY 1084
+V LI L+ E + G + HL G+ E + + + +AL +
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------H 115
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH+ +I+RD K NILL+ K++DFGL + ++ E + ++ GT Y+APE
Sbjct: 116 LHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPE 170
Query: 1145 YAM-TGHLLVKS-DVYSYGVVILELLSGRKP 1173
M +GH K+ D +S G ++ ++L+G P
Sbjct: 171 ILMRSGH--GKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 1e-09
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 17/206 (8%)
Query: 977 LGEGGFGLVYSGVLDDGTKV--AVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
LG+G +G VY VL T V A+K ++ +D+ + + E+++L + +V G
Sbjct: 9 LGKGNYGSVYK-VLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGA 67
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
E A + E + GS++ L+ + + D +I + L +L E+ + +
Sbjct: 68 FFIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--I 124
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1152
IHRD K +N+L+ + K+ DFG+ S S ++ +G Y+APE +G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVAS--LAKTNIGCQSYMAPERIKSGGPNQ 180
Query: 1153 -----VKSDVYSYGVVILELLSGRKP 1173
V+SDV+S G+ ILE+ GR P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 14/198 (7%)
Query: 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
LGEG + VY G +G VA+KV+ R+ ++ G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVI-RLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
++ LV+E + + +DK L + R L+Y+H+ +
Sbjct: 72 IHTKETLTLVFEYVHTDLCQY----MDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---I 124
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLL 1152
+HRD K N+L+ K++DFGLAR+ H + + T Y P+ + +
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182
Query: 1153 VKSDVYSYGVVILELLSG 1170
D++ G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 51/266 (19%), Positives = 79/266 (29%), Gaps = 25/266 (9%)
Query: 109 SPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAF 168
P P V A P + A V +L P A+ +
Sbjct: 366 GAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEA 425
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTA 228
PPA+P A ++ P + + A + A P AS P++ A
Sbjct: 426 PPAAPAPPATADRGDDAADGDAPVPAKANARASADSRCDERDAQPP-ADSGSASAPASDA 484
Query: 229 LPPA----SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P A + + A PA+ + +P A+ P+ A PP P+ AP
Sbjct: 485 PPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAAAAPPAPEARPPT--PAAAAP 542
Query: 285 PPASHPSKTA----------------PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
+ + A A+ A P A+ P+ A
Sbjct: 543 AARAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPAAAPAAAPKPAAPRVAVQVPTPRAR 602
Query: 329 PPASH--PSNTAPPPASHSSKTAPPP 352
P+ A + S+ APPP
Sbjct: 603 AATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-09
Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 18/144 (12%)
Query: 124 PPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPAS 183
P + A P P A+P++ A+ P+ AA P A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPE-----------AAAPAAAPVA----QAAAAPAPAAAPAAA 410
Query: 184 HPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP-PASLPSKTAPPP 242
+ A P A+ P+ A P A+ P+ + A + A P A P ++P + AP P
Sbjct: 411 ASAPAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEP 470
Query: 243 ASHLSNTAPPPASHPYKTSPLPAS 266
A ++ AP PA+ P P
Sbjct: 471 AV--ASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-09
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 24/206 (11%)
Query: 975 RILGEGGFGLVYSGVLDD--GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKL 1030
+ +G G G+V + D G VAVK L R +Q + E+ +L ++H+N++ L
Sbjct: 27 KPIGSGAQGIVCAA-FDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 1031 IGI-----CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+ + +EE Q LV EL+ + +D E R+ L + L
Sbjct: 86 LNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHE--------RMSYLL--YQMLCG 135
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
+ S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 136 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPE 192
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSG 1170
+ D++S G ++ EL+ G
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 2e-09
Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 31/240 (12%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGT--KVAVKVLKR---VDQQGGREFLAEVEMLSRLHH 1024
+F+ R LG G FG V + VA+K ++ + Q+ +E ++L+ ++H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
V L G +E LV E + G + L + +G +I L Y
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEY 146
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
L S +++RD K N+LL+ D K++DFG A+ ++R + + GT Y+APE
Sbjct: 147 LQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV---DTR--TYTLCGTPEYIAPE 198
Query: 1145 YAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203
+ GH +D ++ G+ I E+L G PP N PLL ++ LE II
Sbjct: 199 ILLNVGHGKA-ADWWTLGIFIYEILVG-------CPPFYAN-----EPLLIYQKILEGII 245
|
Length = 340 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-09
Identities = 61/244 (25%), Positives = 97/244 (39%), Gaps = 54/244 (22%)
Query: 969 GNFDASRILGEGGFGLVYSGVLDD---GTKVAVKVLKRVDQQGG----REFLAEVEMLSR 1021
+D R++G+GG G VY D +VA+K + R D + FL E ++ +
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAY--DPVCSRRVALKKI-REDLSENPLLKKRFLREAKIAAD 58
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIP----------------NGSVESHLHGVDKESAP 1065
L H +V + IC + VY +P S+ L +K S
Sbjct: 59 LIHPGIVPVYSICSDGDP---VYYTMPYIEGYTLKSLLKSVWQKESLSKELA--EKTSVG 113
Query: 1066 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125
A L I + Y+H S V+HRD K NILL + D+G A E
Sbjct: 114 ----AFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLE 166
Query: 1126 ESRHIST----------------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
E + +++GT Y+APE + +D+Y+ GV++ ++L+
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226
Query: 1170 GRKP 1173
P
Sbjct: 227 LSFP 230
|
Length = 932 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-09
Identities = 60/210 (28%), Positives = 96/210 (45%), Gaps = 23/210 (10%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLH---HRNLVKL 1030
+G G +G VY G VA+K ++ + G + EV +L RL H N+V+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 1031 IGICI-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ +C E LV+E + + + ++L V P + + R L +L
Sbjct: 68 MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPA--ETIKDLMRQFLRGLDFL 124
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-TRVMGTFGYVAPE 1144
H + ++HRD K NIL+ K++DFGLAR S ++ T V+ T Y APE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYRAPE 177
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPV 1174
+ D++S G + E+ RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-09
Identities = 108/506 (21%), Positives = 148/506 (29%), Gaps = 42/506 (8%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
SP + R S+T P ++ S P++ PS+ ++
Sbjct: 74 TSPLKSTKRQREKPASDTEEPERVTAKKSKTQELSRPNS---PSEGEGEGEGEGESSDSR 130
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
+ + P + ++ P P S + P PS PP A+
Sbjct: 131 SVNEEGSSDPKDIDQDNRSSSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALA 190
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
PP PS A PP P P P P S S + P +P
Sbjct: 191 PSAPPPT---PSAQAVPPQGSPIAAQPAP-------QPQQPSPLSLISAPSLHPQRLPSP 240
Query: 351 PPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASH 410
P P + P+ + P S + PP H P HPS ++
Sbjct: 241 HPPLQPQTASQQSPQPPAPSSRHPQS-SHHGPGPPMPHALQQGPVFLQHPS------SNP 293
Query: 411 PSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPP 470
P VP LP + P P PR +P++ P P P
Sbjct: 294 PQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQPQQPPREQPLPPAPSMPHIKPPPTTP 353
Query: 471 VAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLS 530
+ Q N S++ P + P PFP S P P P +S PPS P
Sbjct: 354 IPQLPNQSHKHPPHLQ--GPSPFPQMPSNLPPP------PALKPLSSLPTHHPPSAHPPP 405
Query: 531 VDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGND 590
+ +P+ P+ P KA + HS P P
Sbjct: 406 LQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGGLPAI 465
Query: 591 TPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPL 650
P S S P A+ P S P S P PL
Sbjct: 466 GPPPSLPTSTP---------AAPPRASSGSQPPGSALPSSGGCAGPGPPLPPIQIKEEPL 516
Query: 651 NSVSPSHSPLPTPVSRVPTSPSPSPT 676
+ SP P P SPSP PT
Sbjct: 517 DEAEEPESPPPP-----PRSPSPEPT 537
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 3e-09
Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 18/204 (8%)
Query: 1000 VLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGV 1059
V+ ++ Q+G L E +L ++H +++++ + C+V +P+ S + + + +
Sbjct: 94 VVLKIGQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTY-L 147
Query: 1060 DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119
K S PL D L I L YLH R+IHRD K+ NI + + D G A
Sbjct: 148 TKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAA 204
Query: 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1179
+ + + + GT APE K+D++S G+V+ E+L+ + P
Sbjct: 205 QFPVVAPA---FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPP 261
Query: 1180 PGQENLVAWARPLLTSREGLERII 1203
E + + L +II
Sbjct: 262 STPEE------YVKSCHSHLLKII 279
|
Length = 357 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 30/126 (23%), Positives = 43/126 (34%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
P + +N+ + S P ++P S PS P +
Sbjct: 149 NPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPS 208
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
S P P+S S+T PP P+N +PPP P P +TA P +S T
Sbjct: 209 DSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATP 268
Query: 350 PPPASH 355
P
Sbjct: 269 APIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 31/134 (23%), Positives = 43/134 (32%)
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P P L + + A S P +++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
+ S+ P P+S S+T PP P+N +PPP P TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 358 NTALPPASHPSNPA 371
T P +
Sbjct: 266 ATPAPIGGITLDDD 279
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 3e-09
Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 25/205 (12%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLHHRNLVKL 1030
+G G +G V S + G KVA+K L R Q E A E+ +L + H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS---EIFAKRAYRELTLLKHMQHENVIGL 79
Query: 1031 IGICIEEQARCLVYE---LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
+ + + + ++P +++ L + PL D + L Y+H
Sbjct: 80 LDVFTSAVSGDEFQDFYLVMP--YMQTDLQKI--MGHPLSEDKVQYLVYQMLCGLKYIH- 134
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1147
S +IHRD K N+ + D K+ DFGLAR A E + ++ TR Y APE +
Sbjct: 135 --SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR-----WYRAPEVIL 187
Query: 1148 TG-HLLVKSDVYSYGVVILELLSGR 1171
H D++S G ++ E+L+G+
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 4e-09
Identities = 46/212 (21%), Positives = 70/212 (33%), Gaps = 12/212 (5%)
Query: 330 PASHPSNTAPPPASHSSKTAPPPASHPSNTALP-PASHPSNPAIPPASHPSNTAIPPASH 388
P P A+ + P PA+ A P PA+ P+ PA PA+ A A+
Sbjct: 365 PGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAA--AARAVAAA 422
Query: 389 PSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV------LPSALPGKAPVSQSPISLP 442
P+ +P + + + AP P +A P + +
Sbjct: 423 PARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPAR 482
Query: 443 DAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIA-PGPFPPGNSRQK 501
APAA P P +P A + + +AE I P P ++ +
Sbjct: 483 AAPAAAPAPADDDPPP--WEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFET 540
Query: 502 SPVARPIIPGGTPTASPDPDVPPSTPPLSVDG 533
A P A+ +P V P P S G
Sbjct: 541 LAPAPAAAPAPRAAAATEPVVAPRPPRASASG 572
|
Length = 700 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 4e-09
Identities = 54/238 (22%), Positives = 75/238 (31%), Gaps = 16/238 (6%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
A P +A P+ PA A D + PV + + A
Sbjct: 405 AAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDDAADGDA-PVPAKANARASADSRC 463
Query: 122 APPPSLIPTTPV-ASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP 180
+ P AS P APP PAP + A PA+ A
Sbjct: 464 DERDAQPPADSGSASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPA 523
Query: 181 PASHPSNTARPPASHPSRTAPPPASHPSNTALPS-KTAPSPASHPSNTALPPASLPSKTA 239
A+ P+ ARPP P+ AP + + AL + A S S+ A+ A
Sbjct: 524 AAAPPAPEARPPT--PAAAAPAARAGGAAAALDVLRNAGMRVS--SDRGARAAAAAKPAA 579
Query: 240 PPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P A P A + P A + P+ A + S+ APPP
Sbjct: 580 APAA-----APKPAAPRV----AVQVPTPRARAATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 5e-09
Identities = 30/129 (23%), Positives = 45/129 (34%)
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
P P + + + ++ A S P ++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 309 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPS 368
+ S+ P P+S S+T PP P+N +PPP + P P +TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 369 NPAIPPASH 377
P
Sbjct: 266 ATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 970 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREFL-AEVEMLSR 1021
NF+ ++LG G +G V+ D G A+KVL++ V + E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 1022 LHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA- 1079
+ + + + +A+ L+ + + G + +HL+ D S + ++ G
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS-----EDEVRFYSGEII 115
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
AL +LH+ +++RD K NILL+ + ++DFGL++ + EE + GT
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKER-TYSFCGTIE 171
Query: 1140 YVAPEY--AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y+APE GH D +S G++I ELL+G P
Sbjct: 172 YMAPEIIRGKGGHGKA-VDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-09
Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 975 RILGEGGFG-LVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKL 1030
++LG+G FG ++ G A+K+LK+ + + L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+ C V E + G + HL V E + A + AL YLH
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI------VSALDYLH-- 112
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
S ++++RD K N++L+ D K++DFGL + + + + + GT Y+APE
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEVLED 169
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKP 1173
D + GVV+ E++ GR P
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-09
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 25/209 (11%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 1027
++LG+G FG V +L G A+K+LK+ + + L E +L H L
Sbjct: 1 KLLGKGTFGKV---ILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFL 57
Query: 1028 VKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAY 1084
L + R C V E G + HL V E + A + ALG Y
Sbjct: 58 TAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG------Y 110
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH S V++RD K N++L+ D K++DFGL + + + + T GT Y+APE
Sbjct: 111 LH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKT-FCGTPEYLAPE 165
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
D + GVV+ E++ GR P
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 9e-09
Identities = 52/266 (19%), Positives = 78/266 (29%), Gaps = 27/266 (10%)
Query: 73 APPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSL-IPTT 131
AP + S A +L P A+ + PP APP +
Sbjct: 382 APGARAAAAVGASAVPAVTAVTGAAGAALAPKAAAAAAATRAEAPPAAPAPPATADRGDD 441
Query: 132 PVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARP 191
P+ PA + + + A PPA S +A P + P + A
Sbjct: 442 AADGDAPV---------PAKANARASADSRCDERDAQPPADSGSASA-PASDAPPDAAFE 491
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA- 250
PA + A PA+ A A+ P+ A PP + A
Sbjct: 492 PAP-RAAAPSAATPAAVPDARA------PAAASREDAPAAAAPPAPEARPPTPAAAAPAA 544
Query: 251 ----PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
A + + + S A+ P+ A P A+ P+ A
Sbjct: 545 RAGGAAAALDVLRNAGMRVSSDRGARAAAAAKPA--AAPAAAPKPAAPRVAVQVPTPRAR 602
Query: 307 PPASH--PSNTAPPPASHPSNTAPPP 330
P+ A + S APPP
Sbjct: 603 AATGDAPPNGAARAEQAAESRGAPPP 628
|
Length = 830 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-08
Identities = 80/296 (27%), Positives = 101/296 (34%), Gaps = 22/296 (7%)
Query: 61 HAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVN 120
H P P +P PV + S + P PP +P+ + + +
Sbjct: 269 HGPGP-PMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQ 327
Query: 121 MAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP 180
PP P P S P I PP P P L + P P PSN P
Sbjct: 328 PQQPPREQPLPPAPSMPHIKPPPTT---PIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPP 384
Query: 181 PASHPSNTARPPASHPSRTAPPPAS-HPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
PA P ++ P HP PPP P + L S A P S + P AS
Sbjct: 385 PALKPLSSL--PTHHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTH---- 438
Query: 240 PPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPAS 299
P H P A HP+ + LPA PPP+ S A PP + P A
Sbjct: 439 PHSGLHSGPPQSPFAQHPFTSGGLPA-----IGPPPSLPTSTPAAPPRASSGSQPPGSAL 493
Query: 300 HPS-----NTAPPPASHPSNTAPPPASHPSNTAPPPAS-HPSNTAPPPASHSSKTA 349
S P P A P + PPP S P T SH+S++A
Sbjct: 494 PSSGGCAGPGPPLPPIQIKEEPLDEAEEPESPPPPPRSPSPEPTVVNTPSHASQSA 549
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-08
Identities = 37/139 (26%), Positives = 58/139 (41%), Gaps = 13/139 (9%)
Query: 151 PSLIPTTPLASPLSSKAFPPASPPSNAARP-PASHPSNTARPPASHPSRTAPPPASHPSN 209
P+ + + A P A+ P+ A A+ P+ A P A+ + APP A+ P+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 210 TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS 269
A P+ AP+ A + A+ A P A AP + P + +P PA +
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQA----------APETVAIPVRVAPEPA--VA 473
Query: 270 KTAPPPASHPSNTAPPPAS 288
AP PA+ P+ P
Sbjct: 474 SAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 31/117 (26%), Positives = 41/117 (35%), Gaps = 4/117 (3%)
Query: 228 ALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA 287
+ + + A S + P S SP S PS P + S+ P P+
Sbjct: 162 DVATTNSDNSFPGEDADPASASPSDPPSS----SPGVPSFPSPPEDPSSPSDSSLPPAPS 217
Query: 288 SHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 344
S S T PP P+N +PPP P P +TA P S T P
Sbjct: 218 SFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 1e-08
Identities = 29/129 (22%), Positives = 43/129 (33%)
Query: 282 TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
P P + +N+ ++ A S P +++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 342 ASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPS 401
+ S P P+S S+T P P+NP+ PP P +TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 402 NTALTPASH 410
T
Sbjct: 266 ATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-08
Identities = 49/183 (26%), Positives = 82/183 (44%), Gaps = 3/183 (1%)
Query: 991 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050
D KV K + D++ +E+ L+ H +VK + L+ E G
Sbjct: 91 DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGG 150
Query: 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110
+ + KE P ++ L + + L E S +++HRD KS+NI L
Sbjct: 151 DLNKQIKQRLKEHLPF---QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI 207
Query: 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1170
K+ DFG ++ D S +++ GT Y+APE K+D++S GV++ ELL+
Sbjct: 208 IKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTL 267
Query: 1171 RKP 1173
+P
Sbjct: 268 HRP 270
|
Length = 478 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/229 (27%), Positives = 108/229 (47%), Gaps = 28/229 (12%)
Query: 970 NFDASRILGEGGFGLVY-----SGVLDDGTKVAVKVLKR---VDQQGGREFL-AEVEMLS 1020
NF+ ++LG G +G V+ SG D G A+KVLK+ V + E E ++L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSG-HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 1021 RLHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA- 1078
+ + + + + L+ + I G + +HL ++ + ++I G
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK-----EQEVQIYSGEI 114
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
AL +LH+ +I+RD K NILL+ + ++DFGL++ ++E + GT
Sbjct: 115 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVER-AYSFCGTI 170
Query: 1139 GYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1184
Y+AP+ GH D +S GV++ ELL+G P + G++N
Sbjct: 171 EYMAPDIVRGGDGGHDKA-VDWWSMGVLMYELLTGASPFTVD---GEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 65/212 (30%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-----EVEMLSRLH---HRNL 1027
+GEG +G V+ L +G + LKRV Q G E + EV +L L H N+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 66
Query: 1028 VKLIGICI-----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
V+L +C E LV+E + + + ++L V + P + + R L
Sbjct: 67 VRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPT--ETIKDMMFQLLRGL 123
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
+LH S RV+HRD K NIL+ K++DFGLAR + T V+ T Y A
Sbjct: 124 DFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 177
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1174
PE + D++S G + E+ RKP+
Sbjct: 178 PEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 2e-08
Identities = 34/128 (26%), Positives = 50/128 (39%), Gaps = 4/128 (3%)
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
P A+ + + A PA+ P A+ P+ A P A+ S+ APP A+
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAP 422
Query: 356 PSNTALPPASHPSN-PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNI 414
P+ A P A+ P+ PA PA+ A P + P A P P + A P+
Sbjct: 423 PAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAPAAA 482
Query: 415 APPPLFVP 422
P
Sbjct: 483 PAAARLTP 490
|
Length = 618 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-08
Identities = 48/269 (17%), Positives = 56/269 (20%), Gaps = 29/269 (10%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
+ P + + T P P SL TAP P
Sbjct: 86 SVGPDSDLSQKTSTFSPCQSGYEASTDPEYIPDLQ----PDPSLWG-TAPKPEP-----Q 135
Query: 251 PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
PP A PA A P + PP PP +
Sbjct: 136 PPQAPESQPQPQTPAQKMLSLEEVEAQLQQRQQAP------QLPQPPQQVLPQGMPPRQA 189
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
PP P PP HP P + AP P P P
Sbjct: 190 AFPQQGPPEQ--PPGYPQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQ---LPQQPPPLQ 244
Query: 371 AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPG 430
+PP P P P P P P
Sbjct: 245 QPQFPGLSQQ--MPP---PPPQPPQQQQQPPQPQAQPPPQNQPTPHPG---LPQGQNAPL 296
Query: 431 KAPVSQSPISLPDAPAATPRGNFHRHSPA 459
P + L P RG R
Sbjct: 297 PPPQQPQLLPLVQQPQGQQRGPQFREQLV 325
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 2e-08
Identities = 33/148 (22%), Positives = 49/148 (33%), Gaps = 6/148 (4%)
Query: 265 ASHPSKTAPPPASHPSNTAPPPAS--HPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
A HP+ P P P + AP ++ + TA PPPAS P P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPP-ASHPSNPAIPPASHPSNT 381
++ + S+ A + P N+AL AS P+ +
Sbjct: 418 TTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKE 477
Query: 382 AIP-PASHPSNTAPPHASHPSNTALTPA 408
A A++P + P AL A
Sbjct: 478 AYRWKATNPVEVKKEPVATPK--ALKKA 503
|
Length = 647 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 32/208 (15%)
Query: 977 LGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGI 1033
LGEG + VY G L D VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 1034 CIEEQARCLVYELIPNGSVES--------HLHGVDKESAPLGWDARLKIAL-GAARALAY 1084
E++ LV+E + + ++H V K+ L R L Y
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNV-------------KLFLFQLLRGLNY 119
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
H +V+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+
Sbjct: 120 CHRR---KVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYSNEVV-TLWYRPPD 174
Query: 1145 YAM-TGHLLVKSDVYSYGVVILELLSGR 1171
+ + + D++ G + E+ +GR
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 43/152 (28%), Positives = 74/152 (48%), Gaps = 16/152 (10%)
Query: 1030 LIGI--CIEEQARC-LVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAY 1084
L+G+ C + +R LV E + G + H+ K E + A + IAL +
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALN------F 111
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LHE +I+RD K N+LL+ D K++D+G+ + + ++ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD--TTSTFCGTPNYIAPE 166
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1176
D ++ GV++ E+++GR P D+
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 55/216 (25%), Positives = 98/216 (45%), Gaps = 25/216 (11%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 1025
++D +++G G FG V KV A+K+L + + + F E ++++ +
Sbjct: 44 DYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW----DARLKIALGAARA 1081
+V+L +++ +V E +P G + + + D P W A + +AL A +
Sbjct: 104 WVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHS 160
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+ +IHRD K N+LL+ K++DFG MDE +GT Y+
Sbjct: 161 MG---------LIHRDVKPDNMLLDKHGHLKLADFGTCMK-MDETGMVRCDTAVGTPDYI 210
Query: 1142 APEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 1173
+PE + G+ + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 2e-08
Identities = 57/248 (22%), Positives = 88/248 (35%), Gaps = 17/248 (6%)
Query: 78 NIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPP 137
IPS A P P+ T SPP PP P L P T
Sbjct: 322 KIPSQRVPPKESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLK 381
Query: 138 PITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT--ARPPASH 195
P T+P IPT P +SP SSK+ + P+ P+ ++ PA
Sbjct: 382 PPTSP-----------IPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQV 430
Query: 196 PSRTAPP--PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
++ P P + + P+ +P+ + S + +S+P+ PA+ ++ A PP
Sbjct: 431 EAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPP 490
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
++ SP K PP + P+ A + + TA H +
Sbjct: 491 PANMRPLSPYAVYDDLK--PPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHA 548
Query: 314 NTAPPPAS 321
P P S
Sbjct: 549 QPKPRPLS 556
|
Length = 576 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 2e-08
Identities = 50/209 (23%), Positives = 95/209 (45%), Gaps = 18/209 (8%)
Query: 975 RILGEGGFGLVYSGVLDDGTKV-AVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKL 1030
R++G G + V L ++ A+KV+K+ D + E + + + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 1031 IGICIEEQARCL-VYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAYLHE 1087
+ C + ++R V E + G + H+ K E + A + +AL YLHE
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN------YLHE 114
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1147
+I+RD K N+LL+ + K++D+G+ + + ++ GT Y+APE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RPGDTTSTFCGTPNYIAPEILR 169
Query: 1148 TGHLLVKSDVYSYGVVILELLSGRKPVDM 1176
D ++ GV++ E+++GR P D+
Sbjct: 170 GEDYGFSVDWWALGVLMFEMMAGRSPFDI 198
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 22/211 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLH 1023
+F+ LG G FG V G A+K LK ++ Q + E +L L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQV--QHVAQEKSILMELS 76
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
H +V ++ +E + E + G + +HL + + ++ L A
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVL----AFE 132
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
YLH +I+RD K N+LL++ KV+DFG A+ D + + GT Y+AP
Sbjct: 133 YLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLCGTPEYLAP 184
Query: 1144 EYAMT-GHLLVKSDVYSYGVVILELLSGRKP 1173
E + GH D ++ GV++ E ++G P
Sbjct: 185 EVIQSKGHGKA-VDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 33/94 (35%), Positives = 55/94 (58%), Gaps = 7/94 (7%)
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L +LH +I+RD K N+LL+ D K++DFG+ + M+ E + ++ GT Y
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162
Query: 1141 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
+APE + G +S D +S+GV++ E+L G+ P
Sbjct: 163 IAPE-ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 29/133 (21%), Positives = 43/133 (32%), Gaps = 2/133 (1%)
Query: 262 PLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
P P + +N+ + A S P +++P S PS P +
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 322 HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNT 381
S+ PPA + PP S S T P P P+ PP + + PS +
Sbjct: 208 SDSS--LPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 382 AIPPASHPSNTAP 394
A P
Sbjct: 266 ATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 3e-08
Identities = 27/127 (21%), Positives = 41/127 (32%)
Query: 207 PSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPAS 266
P+ + +N+ + A S +++P S P +
Sbjct: 148 PNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSP 207
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 326
S P P+S S+T PP P+ +PPP P P +TA P S T
Sbjct: 208 SDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASAT 267
Query: 327 APPPASH 333
P
Sbjct: 268 PAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 30/92 (32%), Positives = 52/92 (56%), Gaps = 5/92 (5%)
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L +LH S +I+RD K N++L+ D K++DFG+ + + ++R ++ GT Y+
Sbjct: 109 LQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYI 163
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
APE D +S+GV++ E+L G+ P
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 977 LGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGI 1033
LGEG + V+ G L + VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDSSPR 1092
+++ LV+E + + L + + +KI L R LAY H +
Sbjct: 73 VHTDKSLTLVFEYL-----DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---K 124
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHL 1151
V+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+ + +
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSSEY 182
Query: 1152 LVKSDVYSYGVVILELLSGR 1171
+ D++ G + E+ SGR
Sbjct: 183 STQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 3e-08
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 16/212 (7%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHR 1025
+F+ +LG+G FG V ++ A+K+LK+ V Q E + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 1026 NLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+ + C + R V E + G + + V + P +IA+G L +
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIG----LFF 116
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVAP 1143
LH S +I+RD K N++L+ + K++DFG+ + M + ++T+ GT Y+AP
Sbjct: 117 LH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---GVTTKTFCGTPDYIAP 170
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
E D +++GV++ E+L+G+ P +
Sbjct: 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 3e-08
Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 17/207 (8%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF----LAEVEMLSRLHHRN 1026
F+ ++GEG +G+V TK V + K D + E L E++ML L N
Sbjct: 3 FEVLGVVGEGAYGVVLK-CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW--DARLKIALGAARALAY 1084
+V+L LV+E + +E E P G + +A+ +
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLEL------LEEMPNGVPPEKVRSYIYQLIKAIHW 115
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
H++ ++HRD K N+L+ H+ K+ DFG AR+ + E S T + T Y +PE
Sbjct: 116 CHKND---IVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATRWYRSPE 171
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGR 1171
+ D++S G ++ EL G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 3e-08
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGR-EFLAEVEMLSRLHHRNLVKLIGIC 1034
LGEG + V+ G VA+K ++ ++G + EV +L L H N+V L I
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAYLHEDSSPRV 1093
E+ LV+E + +S L L +KI + R L+Y H+ ++
Sbjct: 73 HTERCLTLVFEYL-----DSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KI 124
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLL 1152
+HRD K N+L+ K++DFGLAR A ++ S V+ T Y P+ + +
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR-AKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYS 182
Query: 1153 VKSDVYSYGVVILELLSGR 1171
D++ G ++ E+ +GR
Sbjct: 183 TPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 30/129 (23%), Positives = 43/129 (33%)
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
P P + + ++ A S P +++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
+ S+ P P+S S T PP P+N + PP P P +TA P S
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 391 NTAPPHASH 399
T P
Sbjct: 266 ATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 975 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR--VDQQGGRE-FLAEVEMLSRLHHRNLVKL 1030
++LG+G FG V L +V A+KVLK+ + Q + + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 1031 IGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+ C + + R V E + G + + K P +R A AL +LH
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP---RSRF-YAAEVTLALMFLHRHG 116
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
VI+RD K NILL+ + K++DFG+ + + +T GT Y+APE
Sbjct: 117 ---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAPEILQEL 171
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D ++ GV++ E+++G+ P
Sbjct: 172 EYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 43/161 (26%), Positives = 77/161 (47%), Gaps = 19/161 (11%)
Query: 1030 LIGI--CIEEQARC-LVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAY 1084
L+G+ C + ++R V E + G + H+ K E + A + +AL +
Sbjct: 58 LVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALN------F 111
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LHE +I+RD K N+LL+ + K++D+G+ + + ++ GT Y+APE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD--TTSTFCGTPNYIAPE 166
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVD---MTQPPGQ 1182
D ++ GV++ E+++GR P D M+ P Q
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 5e-08
Identities = 36/113 (31%), Positives = 62/113 (54%), Gaps = 9/113 (7%)
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
K+++ + L YL E +++HRD K SNIL+ K+ DFG++ +D ++
Sbjct: 107 KVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MAN 160
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1185
+GT Y++PE H V+SD++S G+ ++E+ GR P+ PP + L
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI---PPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 6e-08
Identities = 65/351 (18%), Positives = 100/351 (28%), Gaps = 35/351 (9%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKT---APPPASHPSNTAPPPASHPSNTAPPPA 320
A+ PS A PA+ P+ A PA+ + AP PA P+ PP+ + A
Sbjct: 395 AAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPAGGAP 454
Query: 321 SHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHP-- 378
S P AP P+ A P + + APP A P+ PA+ + A+
Sbjct: 455 SPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGADDAATLRE 514
Query: 379 -----------SNTAIPPASHPSNTAPP---------HASHPSNTALTPASHPSNIAP-- 416
+ P T ++ + +
Sbjct: 515 RWPEILAAVPKRSRKTWAILLPEATVLGVRGDTLVLGFSTGGLARRFASPGNAEVLVTAL 574
Query: 417 -PPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKR 475
L A+ G AP + P ++ P R + P P A
Sbjct: 575 AEELGGDWQVEAVVGPAPGAAGGEGPPAPASSGPPEEAARPAAP-----AAPAAPAAPAP 629
Query: 476 NASNRE-APIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGK 534
+ A + APG P + + V G A P + PP
Sbjct: 630 AGAAAAPAEASAAPAPGVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAA 689
Query: 535 RVGKPVAEPSYDIPMPPPVNHS-PSKAPSTHKYMRHSNHSPLPPFSSPKPP 584
A P+ P P + + P+ S P + P
Sbjct: 690 PAAPAGAAPAQPAPAPAATPPAGQADDPAAQPPQAAQGASAPSPAADDPVP 740
|
Length = 824 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-08
Identities = 48/263 (18%), Positives = 65/263 (24%), Gaps = 7/263 (2%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLI-PTTPLAS 161
P PV P + + P + P + P+ AP P
Sbjct: 336 PVEPVTQTPPVASVDVPPAQPTVAWQPVPGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNE 395
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA 221
PL P + AA PA P P P P
Sbjct: 396 PLQQPVQPQQPYYAPAAEQPAQQPYYAPAPEQPAQQPYYAPAPEQPVAGNAWQAEEQQST 455
Query: 222 SHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSN 281
P +T + A P P P P P +K A PP +
Sbjct: 456 FAPQSTYQTEQTYQQPAAQEPLYQ----QPQPVEQQPVVEPEPVVEETKPARPPLYYFEE 511
Query: 282 TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
A + A P P S AP A+ P A S ++
Sbjct: 512 VEEKRAREREQLAAWYQPIPEPVKEPEPIKSSLKAPSVAAVPPVEAAAAVSPLASGVKKA 571
Query: 342 ASHSSKTAPP--PASHPSNTALP 362
+ A P +N+ P
Sbjct: 572 TLATGAAATVAAPVFSLANSGGP 594
|
Length = 1355 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 60/220 (27%), Positives = 98/220 (44%), Gaps = 57/220 (25%)
Query: 975 RILGEGGFGLVYSGVL--DDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHRNLVK 1029
R++G+G +G V S V DG + +K L + RE A E ++LS+L H N+V
Sbjct: 6 RVVGKGSYGEV-SLVRHRTDGKQYVIKKLN-LRNASRRERKAAEQEAQLLSQLKHPNIVA 63
Query: 1030 --------------LIGIC--------IEEQARCLVYELIPNGSVESHLHGVDKESAPLG 1067
++G C ++EQ +L+P E+ +
Sbjct: 64 YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG----KLLP-------------ENQVVE 106
Query: 1068 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127
W ++ A AL YLHE ++HRD K+ N+ L KV D G+AR + E
Sbjct: 107 WFVQI------AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIAR--VLENQ 155
Query: 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILEL 1167
+++ ++GT Y++PE KSDV++ G + E+
Sbjct: 156 CDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
LGEG + VY G+ +G VA+KV+ + + G F A E +L L H N+V L I
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVIS-MKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 1034 CIEEQARCLVYELIPNGSVE---SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
++ V+E + + H G+ + L R LAY+H
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRL-------FMFQLLRGLAYIHGQ-- 122
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1150
++HRD K N+L+ + K++DFGLAR A S+ S+ V+ T Y P+ + G
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLAR-AKSIPSQTYSSEVV-TLWYRPPD-VLLGA 178
Query: 1151 LLVKS--DVYSYGVVILELLSGR 1171
S D++ G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-08
Identities = 37/120 (30%), Positives = 58/120 (48%), Gaps = 7/120 (5%)
Query: 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111
VE G + PL + + + AR + +L +S + IHRD + NILL +
Sbjct: 156 VEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVV 212
Query: 1112 KVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
K+ DFGLAR + R R+ ++APE +SDV+S+GV++ E+ S
Sbjct: 213 KICDFGLARDIYKDPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 7e-08
Identities = 31/133 (23%), Positives = 42/133 (31%), Gaps = 4/133 (3%)
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNT 249
P P + + T + A S + P S ++P S S
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPS----SSPGVPSFPSPP 201
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
P + P P+S S T PP P+N +PPP P P +TA P
Sbjct: 202 EDPSSPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTP 261
Query: 310 SHPSNTAPPPASH 322
S T P
Sbjct: 262 PSASATPAPIGGI 274
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 7e-08
Identities = 38/195 (19%), Positives = 52/195 (26%), Gaps = 13/195 (6%)
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
PP H T+ P P + P + P L PA Y+
Sbjct: 95 PAPPPPHARRTSEPELPRPGRRPYEGYGG--PRADDRPPGLPRQDQLPT--ARPAYPAYQ 150
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP- 318
P P + P PP A + S + P P +
Sbjct: 151 QRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAP--EQERDREPYDAGRPEYDQRR 208
Query: 319 -PASHPSNTAPPPASHPSNT--APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPA 375
HP P ++ PP A H + P P +P PS P P A
Sbjct: 209 RDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIR--PSAPG-PLA 265
Query: 376 SHPSNTAIPPASHPS 390
+ P+ P
Sbjct: 266 AQPAPAPGPGEPTAR 280
|
Length = 617 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-08
Identities = 31/139 (22%), Positives = 48/139 (34%), Gaps = 12/139 (8%)
Query: 106 PVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSS 165
P A+ + A P P A+P A + A+P ++
Sbjct: 366 PAAAAEAAAPAEKKTPARPE---AAAPAAAPVAQAAAAPAPAAAPAAAAS--APAAPPAA 420
Query: 166 KAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPS 225
P + P+ AA A + A A PP + P A+P + AP PA +
Sbjct: 421 APPAPVAAPAAAAPAAAPAAAPAAVALAPA-----PPAQAAPETVAIPVRVAPEPA--VA 473
Query: 226 NTALPPASLPSKTAPPPAS 244
+ A PA+ P+ P
Sbjct: 474 SAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 8e-08
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 19/212 (8%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
+++ + +G G +G VY L G AVK++K E+ M+ H N+V
Sbjct: 10 DYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIV 69
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYL 1085
G + + + E GS++ H + PL + L+IA + LAYL
Sbjct: 70 AYFGSYLSREKLWICMEYCGGGSLQDIYH----VTGPL---SELQIAYVCRETLQGLAYL 122
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H +HRD K +NILL + K++DFG+A ++ S +GT ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIGTPYWMAPEV 177
Query: 1146 AM---TGHLLVKSDVYSYGVVILELLSGRKPV 1174
A G D+++ G+ +EL + P+
Sbjct: 178 AAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-08
Identities = 59/204 (28%), Positives = 92/204 (45%), Gaps = 14/204 (6%)
Query: 975 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 1029
+++G+G FG V + DG AVKVL++ + ++ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L V + + G + HL +E + AR A A AL YLH
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQ---RERSFPEPRARF-YAAEIASALGYLH--- 113
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S +I+RD K NILL+ ++DFGL + ++ ++ GT Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAPEVLRKQ 171
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 9e-08
Identities = 46/179 (25%), Positives = 80/179 (44%), Gaps = 13/179 (7%)
Query: 994 TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 1053
K V+ + Q+GG E +L ++H ++++L G + CL+ +P +
Sbjct: 114 NKTCEHVVIKAGQRGGT--ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTD 168
Query: 1054 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113
+ + K + + L I RA+ YLHE+ R+IHRD K+ NI + H +
Sbjct: 169 LYCYLAAKRNIAIC--DILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCL 223
Query: 1114 SDFGLARSAMD-EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1171
DFG A +D +++ GT APE D++S G+V+ E+ +
Sbjct: 224 GDFGAACFPVDINANKYYGW--AGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 1e-07
Identities = 53/211 (25%), Positives = 68/211 (32%), Gaps = 9/211 (4%)
Query: 88 AVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNV 147
AV P A P + PP A P AP P A+ P A
Sbjct: 586 AVVGPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAP 645
Query: 148 LPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
A +A P +S + A P A P+ PA+ PA P
Sbjct: 646 GVAAPEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAP 705
Query: 208 SNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASH 267
+ P A PP + +AP PA+ PP P + PA
Sbjct: 706 A-------ATPPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQP 758
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
P AP PA+ P+ A PP S PS+
Sbjct: 759 PPPPAPAPAAAPA--AAPPPSPPSEEEEMAE 787
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.6 bits (135), Expect = 1e-07
Identities = 32/172 (18%), Positives = 49/172 (28%), Gaps = 15/172 (8%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
A HP+ P P AP ++ + + P + P A P P+ P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPE 417
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
S L + +K + P A+ + P + + P
Sbjct: 418 TTSQLLAARQQLQRA-------QGATKAKKSEPAAA----SRARPVNSALERLASVRPAP 466
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
S PA A++P P + P A A KT A
Sbjct: 467 SALEKAPAK--KEAYRWKATNPVEVKKEPVATPK--ALKKALEHEKTPELAA 514
|
Length = 647 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-07
Identities = 73/274 (26%), Positives = 100/274 (36%), Gaps = 22/274 (8%)
Query: 137 PPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP-PASHPSNTARPPA-- 193
P T P +LPAP L P + + +S PS A P P HPS T PP
Sbjct: 553 PASTEPVHDQLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPPTTQ 612
Query: 194 SHPSRTAPP----------PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
SH T+ P P + P H P+ T
Sbjct: 613 SHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQIGHI 672
Query: 244 SHLSNTAPPPASHPYKTSPLPASHPSKT---APPPASHPSNTAPPPASHPSKTAPPPASH 300
+ + P + +P P + PPA+ P P A+ + A PPA+
Sbjct: 673 PYQPSPTGANTMLPIQWAPGTMQPPPRAPTPMRPPAAPPGRAQRPAAA--TGRARPPAAA 730
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
P PP A+ A PPA+ P A PPA+ P PP A+ + T PP P
Sbjct: 731 PGRARPPAAA--PGRARPPAAAPG-RARPPAAAPGRARPPAAAPGAPTPQPPPQAPPAPQ 787
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTAP 394
P P+ P PP + P++ + P + P P
Sbjct: 788 QRPRGAPT-PQPPPQAGPTSMQLMPRAAPGQQGP 820
|
Length = 991 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 1e-07
Identities = 50/190 (26%), Positives = 78/190 (41%), Gaps = 13/190 (6%)
Query: 992 DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 1051
KV VK + GG+ E+++L + HR ++ LI + C+V +P
Sbjct: 118 QRKKVIVKAV-----TGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK 169
Query: 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111
+ + VD+ S PL + + I ALAYLH +IHRD K+ NI L+
Sbjct: 170 CDLFTY-VDR-SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENA 224
Query: 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1171
+ DFG A GT +PE K+D++S G+V+ E+
Sbjct: 225 VLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKN 284
Query: 1172 KPVDMTQPPG 1181
+ Q
Sbjct: 285 VTLFGKQVKS 294
|
Length = 392 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 59/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 1027
++LG+G FG V +L G A+K+L++ + + + E +L H L
Sbjct: 1 KLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA--ARALAYL 1085
L C V E G + HL +E AR GA AL YL
Sbjct: 58 TALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARF---YGAEIVSALEYL 111
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S V++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 112 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPEV 166
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
D + GVV+ E++ GR P
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-07
Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 10/93 (10%)
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE--ESRHISTRVMGTF 1138
+ +LH S +IHRD K SNI+++ D T K+ DFGLAR+A + ++ TR
Sbjct: 130 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---- 182
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1171
Y APE + D++S G ++ E++ G
Sbjct: 183 -YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 56.1 bits (136), Expect = 1e-07
Identities = 21/92 (22%), Positives = 34/92 (36%)
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
P+ + P S + TA A+ + +AP A A P + P+ AP
Sbjct: 26 DPSWREFFADYGPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPK 85
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
P+ A A+ + A A+ P+ A
Sbjct: 86 PAAAAAAAAAPAAPPAAAAAAAPAAAAVEDEV 117
|
Length = 1228 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 61/204 (29%), Positives = 94/204 (46%), Gaps = 14/204 (6%)
Query: 975 RILGEGGFGLVY-SGVLDDGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 1029
+++G+G FG V + DG+ AVKVL++ + ++ +AE +L L H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L + V + + G + HL +E L AR A A A+ YLH
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQ---RERCFLEPRARF-YAAEVASAIGYLH--- 113
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S +I+RD K NILL+ ++DFGL + ++ E ++ GT Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAPEVLRKE 171
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-07
Identities = 50/203 (24%), Positives = 71/203 (34%), Gaps = 15/203 (7%)
Query: 362 PPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFV 421
A+ P P A+ P+ A PA+ P+ AP A + A A+ P+ +P P +
Sbjct: 376 TAAAAPVAQPAPAAAAPAAAAPAPAAPPA--APAAAPAAAAAARAVAAAPARRSPAPEAL 433
Query: 422 PVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNRE 481
A + +P APAA P + A P+ GP P A A R
Sbjct: 434 AAARQASARGPGGAPAPAP---APAAAP-------AAAARPAAAGPRPVAAAAAAAPARA 483
Query: 482 APIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP-PLSVDGKRVGKPV 540
AP A P PP ++ P P A+P V S P P + D + +
Sbjct: 484 APAAAPAPADDDPP--PWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETL 541
Query: 541 AEPSYDIPMPPPVNHSPSKAPST 563
A P P +
Sbjct: 542 APAPAAAPAPRAAAATEPVVAPR 564
|
Length = 700 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-07
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 16/136 (11%)
Query: 165 SKAFPPASPPSNAARP-PASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+ A P+ PA+ P A+ P+ A P A+ + A P+ P+P +
Sbjct: 372 AAAPAEKKTPARPEAAAPAAAP---VAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAA 428
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
P A+ + A PA+ + P + +P + P + AP PA ++ A
Sbjct: 429 P-----AAAAPAAAPAAAPAA-----VALAPAPPAQAAPETVAIPVRVAPEPA--VASAA 476
Query: 284 PPPASHPSKTAPPPAS 299
P PA+ P+ P
Sbjct: 477 PAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-07
Identities = 32/127 (25%), Positives = 48/127 (37%), Gaps = 7/127 (5%)
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
+ A PA + P A+ ++ A+ P+ A P A+ + A P A+ P
Sbjct: 369 AAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPP----- 423
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPD 443
P + P+ AP A + A+ A P P V + P A S +P
Sbjct: 424 APVAAPAAAAPAAAPAAAPAAVALAPAPP-AQAAPETVAIPVRVAPEPAVASAAPAPAA- 481
Query: 444 APAATPR 450
APAA
Sbjct: 482 APAAARL 488
|
Length = 618 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 2e-07
Identities = 28/125 (22%), Positives = 45/125 (36%), Gaps = 2/125 (1%)
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS 288
+ + A P A+ + A P + + + + AP PA P+ PP+
Sbjct: 387 VAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA--APQPAPAPAPAPAPPSP 444
Query: 289 HPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
+ A S P AP P+ A P + APP A P+ PA+ ++
Sbjct: 445 AGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPA 504
Query: 349 APPPA 353
A
Sbjct: 505 GADDA 509
|
Length = 824 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-07
Identities = 47/249 (18%), Positives = 74/249 (29%), Gaps = 8/249 (3%)
Query: 184 HPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
N A PPA P P + P + P PPP+
Sbjct: 67 QQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPS 126
Query: 244 SHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPP---ASHPSKTAPPPASH 300
A P + + P +PP PP A S P + +
Sbjct: 127 QPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESPY 186
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
+ PP PS+ A P + APP P P + P + PS
Sbjct: 187 QPQSYPPNEPLPSSMAM---QPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQ 243
Query: 361 LPPA--SHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPP 418
PP+ + PP S ++ ++ + ++ ++PS A T ++ P
Sbjct: 244 PPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPMSSAP 303
Query: 419 LFVPVLPSA 427
+ S
Sbjct: 304 MSGGGSGSP 312
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 16/205 (7%)
Query: 975 RILGEGGFG-LVYSGVLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKL 1030
++LG+G FG ++ G A+K+LK+ V + L E +L H L L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 1088
C V E G + HL V E + A + AL YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI------VSALDYLH-- 112
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
S V++RD K N++L+ D K++DFGL + + + + + GT Y+APE
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLED 170
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKP 1173
D + GVV+ E++ GR P
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-07
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 4/96 (4%)
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
A+ +++L +S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
++APE +SDV+SYG+++ E+ S G P
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 76/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)
Query: 970 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRLHH 1024
+F++ +++G G FG V D G A+K+L++ D +Q G AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVG-HIRAERDILVEADS 60
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARAL 1082
+VK+ ++ L+ E +P G + + L D E + A +A+ + L
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQL 120
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA----------------------- 1119
+ IHRD K N+LL+ K+SDFGL
Sbjct: 121 GF---------IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 1120 -----RSAMDEES-----RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
S E+ R ++ +GT Y+APE M D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 1170 GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQP 1229
G P P QE + ++ +E L I P +VP AK + C
Sbjct: 232 GYPPFCSETP--QETY----KKVMNWKETL--IFPP----EVPISEKAKDLILRFCC--- 276
Query: 1230 EVQHR 1234
E +HR
Sbjct: 277 EWEHR 281
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 32/216 (14%)
Query: 977 LGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+G G G+V Y VLD VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 1032 GI-----CIEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ +EE Q LV EL+ + +D E +++ + L +
Sbjct: 83 NVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHE----------RMSYLLYQMLCGI 132
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 189
Query: 1146 AMTGHLLVKSDVYSYGVVILE------LLSGRKPVD 1175
+ D++S G ++ E L GR +D
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-07
Identities = 76/389 (19%), Positives = 108/389 (27%), Gaps = 27/389 (6%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
P PS PP A+ + PP S + + P P + P+ HP
Sbjct: 175 PQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGSPIAAQPAPQPQQPSPLSLISAPSLHP 234
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSA 427
P TA + P + H + P H P L P
Sbjct: 235 QRLPSPHPPLQPQTASQQSPQPPAPSSRHPQSSHHGPGPPMPHALQQGPVFLQHPSSNPP 294
Query: 428 LPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEP 487
P SQ P P P S P P P +P
Sbjct: 295 QPFGLAQSQVP------PLPLPSQAQPHSHTPPSQSALQPQQP------------PREQP 336
Query: 488 IAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDI 547
+ P P P K P PI + P + +P + P +P +
Sbjct: 337 LPPAPSMP---HIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNLPPPPALKPLSSL 393
Query: 548 PMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVR 607
P +H PS P + M S P P Q+ S+ S +
Sbjct: 394 P----THHPPSAHPPPLQLMPQSQPLQSVPAQPPVLTQSQSLPPKASTHPHSGLHSGPPQ 449
Query: 608 NKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRV 667
+ A P S + P P+ P + PP +++ S
Sbjct: 450 SPFAQHPFTSGGLPAIGPPPSLPTSTPAAPPRASSG--SQPPGSALPSSGGCAGPGPPLP 507
Query: 668 PTSPSPSPTSASGQTELPLLPPKSSPSEP 696
P P + + E P PP+S EP
Sbjct: 508 PIQIKEEPLDEAEEPESPPPPPRSPSPEP 536
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-07
Identities = 51/263 (19%), Positives = 63/263 (23%), Gaps = 23/263 (8%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
++ + ST D+ P PSL T P P AP P+
Sbjct: 94 SQKTSTFSPCQSGYEAST-DPEYIPDLQPDPSLWGTAPKPEPQPPQAPESQPQPQTPAQK 152
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
+ + LP P P P AFP PP P
Sbjct: 153 MLSLEEVEAQLQQRQQAPQLPQP-PQQVLPQGMPPRQAAFPQQGPPE--------QPPGY 203
Query: 189 ARPPASHPSRTAPPPA-SHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLS 247
+PP HP + P PS P P P S+ PPP
Sbjct: 204 PQPPQGHPEQVQPQQFLPAPSQAPAQPPLPPQLPQQPPPLQQPQFPGLSQQMPPP----- 258
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
PP + P P + P P HP A P P P P
Sbjct: 259 ---PPQPPQQQQQPPQPQAQPPPQNQPTP-HPGLPQGQNAPLPPPQQPQ--LLPLVQQPQ 312
Query: 308 PASHPSNTAP-PPASHPSNTAPP 329
Sbjct: 313 GQQRGPQFREQLVQLSQQQREAL 335
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 3e-07
Identities = 31/162 (19%), Positives = 45/162 (27%), Gaps = 6/162 (3%)
Query: 82 FSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITA 141
F P+ P PP P AS + AP P +P P ++P A
Sbjct: 359 FHPAAPLPEPE---VPPQ---SAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPA 412
Query: 142 PPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAP 201
PL + ++KA ++ ARP S A + +
Sbjct: 413 VPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKA 472
Query: 202 PPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
P + + AL A KT A
Sbjct: 473 PAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPELAA 514
|
Length = 647 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-07
Identities = 55/262 (20%), Positives = 78/262 (29%), Gaps = 11/262 (4%)
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
P ++ P + PA P + P+ + ++ P P HPS T PP
Sbjct: 553 PASTEPVHDQLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWPVPHPSQTPEPP--- 609
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
+ + P + + + P P L N + P H P+ T
Sbjct: 610 -TTQSHIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPTPHQPPQVEITPYKPTWTQ 668
Query: 394 PPHASHPSNTALTPASHPSNIAP----PPLFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
H + + P AP PP P P P P + A P
Sbjct: 669 IGHIPYQPSPTGANTMLPIQWAPGTMQPPPRAPT-PMRPPAAPPGRAQRPAAATGRARPP 727
Query: 450 RGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPII 509
R P + PG P A + A P PG + P P
Sbjct: 728 AAAPGRARPP--AAAPGRARPPAAAPGRARPPAAAPGRARPPAAAPGAPTPQPPPQAPPA 785
Query: 510 PGGTPTASPDPDVPPSTPPLSV 531
P P +P P PP P S+
Sbjct: 786 PQQRPRGAPTPQPPPQAGPTSM 807
|
Length = 991 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 3e-07
Identities = 61/246 (24%), Positives = 104/246 (42%), Gaps = 45/246 (18%)
Query: 949 IATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVL--KRVDQ 1006
++ Y +A+ + ++ +FD +++G G FG V+++ K Q
Sbjct: 25 LSRYEKAAEKITKLRMKAE--DFDVIKVIGRGAFG-------------EVQLVRHKSSKQ 69
Query: 1007 QGGREFLAEVEMLSR------------LHHRN---LVKLIGICIEEQARCLVYELIPNGS 1051
+ L++ EM+ R + H N +V+L +++ +V E +P G
Sbjct: 70 VYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD 129
Query: 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111
+ + + D P W AR A AL +H S IHRD K N+LL+
Sbjct: 130 LVNLMSNYD---IPEKW-ARFYTA-EVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHL 181
Query: 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILEL 1167
K++DFG MD +GT Y++PE + G+ + D +S GV + E+
Sbjct: 182 KLADFGTCMK-MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240
Query: 1168 LSGRKP 1173
L G P
Sbjct: 241 LVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 977 LGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
+G+G FG V D ++ A+K +++ V + LAE +L++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ LV I G + HL +E AR A AL LH+ +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQ---REGRFDLSRARFYTA-ELLCALENLHKFN--- 113
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
VI+RD K NILL++ + DFGL + M ++ + + GT Y+APE + GH
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPEL-LLGHGY 170
Query: 1153 VKS-DVYSYGVVILELLSGRKP 1173
K+ D ++ GV++ E+L+G P
Sbjct: 171 TKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 4e-07
Identities = 36/127 (28%), Positives = 50/127 (39%), Gaps = 8/127 (6%)
Query: 216 TAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
A+ PS A PA+ P+ A PA+ AP PA+ +P PA P+ PP
Sbjct: 391 AGAPAAAAPSAAAAAPAAAPAPAAAAPAAA---AAPAPAA-----APQPAPAPAPAPAPP 442
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
+ + A S P AP P+ A P + APP A P+ PA+ +
Sbjct: 443 SPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAA 502
Query: 336 NTAPPPA 342
A
Sbjct: 503 PAGADDA 509
|
Length = 824 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 4e-07
Identities = 30/147 (20%), Positives = 36/147 (24%), Gaps = 1/147 (0%)
Query: 85 STPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPL 144
+ P+D +P P + P P A P + P PP
Sbjct: 41 QSGVAEFPWDPSPQAPP-PVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPA 99
Query: 145 VNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPA 204
LPA PT P N A P P+ AP
Sbjct: 100 TFALPAGPAGPTIQTEPGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYGAPASG 159
Query: 205 SHPSNTALPSKTAPSPASHPSNTALPP 231
PS K S N PP
Sbjct: 160 QLPSQQQSAQKNDESQLQQQPNGETPP 186
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 4e-07
Identities = 38/179 (21%), Positives = 49/179 (27%), Gaps = 20/179 (11%)
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
PS APPP A P P P A A H + T P A+ P+ A
Sbjct: 51 PSPQAPPP------VAQLPQPLP-QPPPTQALQAL-PAGDQQQHNTPTGSPAANPPATFA 102
Query: 339 PPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHAS 398
P P +P NPA P P+ AP
Sbjct: 103 LPAGPAGPTIQTEP-GQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQ 160
Query: 399 HPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHS 457
PS + S + P G+ P Q+ + D A R +
Sbjct: 161 LPSQQQSAQKNDESQLQQQP----------NGETPPQQTDGAGDDESEALVRLREADGT 209
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 60/241 (24%), Positives = 105/241 (43%), Gaps = 33/241 (13%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA---EVEMLSRLHHR 1025
+F+ + +G G +G VY ++ G A+KV+K + G +F E+ M+ H
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIK---LEPGEDFAVVQQEIIMMKDCKHS 66
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N+V G + + E GS++ H + PL ++ + L YL
Sbjct: 67 NIVAYFGSYLRRDKLWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYL 122
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H +HRD K +NILL + K++DFG++ ++ S +GT ++APE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKS--FIGTPYWMAPEV 177
Query: 1146 AMT---GHLLVKSDVYSYGVVILELLSGRKPVD----------MT----QPPGQENLVAW 1188
A G D+++ G+ +EL + P+ MT QPP ++ + W
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKW 237
Query: 1189 A 1189
+
Sbjct: 238 S 238
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-07
Identities = 27/128 (21%), Positives = 41/128 (32%), Gaps = 3/128 (2%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPP--PVNMAPPPS 126
P +A +P+ P +AP + P A+P + + P P APP
Sbjct: 366 PAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAP 425
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPS 186
+ A A P L P + + P + S AA PA+ P+
Sbjct: 426 VAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVAS-AAPAPAAAPA 484
Query: 187 NTARPPAS 194
P
Sbjct: 485 AARLTPTE 492
|
Length = 618 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 53/201 (26%), Positives = 85/201 (42%), Gaps = 9/201 (4%)
Query: 975 RILGEGGFG--LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
R++GEG FG L+ V D ++ + E +L+++ H N+V
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKE 65
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ +V E G + + + D L+ + + ++HE R
Sbjct: 66 SFEADGHLYIVMEYCDGGDLMQKIK--LQRGKLFPEDTILQWFVQMCLGVQHIHEK---R 120
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
V+HRD KS NI L + K+ DFG AR + + T V GT YV PE
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSAR-LLTSPGAYACTYV-GTPYYVPPEIWENMPYN 178
Query: 1153 VKSDVYSYGVVILELLSGRKP 1173
KSD++S G ++ EL + + P
Sbjct: 179 NKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 5e-07
Identities = 53/216 (24%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHR 1025
+++ +++G G FG V KV A+K+L + + + F E ++++ +
Sbjct: 44 DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGW----DARLKIALGAARA 1081
+V+L +++ +V E +P G + + + D P W A + +AL A +
Sbjct: 104 WVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD---VPEKWARFYTAEVVLALDAIHS 160
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+ + IHRD K N+LL+ K++DFG M++E +GT Y+
Sbjct: 161 MGF---------IHRDVKPDNMLLDKSGHLKLADFGTCMK-MNKEGMVRCDTAVGTPDYI 210
Query: 1142 APEYAMT----GHLLVKSDVYSYGVVILELLSGRKP 1173
+PE + G+ + D +S GV + E+L G P
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 5e-07
Identities = 66/367 (17%), Positives = 109/367 (29%), Gaps = 33/367 (8%)
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPP 174
AP + T P TA P LP S PT A P S P
Sbjct: 425 APDTTKSVI---FVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGT---PTGTT 478
Query: 175 SNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASL 234
S+ S S T + S T + ++ + A+ P+ P
Sbjct: 479 SSTLPEDTSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPT----PIVIG 534
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP-----ASHPSNTAPPPASH 289
+ TA P + ++ + + SP+ ++ P A +
Sbjct: 535 VTTTATSPPTGTTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPT 594
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT--------APPPASHPSNTAP-P 340
+ P +SH + P ++ S T ++HP+ + P +H S +P P
Sbjct: 595 SQQPGIPSSSHST----PRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGP 650
Query: 341 PASHSSKTAPPPAS----HPSNTALPPASHPSNPAIPPASHPSNTAIPPAS-HPSNTAPP 395
+S+ + P S +P + N P A TA+P +
Sbjct: 651 GPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANST 710
Query: 396 HASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHR 455
+T + S +N + LP P +P T +
Sbjct: 711 TKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVP 770
Query: 456 HSPAIHP 462
P HP
Sbjct: 771 VPPTQHP 777
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.7 bits (127), Expect = 5e-07
Identities = 67/242 (27%), Positives = 95/242 (39%), Gaps = 52/242 (21%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKV--AVKVL-KRVDQQGGR--EFLAEVEMLSRLHHR 1025
F ++LG+G G V+ V GT A+KVL K+ + + L E E+L+ L H
Sbjct: 3 FKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHL----HGVDKESAPLGWDARLKIALGAARA 1081
L L E CLV + P G + L E AR A A
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-----VARFYAAEVLL-A 115
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD----------------- 1124
L YLH +++RD K NILL +SDF L++ +
Sbjct: 116 LEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 1125 ----------EESRHISTRVMGTFGYVAPEY-AMTGHLLVKSDV--YSYGVVILELLSGR 1171
EE S +GT Y+APE + GH S V ++ G+++ E+L G
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH---GSAVDWWTLGILLYEMLYGT 229
Query: 1172 KP 1173
P
Sbjct: 230 TP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.8 bits (130), Expect = 6e-07
Identities = 37/139 (26%), Positives = 52/139 (37%), Gaps = 14/139 (10%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
A P A+ PS A PA+ P+ A PA+ AP+PA+ P
Sbjct: 385 LGVAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAA---------APAPAAAP-----Q 430
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
PA P+ PP+ + A S P +P P+ A P + APP A P
Sbjct: 431 PAPAPAPAPAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAP 490
Query: 291 SKTAPPPASHPSNTAPPPA 309
+ PA+ + A
Sbjct: 491 AAAPAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 6e-07
Identities = 50/188 (26%), Positives = 80/188 (42%), Gaps = 28/188 (14%)
Query: 1011 EFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVYELIPNGSVESHLHGVDKESAPLGW 1068
+ + EV ++ L H+N+V+ I + + Q ++ E G + ++ K +
Sbjct: 58 QLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEE 117
Query: 1069 DARLKIALGAARALAYLHE----DSSPRVIHRDFKSSNILLEHDF--------------- 1109
A + I ALAY H + RV+HRD K NI L
Sbjct: 118 HAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG 177
Query: 1110 --TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVIL 1165
K+ DFGL+++ E H +GT Y +PE + T KSD+++ G +I
Sbjct: 178 RPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIY 234
Query: 1166 ELLSGRKP 1173
EL SG+ P
Sbjct: 235 ELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-07
Identities = 29/147 (19%), Positives = 42/147 (28%), Gaps = 7/147 (4%)
Query: 287 ASHPSKTAPPPASHPSNTAPPPAS----HPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
A HP+ P P P + AP ++ P+ PP PPPAS P P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQ--APAVPPPPASAPQQAPAVPL 415
Query: 343 SHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSN 402
++ + S PA + P N+A+ + P
Sbjct: 416 PETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAP-A 474
Query: 403 TALTPASHPSNIAPPPLFVPVLPSALP 429
+N P AL
Sbjct: 475 KKEAYRWKATNPVEVKKEPVATPKALK 501
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-07
Identities = 32/167 (19%), Positives = 51/167 (30%), Gaps = 14/167 (8%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P PL P PP S A+ + P+ PP + P A A+P
Sbjct: 361 PAAPLPEPEV----PPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAP-QQAPAVPL 415
Query: 215 KTAPSPASHPSNTAL-PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
S + +K + P A+ + P + + L + P+ +A
Sbjct: 416 PETTSQLLAARQQLQRAQGATKAKKSEPAAA----SRARPVNSALE--RLASVRPAPSAL 469
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPA 320
A A++P + P + P A A T A
Sbjct: 470 EKAPAKKEAYRWKATNPVEVKKEPVATPK--ALKKALEHEKTPELAA 514
|
Length = 647 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 7e-07
Identities = 37/180 (20%), Positives = 57/180 (31%), Gaps = 12/180 (6%)
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
A HP+ P P P + AP ++ + + P A P PPPAS P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVP---------PPPASAPQ 408
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
P ++ + + S A + P N+AL +
Sbjct: 409 QAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSA 468
Query: 418 PLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNA 477
P A KA +P+ + P ATP+ P + L A +R+
Sbjct: 469 LEKAPAKKEAYRWKA---TNPVEVKKEPVATPKALKKALEHEKTPELAAKLAAEAIERDP 525
|
Length = 647 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-07
Identities = 65/248 (26%), Positives = 114/248 (45%), Gaps = 37/248 (14%)
Query: 959 FSASEIEKAT----GNFDASRILGEGGFGLV---YSGVLDDGTKVAVKVLKR--VDQQGG 1009
F + EI +T + + +G G G+V Y +L+ VA+K L R +Q
Sbjct: 10 FYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHA 67
Query: 1010 REFLAEVEMLSRLHHRNLVKLIGI-----CIEE-QARCLVYELIPNGSVESHLHGVDKES 1063
+ E+ ++ ++H+N++ L+ + +EE Q +V EL+ + +D E
Sbjct: 68 KRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHE- 126
Query: 1064 APLGWDARLKIALGAAR-ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122
R+ L + +LH S +IHRD K SNI+++ D T K+ DFGLAR+A
Sbjct: 127 -------RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176
Query: 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
+ + T + T Y APE + D++S G ++ E++ G PG
Sbjct: 177 ---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG-----VLFPGT 228
Query: 1183 ENLVAWAR 1190
+++ W +
Sbjct: 229 DHIDQWNK 236
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 7e-07
Identities = 49/184 (26%), Positives = 79/184 (42%), Gaps = 37/184 (20%)
Query: 1041 CLVYELIPNGSVESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFK 1099
C+V E + G + L K L D AR+ A AL YLH + ++HRD K
Sbjct: 77 CMVMEYVEGGDCATLL----KNIGALPVDMARMYFA-ETVLALEYLH---NYGIVHRDLK 128
Query: 1100 SSNILLEHDFTPKVSDFGLAR------------SAMDEESRHISTR-VMGTFGYVAPEYA 1146
N+L+ K++DFGL++ +++++R + V GT Y+APE
Sbjct: 129 PDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVI 188
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP---------------VDMTQPPGQENLVAWARP 1191
+ D ++ G+++ E L G P D+ P G E L A A+
Sbjct: 189 LRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQD 248
Query: 1192 LLTS 1195
L++
Sbjct: 249 LISR 252
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 53.2 bits (127), Expect = 8e-07
Identities = 74/384 (19%), Positives = 123/384 (32%), Gaps = 33/384 (8%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
T S + P PP S PT A P S T + P
Sbjct: 428 TTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPEDTS 487
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
PT+ S P +P+ TTP A+ +++ S NA P T
Sbjct: 488 PTSRTTSATPNA--------TSPTPAVTTPNATSPTTQK---TSDTPNATSPTPIVIGVT 536
Query: 189 ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSN 248
+ T+ P A+ P ++ +P ++ P+ L S A H
Sbjct: 537 TTATSPPTGTTSVPNATSPQ----VTEESPVNNTNTPVVTSAPSVLTS--AVTTGQH--- 587
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS-HPSKTAPPPASHPSNTAPP 307
S P P PS + P S+ ++T P S HP+ PS P
Sbjct: 588 ---GTGSSPTSQQPGI---PSSSHSTPRSNSTSTTPLLTSAHPTGGENITEETPSV---P 638
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
+H S +P P ++ P + ++ P + P A+ PS + + P
Sbjct: 639 STTHVSTLSPGPGPGTTSQVSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVP 698
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSA 427
+ + ++ + ++ ++T+P T A+ + P
Sbjct: 699 TVTSTGGKANSTTKETSGSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFT 758
Query: 428 LPGKAPVSQSPISLPDAPAATPRG 451
P PV+ ++P P P
Sbjct: 759 SP---PVTTKQATVPVPPTQHPDH 779
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 9e-07
Identities = 33/154 (21%), Positives = 37/154 (24%), Gaps = 15/154 (9%)
Query: 163 LSSKA--FPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNT------ALPS 214
S FP P A P A P +PP + + P NT A P
Sbjct: 40 SQSGVAEFPWD-PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPP 98
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
T PA T P N A P P + L AP
Sbjct: 99 ATFALPAGPAGPTIQTEPGQLYPVQVPVMVTQ-NPANSPLDQPAQQRALQQLQQRYGAP- 156
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
S P K N PP
Sbjct: 157 ----ASGQLPSQQQSAQKNDESQLQQQPNGETPP 186
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-06
Identities = 67/265 (25%), Positives = 81/265 (30%), Gaps = 31/265 (11%)
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA 221
PL PA PP A TAR PP A+ P+ A P A
Sbjct: 247 PLRGDIAAPAPPPVVGEG--ADRAPETARGA---TGPPPPPEAAAPNGAAAPPDGVWGAA 301
Query: 222 SHPSNTALPPASLPSKTAPPPASHLSNTAPP--------PASHPYKTSPLPASHPSK-TA 272
+ ALP P P PA P P + PL + T
Sbjct: 302 LAGAPLALPAP--PDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTW 359
Query: 273 PPPAS--------HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 324
PP+S H A P + + A+ P P AP PAS P+
Sbjct: 360 TPPSSLEDLSAGRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPT 417
Query: 325 NTAPP-PASHPSNTAPPPASHSSKT----APPPASHPSNTALPPASHPSNPAIPPASHPS 379
P PAS P A P S + APPP P A PA + A A
Sbjct: 418 PAPTPVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDAL 477
Query: 380 NTAIPPASHPSNTAPPHASHPSNTA 404
PP ++ A HP
Sbjct: 478 RERRPPEPPGADLAELLGRHPDTAG 502
|
Length = 3151 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 1e-06
Identities = 31/133 (23%), Positives = 44/133 (33%), Gaps = 5/133 (3%)
Query: 293 TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP 352
P P +N+ ++ A S P +++P S S P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 353 ASHPSNTALPPASHPSNPAIPPASH--PSNTAIPPASHPSNTAPPHASHPSNTAL-TPAS 409
+ S+ LPPA PP S P+N + PP P P +TA TP S
Sbjct: 206 SPSDSS--LPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPS 263
Query: 410 HPSNIAPPPLFVP 422
+ AP
Sbjct: 264 ASATPAPIGGITL 276
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-06
Identities = 21/82 (25%), Positives = 34/82 (41%)
Query: 286 PASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHS 345
P S + TA A+ + +AP A A P + P+ AP P+ A A+ +
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 346 SKTAPPPASHPSNTALPPASHP 367
+ A A+ P+ A+ P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 59/204 (28%), Positives = 93/204 (45%), Gaps = 14/204 (6%)
Query: 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 1029
+++G+G FG V DG AVKVL++ ++++ + +AE +L + H LV
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L + V + + G + HL +E + AR A A AL YLH
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQ---RERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S +++RD K NILL+ ++DFGL + + + +T GT Y+APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TTTTFCGTPEYLAPEVIRKQ 171
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D + G V+ E+L G P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-06
Identities = 59/249 (23%), Positives = 79/249 (31%), Gaps = 22/249 (8%)
Query: 104 TNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL 163
PV + AP A P P P A+ P A P V A + PLA P
Sbjct: 257 PPPVVGEGADRAPETARGATGP---PPPPEAAAPNGAAAPPDGVWGAA--LAGAPLALP- 310
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
+PP PA + + P P + P+
Sbjct: 311 --------APPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPP 362
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
S L K A P + A+ P+ P AP PAS P+
Sbjct: 363 SSLEDLSAGRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAP 420
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
P + +APPP + P +A P + APPP P A PA + A A
Sbjct: 421 TPVPA----SAPPPPATPLPSAEPGS--DDGPAPPPERQPPAPATEPAPDDPDDATRKAL 474
Query: 344 HSSKTAPPP 352
+ + PP
Sbjct: 475 DALRERRPP 483
|
Length = 3151 |
| >gnl|CDD|236669 PRK10263, PRK10263, DNA translocase FtsK; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-06
Identities = 52/275 (18%), Positives = 73/275 (26%), Gaps = 24/275 (8%)
Query: 153 LIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTAL 212
L+ P+ P++ A + S AA P S PP + +
Sbjct: 310 LLNGAPITEPVAVAAAATTATQSWAA------PVEPVTQTPPVASVDVPPAQPTVAWQPV 363
Query: 213 PSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTA 272
P P P+ P S ++ A L P + + PA P
Sbjct: 364 PGPQTGEPVIAPAPEGYPQQSQYAQPAVQYNEPLQQPVQPQQPYYAPAAEQPAQQPYYAP 423
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNT-APPPASHPSNTAPPP-ASHPSNTAPPP 330
P P P A +T AP T P A P P P
Sbjct: 424 APEQPAQQPYYAPAPEQPVAGNAWQAEEQQSTFAPQSTYQTEQTYQQPAAQEPLYQQPQP 483
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNT----------------ALPPASHPSNPAIPP 374
P P +K A PP + +P P
Sbjct: 484 VEQQPVVEPEPVVEETKPARPPLYYFEEVEEKRAREREQLAAWYQPIPEPVKEPEPIKSS 543
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPAS 409
PS A+PP + +P + T T A+
Sbjct: 544 LKAPSVAAVPPVEAAAAVSPLASGVKKATLATGAA 578
|
Length = 1355 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 2e-06
Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 7/80 (8%)
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHP 334
P S + TA A+ + +AP AP + + PPA+ P PA+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAA-------APAAKAPAAPAPAPPAAAAPAAPPKPAAAA 90
Query: 335 SNTAPPPASHSSKTAPPPAS 354
+ A P A ++ A PA+
Sbjct: 91 AAAAAPAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 2e-06
Identities = 25/109 (22%), Positives = 35/109 (32%), Gaps = 3/109 (2%)
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
L S + APP A+ P+ PPPA+ P+ + P A + AP H
Sbjct: 43 LADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAA-PAAEPAPWLVEHAKRLTAQREQL 101
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
+ A P A AP + + A P A
Sbjct: 102 VARAAAPAAPEA--QAPAAPAERAAAENAARRLARAAAAAPRPRVPADA 148
|
Length = 484 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-06
Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 8/98 (8%)
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMG 1136
A+ + +L +S + IHRD + NILL + K+ DFGLAR + R R+
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
++APE ++SDV+S+GV++ E+ S G P
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-06
Identities = 110/514 (21%), Positives = 158/514 (30%), Gaps = 53/514 (10%)
Query: 251 PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
P P +HP K + + S S A S P P P+ PS P P
Sbjct: 422 PTPKTHPVKRTLVKTSGRSDEAEQAQSTPER--PGPSDQPSVPVEPAHLTPVEHTTVILH 479
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNT-------------APPPASHSSKTAPPPASHPS 357
P + P A P APPP+ S T P
Sbjct: 480 QPPQSPPTVAIKP---APPPSRRRRGACVVYDDDIIEVIDVETTEEEESVTQPAKPHRKV 536
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
+ A PP PS+ PP + P APP TP++ P ++APP
Sbjct: 537 QDGFQRSGRRQKRATPPKVSPSDRG-PPKASPPVMAPPSTGPRV--MATPSTGPRDMAPP 593
Query: 418 ---PLFVPVLPSALPGKAP-VSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGP--LPPV 471
P P P Q P S P A + F R + P P +
Sbjct: 594 STGPRQQAKCKDGPPASGPHEKQPPSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEM 653
Query: 472 AQKRNASNREAPIAEPIAPG--PFPPGNSRQKSPVARPIIPGGTPTASPDP---DVPPST 526
R+ S + + P PP S S P + G S + + P+
Sbjct: 654 RAGRDGSGIQQEPSSRRQPATQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQ 713
Query: 527 PPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPS-KAPSTHKYMRHSNHSPLPPFSSPKPPQ 585
P + R P + D+ + P PS +AP + + +P P + P+PPQ
Sbjct: 714 PISHEEQPRYEDP--DDPLDLSLHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQ 771
Query: 586 --------------NNGNDTPVSSPLASFPKHRDVRNKIAS-SPAPSYFISPTTSIHQGP 630
+ + P +H R+ A S P + + P
Sbjct: 772 APYLGYQEPQAQGVQVSSYPGYAGPWGLRAQHPRYRHSWAYWSQYPGHGHPQGPWAPRPP 831
Query: 631 VVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPK 690
+PP + ++ + P +S+VP P +S P
Sbjct: 832 HLPPQWDGSAGHGQDQVSQFPHLQSETGPPRLQLSQVPQLPYSQTLVSSSAPSW-SSPQP 890
Query: 691 SSPSEPI--RAFPPPPPNADCSTTICTEPYTNTP 722
+P PI R PPP P D C T P
Sbjct: 891 RAPIRPIPTRFPPPPMPLQDSMAVGCDSSGTACP 924
|
Length = 1000 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 2e-06
Identities = 61/243 (25%), Positives = 100/243 (41%), Gaps = 48/243 (19%)
Query: 970 NFDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR 1025
+F++ +++G G FG V D G A+K+L++ D ++ AE ++L
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA 61
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALA 1083
+VK+ +++ L+ E +P G + + L D E A + A +A+ A L
Sbjct: 62 WVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 1119
+ IHRD K N+LL+ K+SDFGL
Sbjct: 122 F---------IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFS 172
Query: 1120 -------RSA--MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1170
R A + R ++ +GT Y+APE M D +S GV++ E+L G
Sbjct: 173 FQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 1171 RKP 1173
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 63/274 (22%), Positives = 104/274 (37%), Gaps = 61/274 (22%)
Query: 971 FDASRILGEGGFGLV-YSGVLDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRN 1026
F + LG G FG V + +D A+K L++ D + AE ++L+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAY 1084
+V+L ++ V + IP G + S L G+ E + A L A+ + + +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------- 1119
IHRD K NIL++ D K++DFGL
Sbjct: 123 ---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 1120 --------------------RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 1159
R A + R ++ ++GT Y+APE + D +S
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 1160 YGVVILELLSGRKPVDMTQP-PGQENLVAWARPL 1192
GV++ E+L G+ P P Q ++ W L
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 7/108 (6%)
Query: 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123
+PL + + + AR + +L +S + IHRD + NILL + K+ DFGLAR
Sbjct: 169 SPLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 1124 DEES--RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
+ R S R+ ++APE +SDV+S+GV++ E+ S
Sbjct: 226 KDPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-06
Identities = 25/115 (21%), Positives = 37/115 (32%), Gaps = 1/115 (0%)
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHP-Y 258
S S + A + S P +++ S PS P + S+ P P+S
Sbjct: 163 VATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPAPSSFQSD 222
Query: 259 KTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
P P S + + PP + P S P P S + AP
Sbjct: 223 TPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLD 277
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 3e-06
Identities = 30/144 (20%), Positives = 45/144 (31%), Gaps = 3/144 (2%)
Query: 221 ASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS 280
A HP+ LP +P ++A P AS + AP A P + +P S PA
Sbjct: 358 AFHPA-APLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLP 416
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 340
T + + + + + P A S P ++ + PA AP
Sbjct: 417 ETTSQLLAARQQLQRAQGATKAKKSEPAA--ASRARPVNSALERLASVRPAPSALEKAPA 474
Query: 341 PASHSSKTAPPPASHPSNTALPPA 364
A P P
Sbjct: 475 KKEAYRWKATNPVEVKKEPVATPK 498
|
Length = 647 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 3e-06
Identities = 24/159 (15%), Positives = 35/159 (22%), Gaps = 5/159 (3%)
Query: 220 PASHPSNTALPPASLPSKTAPPPASHLS-NTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
P+ + P A + P + PA++P T PA
Sbjct: 51 PSPQAPPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTP---TGSPAANPPATFALPAGP 107
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
T P N A P P+ AP PS
Sbjct: 108 AGPTIQTEPGQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQ 166
Query: 339 PPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
+ S+ P A + A+
Sbjct: 167 SAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 51.1 bits (123), Expect = 3e-06
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 6/120 (5%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
S L+ APP A+ P P PA+ P+ + P A + AP H +
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAA-PAAEPAPWLVEHAKRLTAQREQLV 102
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTAL 361
+ A P A AP + + A+ + A+ ++
Sbjct: 103 ARAAAPAAPEA--QAPAAPAERAAAENAARRLA---RAAAAAPRPRVPADAAAAVADAVK 157
|
Length = 484 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 3e-06
Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 29/221 (13%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
+ + + T VAVK L ++ + E+ +L H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHEDS 1089
I + +V L+ GS E L E P L IA AL Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLP-----ELAIAFILKDVLNALDYIH--- 118
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG--------YV 1141
S IHR K+S+ILL D +S + S + R RV+ F ++
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ---RVVHDFPKSSVKNLPWL 175
Query: 1142 APEY---AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1179
+PE + G+ KSD+YS G+ EL +G P
Sbjct: 176 SPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-06
Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 977 LGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK------ 1029
+G+G FG VY D ++ A+KVL + +E +A+ E+ + RN++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54
Query: 1030 ---LIGICIEEQARC---LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
++G+ Q LV + + G + HL KE A+ IA AL
Sbjct: 55 SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ---KEGRFSEDRAKFYIA-ELVLALE 110
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
+LH+ +++RD K NILL+ + DFGL+++ + + + GT Y+AP
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYLAP 165
Query: 1144 EYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
E + K D +S GV++ E+ G P
Sbjct: 166 EVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-06
Identities = 61/258 (23%), Positives = 78/258 (30%), Gaps = 16/258 (6%)
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
A PP + P + T P P ++ A+PP A + A P
Sbjct: 253 AAPAPPPVVGEGADRAPETARGATGPPPPPEAAAPNGAAAPPDGVW-GAALAGAPLALPA 311
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN---TALPPASLPSKTAPPPASHLSNT 249
P AP + + + SP P P P+ T P LS
Sbjct: 312 PPDPPPPAPAGDAEEEDDEDGAMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLEDLSA- 370
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP-P 308
H K + LP + + A+ P P AP PAS P+ P P
Sbjct: 371 ----GRHHPKRASLPTR--KRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVP 424
Query: 309 ASHPSNTAPPPAS----HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPA 364
AS P A P S APPP P A PA A A PP
Sbjct: 425 ASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDATRKALDALRERRPPE 484
Query: 365 SHPSNPAIPPASHPSNTA 382
++ A HP
Sbjct: 485 PPGADLAELLGRHPDTAG 502
|
Length = 3151 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-06
Identities = 34/151 (22%), Positives = 51/151 (33%), Gaps = 13/151 (8%)
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
A P+ A A P+ P A PA+ P A+ + A P A+ +
Sbjct: 363 AFKPAAAAEAAA--PAEKKTPARP----EAAAPAAAP---VAQAAAAPAPAAAPAAAASA 413
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
A P A+ P+ A P A+ P + + P+ A + P +AP
Sbjct: 414 PAAPPAAAPPAPVAAPAAAAP----AAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPE 469
Query: 418 PLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
P P+ A +P D AT
Sbjct: 470 PAVASAAPAPAAAPAAARLTPTEEGDVWHAT 500
|
Length = 618 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.4 bits (124), Expect = 4e-06
Identities = 18/81 (22%), Positives = 29/81 (35%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
A + A A+ AP + + PPA+ P PA+ ++ A P A
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 354 SHPSNTALPPASHPSNPAIPP 374
+ A PA+ + P
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 4e-06
Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 61/272 (22%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVD----QQGGREFLAEVEMLSRLHHR 1025
F + +G G FG V D + A+K L++ D Q AE ++L+ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAA-HVKAERDILAEADNE 61
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALA 1083
+VKL ++ V + IP G + S L G+ +E AR IA A+
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL-----ARFYIA-ELTCAIE 115
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA------------------------ 1119
+H+ IHRD K NIL++ D K++DFGL
Sbjct: 116 SVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSME 172
Query: 1120 -----------------RSAMDEESRHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYG 1161
R + R ++ ++GT Y+APE TG+ + D +S G
Sbjct: 173 PSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVG 231
Query: 1162 VVILELLSGRKPVDMTQPPG-QENLVAWARPL 1192
V++ E+L G+ P P Q ++ W L
Sbjct: 232 VILYEMLVGQPPFLADTPAETQLKVINWETTL 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 4e-06
Identities = 32/124 (25%), Positives = 38/124 (30%), Gaps = 8/124 (6%)
Query: 256 HPYKTSPLP-ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSN 314
Y PL A + P PA P A P A+ PS P PA PS A+
Sbjct: 344 TSYGQLPLELAVIEALLVPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIP 398
Query: 315 TAPPPAS--HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAI 372
P P P P + P P A ++ A P P T P I
Sbjct: 399 PKEPVRETATPPPVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALI 458
Query: 373 PPAS 376
Sbjct: 459 ADGD 462
|
Length = 585 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 4e-06
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 5/126 (3%)
Query: 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1103
Y+ + V++ L D S L L AR + +L +S +HRD + N+
Sbjct: 214 YKGSNDSEVKNLLS--DDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNV 268
Query: 1104 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 1163
LL K+ DFGLAR M + + ++APE SDV+SYG++
Sbjct: 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGIL 328
Query: 1164 ILELLS 1169
+ E+ S
Sbjct: 329 LWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 51.0 bits (123), Expect = 5e-06
Identities = 19/82 (23%), Positives = 31/82 (37%)
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
P S + TA A+ + +AP A + + P+ AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 291 SKTAPPPASHPSNTAPPPASHP 312
+ A A+ P+ A P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-06
Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 25/218 (11%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTK--VAVKVLKR---VDQQGGREFLAEVEMLSRLHH 1024
+FD ++G G FG V V + T A+KV+K+ + Q+ F E ++LS +
Sbjct: 2 DFDVKSLVGRGHFGEVQV-VREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD---KESAPLGWDARLKIALGAARA 1081
+ +L ++ LV E P G + S L+ + E + A L +A+ +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ 120
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+ Y +HRD K N+L++ K++DFG A + + S +GT Y+
Sbjct: 121 MGY---------VHRDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSKLPVGTPDYI 170
Query: 1142 APEY--AMTGHLL----VKSDVYSYGVVILELLSGRKP 1173
APE M G V+ D +S GV+ E++ GR P
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 6e-06
Identities = 43/227 (18%), Positives = 58/227 (25%), Gaps = 19/227 (8%)
Query: 20 AFTVQGSAGYGIPPSPAIIGGHFLLPRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNI 79
AF S G P + A P P A P +A
Sbjct: 362 AFRPGQSGGGAGPATAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAA-PAAAAAARAVA 420
Query: 80 PSFSPSTPAVSA------PFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPV 133
+ + +PA A P + P A+ P+ A P P
Sbjct: 421 AAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPV-----AAA 475
Query: 134 ASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPA 193
A+ P A P PA P P F +P A P + P
Sbjct: 476 AAAAPARAAPAAAPAPADDDPPPWEELPP----EFASPAPAQPDAAPAGWVAESIPDPAT 531
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAP 240
+ P A P+ P A + P PP + S
Sbjct: 532 ADPDDAFETLAPAPAAAPAPRAAAATE---PVVAPRPPRASASGLPD 575
|
Length = 700 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 6e-06
Identities = 27/131 (20%), Positives = 42/131 (32%), Gaps = 9/131 (6%)
Query: 168 FPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNT 227
+ AA P A+ + A P + + A + + AP PA P+
Sbjct: 387 VAGGAGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAA--------APQPAPAPAPA 438
Query: 228 ALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA 287
PP+ + A S AP P + P + PPA+ AP
Sbjct: 439 PAPPSPAGNAPAGGAPSPPPAAAPSAQPAPAPAAA-PEPTAAPAPAPPAAPAPAAAPAAP 497
Query: 288 SHPSKTAPPPA 298
+ P+ A
Sbjct: 498 AAPAAPAGADD 508
|
Length = 824 |
| >gnl|CDD|223065 PHA03378, PHA03378, EBNA-3B; Provisional | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 6e-06
Identities = 71/306 (23%), Positives = 92/306 (30%), Gaps = 42/306 (13%)
Query: 56 HLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITA 115
LL P+++ ++P + S +PS P P PS P PP+ +
Sbjct: 562 QLLPAPGLGPLQIQPLTSPTTSQLASSAPSYAQTPWP---VPHPSQTP-----EPPTTQS 613
Query: 116 PPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
P AP +P P+ P P NVL P+ P PP
Sbjct: 614 HIPETSAPRQWPMPLRPIPMRPLRMQPITFNVLVFPT-----------------PHQPPQ 656
Query: 176 NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
P + P P P NT LP + AP T PP P
Sbjct: 657 VEITPYKPTWTQIGHIPYQ------PSPTGA--NTMLPIQWAPG-------TMQPPPRAP 701
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAP 295
+ PP A P A+ + A P A P + P AP
Sbjct: 702 TPMRPPAAPPGRAQRPAAATGRARPPAAAPGRARPPAAAPGRARPPAAAPGRARPPAAAP 761
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
A P+ P P APP AP P P A P + A P
Sbjct: 762 GRARPPAAAPGAPTPQPPPQAPPAPQQRPRGAPTPQPPPQ--AGPTSMQLMPRAAPGQQG 819
Query: 356 PSNTAL 361
P+ L
Sbjct: 820 PTKQIL 825
|
Length = 991 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-06
Identities = 33/123 (26%), Positives = 46/123 (37%), Gaps = 14/123 (11%)
Query: 86 TPAVSAPFDMAPPPSLIPTNPVASP--PSITAPPPVNMAPPPSLIPTTPVASPPPITAPP 143
T P ++A +L+ P P P+ AP PV P PS P A+ P P
Sbjct: 344 TSYGQLPLELAVIEALLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIP-PKEP 402
Query: 144 LVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPP 203
+ P +P P+A P P +P S A+ P + P + P APP
Sbjct: 403 VRETAT-PPPVPPRPVAPP------VPHTPESAPKLTRAAIPVDEK-PKYTPP---APPK 451
Query: 204 ASH 206
Sbjct: 452 EEE 454
|
Length = 585 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 50.2 bits (121), Expect = 7e-06
Identities = 35/187 (18%), Positives = 51/187 (27%), Gaps = 31/187 (16%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASP 162
P P+ P + + PT VA P PP
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPP------------------- 401
Query: 163 LSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS 222
PPAS P A P ++ R + S A S+ P ++
Sbjct: 402 ------PPASAPQQAPAVPLPETTSQLLAARQQLQRAQGATKAKKSEPAAASRARPVNSA 455
Query: 223 HPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS--KTAPPPASHPS 280
++ PA + AP A++P + P + P K A P
Sbjct: 456 LERLASVRPAPSALEKAPAKK----EAYRWKATNPVEVKKEPVATPKALKKALEHEKTPE 511
Query: 281 NTAPPPA 287
A A
Sbjct: 512 LAAKLAA 518
|
Length = 647 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.7 bits (119), Expect = 7e-06
Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 57/249 (22%)
Query: 970 NFDASRILGEGGFG---LVYSGVLDDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL 1022
+F++ +++G G FG LV D G A+K L++ + +Q AE ++L+
Sbjct: 2 DFESIKVIGRGAFGEVRLVQK--KDTGHIYAMKKLRKSEMLEKEQVA-HVRAERDILAEA 58
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAAR 1080
+ +VKL +E L+ E +P G + + L D E + A +A+ +
Sbjct: 59 DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH 118
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA-------RSAMDEESRHIST- 1132
L Y IHRD K N+LL+ K+SDFGL R+ H
Sbjct: 119 KLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPS 169
Query: 1133 -----------------------RVM-----GTFGYVAPEYAMTGHLLVKSDVYSYGVVI 1164
R + GT Y+APE + + D +S GV++
Sbjct: 170 NFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIM 229
Query: 1165 LELLSGRKP 1173
E+L G P
Sbjct: 230 YEMLVGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-06
Identities = 86/368 (23%), Positives = 111/368 (30%), Gaps = 70/368 (19%)
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPV 434
S P P P A P A A P PP P A P AP
Sbjct: 2466 LSLLLGELFP--GAPVYRRPAEARFPF--AAGAAPDPGGGGPPD------PDAPP--APS 2513
Query: 435 SQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFP 494
+P LPD P P +HP M + + + +A A P P
Sbjct: 2514 RLAPAILPDEPVGEP----------VHPRMLTWIRGLEE----------LASDDAGDPPP 2553
Query: 495 PGNSRQKSPVARPIIPGGTPTASPDPDVPPST----PPLSVDGKRVGKPVAEPSYDIPMP 550
P +P P A+PD VPP P R +P A P P
Sbjct: 2554 P-------------LPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRARRPDAPPQSARPRA 2600
Query: 551 PPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKI 610
P + + P+ + H+P PP SP P N+ P P R
Sbjct: 2601 PVDDRGDPRGPAPPSPLPPDTHAPDPPPPSPSP---AANEPDPHPPPTVPPPERPRD--- 2654
Query: 611 ASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTP------- 663
PAP P + G S P +R P + S++ P P P
Sbjct: 2655 --DPAPGRVSRPRRARRLGRAAQASSPPQRPRRRAARPTVGSLTSLADPPPPPPTPEPAP 2712
Query: 664 ---VSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEPYTN 720
VS P P P +A+ Q L + P+ P P P P
Sbjct: 2713 HALVSATPLPPGP---AAARQASPALPAAPAPPAVPAGPATPGGPARPARPPTTAGPPAP 2769
Query: 721 TPPGSPCG 728
PP +P
Sbjct: 2770 APPAAPAA 2777
|
Length = 3151 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 8e-06
Identities = 26/151 (17%), Positives = 35/151 (23%), Gaps = 2/151 (1%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTA-PPPASHPSNTAPPPASHPSKTAPPP 297
PP A PP + + P T PA++P T PA T
Sbjct: 56 PPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTE 115
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
P N A P P+ AP S+ + S
Sbjct: 116 PGQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQLPSQQQSAQKNDES 174
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPASH 388
P A + A+
Sbjct: 175 QLQQQPNGETPPQQTDGAGDDESEALVRLRE 205
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 8e-06
Identities = 56/260 (21%), Positives = 76/260 (29%), Gaps = 66/260 (25%)
Query: 45 PRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPT 104
PRL L+ LLG LP+ N + + TPA + AP P
Sbjct: 348 PRL----WLEVTLLG-------LLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPK 396
Query: 105 NPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVN---------VLPAPSLIP 155
A+ P + P PT P +PP A + +L L
Sbjct: 397 TKQAATTPSPPPAKASPPIPVPAEPTEPSPTPPANAANAPPSLNLEELWQQILAKLELPS 456
Query: 156 TTPLAS-----------------------------PLSSKAF----------------PP 170
T L S PL +AF
Sbjct: 457 TRMLLSQQAELVSLDSNRAVIAVSPNWLGMVQSRKPLLEQAFAKVLGRSIKLNLESQSGS 516
Query: 171 ASPPSNAARPPASHPSNTAR-PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
AS + PP P A PP P+ TAPPP P ++ +PA P++++
Sbjct: 517 ASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADSSP 576
Query: 230 PPASLPSKTAPPPASHLSNT 249
PP T P
Sbjct: 577 PPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|221188 pfam11725, AvrE, Pathogenicity factor | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-06
Identities = 43/226 (19%), Positives = 67/226 (29%), Gaps = 6/226 (2%)
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHP--SNTALPPASLPSKTAPPP 242
NTA A P A P A P+ S++ ASH S +P
Sbjct: 5 SINTATKTAVQPE--ATPSAGAPTGLQQSSESPTQRASHSLASEGKKNRKKMPKVFQKSS 62
Query: 243 ASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPS 302
A APP A +P +P + P T + P + A S +A
Sbjct: 63 APRQIQAAPPQALNPTAAAPQSSRGP--TLRELLALPEDDGETQAPESSPSARRLTRSEG 120
Query: 303 NTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
P + S+ PP + ++ PA+ ++ AL
Sbjct: 121 VARHEMEDLAGRPVVKPDADRQLRQDILNKSSSSRRPPVSKEEGTSSKMPATALASAALF 180
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPA 408
S ++ + S + A P + P LT +
Sbjct: 181 KDDEIRQEVDAARSDQASQSRLSRSRGNPPAIPPDAAPRQPMLTRS 226
|
This family is secreted by gram-negative Gammaproteobacteria such as Pseudomonas syringae of tomato and the fire blight plant pathogen Erwinia amylovora, amongst others. It is an essential pathogenicity factor of approximately 198 kDa. Its injection into the host-plant is dependent upon the bacterial type III or Hrp secretion system. The family is long and carries a number of predicted functional regions, including an ERMS or endoplasmic reticulum membrane retention signal at both the C- and the N-termini, a leucine-zipper motif from residues 539-560, and a nuclear localisation signal at 1358-1361. this conserved AvrE-family of effectors is among the few that are required for full virulence of many phytopathogenic pseudomonads, erwinias and pantoeas. Length = 1771 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-06
Identities = 32/148 (21%), Positives = 54/148 (36%), Gaps = 16/148 (10%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KLIG 1032
++L G VY + +K+ ++ G + EV +L L + L K++
Sbjct: 4 KLLKGGLTNRVYL-LGTKDEDYVLKINPS--REKGADREREVAILQLLARKGLPVPKVLA 60
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ L+ E I G + +KE IA A LA LH+
Sbjct: 61 SGESDGWSYLLMEWIE-GETLDEVSEEEKE----------DIAEQLAELLAKLHQLPLLV 109
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLAR 1120
+ H D NIL++ + D+ A
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-05
Identities = 31/173 (17%), Positives = 45/173 (26%), Gaps = 12/173 (6%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPP-PSLIPTNPVASPPSITAPPPVN 120
A + P +P P + + ++ P P+ P + P
Sbjct: 416 ARAVAAAPARRSPAPEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAA 475
Query: 121 MAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP 180
A P A+P AP + P L P +P A P + P
Sbjct: 476 AAAAP------ARAAPAAAPAPADDDPPPWEELPPEFASPAPAQPDAAPAGWVAESIPDP 529
Query: 181 PASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ P A AP A P A S + LP
Sbjct: 530 ATADP-----DDAFETLAPAPAAAPAPRAAAATEPVVAPRPPRASASGLPDMF 577
|
Length = 700 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 1e-05
Identities = 32/177 (18%), Positives = 47/177 (26%), Gaps = 12/177 (6%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
P A P A A AP P P V +
Sbjct: 615 PAAPAAPAAPAAPAPAGAAAAPAEASAAPAP--------GVAAPEHHPKHVAVPDASDGG 666
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
P + A P PA P + + P A+PP+ A PA+ P
Sbjct: 667 DGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPA--PAATPPAGQADDPAAQPPQA 724
Query: 189 ARPPASHPSRTAP--PPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPA 243
A+ ++ P P + P+ P P+ + +PP
Sbjct: 725 AQGASAPSPAADDPVPLPPEPDDPPDPAGAPAQPPPPPAPAPAAAPAAAPPPSPPSE 781
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 1e-05
Identities = 33/158 (20%), Positives = 42/158 (26%), Gaps = 24/158 (15%)
Query: 137 PPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHP 196
P PPL + T S A P ++ PS+ PS + P
Sbjct: 147 DPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSS 206
Query: 197 SRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH 256
+ P PA + PP S S T P P PP +
Sbjct: 207 PSDSSLP----------------PAPSSFQSDTPPPSPESPTNPSP--------PPGPAA 242
Query: 257 PYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTA 294
P S P P S + AP A
Sbjct: 243 PPPPPVQQVPPLSTAKPTPPSASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 1e-05
Identities = 30/202 (14%), Positives = 48/202 (23%), Gaps = 20/202 (9%)
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP- 307
APPP + P + ++ PP + ++P+ P
Sbjct: 95 PAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLPTARPAYPAYQQRPE 154
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN--TALPPAS 365
P + P PP A + S + P + P +
Sbjct: 155 PGAWPRAADDYGWQQQRLGFPPRAPYASPASYAP--EQERDREPYDAGRPEYDQRRRDYD 212
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
HP P ++ P P P V +
Sbjct: 213 HPRPDWDRPRRDRTDR---PEPPPGAGHVHRGG------------PGPPERDDAPVVPIR 257
Query: 426 SALPGKAPVSQSPISLPDAPAA 447
+ PG +P P P A
Sbjct: 258 PSAPGPLAAQPAPAPGPGEPTA 279
|
Length = 617 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-05
Identities = 20/82 (24%), Positives = 31/82 (37%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
P S + TA A+ ++P A A P + P+ AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 302 SNTAPPPASHPSNTAPPPASHP 323
+ A A+ P+ A P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-05
Identities = 19/75 (25%), Positives = 29/75 (38%), Gaps = 2/75 (2%)
Query: 170 PASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
P S + A A+ + +A A P+ AP + A P PA+ + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAA--PAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 230 PPASLPSKTAPPPAS 244
P A + A PA+
Sbjct: 96 PAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 49.9 bits (120), Expect = 1e-05
Identities = 20/82 (24%), Positives = 31/82 (37%)
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
P S T+ A+ + +AP A A P + P+ AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 313 SNTAPPPASHPSNTAPPPASHP 334
+ A A+ P+ A P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.8 bits (115), Expect = 1e-05
Identities = 49/153 (32%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 265 ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA---SHPSNTAPPPA---SHPSNTAPP 318
A+ K A A+ PS A+ P+K A PA + P+ A PA + P+ A P
Sbjct: 197 AAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAP 256
Query: 319 PA---SHPSNTAPPPASHPSNTAPPPASHSSKTAPPP--ASHPSNTALPPASHPSNPAIP 373
PA + P+ A PPA + A A + APP A+ P+ A PA + PA
Sbjct: 257 PAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAAPA-K 315
Query: 374 PASHPSNTAIPPASHPSNTAPPHASHPSNTALT 406
A+ P+ A PPA + T P A+ P A
Sbjct: 316 AAAPPAKAAAPPAK--AATPPAKAAAPPAKAAA 346
|
Length = 357 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 1e-05
Identities = 51/259 (19%), Positives = 69/259 (26%), Gaps = 26/259 (10%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
P AS AP SK + P P
Sbjct: 514 PEASGLPPKAPGDKEGEEGEHEDSKESDEPKEGGK--------------PGETKEGEVGK 559
Query: 251 PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
P + +K S +P P HP + P ++A P S P
Sbjct: 560 KPGPAKEHKPSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLD 619
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
P + P S S PPP PS+ P K+ PP S P +P
Sbjct: 620 IP-KSPKRPESPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKS---------PKPPFDP 669
Query: 371 AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPG 430
+ + + A+ T S ++ + P P LP LP
Sbjct: 670 KFKEKFY--DDYLDAAAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPR 727
Query: 431 KAPVSQSPISLPDAPAATP 449
PI PDA
Sbjct: 728 DEEFPFEPIGDPDAEQPDD 746
|
Length = 943 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-05
Identities = 69/244 (28%), Positives = 110/244 (45%), Gaps = 33/244 (13%)
Query: 940 SASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAV 998
S+S S SS A+ + + S SE+E+ +G G G VY + G A+
Sbjct: 52 SSSSSSSSSSASGSAPSAAKSLSELERV-------NRIGSGAGGTVYKVIHRPTGRLYAL 104
Query: 999 KVL-KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH 1057
KV+ + R+ E+E+L ++H N+VK + ++ E + GS+E
Sbjct: 105 KVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI 164
Query: 1058 GVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117
++ A D +I G +AYLH ++HRD K SN+L+ K++DFG
Sbjct: 165 ADEQFLA----DVARQILSG----IAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFG 213
Query: 1118 LAR---SAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLS 1169
++R MD + + GT Y++PE T + D++S GV ILE
Sbjct: 214 VSRILAQTMDPCNSSV-----GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYL 268
Query: 1170 GRKP 1173
GR P
Sbjct: 269 GRFP 272
|
Length = 353 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 1e-05
Identities = 20/86 (23%), Positives = 27/86 (31%), Gaps = 6/86 (6%)
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
T P PA+ T + TAP PA P A S + AP
Sbjct: 174 TTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS------QANVDTAATPAPAA 227
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHP 356
+ P AP P + + P +
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-05
Identities = 45/198 (22%), Positives = 58/198 (29%), Gaps = 7/198 (3%)
Query: 60 GHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPV 119
G AP AP P + A +AP A P A + AP
Sbjct: 589 GPAPGAAGGEGPPAPASSGPPEEAARPAAPAAPAAPAAPAPAGAAAAPAEASAAPAPGVA 648
Query: 120 NMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
P + + PA P A + A P P+ AA
Sbjct: 649 APEHHPKHVAVPDASDGGDGWPAKAGGAAPAAPPPAPAPAAPAAPAGAAPAQPAPAPAAT 708
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
PPA + A P + P + LP + P PA P A
Sbjct: 709 PPAGQADDPAAQPPQAAQGASAPSPAADDPVPLPPEPDDPPDPAG-----APAQPPPPPA 763
Query: 240 PPPASHLSNTAPPPASHP 257
P PA+ + A PP S P
Sbjct: 764 PAPAA--APAAAPPPSPP 779
|
Length = 824 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-05
Identities = 27/149 (18%), Positives = 40/149 (26%), Gaps = 10/149 (6%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPP--PASHPSKTAPPPAS 299
PA+ L PP S S + P+ PP + P P P+ P S
Sbjct: 361 PAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPPASAPQQAPAVPLPETTS 420
Query: 300 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS--HPSNTAPPPASHSSKTAPPPASHPS 357
T + + + P + + PA + + AP
Sbjct: 421 QLLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRPAPSALEKAPAKKEAYR 480
Query: 358 NTALPPASHPSNPAIPPASHPSNTAIPPA 386
A P P P A+ A
Sbjct: 481 WKATNPVEVKKEPVATP------KALKKA 503
|
Length = 647 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 2e-05
Identities = 20/83 (24%), Positives = 31/83 (37%)
Query: 219 SPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
P S + TA A+ + +AP A A P + P +P P+ A A+
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAP 96
Query: 279 PSNTAPPPASHPSKTAPPPASHP 301
+ A A+ P+ A P
Sbjct: 97 AAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 2e-05
Identities = 22/137 (16%), Positives = 32/137 (23%), Gaps = 7/137 (5%)
Query: 272 APPPASHPSNTAPPPASHPSKTAPPPASHPSNTA-PPPASHPSNTAPPPASHPSNTAPPP 330
PP A P PP + + P NT PA++P T PA T
Sbjct: 56 PPPVAQLPQPLPQPPPTQALQALPAGDQQQHNTPTGSPAANPPATFALPAGPAGPTIQTE 115
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
P + P AL + + ++ +
Sbjct: 116 PGQLYPVQVPVMVTQNPANSPLDQPAQQRALQQLQQRYG----APASGQLPSQQQSAQKN 171
Query: 391 NTAPPHASHPSNTALTP 407
N P
Sbjct: 172 --DESQLQQQPNGETPP 186
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 24/120 (20%), Positives = 37/120 (30%), Gaps = 6/120 (5%)
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHP 334
S + APP A+ P+ PPPA+ P+ PA+ + AP H
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPA-AVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 335 SNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAP 394
+ A P A AP + + A P A+ ++
Sbjct: 103 ARAAAPAA--PEAQAPAAPAERAAAENAARRLARAAAAAPRPRVP---ADAAAAVADAVK 157
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 29/112 (25%), Positives = 38/112 (33%), Gaps = 7/112 (6%)
Query: 219 SPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
S P A+ A L AP PA A P + +P P++ P A A+
Sbjct: 345 SYGQLPLELAVIEALLVPVPAPQPA-----KPTAAAPSPVRPTPAPSTRP--KAAAAANI 397
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
P + P P P + P P A + A P P T P P
Sbjct: 398 PPKEPVRETATPPPVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (114), Expect = 2e-05
Identities = 59/175 (33%), Positives = 77/175 (44%), Gaps = 39/175 (22%)
Query: 211 ALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSK 270
A K A A+ PS A+ P+K A PA A PPA A+ P+K
Sbjct: 198 AAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPA----KAAAPPAK--------AAAAPAK 245
Query: 271 TAPPPA---SHPSNTAPPPA---SHPSKTAPPPA---SHPSNTAPPPA---SHPSNTAPP 318
A PA + P+ A PPA + P+K A PPA + P+ A PPA + P+ A
Sbjct: 246 AAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAA 305
Query: 319 PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP---ASHPSNTALPPASHPSNP 370
PA A+ P+ A PPA K A PP A+ P+ A PPA + P
Sbjct: 306 PAK--------AAAAPAKAAAPPA----KAAAPPAKAATPPAKAAAPPAKAAAAP 348
|
Length = 357 |
| >gnl|CDD|219916 pfam08580, KAR9, Yeast cortical protein KAR9 | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 2e-05
Identities = 38/252 (15%), Positives = 66/252 (26%), Gaps = 17/252 (6%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSK--TA 217
++P SS P +SP S+ P + + P S L +
Sbjct: 388 SNPGSSIDTPSSSPSSSVIMTPPDSGPGSNVSSRRVGT---PGSKSDRVGAVLLRRMNIK 444
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P+ AS P + P +S L PP + +
Sbjct: 445 PTLASIPDEKPSNISVFEDSETSPNSSTLLRDPPPKKC---GEESGHLPNNPFFNKLKLT 501
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPP--ASHPSNTAPPPASHPSNTAPPPASHPS 335
S+ P T P P+ S + S + P +P+ + A+ S
Sbjct: 502 L-SSIPPLSPRQSIITLPTPSRPASRISSLSLRLGSYSGSIVSPPPYPTLVSRKGAAGLS 560
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
+ ALP + + S ++++P +
Sbjct: 561 FNRSVSDIEGERIGRYNLLPTRIPALPFKAEST------TSSRRSSSLPSPTGVIGFPGS 614
Query: 396 HASHPSNTALTP 407
L P
Sbjct: 615 VPRFDHENLLPP 626
|
The KAR9 protein in Saccharomyces cerevisiae is a cytoskeletal protein required for karyogamy, correct positioning of the mitotic spindle and for orientation of cytoplasmic microtubules. KAR9 localises at the shmoo tip in mating cells and at the tip of the growing bud in anaphase. Length = 626 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-05
Identities = 30/123 (24%), Positives = 35/123 (28%), Gaps = 16/123 (13%)
Query: 232 ASLPSK--TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
A L K A P P T P A PS A S ++A S
Sbjct: 360 AQLTQKGDDASGG------RGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS- 412
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAP-PPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
AP A+ P+ T P + P P P S P P S S
Sbjct: 413 ----APQSATQPAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEK--KIPVSKVSSL 466
Query: 349 APP 351
P
Sbjct: 467 GPS 469
|
Length = 614 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-05
Identities = 58/229 (25%), Positives = 80/229 (34%), Gaps = 22/229 (9%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVA-SPPSI 113
P ++G A E + PP P +AP A PP + +A +P ++
Sbjct: 258 PPVVGEGADRAPETARGATGPP--------PPPEAAAPNGAAAPPDGVWGAALAGAPLAL 309
Query: 114 TAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
APP PPP A +V+ LP P + P +P
Sbjct: 310 PAPPD----PPPPAPAGDAEEEDDEDGAMEVVSPLPRPR----QHYPLGFPKRRRPTWTP 361
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAP----PPASHPSNTALPSKTAPSPASHPSNTAL 229
PS+ A + R+A P A P AP PAS P+
Sbjct: 362 PSSLEDLSAGRHHPKRASLPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPT 421
Query: 230 P-PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P PAS P A P S + PA P + P PA+ P+ P A+
Sbjct: 422 PVPASAPPPPATPLPSAEPGSDDGPAPPPERQPPAPATEPAPDDPDDAT 470
|
Length = 3151 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-05
Identities = 63/280 (22%), Positives = 97/280 (34%), Gaps = 20/280 (7%)
Query: 199 TAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPY 258
TAP +PS+ P S + A P +P+K P A PP
Sbjct: 310 TAPLTPMEELLAKIPSQRVPPKES---DAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAV 366
Query: 259 KTSPL-PASHPSKTAPPPASHP-SNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTA 316
PL P + PP + P ++ P +S PA +P AS+
Sbjct: 367 VPRPLSPYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVE 426
Query: 317 PPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPAS 376
P + P + + P + S TAP S + +S P+ P PA+
Sbjct: 427 PAQV--EAKKTRPLSPYARYEDLKPPTSPSPTAPTGV---SPSVSSTSSVPAVPDTAPAT 481
Query: 377 HPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQ 436
++ A PP ++ P + + L P + PS AP P + + K S
Sbjct: 482 AATDAAAPPPANMR----PLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVV-KVGNSA 536
Query: 437 SPISLPDA-----PAATPRGNFHRHSPAIHPSMPGPLPPV 471
P +L D P P + + P+ P P P +
Sbjct: 537 PPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPVL 576
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 3e-05
Identities = 21/82 (25%), Positives = 33/82 (40%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
P S + TA A+ + +AP A A P + + AP P+ A A+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 368 SNPAIPPASHPSNTAIPPASHP 389
+ PA A+ P+ A+ P
Sbjct: 98 APPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 3e-05
Identities = 24/105 (22%), Positives = 36/105 (34%), Gaps = 7/105 (6%)
Query: 239 APPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
APP A+ + PPPA+ P PA+ ++ AP H ++ A P A
Sbjct: 52 APPAAAAPAAAQPPPAAAP-AAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAA 110
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
AP + + A A+ P P A+
Sbjct: 111 PEA--QAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|177614 PHA03377, PHA03377, EBNA-3C; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 3e-05
Identities = 104/482 (21%), Positives = 143/482 (29%), Gaps = 67/482 (13%)
Query: 80 PSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPI 139
PS PS P A P T + PP + APPPS +
Sbjct: 455 PSDQPSVPVEPA----HLTPVEHTTVILHQPPQSPPTVAIKPAPPPSRRRRGACV----V 506
Query: 140 TAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRT 199
++ V+ + TT ++ A P R + A PP PS
Sbjct: 507 YDDDIIEVID----VETTEEEESVTQPAKPHRKVQDGFQR--SGRRQKRATPPKVSPSDR 560
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
PP AS P P T P + PS P P T P + PPAS P++
Sbjct: 561 GPPKASPPV--MAPPSTGPRVMATPS--TGPRDMAPPSTGPRQQAKCK--DGPPASGPHE 614
Query: 260 TSPLPASHPSKTAPPPASH-------PSNTAPPPAS--------HPSKTAPPPASHPSNT 304
P P+S P AP +T P P S S P+S
Sbjct: 615 KQP-PSSAPRDMAPSVVRMFLRERLLEQSTGPKPKSFWEMRAGRDGSGIQQEPSSRRQPA 673
Query: 305 APPPASHPS---NTAPPPASHPSNTAPPPASHPSNTAPP-PASHSSKTAPPPASHPSNTA 360
PS + P+ P SH S+ +P P SH + P + +
Sbjct: 674 TQSTPPRPSWLPSVFVLPSVDAGRAQPSEESHLSSMSPTQPISHEEQPRYEDPDDPLDLS 733
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA-------SHPSNTALTPASHPSN 413
L P P P S A +P P P + +S+P
Sbjct: 734 LHPDQAPPPSHQAPYSGHEEPQAQQAPYPGYWEPRPPQAPYLGYQEPQAQGVQVSSYPGY 793
Query: 414 IAPPPL------------FVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIH 461
P L + P + P + P LP + G+
Sbjct: 794 AGPWGLRAQHPRYRHSWAYWSQYPGHGHPQGPWAPRPPHLPPQWDGSA-GHGQDQVSQFP 852
Query: 462 PSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPD 521
PP Q + P ++ + P +S Q RPI PT P P
Sbjct: 853 HLQSETGPPRLQLSQV--PQLPYSQTLVSSSAPSWSSPQPRAPIRPI-----PTRFPPPP 905
Query: 522 VP 523
+P
Sbjct: 906 MP 907
|
Length = 1000 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 3e-05
Identities = 57/216 (26%), Positives = 97/216 (44%), Gaps = 22/216 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLKRVDQQGGRE---FLAEVEMLSRLHHR 1025
+F+ +++G G FG V L + KV A+K+L + + E F E ++L ++
Sbjct: 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARAL 1082
+ L +E LV + G + + L + E + A + IA+ + L
Sbjct: 62 WITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
Y +HRD K NIL++ + +++DFG M++ + S V GT Y++
Sbjct: 122 HY---------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYIS 171
Query: 1143 PEY--AM---TGHLLVKSDVYSYGVVILELLSGRKP 1173
PE AM G + D +S GV + E+L G P
Sbjct: 172 PEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 4e-05
Identities = 30/124 (24%), Positives = 44/124 (35%), Gaps = 1/124 (0%)
Query: 315 TAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
P P +N+ + A S P +++ S PS P P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPV 434
+ S+ P+S S+T PP P+N + P PP VP L +A P
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPP-PPPVQQVPPLSTAKPTPPSA 264
Query: 435 SQSP 438
S +P
Sbjct: 265 SATP 268
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 4e-05
Identities = 58/280 (20%), Positives = 89/280 (31%), Gaps = 24/280 (8%)
Query: 153 LIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARP-PASHPSRTAPPPASHPSNTA 211
L P L + + S+ PP S+AA P P+ P S P PP
Sbjct: 313 LTPMEELLAKIPSQRVPP--KESDAADGPKPVPTKPVTPEAPSPPIEEEPPQPKAVVPRP 370
Query: 212 LPSKTA------PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPA 265
L TA P+ ++ P +S PA +P AS+ + P
Sbjct: 371 LSPYTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQV 430
Query: 266 SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSN 325
+K P + + P + PS TAP S P S S+ P +
Sbjct: 431 --EAKKTRPLSPYARYEDLKPPTSPSPTAPTGVS-------PSVSSTSSVPAVPDT---- 477
Query: 326 TAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPP 385
P + APPPA+ + P + P P +++
Sbjct: 478 --APATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNS 535
Query: 386 ASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
A + H + P L+P + ++ PP P
Sbjct: 536 APPTALADEQHHAQPKPRPLSPYTMYEDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 4e-05
Identities = 22/116 (18%), Positives = 33/116 (28%), Gaps = 4/116 (3%)
Query: 120 NMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
+APP + P A PPP AP V+ AP+ P L + AA
Sbjct: 50 ALAPPAAAAP--AAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAA 107
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
P A A + + A + + + A +
Sbjct: 108 PAAPEA--QAPAAPAERAAAENAARRLARAAAAAPRPRVPADAAAAVADAVKARIE 161
|
Length = 484 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 47.3 bits (111), Expect = 4e-05
Identities = 53/170 (31%), Positives = 71/170 (41%), Gaps = 25/170 (14%)
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
A A+ AA A+ PS A+ P++ A PA + A + A+ P+
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAK 252
Query: 227 TALPPA---SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
A PPA + P+K A PPA A PPA A+ P+K A PPA
Sbjct: 253 AAAPPAKAAAPPAKAAAPPA----KAAAPPAK--------AAAPPAKAAAPPAK------ 294
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP--PASHPSNTAPPPA 331
A+ P+K A PA + A A APP A+ P+ A PPA
Sbjct: 295 --AAAAPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 4e-05
Identities = 23/93 (24%), Positives = 37/93 (39%), Gaps = 6/93 (6%)
Query: 187 NTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHL 246
+T PA+ P+ AP + ++ TAP+PA P A+ PS+ A
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVA---PSQANVDTA--- 220
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHP 279
+ AP + P +PLP + P +
Sbjct: 221 ATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 4e-05
Identities = 26/127 (20%), Positives = 39/127 (30%), Gaps = 7/127 (5%)
Query: 285 PPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH--PSNTAPPPASHPSNTAPPPA 342
P + P + P+ AP P++ + + P S +AP A+ P+ T P +
Sbjct: 370 SGGRGPKQHIKPVFTQPAA-APQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTPPTVS 428
Query: 343 SHSSKTAP-PPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPS 401
P P S P IP + S P P A+
Sbjct: 429 VDPPAAVPVNPPSTAPQAVRPAQFKEEKK-IPVSKVSSLG--PSTLRPIQEKAEQATGNI 485
Query: 402 NTALTPA 408
A T
Sbjct: 486 KEAPTGT 492
|
Length = 614 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-05
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 1062 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121
ES L + + + A + +L +S +HRD + N+L+ K+ DFGLAR
Sbjct: 232 ESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARD 288
Query: 1122 AMDEESRHISTRVMGTF---GYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
M +S +IS TF ++APE SDV+S+G+++ E+ +
Sbjct: 289 IM-RDSNYISKG--STFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 4e-05
Identities = 46/151 (30%), Positives = 62/151 (41%), Gaps = 17/151 (11%)
Query: 144 LVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARP-PASHPSNTARPPASHPSRTAPP 202
L+N+ P L+P L + AS PS +A PAS + T P + + P
Sbjct: 356 LLNLAMLPRLMPVESL-----RPSGGGASAPSGSAAEGPASGGAATIPTPGTQGPQGTAP 410
Query: 203 PASHPSNTALPSKTAPSPASHPSN--TALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
A ++A P+ APS A P PPA S P PA + +P P +
Sbjct: 411 AAGMTPSSAAPATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGA----- 465
Query: 261 SPLPASHPSKT-APPPASHPSNTAPPPASHP 290
P S S + APP PS+TA S P
Sbjct: 466 ---PDSVASASDAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-05
Identities = 31/133 (23%), Positives = 42/133 (31%), Gaps = 5/133 (3%)
Query: 304 TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPP 363
P P +N+ ++ A S ++P S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 364 ASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV 423
+ S+ PPA + PP S S T P S P A P + P P
Sbjct: 206 SPSDSSL--PPAPSSFQSDTPPPSPESPTNP---SPPPGPAAPPPPPVQQVPPLSTAKPT 260
Query: 424 LPSALPGKAPVSQ 436
PSA AP+
Sbjct: 261 PPSASATPAPIGG 273
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-05
Identities = 56/227 (24%), Positives = 76/227 (33%), Gaps = 26/227 (11%)
Query: 63 PSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSIT-------- 114
P P PP P +P +A D+ PP S IPT P +SP S
Sbjct: 349 PEAPSPPIEEEPPQPKAVVPRPLSP-YTAYEDLKPPTSPIPTPPSSSPASSKSVDAVAKP 407
Query: 115 -APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
P V S +P A PL L P T + + P S
Sbjct: 408 AEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYARYEDLKPPTSPSPTAPTGVSPSVSS 467
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS-------HPSN 226
S+ P + P+ A A+ P P + + L T+PSPA+ +N
Sbjct: 468 TSSVPAVPDTAPATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSSTN 527
Query: 227 TALPPASLPSKTAPPPASHLSNTAPPPASHPYK--------TSPLPA 265
+ + TA H + P P S PY TSP P+
Sbjct: 528 EVVKVGNSAPPTALADEQHHAQPKPRPLS-PYTMYEDLKPPTSPTPS 573
|
Length = 576 |
| >gnl|CDD|217392 pfam03153, TFIIA, Transcription factor IIA, alpha/beta subunit | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 34/223 (15%), Positives = 53/223 (23%), Gaps = 17/223 (7%)
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
PS APPP A P P P A A H++ T P A+ P+ A
Sbjct: 51 PSPQAPPP------VAQLPQPLP-QPPPTQALQAL-PAGDQQQHNTPTGSPAANPPATFA 102
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLF 420
LP +P N A P+ AP
Sbjct: 103 LPAGPAG-PTIQTEPGQLYPVQVPVMVT-QNPANSPLDQPAQQRALQQLQQRYGAPASGQ 160
Query: 421 VPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNR 480
+P + P+ + + + ++R
Sbjct: 161 LPSQQQ--SAQKNDESQLQQQPNGETPPQQTDGAGDDESEALVRLREADGTLEQRIKGAE 218
Query: 481 EAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVP 523
+ + + KS R I + + D
Sbjct: 219 GGGAMKVLK-----QPKKQAKSSKRRTIAQIDGIDSDDEGDGS 256
|
Transcription initiation factor IIA (TFIIA) is a heterotrimer, the three subunits being known as alpha, beta, and gamma, in order of molecular weight. The N and C-terminal domains of the gamma subunit are represented in pfam02268 and pfam02751, respectively. This family represents the precursor that yields both the alpha and beta subunits. The TFIIA heterotrimer is an essential general transcription initiation factor for the expression of genes transcribed by RNA polymerase II. Together with TFIID, TFIIA binds to the promoter region; this is the first step in the formation of a pre-initiation complex (PIC). Binding of the rest of the transcription machinery follows this step. After initiation, the PIC does not completely dissociate from the promoter. Some components, including TFIIA, remain attached and re-initiate a subsequent round of transcription. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 56/231 (24%), Positives = 92/231 (39%), Gaps = 52/231 (22%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+F+ +++G G FG +VAV +K ++ + L + EML R
Sbjct: 2 DFEIIKVIGRGAFG-----------EVAVVKMKHTERIYAMKILNKWEMLKRAE------ 44
Query: 1030 LIGICIEEQARCLVYELIPNGSV------------ESHLH-------GVDKESAPLGWDA 1070
C E+ LV NG E++L+ G D + ++
Sbjct: 45 --TACFREERNVLV-----NGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFED 97
Query: 1071 RLKIALG---AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127
RL + A + +H +HRD K N+LL+ + +++DFG + +
Sbjct: 98 RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT 157
Query: 1128 RHISTRVMGTFGYVAPEY--AM---TGHLLVKSDVYSYGVVILELLSGRKP 1173
S V GT Y++PE AM G + D +S GV + E+L G P
Sbjct: 158 VQSSVAV-GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 6e-05
Identities = 46/277 (16%), Positives = 60/277 (21%), Gaps = 30/277 (10%)
Query: 307 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASH 366
+ P + AS P S P P PP +
Sbjct: 86 SVGPDSDLSQKTSTFSPCQS-GYEASTDPEYIPDLQPDPSLWGTAPKPEPQ----PPQAP 140
Query: 367 PSNPAIPPASHPSNTAIP-PASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
S P + + A P P L P A P P P
Sbjct: 141 ESQPQPQTPAQKMLSLEEVEAQLQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGPPEQP 200
Query: 426 SA---LPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREA 482
P P P AP+ P P P P PL
Sbjct: 201 PGYPQPPQGHPEQVQPQQFLPAPSQAPAQ---PPLPPQLPQQPPPLQQPQF-------PG 250
Query: 483 PIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAE 542
+ P P PP +Q P PT P + P P +
Sbjct: 251 LSQQMPPPPPQPPQQQQQPPQPQAQPPPQNQPTPHPGLPQGQNAPL---------PPPQQ 301
Query: 543 PSYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFS 579
P + P P + + + S
Sbjct: 302 PQLLPLVQQPQGQQR--GPQFREQLVQLSQQQREALS 336
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-05
Identities = 24/98 (24%), Positives = 30/98 (30%), Gaps = 9/98 (9%)
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
P PA P+ + + P PS A+ P TA PP
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRE----TATPP-----P 411
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P P + P P A + A P P T P P
Sbjct: 412 VPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 6e-05
Identities = 21/95 (22%), Positives = 30/95 (31%), Gaps = 1/95 (1%)
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPIT 140
P A A P + PT ++ P A + P T P P P
Sbjct: 359 LLVPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRP-V 417
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
APP+ + + + + K PPA P
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKE 452
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 7e-05
Identities = 29/125 (23%), Positives = 37/125 (29%), Gaps = 7/125 (5%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
LP + A A + AP PA T+ P+ AP + A P
Sbjct: 345 SYGQLPLELAVIEALLVPVPAPQPAK---PTAAAPSPVRPTPAPSTRPKAAAAANIPPKE 401
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
P + P P P P + P P A + A P P T P P K
Sbjct: 402 PVRETATP---PPVP-PRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKAL 457
Query: 350 PPPAS 354
Sbjct: 458 IADGD 462
|
Length = 585 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 7e-05
Identities = 33/156 (21%), Positives = 47/156 (30%), Gaps = 14/156 (8%)
Query: 164 SSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP-------SNTALPSKT 216
SS P +PPS A PPAS + P AS S + AL S +
Sbjct: 639 SSADRKPKTPPSRA--PPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGS 696
Query: 217 APSPASHPSNTALPPASLPSKTAP---PPASHLSNTAPPPASHPYKTSPLPASHPSKTAP 273
AP+P P PP + A P + S L A +
Sbjct: 697 APAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESV-EDASNSELQAVEQ-QATH 754
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
P +P + ++T+ N +
Sbjct: 755 QPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-05
Identities = 25/91 (27%), Positives = 31/91 (34%), Gaps = 15/91 (16%)
Query: 157 TPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKT 216
+P SP K P P P + P PA P PAS P P +
Sbjct: 383 SPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPA-----ELPSPASAP----TPEQQ 433
Query: 217 APSPASHPSNTALPPASLPSKTAPPPASHLS 247
P S P LPP+ P +AP +
Sbjct: 434 PPVARSAP----LPPS--PQASAPRNVASGK 458
|
Length = 620 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-05
Identities = 62/270 (22%), Positives = 103/270 (38%), Gaps = 61/270 (22%)
Query: 975 RILGEGGFGLV-YSGVLDDGTKVAVKVLKRVDQQGGREFL---AEVEMLSRLHHRNLVKL 1030
+ LG G FG V + +D A+K L++ D + AE ++L+ + +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 1031 IGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHED 1088
++ V + IP G + S L V E + A L +A+ + + +
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF---- 122
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLA----------------------------- 1119
IHRD K NIL++ D K++DFGL
Sbjct: 123 -----IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177
Query: 1120 ----------------RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 1163
+ A + R ++ ++GT Y+APE + D +S GV+
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237
Query: 1164 ILELLSGRKPVDMTQPP-GQENLVAWARPL 1192
+ E+L G+ P P Q ++ W L
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINWENTL 267
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 8e-05
Identities = 28/159 (17%), Positives = 42/159 (26%), Gaps = 5/159 (3%)
Query: 61 HAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVN 120
P P P +AP + +P+ PPP + P +P
Sbjct: 364 PLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPPP--ASAPQQAPAVPLPETTSQ 421
Query: 121 -MAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
+A L P S + P + A A A R
Sbjct: 422 LLAARQQLQRAQGATKAKKSEPAAASRARPVNSALERLASVRP-APSALEKAPAKKEAYR 480
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAP 218
A++P + P + P H L +K A
Sbjct: 481 WKATNPVEVKKEPVATPK-ALKKALEHEKTPELAAKLAA 518
|
Length = 647 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 8e-05
Identities = 26/107 (24%), Positives = 31/107 (28%), Gaps = 7/107 (6%)
Query: 283 APPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS--HPSNTAPP 340
P PA P A P A+ PS P PA PS A+ P P P
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIPPKEPVRETATPPPVPPR 415
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
P + P A + A+P P P I
Sbjct: 416 PVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALIADGD 462
|
Length = 585 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 8e-05
Identities = 18/92 (19%), Positives = 27/92 (29%), Gaps = 6/92 (6%)
Query: 309 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPS 368
+ T P PA+ T + TAP PA + A S + +
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPSQAN------VDTAA 221
Query: 369 NPAIPPASHPSNTAIPPASHPSNTAPPHASHP 400
PA + P A P + P +
Sbjct: 222 TPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 9e-05
Identities = 23/110 (20%), Positives = 35/110 (31%), Gaps = 3/110 (2%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
S + APP A+ P+ PPPA+ P+ PA+ +++ AP H
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPA-AVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPP 417
+ A P A A + + A P A
Sbjct: 103 ARAAAPAAPEAQAPA--APAERAAAENAARRLARAAAAAPRPRVPADAAA 150
|
Length = 484 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 9e-05
Identities = 26/121 (21%), Positives = 35/121 (28%), Gaps = 13/121 (10%)
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 326
P P T P A PS A S ++A S AP A+ P+ T
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS-----APQSATQPAGT 423
Query: 327 APPPASHPSNTAP-PPASHSSKTAPPPASHPSNTALPPASHPS------NPAIPPASHPS 379
P + P P P S + + P P + S P A +
Sbjct: 424 PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKI-PVSKVSSLGPSTLRPIQEKAEQAT 482
Query: 380 N 380
Sbjct: 483 G 483
|
Length = 614 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 9e-05
Identities = 46/175 (26%), Positives = 72/175 (41%), Gaps = 15/175 (8%)
Query: 175 SNAARPPASHPSNT--ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPA 232
SNAA+ A SN + P S+P P ++ P N S T P S+P N+ P +
Sbjct: 400 SNAAQSNAGF-SNAGYSNPGNSNPGYNNAPNSNTPYNNPPNSNT---PYSNPPNSNPPYS 455
Query: 233 SLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSK 292
+LP P + LSN PP+S S A++ + A PA++ P ++
Sbjct: 456 NLPYSNTPYSNAPLSNA--PPSSAKDHHSAYHAAYQHRAANQPAAN------LPTANQPA 507
Query: 293 TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSK 347
+ ++ P AS P +A P + + TA P P ++ K
Sbjct: 508 ANNFHGAAGNSVGNPFASRPFGSA-PYGGNAATTADPNGIAKREDHPEGGTNRQK 561
|
Length = 1560 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 9e-05
Identities = 38/214 (17%), Positives = 56/214 (26%), Gaps = 22/214 (10%)
Query: 65 PIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPP 124
P+ P P V+ A ++ V + + P V P
Sbjct: 846 PVVRPQDVQVEEQREAEEVQVQPVVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQ 905
Query: 125 PSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASH 184
P + P I AP V P +A ++ A P P
Sbjct: 906 PEEVVVVETTHPEVIAAP--VTEQPQVITESDVAVAQEVAEHAEPVVEPQ---------- 953
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
A+ + + A P A A + TA+ P P++
Sbjct: 954 DETADIEEAAETAEVVVAEPEVVAQPAAPV-VAEVAAEVETVTAVEPEVAPAQVPEATVE 1012
Query: 245 HLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
H TA P +P P P P S
Sbjct: 1013 HNHATA------PMTRAPAPEYVPE---APRHSD 1037
|
Length = 1068 |
| >gnl|CDD|236138 PRK07994, PRK07994, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-04
Identities = 41/180 (22%), Positives = 52/180 (28%), Gaps = 28/180 (15%)
Query: 353 ASHPSNT-ALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHP 411
A HP+ P S A + A + PP PAS P
Sbjct: 358 AFHPAAPLPEPEVPPQSAAPAASAQATAAPTAAVAPPQAPAVPPP----------PASAP 407
Query: 412 SNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPV 471
PL + + + L A AT + P+ PV
Sbjct: 408 QQAPAVPLPETT--------SQLLAARQQLQRAQGATK-------AKKSEPAAASRARPV 452
Query: 472 --AQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPL 529
A +R AS R AP A AP + +PV P TP A TP L
Sbjct: 453 NSALERLASVRPAPSALEKAPAKKEAYRWKATNPVEVKKEPVATPKALKKALEHEKTPEL 512
|
Length = 647 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 1e-04
Identities = 20/73 (27%), Positives = 31/73 (42%), Gaps = 2/73 (2%)
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPAS--HPSNTAPPPASHSSKTAPPPASHPSNTALPP 363
P + P+ A A+ S A PA+ + PPA+ + P PA+ + A P
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPA 97
Query: 364 ASHPSNPAIPPAS 376
A + A PA+
Sbjct: 98 APPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 1e-04
Identities = 27/107 (25%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
S + APP A+ P+ PPPA+ P+ PA+ + AP H+ +
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPA-AVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 357 SNTALPPASHPSNPAIPPA-----SHPSNTAIPPASHPSNTAPPHAS 398
+ A P A PA P + A A+ P P A+
Sbjct: 103 ARAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (107), Expect = 1e-04
Identities = 49/151 (32%), Positives = 68/151 (45%), Gaps = 15/151 (9%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA---SHPSKTAPPPASHPSNTAP 306
A A+ K + A+ PS A+ P+ A PA + P+K A PA + A
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAK 252
Query: 307 PPASHPSNTAPPP--ASHPSNTAPPP---ASHPSNTAPPPASHSS---KTAPPP---ASH 355
A APP A+ P+ A PP A+ P+ A PPA ++ K A P A+
Sbjct: 253 AAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAAPAKAAAA 312
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
P+ A PPA + PA A+ P+ A PPA
Sbjct: 313 PAKAAAPPAKAAAPPA-KAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (107), Expect = 1e-04
Identities = 54/154 (35%), Positives = 73/154 (47%), Gaps = 26/154 (16%)
Query: 150 APSLIPTTPLASPLSSKAFPP--ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
APS + A+P + A P A+PP+ AA PA + A+ A P++ A PPA
Sbjct: 210 APSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAP-PAKAAAPPAK-- 266
Query: 208 SNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASH 267
A P+K A PA A+ P+K A PPA + AP A+ + A+
Sbjct: 267 -AAAPPAKAAAPPAK--------AAAPPAKAAAPPAK--AAAAPAKAAAAPAKA---AAA 312
Query: 268 PSKTAPPPASHPSNTAPPP---ASHPSKTAPPPA 298
P+K A PPA A PP A+ P+K A PPA
Sbjct: 313 PAKAAAPPA----KAAAPPAKAATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (106), Expect = 1e-04
Identities = 44/132 (33%), Positives = 60/132 (45%), Gaps = 13/132 (9%)
Query: 115 APPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPA--- 171
AP AP + P A+ P A PA + P A+P + A PPA
Sbjct: 221 APAKAAAAPAKAAAPPAKAAAAPAKAAAA-----PAKAAAPPAKAAAPPAKAAAPPAKAA 275
Query: 172 SPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
+PP+ AA PPA + A+ A+ P++ A PA A P+K A PA + A
Sbjct: 276 APPAKAAAPPAKAAAPPAKA-AAAPAKAAAAPAK---AAAAPAKAAAPPAKAAAPPA-KA 330
Query: 232 ASLPSKTAPPPA 243
A+ P+K A PPA
Sbjct: 331 ATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 20/89 (22%), Positives = 28/89 (31%), Gaps = 5/89 (5%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA--SHPSNTA 228
+ PA+ T + TAP PA P A+ APS A + A
Sbjct: 168 TTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAV---VAPSQANVDTAATPA 224
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPASHP 257
+ P AP P + P +
Sbjct: 225 PAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 1e-04
Identities = 25/94 (26%), Positives = 32/94 (34%), Gaps = 9/94 (9%)
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 340
+T PA T P PA+ T + TAP PA P A S +N
Sbjct: 167 STTTDPA-----TTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS-QANVDTA 220
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
+ A P + P T + S PA P
Sbjct: 221 ATPAPAAPATPDGAAPLPTD---QAGVSTPAADP 251
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-04
Identities = 23/99 (23%), Positives = 33/99 (33%), Gaps = 8/99 (8%)
Query: 256 HPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNT 315
P P T P A PS A + PS+++ +AP A+ P+
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSA-AAAASPSPSQSSAAAQP----SAPQSATQPA-G 422
Query: 316 APPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
PP S A P + P +TAP +
Sbjct: 423 TPPTVSVDP-PAAVPVN-PPSTAPQAVRPAQFKEEKKIP 459
|
Length = 614 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-04
Identities = 58/204 (28%), Positives = 90/204 (44%), Gaps = 14/204 (6%)
Query: 975 RILGEGGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVE-MLSRLHHRNLVK 1029
+++G+G FG V K AVKVL++ + ++ + ++E +L + H LV
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L V + I G + HL +E L AR A A AL YLH
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQ---RERCFLEPRARF-YAAEIASALGYLH--- 113
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S +++RD K NILL+ ++DFGL + ++ ++ GT Y+APE
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAPEVLHKQ 171
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
D + G V+ E+L G P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-04
Identities = 40/171 (23%), Positives = 55/171 (32%), Gaps = 31/171 (18%)
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
A P+ A A KT P + A P A+ + A PA P A+ +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEA-----AAPAAAPVAQAAAAPAPAA----APAAAASA 413
Query: 391 NTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT-P 449
APP A+ P+ +A P P+A P AP + + P A AA
Sbjct: 414 PAAPP-----------AAAPPAPVAAPA---AAAPAAAPAAAPAAVALAPAPPAQAAPET 459
Query: 450 RGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQ 500
R +P + P P A A P G +Q
Sbjct: 460 VAIPVRVAPEPAVASAAPAPAAAP-------AAARLTPTEEGDVWHATVQQ 503
|
Length = 618 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-04
Identities = 23/102 (22%), Positives = 34/102 (33%), Gaps = 3/102 (2%)
Query: 61 HAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPS---ITAPP 117
+ A P S + PA + P +A P + P A+ P+ + P
Sbjct: 392 APVAQAAAAPAPAAAPAAAASAPAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAP 451
Query: 118 PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPL 159
P AP IP P +A P PA + + T
Sbjct: 452 PAQAAPETVAIPVRVAPEPAVASAAPAPAAAPAAARLTPTEE 493
|
Length = 618 |
| >gnl|CDD|220392 pfam09770, PAT1, Topoisomerase II-associated protein PAT1 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 2e-04
Identities = 28/161 (17%), Positives = 36/161 (22%), Gaps = 6/161 (3%)
Query: 51 FTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASP 110
+ P LP P P P P + P P
Sbjct: 163 LQQRQQAPQLPQPPQQVLPQGMPPRQAAFPQQGP--PEQPPGYPQPPQGHPEQVQPQQFL 220
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP 170
P+ + P P P +P P P + P P P P PP
Sbjct: 221 PAPSQAPA--QPPLPPQLPQQPPPLQQPQFPGLSQQMPPPPPQPPQQQQQPPQPQAQPPP 278
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTA 211
+ P+ P N PP P
Sbjct: 279 QNQPTPHPGLPQG--QNAPLPPPQQPQLLPLVQQPQGQQRG 317
|
Members of this family are necessary for accurate chromosome transmission during cell division. Length = 804 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 28/73 (38%), Positives = 39/73 (53%), Gaps = 8/73 (10%)
Query: 970 NFDASRILGEGGFGLVYS------GVLDDGTKVAVKVLKRVDQQGGREFL-AEVEMLSRL 1022
N + LG G FG V G D+ +VAVK+LK RE L +E+++LS L
Sbjct: 39 NLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHL 98
Query: 1023 -HHRNLVKLIGIC 1034
H+N+V L+G C
Sbjct: 99 GQHKNIVNLLGAC 111
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 26/133 (19%), Positives = 39/133 (29%), Gaps = 5/133 (3%)
Query: 337 TAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPH 396
P P + +N+ ++PA S P +++ S PS P
Sbjct: 146 EDPNPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPS 205
Query: 397 ASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLP-----DAPAATPRG 451
+ S+ P+S S+ PP P PS PG A P+ P
Sbjct: 206 SPSDSSLPPAPSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVPPLSTAKPTPPSAS 265
Query: 452 NFHRHSPAIHPSM 464
I
Sbjct: 266 ATPAPIGGITLDD 278
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 60/262 (22%), Positives = 89/262 (33%), Gaps = 19/262 (7%)
Query: 114 TAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
TAP + P L+ P PP + P P+ T SP + P P
Sbjct: 310 TAP----LTPMEELLAKIPSQRVPPKESDAADGPKPVPTKPVTPEAPSPPIEEE--PPQP 363
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ RP + + + P + P T PP +S S+ ++ + P+ +
Sbjct: 364 KAVVPRPLSPYTAYEDLKPPTSPIPT-PPSSSPASSKSVDAVAKPAEPDVVPSPGSASNV 422
Query: 234 LPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKT 293
+ A A +P K P + PS TAP S PS ++ T
Sbjct: 423 PEVEPAQVEAKKTRPLSPYARYEDLK----PPTSPSPTAPTGVS-PSVSSTSSVPAVPDT 477
Query: 294 APPPASHPSNTAPPPASHPSNTAP-----PPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
AP A+ + PP P + P + PS AP PS+T +
Sbjct: 478 APATAATDAAAPPPANMRPLSPYAVYDDLKPPTSPSPAAPVGKVAPSST--NEVVKVGNS 535
Query: 349 APPPASHPSNTALPPASHPSNP 370
APP A P P +P
Sbjct: 536 APPTALADEQHHAQPKPRPLSP 557
|
Length = 576 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-04
Identities = 38/208 (18%), Positives = 53/208 (25%), Gaps = 20/208 (9%)
Query: 102 IPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLAS 161
I +P A P+ PP P L P P + P P A
Sbjct: 86 ITVDPSAGEPA-PPPPHARRTSEPEL-PRPGRRPYEGYGGPRADDRPPGLPRQDQLPTAR 143
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTAR----PPASHPSRTAPPPASHPSNTALPSKTA 217
P + A+ P R + R P A + S + P P
Sbjct: 144 P-AYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAP--EQERDREPYDAG 200
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNT--APPPASHPYKTSPLPASHPSKTAPPP 275
P P ++ PP A H ++ P P P
Sbjct: 201 RPEYDQRR----RDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPI 256
Query: 276 ASHPSNTAP-PPASHPSKTAPPPASHPS 302
+AP P A+ P+ P
Sbjct: 257 RP----SAPGPLAAQPAPAPGPGEPTAR 280
|
Length = 617 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 2e-04
Identities = 23/92 (25%), Positives = 34/92 (36%), Gaps = 8/92 (8%)
Query: 172 SPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
P S AA A+ + A + P A P A P+ AP+ P+ A
Sbjct: 37 GPGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAP---APPAAAAPAAPPKPAAAAAAA 93
Query: 232 ASLPSKTAPPPASHLSNTAPPPASHPYKTSPL 263
A+ + A A AP A+ + +PL
Sbjct: 94 AAPAAPPAAAAA-----AAPAAAAVEDEVTPL 120
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 2e-04
Identities = 23/104 (22%), Positives = 33/104 (31%), Gaps = 8/104 (7%)
Query: 185 PSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
P+ A A P AP S P+ A ++ AP H L ++ A P A
Sbjct: 54 PAAAAPAAAQPPPAAAPAAVSRPA--APAAEPAPWLVEHAKRLTAQREQLVARAAAPAAP 111
Query: 245 HLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPAS 288
AP + + A A+ P P A+
Sbjct: 112 --EAQAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 28/99 (28%), Positives = 34/99 (34%), Gaps = 7/99 (7%)
Query: 210 TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS 269
L AP PA P A+ PS P PA A A+ P K + P
Sbjct: 358 ALLVPVPAPQPAK-------PTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPP 410
Query: 270 KTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
P P + P P A ++ A P P T P P
Sbjct: 411 PVPPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (105), Expect = 2e-04
Identities = 47/142 (33%), Positives = 61/142 (42%), Gaps = 26/142 (18%)
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPA---SPPSNAARPPA---SHPSNTARPPAS 194
AP PA + P A+ + A PA +PP+ AA PPA + P+ A PPA
Sbjct: 221 APAKAAAAPAKAAAPPAKAAAAPAKAAAAPAKAAAPPAKAAAPPAKAAAPPAKAAAPPAK 280
Query: 195 HPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPA 254
+ A A A P+K A +PA A+ P+K A PPA A PPA
Sbjct: 281 AAAPPAKAAAPPAKAAAAPAKAAAAPAK--------AAAAPAKAAAPPA----KAAAPPA 328
Query: 255 SHPYKTSPLPASHPSKTAPPPA 276
A+ P+K A PPA
Sbjct: 329 K--------AATPPAKAAAPPA 342
|
Length = 357 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-04
Identities = 21/97 (21%), Positives = 27/97 (27%), Gaps = 6/97 (6%)
Query: 300 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNT 359
P P T P A PS A S ++A S AP A+ P+ T
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS-----APQSATQPAGT 423
Query: 360 ALPPASHPSNPA-IPPASHPSNTAIPPASHPSNTAPP 395
+ P + P S P P
Sbjct: 424 PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-04
Identities = 28/115 (24%), Positives = 34/115 (29%), Gaps = 6/115 (5%)
Query: 64 SPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAP 123
S P P P+ +P A +A +P S P A A P P
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAA-SPSPSQSSAAAQPSAPQS---ATQPAGTPP 425
Query: 124 PPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAA 178
S+ P V PP TAP V S +SS P A
Sbjct: 426 TVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPV--SKVSSLGPSTLRPIQEKA 478
|
Length = 614 |
| >gnl|CDD|184918 PRK14954, PRK14954, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 2e-04
Identities = 19/79 (24%), Positives = 25/79 (31%), Gaps = 4/79 (5%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP----A 232
A P S P P P + P PSPAS P+ PP A
Sbjct: 381 APSPAGSPDVKKKAPEPDLPQPDRHPGPAKPEAPGARPAELPSPASAPTPEQQPPVARSA 440
Query: 233 SLPSKTAPPPASHLSNTAP 251
LP ++++ P
Sbjct: 441 PLPPSPQASAPRNVASGKP 459
|
Length = 620 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-04
Identities = 27/93 (29%), Positives = 34/93 (36%), Gaps = 6/93 (6%)
Query: 225 SNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
S T +PP P + AP P L T H ++ +P P P+ P N A
Sbjct: 168 SGTYIPPN--PPREAPAPG--LPKTFTSSHGHRHRHAPKPTQQPTVQNPAQQPTVQNPAQ 223
Query: 285 PPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
P P + PA P T PA P T
Sbjct: 224 QPQQQPQQQPVQPAQQP--TPQNPAQQPPQTEQ 254
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|217393 pfam03154, Atrophin-1, Atrophin-1 family | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-04
Identities = 83/390 (21%), Positives = 112/390 (28%), Gaps = 34/390 (8%)
Query: 345 SSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTA 404
SS + P P + S++ P PP+ A S P T A P +
Sbjct: 150 SSPSIPSPQDNESDSDSSAQQQLLQPQGPPSIQVPPGAALAPSAPPPTPSAQAVPPQGSP 209
Query: 405 LTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSM 464
+ P P PL + PS P + P P+ P + S S
Sbjct: 210 IAAQPAPQPQQPSPLSLISAPSLHPQRLPSPHPPLQ-PQTASQQSPQPPAPSSRHPQSSH 268
Query: 465 PGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQK-SPVARPIIPGGTPTASPDPDVP 523
GP PP+ P PF S+ P+ P S P
Sbjct: 269 HGPGPPMPHALQQGPVFLQHPSSNPPQPFGLAQSQVPPLPLPSQAQPHSHTPPSQSALQP 328
Query: 524 PSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRH-SNHSPLPPFSSPK 582
P R PS PPP P +HK+ H SP P S
Sbjct: 329 QQPP-------REQPLPPAPSMPHIKPPPTTPIPQLPNQSHKHPPHLQGPSPFPQMPSNL 381
Query: 583 PPQNNGNDTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRK 642
PP P PL+S P H S+ P + P + Q P+ P +
Sbjct: 382 PP------PPALKPLSSLPTHHP-----PSAHPPPLQLMPQS---QPLQSVPAQPPVLTQ 427
Query: 643 RHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPP 702
PP ++ S P S P S LP P + P
Sbjct: 428 SQSLPPKASTHPHSGLHSGPPQSPFAQHPFTSGG----------LPAIGPPPSLPTSTPA 477
Query: 703 PPPNADCSTTICTEPYTNTPPGSPCGCVWP 732
PP A + ++ + G P
Sbjct: 478 APPRASSGSQPPGSALPSSGGCAGPGPPLP 507
|
Atrophin-1 is the protein product of the dentatorubral-pallidoluysian atrophy (DRPLA) gene. DRPLA OMIM:125370 is a progressive neurodegenerative disorder. It is caused by the expansion of a CAG repeat in the DRPLA gene on chromosome 12p. This results in an extended polyglutamine region in atrophin-1, that is thought to confer toxicity to the protein, possibly through altering its interactions with other proteins. The expansion of a CAG repeat is also the underlying defect in six other neurodegenerative disorders, including Huntington's disease. One interaction of expanded polyglutamine repeats that is thought to be pathogenic is that with the short glutamine repeat in the transcriptional coactivator CREB binding protein, CBP. This interaction draws CBP away from its usual nuclear location to the expanded polyglutamine repeat protein aggregates that are characteristic of the polyglutamine neurodegenerative disorders. This interferes with CBP-mediated transcription and causes cytotoxicity. Length = 979 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-04
Identities = 23/133 (17%), Positives = 35/133 (26%), Gaps = 13/133 (9%)
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLP 149
+ S + + S + PP + P P +SP + PP
Sbjct: 161 ADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPP------ 214
Query: 150 APSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSN 209
APS + S P P A PP + P+ P S +
Sbjct: 215 APSSFQSDTPPPSPESPTNPSPPPGPAAPPPPPVQQVP--PLSTAKPT-----PPSASAT 267
Query: 210 TALPSKTAPSPAS 222
A +
Sbjct: 268 PAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-04
Identities = 28/138 (20%), Positives = 34/138 (24%), Gaps = 6/138 (4%)
Query: 102 IPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLAS 161
P P+ N P ++ P V PS S
Sbjct: 149 NPGPPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPS 208
Query: 162 PLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPA 221
S PPA + PP S S S P A PP S P+P
Sbjct: 209 DSSL---PPAPSSFQSDTPPPSPESP---TNPSPPPGPAAPPPPPVQQVPPLSTAKPTPP 262
Query: 222 SHPSNTALPPASLPSKTA 239
S + A A
Sbjct: 263 SASATPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 45.3 bits (108), Expect = 3e-04
Identities = 19/76 (25%), Positives = 28/76 (36%), Gaps = 4/76 (5%)
Query: 213 PSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTA 272
S AP+ A+ + A + P A PPA+ P PA+ + A
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAP----APAPPAAAAPAAPPKPAAAAAAAA 94
Query: 273 PPPASHPSNTAPPPAS 288
P A + A PA+
Sbjct: 95 APAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-04
Identities = 21/105 (20%), Positives = 33/105 (31%), Gaps = 7/105 (6%)
Query: 217 APSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPA 276
AP A+ P+ PPA+ P+ + P A + AP H +
Sbjct: 52 APPAAAAPAAAQPPPAAAPAAVSRPAA-PAAEPAPWLVEHAKR--LTAQREQLVARAAAP 108
Query: 277 SHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
+ P AP + + A A+ P P A+
Sbjct: 109 AAPEAQAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-04
Identities = 26/93 (27%), Positives = 31/93 (33%), Gaps = 7/93 (7%)
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS--HPSNTALP 362
P PA P A P A+ PS P PA PS A+ + P P
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIPPKEPVRETATPPPVPPR 415
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
P + P A + AIP P T P
Sbjct: 416 PVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPA 448
|
Length = 585 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 3e-04
Identities = 20/87 (22%), Positives = 26/87 (29%), Gaps = 6/87 (6%)
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
T P PA+ T + TAP PA P A S + AP
Sbjct: 173 ATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS------QANVDTAATPAPA 226
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHP 334
+ P AP P + P +
Sbjct: 227 APATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 3e-04
Identities = 16/81 (19%), Positives = 24/81 (29%), Gaps = 1/81 (1%)
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
+ T P PA+ T P + P+ P + A +N P+
Sbjct: 168 TTTDPATTPAPAAPVD-TTPTNSQTPAVATAPAPAVDPQQNAVVAPSQANVDTAATPAPA 226
Query: 336 NTAPPPASHSSKTAPPPASHP 356
A P + T S P
Sbjct: 227 APATPDGAAPLPTDQAGVSTP 247
|
Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-04
Identities = 24/104 (23%), Positives = 30/104 (28%), Gaps = 9/104 (8%)
Query: 289 HPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
P P T P A PS A S ++A S AP A+
Sbjct: 369 ASGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAAAQPS-----APQSAT-QPAG 422
Query: 349 APPPASH--PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPS 390
PP S P+ + P S P IP + S
Sbjct: 423 TPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKK-IPVSKVSS 465
|
Length = 614 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-04
Identities = 47/227 (20%), Positives = 72/227 (31%), Gaps = 24/227 (10%)
Query: 150 APSLIPTTPLASPLSSKAFPPAS-------PPSNAARPPASHPSNTARPPASHPSRTAPP 202
A ++I T L SP + A + P + A+ P S A P +TA P
Sbjct: 368 ANAVIENTELQSPSAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMPSEG---KTAGP 424
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSP 262
++ +N P + AP A TA A +K+ S PP + K
Sbjct: 425 VSNQENNDVPPWEDAPDEAQ----TAAGTAQTSAKSI----QTASEAETPPENQVSKNKA 476
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
+ + P+ +P P + ++T A P N PP
Sbjct: 477 ADNETDAPLSEVPSENPIQATPNDEAVETETFAHEAPAE---PFYGYGFPDNDCPP---E 530
Query: 323 PSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
PPP + A + + A +NT P S
Sbjct: 531 DGAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPPPEFST 577
|
Length = 709 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 3e-04
Identities = 50/206 (24%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-----LHEDSS 1090
R + L+ + + H + A +++ G ++L Y +H +
Sbjct: 69 SHADRKVW--LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA 126
Query: 1091 PRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHIS--TRVMGTFGYVAPE 1144
V+HRD K +NIL+ + K++D G AR + + ++ V+ TF Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1145 YAMTGHLLVKS-DVYSYGVVILELLS 1169
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 3e-04
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 17/154 (11%)
Query: 980 GGFGLVYSGVLDDGTKV-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035
G FG VY G + +K+ AVKV+K+ +++ + AE + L+ +V L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74
Query: 1036 EEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
LV E + G V+S LH D+E A +K A AL YLH
Sbjct: 75 SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA-------VKYISEVALALDYLHRHG--- 124
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126
+IHRD K N+L+ ++ K++DFGL++ ++ E
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-04
Identities = 53/254 (20%), Positives = 79/254 (31%), Gaps = 22/254 (8%)
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
PS+ PP S ++ P + P P S P PP P +
Sbjct: 324 PSQRVPPKESDAADGPKPVPTKP--VTPEAPSPPIEEEPPQPKAVVPRPLSPYTAYEDLK 381
Query: 350 PPPASHP-SNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPA 408
PP + P ++ P +S + PA + AS+ P L+P
Sbjct: 382 PPTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPY 441
Query: 409 SHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPA--------- 459
+ ++ PP P P+ + + S ++PD AT + PA
Sbjct: 442 ARYEDLKPPTSPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSPYA 501
Query: 460 -----IHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIP---- 510
P+ P P PV + +S E AP P RP+ P
Sbjct: 502 VYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQHHAQPKPRPLSPYTMY 561
Query: 511 -GGTPTASPDPDVP 523
P SP P
Sbjct: 562 EDLKPPTSPTPSPV 575
|
Length = 576 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-04
Identities = 52/281 (18%), Positives = 74/281 (26%), Gaps = 8/281 (2%)
Query: 221 ASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS 280
A + S AP + P P PA + S
Sbjct: 34 AQSSEAHSFHVDSTKQPPAPEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAP 93
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS---HPSNT 337
+ P+ P + P+ P PS PPPA P P P
Sbjct: 94 PSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQPQPPPQVPQQQQY 153
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
PP + PPP + +P P S+P N +P + P
Sbjct: 154 QSPPQQPQYQQNPPPQ--AQSAPQVSGLYPEESPYQPQSYPPNEPLPSSMAMQ--PPYSG 209
Query: 398 SHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHS 457
+ PS P + P P + P SQ + +GN +
Sbjct: 210 APPSQQFYGPPQPSPYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVA 269
Query: 458 PAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNS 498
P A + P A P++ P G S
Sbjct: 270 SY-APQGSSQSYSTAYPSLPAATVLPQALPMSSAPMSGGGS 309
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-04
Identities = 22/80 (27%), Positives = 30/80 (37%), Gaps = 2/80 (2%)
Query: 263 LPASHPSKTAPPPASHPSN--TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPA 320
AS+ +KT PPP P PP + PP P TA +S+ P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 321 SHPSNTAPPPASHPSNTAPP 340
S P P P+ + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-04
Identities = 20/83 (24%), Positives = 27/83 (32%), Gaps = 2/83 (2%)
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
S +A A P P P PP + PP P TA +S+ P
Sbjct: 514 SGSASNTAKTPPPPQKSPP--PPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 329 PPASHPSNTAPPPASHSSKTAPP 351
+S P P +K + P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 4e-04
Identities = 21/80 (26%), Positives = 29/80 (36%), Gaps = 2/80 (2%)
Query: 285 PPASHPSKTAPPPASHPSN--TAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
AS+ +KT PPP P PP + PP P TA +S+ P +
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIPADS 574
Query: 343 SHSSKTAPPPASHPSNTALP 362
S P P+ + P
Sbjct: 575 SPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 4e-04
Identities = 22/107 (20%), Positives = 35/107 (32%), Gaps = 8/107 (7%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
P + P + P+ PS A + + PS ++ +AP A+ + T
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPS-AAAAASPSPSQSSAAAQP----SAPQSATQPAGTP 424
Query: 251 PPPASHPYKTSPL-PASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
P + P P+ P S + P P S S P
Sbjct: 425 PTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEK--KIPVSKVSSLGPS 469
|
Length = 614 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 44.3 bits (104), Expect = 4e-04
Identities = 29/119 (24%), Positives = 46/119 (38%), Gaps = 10/119 (8%)
Query: 130 TTPVASPPPITA-------PPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPA 182
T PVA+ P +A P +P+P++IP++ ++ + S P
Sbjct: 298 TVPVAAVTPSSAVTQSSAITPSSAAIPSPAVIPSSVTTQSATTTQASAVALSSAGVLPSD 357
Query: 183 SHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
T PA+ P P P S + S A+ P+ T+LP A P+ P
Sbjct: 358 VTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPT-TSLPAA--PASNIPV 413
|
Length = 421 |
| >gnl|CDD|237057 PRK12323, PRK12323, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 5e-04
Identities = 38/200 (19%), Positives = 54/200 (27%), Gaps = 12/200 (6%)
Query: 406 TPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMP 465
T A+ P P P + P P + + A A R SPA
Sbjct: 376 TAAAAPVAQPAPAAAAPAAAAPAPAAPPAAPAAAPAAAAAARAVAAAPARRSPA------ 429
Query: 466 GPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPS 525
+A R AS R A AP P + + A P A+P P +
Sbjct: 430 --PEALAAARQASARGPGGAPAPAPAPAAAPAAAARPAAAGPRPVAAAAAAAPARAAPAA 487
Query: 526 TPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAP-STHKYMRHSNHSPLPPFSSPKPP 584
P + D P E + P P + A + P F + P
Sbjct: 488 APAPADDDP---PPWEELPPEFASPAPAQPDAAPAGWVAESIPDPATADPDDAFETLAPA 544
Query: 585 QNNGNDTPVSSPLASFPKHR 604
++ R
Sbjct: 545 PAAAPAPRAAAATEPVVAPR 564
|
Length = 700 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 5e-04
Identities = 28/117 (23%), Positives = 39/117 (33%), Gaps = 4/117 (3%)
Query: 130 TTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTA 189
P A+ P A + P A ++ PA P+ A PP+ + A
Sbjct: 392 GAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAP-QPAPAPAPAPAPPSPAGNAPA 450
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTA---PSPASHPSNTALPPASLPSKTAPPPA 243
S P AP P+ A P TA P+P + P+ A P A
Sbjct: 451 GGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAAPAAPAAPAAPAGAD 507
|
Length = 824 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 5e-04
Identities = 57/270 (21%), Positives = 82/270 (30%), Gaps = 10/270 (3%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
AP + + P + + P PA +P S P P PS P V
Sbjct: 52 APEQVAKHELADAPLQQVNAALPPAPAPQSPQPDQQQQSQAP--PSHQYPSQLPPQQVQS 109
Query: 122 APPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPP 181
P P PP PP A P P P + P P PP
Sbjct: 110 VPQQPTPQQEPYYPPPSQPQPPPAQQPQAQQ--PQPPPQVPQQQQYQSPPQQPQYQQNPP 167
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
S + +P + P S+P N LPS A P P + A P P
Sbjct: 168 PQAQS-APQVSGLYPEESPYQPQSYPPNEPLPSSMAMQP---PYSGAPPSQQFYGPPQPS 223
Query: 242 PASHLSNTAPPPASHPYKTSPLPA--SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPAS 299
P + P + P P P+ + PP S ++ + + + +
Sbjct: 224 PYMYGGPGGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTA 283
Query: 300 HPSNTAPPPASHPSNTAPPPASHPSNTAPP 329
+PS A + P S + +P
Sbjct: 284 YPSLPAATVLPQALPMSSAPMSGGGSGSPQ 313
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 20/104 (19%), Positives = 28/104 (26%), Gaps = 17/104 (16%)
Query: 209 NTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHP 268
+T T P+PA+ T + TAP PA A S
Sbjct: 167 STTTDPATTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVAPS------------- 213
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
+ AP + P AP P + P +
Sbjct: 214 ----QANVDTAATPAPAAPATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|236776 PRK10856, PRK10856, cytoskeletal protein RodZ; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 5e-04
Identities = 22/86 (25%), Positives = 31/86 (36%), Gaps = 6/86 (6%)
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
T P PA+ + T + T+P PA P + A PS A+ P AP
Sbjct: 174 TTPAPAAPVDTTPTNSQTPAVATAPAPAVDPQQNAVVA---PSQANVDTAATP---APAA 227
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHP 323
+ P AP P + P +
Sbjct: 228 PATPDGAAPLPTDQAGVSTPAADPNA 253
|
Length = 331 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 5e-04
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 16/161 (9%)
Query: 1015 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG------VDKESAPLGW 1068
E+ L RL+H N++K IEE R + + L+ D + PL
Sbjct: 213 EILALGRLNHENILK-----IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLK 267
Query: 1069 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128
R I A+ Y+H ++IHRD K NI L D + DFG A ++E
Sbjct: 268 QTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTA-MPFEKERE 322
Query: 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS 1169
+GT +PE +D++S G+++L++LS
Sbjct: 323 AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 45/180 (25%), Positives = 69/180 (38%), Gaps = 26/180 (14%)
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALA 1083
N+V L + E + LV + G + SH+ E W A + +AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
LH + ++ RD +NILL+ +++ F D + Y AP
Sbjct: 101 -LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----YCAP 151
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAW----ARPLLT 1194
E D +S G ++ ELL+G+ V+ P G N+ W AR LL
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLVE-CHPSGINTHTTLNIPEWVSEEARSLLQ 210
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|223039 PHA03307, PHA03307, transcriptional regulator ICP4; Provisional | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 6e-04
Identities = 39/191 (20%), Positives = 54/191 (28%), Gaps = 3/191 (1%)
Query: 142 PPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAP 201
P LV A +L P + + PP + RP S A AS +
Sbjct: 761 PSLVPAKLAEALALLEPAEPQRGAGSSPPVRAEAAFRRPGRLRRSGPAADAASRTASKRK 820
Query: 202 PPASHPSNTALPS--KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH-PY 258
+ P + S P A+ P +S A + N P P
Sbjct: 821 SRSHTPDGGSESSGPARPPGAAARPPPARSSESSKSKPAAAGGRARGKNGRRRPRPPEPR 880
Query: 259 KTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP 318
A + A PPA P+ P PP P +T P
Sbjct: 881 ARPGAAAPPKAAAAAPPAGAPAPRPRPAPRVKLGPMPPGGPDPRGGFRRVPPGDLHTPAP 940
Query: 319 PASHPSNTAPP 329
A+ + PP
Sbjct: 941 SAAALAAYCPP 951
|
Length = 1352 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 6e-04
Identities = 45/242 (18%), Positives = 76/242 (31%), Gaps = 18/242 (7%)
Query: 62 APSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNM 121
A SP S + SA PT+ PS + P +
Sbjct: 552 ATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQHGTGSSPTSQQPGIPSSSHSTPRS- 610
Query: 122 APPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPP 181
S T + S P + P+ SP P S + P
Sbjct: 611 ---NSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPG-----PGPGTTSQVSGPG 662
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
S S + P H + P P N PS + + P+ T+ + +
Sbjct: 663 NS--STSRYPGEVHVTEGMPNP-----NATSPSAPSGQKTAVPTVTSTGGKANSTTKETS 715
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHP--SNTAPPPASHPSKTAPPPAS 299
++ +++T+P ++T+P A+ + P + T+PP + + PP
Sbjct: 716 GSTLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVPPTQ 775
Query: 300 HP 301
HP
Sbjct: 776 HP 777
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|218439 pfam05109, Herpes_BLLF1, Herpes virus major outer envelope glycoprotein (BLLF1) | Back alignment and domain information |
|---|
Score = 44.0 bits (103), Expect = 6e-04
Identities = 67/356 (18%), Positives = 118/356 (33%), Gaps = 19/356 (5%)
Query: 196 PSRTAPPPASHPSNTALPSKTA--PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
P T + P KT P+ S P + P S T+ P S+T P
Sbjct: 426 PDTTKSVIFVYTLVHVEPHKTTAVPTTPSLPPASTGPTVSTADPTSGTPTGTTSSTLPED 485
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
S +T+ + S T + ++ S P T +
Sbjct: 486 TSPTSRTTSATPNATSPTPAVTTPNATSPTTQKTSDTPNATSPTPIVIGVTTTATSPPTG 545
Query: 314 NTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP 373
T+ P A+ P T P ++ + A +A H T P S P IP
Sbjct: 546 TTSVPNATSPQVTEESPVNNTNTPVVTSAPSVLTSAVTTGQH--GTGSSPTS--QQPGIP 601
Query: 374 PASHPSNTAIPPASHPSNTAPPHASHPSN----TALTPAS----HPSNIAPPPLFVPVLP 425
+SH + P ++ S T ++HP+ T TP+ H S ++P P
Sbjct: 602 SSSHST----PRSNSTSTTPLLTSAHPTGGENITEETPSVPSTTHVSTLSPGPGPGTTSQ 657
Query: 426 SALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIA 485
+ PG + S+ P + +P+ + + K N++ +E +
Sbjct: 658 VSGPGNSSTSRYPGEVHVTEGMPNPNATSPSAPSGQKTAVPTVTSTGGKANSTTKETSGS 717
Query: 486 EPIAPG-PFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPV 540
+A P + + +P + ++ P ++PP++ V P
Sbjct: 718 TLMASTSPHTNEGAFRTTPYNATTYLPPSTSSKLRPRWTFTSPPVTTKQATVPVPP 773
|
This family consists of the BLLF1 viral late glycoprotein, also termed gp350/220. It is the most abundantly expressed glycoprotein in the viral envelope of the Herpesviruses and is the major antigen responsible for stimulating the production of neutralising antibodies in vivo. Length = 830 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 6e-04
Identities = 27/121 (22%), Positives = 39/121 (32%), Gaps = 4/121 (3%)
Query: 319 PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHP 378
S + APP A+ P+ PPPA + PA+ + A H
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPA-AAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLV 102
Query: 379 SNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSP 438
+ A P A A P + A + + AP P V A A ++
Sbjct: 103 ARAAAPAAPEAQAPAAPAERAAAENAARRLARAAAAAPRP---RVPADAAAAVADAVKAR 159
Query: 439 I 439
I
Sbjct: 160 I 160
|
Length = 484 |
| >gnl|CDD|185594 PTZ00395, PTZ00395, Sec24-related protein; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-04
Identities = 32/142 (22%), Positives = 60/142 (42%), Gaps = 13/142 (9%)
Query: 219 SPASHPSNTALPPASLPSKTAP---PPASHLSNTAPPPASHPYKTSPL---PASHPSKTA 272
+ S+P N+ + P+ P PP S+ + PP ++ PY P P S+ +
Sbjct: 412 AGYSNPGNSNPGYNNAPNSNTPYNNPPNSNTPYSNPPNSNPPYSNLPYSNTPYSNAPLSN 471
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
PP+S + + A++ + A PA++ P ++ + ++ P AS
Sbjct: 472 APPSSAKDHHSAYHAAYQHRAANQPAANL------PTANQPAANNFHGAAGNSVGNPFAS 525
Query: 333 HPSNTAPPPASHSSKTAPPPAS 354
P +A P +++ TA P
Sbjct: 526 RPFGSA-PYGGNAATTADPNGI 546
|
Length = 1560 |
| >gnl|CDD|236333 PRK08691, PRK08691, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 6e-04
Identities = 48/232 (20%), Positives = 64/232 (27%), Gaps = 18/232 (7%)
Query: 167 AFPPASPPS---NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH 223
AF P + S NA S +A+ + P P P +TA + A
Sbjct: 357 AFAPLAAASCDANAVIENTELQSPSAQTAEKETAAKKPQPRPEAETAQTPVQTASAAAMP 416
Query: 224 PSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA 283
P S PP AP A T+ A TA + P N
Sbjct: 417 SEGKTAGPVSNQENNDVPPWE----DAPDEAQTAAGTAQTSAKSIQ-TASEAETPPENQV 471
Query: 284 PPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA----SHPSNTAP 339
+ ++T P + PS P N ++ AP P N P
Sbjct: 472 SKNKAADNETDAPLSEVPS---ENPIQATPNDEAVETETFAHEAPAEPFYGYGFPDNDCP 528
Query: 340 PPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
P PPP + A A +NT P S
Sbjct: 529 P---EDGAEIPPPDWEHAAPADTAGGGADEEAEAGGIGGNNTPSAPPPEFST 577
|
Length = 709 |
| >gnl|CDD|114270 pfam05539, Pneumo_att_G, Pneumovirinae attachment membrane glycoprotein G | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 6e-04
Identities = 41/169 (24%), Positives = 55/169 (32%), Gaps = 13/169 (7%)
Query: 240 PPPASHLSNTAPPPA--SHP-YKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
P A S T P SHP Y + P S P+ A+ + T
Sbjct: 168 PKTAVTTSKTTSWPTEVSHPTYPSQVTPQSQPATQGHQTATANQRLSSTEPVGTQGTTTS 227
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
P PP PS + P S S +T H+ + PPA
Sbjct: 228 SNPEPQTEPPPSQRGPSGSPQHPPSTT--------SQDQSTTGDGQEHTQRRKTPPA--T 277
Query: 357 SNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTAL 405
SN P ++ P T P A+ S ++PPH+S P A
Sbjct: 278 SNRRSPHSTATPPPTTKRQETGRPTPRPTATTQSGSSPPHSSPPGVQAN 326
|
Length = 408 |
| >gnl|CDD|217835 pfam03999, MAP65_ASE1, Microtubule associated protein (MAP65/ASE1 family) | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-04
Identities = 28/201 (13%), Positives = 48/201 (23%), Gaps = 26/201 (12%)
Query: 179 RPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS-K 237
R + + PP S S + PS + N SL
Sbjct: 437 RQEKQRAKARKKLANKTSTVMEPPYGSTES----SVPSTPSTRRNDRNITSNTPSLKRTP 492
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS-NTAPPPASHPSKTAPP 296
+ + ++ P + P AS S ++ +
Sbjct: 493 NLTKSSLSQEASLISKSTGNTHKHSTPRRLTTLPKLPAASRSSKGNLIRSGANGNA---- 548
Query: 297 PASHPSNTAPPPAS----HPSNTAPP--PASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
S+ P S P ++ P AS P+++ K
Sbjct: 549 -----SSDLSSPGSINSKSPEHSVPLVRVFDIHLR-----ASTTKGRHSTPSTNEKKKRL 598
Query: 351 PPASHPSNTALPPASHPSNPA 371
S S A+ P +
Sbjct: 599 LKRSPLSPPKESVATTPRLNS 619
|
Length = 619 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 7e-04
Identities = 27/104 (25%), Positives = 36/104 (34%), Gaps = 9/104 (8%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
P PA P A P A+ PS P PA PS A+ P + T PP
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPA--PSTRPKAAAAANIPPKEPVRE--TATPPPVP 413
Query: 354 SHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
P +P S P + A+ P + P + P+
Sbjct: 414 PRPVAPPVPHTP-ESAPKLTRAAIPVDEK-PKYTPPAPPKEEEK 455
|
Length = 585 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 7e-04
Identities = 39/140 (27%), Positives = 51/140 (36%), Gaps = 14/140 (10%)
Query: 262 PLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
P+ + PS S + A PAS + T P P + P A ++A P
Sbjct: 367 PVESLRPSGGGASAPS--GSAAEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATP 424
Query: 322 HPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNT 381
PS A P P + APP S P P + +P A P S S +
Sbjct: 425 APS--AAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGA---------PDSVASAS 473
Query: 382 AIPPA-SHPSNTAPPHASHP 400
PP PS+TA S P
Sbjct: 474 DAPPTLGDPSDTAEHTPSGP 493
|
Length = 624 |
| >gnl|CDD|237182 PRK12727, PRK12727, flagellar biosynthesis regulator FlhF; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 7e-04
Identities = 45/214 (21%), Positives = 66/214 (30%), Gaps = 19/214 (8%)
Query: 128 IPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSN 187
P T A P P P P + + + A+ + A+ AA
Sbjct: 62 TPATAAA-PAPAPQAPTKPAAPVHAPLKLSANANMSQRQRVASAAEDMIAAM-------- 112
Query: 188 TARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLS 247
R P S P PA+ P A + PSPA+ A + P + A
Sbjct: 113 ALRQPVSVP---RQAPAAAPVRAA----SIPSPAAQALAHAAAVRTAPRQEHALSAVPEQ 165
Query: 248 NTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP 307
A + P +P+ A + AP PA + A + + A P
Sbjct: 166 LFADFLTTAPVPRAPVQAPVVAAPAPVPAIAAALAAHAAYAQDDDEQLDDDGFDLDDALP 225
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
P A P + AP + + AP P
Sbjct: 226 QILPP---AALPPIVVAPAAPAALAAVAAAAPAP 256
|
Length = 559 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 8e-04
Identities = 29/120 (24%), Positives = 43/120 (35%), Gaps = 5/120 (4%)
Query: 96 APPPSLIPTNPVASPPSITAPP----PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAP 151
A P+ + A+ P+ P P A P P +P P APP
Sbjct: 391 AGAPAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQPAPAPAPAPAPPSPAGNAPA 450
Query: 152 SLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTA 211
P+ P A+ S++ P + PA P P A+ P+ A P A ++ A
Sbjct: 451 GGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPPAAPAPAAA-PAAPAAPAAPAGADDA 509
|
Length = 824 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 8e-04
Identities = 22/89 (24%), Positives = 34/89 (38%), Gaps = 7/89 (7%)
Query: 319 PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHP 378
P S + TA A+ + +AP A + A P + PPA+ PA+
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPA-------PPAAAAPAAPPKPAAAA 90
Query: 379 SNTAIPPASHPSNTAPPHASHPSNTALTP 407
+ A P A + A A+ +TP
Sbjct: 91 AAAAAPAAPPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 8e-04
Identities = 34/111 (30%), Positives = 43/111 (38%), Gaps = 10/111 (9%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPA 309
A PAS T P P + + P A ++A P PS A P P + APP
Sbjct: 386 AEGPASGGAATIPTPGTQGPQGTAPAAGMTPSSAAPATPAPS--AAPSPRVPWDDAPP-- 441
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
APP + P AP P + S+ APP PS+TA
Sbjct: 442 ------APPRSGIPPRPAPRMPEASPVPGAPDSVASASDAPPTLGDPSDTA 486
|
Length = 624 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 8e-04
Identities = 27/87 (31%), Positives = 43/87 (49%), Gaps = 6/87 (6%)
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY--AM-- 1147
+HRD K N+LL+ + +++DFG + + S +GT Y++PE AM
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLR-LLADGTVQSNVAVGTPDYISPEILQAMED 180
Query: 1148 -TGHLLVKSDVYSYGVVILELLSGRKP 1173
G + D +S GV + E+L G P
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 9e-04
Identities = 20/101 (19%), Positives = 31/101 (30%), Gaps = 11/101 (10%)
Query: 219 SPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASH 278
S P P + P+ P A+ ++ +P +S +AP A+
Sbjct: 370 SGGRGPKQHIKPVFTQPAAAPQPSAAAAASPSPSQSSAA----------AQPSAPQSATQ 419
Query: 279 PSNTAPPPASHPSKTAP-PPASHPSNTAPPPASHPSNTAPP 318
P+ T P + P P P S P P
Sbjct: 420 PAGTPPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|235906 PRK07003, PRK07003, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.001
Identities = 60/359 (16%), Positives = 94/359 (26%), Gaps = 35/359 (9%)
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
A P P + + A+ + PA + + A A
Sbjct: 361 AVTGGGAPGGGVPARVAGAVPAPGARAAAAVGASAVPAVTA--VTGAAGAALAPKAAAAA 418
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPA 446
+ APP A P TA AP +P+ +A P
Sbjct: 419 AATRAEAPPAAPAPPATADRGDDAADGDAP-------VPAKANARASADSRCDERDAQPP 471
Query: 447 ATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVAR 506
A A P+ P + + + P P + ++ A
Sbjct: 472 ADSG-------SASAPASDAPPDAAFEPAPRAAAPSAATPAAVPDARAPAAASREDAPAA 524
Query: 507 PIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKY 566
A P P+ P TP + R G A + D+ + S +
Sbjct: 525 A--------APPAPEARPPTPAAAAPAARAGGAAA--ALDVLRNAGMRVSSDRGARAAAA 574
Query: 567 MRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSI 626
+ + P + V +P A N A + +
Sbjct: 575 AKPAAAPAAAPKPAAPRVA-----VQVPTPRARAATGDAPPNGAARAEQAAESRGAPPPW 629
Query: 627 HQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELP 685
P P ++P S +G P V P P V RV P+ +P LP
Sbjct: 630 EDIP--PDDYVPLSADEGFGGPDDGFV-PVFDSGPDDV-RVAPKPADAPAPPVDTRPLP 684
|
Length = 830 |
| >gnl|CDD|236090 PRK07764, PRK07764, DNA polymerase III subunits gamma and tau; Validated | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 0.001
Identities = 31/121 (25%), Positives = 42/121 (34%), Gaps = 5/121 (4%)
Query: 80 PSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPI 139
P+ + + A +AP P + P A P+ P P A P
Sbjct: 394 PAAAAPSAAAAAPAAAPAPAAAAPAAAAAPAPAAAPQP---APAPAPAPAPPSPAGNAPA 450
Query: 140 TAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRT 199
P APS P A+ A P +PP AA PA+ P+ A P A +
Sbjct: 451 GGAPSPPPAAAPSAQPAPAPAAAPEPTAAPAPAPP--AAPAPAAAPAAPAAPAAPAGADD 508
Query: 200 A 200
A
Sbjct: 509 A 509
|
Length = 824 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.001
Identities = 26/125 (20%), Positives = 40/125 (32%), Gaps = 4/125 (3%)
Query: 63 PSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMA 122
P E + N + P A A + PPS P P P P + +
Sbjct: 152 PPLDEEDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSS 211
Query: 123 PPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPA 182
PP+ P++ + PP + N P P P P P+ + P+ +
Sbjct: 212 LPPA--PSSFQSDTPPPSPESPTNPSPPPG--PAAPPPPPVQQVPPLSTAKPTPPSASAT 267
Query: 183 SHPSN 187
P
Sbjct: 268 PAPIG 272
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237605 PRK14086, dnaA, chromosomal replication initiation protein; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 38/201 (18%), Positives = 51/201 (25%), Gaps = 10/201 (4%)
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHP 400
S+ PP H T+ P P P PP + P + P
Sbjct: 87 TVDPSAGEPAPPPPHARRTSEPELPRPGRRPYEGYGGPRADDRPPGLPRQDQLP--TARP 144
Query: 401 SNTALTPASHPSNIAPPPLFVPV------LPSALPGKAPVSQSPISLPDA-PAATPRGNF 453
+ A P P P +P S +P D P R +
Sbjct: 145 AYPAYQQRPEPGAWPRAADDYGWQQQRLGFPPRAPYASPASYAPEQERDREPYDAGRPEY 204
Query: 454 HRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGT 513
+ P P + + GP PP RP P G
Sbjct: 205 DQRRRDYDHPRPDWDRPRRDRTDRPEPPPGAGHVHRGGPGPPERDDAPVVPIRPSAP-GP 263
Query: 514 PTASPDPDVPPSTPPLSVDGK 534
A P P P P ++ K
Sbjct: 264 LAAQPAPAPGPGEPTARLNPK 284
|
Length = 617 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 0.001
Identities = 17/86 (19%), Positives = 31/86 (36%)
Query: 210 TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPS 269
+ + TA + A+ + +A A A P + + AP P + A+ +
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 270 KTAPPPASHPSNTAPPPASHPSKTAP 295
A A+ P+ A P + A
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 11/93 (11%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
P S + TA A+ + +A + A + P PPA+ P PA+ + A
Sbjct: 38 PGSTAAPTAAAAAAAAAASAPAAAPAAKAPAAP--APAPPAAAAPAAPPKPAAAAAAAAA 95
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P A P + + AP A+ P
Sbjct: 96 PAA---------PPAAAAAAAPAAAAVEDEVTP 119
|
Length = 1228 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 0.001
Identities = 45/249 (18%), Positives = 78/249 (31%), Gaps = 13/249 (5%)
Query: 116 PPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
VN A PP+ P +P + P + P+ + P PP
Sbjct: 66 LQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPP 125
Query: 176 NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASL- 234
+ +PP A+ P + + P + P + P + P S
Sbjct: 126 SQPQPP------PAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGL 179
Query: 235 -PSKTAPPPASHLSNTAPPPA---SHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
P ++ P S+ N P + PY +P P P + P + P
Sbjct: 180 YPEESPYQPQSYPPNEPLPSSMAMQPPYSGAPPSQQFYGPPQPSPYMYGGPGGRPNSGFP 239
Query: 291 SKTAPPPA--SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKT 348
S PPP+ + PP S ++ + + ++ ++PS A +
Sbjct: 240 SGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAATVLPQALPM 299
Query: 349 APPPASHPS 357
+ P S
Sbjct: 300 SSAPMSGGG 308
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 23/110 (20%), Positives = 33/110 (30%), Gaps = 6/110 (5%)
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPA--SHPYKT 260
S + A P+ AP+ A P A S P+ A PA L A
Sbjct: 44 ADSDLAALAPPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVA 103
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPAS 310
+ P AP + + + A A+ P P A+
Sbjct: 104 RAAAPAAPEAQAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 0.001
Identities = 20/103 (19%), Positives = 31/103 (30%), Gaps = 6/103 (5%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
PPA+ A PP + PA+ + +P H + + A P A
Sbjct: 53 PPAAAAPAAAQPPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAAAPAAPE 112
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
AP + + A A+ P P A+
Sbjct: 113 A--QAPAAPAERAAAENAAR----RLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 17/88 (19%), Positives = 25/88 (28%), Gaps = 5/88 (5%)
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
S + ++ + T P S P P A A+ + P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSA-----PKTKQAATTPSPPPAKASPPI 415
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPP 363
P S A+ P + L
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPSLNLEE 443
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 23/86 (26%), Positives = 34/86 (39%), Gaps = 4/86 (4%)
Query: 274 PPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
AS+ + T PPP P AP P P A P+ PPP + +++ P
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTP---PLPQPTATAPPPTPPPPPPTATQASSNAPAQI- 570
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNT 359
P++++PPP T P
Sbjct: 571 PADSSPPPPIPEEPTPSPTKDSSPEE 596
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (102), Expect = 0.001
Identities = 21/82 (25%), Positives = 28/82 (34%), Gaps = 1/82 (1%)
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
L S ++ + T P S P P A A P+ P A PP
Sbjct: 359 LLPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSP-PPAKASPPIPV 417
Query: 323 PSNTAPPPASHPSNTAPPPASH 344
P+ P + P+N A P S
Sbjct: 418 PAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|218056 pfam04388, Hamartin, Hamartin protein | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 0.001
Identities = 37/139 (26%), Positives = 48/139 (34%), Gaps = 6/139 (4%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
S ++A P +S PP S P NT+ + S NT A+
Sbjct: 274 YSFSRSSAYPNSSPRQAL-PPSISLPQNTSTSGSLHSAQTSRRPNTTFDKAASSGTKDSL 332
Query: 242 -PASHLSNTAPPPASHPYKTSPLPA--SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
S L A PP+S L SH S AP P S PS T+PPP
Sbjct: 333 WSPSSLCGMATPPSSIGMSPLILSLSPSHLSGRAPGTTG-SGKGEPASESTPS-TSPPPP 390
Query: 299 SHPSNTAPPPASHPSNTAP 317
+ + S +AP
Sbjct: 391 GLADDIVRAIFATSSRSAP 409
|
This family includes the hamartin protein which is thought to function as a tumour suppressor. The hamartin protein interacts with the tuberin protein pfam03542. Tuberous sclerosis complex (TSC) is an autosomal dominant disorder and is characterized by the presence of hamartomas in many organs, such as brain, skin, heart, lung, and kidney. It is caused by mutation either TSC1 or TSC2 tumour suppressor gene. TSC1 encodes a protein, hamartin, containing two coiled-coil regions, which have been shown to mediate binding to tuberin. The TSC2 gene codes for tuberin pfam03542. These two proteins function within the same pathway(s) regulating cell cycle, cell growth, adhesion, and vesicular trafficking. Length = 667 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 64/308 (20%), Positives = 89/308 (28%), Gaps = 17/308 (5%)
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLV--NVLPAPSLIPTTPLASPLSSKAF 168
PS++ PV+ P PS P SP PL L + + L S +
Sbjct: 151 PSLSNSRPVHELPKPSTPVLQPRRSPRKQLHRPLSLPRSLHLHNSRQHSSLHPRRSPRRQ 210
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPP-ASHPSNTALPSKTAPSPASHPSNT 227
+P HP + +P P P P H + + P S P +
Sbjct: 211 LQPAPRRPLLAENQLHPLPSPQPVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSP 270
Query: 228 ALPPASLP-----SKTAPPPASHLSNTAPPPASHPYKTSPLPAS-HPSKTAPPP------ 275
P++ + HL P P H S+ P
Sbjct: 271 LPRPSTRRGLLPNPRLPRASRGHLPPPTSSAPPRPNGGLRRPLHLHSSRPNSPNLRPRRI 330
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH--PSNTAPPPASHPSNTAPPPASH 333
+ H P S PP PP TA P
Sbjct: 331 RKNSLQQTRARLGHSKSLGQSPNLRSSQLPPPTKRRLRLLPVPPPKVQALPLTALAPLVR 390
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
S + P P S+ + AS + LPP+ P P+ PS P + P +
Sbjct: 391 HSPSIPLPHPPSALPSHVGASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPAS 450
Query: 394 PPHASHPS 401
PP S PS
Sbjct: 451 PPTPSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.001
Identities = 24/122 (19%), Positives = 36/122 (29%), Gaps = 2/122 (1%)
Query: 442 PDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQK 501
A H++ P + P PV Q A P P P P +
Sbjct: 78 AQEHEAARPSPQHQYQPPYASAQPRQ--PVQQPPEAQVPPQHAPRPAQPAPQPVQQPAYQ 135
Query: 502 SPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAP 561
+P+ +P +P P S P + + +PVA P + P K
Sbjct: 136 PQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVMDKPKRK 195
Query: 562 ST 563
Sbjct: 196 EA 197
|
Length = 333 |
| >gnl|CDD|222997 PHA03132, PHA03132, thymidine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 0.001
Identities = 27/135 (20%), Positives = 44/135 (32%), Gaps = 9/135 (6%)
Query: 240 PPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP-----SKTA 294
PP S S Y P P P +T P S P++ PP P + A
Sbjct: 55 YPPRETGSGGGVAT-STIYTV-PRPPRGPEQTLDKPDSLPASRELPPGPTPVPPGGFRGA 112
Query: 295 PPPASHPSNTAPPPASHPSNTA-PPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
P +T+P + P ++++ + ++ PPP+ S K
Sbjct: 113 SSPRLGADSTSPRFLYQVNFPVILAPIGESNSSSEELSEEEEHSRPPPSE-SLKVKNGGK 171
Query: 354 SHPSNTALPPASHPS 368
+P + S
Sbjct: 172 VYPKGFSKHKTHKRS 186
|
Length = 580 |
| >gnl|CDD|223021 PHA03247, PHA03247, large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 0.002
Identities = 45/246 (18%), Positives = 61/246 (24%), Gaps = 13/246 (5%)
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
APPP P + + T PP + P A A P P
Sbjct: 256 APPPVVGEGADRAPETARGA-TGPPPPPEAAAPNGAAAPPDGVWGAALAGAPLALPAPPD 314
Query: 398 SHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDA--PAATPRGNFHR 455
P A + P P P+ P P TP +
Sbjct: 315 PPPPAPAGDAEEEDDEDG-------AMEVVSPLPRPRQHYPLGFPKRRRPTWTPPSSLED 367
Query: 456 HSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPT 515
S H P ++R+A + P A + + V P +
Sbjct: 368 LSAGRHHPKRAS-LPTRKRRSARHAATPFARGPGGDDQTRPAAPVPASVPTPAPTPVPAS 426
Query: 516 ASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPL 575
A P P P + D P +P P P P A P
Sbjct: 427 APPPPATPLPSAEPGSDDGPAPPPERQPPA--PATEPAPDDPDDATRKALDALRERRPPE 484
Query: 576 PPFSSP 581
PP +
Sbjct: 485 PPGADL 490
|
Length = 3151 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.002
Identities = 30/126 (23%), Positives = 43/126 (34%), Gaps = 4/126 (3%)
Query: 404 ALTPASHPSNIAPPPLFVPVLPSA-LPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHP 462
A PA+ AP P P A P APV+Q+ APAA P +
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEAAAPAAAPVAQAA--AAPAPAAAPAAAASAPAAPPAA 420
Query: 463 SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDV 522
+ P P+ A A+ A +A P PP + ++ + AS P
Sbjct: 421 APPAPVAAPAAAAPAA-APAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAVASAAPAP 479
Query: 523 PPSTPP 528
+
Sbjct: 480 AAAPAA 485
|
Length = 618 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 42.6 bits (101), Expect = 0.002
Identities = 20/86 (23%), Positives = 35/86 (40%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
+T + ++ A AS P+ A A A P A+ P+ P A+ + A +
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAAAAPAA 98
Query: 215 KTAPSPASHPSNTALPPASLPSKTAP 240
A + A+ P+ A+ P + A
Sbjct: 99 PPAAAAAAAPAAAAVEDEVTPLRGAA 124
|
Length = 1228 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 0.002
Identities = 15/83 (18%), Positives = 23/83 (27%), Gaps = 6/83 (7%)
Query: 191 PPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTA 250
+ P+ A A+ S A A P+ A + P K A A A
Sbjct: 39 GSTAAPTAAAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAA------A 92
Query: 251 PPPASHPYKTSPLPASHPSKTAP 273
+ P + A +
Sbjct: 93 AAAPAAPPAAAAAAAPAAAAVED 115
|
Length = 1228 |
| >gnl|CDD|235904 PRK06995, flhF, flagellar biosynthesis regulator FlhF; Validated | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 22/104 (21%), Positives = 33/104 (31%), Gaps = 6/104 (5%)
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTA 200
APP A P + + PA+P + A H +R A
Sbjct: 52 APPAAAAPAAAQ-----PPPAAAPAAVSRPAAPAAEPAPWLVEHAKRLTAQREQLVARAA 106
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPAS 244
P A A P++ A + + A A+ P P A+
Sbjct: 107 APAAPEAQAPAAPAERAAAENA-ARRLARAAAAAPRPRVPADAA 149
|
Length = 484 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.002
Identities = 22/88 (25%), Positives = 30/88 (34%), Gaps = 1/88 (1%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P + ++ A P P + P + + PP TA PP P A P
Sbjct: 363 VPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANI-PPKEPVRETATPPPVPPRPVAPPV 421
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPP 242
P A + A+P P T P P
Sbjct: 422 PHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 20/83 (24%), Positives = 28/83 (33%), Gaps = 2/83 (2%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
S +A A P P + P PP + PP P TA +S+ P
Sbjct: 514 SGSASNTAKTP--PPPQKSPPPPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 307 PPASHPSNTAPPPASHPSNTAPP 329
+S P P P+ + P
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSSP 594
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 19/80 (23%), Positives = 27/80 (33%), Gaps = 1/80 (1%)
Query: 287 ASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSS 346
S ++ + T P S P P A A P+ P A PP +
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSP-PPAKASPPIPVPA 419
Query: 347 KTAPPPASHPSNTALPPASH 366
+ P + P+N A P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 19/80 (23%), Positives = 26/80 (32%), Gaps = 2/80 (2%)
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
S +A A P P P PP + PP P TA +S++ P
Sbjct: 514 SGSASNTAKTPPPPQKSPP--PPAPTPPLPQPTATAPPPTPPPPPPTATQASSNAPAQIP 571
Query: 351 PPASHPSNTALPPASHPSNP 370
+S P P P+
Sbjct: 572 ADSSPPPPIPEEPTPSPTKD 591
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 25/82 (30%), Positives = 34/82 (41%), Gaps = 4/82 (4%)
Query: 307 PPASHPSNTAPPPASHPSN-TAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
AS+ + T PPP P PP P+ TAPPP PP A+ S+ A
Sbjct: 515 GSASNTAKTPPPPQKSPPPPAPTPPLPQPTATAPPPTPPP---PPPTATQASSNAPAQIP 571
Query: 366 HPSNPAIPPASHPSNTAIPPAS 387
S+P P P+ + +S
Sbjct: 572 ADSSPPPPIPEEPTPSPTKDSS 593
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 0.002
Identities = 17/84 (20%), Positives = 24/84 (28%), Gaps = 5/84 (5%)
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPS 357
S + ++ + T P S P P A A P+ P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPS-----PPPAKASPPI 415
Query: 358 NTALPPASHPSNPAIPPASHPSNT 381
P P A+ P +
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.002
Identities = 42/233 (18%), Positives = 55/233 (23%), Gaps = 35/233 (15%)
Query: 320 ASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPS 379
S + ++ + T P S PP PS A+ +P AS P
Sbjct: 361 PSAFISEIANASAPANPTPAPNPSP-----PPAPIQPSAPKTKQAATTPSPPPAKASPPI 415
Query: 380 NTAIPPASHPSNTAPPHASHPSNTALTPASHP--SNIAPPP---LF-------------- 420
P A+ P + L + + P L
Sbjct: 416 PVPAEPTEPSPTPPANAANAPPSLNLEELWQQILAKLELPSTRMLLSQQAELVSLDSNRA 475
Query: 421 VPVLPSALPGKAPVSQSPISLPDAPAATPRG-----NFHRHSPAIHPSMPGPLPPVAQKR 475
V + G QS L + A G N S + S PP QK
Sbjct: 476 VIAVSPNWLGMV---QSRKPLLEQAFAKVLGRSIKLNLESQSGSA--SNTAKTPPPPQKS 530
Query: 476 NASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPP 528
P PP P A D PP P
Sbjct: 531 PPPPAPTPPLPQPTATAPPPTPPPP-PPTATQASSNAPAQIPADSSPPPPIPE 582
|
Length = 620 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 0.002
Identities = 20/89 (22%), Positives = 29/89 (32%), Gaps = 6/89 (6%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASP 162
PV + P+ A P + A S P+ A+ P P PT + P
Sbjct: 378 HIKPVFTQPA--AAPQPSAAAAASPSPSQSSAAAQPSAPQSATQPAGTP---PTVSVDPP 432
Query: 163 LSSKAFPPASPPSNAARPPASHPSNTARP 191
+ PP++ P A RP
Sbjct: 433 AAVPVNPPSTAP-QAVRPAQFKEEKKIPV 460
|
Length = 614 |
| >gnl|CDD|237874 PRK14971, PRK14971, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.002
Identities = 27/133 (20%), Positives = 46/133 (34%), Gaps = 13/133 (9%)
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
P +P + P+ AP P++ + + PS+++ + +A A+ P+
Sbjct: 370 SGGRGPKQHIKPVFTQPA-AAPQPSAAAAASPSPSQSSAAAQP----SAPQSATQPA-GT 423
Query: 240 PPPASHLSNTA---PPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
PP S A PP++ P P K P + S P P +
Sbjct: 424 PPTVSVDPPAAVPVNPPSTAPQAVRPAQFKEEKK--IPVSKVSSLG--PSTLRPIQEKAE 479
Query: 297 PASHPSNTAPPPA 309
A+ AP
Sbjct: 480 QATGNIKEAPTGT 492
|
Length = 614 |
| >gnl|CDD|222095 pfam13388, DUF4106, Protein of unknown function (DUF4106) | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 29/107 (27%), Positives = 32/107 (29%), Gaps = 6/107 (5%)
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
PA Y + S T PP +P AP P KT H AP P P
Sbjct: 152 PAGGTYIPAGGTYILASGTYIPP--NPPREAPAPGL--PKTFTSSHGHRHRHAPKPTQQP 207
Query: 313 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNT 359
T PA P+ P P T PA P T
Sbjct: 208 --TVQNPAQQPTVQNPAQQPQQQPQQQPVQPAQQPTPQNPAQQPPQT 252
|
This family of proteins are found in large numbers in the Trichomonas vaginalis proteome. The function of this protein is unknown. Length = 422 |
| >gnl|CDD|217453 pfam03251, Tymo_45kd_70kd, Tymovirus 45/70Kd protein | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.002
Identities = 47/230 (20%), Positives = 64/230 (27%), Gaps = 15/230 (6%)
Query: 106 PVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSS 165
PV P I P P++ P + P PL L+P L
Sbjct: 233 PVRHSPGILGPSPLHPHTTRPSPPRPAFSRSPSSPLSPLPRPSTRRGLLPNPRLPRASRG 292
Query: 166 KAFPPASPPSNAA-----RPPASHPSNTARPP------ASHPSRTAPPPASHPSNTALPS 214
PP S RP H S P + + H +
Sbjct: 293 HLPPPTSSAPPRPNGGLRRPLHLHSSRPNSPNLRPRRIRKNSLQQTRARLGHSKSLGQSP 352
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
S P+ L +P TA P + PLP + +
Sbjct: 353 NLRSSQLPPPTKRRLRLLPVPPPKVQALPL----TALAPLVRHSPSIPLPHPPSALPSHV 408
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 324
AS + PP+ P P+ PS P + P +PP S PS
Sbjct: 409 GASSSKHHRLPPSVLPGPRLSSPSPSPSLPTRRPGTPPPPASPPTPSPPS 458
|
Tymoviruses are single stranded RNA viruses. This family includes a protein of unknown function that has been named based on its molecular weight. Tymoviruses such as the ononis yellow mosaic tymovirus encode only three proteins. Of these two are overlapping this protein overlaps a larger ORF that is thought to be the polymerase. Length = 458 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 0.002
Identities = 21/72 (29%), Positives = 27/72 (37%), Gaps = 6/72 (8%)
Query: 280 SNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 339
PP++ P + APPPA+ P PA P+ P PA P A
Sbjct: 379 RGAPAPPSAAWGAPTPAAPA-----APPPAAAPPVPPAAPAR-PAAARPAPAPAPPAAAA 432
Query: 340 PPASHSSKTAPP 351
PPA + A
Sbjct: 433 PPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 29/141 (20%), Positives = 39/141 (27%), Gaps = 11/141 (7%)
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSP 262
AS S + S A SP S L S AS PAS P +
Sbjct: 2 AASVSSGS--TSGDASSPRS------SSRRRLSSSFLSTSASSRPRRLNAPASPPSSSPA 53
Query: 263 LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASH 322
S S S ++ S+ P PS A S + + +S
Sbjct: 54 RNTSSSSSFGL---SKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSP 110
Query: 323 PSNTAPPPASHPSNTAPPPAS 343
+ + S P S
Sbjct: 111 SRSRRTTSSDLSSGNGPSVLS 131
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|218107 pfam04484, DUF566, Family of unknown function (DUF566) | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 29/131 (22%), Positives = 45/131 (34%), Gaps = 4/131 (3%)
Query: 160 ASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPS 219
AS S AS P +++R S+ AS R PAS PS++ + ++ S
Sbjct: 3 ASVSSGSTSGDASSPRSSSR--RRLSSSFLSTSASSRPRRLNAPASPPSSSPARNTSSSS 60
Query: 220 PA--SHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
S ++L L S+ P S A S ++ +S +
Sbjct: 61 SFGLSKQRPSSLSRGRLSSRFVSPSRGSPSAAASLNGSLATASTSGSSSPSRSRRTTSSD 120
Query: 278 HPSNTAPPPAS 288
S P S
Sbjct: 121 LSSGNGPSVLS 131
|
Family of related proteins that is plant specific. Length = 313 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 49/206 (23%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 1036 EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-----LHEDSS 1090
R + L+ + + H + A +++ ++L Y +H +
Sbjct: 69 SHSDRKVW--LLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA 126
Query: 1091 PRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHIS--TRVMGTFGYVAPE 1144
V+HRD K +NIL+ + K++D G AR + + ++ V+ TF Y APE
Sbjct: 127 NWVLHRDLKPANILVMGEGPERGRVKIADMGFAR-LFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 1145 YAMTGHLLVKS-DVYSYGVVILELLS 1169
+ K+ D+++ G + ELL+
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 0.002
Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 12/108 (11%)
Query: 1074 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH---- 1129
I GA R L YLH++ IHR+ K+S+IL+ D +S S + +
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162
Query: 1130 ----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
ST V+ + G+ VKSD+YS G+ EL +GR P
Sbjct: 163 DFPQFSTSVLPWLSPELLRQDLYGYN-VKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|237081 PRK12372, PRK12372, ribonuclease III; Reviewed | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.002
Identities = 32/148 (21%), Positives = 47/148 (31%), Gaps = 7/148 (4%)
Query: 179 RPPASHPSNTARP-PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSK 237
R P AR A+ + A A+ P+ + A A+H A
Sbjct: 261 RSPERKERAAAREARAAAAAPAATAAAAAPAEEPAVAPMAAIRAAHVETAADKGER---A 317
Query: 238 TAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPP 297
P A ++ K + PA + A PA ++ A A P +A
Sbjct: 318 AKPAAADKAADKPADRPDAAEKAAEKPAEAAPRAADKPAGQAADPASSSADKPGASADAA 377
Query: 298 ASHPSNT---APPPASHPSNTAPPPASH 322
A P+ A P A P A A+
Sbjct: 378 ARTPARARDAAAPDADTPPGGASLAAAQ 405
|
Length = 413 |
| >gnl|CDD|219321 pfam07174, FAP, Fibronectin-attachment protein (FAP) | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 27/81 (33%), Positives = 31/81 (38%), Gaps = 6/81 (7%)
Query: 262 PLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPAS 321
LPA+ + APPP + A P A PP P P P N APPP
Sbjct: 32 ALPATANADPAPPPPPPSTAAAAPAP------AAPPPPPPPAAPPAPQPDDPNAAPPPPP 85
Query: 322 HPSNTAPPPASHPSNTAPPPA 342
N PPP P+ PP
Sbjct: 86 ADPNAPPPPPVDPNAPPPPAP 106
|
This family contains bacterial fibronectin-attachment proteins (FAP). Family members are rich in alanine and proline, are approximately 300 long, and seem to be restricted to mycobacteria. These proteins contain a fibronectin-binding motif that allows mycobacteria to bind to fibronectin in the extracellular matrix. Length = 297 |
| >gnl|CDD|218397 pfam05044, Prox1, Homeobox prospero-like protein (PROX1) | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 41/229 (17%), Positives = 62/229 (27%), Gaps = 25/229 (10%)
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP---PASHLSNTA 250
+ P R AP SP +H N P + + A
Sbjct: 486 AKPERAAPEQLFKDLMLPSQMLDRKSPRTHTVNDRGQCFGDPDISTAAMFIIPKPPDSFA 545
Query: 251 PPPASHPYKTSP------LPASHPSKT-------APPPASHP-SNTAPPPASHPSKTAPP 296
A+ Y + P P +T P H ++T P + A
Sbjct: 546 NVAAAALYNSPFCMPQTPQPQDAPEQTEALSLVVTPKKKRHKVTDTRITPRTVSRILALR 605
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
A P+ HPS+ + HP P + P P+ H S+
Sbjct: 606 DAVGPAAGTHHQPLHPSSLSASMGFHPPPFRHPFPLPLTVAIPNPSLHQSEVFMGYPFQS 665
Query: 357 SNTALPPASHPSNP-AIPPASHPSNTAIPPASHPSNTAPPHASHPSNTA 404
+ P S P P P + HP + HP ++
Sbjct: 666 PHLGAPSGSPPGKDRDSPDLPRP-----TTSLHPKLLS--AHHHPGSSP 707
|
The homeobox gene Prox1 is expressed in a subpopulation of endothelial cells that, after budding from veins, gives rise to the mammalian lymphatic system. Prox1 has been found to be an early specific marker for the developing liver and pancreas in the mammalian foregut endoderm. This family contains an atypical homeobox domain. Length = 908 |
| >gnl|CDD|165527 PHA03269, PHA03269, envelope glycoprotein C; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 0.002
Identities = 39/140 (27%), Positives = 56/140 (40%), Gaps = 10/140 (7%)
Query: 219 SPASHPSNTALP---PASLPSKTAPPPASH-LSNTAPPPASHPYKTSPLPASHPSKTAPP 274
A+ +N +P ++ K P PA H ++ AP PA P TS AP
Sbjct: 18 IIANLNTNIPIPELHTSAATQKPDPAPAPHQAASRAPDPAVAP--TSAASRKPDLAQAPT 75
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHP-SNTAPPPASHPSNTAPPPASHPSNTAPPPASH 333
PA+ P + AP PA P AP P + + T+ A A A
Sbjct: 76 PAASEKFDPAPAPHQAASRAPDPAVAPQLAAAPKPDAAEAFTSAAQAHEAPADAGTSA-- 133
Query: 334 PSNTAPPPASHSSKTAPPPA 353
++ P PA+H+ + PP A
Sbjct: 134 -ASKKPDPAAHTQHSPPPFA 152
|
Length = 566 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.002
Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 23/160 (14%)
Query: 970 NFDASRILGEGGFG---LVYSGVLDDGTKVAVKVLKRV-----DQQGGREFLAEVEMLSR 1021
+F +++G+G FG LV D G A+K L + DQ AE ++L+
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQK--KDTGKIYAMKTLLKSEMFKKDQLA--HVKAERDVLAE 57
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAA 1079
+V L + Q L+ E +P G + + L D E + A +A+ A
Sbjct: 58 SDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119
L + IHRD K NIL++ K+SDFGL+
Sbjct: 118 HKLGF---------IHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.003
Identities = 25/140 (17%), Positives = 37/140 (26%), Gaps = 11/140 (7%)
Query: 57 LLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAP 116
L G P+P + S + D A P + PS +P
Sbjct: 142 LKEGEDPNPGPPLDEEDEDADVATTNSDN-SFPGEDADPASASPSDPPSSSPGVPSFPSP 200
Query: 117 PPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSN 176
P +P S +P P + P + SP A PP P
Sbjct: 201 PEDPSSPSDSSLPPAPSSFQSD----------TPPPSPESPTNPSPPPGPAAPPPPPVQQ 250
Query: 177 AARPPASHPSNTARPPASHP 196
+ P+ + P
Sbjct: 251 VPPLSTAKPTPPSASATPAP 270
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|178748 PLN03209, PLN03209, translocon at the inner envelope of chloroplast subunit 62; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.003
Identities = 47/200 (23%), Positives = 71/200 (35%), Gaps = 19/200 (9%)
Query: 487 PIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP---PLSVDGKRVGKPVAEP 543
P +P P PP +S S + P P P + P P V+ K+
Sbjct: 383 PTSPIPTPPSSSPASSKSVDAVAKPAEPDVVPSPGSASNVPEVEPAQVEAKKTRPLSPYA 442
Query: 544 SYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGND----TPVSSPLAS 599
Y+ PP SPS T S+ S +P P + PL+
Sbjct: 443 RYEDLKPPT---SPSPTAPTGVSPSVSSTSSVPAVPDTAPATAATDAAAPPPANMRPLSP 499
Query: 600 FPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHSP 659
+ + D++ + SPA +S ++ V S PT+ + P P
Sbjct: 500 YAVYDDLKPPTSPSPAAPVGKVAPSSTNEVVKVGNSAPPTALADEQ-----HHAQPKPRP 554
Query: 660 L-PTPVS---RVPTSPSPSP 675
L P + + PTSP+PSP
Sbjct: 555 LSPYTMYEDLKPPTSPTPSP 574
|
Length = 576 |
| >gnl|CDD|237030 PRK12270, kgd, alpha-ketoglutarate decarboxylase; Reviewed | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 0.003
Identities = 20/77 (25%), Positives = 31/77 (40%), Gaps = 3/77 (3%)
Query: 311 HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNP 370
P +TA P A + A A+ AP + ++ PPA+ PA+ +
Sbjct: 37 GPGSTAAPTA---AAAAAAAAASAPAAAPAAKAPAAPAPAPPAAAAPAAPPKPAAAAAAA 93
Query: 371 AIPPASHPSNTAIPPAS 387
A P A + A PA+
Sbjct: 94 AAPAAPPAAAAAAAPAA 110
|
Length = 1228 |
| >gnl|CDD|219339 pfam07223, DUF1421, Protein of unknown function (DUF1421) | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.003
Identities = 53/263 (20%), Positives = 71/263 (26%), Gaps = 17/263 (6%)
Query: 47 LPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNP 106
L P +P P + APP PS P S P P P
Sbjct: 66 LQQVNAALPPAPAPQSPQPDQQQQSQAPPSHQYPSQLPPQQVQSVPQQPTPQQEPYYPPP 125
Query: 107 VASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSK 166
P P PP +P PP N P P P S
Sbjct: 126 SQPQPPPAQQPQAQQPQPPPQVPQQQQYQSPPQQPQYQQNPPPQAQSAPQVSGLYPEESP 185
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
P + PP N P + PP + P + PSP +
Sbjct: 186 YQPQSYPP------------NEPLPSSMAMQ---PPYSGAPPSQQFYGPPQPSPYMYGGP 230
Query: 227 TALPPASLPSKTAPPPA--SHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAP 284
P + PS PPP+ + PP S S + + ++PS A
Sbjct: 231 GGRPNSGFPSGQQPPPSQGQEGYGYSGPPPSKGNHGSVASYAPQGSSQSYSTAYPSLPAA 290
Query: 285 PPASHPSKTAPPPASHPSNTAPP 307
+ P S + +P
Sbjct: 291 TVLPQALPMSSAPMSGGGSGSPQ 313
|
This family represents a conserved region approximately 350 residues long within a number of plant proteins of unknown function. Length = 357 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.003
Identities = 20/103 (19%), Positives = 27/103 (26%), Gaps = 2/103 (1%)
Query: 176 NAARPPASHPSNTARPPASHPSRT-APPPASHPSNTALPSKTAPSPASHPSNTALPPASL 234
P A P P+ + P + + P + A P P +
Sbjct: 361 VPVPAPQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETA-TPPPVPPRPVAP 419
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
P P A L+ A P P T P P K
Sbjct: 420 PVPHTPESAPKLTRAAIPVDEKPKYTPPAPPKEEEKALIADGD 462
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 23/92 (25%), Positives = 30/92 (32%), Gaps = 3/92 (3%)
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
P PA P A P A+ S P PA A A+ P + + P P
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRETATPPPVPPRPV 417
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPP 418
+ P P A + A+ P P P
Sbjct: 418 APPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.003
Identities = 29/103 (28%), Positives = 35/103 (33%), Gaps = 14/103 (13%)
Query: 217 APSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPA 276
P PA P A P A+ PS P PA + P A+ P + T PP
Sbjct: 361 VPVPAPQP---AKPTAAAPSPVRPTPAP----STRPKAAAAANIPPKEPVRETATPPPV- 412
Query: 277 SHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPP 319
P P + P P A + A P P T P P
Sbjct: 413 ------PPRPVAPPVPHTPESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (96), Expect = 0.003
Identities = 44/148 (29%), Positives = 60/148 (40%), Gaps = 10/148 (6%)
Query: 305 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP---ASHPSNTAL 361
A A+ A A+ PS A+ P+ A PA K A PP A+ P+ A
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPA----KAAAPPAKAAAAPAKAAA 248
Query: 362 PPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFV 421
PA + PA A+ P+ A PPA + P A+ P A P + +
Sbjct: 249 APAKAAAPPA-KAAAPPAKAAAPPAK--AAAPPAKAAAPPAKAAAPPAKAAAAPAKAAAA 305
Query: 422 PVLPSALPGKAPVSQSPISLPDAPAATP 449
P +A P KA + + P A AATP
Sbjct: 306 PAKAAAAPAKAAAPPAKAAAPPAKAATP 333
|
Length = 357 |
| >gnl|CDD|185616 PTZ00436, PTZ00436, 60S ribosomal protein L19-like protein; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (95), Expect = 0.003
Identities = 47/160 (29%), Positives = 67/160 (41%), Gaps = 11/160 (6%)
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPP- 352
A A+ A A+ PS A+ P+ A PA + A A+ + A P
Sbjct: 193 AAAAAAAKQKAAAKKAAAPSGKKSAKAAAPAKAAAAPAKAAAPPAKAAAAPAKAAAAPAK 252
Query: 353 -ASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTP---A 408
A+ P+ A PPA + PA A+ P+ A PPA + A A+ P+ A P A
Sbjct: 253 AAAPPAKAAAPPAKAAAPPA-KAAAPPAKAAAPPAKAAAPPAKA-AAAPAKAAAAPAKAA 310
Query: 409 SHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAAT 448
+ P+ A P P +A P KA + + P A AA
Sbjct: 311 AAPAKAAAP----PAKAAAPPAKAATPPAKAAAPPAKAAA 346
|
Length = 357 |
| >gnl|CDD|185628 PTZ00449, PTZ00449, 104 kDa microneme/rhoptry antigen; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.003
Identities = 45/250 (18%), Positives = 54/250 (21%), Gaps = 16/250 (6%)
Query: 151 PSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNT 210
PS IPT P P RP + P S
Sbjct: 569 PSKIPTLSKKPEFPKDPKHPKDPEEPKKPKRPRSAQRPTRPKSPKLPELLDIPKSPKRPE 628
Query: 211 ALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSK 270
+ S P P PS+ P K+ PP S P P P +
Sbjct: 629 SPKSPKRPPPPQRPSSPERPEGPKIIKSPKPPKS------PKPPFDPKFKEKFYDDYLDA 682
Query: 271 TAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 330
A + + K P T P P P
Sbjct: 683 AAKSKETKTTVVLDESFESILKETLPETPGTPFTTPRPLPPKLPRDEEFPFEPIGDPDAE 742
Query: 331 ASHPSNTAPPPASHSSKTAPPPASHPSNTAL----------PPASHPSNPAIPPASHPSN 380
PP + PA P L P P S +
Sbjct: 743 QPDDIEFFTPPEEERTFFHETPADTPLPDILAEEFKEEDIHAETGEPDEAMKRPDSPSEH 802
Query: 381 TAIPPASHPS 390
PP HPS
Sbjct: 803 EDKPPGDHPS 812
|
Length = 943 |
| >gnl|CDD|184923 PRK14959, PRK14959, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.003
Identities = 41/140 (29%), Positives = 54/140 (38%), Gaps = 19/140 (13%)
Query: 209 NTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASH-PYKTSPLPASH 267
N A+ + P + PS S A PAS + T P P + P T+P
Sbjct: 358 NLAMLPRLMPVESLRPSGGGASAPS--GSAAEGPASGGAATIPTPGTQGPQGTAPAAGMT 415
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAP----PPASHPSNTAPPPASHPSNTAP----PP 319
PS AP P P++ PS P PPA S P PA +P P
Sbjct: 416 PSSAAP--------ATPAPSAAPSPRVPWDDAPPAPPRSGIPPRPAPRMPEASPVPGAPD 467
Query: 320 ASHPSNTAPPPASHPSNTAP 339
+ ++ APP PS+TA
Sbjct: 468 SVASASDAPPTLGDPSDTAE 487
|
Length = 624 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 0.003
Identities = 28/146 (19%), Positives = 43/146 (29%), Gaps = 8/146 (5%)
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP--PPASHPSNTAPPPASHPSN 325
P PPAS + P AS S + T P A+ S +AP P P
Sbjct: 648 PPS-RAPPASLSKPASSPDASQTSASFDLDPDFELATHQSVPEAALASGSAPAPPPVPDP 706
Query: 326 TAPPP---ASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTA 382
PP A ++ P + + SN+ L + P +
Sbjct: 707 YDRPPWEEAPEVASANDGPNNAAEGNLSESVEDASNSELQAVEQQATH--QPQVQAEAQS 764
Query: 383 IPPASHPSNTAPPHASHPSNTALTPA 408
+ + T+ N L +
Sbjct: 765 PASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|236766 PRK10811, rne, ribonuclease E; Reviewed | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 0.003
Identities = 30/174 (17%), Positives = 45/174 (25%), Gaps = 15/174 (8%)
Query: 62 APSPIELP-THSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPP--- 117
A P P + + + + P + P T P
Sbjct: 861 AEEVQVQPVVAEVPVAAAVEPVVSAPVVEAVAEVVEEPVVVAEPQPEEVVVVETTHPEVI 920
Query: 118 --PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL-----SSKAFPP 170
PV P VA A P+V + I + + A P
Sbjct: 921 AAPVTEQPQVITESDVAVAQEVAEHAEPVVEPQDETADIEEAAETAEVVVAEPEVVAQPA 980
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHP 224
A + A + + P P++ H TA P AP+P P
Sbjct: 981 APVVAEVAAEVETVTA---VEPEVAPAQVPEATVEHNHATA-PMTRAPAPEYVP 1030
|
Length = 1068 |
| >gnl|CDD|183756 PRK12799, motB, flagellar motor protein MotB; Reviewed | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.003
Identities = 28/119 (23%), Positives = 43/119 (36%), Gaps = 12/119 (10%)
Query: 282 TAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPP 341
A P+S ++++ S S P PA PS+ A+ T + S P
Sbjct: 302 AAVTPSSAVTQSSAITPS--SAAIPSPAVIPSSVTTQSAT---TTQASAVALSSAGVLPS 356
Query: 342 ASHSSKTAPPPASHPSNTALPPASHP-----SNPAIPPASHPSNTAIPPASHPSNTAPP 395
T PA+ P N P S S I ++ T++P A P++ P
Sbjct: 357 DVTLPGTVALPAAEPVNMQPQPMSTTETQQSSTGNITSTANGPTTSLPAA--PASNIPV 413
|
Length = 421 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.003
Identities = 32/131 (24%), Positives = 44/131 (33%), Gaps = 12/131 (9%)
Query: 241 PPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH 300
P + A P H Y+ P ++ P + P P A P++ AP P
Sbjct: 75 PANAQEHEAARPSPQHQYQ-PPYASAQPRQPVQQPPEAQ--VPPQHAPRPAQPAPQPV-- 129
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
PA P P AP P P ++AP PA + + A P A+
Sbjct: 130 -----QQPAYQPQPEQPLQQPVSPQVAPAPQ--PVHSAPQPAQQAFQPAEPVAAPQPEPV 182
Query: 361 LPPASHPSNPA 371
PA P
Sbjct: 183 AEPAPVMDKPK 193
|
Length = 333 |
| >gnl|CDD|235124 PRK03427, PRK03427, cell division protein ZipA; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.003
Identities = 28/123 (22%), Positives = 36/123 (29%), Gaps = 1/123 (0%)
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTA 228
P+NA A+ PS + + S P P +P + AP PA
Sbjct: 70 RVNHAPANAQEHEAARPSPQHQYQPPYASAQPRQPVQQPPEAQVPPQHAPRPAQPAPQPV 129
Query: 229 LPPASLPSKTAPPPASHLSNTAPPPA-SHPYKTSPLPASHPSKTAPPPASHPSNTAPPPA 287
PA P P AP P H A P++ P P P
Sbjct: 130 QQPAYQPQPEQPLQQPVSPQVAPAPQPVHSAPQPAQQAFQPAEPVAAPQPEPVAEPAPVM 189
Query: 288 SHP 290
P
Sbjct: 190 DKP 192
|
Length = 333 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.003
Identities = 21/72 (29%), Positives = 26/72 (36%), Gaps = 6/72 (8%)
Query: 269 SKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAP 328
PP++ P + APPPA+ P PA P+ P PA P A
Sbjct: 379 RGAPAPPSAAWGAPTPAAPA-----APPPAAAPPVPPAAPAR-PAAARPAPAPAPPAAAA 432
Query: 329 PPASHPSNTAPP 340
PPA A
Sbjct: 433 PPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|223061 PHA03369, PHA03369, capsid maturational protease; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.003
Identities = 54/320 (16%), Positives = 79/320 (24%), Gaps = 52/320 (16%)
Query: 145 VNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPA 204
+N L A + I T + S A AA + P++ RP + P
Sbjct: 338 INGLKAHNEILKTASLTAPSRVLAAAAKVAVIAAPQTHTGPADRQRPQRPDGIPYSVPAR 397
Query: 205 SHPSN----TALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
S + +P + P PP ++ A+ Y
Sbjct: 398 SPMTAYPPVPQFCGDPGLVSPYNPQSPGTSYGPEPVGPVPPQPTNPYVMPISMANMVYPG 457
Query: 261 SPLPASHPSK-----------------------TAPPPASHPSNTAPPPASHPSKTAPPP 297
P H K A TA +
Sbjct: 458 HPQEHGHERKRKRGGELKEELIETLKLVKKLKEEQESLAKELEATAHKSEIKKIAESEFK 517
Query: 298 ASHPSNTAPPPASHPSNTAPPPASHPS------------------NTAPPPA---SHPSN 336
+ A + S A PA+ + PA S S
Sbjct: 518 NAGAKTAAANIEPNCSADAAAPATKRARPETKTELEAVVRFPYQIRNMESPAFVHSFTST 577
Query: 337 TAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI----PPASHPSNT 392
T A S TA A ++ P+ ++P + P N + PP P
Sbjct: 578 TLAAAAGQGSDTAEALAGAIETLLTQASAQPAGLSLPAPAVPVNASTPASTPPPLAPQEP 637
Query: 393 APPHASHPSNTALTPASHPS 412
P S PS P P
Sbjct: 638 PQPGTSAPSLETSLPQQKPV 657
|
Length = 663 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (96), Expect = 0.003
Identities = 33/109 (30%), Positives = 46/109 (42%), Gaps = 24/109 (22%)
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK-----VSDFGLARSAMDEES 1127
KI AL LH +IH D K N+L + + D+GL
Sbjct: 113 KIIRQLVEALNDLH---KHNIIHNDIKLENVL----YDRAKDRIYLCDYGL--------C 157
Query: 1128 RHISTRVM--GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
+ I T GT Y +PE + GH S D ++ GV+ ELL+G+ P
Sbjct: 158 KIIGTPSCYDGTLDYFSPE-KIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|237865 PRK14951, PRK14951, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.004
Identities = 32/140 (22%), Positives = 42/140 (30%), Gaps = 10/140 (7%)
Query: 364 ASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV 423
A P+ A A T P + A P A+ + A PA A P
Sbjct: 363 AFKPAAAAEAAAPAEKKTPARPEA-----AAPAAAPVAQAAAAPAP-----AAAPAAAAS 412
Query: 424 LPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAP 483
P+A P AP + APAA P + A P VA + A
Sbjct: 413 APAAPPAAAPPAPVAAPAAAAPAAAPAAAPAAVALAPAPPAQAAPETVAIPVRVAPEPAV 472
Query: 484 IAEPIAPGPFPPGNSRQKSP 503
+ AP P +
Sbjct: 473 ASAAPAPAAAPAAARLTPTE 492
|
Length = 618 |
| >gnl|CDD|218191 pfam04652, DUF605, Vta1 like | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.004
Identities = 26/134 (19%), Positives = 39/134 (29%), Gaps = 10/134 (7%)
Query: 67 ELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPS 126
E + SF ++ PP S SPP + P + PP
Sbjct: 157 EDEDADVATTNSDNSFPGEDADPASASPSDPPSSSPGVPSFPSPPEDPSSPSDSSLPPA- 215
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPS 186
P++ + PP + N P P P P P+ + P+ P S +
Sbjct: 216 --PSSFQSDTPPPSPESPTNPSPPPG--PAAPPPPPVQQVPPLSTAKPT-----PPSASA 266
Query: 187 NTARPPASHPSRTA 200
A A
Sbjct: 267 TPAPIGGITLDDDA 280
|
Vta1 (VPS20-associated protein 1) is a positive regulator of Vps4. Vps4 is an ATPase that is required in the multivesicular body (MVB) sorting pathway to dissociate the endosomal sorting complex required for transport (ESCRT). Vta1 promotes correct assembly of Vps4 and stimulates its ATPase activity through its conserved Vta1/SBP1/LIP5 region. Length = 315 |
| >gnl|CDD|237864 PRK14950, PRK14950, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.004
Identities = 20/85 (23%), Positives = 28/85 (32%), Gaps = 1/85 (1%)
Query: 169 PPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTA 228
P + P+ AA P + P + + PP TA P P P + P
Sbjct: 366 PQPAKPTAAAPSPVRPTPAPSTRPKAAAAANIPPKEPVRE-TATPPPVPPRPVAPPVPHT 424
Query: 229 LPPASLPSKTAPPPASHLSNTAPPP 253
A ++ A P T P P
Sbjct: 425 PESAPKLTRAAIPVDEKPKYTPPAP 449
|
Length = 585 |
| >gnl|CDD|237862 PRK14948, PRK14948, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.004
Identities = 24/80 (30%), Positives = 32/80 (40%), Gaps = 2/80 (2%)
Query: 234 LPSKTAPPPA--SHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPS 291
LPS A S +N P P P P++ +K A S P A PP P+
Sbjct: 360 LPSAFISEIANASAPANPTPAPNPSPPPAPIQPSAPKTKQAATTPSPPPAKASPPIPVPA 419
Query: 292 KTAPPPASHPSNTAPPPASH 311
+ P + P+N A P S
Sbjct: 420 EPTEPSPTPPANAANAPPSL 439
|
Length = 620 |
| >gnl|CDD|237863 PRK14949, PRK14949, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.004
Identities = 31/229 (13%), Positives = 56/229 (24%), Gaps = 31/229 (13%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS------------------- 222
+ A + A P + S + + A S A
Sbjct: 569 DDEQHSANVQSAQSAA-EAQPSSQSLSPISAVTTAAASLADDDILDAVLAARDSLLSDLD 627
Query: 223 --HPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPS 280
P +S K PP S P S P + + S P +
Sbjct: 628 ALSPKEGDGKKSSADRKPKTPP----SRAPPASLSKPASSPDASQTSASFDLDPDFELAT 683
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPP---ASHPSNTAPPPASHPSNTAPPPASHPSNT 337
+ + P A+ S +AP P P PP A ++ P + +
Sbjct: 684 HQSVPEAALASGSAPAPPPVPDPYDRPPWEEAPEVASANDGPNNAAEGNLSESV--EDAS 741
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
+ + P + + + + N + +
Sbjct: 742 NSELQAVEQQATHQPQVQAEAQSPASTTALTQTSSEVQDTELNLVLLSS 790
|
Length = 944 |
| >gnl|CDD|237871 PRK14965, PRK14965, DNA polymerase III subunits gamma and tau; Provisional | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.004
Identities = 16/72 (22%), Positives = 22/72 (30%), Gaps = 6/72 (8%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAP 306
PP++ +P + P A PP PA+ AP P +
Sbjct: 379 RGAPAPPSAAWGAPTPAAPAAPPPAAAPPVPPA--APARPAAARPAPAPAPPAAA----A 432
Query: 307 PPASHPSNTAPP 318
PPA A
Sbjct: 433 PPARSADPAAAA 444
|
Length = 576 |
| >gnl|CDD|225711 COG3170, FimV, Tfp pilus assembly protein FimV [Cell motility and secretion / Intracellular trafficking and secretion] | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.004
Identities = 57/356 (16%), Positives = 90/356 (25%), Gaps = 40/356 (11%)
Query: 106 PVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPL-- 163
P SP S + P + P P+ P AP T L
Sbjct: 142 PGYSPKSALSAEPSHPVPAPAAASAPPPPPRAARPVRQPAPAPAAPGDTYTVRSGDTLWD 201
Query: 164 -SSKAFPPASPPSN-------AARPPASHPSNTAR---------PPASHPSRTAPPPA-- 204
+S+ P P A N R P A+ R +P A
Sbjct: 202 IASRLRPQDHVTVEQMLLALYQLNPQAFVNGNINRLRAGSVLRIPSAAQILRESPQEALA 261
Query: 205 ---SHPS------NTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPAS 255
+ + + A + A A LP++ A A
Sbjct: 262 EVKAQTAAFAGEPSKADRVGKPVAKAPAKVAKERALAELPARVAELQA----QLNKAQHE 317
Query: 256 HPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSN- 314
K +PL A+ + AP + + P S S A P + + P +
Sbjct: 318 LAQKAAPLAAAQAALDAPAETATAPSAPAPQVSAESSPAQPGSYLLAAPGDAPLGELAQA 377
Query: 315 -TAPPPASHPSNTAPPPASH--PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
+A + S A P S P P + + L
Sbjct: 378 QSARERLAEESVPAAEPRSRLAPVAAVEQPFAEVESPLSSLPAPLLALGLVALDGGWLVL 437
Query: 372 IPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSA 427
P T + A+ +N+ A + +P P+ +
Sbjct: 438 RRAQQPPVETQGFQNRLLNRADTLLAA--ANSLFGGAGLQWDTSPHPVPAADFRAG 491
|
Length = 755 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.004
Identities = 49/213 (23%), Positives = 89/213 (41%), Gaps = 18/213 (8%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVK-VLKRVDQQG-GREFLAEVEMLSRLHHRN 1026
++ +GEG +G VY + G VA+K +D++G L E+ +L L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESI 61
Query: 1027 -LVKLIGICIEEQAR-----CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIALGAA 1079
+V+L+ + E+ LV+E + + ++ + + PL
Sbjct: 62 YIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-KVSDFGLARSAMDEESRHISTRVMGTF 1138
+ +A+ H V+HRD K N+L++ K++D GL R+ + T + T
Sbjct: 121 KGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSY--THEIVTL 175
Query: 1139 GYVAPEYAMTG-HLLVKSDVYSYGVVILELLSG 1170
Y APE + H D++S G + E+
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|237015 PRK11901, PRK11901, hypothetical protein; Reviewed | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.004
Identities = 38/196 (19%), Positives = 58/196 (29%), Gaps = 32/196 (16%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
P H S+ + A N L ++ S + S +A S +
Sbjct: 61 PTEHESQQSSNNAGAEKNIDLSGSSSLSSGNQSSPSAANNTSDGH----------DASGV 110
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPS---------------------NTAPPPASHP 290
+ P S P S A PP + N A A
Sbjct: 111 KNTAPPQDISAPPISPTPTQAAPPQTPNGQQRIELPGNISDALSQQQGQVNAASQNAQGN 170
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
+ T P + + + + T P P P+ P H + T P + S K
Sbjct: 171 TSTLPTAPATVAPSKGAKVPATAETHPTPPQKPATKKPAVNHHKTATVAVPPATSGKPKS 230
Query: 351 PPASHPSNTALPPASH 366
AS + ++ PASH
Sbjct: 231 GAASARALSSA-PASH 245
|
Length = 327 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1368 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.98 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.98 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.96 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.96 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.91 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.79 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.71 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.7 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.67 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.67 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.56 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.37 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.37 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.37 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.3 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.25 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.25 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.19 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.15 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.94 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.92 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.89 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.85 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.77 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.63 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.49 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.41 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.37 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.23 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 98.19 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.17 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.16 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.11 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.1 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.07 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.93 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.9 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.88 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.82 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.74 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.73 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.68 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.65 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 97.6 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.26 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.24 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.22 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.13 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.11 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.08 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.04 | |
| PLN02236 | 344 | choline kinase | 96.97 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.64 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.6 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.58 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.57 | |
| PHA03247 | 3151 | large tegument protein UL36; Provisional | 96.5 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 96.31 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.27 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.12 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.08 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.02 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.93 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.8 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.65 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 95.65 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-55 Score=501.86 Aligned_cols=290 Identities=57% Similarity=0.946 Sum_probs=256.7
Q ss_pred CCcCCCHHHHHHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeee
Q 000659 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034 (1368)
Q Consensus 955 S~~~fsleELe~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~ 1034 (1368)
....|++.+|+.+|++|...++||+|+||.||+|.+++|+.||||++.....+..++|.+|+++|.+++|+|||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999988754432156799999999999999999999999
Q ss_pred eecc-ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccc
Q 000659 1035 IEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113 (1368)
Q Consensus 1035 ~d~~-~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKL 1113 (1368)
.+.+ +.+||||||.+|+|+++|+..... .|+|.+|++|+.++|+||+|||+.+.+.|||||||++|||||+++++||
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 9988 499999999999999999864432 7999999999999999999999998889999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1114 sDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
+|||||+..... .....+...||.+|+|||++..+..++|+|||||||+|+||+||+.+++.....+..++++|++..+
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999765431 1111111179999999999999999999999999999999999999998776666777999998888
Q ss_pred ccccccceeecCCCC-CCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1194 TSREGLERIIDPSLG-NDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~-~~~~~-ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
.+. .+.+++|+.+. +.+.. +++.++..++.+|++.++++||+|.||+++|+.+.
T Consensus 298 ~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 298 EEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 765 79999999987 55654 68899999999999999999999999999985544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=482.98 Aligned_cols=402 Identities=24% Similarity=0.382 Sum_probs=287.6
Q ss_pred hhHHHHhhhhccCcccccccCCCCCceEEEeeCCCCCCCCCCCCCCCCcCCCCCCCCCCCCCCCCCcc--cCCccccccC
Q 000659 797 NTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNGRATKPEGV--DVPKRRQKYG 874 (1368)
Q Consensus 797 ~sEaldLssnlLsGeIP~qls~LgrL~vLNVS~N~LsGpIPs~lq~isTf~assFsGN~GLCG~PL~v--d~~ssrskkg 874 (1368)
.=+.+||++|.++|.||..+..+..|+.|+|++|+|.|.+|...+. .++....|.||.++||..... ..|....+
T Consensus 548 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~-~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~-- 624 (968)
T PLN00113 548 VLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAF-LAINASAVAGNIDLCGGDTTSGLPPCKRVRK-- 624 (968)
T ss_pred cCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchh-cccChhhhcCCccccCCccccCCCCCccccc--
Confidence 3456889999999999999999999999999999999999976554 357788999999999865432 22322111
Q ss_pred CCCceeeehhhHHHHHHHHHHHHHHHHHHhhccccccccccccccccCCcCCCCCCCcccccCCCCCccccCcccceecC
Q 000659 875 LSGGMIAIVVLSAFVAVVLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTG 954 (1368)
Q Consensus 875 lSggiIa~IVVgavVaVVLvlaIa~l~l~RrKrrr~k~ee~~~slq~Sa~~~s~aagl~vsS~~dSsS~s~gSS~a~~sg 954 (1368)
+...+.++ +++++++++++++++++++++++++.+.++... ..+... .. .+. ..
T Consensus 625 -~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~---~~----~~~------~~ 678 (968)
T PLN00113 625 -TPSWWFYI-TCTLGAFLVLALVAFGFVFIRGRNNLELKRVEN-----------EDGTWE---LQ----FFD------SK 678 (968)
T ss_pred -cceeeeeh-hHHHHHHHHHHHHHHHHHHHHhhhccccccccc-----------cccccc---cc----ccc------cc
Confidence 11122222 222222222222222233322222111111000 000000 00 000 00
Q ss_pred CCcCCCHHHHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeee
Q 000659 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033 (1368)
Q Consensus 955 S~~~fsleELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~ 1033 (1368)
....++.+++ ...|...++||+|+||.||+|+. .+|+.||||+++..... ..+|++++++++|+|||+++|+
T Consensus 679 ~~~~~~~~~~---~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~ 751 (968)
T PLN00113 679 VSKSITINDI---LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGL 751 (968)
T ss_pred cchhhhHHHH---HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEE
Confidence 1122344444 34577788999999999999996 57899999998754322 2356889999999999999999
Q ss_pred eeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccc
Q 000659 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113 (1368)
Q Consensus 1034 ~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKL 1113 (1368)
|.+++..|+||||+++|+|.++++ .++|.++++|+.|+++||+|||..+.++|+|||||++|||+|.++..++
T Consensus 752 ~~~~~~~~lv~Ey~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~ 824 (968)
T PLN00113 752 CRSEKGAYLIHEYIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824 (968)
T ss_pred EEcCCCCEEEEeCCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence 999999999999999999999994 3899999999999999999999776667999999999999999988877
Q ss_pred ccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1114 sDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
. ||....... .....|+..|||||++.+..++.|+|||||||+||||++|+.||+... .....+++|++...
T Consensus 825 ~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~ 896 (968)
T PLN00113 825 R-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF-GVHGSIVEWARYCY 896 (968)
T ss_pred E-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCccc-CCCCcHHHHHHHhc
Confidence 5 665543321 122358899999999999999999999999999999999999996533 23456778876554
Q ss_pred ccccccceeecCCCCCC--CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1194 TSREGLERIIDPSLGND--VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~--~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.. .....++|+.+... ...++..++.+++.+||+.||++||+|+||+++|+++.+.
T Consensus 897 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 897 SD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred Cc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 43 33555667666443 3346677899999999999999999999999999977653
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=426.19 Aligned_cols=260 Identities=34% Similarity=0.566 Sum_probs=216.1
Q ss_pred ceeeEEeecCcEEEEEEEecCCCEEEEEEeecccch--hhHHHHHHHHHHhhcccccceeeeeeeeecc-ceEEEEeecC
Q 000659 972 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELIP 1048 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~--~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-~~~LVmEYm~ 1048 (1368)
.+.+.||+|+||+||+|.++....||||++...+.. ..++|.+|+.+|.+|+|+|||+|+|+|.+.. ..+||||||+
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 344569999999999999994444999999754322 2568999999999999999999999999887 7999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Cccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsDFGLArll~~~~~ 1127 (1368)
+|+|.++|+.. ....+++..+++|+.|||+||.|||+++. |||||||++||||+.++ .+||+|||+++......
T Consensus 124 ~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~- 198 (362)
T KOG0192|consen 124 GGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK- 198 (362)
T ss_pred CCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence 99999999764 35679999999999999999999998752 99999999999999998 99999999998664321
Q ss_pred ccccccccccccccCcchhc--cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1128 RHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~--~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
...+...||..|||||+++ ...|+.|+|||||||+||||+||+.||..... . . ....++..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~--~-------------~~~~v~~~ 261 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V--Q-------------VASAVVVG 261 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H--H-------------HHHHHHhc
Confidence 2234467999999999999 66999999999999999999999999976532 1 1 11122223
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhhh
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1253 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~e 1253 (1368)
..+..++..+...+..|+.+||+.||++||++.|++..|+.+......
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~ 309 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS 309 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence 334455555778899999999999999999999999999988876543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=433.15 Aligned_cols=266 Identities=29% Similarity=0.488 Sum_probs=225.4
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeecc
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~ 1038 (1368)
.-..+.+..+.||+|+||+||+|... +...||||.||+.... ..++|+||+++|..|+|+|||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33456677889999999999999943 4567999999986665 7889999999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhccccccc------C----CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDK------E----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1108 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~------~----~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n 1108 (1368)
-+|+|+|||..|+|.+||+.... . ...|+..+.+.|+.|||.||+||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999974221 1 223899999999999999999999876 9999999999999999
Q ss_pred CCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHH
Q 000659 1109 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVA 1187 (1368)
Q Consensus 1109 g~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~ 1187 (1368)
..|||+||||+|.....++.....+-+-..+||+||.++.++|+.+||||||||+|||+++ |+-||.....
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn-------- 711 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN-------- 711 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch--------
Confidence 9999999999998877666665555556789999999999999999999999999999999 9999865432
Q ss_pred hhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1188 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1188 Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
++.++.+-+..+ -..++.+..+++.||..||+.+|++||+++||-..|+...+..
T Consensus 712 --------~EVIe~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s 766 (774)
T KOG1026|consen 712 --------QEVIECIRAGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS 766 (774)
T ss_pred --------HHHHHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence 122222222222 2456788899999999999999999999999999999877654
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=395.47 Aligned_cols=250 Identities=27% Similarity=0.456 Sum_probs=202.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.++|.+.+.||+|+||+||+|+++ ++..||||.+.+. .....+.+..||++|+.|+|+|||+|++++++++.+||||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 467888999999999999999954 6899999999654 5556677889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC------CCcccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD------FTPKVSDFGL 1118 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n------g~VKLsDFGL 1118 (1368)
|||+||+|.+||+.. ..+++.+...++.|||.||++||+++ ||||||||+||||+.+ -.+||+|||+
T Consensus 89 EyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 999999999999743 36999999999999999999999998 9999999999999764 3589999999
Q ss_pred cccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~ 1198 (1368)
||.+.. .....+.||++.|||||+++.++|+.|+|+||+|+|||||++|+.||+.....+ +..+ .+....
T Consensus 162 AR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e---L~~~----~~k~~~ 231 (429)
T KOG0595|consen 162 ARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE---LLLY----IKKGNE 231 (429)
T ss_pred hhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH---HHHH----Hhcccc
Confidence 998853 344567899999999999999999999999999999999999999998644321 1111 111111
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1199 L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
+....+......+.+++...++.++++|-++.+.+.
T Consensus 232 --------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~ 267 (429)
T KOG0595|consen 232 --------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFD 267 (429)
T ss_pred --------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhh
Confidence 111122222334456677777777777777666543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=409.08 Aligned_cols=255 Identities=32% Similarity=0.495 Sum_probs=216.4
Q ss_pred cceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+.+.+.||+|-||.||+|.++....||||.++.. ....++|.+|+++|++|+|+|||+|+|+|..++.+|||||||..|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 3456789999999999999998889999999864 445578999999999999999999999999988999999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~ 1130 (1368)
+|.+||+. .+...+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+...++.+ ..
T Consensus 287 sLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y-~~ 360 (468)
T KOG0197|consen 287 SLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY-TA 360 (468)
T ss_pred cHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce-ee
Confidence 99999975 34457889999999999999999999888 99999999999999999999999999995544332 22
Q ss_pred cccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....-...|.|||.+..+.++.|||||||||+||||+| |+.||..... ..+.+.++...+-
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-----------------~ev~~~le~GyRl 423 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-----------------EEVLELLERGYRL 423 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-----------------HHHHHHHhccCcC
Confidence 333334678999999999999999999999999999999 9988865421 1122233444445
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
..+..|...+.+||..||+.+|++|||++.+...|+++..
T Consensus 424 p~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 424 PRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 5667788999999999999999999999998888887654
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-43 Score=393.73 Aligned_cols=259 Identities=28% Similarity=0.406 Sum_probs=214.3
Q ss_pred CCHHHHHHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeec-ccchhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 959 fsleELe~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~-~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
+++.||+ ..+.||+|..|+|||+.++ +++.+|+|.+.. .+....+++.+|++++++.+|+|||.++|.|..
T Consensus 76 i~~~dle-------~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLE-------RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhh-------hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 4555555 4579999999999999966 788999999953 355667889999999999999999999999999
Q ss_pred cc-ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeeecCCCCcccc
Q 000659 1037 EQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVS 1114 (1368)
Q Consensus 1037 ~~-~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILLD~ng~VKLs 1114 (1368)
++ .++|+||||++|+|++++... +.+++...-+|+.+|++||.|||+ ++ ||||||||+||||+.+|++|||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKic 221 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKIC 221 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEec
Confidence 88 499999999999999999643 469999999999999999999996 54 9999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcc
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls 1194 (1368)
|||.++.+... .....+||..|||||.+.+..|+.++||||||+.|+||.+|+.||-..+ .....|+.
T Consensus 222 DFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~----~~~~~~~~---- 289 (364)
T KOG0581|consen 222 DFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPN----PPYLDIFE---- 289 (364)
T ss_pred cccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcC----CCCCCHHH----
Confidence 99999877432 5566789999999999999999999999999999999999999996541 11122221
Q ss_pred cccccceeecCCCCCCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1195 SREGLERIIDPSLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1195 ~~e~L~eIvDp~L~~~~~~-ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.+..|++... ...+. .+..+|..++..||++||.+|++..|+++.-...
T Consensus 290 ---Ll~~Iv~~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~ 339 (364)
T KOG0581|consen 290 ---LLCAIVDEPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIK 339 (364)
T ss_pred ---HHHHHhcCCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHh
Confidence 1222333111 12333 3778999999999999999999999999875543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=405.20 Aligned_cols=250 Identities=27% Similarity=0.415 Sum_probs=213.5
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~---~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.+|...++||+|||++||+++. .+|+.||+|++.+ ......+++.+||+|.++|+|+|||+++++|++.+++|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 8999999999965 23445677899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
|+|.+|+|.++++ ....+++.+++.++.||+.||.|||+++ |||||||..||||+++.++||+|||||..+..
T Consensus 98 ELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~ 170 (592)
T KOG0575|consen 98 ELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEY 170 (592)
T ss_pred EecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecC
Confidence 9999999999995 3457999999999999999999999888 99999999999999999999999999998864
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
+.. ...+.|||+.|+|||++.....+..+||||+|||||.||+|+.||+.....+ -.+.....+
T Consensus 171 ~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke------ty~~Ik~~~-------- 234 (592)
T KOG0575|consen 171 DGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE------TYNKIKLNE-------- 234 (592)
T ss_pred ccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH------HHHHHHhcC--------
Confidence 333 2356899999999999999999999999999999999999999998643211 111111000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..++.....+..+||.++|+.+|.+||++++|++.-.
T Consensus 235 ----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~F 271 (592)
T KOG0575|consen 235 ----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPF 271 (592)
T ss_pred ----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHh
Confidence 1223345577889999999999999999999987533
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=382.84 Aligned_cols=264 Identities=25% Similarity=0.423 Sum_probs=207.8
Q ss_pred hCCcceeeEEeecCcEEEEEEEe------cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeeeeeeeec-c
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE-Q 1038 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl------kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~-~ 1038 (1368)
.++|++.++||+|+||.||+|.+ .+++.||||+++... ....+.+.+|+++|+++ +|+||++++++|.+. +
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46799999999999999999974 235679999997533 23456789999999999 899999999998764 4
Q ss_pred ceEEEEeecCCCChhhccccccc---------------------------------------------------------
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDK--------------------------------------------------------- 1061 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~--------------------------------------------------------- 1061 (1368)
.+++||||+++|+|.++|+....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864221
Q ss_pred -CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccccc
Q 000659 1062 -ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140 (1368)
Q Consensus 1062 -~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gY 1140 (1368)
....+++.++++++.||++||+|||+.+ |+|||||++||||++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0235889999999999999999999887 999999999999999999999999999865432222222234467889
Q ss_pred cCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHH
Q 000659 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKV 1219 (1368)
Q Consensus 1141 mAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eL 1219 (1368)
+|||++.+..++.++|||||||+||||++ |+.||....... .+... +.... .......+...+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~----~~~~~----------~~~~~~~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQR----LKDGT----------RMRAPENATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHH----HhcCC----------CCCCCCCCCHHH
Confidence 99999999999999999999999999997 999997643211 11111 11110 001122345678
Q ss_pred HHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1220 AAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1220 l~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.+|+.+||+.||++||++.||++.|+.++.+
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=386.55 Aligned_cols=259 Identities=26% Similarity=0.360 Sum_probs=209.6
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccch-------hhHHHHHHHHHHhhcccccceeeeeeeeecc
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ-------GGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~-------~~keFlrEIeILsrLrHPNIVrLlG~~~d~~ 1038 (1368)
..+.|.+.+.||+|+||.|-+|. .++|+.||||++++.... ....+.+|+++|++|+|||||+++++++..+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 45678889999999999999999 568999999999653221 2234679999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC---CCccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVSD 1115 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n---g~VKLsD 1115 (1368)
..|||||||+||+|.+++- .+..+.++.-..+++|++.||.|||++| |+||||||+||||..+ ..+||+|
T Consensus 250 s~YmVlE~v~GGeLfd~vv----~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVV----ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred ceEEEEEEecCccHHHHHH----hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 9999999999999999984 3446888888999999999999999998 9999999999999665 7799999
Q ss_pred ccccccccccccccccccccccccccCcchhccCC---CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1116 FGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~---~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
||||+.... .....+.|||+.|+|||++.++. +..|+|+||+|||||-+|+|..||....... .+.+.+
T Consensus 323 FGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI--- 394 (475)
T KOG0615|consen 323 FGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQI--- 394 (475)
T ss_pred cchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHH---
Confidence 999997752 34456789999999999998653 3458899999999999999999997543221 121111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
.+ +.+ .+....+.+..++.++|+.+||..||++|+++.|+++.-|..+
T Consensus 395 ~~--G~y------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 395 LK--GRY------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred hc--Ccc------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhc
Confidence 01 000 0111233456788999999999999999999999998876543
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=361.42 Aligned_cols=264 Identities=26% Similarity=0.444 Sum_probs=206.2
Q ss_pred CCcceeeEEeecCcEEEEEEEecC-----------------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD-----------------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKL 1030 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd-----------------Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrL 1030 (1368)
++|++.+.||+|+||.||+|.+++ +..||||+++... ....++|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 578899999999999999998543 3369999987542 3345679999999999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhccccccc---------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccc
Q 000659 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDK---------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095 (1368)
Q Consensus 1031 lG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~---------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVH 1095 (1368)
++++.+.+..++||||+.+|+|.+++..... ....++|.++++|+.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 9999999999999999999999998854211 1135788999999999999999999887 999
Q ss_pred cCCcccCeeecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh--CCCC
Q 000659 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKP 1173 (1368)
Q Consensus 1096 RDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT--Gr~P 1173 (1368)
||||++||||+.++.+||+|||+++...............++..|||||++..+.++.++|||||||++|||++ |..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986644332223334456889999999999999999999999999999987 5567
Q ss_pred CCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1174 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1174 Fd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
|..... .....++...+........ ......+...+.+|+.+||+.+|++||++.||++.|+
T Consensus 242 ~~~~~~---~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 242 YGELTD---EQVIENAGEFFRDQGRQVY-------LFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCcCCH---HHHHHHHHHHhhhcccccc-------ccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 754321 2222222222211110000 0112234567999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=378.88 Aligned_cols=253 Identities=26% Similarity=0.373 Sum_probs=209.3
Q ss_pred HHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc----cc-hhhHHHHHHHHHHhhcc-cccceeeeeeeeecc
Q 000659 966 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV----DQ-QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~----d~-~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~ 1038 (1368)
...++|.+.+.||+|.||+||+|. ..+|+.||||++++. .. ...+.+.+|+.++++++ |+||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 446789999999999999999998 457899999977553 12 33556778999999999 999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC-CCccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFG 1117 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n-g~VKLsDFG 1117 (1368)
.+|+||||+.||+|.+++.. ..++.+.+..+++.|++.||+|||++| |+|||||++|||||.+ +++||+|||
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999953 346888999999999999999999998 9999999999999999 999999999
Q ss_pred ccccccccccccccccccccccccCcchhccCC-CC-cccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGH-LL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~~~-~T-~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
++.... .......+.|||+.|+|||++.+.. |+ .++|||||||+||.|++|+.||+..+. ....+.....
T Consensus 167 ~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRKIRKG 238 (370)
T ss_pred cccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHHHhcC
Confidence 998763 2334456789999999999999876 75 899999999999999999999987321 1111111111
Q ss_pred ccccceeecCCCCCCCChhh-HHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDS-VAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee-~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.- .++... ..++..|+.+|+..||.+|+++.||++.=+
T Consensus 239 ~~------------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w 277 (370)
T KOG0583|consen 239 EF------------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW 277 (370)
T ss_pred Cc------------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence 11 122222 567899999999999999999999985433
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=359.87 Aligned_cols=261 Identities=19% Similarity=0.349 Sum_probs=208.0
Q ss_pred CCcCCCHHHHHHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchh---hHHHHHHHHHHhhcccccceeee
Q 000659 955 SAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG---GREFLAEVEMLSRLHHRNLVKLI 1031 (1368)
Q Consensus 955 S~~~fsleELe~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~---~keFlrEIeILsrLrHPNIVrLl 1031 (1368)
+.+.++.++++ +.....||+|++|.||+|.++ |+.||||+++...... .+.|.+|+++|++++|+|||+++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 44555666663 222368999999999999985 8999999997543322 46788999999999999999999
Q ss_pred eeeee----ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhcc-CCCCccccCCcccCeeec
Q 000659 1032 GICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLE 1106 (1368)
Q Consensus 1032 G~~~d----~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~-gsp~IVHRDIKPsNILLD 1106 (1368)
|++.+ ....++||||+.+|+|.++++. ...++|..+++++.|++.||.|||+. + ++|||||++|||++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~ 157 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVT 157 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEEC
Confidence 99876 3467899999999999999963 23689999999999999999999975 5 88999999999999
Q ss_pred CCCCcccccccccccccccccccccccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh
Q 000659 1107 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1184 (1368)
Q Consensus 1107 ~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n 1184 (1368)
+++.+||+|||+++...... ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||+.... ..
T Consensus 158 ~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~---~~ 229 (283)
T PHA02988 158 ENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT---KE 229 (283)
T ss_pred CCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH---HH
Confidence 99999999999998653211 23458899999999876 6899999999999999999999999975432 11
Q ss_pred HHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1185 Lv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
+... ..... .....+..+...+.+|+.+||+.||++||++.||++.|+++..
T Consensus 230 ~~~~---i~~~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 230 IYDL---IINKN----------NSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred HHHH---HHhcC----------CCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 11111 1111222455679999999999999999999999999987653
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=412.36 Aligned_cols=264 Identities=31% Similarity=0.499 Sum_probs=220.8
Q ss_pred CCcceeeEEeecCcEEEEEEEecC--CC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD--GT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd--Gr----~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
.+.++.+.||+|.||.||+|.+.+ |. .||||.+++. +.+...+|++|..+|++++|+|||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 456678899999999999999653 33 4999999764 5566789999999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccC---CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKE---SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~---~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGL 1118 (1368)
|++|||++|+|..||+..+.. ...|...+++.|+.|||+|+.||++++ +|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999754221 346899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSRE 1197 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e 1197 (1368)
|+.+.+.++.......+-...|||||.++++.++.|+|||||||+||||+| |..||...+. .+-+..|.+ .+
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n--~~v~~~~~~-----gg 921 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN--FEVLLDVLE-----GG 921 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch--HHHHHHHHh-----CC
Confidence 997766555444433344579999999999999999999999999999999 9999965432 122222211 11
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhh
Q 000659 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1198 ~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
+-+.+..|...+++||..||+.+|++||++..|++.+..+.+...
T Consensus 922 ----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~ 966 (1025)
T KOG1095|consen 922 ----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAAL 966 (1025)
T ss_pred ----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhc
Confidence 224566788999999999999999999999999998888877554
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=370.86 Aligned_cols=257 Identities=26% Similarity=0.420 Sum_probs=212.0
Q ss_pred CcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeeeee-eeeccc-eEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGI-CIEEQA-RCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~-~~d~~~-~~LVm 1044 (1368)
+|++.++||+|.||+|||+. +.+|+.||.|.++. .+....+++..||.+|++|+|+|||+++++ +.++.+ ++|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 47788999999999999999 67899999999863 355566788999999999999999999994 555555 79999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCC--ccccCCcccCeeecCCCCcccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR--VIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~--IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
|||++|+|.+.++.+.+....+.+.++|+++.|+++||..||..- ++ |+||||||.||+||.+|.+||+||||++.+
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999999888888889999999999999999999999842 33 999999999999999999999999999987
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
... .......+||+.||+||.+....|+.|+||||+||+||||+.-+.||...+ +...-+. +.
T Consensus 179 ~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~~L~~K-I~-------- 241 (375)
T KOG0591|consen 179 SSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LLSLCKK-IE-------- 241 (375)
T ss_pred cch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HHHHHHH-HH--------
Confidence 542 334456789999999999999999999999999999999999999997642 2111111 10
Q ss_pred ecCCCCCCCC-hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1203 IDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1203 vDp~L~~~~~-~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
.-.+ ...+ .-...++..|+..|+..|++.||+.-.+++.+..
T Consensus 242 -qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 242 -QGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred -cCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 0011 1122 4567789999999999999999997666555443
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=375.64 Aligned_cols=261 Identities=25% Similarity=0.400 Sum_probs=206.6
Q ss_pred hCCcceeeEEeecCcEEEEEEEe------cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccc
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl------kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~ 1039 (1368)
.++|++.+.||+|+||.||+|.. +++..||||+++... ....+.+.+|+++|+.+ +|+||++++++|.+.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 34688899999999999999973 345689999997432 33456789999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 1061 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~---------------------------------------------------------- 1061 (1368)
.++||||+++|+|.++++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999864221
Q ss_pred -------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1062 -------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1062 -------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
....++|.++++|+.||++||+|||+.+ |+|||||++||||++++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1125889999999999999999999887 999999999999999999999999999866433222
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.......++..|+|||++.+..++.++|||||||+||||++ |..||...... ..+..+.....
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~~~-------------- 334 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKEGY-------------- 334 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHhCc--------------
Confidence 22222345678999999999999999999999999999998 88888653221 22222221100
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
..........++.+|+.+||+.||++||++.||++.|++.
T Consensus 335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0011112345789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=352.61 Aligned_cols=258 Identities=30% Similarity=0.506 Sum_probs=208.6
Q ss_pred CCcceeeEEeecCcEEEEEEEecC------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd------Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
++|++.+.||+|+||.||+|.... ++.|++|.++... ....++|.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 368888999999999999998542 2579999986433 334567899999999999999999999999989999
Q ss_pred EEEeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC
Q 000659 1042 LVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1109 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng 1109 (1368)
++|||+++|+|.++|..... ....+++.+++.++.|++.||+|||+.+ |+|||||++||||++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 1145889999999999999999999987 99999999999999999
Q ss_pred CcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHh
Q 000659 1110 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAW 1188 (1368)
Q Consensus 1110 ~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~W 1188 (1368)
.+||+|||+++...............++..|+|||++.++.++.++|||||||+||||++ |..||..... ..+..+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986543332223334457889999999998999999999999999999998 9999865432 222222
Q ss_pred hhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
+.. .........+..++.+|+.+||+.+|++||++.||++.|+.
T Consensus 239 i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 239 IRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 01111233456789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=374.33 Aligned_cols=262 Identities=27% Similarity=0.447 Sum_probs=206.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEe------cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccc
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl------kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~ 1039 (1368)
.++|++.+.||+|+||.||+|+. ++++.||||+++... ....+.+.+|+++|+++ +|+|||+++++|.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 34789999999999999999883 234579999997533 33345688999999999 89999999999999999
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 1061 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~---------------------------------------------------------- 1061 (1368)
.++||||+.+|+|.++++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 9999999999999998853210
Q ss_pred --------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccccc
Q 000659 1062 --------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1133 (1368)
Q Consensus 1062 --------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~ 1133 (1368)
....+++.++++|+.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++.............
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1235889999999999999999999887 99999999999999999999999999986543222222222
Q ss_pred ccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1134 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1134 v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
..++..|||||++.+..++.++|||||||+||||++ |+.||....... .+... .. ........
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~----~~----------~~~~~~~~ 337 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKM----VK----------RGYQMSRP 337 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHH----HH----------cccCccCC
Confidence 345678999999999999999999999999999997 999996543211 11110 00 00011111
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
.....++.+++.+||+.||++||++.||++.|+++.
T Consensus 338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 123467899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=351.69 Aligned_cols=252 Identities=24% Similarity=0.355 Sum_probs=202.4
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.|+..+.||+|+||.||+|.. .+|+.||||++.... ......+.+|+++|++++|+||+.+++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 378899999999999999995 579999999986432 2334567899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.....
T Consensus 81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05631 81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG 155 (285)
T ss_pred ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence 99999999888532 2235899999999999999999999887 999999999999999999999999999865322
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||.......... ..... +..
T Consensus 156 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~-~~~---------- 219 (285)
T cd05631 156 E---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRR-VKE---------- 219 (285)
T ss_pred C---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHHH-hhc----------
Confidence 1 1233568999999999999999999999999999999999999997643321111 11000 000
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-----MsEVLq~ 1243 (1368)
....+.......+.+|+.+||+.||++|++ ++|+++.
T Consensus 220 -~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 261 (285)
T cd05631 220 -DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261 (285)
T ss_pred -ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence 001122234567899999999999999997 7777764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=352.11 Aligned_cols=251 Identities=34% Similarity=0.582 Sum_probs=197.1
Q ss_pred ceeeEEeecCcEEEEEEEec-----CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 972 DASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlk-----dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++.+.||.|.||.||+|.+. .+..|+||+++.. .....++|.+|+++|++++|+||++++|+|...+..++|||
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccc
Confidence 46789999999999999977 3567999999653 33447889999999999999999999999998888999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+|+|.++|+.. ....+++.++++|+.||++||.|||+++ |+||||+++||||++++.+||+|||+++.....
T Consensus 82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~ 156 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK 156 (259)
T ss_dssp --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred cccccccccccccc--cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccc
Confidence 99999999999754 2346999999999999999999999887 999999999999999999999999999876332
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
..........+...|+|||.+....++.++||||||+++|||++ |+.||.... ...+...+. . ..
T Consensus 157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~---~~~~~~~~~---~-~~------- 222 (259)
T PF07714_consen 157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYD---NEEIIEKLK---Q-GQ------- 222 (259)
T ss_dssp SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSC---HHHHHHHHH---T-TE-------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccc---c-cc-------
Confidence 22222333457789999999999999999999999999999999 778875432 122222211 1 10
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.......+...+.+++.+||+.+|++||+|.||++.|
T Consensus 223 ---~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 ---RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ---ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ---cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 0112223456789999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=349.34 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=208.5
Q ss_pred CCcceeeEEeecCcEEEEEEEecC------CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd------Gr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
++|.+.+.||+|+||.||+|...+ ++.||||+++..... ..++|.+|+++|++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 468888999999999999998643 478999999765443 4578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccc----------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCc
Q 000659 1042 LVYELIPNGSVESHLHGVD----------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~----------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~V 1111 (1368)
+||||+.+|+|.++|+... .....+.+.++++++.|++.||+|||+.+ |+|||||++||||+.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996432 12345889999999999999999999887 9999999999999999999
Q ss_pred ccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhh
Q 000659 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1112 KLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~ 1190 (1368)
||+|||+++...............++..|+|||++....++.++|||||||+||||++ |+.||..... ....++..
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~---~~~~~~~~ 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN---EEVIECIT 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH
Confidence 9999999986533222222233446788999999999999999999999999999998 9999865332 22222221
Q ss_pred hhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1191 plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
. ... ..........+.+++.+||+.||++||++.||++.|+
T Consensus 239 ---~--~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 239 ---Q--GRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred ---c--CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 0 000 1112234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.45 Aligned_cols=259 Identities=25% Similarity=0.435 Sum_probs=206.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCC----EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr----~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
.+|++.+.||+|+||.||+|++. +|+ .||||+++... ....++|.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 46999999999999999999853 344 38999987543 34457899999999999999999999999864 5689
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
|+||+.+|+|.++++.. ...+++..+++++.||++||+|||+.+ |+|||||++||||++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999643 235889999999999999999999887 999999999999999999999999999876
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.............++..|++||++.+..++.++|||||||+||||++ |+.||+.... ..+..+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~---~~~~~~~~----~~~---- 228 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA---SEISSILE----KGE---- 228 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----CCC----
Confidence 43322221222335678999999999999999999999999999998 9999965321 11111111 110
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
.......+..++.+++.+||..+|++||++.|+++.|..+.++.
T Consensus 229 ------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 229 ------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred ------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 00111234457899999999999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=348.14 Aligned_cols=255 Identities=25% Similarity=0.375 Sum_probs=204.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec----CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk----dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|.+. .+..||+|+++... ....+.|.+|+.++++++|+||++++|++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46899999999999999999853 35689999997543 23346789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|.+++... ...++|.++++++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||++....
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 85 TEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999632 246899999999999999999999887 9999999999999999999999999876542
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.... .......++..|+|||++.+..++.++|||||||++|||++ |+.||..... ..+.+.. .+.
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~---~~~~~~~----~~~------ 224 (266)
T cd05064 159 SEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG---QDVIKAV----EDG------ 224 (266)
T ss_pred ccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHH----HCC------
Confidence 2111 11112345678999999999999999999999999999875 9999965422 1111211 100
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
........+...+.+++.+||+.+|++||++.||++.|.++
T Consensus 225 ----~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ----FRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 00111233456789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=349.61 Aligned_cols=263 Identities=25% Similarity=0.414 Sum_probs=210.0
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeec
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 1037 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~ 1037 (1368)
...++|++.+.||+|+||.||++... +...|++|+++.. ......++.+|+++++++ +|+||+++++++.++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34467899999999999999999854 2367999998753 233446788999999999 799999999999999
Q ss_pred cceEEEEeecCCCChhhcccccc------------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee
Q 000659 1038 QARCLVYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~------------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL 1105 (1368)
+..++||||+.+|+|.++++... .....+++..+++|+.|++.||+|||+.+ |+|||||++|||+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 99999999999999999986421 23456899999999999999999999887 9999999999999
Q ss_pred cCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchh
Q 000659 1106 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1184 (1368)
Q Consensus 1106 D~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~n 1184 (1368)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...... .
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~ 242 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE---E 242 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHH---H
Confidence 9999999999999987644322222223345678999999999999999999999999999998 98888643211 1
Q ss_pred HHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1185 Lv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
+.... . ..........+...+.+|+.+||+.+|++||++.||++.|+.+.
T Consensus 243 ~~~~~----~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 LFKLL----K----------EGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHH----H----------cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 11111 0 01111222344567999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=393.48 Aligned_cols=268 Identities=27% Similarity=0.452 Sum_probs=223.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec----CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk----dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
....+.++||.|.||+||+|+++ ....||||.||.. .+...++|+.|+.||.+++||||++|.|+.....-.+||
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 34567899999999999999976 2457999999875 345567899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
.|||+||+|+.||+..+ ..+++.++.-++++||.||.||-+++ +|||||..+||||+.+..+||+||||+|.+.
T Consensus 709 TEyMENGsLDsFLR~~D---GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQND---GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred hhhhhCCcHHHHHhhcC---CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999997654 45999999999999999999999888 9999999999999999999999999999775
Q ss_pred ccccccccc-cccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1124 DEESRHIST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1124 ~~~~~~~st-~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
++......+ ...-..+|.|||.+..+++|.++|||||||+|||.|+ |.+||-... +....+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS-----------------NQdVIk 845 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS-----------------NQDVIK 845 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc-----------------hHHHHH
Confidence 543222111 1223479999999999999999999999999999998 988873321 111222
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhhhhhhcCC
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGS 1259 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~e~~ev~s 1259 (1368)
.++..++---+.+|...|.+||+.||+.|-.+||.+.||+..|.++..+...-+....
T Consensus 846 aIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~SLk~~~~ 903 (996)
T KOG0196|consen 846 AIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPNSLKTIAP 903 (996)
T ss_pred HHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCchhhcccCC
Confidence 3344455566789999999999999999999999999999999998886654444333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=375.32 Aligned_cols=265 Identities=25% Similarity=0.444 Sum_probs=221.8
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
.....+++.||+|.||+|.++..+.+..||||+++.... ...++|.+||++|.+|+|||||+|+|+|..++-+++|+||
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 455667899999999999999999889999999986544 4458999999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
|++|+|.+||...... .+.....++|+.||+.||+||.+.+ +|||||.++|||+|.++++||+|||++|.+..++
T Consensus 617 mEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~ 691 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD 691 (807)
T ss_pred HhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCC
Confidence 9999999999643322 2566677889999999999999887 9999999999999999999999999999887777
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh--CCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT--Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
+.....+.+-..+|||+|.+..++++.++|||+|||+|||+++ .+.||.... .+..++-...++.....-.-+
T Consensus 692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~~~~~~~~~~~l-- 766 (807)
T KOG1094|consen 692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGEFFRDQGRQVVL-- 766 (807)
T ss_pred ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhhhcCCCCcceec--
Confidence 7777777778899999999999999999999999999999876 778886543 233444444344332221111
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
..+.-+..++++++.+||..|-++||++++|...|.+.
T Consensus 767 -----~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 767 -----SRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred -----cCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 22345678899999999999999999999999888754
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=381.21 Aligned_cols=272 Identities=26% Similarity=0.437 Sum_probs=216.4
Q ss_pred CCHHHHHHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 959 fsleELe~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
...++++...+.+.+.+.||+|.||+||||.+. | .||||+|+.. ..+..+.|++|+.+|++-||.||+-++|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh-G-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWH-G-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccc-c-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 344566666677788999999999999999977 2 4999999754 34466789999999999999999999999998
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
... .||..+|+|.+|+.+||..+ ..++..+.+.|++|||+||.|||.++ |||||||..||||+++++|||+||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDF 532 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDF 532 (678)
T ss_pred Cce-eeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecc
Confidence 776 99999999999999998644 45889999999999999999999998 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhcc---CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~---~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
||+..-..-........-.|...|||||+++. ..|+..+||||||+|+|||++|..||...+. ++ . -|+ +
T Consensus 533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dq-I--ifm---V 605 (678)
T KOG0193|consen 533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQ-I--IFM---V 605 (678)
T ss_pred cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hh-e--EEE---e
Confidence 99975432222222223447889999999874 4689999999999999999999999973221 11 1 110 1
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhh
Q 000659 1194 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
.+.....++ ......+..+|.+|+..||..++++||.+.+|+..|+.+.....
T Consensus 606 GrG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~p 658 (678)
T KOG0193|consen 606 GRGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLP 658 (678)
T ss_pred cccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhccc
Confidence 111001111 12234567889999999999999999999999999888877543
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=359.05 Aligned_cols=253 Identities=26% Similarity=0.378 Sum_probs=206.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|++++++++|+||+++++++.+.+..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999965 58999999997532 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+.+.+++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~ 153 (333)
T cd05600 81 EYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT 153 (333)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence 99999999999953 235889999999999999999999888 99999999999999999999999999986533
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhcccccccceee
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+..+. ..+..|.. .+..
T Consensus 154 -----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~-------~~~~-- 219 (333)
T cd05600 154 -----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE-------TLQR-- 219 (333)
T ss_pred -----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc-------cccC--
Confidence 23446799999999999999999999999999999999999999976432211 11122211 0000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+. ..........++.+++.+||..++++|+++.|+++.-
T Consensus 220 -~~-~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~ 258 (333)
T cd05600 220 -PV-YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP 258 (333)
T ss_pred -CC-CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence 00 0000123456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=359.58 Aligned_cols=266 Identities=23% Similarity=0.349 Sum_probs=207.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.++|++.+.||+|+||.||+++.. +|..||+|+++.. .....++|.+|+++|++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999955 6888999998753 23345679999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+++|+|.+++.. ...+++..+.+++.|++.||+|||+.+ +|+|||||++||||+.++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 157 (331)
T cd06649 84 HMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (331)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc
Confidence 9999999999853 235889999999999999999999753 3999999999999999999999999999765332
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhh-hcccccc------
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP-LLTSREG------ 1198 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~p-lls~~e~------ 1198 (1368)
......|+..|+|||++.+..++.++|||||||+||||++|+.||...... .+...... .......
T Consensus 158 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK---ELEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred ----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHhcccccccccCCccccC
Confidence 223456999999999999999999999999999999999999999653321 11111110 0000000
Q ss_pred --------------------------cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1199 --------------------------LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1199 --------------------------L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
+..++..............++.+|+.+||+.||++||+++||++..+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~ 304 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFI 304 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHH
Confidence 000000000000111234678999999999999999999999887653
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.91 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=203.9
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
++|++.+.||+|+||.||++.++++..+++|.++.. ....++|.+|+++|++++|+||+++++++.+++..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 358889999999999999999988889999998643 3345689999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.++++.. ...++|..+++++.|++.||+|||+.+ |+|||||++||+|++++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05114 83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence 99999998642 235899999999999999999999887 999999999999999999999999999865332111
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......++..|+|||++....++.++||||||++||||++ |+.||..... .....+... .. ...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~---~~~~~~i~~----~~---~~~---- 221 (256)
T cd05114 157 -SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN---YEVVEMISR----GF---RLY---- 221 (256)
T ss_pred -ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHHC----CC---CCC----
Confidence 1122235678999999988889999999999999999999 8999865321 222222211 00 000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.+......+.+++.+||+.+|++||++.|+++.|
T Consensus 222 ---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 ---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1112335789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=350.21 Aligned_cols=262 Identities=27% Similarity=0.443 Sum_probs=212.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
++|.+.+.||+|+||.||+|... ++..|++|.++.......+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 46888999999999999999742 355689999876665566789999999999999999999999999999999
Q ss_pred EEeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC
Q 000659 1043 VYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~ 1110 (1368)
||||+.+++|.++++.... ....++|.++++|+.||+.||+|||+++ |+|||||++||||+.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999864321 1235899999999999999999999888 999999999999999999
Q ss_pred cccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhh
Q 000659 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 1189 (1368)
Q Consensus 1111 VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa 1189 (1368)
+||+|||+++...............++..|+|||++....++.++|||||||++|||++ |+.||..... ....++.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~ 238 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN---TEVIECI 238 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH
Confidence 99999999986543332222334557889999999999999999999999999999999 9999865432 1122221
Q ss_pred hhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1190 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1190 ~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.. .... .....+...+.+++.+||+.+|++||++.||+++|+++.+.
T Consensus 239 ~~-----~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 239 TQ-----GRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred hC-----CCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 10 0000 11122346789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=342.46 Aligned_cols=256 Identities=26% Similarity=0.430 Sum_probs=207.4
Q ss_pred CCcceeeEEeecCcEEEEEEEecC----CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|.+.. ...|+||+++... ....++|.+|+.++++++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 578999999999999999999642 4579999986533 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|.+++... ...+++.++++++.|++.||+|||+++ |+|||||++||||++++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998642 236899999999999999999999887 9999999999999999999999999998764
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
............++..|++||++.+..++.++||||||+++|||++ |+.||.... ...+.++....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~---------- 224 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS---NQDVIKAVEDG---------- 224 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC---HHHHHHHHHcC----------
Confidence 2222222222345678999999998999999999999999999998 999985432 12222222110
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
........+...+.+++.+||+.+|++||++.||++.|+++
T Consensus 225 ----~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 ----YRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00011223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=343.22 Aligned_cols=255 Identities=28% Similarity=0.444 Sum_probs=207.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.++|++.+.||+|+||.||+|.+++++.||||.++... ...++|.+|++++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 46799999999999999999998888899999987533 34567999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++.... ...++|.++++++.|++.||.|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 84 KYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred cCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 9999999996432 346899999999999999999999887 99999999999999999999999999987643211
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||..... ..+..... ..
T Consensus 159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~----~~---------- 220 (261)
T cd05068 159 E-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN---AEVLQQVD----QG---------- 220 (261)
T ss_pred c-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHH----cC----------
Confidence 1 1111223458999999999999999999999999999999 9999865321 11111111 00
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
............+.+++.+||+.+|++||++.++++.|+.
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 221 YRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 0011122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=349.26 Aligned_cols=262 Identities=27% Similarity=0.448 Sum_probs=211.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
.+|.+.+.||+|+||.||++... ++..|++|.++.......+.|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999842 345689999976666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccc---------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccc
Q 000659 1043 VYELIPNGSVESHLHGVD---------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~---------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKL 1113 (1368)
||||+.+|+|.++++... .....+++.++++++.|++.||+|||+.+ |+||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 12235899999999999999999999887 999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhh
Q 000659 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1114 sDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||..... ....+...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~---~~~~~~i~-- 236 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN---NEVIECIT-- 236 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH--
Confidence 99999986543222222233446788999999999999999999999999999998 8999865432 11111111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
. .... .........+.+|+.+||+.+|.+||++.||++.|+++.+.
T Consensus 237 -~--~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 237 -Q--GRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred -c--CCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 0 0000 01112345799999999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=347.81 Aligned_cols=259 Identities=28% Similarity=0.503 Sum_probs=205.9
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccc
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~ 1039 (1368)
..++|++.+.||+|+||.||+|.+. +++.||||+++... .....+|.+|+.++++++|+||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4577999999999999999999853 35679999986432 2344578999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccC------CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKE------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~------~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKL 1113 (1368)
.++||||+.+|+|.++++..... ...+++..++.++.|++.||+|||+.+ ++|||||++||||++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 99999999999999998643211 234688999999999999999999887 999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhh
Q 000659 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1114 sDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
+|||+++...............++..|||||++.++.++.++|||||||+||||++ |+.||..... ....++..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~---~~~~~~~~-- 235 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---EQVLRFVM-- 235 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH--
Confidence 99999986543222222223446788999999999999999999999999999999 7888864321 11122111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
. . .. ......+...+.+++.+||+.+|++||++.|+++.|+
T Consensus 236 -~-~-~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 236 -E-G-GL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred -c-C-Cc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 0 0 00 0112234567899999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-39 Score=341.08 Aligned_cols=260 Identities=24% Similarity=0.376 Sum_probs=210.2
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|+. .+++.||||+++.. +....++|.+|++++++++|+||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5799999999999999999995 47899999987542 2344457899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.........+++.++++++.|+++||+|||+.+ |+|||||++||||+.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 999999999988654444456889999999999999999999887 99999999999999999999999999886543
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ...+...... ..
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~~~~-~~------- 224 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQKIEQ-CD------- 224 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHHHhc-CC-------
Confidence 221 122346889999999999888999999999999999999999998543221 1122111110 00
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
............+.+++.+||+.+|++||++.||++.|+.+
T Consensus 225 --~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 225 --YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 00111123446789999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=347.42 Aligned_cols=266 Identities=20% Similarity=0.266 Sum_probs=202.6
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|+.+ +++.||||+++... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 47999999999999999999965 67899999987532 3345678899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.++.|..+.. ....+++..++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++.....
T Consensus 81 ~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 153 (287)
T cd07848 81 YVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEG 153 (287)
T ss_pred cCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence 999887765542 1235899999999999999999999887 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhh-hhh-------ccccc
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA-RPL-------LTSRE 1197 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa-~pl-------ls~~e 1197 (1368)
.. .......|+..|+|||++.+..++.++|||||||+||||++|+.||......+........ ... +....
T Consensus 154 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 154 SN-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cc-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 21 1223456899999999999889999999999999999999999999764322111111110 000 00000
Q ss_pred ccceeecCCCC------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1198 GLERIIDPSLG------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1198 ~L~eIvDp~L~------~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
....+..+... ..+.......+.+|+.+||+.||++|++++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0111123457999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=345.05 Aligned_cols=256 Identities=29% Similarity=0.487 Sum_probs=212.7
Q ss_pred HhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
...+|++.++||+|+||.||+|...+++.|++|+++........++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 44568899999999999999999888999999999876665667899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++|+|.++++... ...+++.++++++.||+.||.|||+.+ |+|||||++||||++++.+||+|||++.......
T Consensus 84 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 84 MEKGSLLAFLRSPE--GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred cccCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 99999999996432 346899999999999999999999887 9999999999999999999999999998664322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......++..|++||++..+.++.++||||||+++|||++ |+.||.... ......+...
T Consensus 159 ~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~-------------- 219 (261)
T cd05148 159 Y--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITA-------------- 219 (261)
T ss_pred c--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHh--------------
Confidence 1 1123346778999999998899999999999999999998 899996533 1122222111
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
.........+...+.+++.+||+.+|++||++.|+++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 220 GYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11112223455778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=341.61 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=207.9
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.++|++.++||+|+||.||+|...+++.|++|.++.. ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 3578999999999999999999888899999998643 334578999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+|+|.++++.. ....+++.++++++.|++.||+|||+.+ ++|||||++|||++.++.+||+|||+++.......
T Consensus 84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 999999999643 2345889999999999999999999887 99999999999999999999999999986643221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......++..|+|||++....++.++|||||||++|||++ |+.||..... .....++.... ..
T Consensus 159 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~~~----~~------- 223 (261)
T cd05072 159 -TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN---SDVMSALQRGY----RM------- 223 (261)
T ss_pred -eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH---HHHHHHHHcCC----CC-------
Confidence 11222346778999999998899999999999999999998 9999965321 22222221100 00
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
........++.+++.+||+.+|++||+++++.+.|+.
T Consensus 224 ---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 224 ---PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred ---CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1111234578899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=348.05 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=208.2
Q ss_pred CcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
+|++.+.||+|+||.||+|... ..+.+++|.++... ....+++.+|+.++++++|+||+++++.|..++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 5788899999999999999853 23578999886433 3345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhccccccc--------------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccC
Q 000659 1043 VYELIPNGSVESHLHGVDK--------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 1102 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~--------------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsN 1102 (1368)
||||+.+|+|.+++..... ....+++.++++++.|++.||+|||+.+ |+|||||++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 9999999999999864211 1235889999999999999999999887 9999999999
Q ss_pred eeecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCc
Q 000659 1103 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPG 1181 (1368)
Q Consensus 1103 ILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~ 1181 (1368)
|||++++.+||+|||+++...............++..|++||++.+..++.++||||||+++|||++ |+.||.....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-- 235 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-- 235 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH--
Confidence 9999999999999999986543322222233456788999999988899999999999999999999 9999864321
Q ss_pred chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1182 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1182 ~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
..+.++... .............+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 236 -~~~~~~~~~--------------~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 -ERLFNLLKT--------------GYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred -HHHHHHHhC--------------CCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 222222111 01111223345678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=345.91 Aligned_cols=258 Identities=28% Similarity=0.478 Sum_probs=206.2
Q ss_pred CCcceeeEEeecCcEEEEEEEe-----cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-----kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
.+|++.+.||+|+||.||+|.+ .+++.|++|.++... ....++|.+|++++++++|+||+++++++..++..|+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4688899999999999999984 356789999997433 3344678999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccc-------------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC
Q 000659 1043 VYELIPNGSVESHLHGVD-------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1109 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~-------------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng 1109 (1368)
||||+.+|+|.+++.... .....+++.+++.++.|++.||+|||+.+ |+||||||+||||++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985221 11235889999999999999999999887 99999999999999999
Q ss_pred CcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHh
Q 000659 1110 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAW 1188 (1368)
Q Consensus 1110 ~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~W 1188 (1368)
.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||..... ..+.+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~---~~~~~~ 238 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN---QEVIEM 238 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH
Confidence 999999999986644332222333446778999999988889999999999999999998 9889864321 122222
Q ss_pred hhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
... .. ..........++.+++.+||+.+|++||++.+|++.|+.
T Consensus 239 ~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 239 VRK----RQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHc----CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 00 001122344678999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=361.52 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=195.4
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
+|+..+.||+|+||.||+|+.. +|+.||||++.... ....++|.+|+++|++++|+||+++++++.+++..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 4556789999999999999954 78999999996433 334567899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++|+|.+.. .+.+..+.+|+.||++||+|||+.+ |+|||||++||||++++++||+|||+++......
T Consensus 155 ~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 155 DGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 999986543 3567788899999999999999887 9999999999999999999999999998654321
Q ss_pred ccccccccccccccCcchhcc-----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1128 RHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~-----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.......||..|+|||++.. ...+.++|||||||+||||++|+.||......+...+.... ..
T Consensus 223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~---~~-------- 290 (353)
T PLN00034 223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI---CM-------- 290 (353)
T ss_pred -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hc--------
Confidence 11234569999999998743 23456899999999999999999999743222111111110 00
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
............++.+|+.+||+.||++||++.||++.-
T Consensus 291 ---~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp 329 (353)
T PLN00034 291 ---SQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP 329 (353)
T ss_pred ---cCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000112223456789999999999999999999998753
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=339.95 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=204.1
Q ss_pred cceeeEEeecCcEEEEEEEecC----CCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccc-----
Q 000659 971 FDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA----- 1039 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~----- 1039 (1368)
|++.+.||+|+||.||+|.+.. +..||||+++.. .....+++.+|++++++++|+||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999998642 367999998743 23445678999999999999999999999876554
Q ss_pred -eEEEEeecCCCChhhcccccc--cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1040 -RCLVYELIPNGSVESHLHGVD--KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1040 -~~LVmEYm~gGSL~d~L~~~~--~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
.++||||+.+|+|.+++.... .....+++..++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 22346899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
|+++...............++..|++||++....++.++|||||||++|||++ |..||..... ..+.++...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN---HEIYDYLRH---- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHc----
Confidence 99986644332222222335678999999988899999999999999999999 8888865321 122222210
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.. .......+..++.+++.+||+.||++||++.||++.|+++
T Consensus 231 ~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GN----------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CC----------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112234556899999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.72 Aligned_cols=262 Identities=24% Similarity=0.414 Sum_probs=211.9
Q ss_pred hCCcceeeEEeecCcEEEEEEEecC-----CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeee-ccce
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQAR 1040 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkd-----Gr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d-~~~~ 1040 (1368)
.++|++.++||+|+||.||+|...+ +..|++|+++.. .....+.+.+|+.++++++|+||+++++++.+ ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4679999999999999999999765 688999998754 33445678999999999999999999999876 4678
Q ss_pred EEEEeecCCCChhhcccccccC----CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKE----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~----~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
++++||+.+|+|.++|...... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998653221 146899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
|+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||+..+. ..+..+.....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~~~-- 236 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP---FEMAAYLKDGY-- 236 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH---HHHHHHHHcCC--
Confidence 99986644333222233456788999999998899999999999999999999 9999965422 22333322110
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
.+ .....+...+.+++.+||..+|++||++.|+++.|+.+.+
T Consensus 237 --~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 237 --RL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --CC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 00 1112234678999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=363.39 Aligned_cols=243 Identities=26% Similarity=0.380 Sum_probs=203.7
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
.++|+++++||+|+||+||.++ .++++.+|+|++++. .....+..++|..||.+++||+||.|+..+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 4679999999999999999999 557899999999753 334456788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
+||+.||.|..+|.+ ...+.++.+.-++..|+.||.|||+.+ ||||||||+|||||.+|.++|+||||++...
T Consensus 104 ld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999953 446889989999999999999999998 9999999999999999999999999999654
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
... ....+.|||..|||||++.+..|+..+|.||||++|||||+|..||...+ ...|.+..+...
T Consensus 177 ~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~------~~~~~~~I~~~k------- 241 (357)
T KOG0598|consen 177 KDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAED------VKKMYDKILKGK------- 241 (357)
T ss_pred cCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCcc------HHHHHHHHhcCc-------
Confidence 322 22345899999999999999999999999999999999999999997643 233333322221
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1236 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT 1236 (1368)
....+.-...+..+++...+..||++|.-
T Consensus 242 ----~~~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 242 ----LPLPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred ----CCCCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 01122223467889999999999999964
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=358.07 Aligned_cols=246 Identities=24% Similarity=0.352 Sum_probs=201.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
.++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357999999999999999999965 68899999997532 23446788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|.+++.. ...+.+..+..++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 999999999999953 235889999999999999999999988 9999999999999999999999999998653
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.. ....+||..|+|||++.+..++.++|||||||+||||++|+.||..... .... ......
T Consensus 170 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~---~~~~---~~i~~~-------- 230 (329)
T PTZ00263 170 DR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP---FRIY---EKILAG-------- 230 (329)
T ss_pred CC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH---HHHH---HHHhcC--------
Confidence 32 1235799999999999999999999999999999999999999964321 1111 111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-----MsEVLq~ 1243 (1368)
.+ .++.....++.+|+.+||+.||++|++ +.|+++.
T Consensus 231 --~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 271 (329)
T PTZ00263 231 --RL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH 271 (329)
T ss_pred --Cc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 00 111223456889999999999999997 5666654
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=340.21 Aligned_cols=255 Identities=27% Similarity=0.416 Sum_probs=206.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.+|++.+.||+|+||.||+|..+ +++.|++|+++.. ....+++.+|++++++++|+||+++++++.+++..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45888999999999999999954 5889999998753 344678999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++|+|.+++.... ...+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 85 ~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~ 159 (263)
T cd05052 85 TYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY 159 (263)
T ss_pred CCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence 9999999985432 345899999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
. ......++..|+|||++.+..++.++|||||||+||||++ |..||..... .. +...... .
T Consensus 160 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~---~~~~~~~-----------~ 221 (263)
T cd05052 160 T-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQ---VYELLEK-----------G 221 (263)
T ss_pred e-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH---HH---HHHHHHC-----------C
Confidence 1 1112234568999999999999999999999999999998 9999864321 11 1111111 1
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
...........++.+++.+||+.+|++||++.|++++|+.+
T Consensus 222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11122233457799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-39 Score=357.49 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=197.8
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
++||+|+||.||++.. .+|+.||||+++.. ......++++|+++|++++|+||+++++++.+.+..|+||||+.+|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999985 57899999999753 2334456889999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~ 1130 (1368)
+|.+++.. ...+++.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~ 151 (323)
T cd05571 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cc
Confidence 99999853 346899999999999999999999888 9999999999999999999999999987542211 12
Q ss_pred cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1210 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~ 1210 (1368)
....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.... .... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~---~~~~~~~---~~~~------------~~ 213 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELI---LMEE------------IR 213 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH---HHHHHHH---HcCC------------CC
Confidence 2346799999999999999999999999999999999999999965321 1111111 1100 01
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1211 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1211 ~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
++.....++.+++.+||+.||++|+ ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 2223456789999999999999999 78888754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=339.46 Aligned_cols=260 Identities=24% Similarity=0.374 Sum_probs=210.5
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|.. .+++.|+||.+... +....++|.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999994 58899999988642 2334467899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+++|.+++.........++|.++++++.||++||+|||+.+ |+|+|||++|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999998754444557899999999999999999999887 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.. .......|+..|+|||++.+..++.++||||||+++|||++|+.||...... ...+..... ....
T Consensus 159 ~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~-------~~~~ 225 (267)
T cd08229 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIE-------QCDY 225 (267)
T ss_pred CC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch----HHHHhhhhh-------cCCC
Confidence 22 1123356889999999999889999999999999999999999998643221 111111100 0000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
. ..........+.+++.+||+.+|++||||.+|++.++++
T Consensus 226 ~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 P---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred C---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1 011123456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=377.09 Aligned_cols=254 Identities=22% Similarity=0.283 Sum_probs=207.8
Q ss_pred CcceeeEEeecCcEEEEEEEec-C-CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-D-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-d-Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.|.+.++||+|+||.||+|... + ++.|++|++...+......+.+|+++|++++|+|||++++++.+++..||||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3899999999999999999844 3 6788899876555555567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++|+|.++|++.......+++.++..|+.||+.||.|||+.+ |+|||||++||||+.++.+||+|||+++.......
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999998654444557899999999999999999999887 99999999999999999999999999987654333
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.......+||.+|+|||++.+..++.++|||||||+||||++|+.||..... ..+... .+... . +
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~---~~~~~~---~~~~~--~----~--- 289 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ---REIMQQ---VLYGK--Y----D--- 289 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHH---HHhCC--C----C---
Confidence 2334456799999999999999999999999999999999999999965321 111111 11100 0 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+|+.+||+.+|++||++.|+++.
T Consensus 290 --~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 290 --PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 1122334678999999999999999999999754
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=334.74 Aligned_cols=260 Identities=25% Similarity=0.413 Sum_probs=211.7
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~---~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|... +|+.|++|.++. .+....+++.+|++++++++|+||+++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999976 899999998863 22334567899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.........+++.++++++.|+++||+|||+.+ |+|||||++|||++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 999999999998654444556899999999999999999999887 99999999999999999999999999876533
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.. .......|+..|+|||++.+..++.++|||||||++|||++|+.||..... .+.++.......
T Consensus 159 ~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~--------- 223 (267)
T cd08224 159 KT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM----NLYSLCKKIEKC--------- 223 (267)
T ss_pred CC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc----cHHHHHhhhhcC---------
Confidence 21 112334688999999999988899999999999999999999999864321 111221111100
Q ss_pred CCCCCCCCh-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1205 PSLGNDVPF-DSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1205 p~L~~~~~~-ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
....... .....+.+++.+||+.+|++||++.+|+++|+.+.
T Consensus 224 --~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 --DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred --CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 0011111 34457899999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=376.85 Aligned_cols=239 Identities=28% Similarity=0.486 Sum_probs=204.4
Q ss_pred eeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 973 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
.++.||.|+.|.||+|+++ ++.||||+++..++ .+|+-|++|+|+||+.|.|+|...-.+|||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 4578999999999999999 78899999874332 478889999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
++.|+. ...+.-.....|..+||.||.|||.+. |||||||.-||||..+..|||+|||-++...+. ....
T Consensus 200 ~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkM 269 (904)
T KOG4721|consen 200 YEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKM 269 (904)
T ss_pred HHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh---hhhh
Confidence 999953 456888899999999999999999886 999999999999999999999999999876442 2233
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
.++||..|||||++++...++|+|||||||||||||||..||.+.+.. .. +..+-...+.-.++
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss----AI------------IwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS----AI------------IWGVGSNSLHLPVP 333 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh----ee------------EEeccCCcccccCc
Confidence 478999999999999999999999999999999999999999654311 11 11122223334456
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..+...|.-|++.||+..|..||+|++|+..|.
T Consensus 334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld 366 (904)
T KOG4721|consen 334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD 366 (904)
T ss_pred ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence 678888999999999999999999999998886
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=352.20 Aligned_cols=246 Identities=23% Similarity=0.300 Sum_probs=201.8
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999965 68999999986432 234456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+|+|.+++.. ...+++.+++.|+.|++.||+|||+++ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999853 235889999999999999999999887 99999999999999999999999999986533
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
. ....+|+..|+|||++.+..++.++|||||||+||||++|+.||...... .+... .....
T Consensus 154 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~---~~~~~---i~~~~-------- 214 (291)
T cd05612 154 R-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPF---GIYEK---ILAGK-------- 214 (291)
T ss_pred C-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHH---HHhCC--------
Confidence 1 12356999999999999989999999999999999999999999754311 11111 11100
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQAL 1244 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-----MsEVLq~L 1244 (1368)
..++......+.+|+.+||+.||.+|++ +.|+++.-
T Consensus 215 ----~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 255 (291)
T cd05612 215 ----LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR 255 (291)
T ss_pred ----cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence 0112223456889999999999999995 77776553
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=365.64 Aligned_cols=279 Identities=25% Similarity=0.342 Sum_probs=217.7
Q ss_pred ecCCCcCCCHHHHHHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhh--ccccccee
Q 000659 952 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR--LHHRNLVK 1029 (1368)
Q Consensus 952 ~sgS~~~fsleELe~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsr--LrHPNIVr 1029 (1368)
.+|++.-..+.-.+.+.++..+.+.||+|+||+||+|.++ |+.||||++...+ ++.+.+|.+|++. |+|+||+.
T Consensus 194 tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILg 269 (513)
T KOG2052|consen 194 TSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILG 269 (513)
T ss_pred cCCCCCCchhHhHHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhh
Confidence 3456666777777888899999999999999999999999 8999999997443 3567788888875 59999999
Q ss_pred eeeeeeec----cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-----cCCCCccccCCcc
Q 000659 1030 LIGICIEE----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-----DSSPRVIHRDFKS 1100 (1368)
Q Consensus 1030 LlG~~~d~----~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-----~gsp~IVHRDIKP 1100 (1368)
+++....+ .++|||.+|.++|+|+|||.+ ..++.+..+++++.+|.||++||. +|+|.|.|||||+
T Consensus 270 FIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKS 344 (513)
T KOG2052|consen 270 FIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKS 344 (513)
T ss_pred hhhccccCCCceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcccccc
Confidence 99987643 367999999999999999953 469999999999999999999995 4788899999999
Q ss_pred cCeeecCCCCccccccccccccccccc--ccccccccccccccCcchhccCC------CCcccceeeHHHHHHHHHhC--
Q 000659 1101 SNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVILELLSG-- 1170 (1368)
Q Consensus 1101 sNILLD~ng~VKLsDFGLArll~~~~~--~~~st~v~GT~gYmAPEvL~~~~------~T~KSDVWSLGVILyELLTG-- 1170 (1368)
+||||..++.+.|+|+|||........ .-..+..+||.+|||||++...- -...+||||||+||||+..+
T Consensus 345 KNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~ 424 (513)
T KOG2052|consen 345 KNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCE 424 (513)
T ss_pred ccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhh
Confidence 999999999999999999986644321 11234567999999999986431 22568999999999999863
Q ss_pred --------CCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1171 --------RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1171 --------r~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~-----~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
+.||..... ..-..++..+-+-...++..+ ..+++..+.+||+.||..+|..|-|+
T Consensus 425 ~ggi~eey~~Pyyd~Vp-----------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 425 SGGIVEEYQLPYYDVVP-----------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred cCCEehhhcCCcccCCC-----------CCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 234433222 112212211222222333222 25678899999999999999999999
Q ss_pred HHHHHHHHHHHHh
Q 000659 1238 GEVVQALKLVCNE 1250 (1368)
Q Consensus 1238 sEVLq~Le~I~~e 1250 (1368)
-.|.+.|.++.+.
T Consensus 494 LriKKtl~~l~~~ 506 (513)
T KOG2052|consen 494 LRIKKTLAKLSNS 506 (513)
T ss_pred HHHHHHHHHHhcC
Confidence 9999999888753
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=356.25 Aligned_cols=253 Identities=25% Similarity=0.325 Sum_probs=205.1
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++..++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999965 78999999997532 244567889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+|+|.+++... ..+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 153 (350)
T cd05573 81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153 (350)
T ss_pred cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence 999999999999642 46899999999999999999999887 99999999999999999999999999986543
Q ss_pred cc---------------------------cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCC
Q 000659 1125 EE---------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 1177 (1368)
Q Consensus 1125 ~~---------------------------~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s 1177 (1368)
.. .........||..|+|||++.+..++.++|||||||+||||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~ 233 (350)
T cd05573 154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD 233 (350)
T ss_pred cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence 22 011223456999999999999999999999999999999999999999764
Q ss_pred CCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-HHHHHHHH
Q 000659 1178 QPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-MGEVVQAL 1244 (1368)
Q Consensus 1178 ~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-MsEVLq~L 1244 (1368)
..... ..+..|. ..+ ...........+.+++.+|+. +|++|++ ++|+++..
T Consensus 234 ~~~~~~~~i~~~~-------~~~--------~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp 286 (350)
T cd05573 234 TLQETYNKIINWK-------ESL--------RFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP 286 (350)
T ss_pred CHHHHHHHHhccC-------Ccc--------cCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence 32110 0111110 000 000011135678899999997 9999999 99998753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=340.15 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=208.0
Q ss_pred hCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccce
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~ 1040 (1368)
.++|++.+.||+|+||.||+|... ++..|++|.+.... .....+|.+|+.+|++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 457899999999999999999864 24689999986443 23445788999999999999999999999999999
Q ss_pred EEEEeecCCCChhhccccccc------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDK------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1114 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLs 1114 (1368)
++||||+.+|+|.+++..... ....++|..+++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864322 1234789999999999999999999887 9999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
|||+++...............++..|+|||++.++.++.++|||||||++|||++ |+.||..... ....++..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~---~~~~~~~~--- 235 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN---EEVLKFVI--- 235 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH---HHHHHHHh---
Confidence 9999986644332222334457889999999998899999999999999999998 8988864321 22222221
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1194 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
... ....+..+..++.+++.+||+.+|++||++.|+++.|+
T Consensus 236 -~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 -DGG----------HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred -cCC----------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 000 01122234578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=348.19 Aligned_cols=263 Identities=26% Similarity=0.408 Sum_probs=208.8
Q ss_pred CCcceeeEEeecCcEEEEEEEec--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeecc
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk--------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~ 1038 (1368)
++|.+.+.||+|+||.||++... ++..||+|+++.. .....+++.+|+++++++ +|+||++++++|.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 57999999999999999999742 2356999999753 234456788999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1106 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD 1106 (1368)
..|+||||+.+|+|.+++..... ....++|.++++|+.|++.||+|||+.+ |+|||||++|||++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999965321 1235899999999999999999999887 99999999999999
Q ss_pred CCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 000659 1107 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENL 1185 (1368)
Q Consensus 1107 ~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nL 1185 (1368)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~---~~~ 251 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EEL 251 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHH
Confidence 999999999999976543221111222234568999999999899999999999999999998 8888864321 111
Q ss_pred HHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1186 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1186 v~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
.... .. ............++.+|+.+||+.+|++||+|.||++.|++++...
T Consensus 252 ~~~~----~~----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~ 303 (307)
T cd05098 252 FKLL----KE----------GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALT 303 (307)
T ss_pred HHHH----Hc----------CCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence 1111 10 0111222344568899999999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=350.61 Aligned_cols=265 Identities=24% Similarity=0.359 Sum_probs=197.4
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec-----cceE
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QARC 1041 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~-----~~~~ 1041 (1368)
+|++.++||+|+||.||+|+. .+|+.||||+++.. ......++.+|+++|++++|+||+++++++... ...|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999995 47899999998642 223445788999999999999999999998643 2479
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
+||||+ +++|.+++.. ...+++.+++.|+.||++||+|||+.+ |+|||||++|||++.++.+||+|||+++.
T Consensus 81 lv~e~~-~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~ 152 (338)
T cd07859 81 VVFELM-ESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152 (338)
T ss_pred EEEecC-CCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCccccc
Confidence 999999 4789888843 335899999999999999999999887 99999999999999999999999999986
Q ss_pred cccccc-ccccccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhH-HHhhhh------
Q 000659 1122 AMDEES-RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL-VAWARP------ 1191 (1368)
Q Consensus 1122 l~~~~~-~~~st~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nL-v~Wa~p------ 1191 (1368)
...... .......+||..|+|||++.+ ..++.++|||||||++|||++|+.||...+....... .+....
T Consensus 153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 232 (338)
T cd07859 153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI 232 (338)
T ss_pred cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 532221 112234579999999999875 6789999999999999999999999965432111110 000000
Q ss_pred -hcccccccceeec---CCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1192 -LLTSREGLERIID---PSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 -lls~~e~L~eIvD---p~L~~~~---~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+. .....+.++ ....... .......+.+++.+||+.||++||+++|+++.
T Consensus 233 ~~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 233 SRVR-NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HHhh-hhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 000 000000000 0000000 01123567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=369.47 Aligned_cols=263 Identities=26% Similarity=0.386 Sum_probs=208.2
Q ss_pred hCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccc
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~ 1039 (1368)
.++|++.++||+|+||.||+|+.. .+..||||+++... ....+.|++|+++|++++ |+|||+++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 567889999999999999999843 23469999997533 333467999999999996 9999999999999999
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 1061 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~---------------------------------------------------------- 1061 (1368)
.|||||||++|+|.++|+....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998864211
Q ss_pred ----------------------------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC
Q 000659 1062 ----------------------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH 1107 (1368)
Q Consensus 1062 ----------------------------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ 1107 (1368)
....+++.++++++.||++||+|||+.+ |+|||||++|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 0124888999999999999999999887 999999999999999
Q ss_pred CCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHH
Q 000659 1108 DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLV 1186 (1368)
Q Consensus 1108 ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv 1186 (1368)
++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |+.||...... ..+.
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~--~~~~ 350 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD--STFY 350 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh--HHHH
Confidence 99999999999986543222222233457788999999999999999999999999999997 99998653221 1111
Q ss_pred HhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1187 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1187 ~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
... ... ............+.+++.+||+.+|++||++.+|.++|+.++.
T Consensus 351 ~~~----~~~----------~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 351 NKI----KSG----------YRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HHH----hcC----------CCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 111 100 0011122345678999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=358.95 Aligned_cols=262 Identities=26% Similarity=0.398 Sum_probs=206.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeeeeeeee-ccc
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIE-EQA 1039 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d-~~~ 1039 (1368)
++|++.++||+|+||.||+|+.. +++.||+|+++... ....+.+.+|+++++++ +|+||++++++|.. +..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 47899999999999999999732 34789999987532 33346788999999999 79999999998865 456
Q ss_pred eEEEEeecCCCChhhcccccccC---------------------------------------------------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKE--------------------------------------------------------- 1062 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~--------------------------------------------------------- 1062 (1368)
.+++|||+.+|+|.++|......
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 78999999999999988532110
Q ss_pred CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccccccC
Q 000659 1063 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142 (1368)
Q Consensus 1063 ~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmA 1142 (1368)
...++|..+++++.||+.||+|||+.+ |+|||||++||||++++++||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999887 99999999999999999999999999987643222222233456778999
Q ss_pred cchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHH
Q 000659 1143 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 1221 (1368)
Q Consensus 1143 PEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~ 1221 (1368)
||++.+..++.++|||||||+||||++ |+.||...... +.+.... ... ...........++.+
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~----~~~----------~~~~~~~~~~~~~~~ 307 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRL----KEG----------TRMRAPEYATPEIYS 307 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHH----hcc----------CCCCCCccCCHHHHH
Confidence 999999999999999999999999998 99999653221 1111111 100 001112234467899
Q ss_pred HHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1222 IASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1222 La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
++.+||+.+|++||++.||+++|+.+++
T Consensus 308 l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 308 IMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 9999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.44 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=203.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCC----EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr----~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
++|++.+.||+|+||.||+|.+. +|+ .|++|.+.... ....+++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 46788899999999999999953 454 46777775332 2334678889999999999999999999864 55789
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
++||+.+|+|.++++.. ...++|..+++|+.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~ 159 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLL 159 (279)
T ss_pred EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceec
Confidence 99999999999999642 236899999999999999999999887 999999999999999999999999999866
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.............++..|++||++..+.++.++|||||||++|||++ |+.||..... ..+.++.. ... .
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~---~~~~~~~~----~~~---~ 229 (279)
T cd05111 160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP---HEVPDLLE----KGE---R 229 (279)
T ss_pred cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHH----CCC---c
Confidence 44333223334557789999999998999999999999999999998 9999965421 12222211 111 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.. ....+...+.+++.+||..+|++||++.|+++.|..+.++
T Consensus 230 ~~-------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 230 LA-------QPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred CC-------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00 1112335678899999999999999999999999887653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=355.92 Aligned_cols=253 Identities=23% Similarity=0.314 Sum_probs=200.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.++||+|+||.||+|... +|+.||||+++... ....+.+.+|+++|+.++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999954 68999999997532 233456789999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+|+|.+++.. ...+++.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 153 (364)
T cd05599 81 EYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153 (364)
T ss_pred CCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence 99999999999853 235899999999999999999999888 99999999999999999999999999875422
Q ss_pred cccc------------------------------------cccccccccccccCcchhccCCCCcccceeeHHHHHHHHH
Q 000659 1125 EESR------------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1168 (1368)
Q Consensus 1125 ~~~~------------------------------------~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELL 1168 (1368)
.... ......+||..|+|||++....++.++|||||||+||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~ 233 (364)
T cd05599 154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233 (364)
T ss_pred cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence 1100 0111246999999999999999999999999999999999
Q ss_pred hCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC---HHHHHHH
Q 000659 1169 SGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF---MGEVVQA 1243 (1368)
Q Consensus 1169 TGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT---MsEVLq~ 1243 (1368)
+|+.||...... .....+ ......+. + .........+.+++.+|+. +|.+|++ +.|+++.
T Consensus 234 ~G~~Pf~~~~~~---~~~~~i---~~~~~~~~------~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h 296 (364)
T cd05599 234 VGYPPFCSDNPQ---ETYRKI---INWKETLQ------F--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296 (364)
T ss_pred cCCCCCCCCCHH---HHHHHH---HcCCCccC------C--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence 999999754321 111111 10000000 0 0011234567889999986 8999998 8888775
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=375.37 Aligned_cols=255 Identities=25% Similarity=0.361 Sum_probs=212.6
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccc
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~ 1039 (1368)
.+-..+|..+++||+|+|++||+|+ .++++.||||++.+. .+...+.+.+|-++|.+| .|+.|++|+-.|.|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 4445789999999999999999999 567999999999642 233345678899999999 79999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
+|+|+||++||+|.++|+++ +.|++.....++.+|+.||+|||++| ||||||||+|||||+|+++||+|||-|
T Consensus 149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsA 221 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSA 221 (604)
T ss_pred eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccc
Confidence 99999999999999999754 46899999999999999999999988 999999999999999999999999999
Q ss_pred ccccccccc---------cc--cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh
Q 000659 1120 RSAMDEESR---------HI--STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1188 (1368)
Q Consensus 1120 rll~~~~~~---------~~--st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W 1188 (1368)
+.+...... .. ....+||..|++||++..+..+..+|+|+||||||+|+.|+.||...++.. +
T Consensus 222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---i--- 295 (604)
T KOG0592|consen 222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---I--- 295 (604)
T ss_pred ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---H---
Confidence 977542221 11 144789999999999999999999999999999999999999997754211 0
Q ss_pred hhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+++|++- .-.++......+.+|+.+.|..||.+|.+..||.+..
T Consensus 296 ----------FqkI~~l--~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 296 ----------FQKIQAL--DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred ----------HHHHHHh--cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1122221 1233444457789999999999999999999987764
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=342.48 Aligned_cols=258 Identities=29% Similarity=0.472 Sum_probs=204.6
Q ss_pred hCCcceeeEEeecCcEEEEEEEecC------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccce
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkd------Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~ 1040 (1368)
.++|++.+.||+|+||.||+|.+.+ +..|++|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4679999999999999999999653 5678999886433 33456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhccccccc---CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC---Ccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVS 1114 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~---~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng---~VKLs 1114 (1368)
++||||+.+|+|.++++.... ....++|.++++++.||++||+|||+.+ ++|||||++|||++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999865321 1235899999999999999999999887 99999999999998765 58999
Q ss_pred cccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||+..... .+.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~---~~~~~~---- 234 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ---EVMEFV---- 234 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHH----
Confidence 9999986633222111222334568999999999999999999999999999997 99999753321 111111
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1194 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
... ............+.+++.+||+.+|++||++.||++.|+
T Consensus 235 ~~~----------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 TGG----------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HcC----------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 000 111122334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=350.13 Aligned_cols=252 Identities=25% Similarity=0.336 Sum_probs=199.7
Q ss_pred CcceeeEEeecCcEEEEEEEe----cCCCEEEEEEeecc----cchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccce
Q 000659 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRV----DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl----kdGr~VAVKvLk~~----d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~ 1040 (1368)
+|++.+.||+|+||.||+++. .+++.||+|++++. .....+.+.+|+++|++++ |+||+++++++.+++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 588999999999999999884 36889999999643 2233456789999999994 99999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+.+|+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++
T Consensus 81 ~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~ 153 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSK 153 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence 999999999999999853 235899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
....... ......+||..|||||++.+. .++.++|||||||+||||++|+.||.......... ........
T Consensus 154 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~----- 225 (332)
T cd05614 154 EFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILK----- 225 (332)
T ss_pred cccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhc-----
Confidence 6533222 122345799999999998865 47899999999999999999999997543222111 11111111
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
.+. .+.......+.+++.+||+.||++|+ ++.|+++.
T Consensus 226 ---~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 267 (332)
T cd05614 226 ---CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH 267 (332)
T ss_pred ---CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence 011 12223446788999999999999999 66677654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=340.17 Aligned_cols=268 Identities=29% Similarity=0.405 Sum_probs=206.4
Q ss_pred cceeeEEeecCcEEEEEEEe-----cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEE
Q 000659 971 FDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 1042 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-----kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~L 1042 (1368)
|++.+.||+|+||+||++.+ .+++.||+|+++... ....+.|.+|+++|++++|+||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 38889999999999988653 367889999997543 23456789999999999999999999998653 45789
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.+|+|.+++.. ..++|.++++|+.|+++||+|||+.+ |+|||||++||||++++.+||+|||+++..
T Consensus 86 v~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 86 IMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999853 24899999999999999999999887 999999999999999999999999999866
Q ss_pred ccccccc-ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~-~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
....... ......++..|++||++....++.++|||||||++|||++|+.||....... ..+..+...... ...+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~~ 235 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQMT-VVRLIE 235 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhcccccccc-hhhhhh
Confidence 4322211 1122345677999999998899999999999999999999999986543211 111111110000 111122
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
+++.............++.+++.+||+.+|++||++++|++.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 236 LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 22222222233445678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=335.71 Aligned_cols=248 Identities=28% Similarity=0.419 Sum_probs=197.7
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
+.||+|+||.||+|++. +++.||+|.++.. ......+|.+|++++++++|+||++++++|.+++..++||||+.+++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999964 7899999988643 334456799999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++... ...++|.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+++............
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 9998532 235899999999999999999999887 9999999999999999999999999987543221111111
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1211 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~ 1211 (1368)
...++..|+|||++.++.++.++|||||||++|||++ |..||+.... ........ .......
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~---~~~~~~~~--------------~~~~~~~ 217 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN---QQTREAIE--------------QGVRLPC 217 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH---HHHHHHHH--------------cCCCCCC
Confidence 1123467999999999999999999999999999998 8888864321 11111110 0111112
Q ss_pred ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1212 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1212 ~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
......++.+++.+||+.+|++||++.||+++|+
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 2234567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=343.68 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=204.4
Q ss_pred CcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
+|++.+.||+|+||.||+|... +++.||||+++.... ...++|.+|++++++++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 4667789999999999999853 247899999975433 234678899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccc------------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC
Q 000659 1043 VYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~------------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~ 1110 (1368)
++||+.+++|.+++.... .....+++..+++++.|++.||+|||+++ |+||||||+|||+++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999984211 11235889999999999999999999887 999999999999999999
Q ss_pred cccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhh
Q 000659 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 1189 (1368)
Q Consensus 1111 VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa 1189 (1368)
+||+|||+++...............++..|+|||++..+.++.++|||||||+||||++ |..||..... ..+.+..
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~i 239 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN---QDVIEMI 239 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH
Confidence 99999999986644332222233456789999999998899999999999999999998 8888864321 1222221
Q ss_pred hhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1190 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1190 ~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
. .. . ...+..++...+.+|+..||+.+|++||++.||++.|+
T Consensus 240 ~---~~-~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~ 281 (283)
T cd05091 240 R---NR-Q----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR 281 (283)
T ss_pred H---cC-C----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence 1 10 0 01123345667899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=346.60 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=209.7
Q ss_pred hCCcceeeEEeecCcEEEEEEEec--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeec
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 1037 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk--------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~ 1037 (1368)
.++|++.+.||+|+||.||+|... ++..|++|+++.. .....+++.+|+++++++ +|+||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 456889999999999999999741 3457999998643 234457899999999999 799999999999999
Q ss_pred cceEEEEeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL 1105 (1368)
+..++||||+.+|+|.++|..... ....++|.++++++.||+.||.|||+++ |+|||||++||||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 999999999999999999965321 1235889999999999999999999887 9999999999999
Q ss_pred cCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchh
Q 000659 1106 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1184 (1368)
Q Consensus 1106 D~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~n 1184 (1368)
++++.+||+|||+++...............++..|+|||++.+..++.++|||||||+||||++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~------ 244 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------ 244 (304)
T ss_pred cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC------
Confidence 9999999999999986643322222233446678999999998899999999999999999998 788875432
Q ss_pred HHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1185 Lv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
..++.... .... .......+...+.+|+.+||+.+|++||++.||++.|+++...
T Consensus 245 ~~~~~~~~-~~~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 245 VEELFKLL-KEGH----------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHH-HcCC----------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 11221111 1110 0111234557799999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=337.69 Aligned_cols=257 Identities=25% Similarity=0.415 Sum_probs=199.4
Q ss_pred cceeeEEeecCcEEEEEEEecCC-C--EEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec------cc
Q 000659 971 FDASRILGEGGFGLVYSGVLDDG-T--KVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QA 1039 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkdG-r--~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~------~~ 1039 (1368)
|.+.+.||+|+||.||+|.+.+. + .||||.++.. .....++|.+|++++++++|+||++++++|... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 35678999999999999996543 2 5899988643 344456789999999999999999999987532 24
Q ss_pred eEEEEeecCCCChhhccccc--ccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGV--DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~--~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
.++||||+.+|+|.+++... ......+++.++++++.|++.||+|||+++ |+|||||++|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 68999999999999987422 122345899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+++...............++..|++||++....++.++|||||||++|||++ |+.||..... ..+.+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~---~~~~~~~----~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN---SEIYDYL----RQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHH----HcC
Confidence 9986643222111222346678999999999999999999999999999999 8888864321 1111111 111
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
+.. .........+.+++.+||+.+|++||++.||++.|+.+
T Consensus 231 ~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 110 11123446789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=340.94 Aligned_cols=269 Identities=26% Similarity=0.376 Sum_probs=204.8
Q ss_pred CCcceeeEEeecCcEEEEEEEec-----CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeee--ccceE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARC 1041 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-----dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~~ 1041 (1368)
.+|++.+.||+|+||.||++.++ +++.|+||+++.......++|.+|+++|++++|+||+++++++.. ....+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 57889999999999999999743 578999999987666667789999999999999999999998754 35679
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
+||||+++|+|.+++.+. ...++|..++.++.|+++||+|||+.+ |+|||||++||||++++++||+|||+++.
T Consensus 84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 999999999999999532 235899999999999999999999887 99999999999999999999999999986
Q ss_pred cccccccc-ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc---c
Q 000659 1122 AMDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR---E 1197 (1368)
Q Consensus 1122 l~~~~~~~-~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~---e 1197 (1368)
........ ......++..|++||++.+..++.++|||||||++|||++|..++...... ............ .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDKQGQMIVY 233 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhcccccccccchH
Confidence 64322211 111222445699999999889999999999999999999987765332110 000000000000 0
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1198 ~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.+.++++.............++.+|+.+||+.+|++|||+.||++.|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 234 HLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 00011111111112234456799999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=369.61 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=205.6
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 1042 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~L 1042 (1368)
.+.|+..++||+|+||.||||+ +.+|+.||+|+++... .....-..|||.||++|+|+||++|.+...+. ..+||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457888899999999999999 7789999999997543 33344567999999999999999999999876 68999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
|+|||+. +|.-++.. ..-.+++.++..++.||+.||+|||.++ |+|||||.+|||||.+|.+||+|||||+.+
T Consensus 196 VFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 9999965 77777742 2346899999999999999999999888 999999999999999999999999999987
Q ss_pred cccccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHH----------Hhhhh
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV----------AWARP 1191 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv----------~Wa~p 1191 (1368)
....... .+..+-|++|.+||++.+. .|+.+.|+||+||||.||++|+..|...++-++...+ .|...
T Consensus 269 ~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 269 TPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred cCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 6544433 4455679999999988864 7999999999999999999999999876654433222 23211
Q ss_pred hcccccccceeecC------CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1192 LLTSREGLERIIDP------SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 lls~~e~L~eIvDp------~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+-. ..++.+ .+++. -.......++|+..+|..||.+|.|+.++++.
T Consensus 348 kLP~----~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 348 KLPH----ATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cCCc----ccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1110 011111 11111 01223567889999999999999999998754
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=330.16 Aligned_cols=251 Identities=31% Similarity=0.520 Sum_probs=205.5
Q ss_pred eEEeecCcEEEEEEEecC----CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+.||+|+||.||+|...+ +..|+||+++..... ..+++.+|++++++++|+||+++++++.+++..++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999654 788999999764433 367899999999999999999999999999999999999999
Q ss_pred CChhhcccccccC-----CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1050 GSVESHLHGVDKE-----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1050 GSL~d~L~~~~~~-----~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
++|.+++...... ...+++.++++++.|+++||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 9999999754222 357999999999999999999999887 99999999999999999999999999987754
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
...........++..|+|||++....++.++|||||||++|||++ |+.||..... ..+.+.... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~----~------- 223 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSN---EEVLEYLRK----G------- 223 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----C-------
Confidence 332222344567889999999998899999999999999999999 6999976421 122222111 0
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
...........++.+++.+||+.+|++||++.|+++.|+
T Consensus 224 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 ---YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred ---CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 011122334568999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=373.57 Aligned_cols=249 Identities=24% Similarity=0.395 Sum_probs=211.3
Q ss_pred CcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
.|...+.||+|+.|.||.|. ..+++.||||++....+...+-+++|+.+|+.++|+|||.+++.|..++++|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 45666789999999999998 56789999999987777777778999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
||+|.|.+.. ..|++.++..|+++++.||+|||.++ |||||||.+||||+.+|++||+|||++..+.....
T Consensus 354 ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~- 424 (550)
T KOG0578|consen 354 GGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS- 424 (550)
T ss_pred CCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence 9999999843 35999999999999999999999998 99999999999999999999999999998765433
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
...+.+||+.|||||+...+.|+.|.||||||++++||+-|+.||-..+.... + | ++..++ ...
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrA--l--y---LIa~ng--------~P~ 488 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--L--Y---LIATNG--------TPK 488 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHH--H--H---HHhhcC--------CCC
Confidence 34567899999999999999999999999999999999999999954322110 0 0 011111 111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
-.........|.+|+.+||+.|+++|+++.|+|+.
T Consensus 489 lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 489 LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 23334556789999999999999999999999976
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=338.22 Aligned_cols=252 Identities=27% Similarity=0.431 Sum_probs=204.0
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
++|++.+.||+|+||.||+|.++++..||||.++.. ....++|.+|+.++++++|+||++++++|.+.+..++||||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 458889999999999999999887778999998743 2335679999999999999999999999999889999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.+++.... ..++|.++++++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++........
T Consensus 83 ~~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~ 156 (256)
T cd05113 83 NGCLLNYLREHG---KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT 156 (256)
T ss_pred CCcHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCcee
Confidence 999999986422 25899999999999999999999887 999999999999999999999999998865432211
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......++..|++||++....++.++|||||||+||||++ |+.||...+. ..+..... .. .
T Consensus 157 -~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~---~~-~---------- 218 (256)
T cd05113 157 -SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN---SETVEKVS---QG-L---------- 218 (256)
T ss_pred -ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHh---cC-C----------
Confidence 1112235678999999998889999999999999999998 9999865432 11222111 10 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
...........+.+++.+||+.+|++||++.+|++.|+
T Consensus 219 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00111123468899999999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=362.19 Aligned_cols=261 Identities=26% Similarity=0.383 Sum_probs=207.5
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeecc--ceEEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ--ARCLVY 1044 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~--~~~LVm 1044 (1368)
..++...+.||+|+||.||++... +|+.+|||.+...+....+.+.+|+.+|++|+|+|||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 345677889999999999999965 48999999987654444667899999999999999999999855444 689999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~VKLsDFGLArll~ 1123 (1368)
||+.+|+|.+++.+... .|++..+.++..||++||+|||+++ |||||||++||||+. ++.+||+|||+++...
T Consensus 96 Ey~~~GsL~~~~~~~g~---~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG---KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eccCCCcHHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 99999999999965432 5999999999999999999999888 999999999999999 7999999999998765
Q ss_pred c-cccccccccccccccccCcchhccCC-CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1124 D-EESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1124 ~-~~~~~~st~v~GT~gYmAPEvL~~~~-~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
. ...........||+.|||||++..+. ...++|||||||++.||+||+.||... .....+......
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~------- 237 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGR------- 237 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhc-------
Confidence 3 11122233467999999999999643 335999999999999999999999653 111122111111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
......++.....+..+++.+|+..+|++|||+.|+++......+
T Consensus 238 ---~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~ 282 (313)
T KOG0198|consen 238 ---EDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQN 282 (313)
T ss_pred ---cCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence 111124444566788999999999999999999999988765443
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=349.89 Aligned_cols=239 Identities=23% Similarity=0.269 Sum_probs=194.6
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||.||+|... +++.||||+++.. .....+.+.+|+++|++++|+||+++++++.+.+..|+||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999954 6889999999753 234456788999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~ 151 (312)
T cd05585 81 FHHLQR----EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTN 151 (312)
T ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Cccc
Confidence 999953 335899999999999999999999887 9999999999999999999999999998543221 2234
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
..+||..|+|||++.+..++.++|||||||+||||++|+.||...+. .......+... ..++
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~------~~~~~~~~~~~------------~~~~ 213 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV------NEMYRKILQEP------------LRFP 213 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH------HHHHHHHHcCC------------CCCC
Confidence 46799999999999999999999999999999999999999965321 11222111110 0122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCH---HHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFM---GEVVQ 1242 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTM---sEVLq 1242 (1368)
......+.+++.+||+.||++|+++ .|+++
T Consensus 214 ~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 214 DGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred CcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 2344678899999999999999864 55544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=340.40 Aligned_cols=265 Identities=26% Similarity=0.444 Sum_probs=207.5
Q ss_pred hCCcceeeEEeecCcEEEEEEEecC-----------------CCEEEEEEeeccc-chhhHHHHHHHHHHhhccccccee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDD-----------------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVK 1029 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkd-----------------Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVr 1029 (1368)
.++|++.+.||+|+||.||+|...+ +..||+|++.... ....++|.+|+++|++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4578999999999999999998542 2458999986533 345668899999999999999999
Q ss_pred eeeeeeeccceEEEEeecCCCChhhccccccc-------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccC
Q 000659 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 1102 (1368)
Q Consensus 1030 LlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~-------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsN 1102 (1368)
++++|..++..++||||+.+++|.++|..... ....+++..+++++.|++.||+|||+.+ |+|||||++|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999965431 1235899999999999999999999887 9999999999
Q ss_pred eeecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh--CCCCCCCCCCC
Q 000659 1103 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPP 1180 (1368)
Q Consensus 1103 ILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT--Gr~PFd~s~~~ 1180 (1368)
|||+.++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~- 239 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD- 239 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh-
Confidence 9999999999999999986544332223334556789999999998899999999999999999998 6677754321
Q ss_pred cchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1181 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1181 ~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.....+....+.... ..........+..++.+++.+||+.||++||++.||++.|+
T Consensus 240 --~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 --QQVIENAGHFFRDDG-------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred --HHHHHHHHhcccccc-------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 222222221111100 00000111233467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=353.75 Aligned_cols=242 Identities=24% Similarity=0.325 Sum_probs=196.8
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
++||+|+||.||++.. .+|+.||+|+++.. ......++.+|++++++++|+||+++++++.+.+..||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999995 47899999999753 2334556788999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~ 1130 (1368)
+|.+++.. ...+++.+++.++.||+.||+|||+++ |+|||||++||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 151 (323)
T cd05595 81 ELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--AT 151 (323)
T ss_pred cHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cc
Confidence 99988853 336899999999999999999999887 9999999999999999999999999987542211 11
Q ss_pred cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1210 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~ 1210 (1368)
....+||..|+|||++.++.++.++|||||||+||||++|+.||...+.. .+.... .... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~---~~~~~~---~~~~------------~~ 213 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELI---LMEE------------IR 213 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHH---hcCC------------CC
Confidence 23456999999999999999999999999999999999999999653221 111110 0000 01
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1211 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1211 ~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
++......+.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h 251 (323)
T cd05595 214 FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 251 (323)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence 2223456788999999999999998 78888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-39 Score=375.90 Aligned_cols=264 Identities=28% Similarity=0.450 Sum_probs=215.8
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEecCC-----CEEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVLDDG-----TKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvlkdG-----r~VAVKvLk~---~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
+...++..+.++||+|+||+||+|.+..+ ..||||..+. ......++|++|+++|++++|+|||+|+|++..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 33445666779999999999999996532 2289999874 446677899999999999999999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
+.-+|||||+|.||+|.++|+... ..++..+++++++++|+||+|||.++ +|||||..+|||++.++.+||+||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~---~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDF 306 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNK---KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDF 306 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCC---CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCcc
Confidence 999999999999999999996432 25999999999999999999999888 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
||++.... .........-...|+|||.+..+.|+.++|||||||++||+++ |..||..... ..+..|+
T Consensus 307 GLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~---~~v~~kI------ 375 (474)
T KOG0194|consen 307 GLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN---YEVKAKI------ 375 (474)
T ss_pred ccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH---HHHHHHH------
Confidence 99885431 1111111134679999999999999999999999999999999 8889866432 1222221
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhh
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
+....+...+......+..++.+||..+|++|++|.++.+.|+.+.....
T Consensus 376 -------~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 376 -------VKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -------HhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 12223334445667788999999999999999999999999998887654
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=353.56 Aligned_cols=265 Identities=21% Similarity=0.336 Sum_probs=204.6
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.++|++.+.||+|+||.||++... +++.+|+|+++.. .....+++.+|+++|++++|+||++++++|.+++..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 468999999999999999999965 6888999988753 33345678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+|+|.+++.. ...+++..+.+++.|+++||.|||+.+ +|+|||||++||||++++.+||+|||+++.....
T Consensus 84 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~ 157 (333)
T cd06650 84 HMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 157 (333)
T ss_pred cCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh
Confidence 9999999999953 235889999999999999999999742 3999999999999999999999999999765322
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccc--------
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE-------- 1197 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e-------- 1197 (1368)
......|+..|+|||++.+..++.++|||||||++|||++|+.||......... ...........
T Consensus 158 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 158 ----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE---LMFGCPVEGDPAESETSPR 230 (333)
T ss_pred ----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH---HHhcCcccCCccccccCcc
Confidence 123356899999999999889999999999999999999999999754321111 10000000000
Q ss_pred -------------------ccceeecCCC---CCCCC-hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1198 -------------------GLERIIDPSL---GNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1198 -------------------~L~eIvDp~L---~~~~~-~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
....+.+... ..... .....++.+|+.+||+.||++||++.|+++.-.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~ 301 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAF 301 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHH
Confidence 0000000000 00000 112356899999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=336.51 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=202.3
Q ss_pred CcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+|++.+.||+|+||.||+|.+++++.+++|+++... ...++|.+|++++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 477889999999999999998877889999986432 2345788999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
++|.++++... ..++|..+++|+.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++...+... .
T Consensus 84 ~~L~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~ 156 (256)
T cd05059 84 GCLLNYLRERK---GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-T 156 (256)
T ss_pred CCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccc-c
Confidence 99999986422 36899999999999999999999988 99999999999999999999999999986543211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
......++..|+|||++.+..++.++|||||||+||||++ |+.||+.... ......... ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~---~~~~~~~~~--------------~~~ 219 (256)
T cd05059 157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN---SEVVESVSA--------------GYR 219 (256)
T ss_pred ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH---HHHHHHHHc--------------CCc
Confidence 1111223457999999999999999999999999999999 8999865321 111111110 001
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.........++.+|+.+||..+|++||++.|+++.|
T Consensus 220 ~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 111223456899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=341.88 Aligned_cols=265 Identities=22% Similarity=0.301 Sum_probs=200.7
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||.||+|..+ +++.||+|+++... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 57999999999999999999954 68899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. |+|.+++... ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++......
T Consensus 85 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 85 LD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred CC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 97 5899888532 235789999999999999999999887 9999999999999999999999999997543221
Q ss_pred cccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHH-Hhh-------hhhccccc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWA-------RPLLTSRE 1197 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv-~Wa-------~plls~~e 1197 (1368)
.......|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ... ++.+...+
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 --KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred --ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 11233568999999998865 56899999999999999999999999764322211110 000 00011111
Q ss_pred ccceeecCCCCCC----CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1198 GLERIIDPSLGND----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1198 ~L~eIvDp~L~~~----~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
...+.+.+..... .......++.+|+.+|++.||++|+|++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 1111111111100 01123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=342.84 Aligned_cols=260 Identities=26% Similarity=0.417 Sum_probs=205.3
Q ss_pred CCcceeeEEeecCcEEEEEEEecC-CC--EEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD-GT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd-Gr--~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.++||+|+||.||+|.+++ +. .+++|.++.. .....++|.+|+++++++ +|+||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578999999999999999999653 33 4788888743 334456799999999999 799999999999999999999
Q ss_pred EeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCc
Q 000659 1044 YELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~V 1111 (1368)
|||+++|+|.++++.... ....+.+.++++|+.|++.||+|||+.+ |+|||||++||||++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 999999999999964321 1135889999999999999999999887 9999999999999999999
Q ss_pred ccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhh
Q 000659 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1112 KLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~ 1190 (1368)
||+|||++........ ......+..|++||++....++.++|||||||+||||++ |+.||..... ..+...
T Consensus 159 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~---~~~~~~-- 230 (297)
T cd05089 159 KIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC---AELYEK-- 230 (297)
T ss_pred EECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHH--
Confidence 9999999864321111 111223567999999998899999999999999999997 9999965422 111111
Q ss_pred hhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1191 plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
... .........+...+.+|+.+||+.+|.+||++.++++.|+.+.+..
T Consensus 231 -~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 231 -LPQ-----------GYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred -Hhc-----------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 0111122234467899999999999999999999999998877644
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=342.78 Aligned_cols=262 Identities=28% Similarity=0.477 Sum_probs=206.6
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccc
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~ 1039 (1368)
..++|++.+.||+|+||.||+|..+ .+..||+|.++... .....++.+|++++++++|+||+++++++.+.+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4568999999999999999999754 24579999886433 2334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccC------CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKE------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~------~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKL 1113 (1368)
.++||||+.+|+|.++++..... ...+++..+++++.|++.||+|||+++ |+|||||++|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 99999999999999999643211 234577889999999999999999887 999999999999999999999
Q ss_pred ccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhh
Q 000659 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1114 sDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
+|||+++...............++..|++||++.++.++.++|||||||++|||++ |+.||..... ..+.++.
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~---~~~~~~~--- 234 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN---EQVLKFV--- 234 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHH---
Confidence 99999986543222222223345778999999999999999999999999999998 7888864321 1111111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
.. .+ . ......+...+.+++.+||+.+|++||++.|+++.|++..
T Consensus 235 ~~-~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 235 MD-GG-Y---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred Hc-CC-C---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11 00 0 0112233468999999999999999999999999888654
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=339.97 Aligned_cols=265 Identities=22% Similarity=0.298 Sum_probs=196.6
Q ss_pred CCcceeeEEeecCcEEEEEEEe-c-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhc---ccccceeeeeeee-----e
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-D-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICI-----E 1036 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-k-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrL---rHPNIVrLlG~~~-----d 1036 (1368)
++|++.+.||+|+||.||+|.. . +|+.||||+++... ......+.+|+++++++ +|+||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 4789999999999999999985 3 46889999986432 22234667788887776 6999999999985 2
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
....++||||+. ++|.+++.... ...+++.++++|+.||+.||+|||+.+ |+|||||++||||+.++.+||+||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Df 154 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 154 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccc
Confidence 456899999995 68999986432 235899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~ 1195 (1368)
|+++..... .......|+..|+|||++....++.++|||||||+||||++|+.||......+. ..+.+........
T Consensus 155 g~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~ 231 (290)
T cd07862 155 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 231 (290)
T ss_pred cceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChh
Confidence 999865332 223445689999999999988999999999999999999999999976542211 1111111000000
Q ss_pred c----ccc-ceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1196 R----EGL-ERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1196 ~----e~L-~eIvDp~L~---~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
. ..+ ...+..... .....+....+.+++.+||+.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0 000 000000000 0011123356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=335.31 Aligned_cols=257 Identities=25% Similarity=0.456 Sum_probs=205.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCC---EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGT---KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr---~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
.++|+..+.||+|+||.||+|.+. +++ .++||+++.. .....++|.+|++++++++|+||+++++++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 357888999999999999999965 333 7999998654 23445679999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.+++|.+++... ...+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceec
Confidence 99999999999998532 246899999999999999999999887 999999999999999999999999999865
Q ss_pred ccccccccc-ccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1123 MDEESRHIS-TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1123 ~~~~~~~~s-t~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
......... .....+..|++||++....++.++|||||||++|||++ |+.||..... ..+...+. . .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~---~~~~~~i~---~-~---- 226 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN---HEVMKAIN---D-G---- 226 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH---HHHHHHHh---c-C----
Confidence 432211111 11223457999999998899999999999999999998 9999964321 11111111 0 0
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.......+....+.+++.+||+.+|++||++.+|++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 227 ------FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 01111223456789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=329.81 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=206.0
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|..+ +++.|++|.+.. ......+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 5888999999999999999964 689999999863 2345567899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+++|.++++... ...+++.++++++.|++.||.|||+.+ |+|||||++|||++.++++||+|||+++......
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~ 155 (256)
T cd08529 81 AENGDLHKLLKMQR--GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT 155 (256)
T ss_pred CCCCcHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence 99999999996432 346899999999999999999999887 9999999999999999999999999988664322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......|+..|+|||++.+..++.++|||||||++|||++|+.||...+ ......+.. . .
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~---~--~--------- 216 (256)
T cd08529 156 --NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKII---R--G--------- 216 (256)
T ss_pred --chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHH---c--C---------
Confidence 12234568899999999999999999999999999999999999997543 112222111 0 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
............+.+++.+||+.+|++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 217 VFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 0011122344678999999999999999999999864
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-38 Score=350.64 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=197.8
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
++||+|+||.||++.. .+|+.||||+++.. .....+++.+|+++|++++|+||+++++++.+++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999995 47899999999753 2344567889999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~ 1130 (1368)
+|.+++.. ...+++.+++.|+.||+.||+|||+++ |+|||||++||||+.++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~ 151 (328)
T cd05593 81 ELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--AT 151 (328)
T ss_pred CHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cc
Confidence 99988853 236899999999999999999999887 9999999999999999999999999987543211 12
Q ss_pred cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1210 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~ 1210 (1368)
....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.. ...... ..
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~---~~~~~---~~~~~~------------~~ 213 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFE---LILMED------------IK 213 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH---HHHHH---HhccCC------------cc
Confidence 2346799999999999999999999999999999999999999965321 11111 111100 01
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1211 VPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1211 ~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
++.....++.+++.+||+.||++|+ ++.|+++.
T Consensus 214 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 214 FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 2223446788999999999999997 88898765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=345.59 Aligned_cols=263 Identities=26% Similarity=0.433 Sum_probs=207.8
Q ss_pred CCcceeeEEeecCcEEEEEEEec--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeecc
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk--------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~ 1038 (1368)
++|.+.+.||+|+||.||+|... .+..||+|+++.. .....+++.+|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56889999999999999999742 2457899998753 234456789999999999 6999999999999999
Q ss_pred ceEEEEeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1106 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD 1106 (1368)
..++||||+.+|+|.+++..... ....++|.++++++.|++.||+|||+++ |+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 99999999999999999964321 1245899999999999999999999887 99999999999999
Q ss_pred CCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 000659 1107 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENL 1185 (1368)
Q Consensus 1107 ~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nL 1185 (1368)
+++++||+|||+++...............++..||+||++.++.++.++|||||||++|||++ |+.||..... ..+
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~---~~~ 245 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV---EEL 245 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH---HHH
Confidence 999999999999986643222221222234568999999999999999999999999999999 8888854321 111
Q ss_pred HHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1186 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1186 v~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
..... ... .......+..++.+++.+||+.+|++||++.|+++.|+++....
T Consensus 246 ~~~~~----~~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 FKLLR----EGH----------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred HHHHH----cCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11111 000 01122334567889999999999999999999999999876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=333.79 Aligned_cols=253 Identities=29% Similarity=0.454 Sum_probs=204.2
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
++|++.+.||+|+||.||+|..+++..|++|.++.... ..++|.+|++++++++|+||+++++++. ++..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 46888999999999999999988888999999975332 3467999999999999999999999885 456899999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+++|.++++.. ....+++.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 84 KGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999643 2345899999999999999999999887 999999999999999999999999999865432211
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......++..|+|||++....++.++||||||+++|||++ |+.||...+. ....++... . .
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~---~~~~~~~~~----~----------~ 220 (260)
T cd05070 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN---REVLEQVER----G----------Y 220 (260)
T ss_pred -cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHHc----C----------C
Confidence 1122335678999999988899999999999999999999 8899865321 122222111 0 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
...........+.+|+.+||..+|++||++.++.+.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111223345679999999999999999999999988874
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=340.94 Aligned_cols=257 Identities=26% Similarity=0.454 Sum_probs=206.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
.+|+..+.||+|+||.||++... ++..+++|.++.......++|.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46788899999999999999732 456899999887666667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhccccccc-----------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCc
Q 000659 1043 VYELIPNGSVESHLHGVDK-----------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~-----------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~V 1111 (1368)
||||+.+|+|.++++.... ....+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 1135899999999999999999999887 9999999999999999999
Q ss_pred ccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhh
Q 000659 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1112 KLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~ 1190 (1368)
||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||...... ......
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~~~- 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT---EAIECI- 237 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH---HHHHHH-
Confidence 9999999975543222222223345788999999999999999999999999999998 89998643321 111111
Q ss_pred hhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1191 plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.. .. .......+...+.+|+.+||+.||++||++.||++.|+
T Consensus 238 --~~-~~----------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 238 --TQ-GR----------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --Hc-Cc----------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 00 00 00111234467889999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=355.59 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=197.8
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
+|++.+.||+|+||+||+|+. ++++.||||+++... ....+.+.+|+++|++++|+||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 689999999999999999984 568899999996532 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+++|+|.+++.+ ...+++..+..++.||+.||+|||+.+ |+||||||+||||+.++++||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~ 154 (381)
T cd05626 82 YIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT 154 (381)
T ss_pred cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence 9999999999853 235889999999999999999999887 999999999999999999999999998643110
Q ss_pred cc---------------------------------------------ccccccccccccccCcchhccCCCCcccceeeH
Q 000659 1126 ES---------------------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 1160 (1368)
Q Consensus 1126 ~~---------------------------------------------~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSL 1160 (1368)
.. .......+||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (381)
T cd05626 155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV 234 (381)
T ss_pred cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence 00 001123579999999999998899999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHH--hcCcCcCCCCCH
Q 000659 1161 GVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASM--CVQPEVQHRPFM 1237 (1368)
Q Consensus 1161 GVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~--CL~pDPkeRPTM 1237 (1368)
||+||||++|+.||...+.... ..+..|... +..........++.+++.+ |+..++.+|+++
T Consensus 235 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~ 299 (381)
T cd05626 235 GVILFEMLVGQPPFLAPTPTETQLKVINWENT---------------LHIPPQVKLSPEAVDLITKLCCSAEERLGRNGA 299 (381)
T ss_pred hhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---------------cCCCCCCCCCHHHHHHHHHHccCcccccCCCCH
Confidence 9999999999999976432111 111111100 0000011233566777776 556677779999
Q ss_pred HHHHHH
Q 000659 1238 GEVVQA 1243 (1368)
Q Consensus 1238 sEVLq~ 1243 (1368)
.|+++.
T Consensus 300 ~~~l~h 305 (381)
T cd05626 300 DDIKAH 305 (381)
T ss_pred HHHhcC
Confidence 999865
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=337.72 Aligned_cols=260 Identities=27% Similarity=0.429 Sum_probs=206.0
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr----~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
.++|++.++||+|+||+||+|.+ .+|+ .||+|+++.. .....+++.+|+.++++++|+||++++++|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 35688999999999999999984 3454 4899998643 33446678999999999999999999999975 4578
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
++|||+++|+|.++++.. ...+.+.+++.++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.
T Consensus 85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~ 158 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARL 158 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceee
Confidence 999999999999999642 235899999999999999999999887 99999999999999999999999999986
Q ss_pred ccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1122 l~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
..............++..|++||++.+..++.++|||||||+||||++ |..||+... ...+..++.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~------ 229 (279)
T cd05109 159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP---AREIPDLLEKGER------ 229 (279)
T ss_pred cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHHHCCCc------
Confidence 643222111122235678999999998899999999999999999998 899986532 2223333221100
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
......+..++.+++.+||+.||++||++.|+++.|+.+.+..
T Consensus 230 --------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 230 --------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred --------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 0111234467889999999999999999999999988765543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=349.97 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=195.9
Q ss_pred eEEeecCcEEEEEEEe----cCCCEEEEEEeeccc----chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl----kdGr~VAVKvLk~~d----~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+.||+|+||.||++.. .+++.||||+++... ......+.+|+++|++++|+||+++++++.+++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999985 357899999997532 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+|+|.+++.. ...+.+.++..++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 154 (323)
T cd05584 82 LSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154 (323)
T ss_pred CCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence 999999999853 235788899999999999999999887 9999999999999999999999999987543221
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
......+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. ..........
T Consensus 155 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~------~~~~~~~~~~---------- 216 (323)
T cd05584 155 --TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK------KTIDKILKGK---------- 216 (323)
T ss_pred --CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH------HHHHHHHcCC----------
Confidence 1223457999999999999888999999999999999999999999754311 1111111110
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
..++......+.+++.+||+.+|++|+ ++.++++.
T Consensus 217 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h 256 (323)
T cd05584 217 --LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH 256 (323)
T ss_pred --CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence 012223346789999999999999999 77777664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=330.38 Aligned_cols=247 Identities=32% Similarity=0.463 Sum_probs=199.5
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChh
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 1053 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~ 1053 (1368)
++||+|+||.||+|...+++.||+|+++... ......|.+|++++++++|+||++++++|.+.+..++||||+++|+|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3799999999999998889999999987543 333457899999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccccc
Q 000659 1054 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1133 (1368)
Q Consensus 1054 d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~ 1133 (1368)
+++... ...+++.++++++.|++.+|.|||+.+ ++|||||++||+|+.++.+||+|||+++....... .....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-~~~~~ 153 (250)
T cd05085 81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-SSSGL 153 (250)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccc-ccCCC
Confidence 998532 235889999999999999999999887 99999999999999999999999999875432211 11112
Q ss_pred ccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1134 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1134 v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
..++..|+|||++..+.++.++|||||||++|||++ |+.||..... ........ .. ......
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~---~~~~~~~~----~~----------~~~~~~ 216 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN---QQAREQVE----KG----------YRMSCP 216 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHH----cC----------CCCCCC
Confidence 234678999999999999999999999999999998 9999965421 11111111 00 011122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.....++.+++.+||+.+|++||++.|++++|.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 217 QKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 334578999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=349.62 Aligned_cols=265 Identities=23% Similarity=0.322 Sum_probs=205.2
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
+.|+.+.++|+|+||.|||++. ++|+.||||++.... ....+-.+|||++|++|+|+|+|.|+++|.....++||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999995 479999999996533 2334456899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||+.--|.+ |..+ ...++.+.+.++++|+++|+.|||.++ +|||||||+||||+.+|.+||||||+|+.+..
T Consensus 82 ~~dhTvL~e-Le~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~- 153 (396)
T KOG0593|consen 82 YCDHTVLHE-LERY---PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA- 153 (396)
T ss_pred ecchHHHHH-HHhc---cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-
Confidence 997644443 4322 235888999999999999999999988 99999999999999999999999999998763
Q ss_pred ccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh--------hhhhcccc
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW--------ARPLLTSR 1196 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W--------a~plls~~ 1196 (1368)
.....+..+.|.+|+|||++.+ -.|+..+|||++||++.||++|..-|-...+-++..+... ....+..+
T Consensus 154 -pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 -PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred -CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2223355678999999999887 6899999999999999999999998876554443322211 11222222
Q ss_pred cccceeecCCC------CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSL------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L------~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+..+.-+.. ...++ ....-+++|+..|++.||.+|.+-+|++..
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred CceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 22222211111 11111 233468999999999999999999999754
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=342.59 Aligned_cols=264 Identities=23% Similarity=0.443 Sum_probs=203.5
Q ss_pred CCcceeeEEeecCcEEEEEEEecC---------------CCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD---------------GTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIG 1032 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd---------------Gr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG 1032 (1368)
++|++.+.||+|+||.||+++..+ ...||||+++.. .....++|.+|+++|++++|+||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 578999999999999999988542 235899998653 3334567999999999999999999999
Q ss_pred eeeeccceEEEEeecCCCChhhccccccc--------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCee
Q 000659 1033 ICIEEQARCLVYELIPNGSVESHLHGVDK--------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 1104 (1368)
Q Consensus 1033 ~~~d~~~~~LVmEYm~gGSL~d~L~~~~~--------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNIL 1104 (1368)
++..++..++||||+.+++|.+++..... ....+.|.++++++.|+++||+|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999999854221 1124789999999999999999999887 999999999999
Q ss_pred ecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh--CCCCCCCCCCCcc
Q 000659 1105 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPGQ 1182 (1368)
Q Consensus 1105 LD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT--Gr~PFd~s~~~~~ 1182 (1368)
|++++.+||+|||+++...............++..|+|||++..+.++.++|||||||++|||++ |..||.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~--- 238 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD--- 238 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh---
Confidence 99999999999999986543322222233445778999999999999999999999999999998 5667754322
Q ss_pred hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1183 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1183 ~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
................ .. ...........+.+|+.+||+.+|++||+|++|++.|+
T Consensus 239 ~~~~~~~~~~~~~~~~--~~-----~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 239 EQVIENTGEFFRNQGR--QI-----YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHHHHHHHhhhhccc--cc-----cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1111111111110000 00 00111123468999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=373.12 Aligned_cols=251 Identities=23% Similarity=0.354 Sum_probs=211.5
Q ss_pred CCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
+-|++++.||+|+.|.|.+|+ ..+|+.+|||++.+. .......+.+||-||+.|.|+||++|++++++..++|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 457889999999999999999 668999999999654 2233456789999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|.|+++|- +++.|.+.+..+++.||+.|+.|||..+ |+|||||++|+|||.++++||+|||+|.+...
T Consensus 92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~ 164 (786)
T KOG0588|consen 92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVP 164 (786)
T ss_pred EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccC
Confidence 9999999999994 3557999999999999999999999888 99999999999999999999999999986532
Q ss_pred cccccccccccccccccCcchhccCCC-CcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~-T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
..+..+-||.+.|.|||++++..| +.++||||+|||||-||||+.||++.+ +......... +..
T Consensus 165 ---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN------ir~LLlKV~~---G~f--- 229 (786)
T KOG0588|consen 165 ---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN------IRVLLLKVQR---GVF--- 229 (786)
T ss_pred ---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc------HHHHHHHHHc---Ccc---
Confidence 344566799999999999999887 489999999999999999999998532 2222111111 111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
+++.....+..+|+.+|+..||.+|.|++||++.-+..
T Consensus 230 ------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~ 267 (786)
T KOG0588|consen 230 ------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS 267 (786)
T ss_pred ------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence 23345567889999999999999999999999886533
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=342.78 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=205.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCC--EEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr--~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|.++ ++. .+++|.++.. .....++|.+|++++.++ +|+||+++++++.+++..|+|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 57889999999999999999964 454 4577777643 334456789999999999 899999999999999999999
Q ss_pred EeecCCCChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCc
Q 000659 1044 YELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~V 1111 (1368)
|||+.+|+|.++++.... ....+++.+++.++.|++.||+|||+++ |+|||||++||||+.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999964321 1235889999999999999999999887 9999999999999999999
Q ss_pred ccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhh
Q 000659 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1112 KLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~ 1190 (1368)
||+|||+++...... ......++..|+|||++....++.++|||||||+||||++ |..||...... ...+...
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~ 237 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELYEKLP 237 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH---HHHHHHh
Confidence 999999986432111 1111234678999999988889999999999999999998 99999654321 1111110
Q ss_pred hhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhh
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1191 plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
. . ............+.+|+.+||+.+|++||++.++++.|+.+.....
T Consensus 238 ---~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~ 285 (303)
T cd05088 238 ---Q-G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285 (303)
T ss_pred ---c-C----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence 0 0 0001112234578999999999999999999999999987766543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=356.87 Aligned_cols=253 Identities=23% Similarity=0.315 Sum_probs=198.2
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||++.. .+|+.||||++... .....+++.+|++++++++|+|||++++++.+.+..||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4799999999999999999984 57899999998643 2334467889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~ 153 (377)
T cd05629 81 EFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK 153 (377)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence 99999999999853 235889999999999999999999888 99999999999999999999999999963321
Q ss_pred cccc---------------------------------------------cccccccccccccCcchhccCCCCcccceee
Q 000659 1125 EESR---------------------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYS 1159 (1368)
Q Consensus 1125 ~~~~---------------------------------------------~~st~v~GT~gYmAPEvL~~~~~T~KSDVWS 1159 (1368)
.... ......+||..|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 233 (377)
T cd05629 154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS 233 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence 0000 0001246999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCC---C
Q 000659 1160 YGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR---P 1235 (1368)
Q Consensus 1160 LGVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeR---P 1235 (1368)
|||+||||++|+.||........ ..+..|. ..+. +.. ......++.+++.+|+. ++.+| +
T Consensus 234 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------~~~~------~p~--~~~~s~~~~dli~~lL~-~~~~r~~r~ 297 (377)
T cd05629 234 LGAIMFECLIGWPPFCSENSHETYRKIINWR-------ETLY------FPD--DIHLSVEAEDLIRRLIT-NAENRLGRG 297 (377)
T ss_pred cchhhhhhhcCCCCCCCCCHHHHHHHHHccC-------CccC------CCC--CCCCCHHHHHHHHHHhc-CHhhcCCCC
Confidence 99999999999999975432110 1111111 0000 000 01234568889999997 66665 5
Q ss_pred CHHHHHHHH
Q 000659 1236 FMGEVVQAL 1244 (1368)
Q Consensus 1236 TMsEVLq~L 1244 (1368)
++.|+++.-
T Consensus 298 ~~~~~l~hp 306 (377)
T cd05629 298 GAHEIKSHP 306 (377)
T ss_pred CHHHHhcCC
Confidence 999988763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=339.41 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=201.9
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
+|++.++||+|+||.||++.. .+++.||||++.... ......+.+|++++++++|+||+.+++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 488999999999999999995 468999999986432 2233567889999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ |+|||||++|||+++++.++|+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05605 81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG 155 (285)
T ss_pred ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence 99999999888542 2345899999999999999999999887 999999999999999999999999999865322
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......|+..|+|||++.+..++.++|||||||+||||++|+.||....... ..... ...+..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~--~~~~~-~~~~~~---------- 219 (285)
T cd05605 156 E---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKV--KREEV-ERRVKE---------- 219 (285)
T ss_pred C---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhh--HHHHH-HHHhhh----------
Confidence 1 1223468999999999999999999999999999999999999997543211 11111 100100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
....+.......+.+|+.+||+.||++|+ +++++++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05605 220 -DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH 261 (285)
T ss_pred -cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence 00112223456789999999999999999 77787654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=348.05 Aligned_cols=263 Identities=25% Similarity=0.398 Sum_probs=208.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeecc
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk--------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~ 1038 (1368)
.+|++.+.||+|+||.||+|... ++..||+|+++.. .....+++.+|+++++++ +|+||++++++|.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46889999999999999999742 1236899988743 233457899999999999 7999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccc------------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec
Q 000659 1039 ARCLVYELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1106 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~------------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD 1106 (1368)
..++||||+.+|+|.++|.... .....+.|.++++++.|++.||+|||+.+ |+|||||++||||+
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986432 12345899999999999999999999887 99999999999999
Q ss_pred CCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhH
Q 000659 1107 HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENL 1185 (1368)
Q Consensus 1107 ~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nL 1185 (1368)
+++.+||+|||+++...............++..|+|||++....++.++|||||||+||||++ |+.||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~------~ 242 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------V 242 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC------H
Confidence 999999999999986543222222222334578999999999999999999999999999998 888886432 1
Q ss_pred HHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1186 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1186 v~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
.++...... . ........+..++.+++.+||+.+|++||++.|+++.|+++....
T Consensus 243 ~~~~~~~~~-~----------~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~ 297 (334)
T cd05100 243 EELFKLLKE-G----------HRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVT 297 (334)
T ss_pred HHHHHHHHc-C----------CCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhc
Confidence 112111111 0 011122234567899999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=374.13 Aligned_cols=262 Identities=24% Similarity=0.320 Sum_probs=211.1
Q ss_pred HHHHHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeecc
Q 000659 962 SEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 962 eELe~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~ 1038 (1368)
.+++...++|++.++||+|+||+||+|. ..+|+.||||+++.. ......++.+|+.+|..++|+||+++++.+...+
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 4445556799999999999999999998 457999999998643 3344567889999999999999999988765432
Q ss_pred --------ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC
Q 000659 1039 --------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110 (1368)
Q Consensus 1039 --------~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~ 1110 (1368)
.+++||||+.+|+|.++|+........+.+.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 367999999999999999755444567999999999999999999999887 999999999999999999
Q ss_pred cccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhh
Q 000659 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1111 VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~ 1190 (1368)
+||+|||+++..............+||..|+|||++.+..++.++|||||||+||||++|+.||...+ ..+++.
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~------~~~~~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN------MEEVMH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC------HHHHHH
Confidence 99999999986643323333345679999999999999999999999999999999999999996532 112222
Q ss_pred hhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1191 plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+... . ...+.....++.+++.+||+.+|++||++.|+++.
T Consensus 256 ~~~~~~------~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 256 KTLAGR------Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred HHhcCC------C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111110 0 01222345679999999999999999999999865
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=334.72 Aligned_cols=255 Identities=28% Similarity=0.431 Sum_probs=204.5
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.++|++.+.||+|+||.||+|.++++..|+||+++... ...++|.+|++++++++|+||+++++++. ++..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 35699999999999999999998777789999997533 33467999999999999999999999875 45679999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+|+|.+++... ....+++..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 83 SKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred CCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 999999999642 2235799999999999999999999887 99999999999999999999999999986543221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......++..|++||++.+..++.++|||||||++|||++ |+.||...... .+.+ .... .
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~---~~~~---~~~~-~---------- 219 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR---EVLD---QVER-G---------- 219 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH---HHHH---HHhc-C----------
Confidence 11122346778999999998999999999999999999999 88888643211 1111 0000 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.......+....+.+|+.+|++.+|++||++.++++.|+..
T Consensus 220 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 220 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 00011223456789999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=332.53 Aligned_cols=254 Identities=27% Similarity=0.440 Sum_probs=205.7
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.++|++.++||+|+||.||+|..++++.||+|.++... ...++|.+|++++++++|+||+++++++. ++..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 46789999999999999999999889999999987533 34568999999999999999999999874 46789999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ ++|||||++||++++++.++|+|||++........
T Consensus 83 ~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 157 (260)
T cd05067 83 ENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY 157 (260)
T ss_pred CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence 999999998643 2346899999999999999999999887 99999999999999999999999999976542211
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......++..|++||++....++.++|||||||++|||++ |+.||..... ..+...... .
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~~----~---------- 219 (260)
T cd05067 158 -TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN---PEVIQNLER----G---------- 219 (260)
T ss_pred -ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh---HHHHHHHHc----C----------
Confidence 11122345678999999998899999999999999999999 9999965431 112222110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
...........++.+++.+||+.+|++||+++++++.|+.
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0011112334679999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=342.26 Aligned_cols=265 Identities=22% Similarity=0.312 Sum_probs=199.0
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.++|++.+.||+|+||.||+|... +++.||||+++.... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999965 789999999864332 233467899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+. ++|.+++... ...+.+.++..++.||+.||+|||+.+ |+||||||+||||++++++||+|||+++.....
T Consensus 84 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 84 YVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred CCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 994 6888887532 245889999999999999999999888 999999999999999999999999998754321
Q ss_pred ccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc--------c
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--------R 1196 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~--------~ 1196 (1368)
. .......|+..|+|||++.+ ..++.++|||||||+||||++|+.||....... ..+ +.....+.. .
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~ 232 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQL-ERIFLVLGTPNEDTWPGV 232 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHH-HHHHHHhCCCChhhccch
Confidence 1 12233568999999998865 457899999999999999999999997543211 111 110000000 0
Q ss_pred cccceeecCCCCCCCC---------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVP---------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~---------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+..+....+..... ......+.+|+.+||+.||++|+|+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h 288 (303)
T cd07869 233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH 288 (303)
T ss_pred hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence 0000000000000000 0123467899999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=331.10 Aligned_cols=250 Identities=30% Similarity=0.486 Sum_probs=206.5
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.++|++.+.||+|+||.||+|... |+.|+||.++.... ..+++.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 357888999999999999999876 78999999976543 5678999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++.... ...++|..++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~ 157 (256)
T cd05039 83 AKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc
Confidence 9999999996432 235899999999999999999999887 99999999999999999999999999986632211
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
...++..|++||++..+.++.++||||||+++|||++ |+.||.... ...+...... .
T Consensus 158 -----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~----~---------- 215 (256)
T cd05039 158 -----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPHVEK----G---------- 215 (256)
T ss_pred -----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHhc----C----------
Confidence 2335678999999998899999999999999999997 999986542 1222222111 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
............+.+++.+||..+|++||++.|++++|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 216 YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 0111122345678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=333.82 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=204.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CC---CEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dG---r~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|.+. ++ ..|+||+++.. +....++|.+|+.++++++|+||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35888999999999999999965 33 35999998754 344457899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|||||++||||+.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccc
Confidence 9999999999998643 235899999999999999999999887 9999999999999999999999999987654
Q ss_pred cccccccccc-cc--ccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1124 DEESRHISTR-VM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1124 ~~~~~~~st~-v~--GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
.......... .. .+..|++||++....++.++|||||||++|||++ |+.||..... .....++....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~---~~~~~~i~~~~------ 228 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN---QDVINAIEQDY------ 228 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH---HHHHHHHHcCC------
Confidence 3222111111 11 2457999999999999999999999999999987 9999865321 22333321110
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.-....++...+.+++.+||+.+|++||++.+|++.|+++
T Consensus 229 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 --------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred --------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011223456788999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=349.20 Aligned_cols=253 Identities=23% Similarity=0.266 Sum_probs=201.8
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||++.. .+|+.||||+++... ....+.+.+|++++++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4799999999999999999995 478999999997532 234566889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+|||||++||||+.++++||+|||+++....
T Consensus 81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~ 154 (330)
T cd05601 81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTA 154 (330)
T ss_pred CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence 999999999999643 236899999999999999999999887 99999999999999999999999999986643
Q ss_pred cccccccccccccccccCcchhc------cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAM------TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~------~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~ 1198 (1368)
... .......||..|+|||++. ...++.++|||||||+||||++|+.||...... ......+...
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~------~~~~~i~~~~-- 225 (330)
T cd05601 155 NKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA------KTYNNIMNFQ-- 225 (330)
T ss_pred CCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH------HHHHHHHcCC--
Confidence 222 1223356899999999986 456789999999999999999999999654321 1111111110
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1199 L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+.++ + .........+.+|+..|++ +|++|+++.++++.
T Consensus 226 --~~~~--~--~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h 263 (330)
T cd05601 226 --RFLK--F--PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH 263 (330)
T ss_pred --CccC--C--CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence 0000 0 0011234678899999998 99999999998754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=348.07 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=198.0
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|... +++.||||+++.. .....+.+.+|+.++.++ +|+||+++++++.+.+..||||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 47999999999999954 6889999999753 223345688999999998 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--~~ 151 (329)
T cd05588 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP--GD 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC--CC
Confidence 999988843 246899999999999999999999887 999999999999999999999999998743221 11
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCc--chhHHHhhhhhcccccccceeecCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG--QENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~--~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||+.....+ .....+|....+.. ...
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------~~~ 222 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------KQI 222 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------CCC
Confidence 2234679999999999999999999999999999999999999997543222 12222332221111 111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCC------HHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPF------MGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPT------MsEVLq~ 1243 (1368)
.++.....++.+++.+||+.||.+|++ +.|+++.
T Consensus 223 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 223 --RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred --CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 122234567899999999999999997 5666543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=347.99 Aligned_cols=239 Identities=25% Similarity=0.355 Sum_probs=192.1
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHH---hhcccccceeeeeeeeeccceEEE
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEML---SRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeIL---srLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++ ++++|+||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 678899999999999999854 68999999997532 23345667776665 566799999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|..+++. ..+++.+++.++.||+.||.|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM 152 (324)
T ss_pred EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence 999999999988842 35899999999999999999999887 9999999999999999999999999987542
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
... ......+|+..|||||++.+..++.++|||||||+||||++|+.||...... . .........
T Consensus 153 ~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~---~---~~~~i~~~~------- 217 (324)
T cd05589 153 GFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE---E---VFDSIVNDE------- 217 (324)
T ss_pred CCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH---H---HHHHHHhCC-------
Confidence 211 2223467999999999999999999999999999999999999999754311 1 111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
..++......+.+++.+||+.||++|+++
T Consensus 218 -----~~~p~~~~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 218 -----VRYPRFLSREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred -----CCCCCCCCHHHHHHHHHHhhcCHhHcCCC
Confidence 01222344678899999999999999954
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=330.80 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=202.7
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
++|++.+.||+|+||.||+|.. ++++.|++|++.... ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999985 468999999986432 1233568899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.+++|.+++.. ...+++..+++++.|++.||.|||+.+ |+|||||++||||++++++||+|||+++..
T Consensus 82 v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~ 154 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL 154 (263)
T ss_pred EEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence 9999999999999853 235889999999999999999999887 999999999999999999999999999755
Q ss_pred ccccccc-ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~-~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
....... ......|+..|+|||++.+..++.++|||||||++|||++|+.||...+.. ....+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~---~------- 221 (263)
T cd06625 155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM---AAIFKIA---T------- 221 (263)
T ss_pred cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH---HHHHHHh---c-------
Confidence 3211111 112345788999999999989999999999999999999999999643211 1111100 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+.......+.+++.+||+.+|++||++.|+++.
T Consensus 222 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 222 ---QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 001112223345678999999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=339.10 Aligned_cols=264 Identities=23% Similarity=0.440 Sum_probs=204.1
Q ss_pred CCcceeeEEeecCcEEEEEEEec-----------------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-----------------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKL 1030 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-----------------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrL 1030 (1368)
++|++.+.||+|+||.||++... ++..||+|+++.. .....++|.+|+++|++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56999999999999999998532 2446899999753 33445689999999999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhccccccc-------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCe
Q 000659 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1103 (1368)
Q Consensus 1031 lG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~-------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNI 1103 (1368)
++++.+++..++||||+.+|+|.+++..... ....+++.++++++.|++.||+|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 1234788999999999999999999887 99999999999
Q ss_pred eecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh--CCCCCCCCCCCc
Q 000659 1104 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS--GRKPVDMTQPPG 1181 (1368)
Q Consensus 1104 LLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT--Gr~PFd~s~~~~ 1181 (1368)
||++++.+||+|||+++...............++..|++||+...+.++.++|||||||+||||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE- 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH-
Confidence 999999999999999986543222222233345678999999888899999999999999999998 67787543221
Q ss_pred chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1182 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1182 ~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
+ ............. ..... .....+...+.+|+.+||+.||++||++.||++.|+
T Consensus 241 -~-~~~~~~~~~~~~~--~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 -Q-VIENTGEFFRDQG--RQVYL-----PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred -H-HHHHHHHHHhhcc--ccccC-----CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 1 1111111111000 00000 111234468899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=354.14 Aligned_cols=202 Identities=27% Similarity=0.391 Sum_probs=175.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||+||+|... +++.||||+++... ....+.+.+|++++.+++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999854 68999999997532 233456788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+++.+++.++.|++.||+|||+++ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~ 153 (363)
T cd05628 81 EFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153 (363)
T ss_pred cCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence 99999999999953 346899999999999999999999887 99999999999999999999999999975432
Q ss_pred ccc---------------------------------ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCC
Q 000659 1125 EES---------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1171 (1368)
Q Consensus 1125 ~~~---------------------------------~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr 1171 (1368)
... .......+||..|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~ 233 (363)
T cd05628 154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (363)
T ss_pred cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 000659 1172 KPVDMT 1177 (1368)
Q Consensus 1172 ~PFd~s 1177 (1368)
.||...
T Consensus 234 ~Pf~~~ 239 (363)
T cd05628 234 PPFCSE 239 (363)
T ss_pred CCCCCC
Confidence 999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=368.57 Aligned_cols=267 Identities=24% Similarity=0.319 Sum_probs=210.5
Q ss_pred HHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHH--HHHHHHHHhhcc-cccceeeeeeeeecc-ce
Q 000659 966 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE--FLAEVEMLSRLH-HRNLVKLIGICIEEQ-AR 1040 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~ke--FlrEIeILsrLr-HPNIVrLlG~~~d~~-~~ 1040 (1368)
...++|.+.+.||.|+||.||+|+ .++|+.||||++++.-.. .++ =+||+..|++|+ |+|||+|.+++.+.+ .+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 345689999999999999999999 678999999999864333 333 368999999998 999999999999887 89
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
|+||||| ..+|++++++. +..+++.+++.|++||++||+|+|.+| +.||||||+||||..+..+||+||||||
T Consensus 86 ~fVfE~M-d~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccc
Confidence 9999999 66999999643 568999999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccccccccccccccCcchhc-cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhH-HHhhh-hh---cc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL-VAWAR-PL---LT 1194 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~-~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nL-v~Wa~-pl---ls 1194 (1368)
.+.. ..-.+..+.|.+|+|||++. .+.|+.+.|||++|||++||++-+.-|-+.++.++... ++-+- +. +.
T Consensus 159 ev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 159 EVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccch
Confidence 7743 33345567899999999765 67899999999999999999999998876654443221 11000 00 00
Q ss_pred cccccceeecCC--------CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1195 SREGLERIIDPS--------LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1195 ~~e~L~eIvDp~--------L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
....+...+.-. +..-++ .+..+.++++.+|+..||++|||+.|+++.-
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 001111111111 111122 2567899999999999999999999998874
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=344.17 Aligned_cols=258 Identities=26% Similarity=0.424 Sum_probs=206.1
Q ss_pred CCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccce
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~ 1040 (1368)
++|++.+.||+|+||.||+|... ++..||||+++... ....+.+.+|+++++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56999999999999999999742 34579999987543 33346789999999999 799999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+.+|+|.++++... ...+++.++++|+.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+++
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999996422 234899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
...............++..|+|||++....++.++|||||||++|||++ |+.||...... .....+...
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~--~~~~~~~~~-------- 259 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVD--SKFYKLIKE-------- 259 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch--HHHHHHHHc--------
Confidence 6543222112222346778999999999999999999999999999998 99998654321 111111110
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
............++.+++.+||+.+|++||++.||++.|+++
T Consensus 260 ------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 260 ------GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ------CCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 001111112346799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=349.85 Aligned_cols=242 Identities=26% Similarity=0.336 Sum_probs=196.4
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
++||+|+||.||++.. .+|+.||+|+++.. ......++.+|++++++++|+||+++++++.+.+..||||||+.+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999984 57899999999753 2334456788999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
+|.+++.. ...+++.+++.|+.||+.||+|||+ .+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 ~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~ 151 (325)
T cd05594 81 ELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--A 151 (325)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--c
Confidence 99998853 2368999999999999999999996 56 9999999999999999999999999987543211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. .+.... .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~---~~~~~i---~~~~------------~ 213 (325)
T cd05594 152 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELI---LMEE------------I 213 (325)
T ss_pred ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH---HHHHHH---hcCC------------C
Confidence 123456999999999999999999999999999999999999999654321 111111 0000 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
.++.....++.+++.+||+.||++|+ ++.|+++.
T Consensus 214 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 214 RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 12223346788999999999999997 88888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.63 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=207.7
Q ss_pred HhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..++|++.+.||+|+||.||+|.+++++.|+||.++.. ....+++.+|++++++++|+||+++++++.++...++||||
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY 82 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence 35689999999999999999999888889999998743 33457899999999999999999999999988999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.+++.... ...+++.+++.|+.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++......
T Consensus 83 ~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 83 MSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred cCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999996432 246899999999999999999999887 9999999999999999999999999998664321
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. .......++..|++||.+.+..++.++|||||||++|||++ |+.||...+. ....+.....
T Consensus 158 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~------------- 220 (261)
T cd05034 158 Y-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN---REVLEQVERG------------- 220 (261)
T ss_pred h-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcC-------------
Confidence 1 11112234578999999998899999999999999999999 9999854321 1111111100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
...........++.+++.+||+.+|++||+++|+++.|+.
T Consensus 221 -~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 221 -YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred -CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 0011112234678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=338.93 Aligned_cols=258 Identities=27% Similarity=0.475 Sum_probs=205.1
Q ss_pred hCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccce
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~ 1040 (1368)
.++|++.+.||+|+||.||+|... ++..|++|+++... ....++|.+|+.++++++|+||++++++|.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 457999999999999999999853 46789999987543 34456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhcccccc------------------cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccC
Q 000659 1041 CLVYELIPNGSVESHLHGVD------------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSN 1102 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~------------------~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsN 1102 (1368)
++||||+.+|+|.+++.... .....+++.++++++.|++.||+|||+.+ ++|||||++|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999996321 11235789999999999999999999887 9999999999
Q ss_pred eeecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCc
Q 000659 1103 ILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPG 1181 (1368)
Q Consensus 1103 ILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~ 1181 (1368)
||+++++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~-- 238 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH-- 238 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH--
Confidence 9999999999999999876533222122222335678999999998999999999999999999998 8888854321
Q ss_pred chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1182 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1182 ~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..+..+.. . . .+. ........++.+|+.+||+.+|++||++.|+++.|+
T Consensus 239 -~~~~~~~~---~-~-~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~ 287 (288)
T cd05050 239 -EEVIYYVR---D-G-NVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ 287 (288)
T ss_pred -HHHHHHHh---c-C-CCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence 11221111 1 0 000 111234467999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=338.01 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=197.9
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||+||++... +|+.||||++.... ....+.+..|++++++++|+||+++.+++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999854 78899999986432 22345678899999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++.........+++.+++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 9888654444557999999999999999999999887 99999999999999999999999999976543221 123
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
...||..|+|||++.+..++.++|||||||+||||++|+.||........ ......... ... ..+.
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~----------~~~--~~~~ 221 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRIL----------NDS--VTYP 221 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh--HHHHHHhhc----------ccC--CCCc
Confidence 45689999999999999999999999999999999999999975432111 111111111 000 0122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
......+.+++.+||+.||++|+ +++|+++.
T Consensus 222 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h 257 (280)
T cd05608 222 DKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH 257 (280)
T ss_pred ccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence 23456789999999999999999 66666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=355.10 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=197.6
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.+|++.+.||+|+||.||+|+. .+++.||||++.... ....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 4799999999999999999995 468999999986432 233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.+ ...+++..+..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||++..+..
T Consensus 81 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~ 153 (376)
T cd05598 81 DYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (376)
T ss_pred eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence 99999999999953 235888999999999999999999888 99999999999999999999999999853210
Q ss_pred cc-----------------------------------------cccccccccccccccCcchhccCCCCcccceeeHHHH
Q 000659 1125 EE-----------------------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVV 1163 (1368)
Q Consensus 1125 ~~-----------------------------------------~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVI 1163 (1368)
.. ........+||..|||||++.+..++.++|||||||+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 233 (376)
T cd05598 154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233 (376)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence 00 0001123579999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC---CHHH
Q 000659 1164 ILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP---FMGE 1239 (1368)
Q Consensus 1164 LyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRP---TMsE 1239 (1368)
||||++|+.||......+. ..+..|.. . +...........+.+++.+|+ .+|.+|+ ++.|
T Consensus 234 lyell~G~~Pf~~~~~~~~~~~i~~~~~-------~--------~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~e 297 (376)
T cd05598 234 LYEMLVGQPPFLADTPAETQLKVINWET-------T--------LHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADE 297 (376)
T ss_pred eeehhhCCCCCCCCCHHHHHHHHhccCc-------c--------ccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHH
Confidence 9999999999976432211 11111100 0 000011123456677777766 4999999 8888
Q ss_pred HHHH
Q 000659 1240 VVQA 1243 (1368)
Q Consensus 1240 VLq~ 1243 (1368)
+++.
T Consensus 298 ll~h 301 (376)
T cd05598 298 IKAH 301 (376)
T ss_pred HhCC
Confidence 8765
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=331.80 Aligned_cols=254 Identities=23% Similarity=0.335 Sum_probs=202.0
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||+|+. .+++.||+|+++.......+.+.+|+.++++++|+||+++++++..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 4689999999999999999995 578899999997555455567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.++++. ...+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 89 GGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 99999999853 235889999999999999999999887 99999999999999999999999999986532211
Q ss_pred ccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1128 RHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
......|+..|++||.+. ...++.++|||||||++|||++|+.||....... ....+.. .. +..
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~--~~~~~~~------~~---~~~ 228 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMSK------SN---FQP 228 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhh--hheeeec------CC---CCC
Confidence 122346889999999874 3457889999999999999999999985432111 0000000 00 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..+. ........+.+++.+||+.+|++||++++|++.|
T Consensus 229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 229 PKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 1110 0112346789999999999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=351.28 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=204.2
Q ss_pred CCcceeeEEeecCcEEEEEEEe------cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhc-ccccceeeeeeeeec-cc
Q 000659 969 GNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE-QA 1039 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl------kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~-~~ 1039 (1368)
++|++.++||+|+||.||+|.. .+++.||||+++... ....+.+.+|+++|.++ +|+||++++++|... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5789999999999999999973 357889999997532 33456788999999999 689999999988654 46
Q ss_pred eEEEEeecCCCChhhccccccc----------------------------------------------------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDK---------------------------------------------------------- 1061 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~---------------------------------------------------------- 1061 (1368)
.++||||+++|+|.++++....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999864211
Q ss_pred -----CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccc
Q 000659 1062 -----ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1136 (1368)
Q Consensus 1062 -----~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~G 1136 (1368)
....++|..+++++.||++||+|||+++ |+|||||++||||++++++||+|||+++...............+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 0124788999999999999999999887 99999999999999999999999999986533222112222345
Q ss_pred cccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhh
Q 000659 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDS 1215 (1368)
Q Consensus 1137 T~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee 1215 (1368)
+..|+|||++.+..++.++|||||||+||||++ |..||...... ..+..- +.... ........
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~----~~~~~----------~~~~~~~~ 307 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID--EEFCRR----LKEGT----------RMRAPDYT 307 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc--HHHHHH----HhccC----------CCCCCCCC
Confidence 678999999999999999999999999999997 99998653221 111111 11000 00111122
Q ss_pred HHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1216 VAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1216 ~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
..++.+++..||+.+|++||++.||++.|+.+.+.
T Consensus 308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 35689999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.90 Aligned_cols=269 Identities=26% Similarity=0.386 Sum_probs=206.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-----CCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeee--ccce
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIE--EQAR 1040 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-----dGr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~ 1040 (1368)
++|++.+.||+|+||.||+|.+. +++.||||+++..... ..++|.+|++++++++|+||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 3688999999754443 56789999999999999999999999877 5678
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||++.
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAK 157 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccc
Confidence 99999999999999996432 25899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccc-cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc--cccc
Q 000659 1121 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL--TSRE 1197 (1368)
Q Consensus 1121 ll~~~~~~-~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll--s~~e 1197 (1368)
........ .......++..|++||++....++.++||||||+++|||++|+.|+......... ++.... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~ 233 (284)
T cd05038 158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIAQGQMIVT 233 (284)
T ss_pred ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccccccccHH
Confidence 76532221 1111233566799999999889999999999999999999999988643221100 000000 0000
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1198 ~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.+.+.+...........+..++.+|+.+||+.+|++||++.||+++|+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 234 RLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 00111111111111223446799999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.53 Aligned_cols=266 Identities=26% Similarity=0.367 Sum_probs=207.3
Q ss_pred CCCHHHHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeee
Q 000659 958 TFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICI 1035 (1368)
Q Consensus 958 ~fsleELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~ 1035 (1368)
.+.++.+..+.++|++.+.||+|+||.||++.. .+++.+++|+++.. ....+++.+|+.+++++ +|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 85 (286)
T cd06638 7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYY 85 (286)
T ss_pred eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeee
Confidence 345566777889999999999999999999985 46789999998643 23346788999999999 6999999999884
Q ss_pred -----eccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC
Q 000659 1036 -----EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110 (1368)
Q Consensus 1036 -----d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~ 1110 (1368)
.++..++||||+++|+|.++++........+++..+..++.|+++||.|||+.+ |+|||||++||++++++.
T Consensus 86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~ 162 (286)
T cd06638 86 KKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGG 162 (286)
T ss_pred ecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCC
Confidence 345689999999999999988644334456899999999999999999999887 999999999999999999
Q ss_pred cccccccccccccccccccccccccccccccCcchhcc-----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhH
Q 000659 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1185 (1368)
Q Consensus 1111 VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nL 1185 (1368)
+||+|||+++...... .......|+..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~--~~~ 238 (286)
T cd06638 163 VKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM--RAL 238 (286)
T ss_pred EEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh--HHH
Confidence 9999999998654321 12233468999999998753 45788999999999999999999999654211 111
Q ss_pred HHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1186 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1186 v~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..+. . .....+. .......++.+++.+||+.+|++||++.||++.+
T Consensus 239 ~~~~----~--~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~ 284 (286)
T cd06638 239 FKIP----R--NPPPTLH-------QPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV 284 (286)
T ss_pred hhcc----c--cCCCccc-------CCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence 1110 0 0000010 1111235689999999999999999999998764
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=352.42 Aligned_cols=245 Identities=24% Similarity=0.311 Sum_probs=199.9
Q ss_pred CCcceeeEEeecCcEEEEEEEecC--CCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd--Gr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|.+++ +..||+|++... .....+.+.+|+++++.++|+||+++++++.+++..|+|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 469999999999999999998543 368999998643 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++++||+|||+++...
T Consensus 110 ~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 999999999999953 235899999999999999999999887 9999999999999999999999999998653
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.. ....+||..|||||++.+..++.++|||||||+||||++|+.||...+.. ....- .....
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~---i~~~~------- 244 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL---LIYQK---ILEGI------- 244 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH---HHHHH---HhcCC-------
Confidence 21 23457999999999999988999999999999999999999999753211 11110 11100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
. .++......+.+++.+||+.||++|+ +++|+++.
T Consensus 245 ---~--~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 245 ---I--YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred ---C--CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 0 11222335678999999999999995 78887665
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.61 Aligned_cols=255 Identities=27% Similarity=0.406 Sum_probs=201.0
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeeec-----
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE----- 1037 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~----- 1037 (1368)
+.+++.|++.+.||+|+||.||+|... +++.||+|++... .....++.+|+++++++ +|+||+++++++.+.
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 346678999999999999999999954 6889999998653 34456789999999998 699999999998753
Q ss_pred -cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1038 -QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1038 -~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
...|+||||+.+|+|.+++... ....+.|..++.++.|++.||+|||+++ |+|||||++||||++++.+||+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Df 155 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDF 155 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccC
Confidence 4578999999999999998642 2346899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhh
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~p 1191 (1368)
|+++...... .......|+..|+|||++. ...++.++|||||||+||||++|+.||+..... ..+..
T Consensus 156 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~-----~~~~~- 227 (272)
T cd06637 156 GVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM-----RALFL- 227 (272)
T ss_pred CCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH-----HHHHH-
Confidence 9998653221 1223466899999999886 346788999999999999999999999643211 11110
Q ss_pred hcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1192 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 lls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.. ......+ ........+.+|+.+||..+|.+||++.|+++.
T Consensus 228 -~~-~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 228 -IP-RNPAPRL--------KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred -Hh-cCCCCCC--------CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 00 0000000 111234578999999999999999999999763
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=361.63 Aligned_cols=264 Identities=24% Similarity=0.398 Sum_probs=207.8
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeeeeeeeec
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE 1037 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~ 1037 (1368)
...++|.+.++||+|+||.||+|++. .++.||||+++... ....+.+++|+++|.++. |+|||+++++|.+.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 33456778899999999999999853 34679999997543 233457899999999997 99999999999999
Q ss_pred cceEEEEeecCCCChhhccccccc--------------------------------------------------------
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDK-------------------------------------------------------- 1061 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~-------------------------------------------------------- 1061 (1368)
+..++||||+.+|+|.++|++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 999999999999999999964321
Q ss_pred --------------------------------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCe
Q 000659 1062 --------------------------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1103 (1368)
Q Consensus 1062 --------------------------------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNI 1103 (1368)
....++|..+++|+.||+.||+|||+.+ |+|||||++||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124788889999999999999999887 99999999999
Q ss_pred eecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcc
Q 000659 1104 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQ 1182 (1368)
Q Consensus 1104 LLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~ 1182 (1368)
||++++.+||+|||+++...............++..||+||++....++.++|||||||+||||++ |+.||......+
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~- 349 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE- 349 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH-
Confidence 999999999999999986543222112223457789999999998889999999999999999998 888986532111
Q ss_pred hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1183 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1183 ~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
.+... +. .......+.....++.+|+.+||+.+|.+||+++||++.|++++
T Consensus 350 -~~~~~----~~----------~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 350 -QFYNA----IK----------RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HHHHH----HH----------cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11111 11 00111122234568999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=351.88 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=194.6
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
+|++.++||+|+||.||+|+. .+++.||||++.... ....+.+.+|++++++++|+|||++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 689999999999999999995 568899999996532 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||++|+|.+++.+. ..+.+..+..++.||+.||+|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~ 154 (382)
T cd05625 82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (382)
T ss_pred CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence 99999999998532 35888999999999999999999887 999999999999999999999999998532100
Q ss_pred c---------------------------------------------cccccccccccccccCcchhccCCCCcccceeeH
Q 000659 1126 E---------------------------------------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSY 1160 (1368)
Q Consensus 1126 ~---------------------------------------------~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSL 1160 (1368)
. ........+||..|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl 234 (382)
T cd05625 155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234 (382)
T ss_pred ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence 0 0001123579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC---
Q 000659 1161 GVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF--- 1236 (1368)
Q Consensus 1161 GVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT--- 1236 (1368)
||+||||++|+.||...+.... ..+..|.. .+..........++.+++.+|+ .+|++|.+
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~ 298 (382)
T cd05625 235 GVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNG 298 (382)
T ss_pred hHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCC
Confidence 9999999999999975432110 01111100 0000001122345666666665 48999997
Q ss_pred HHHHHHH
Q 000659 1237 MGEVVQA 1243 (1368)
Q Consensus 1237 MsEVLq~ 1243 (1368)
+.|+++.
T Consensus 299 ~~ei~~h 305 (382)
T cd05625 299 ADEIKAH 305 (382)
T ss_pred HHHHhcC
Confidence 7777653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.00 Aligned_cols=253 Identities=28% Similarity=0.431 Sum_probs=204.0
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
++|++.+.||+|+||.||+|.++++..|++|++.... ...+.|.+|++++++++|+|++++++++. .+..++||||+.
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 5689999999999999999998877789999986433 34567899999999999999999999875 456899999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.++++... ...++|..++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++........
T Consensus 84 ~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 84 KGSLLDFLKEGD--GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 999999996432 335899999999999999999999887 999999999999999999999999999765432211
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......++..|++||++....++.++|||||||+||||++ |+.||..... ....++.....
T Consensus 159 -~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~-------------- 220 (260)
T cd05069 159 -ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN---REVLEQVERGY-------------- 220 (260)
T ss_pred -ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCC--------------
Confidence 1122346778999999998999999999999999999999 8999865321 12222221100
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
...........+.+++.+||+.+|++||++++|++.|++
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 001122345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=346.15 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=193.5
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|... +++.||+|+++.. +....+.+.+|+.++.++ +|+||+++++++.+++..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999954 6789999999753 233445678899998877 799999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++..++.|+.||+.||+|||+++ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~ 151 (329)
T cd05618 81 GDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--D 151 (329)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--C
Confidence 999988843 246899999999999999999999887 9999999999999999999999999997542211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCc--chhHHHhhhhhcccccccceeecCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG--QENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~--~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||+...... ......|........ .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~---------~- 221 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------Q- 221 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC---------C-
Confidence 2234679999999999999999999999999999999999999996432211 111222222111110 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
..++.....++.+++.+||+.||++|++.
T Consensus 222 -~~~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 222 -IRIPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 12233445678899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=328.37 Aligned_cols=253 Identities=30% Similarity=0.511 Sum_probs=200.7
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhH--HHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGR--EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~k--eFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
|++.+.||+|+||+||++... +++.||+|++......... ...+|+.++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 688999999999999999965 5668999999765433322 3456999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.++|. ....+++.++++++.|+++||+|||+.+ |+|||||++|||++.+++++|+|||++.... ..
T Consensus 81 ~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~--~~ 151 (260)
T PF00069_consen 81 PGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS--EN 151 (260)
T ss_dssp TTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST--ST
T ss_pred cccccccccc----cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc--cc
Confidence 9999999996 2346899999999999999999999988 9999999999999999999999999997541 12
Q ss_pred ccccccccccccccCcchhc-cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~-~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
........++..|+|||++. ...++.++||||||+++|+|++|+.||......+....... ..... +...
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~---~~~~~------~~~~ 222 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEK---ILKRP------LPSS 222 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHH---HHHTH------HHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhh---ccccc------cccc
Confidence 22234466899999999998 88899999999999999999999999976421111111111 11000 0000
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
. .........+.+++.+||+.||++||++.|+++.
T Consensus 223 ~--~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 223 S--QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp T--TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred c--cccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 0 0001113789999999999999999999999763
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=353.74 Aligned_cols=255 Identities=19% Similarity=0.252 Sum_probs=201.8
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
..++|++.++||+|+||.||++... +++.||||+++.. .....+.+.+|+++++.++|+||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567999999999999999999954 6889999999643 22334457899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.+|+|.++++. ..+++..+..++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++..
T Consensus 121 v~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 9999999999999853 24788889999999999999999887 999999999999999999999999999865
Q ss_pred cccccccccccccccccccCcchhccC----CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~----~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~ 1198 (1368)
..... ......+||..|+|||++... .++.++|||||||+||||++|+.||...... ............
T Consensus 193 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~ 265 (370)
T cd05596 193 DANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKIMDHKNS 265 (370)
T ss_pred cCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCc
Confidence 33211 122345799999999988653 4789999999999999999999999754321 111111110000
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHHH
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQAL 1244 (1368)
Q Consensus 1199 L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPke--RPTMsEVLq~L 1244 (1368)
+.-.........+.+++.+||+.+|++ |+++.|+++.-
T Consensus 266 --------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~ 305 (370)
T cd05596 266 --------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP 305 (370)
T ss_pred --------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence 000011123567889999999999988 99999998764
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.88 Aligned_cols=255 Identities=27% Similarity=0.402 Sum_probs=194.7
Q ss_pred eEEeecCcEEEEEEEecC---CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 975 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd---Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+.||+|+||.||+|.+.+ +..+++|.++... .....+|.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 3578999886543 234457899999999999999999999999999999999999999
Q ss_pred Chhhccccccc-CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1051 SVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1051 SL~d~L~~~~~-~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
+|.++|+.... ....+++..+++++.|+++||+|||+.+ |+|||||++|||++.++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999965332 2235678888999999999999999887 9999999999999999999999999997554322222
Q ss_pred ccccccccccccCcchhccC-------CCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1130 ISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~-------~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
......|+..|+|||++... .++.++|||||||++|||++ |+.||......+ ...+.. .+...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~---~~~~~~-----~~~~~~ 229 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ---VLTYTV-----REQQLK 229 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHh-----hcccCC
Confidence 22345578899999988642 35789999999999999996 999996543211 111100 011111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
+.++.+ .......+.+++..|| .+|++||+++||++.|.
T Consensus 230 ~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 230 LPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 122221 1223456788999999 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.88 Aligned_cols=251 Identities=27% Similarity=0.444 Sum_probs=197.4
Q ss_pred eEEeecCcEEEEEEEec-CCC--EEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr--~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|.++ ++. .+++|.++.. .....+.|.+|+++++++ +|+||+++++++...+..++||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 36899999999999965 343 4688888743 344556889999999999 799999999999999999999999999
Q ss_pred CChhhccccccc------------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1050 GSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1050 GSL~d~L~~~~~------------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
|+|.++++.... ....+.+.++++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999864321 1235889999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+++..... ........+..|+|||++....++.++|||||||+||||++ |+.||..... ....... .. .
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~---~~~~~~~---~~-~ 227 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC---AELYEKL---PQ-G 227 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH---HHHHHHH---hC-C
Confidence 98633211 01111234567999999998899999999999999999997 9999964321 1111111 00 0
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~ 1248 (1368)
............+.+++.+||+.+|.+||++.|+++.|+.+.
T Consensus 228 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 ----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ----------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 001111233457899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=330.88 Aligned_cols=247 Identities=28% Similarity=0.409 Sum_probs=197.3
Q ss_pred EEeecCcEEEEEEEe---cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 976 ILGEGGFGLVYSGVL---DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 976 lLGeGgFGtVYKAvl---kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
.||+|+||.||+|.+ ++++.||+|+++... ....++|.+|+.++++++|+||+++++++.. +..++||||+.+|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 589999999999974 367889999986432 3345679999999999999999999999864 5678999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc-
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH- 1129 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~- 1129 (1368)
+|.+++.. ...+++..+++|+.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 153 (257)
T cd05116 81 PLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153 (257)
T ss_pred cHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence 99999853 235899999999999999999999887 9999999999999999999999999998664322211
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
......++..|+|||++....++.++|||||||++|||++ |+.||..... ..+..... .. ..
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~i~----~~----------~~ 216 (257)
T cd05116 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG---NEVTQMIE----SG----------ER 216 (257)
T ss_pred ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHH----CC----------CC
Confidence 1122334678999999988889999999999999999998 9999975422 12222211 00 11
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
...+.....++.+++.+||+.||++||++.+|++.|+..
T Consensus 217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112234456789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=356.77 Aligned_cols=270 Identities=27% Similarity=0.405 Sum_probs=204.4
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhh--cccccceeeeeeeeecc----ceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSR--LHHRNLVKLIGICIEEQ----ARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsr--LrHPNIVrLlG~~~d~~----~~~L 1042 (1368)
...++.++||+|+||.||||.+. ++.||||++.. +..+.|++|-+|++. |+|+||++++++-...+ +++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34556679999999999999998 59999999964 444678888888775 58999999999876544 8899
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccC------CCCccccCCcccCeeecCCCCcccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS------SPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~g------sp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
|+||.++|+|.+||.. ..++|.+..+|+..+++||+|||+.- ++.|+|||||.+||||..|+++.|+||
T Consensus 286 Vt~fh~kGsL~dyL~~-----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA-----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EeeeccCCcHHHHHHh-----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999953 46999999999999999999999752 567999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCC------CCcccceeeHHHHHHHHHhCCCCCCCCCCCc---------
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVILELLSGRKPVDMTQPPG--------- 1181 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~------~T~KSDVWSLGVILyELLTGr~PFd~s~~~~--------- 1181 (1368)
|||..+..+.........+||.+|||||++.+.. .-.+.||||+|.|||||+++..-++.....+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 9999887655554455588999999999987542 2246899999999999999766553211000
Q ss_pred -chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1182 -QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1182 -~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
..-..+-++.+...+....++-|.. ++ ...+..+.+.+..||+.|++.|.|..=|.+.+.++....
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W-~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~ 507 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAW-RK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW 507 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhh-hc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence 0001111111111111111111111 11 134678999999999999999999998888887766543
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=332.18 Aligned_cols=251 Identities=29% Similarity=0.512 Sum_probs=199.5
Q ss_pred eEEeecCcEEEEEEEecC-------CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 975 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd-------Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+.||+|+||.||+|...+ ++.|+||.+.... .....+|.+|++++++++|+||++++++|.+.+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998642 2579999886432 24466899999999999999999999999999999999999
Q ss_pred cCCCChhhccccccc---CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-----Ccccccccc
Q 000659 1047 IPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-----TPKVSDFGL 1118 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~---~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-----~VKLsDFGL 1118 (1368)
+++|+|.++++.... ....++|.+++.++.|++.||+|||+.+ |+|||||++||||+.++ .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 999999999964322 2235889999999999999999999887 99999999999999877 899999999
Q ss_pred cccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSRE 1197 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e 1197 (1368)
++...............++..|++||++.++.++.++|||||||++|||++ |+.||...+. ..+..+.. ...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~---~~~~~~~~----~~~ 230 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN---QEVLQHVT----AGG 230 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH---HHHHHHHh----cCC
Confidence 986543322222223346788999999999999999999999999999998 9999864321 12222211 000
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1198 ~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
...........+.+++.+||..+|++||+++||++.|+
T Consensus 231 ----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 231 ----------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred ----------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 01112234567899999999999999999999999886
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=345.15 Aligned_cols=241 Identities=22% Similarity=0.293 Sum_probs=195.0
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhccc-ccceeeeeeeeeccceEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrH-PNIVrLlG~~~d~~~~~LVm 1044 (1368)
+|++.+.||+|+||.||+|... +++.||||+++.. .....+.+..|++++..++| .+|+.+++++.+.+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999955 5788999999753 23445678899999999975 56888999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+.+.+++.++.||+.||+|||+++ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05587 81 EYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF 153 (324)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence 99999999999853 235889999999999999999999887 99999999999999999999999999875322
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.. ......+||..|+|||++.+..++.++|||||||+||||++|+.||..... ..+...+. ..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~---~~--------- 216 (324)
T cd05587 154 GG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE---DELFQSIM---EH--------- 216 (324)
T ss_pred CC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---cC---------
Confidence 11 122345799999999999999999999999999999999999999975431 11111111 00
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
...++.....++.+++.+||+.||++|++.
T Consensus 217 ---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 ---NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ---CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 011222344678899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=328.91 Aligned_cols=249 Identities=28% Similarity=0.420 Sum_probs=200.4
Q ss_pred eEEeecCcEEEEEEEecC--CC--EEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLDD--GT--KVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd--Gr--~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+.||+|+||.||+|.+.+ ++ .||||+++.... ...++|.+|++++++++|+||+++++++.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 33 689999976554 566789999999999999999999999988 888999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc-
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 1128 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~- 1128 (1368)
|+|.+++..... ..++|.+++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++........
T Consensus 80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 999999965332 46899999999999999999999887 999999999999999999999999999876442221
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.......++..|++||++....++.++|||||||++|||++ |+.||+.... ..+...... ....
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~---~~~~~~~~~---~~~~--------- 219 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSG---SQILKKIDK---EGER--------- 219 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHh---cCCc---------
Confidence 11223457889999999999999999999999999999999 9999964322 112111110 0000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..........+.+++.+||+.+|++||++.||++.|.
T Consensus 220 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 220 -LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0111233467899999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-38 Score=364.32 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=210.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|.+.+.||+|.||+||||+.+ +.+.||||.+.+. .+.+.+.+.+|++|+++|+|+|||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888899999999999999954 6889999999653 34456678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.| +|..+|.. +..|.++.+..|++|++.||.|||+.+ |+|||+||.||||+.++.+|+||||+|+....
T Consensus 82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~- 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST- 152 (808)
T ss_pred hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-
Confidence 9966 99999953 456999999999999999999999887 99999999999999999999999999997643
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
.....+.+.||+.|||||+..++.|+..+|+||||||||||++|+.||... .+...++..+.+
T Consensus 153 -~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I~~d---------- 215 (808)
T KOG0597|consen 153 -NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSILKD---------- 215 (808)
T ss_pred -CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHHhcC----------
Confidence 455667889999999999999999999999999999999999999999532 222222222221
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
. -.++......+..+++..+..||.+|.+..+++..
T Consensus 216 ~--v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H 251 (808)
T KOG0597|consen 216 P--VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH 251 (808)
T ss_pred C--CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence 0 12334667789999999999999999999999865
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.63 Aligned_cols=251 Identities=28% Similarity=0.496 Sum_probs=202.8
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
.+|++.+.||+|+||.||+|.+.+++.+++|+++.. .....+|.+|++++++++|+||+++++++.+....++||||+.
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 468889999999999999999877889999998643 2334679999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.+++... ...+.++.+++++.|++.+|+|||+.+ ++|||||++||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~ 156 (256)
T cd05112 83 HGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT 156 (256)
T ss_pred CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence 99999998532 235889999999999999999999887 999999999999999999999999999865432111
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......++.+|+|||++.++.++.++|||||||++|||++ |+.||+.... ..+.+... . . .....
T Consensus 157 -~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~-~---~~~~~--- 222 (256)
T cd05112 157 -SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN---SEVVETIN---A-G---FRLYK--- 222 (256)
T ss_pred -ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH---HHHHHHHh---C-C---CCCCC---
Confidence 1112235678999999998899999999999999999998 9999864321 11222111 0 0 01111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.......+.+|+.+||+.+|++||++.|+++.|
T Consensus 223 ----~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ----PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 112346799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-37 Score=328.75 Aligned_cols=248 Identities=30% Similarity=0.477 Sum_probs=201.6
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeee-eccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI-EEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~-d~~~~~LVmEYm 1047 (1368)
.+|++.+.||+|+||.||++... |+.|++|.++.. ...+.|.+|+.++++++|+||+++++++. +++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46889999999999999999876 788999998643 33567999999999999999999999865 456789999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++|+|.++++... ...+++..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 83 AKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999986432 235889999999999999999999887 9999999999999999999999999987543211
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
....++..|+|||++....++.++|||||||++|||++ |+.||.... ...+..+....
T Consensus 157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~~~-------------- 215 (256)
T cd05082 157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP---LKDVVPRVEKG-------------- 215 (256)
T ss_pred ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHhcC--------------
Confidence 22335678999999998899999999999999999998 999986432 12222222110
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
........+...+.+++.+||+.+|++||++.++++.|+.
T Consensus 216 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 216 YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 0111222345678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=344.92 Aligned_cols=241 Identities=22% Similarity=0.283 Sum_probs=195.3
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
+|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+..|++++..+ +|++|+.+++++.+.+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999855 67899999997532 23344577888888887 5899999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~ 153 (323)
T cd05616 81 EYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMW 153 (323)
T ss_pred cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence 99999999998853 235889999999999999999999887 99999999999999999999999999975432
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.. ......+||..|+|||++....++.++|||||||+||||++|+.||+..+. ..+...+. .
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~---~~~~~~i~---~---------- 215 (323)
T cd05616 154 DG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIM---E---------- 215 (323)
T ss_pred CC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH---HHHHHHHH---h----------
Confidence 11 122346799999999999999999999999999999999999999975432 11111111 1
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
.. ..++.....++.+++.+|++.+|++|++.
T Consensus 216 ~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 216 HN--VAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CC--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 00 01222345678999999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=331.24 Aligned_cols=256 Identities=27% Similarity=0.433 Sum_probs=204.6
Q ss_pred CCcceeeEEeecCcEEEEEEEec-C---CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-D---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-d---Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|.+. + +..|++|.++... ....+.|.+|++++++++|+||+++++++.+++..|+|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 56889999999999999999853 2 3379999986432 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+++|+|.+++... ...+++.++++|+.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 84 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 84 TEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999643 235899999999999999999999887 9999999999999999999999999998664
Q ss_pred ccccccc-cccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1124 DEESRHI-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1124 ~~~~~~~-st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
....... .....++..|++||++.++.++.++|||||||++|||++ |+.||..... .....+.... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~---~~~~~~~~~~----~---- 226 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN---QDVIKAIEEG----Y---- 226 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH---HHHHHHHhCC----C----
Confidence 3221111 112234568999999998899999999999999999887 9999865322 1122222110 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
...........+.+++.+||+.+|++||+|.++++.|+++
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 227 ------RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ------cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0011123446789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.98 Aligned_cols=248 Identities=30% Similarity=0.467 Sum_probs=200.2
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChh
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 1053 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~ 1053 (1368)
++||+|+||.||++.+.+++.|++|+++..... ..++|.+|++++++++|+||+++++++.+.+..++||||+.+++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 469999999999999877999999998754333 5668999999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccccc
Q 000659 1054 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1133 (1368)
Q Consensus 1054 d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~ 1133 (1368)
+++... ...+++..++.++.+++.+|+|||+.+ |+|||||++||||+.++.+||+|||+++.............
T Consensus 81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 998542 235889999999999999999999887 99999999999999999999999999986542211111112
Q ss_pred ccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1134 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1134 v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
..++..|++||++.++.++.++|||||||++|||++ |..||...... ........ .......
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~---~~~~~~~~--------------~~~~~~~ 217 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ---QTRERIES--------------GYRMPAP 217 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH---HHHHHHhc--------------CCCCCCC
Confidence 234667999999998899999999999999999999 88888654321 11111110 0011122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.....++.+++.+||..+|++||++.||++.|+
T Consensus 218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 234567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=345.09 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=195.0
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|... +++.||||+++.. .....+.+..|++++..+ +|+||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999964 5789999999753 233445678899999876 799999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++..++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~ 151 (321)
T cd05591 81 GDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--V 151 (321)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--c
Confidence 999988853 235889999999999999999999988 9999999999999999999999999987543221 2
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||+..+. ..+.... .... .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~---~~~~~~i---~~~~-----~------- 213 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESI---LHDD-----V------- 213 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH---HHHHHHH---HcCC-----C-------
Confidence 22346799999999999999999999999999999999999999975432 1111111 1110 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCC-------CHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRP-------FMGEVVQA 1243 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRP-------TMsEVLq~ 1243 (1368)
.++.....++.+++.+||+.||++|+ ++.++++.
T Consensus 214 ~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h 254 (321)
T cd05591 214 LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH 254 (321)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence 11112346788999999999999999 67777654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=331.69 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=207.0
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCC----EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr----~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
++|++.+.||+|+||.||+|.++ +|+ .|++|+++... ....+++.+|++++++++|+||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 56888999999999999999954 343 58999886543 3345678999999999999999999999987 78899
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.+|+|.++++.. ...+++..+++++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+++..
T Consensus 86 v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999642 235899999999999999999999887 999999999999999999999999999876
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.............++..|++||.+....++.++|||||||++|||++ |+.||+.... ..+..++. . ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~-~~~--- 229 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA---VEIPDLLE---K-GER--- 229 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH---HHHHHHHh---C-CCC---
Confidence 43322221222234578999999988899999999999999999998 9999975421 22222221 1 000
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
...+..+...+.+++.+||..+|++||++.++++.|+.+.++.
T Consensus 230 -------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 230 -------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred -------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 0111223457889999999999999999999999999887644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=339.27 Aligned_cols=266 Identities=23% Similarity=0.360 Sum_probs=205.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||.||++... +++.|++|+++.. .....+++.+|++++++++|+||++++++|.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 47999999999999999999854 6888999998643 233456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.++++.. ..+++..+.+++.|++.||+|||+.. +|+|||||++|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 9999999999532 45889999999999999999999742 3999999999999999999999999998755322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc--------
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG-------- 1198 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~-------- 1198 (1368)
......|+..|++||++.+..++.++|||||||++|||++|+.||...+.. .+..+..........
T Consensus 154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~ 227 (308)
T cd06615 154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK---ELEAMFGRPVSEGEAKESHRPVS 227 (308)
T ss_pred ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh---hHHHhhcCccccccccCCccccc
Confidence 123456899999999998888999999999999999999999999654321 122211111100000
Q ss_pred -----------cceeecCCC---CCCCC-hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1199 -----------LERIIDPSL---GNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1199 -----------L~eIvDp~L---~~~~~-~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
..++.+... ....+ .....++.+++.+||..+|++||++.||++..+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 228 GHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred CCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000000 00000 11345688999999999999999999999886643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=330.23 Aligned_cols=248 Identities=26% Similarity=0.450 Sum_probs=196.7
Q ss_pred EEeecCcEEEEEEEec---CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCC
Q 000659 976 ILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 1051 (1368)
Q Consensus 976 lLGeGgFGtVYKAvlk---dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGS 1051 (1368)
.||+|+||.||+|++. ++..||+|+++... ....++|.+|++++++++|+||++++++|. .+..++||||+.+|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999854 45679999987543 233467999999999999999999999985 457899999999999
Q ss_pred hhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc-c
Q 000659 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH-I 1130 (1368)
Q Consensus 1052 L~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~-~ 1130 (1368)
|.+++... ...+++.++++++.|++.||+|||+++ ++|||||++|||++.++.+||+|||+++......... .
T Consensus 81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 99998532 346899999999999999999999887 9999999999999999999999999998554322211 1
Q ss_pred cccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....++..|+|||++....++.++|||||||++|||++ |+.||..... ......+. . . ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~---~~~~~~~~---~-~----------~~~ 217 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG---PEVMSFIE---Q-G----------KRL 217 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH---HHHHHHHH---C-C----------CCC
Confidence 112234578999999988889999999999999999996 9999965421 11111111 0 0 111
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
..+..+..++.+++.+||..++++||++.+|.+.|+.+
T Consensus 218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 22234557889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=375.13 Aligned_cols=260 Identities=24% Similarity=0.318 Sum_probs=213.9
Q ss_pred hCCcceeeEEeecCcEEEEEEEecCC-CEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeee-ee---e---cc
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDG-TKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGI-CI---E---EQ 1038 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkdG-r~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~-~~---d---~~ 1038 (1368)
..++++.+.|.+|||+.||.|....+ ..||+|++-..++...+.+.+||++|++|+ |+|||.++|. .. . .-
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 45678899999999999999997655 999999997778888999999999999997 9999999993 22 1 23
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGL 1118 (1368)
+++|.||||.||.|-|+|..+.. ..|++.++++|+.|+++||++||.. .++|||||||-+||||+.+++.||||||.
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 56899999999999999975433 3499999999999999999999988 58899999999999999999999999999
Q ss_pred cccccccccc-c----c--cccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh
Q 000659 1119 ARSAMDEESR-H----I--STRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1188 (1368)
Q Consensus 1119 Arll~~~~~~-~----~--st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W 1188 (1368)
|......... . + .-...-|+.|++||++. +...++|+|||+|||+||-|+....||+...
T Consensus 193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---------- 262 (738)
T KOG1989|consen 193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---------- 262 (738)
T ss_pred cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc----------
Confidence 8743221100 0 0 01133689999999774 6788999999999999999999999997542
Q ss_pred hhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
-..|++-++.---......+|.+||..||+.||++||++.||++.+.++...
T Consensus 263 ----------~laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 263 ----------KLAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ----------ceeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 2334444443333346788999999999999999999999999998877764
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=326.76 Aligned_cols=255 Identities=26% Similarity=0.410 Sum_probs=206.4
Q ss_pred HhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..++|++.+.||+|+||.||+|.++++..+++|.++.. ....++|.+|++++++++|+||+++++++.+ ...++||||
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 35689999999999999999999888888999998743 3345689999999999999999999999887 778999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+|+|.+++... ....+++.+++.++.|++.||+|||+.+ ++|||||++||+|+.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999643 2345889999999999999999999887 9999999999999999999999999997654322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. .......++..|++||++..+.++.++|||||||++|||++ |+.||..... ..+..+... ...
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~---~~~~~~~~~----~~~------- 221 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN---PEVIRALER----GYR------- 221 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH---HHHHHHHhC----CCC-------
Confidence 1 11122335678999999998889999999999999999999 9999865321 222222211 100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
.........++.+++.+||+.+|++||++.++.+.|+.
T Consensus 222 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 222 ---MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ---CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01112344678999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=342.65 Aligned_cols=241 Identities=24% Similarity=0.355 Sum_probs=192.2
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|... +++.||||+++.. .....+.+..|.+++..+ +|+||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999954 6789999999753 223345566777777754 799999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~ 151 (316)
T cd05592 81 GDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--G 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--C
Confidence 999998853 235889999999999999999999887 9999999999999999999999999997543222 2
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.. ..... ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~---~~~~~---~i~~~------------~~ 213 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE---DELFD---SILND------------RP 213 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH---HHHHH---HHHcC------------CC
Confidence 23446799999999999999999999999999999999999999975432 11111 11110 01
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH-HHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQ 1242 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMs-EVLq 1242 (1368)
.++.....++.+++.+||+.+|++|+++. ++++
T Consensus 214 ~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05592 214 HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQ 247 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence 12223345688999999999999999985 4433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=353.29 Aligned_cols=257 Identities=19% Similarity=0.267 Sum_probs=200.1
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccce
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~ 1040 (1368)
....++|++.+.||+|+||.||++... +++.||+|++++. .....+.+.+|+++++.++|+||+++++++.+++..
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 334578999999999999999999964 6889999998642 223345688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
|+||||+++|+|.+++.. ..+++.++..++.||+.||+|||+++ |+|||||++||||++++.+||+|||+++
T Consensus 119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~ 190 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCM 190 (370)
T ss_pred EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccce
Confidence 999999999999999853 24788999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCcchhccC----CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~----~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
...... .......+||..|||||++... .++.++|||||||+||||++|+.||...... .. ........
T Consensus 191 ~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~----~~~i~~~~ 263 (370)
T cd05621 191 KMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GT----YSKIMDHK 263 (370)
T ss_pred ecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HH----HHHHHhCC
Confidence 653321 1122346799999999998754 3789999999999999999999999654211 11 11111100
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQAL 1244 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPke--RPTMsEVLq~L 1244 (1368)
..+ .+ .........+.+++..|+..++++ |+++.|+++.-
T Consensus 264 ~~~------~~--p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp 305 (370)
T cd05621 264 NSL------NF--PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP 305 (370)
T ss_pred ccc------CC--CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence 000 00 011123456788899999765544 88999988763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=325.89 Aligned_cols=250 Identities=22% Similarity=0.295 Sum_probs=202.8
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
+|++.+.||+|+||.||++... +++.|++|.++.. .....+++.+|+.++++++|+||+++++++.+++..|+||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 5889999999999999999954 6889999998643 3344567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++|+|.+++... ....+++..+++++.|++.||.|||+.+ |+|+|||++|||++++++++|+|||+++......
T Consensus 81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 154 (255)
T cd08219 81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG- 154 (255)
T ss_pred CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence 999999988532 2345789999999999999999999887 9999999999999999999999999997653321
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.......|+..|+|||++.+..++.++||||||+++|+|++|+.||+..+. ... ...... ....
T Consensus 155 -~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~---~~~---~~~~~~--~~~~------- 218 (255)
T cd08219 155 -AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW---KNL---ILKVCQ--GSYK------- 218 (255)
T ss_pred -cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH---HHH---HHHHhc--CCCC-------
Confidence 122335688999999999988999999999999999999999999965321 111 111111 0000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+++.+||+.||++||++.||++.
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 --PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred --CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 1112234568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.91 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=203.8
Q ss_pred CCcceeeEEeecCcEEEEEEEe-----cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeec--cce
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-----DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 1040 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-----kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~ 1040 (1368)
+.|++.+.||+|+||.||++.+ .+++.|++|.++... ....+++.+|++++++++|+||+++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3478889999999999999974 357889999987442 33456799999999999999999999998775 567
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+++++|.+++... ...++|.+++.++.|++.||+|||+++ |+|||||++|||++.++.+||+|||+++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence 8999999999999998532 235899999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccc-cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCC---------cchhHHHhhh
Q 000659 1121 SAMDEESR-HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP---------GQENLVAWAR 1190 (1368)
Q Consensus 1121 ll~~~~~~-~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~---------~~~nLv~Wa~ 1190 (1368)
........ .......++..|+|||++.+..++.++|||||||++|||++++.++...... .+.....+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence 66432211 1122345677899999999889999999999999999999987654321100 0001111111
Q ss_pred hhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1191 plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.+. .............++.+|+.+||+.+|++||++.++++.|+.+
T Consensus 238 -~~~----------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 -VLE----------EGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred -HHH----------cCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 000 0011112234567899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=345.97 Aligned_cols=238 Identities=26% Similarity=0.358 Sum_probs=193.6
Q ss_pred eEEeecCcEEEEEEEe----cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl----kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
+.||+|+||.||++.. .+|+.||||+++... .....++.+|+++|++++|+||+++++++.+++..|+||||+.
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999874 367899999997532 2234567889999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++......
T Consensus 82 ~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-- 152 (318)
T cd05582 82 GGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-- 152 (318)
T ss_pred CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence 9999999853 345899999999999999999999887 9999999999999999999999999998653321
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
......+|+..|+|||++....++.++|||||||+||||++|+.||..... ....... ....
T Consensus 153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~---~~~~~~i---~~~~------------ 214 (318)
T cd05582 153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR---KETMTMI---LKAK------------ 214 (318)
T ss_pred CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH---HHHHHHH---HcCC------------
Confidence 122346799999999999988899999999999999999999999975321 1111111 1100
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1239 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsE 1239 (1368)
..++......+.+|+.+||+.||++|+++.+
T Consensus 215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 0122233467889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=332.11 Aligned_cols=252 Identities=23% Similarity=0.319 Sum_probs=201.3
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.++||+|+||.||+|+. .+++.||||++... .....++|.+|++++++++|+||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4688899999999999999984 57889999998643 334456799999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++|+|..+. .+++..+.+++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~- 148 (279)
T cd06619 81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS- 148 (279)
T ss_pred CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence 9999987653 3678889999999999999999887 999999999999999999999999999765322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhcccccccceeecC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
.....+|+..|+|||++.+..++.++|||||||++|||++|+.||......... ....+..... +.
T Consensus 149 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------~~ 215 (279)
T cd06619 149 ---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV----------DE 215 (279)
T ss_pred ---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHh----------cc
Confidence 123457899999999999989999999999999999999999999654322111 0111111000 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
............++.+++.+||+.+|++||+++|+++..+
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~ 255 (279)
T cd06619 216 DPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF 255 (279)
T ss_pred CCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence 0000011123457899999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=327.65 Aligned_cols=257 Identities=28% Similarity=0.421 Sum_probs=204.9
Q ss_pred CCcceeeEEeecCcEEEEEEEecC----CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|.+.+.||+|+||.||+|.+.+ ...|+||...... ....++|.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 458889999999999999998643 2468999886543 4456689999999999999999999999875 557899
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+|+|.+++... ...+++.+++.++.|++.||+|||+.+ ++|||||++||||+.++.+||+|||+++...
T Consensus 85 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 85 MELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999542 235899999999999999999999887 9999999999999999999999999998654
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.... .......++..|+|||++....++.++|||||||++|||++ |+.||...... ....+... ...+
T Consensus 159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~~~~~~~~----~~~~--- 227 (270)
T cd05056 159 DESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN---DVIGRIEN----GERL--- 227 (270)
T ss_pred cccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHHc----CCcC---
Confidence 3321 11222334568999999988889999999999999999996 99999654321 12222110 0000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.....+...+.+++.+|+..+|++||++.|+++.|+++..+
T Consensus 228 -------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 228 -------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred -------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11223456799999999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=326.55 Aligned_cols=248 Identities=31% Similarity=0.450 Sum_probs=198.3
Q ss_pred eEEeecCcEEEEEEEec-C---CCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-D---GTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-d---Gr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|.+. . +..|++|.++.... ...+++.+|++++++++|+||+++++++. .+..++||||+.+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999843 2 26899999875433 35568999999999999999999999876 4567999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.++|... ..+++.++++++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999632 25899999999999999999999887 9999999999999999999999999998664332211
Q ss_pred c-cccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1130 I-STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1130 ~-st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
. .....++..|+|||.+....++.++|||||||++|||++ |+.||+..+. ..+..++... ..
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~----~~--------- 216 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESG----ER--------- 216 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcC----Cc---------
Confidence 1 111224568999999998999999999999999999998 9999965432 2233332211 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
......+...+.+++.+||..+|++||++.+|++.|+++
T Consensus 217 -~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 217 -LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred -CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 012223456789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=325.97 Aligned_cols=252 Identities=28% Similarity=0.474 Sum_probs=195.1
Q ss_pred eEEeecCcEEEEEEEec----CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeee-eccceEEEEeecC
Q 000659 975 RILGEGGFGLVYSGVLD----DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICI-EEQARCLVYELIP 1048 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk----dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~-d~~~~~LVmEYm~ 1048 (1368)
++||+|+||.||+|.+. ++..||||++... .....+.+.+|+.++++++|+||++++++|. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999853 2357999998543 3344568899999999999999999999876 4556799999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.++++.. ...+.+..+++++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 99999999642 234678889999999999999999887 999999999999999999999999999865432111
Q ss_pred c--ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhC-CCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1129 H--ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1129 ~--~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTG-r~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......++..|+|||++....++.++|||||||++|||++| ..+|...+ ...+..+. ... . .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~---~~~~~~~~---~~~-~---~---- 220 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD---SFDITVYL---LQG-R---R---- 220 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCC---HHHHHHHH---hcC-C---C----
Confidence 1 11233467789999999888999999999999999999995 55554322 12222221 110 0 0
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~ 1249 (1368)
..........+.+++.+||+.+|++||++.||++.|+++..
T Consensus 221 ---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 221 ---LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred ---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 00111234578999999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=323.49 Aligned_cols=255 Identities=25% Similarity=0.359 Sum_probs=205.1
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeee--ccceEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~~LVm 1044 (1368)
+|++.+.||+|+||.||++.. .+++.|++|+++.. .....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 588899999999999999984 57889999998642 33445678899999999999999999998764 44578999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccC--CCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~g--sp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||+.+++|.+++.........+++.+++.++.||+.||+|||..+ ..+|+|||||++|||+++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999765444567999999999999999999999332 334999999999999999999999999999876
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
..... ......|+..|++||++....++.++||||||+++|+|++|+.||+... ...+.+....
T Consensus 161 ~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~----------- 224 (265)
T cd08217 161 GHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIKE----------- 224 (265)
T ss_pred cCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHhc-----------
Confidence 43221 1233468999999999998889999999999999999999999997643 1222222111
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.............+.+++.+||+.+|++||++.||++.
T Consensus 225 ---~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 225 ---GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 00112223345688999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=344.69 Aligned_cols=239 Identities=25% Similarity=0.327 Sum_probs=190.4
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHH-HHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||+||+|... +|+.||||++.... ....+++++|.. +++.++|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999964 78999999996432 223345566655 45789999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+.+..++.++.||++||+|||+++ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (323)
T cd05575 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SK 151 (323)
T ss_pred CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CC
Confidence 999998853 346889999999999999999999888 999999999999999999999999998754321 12
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. .+.....+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~------~~~~~~i~~~----------~~-- 213 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT------AEMYDNILNK----------PL-- 213 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH------HHHHHHHHcC----------CC--
Confidence 23446799999999999999999999999999999999999999965321 1111111110 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1240 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEV 1240 (1368)
.........+.+++.+||+.||++|+++.+.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~ 244 (323)
T cd05575 214 RLKPNISVSARHLLEGLLQKDRTKRLGAKDD 244 (323)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCC
Confidence 1111234678899999999999999998643
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=342.06 Aligned_cols=244 Identities=23% Similarity=0.312 Sum_probs=194.5
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|.. .+++.||||+++.. +....+.+.+|+.++.++ +|+||+.+++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 46789999999753 223445688999999988 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.+++.|+.||++||+|||+++ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~ 151 (327)
T cd05617 81 GDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--D 151 (327)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--C
Confidence 999988843 235899999999999999999999987 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||+........+..++....... .. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~---------~~--~ 220 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE---------KP--I 220 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh---------CC--C
Confidence 223467999999999999999999999999999999999999999754332222222222211111 00 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMG 1238 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMs 1238 (1368)
.++.....++.+++.+||+.||++|+++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 12223346788999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=327.95 Aligned_cols=258 Identities=24% Similarity=0.410 Sum_probs=205.1
Q ss_pred HHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 963 EIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 963 ELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
|++..++++.....||+|+||.||+|.+ ++++.|++|.+........+.+.+|++++++++|+||+++++++.+++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 3456677888888999999999999994 467889999987666666778999999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCC--ChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCcccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPL--GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGL 1118 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pL--sw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~VKLsDFGL 1118 (1368)
+||||+.+++|.++++... ..+ ++..++.++.||++||+|||+.+ |+|||||++||||+. ++.+||+|||+
T Consensus 82 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEEecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchh
Confidence 9999999999999996321 234 78889999999999999999887 999999999999986 67999999999
Q ss_pred cccccccccccccccccccccccCcchhccCC--CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~~~--~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+....... .......|+..|+|||++.... ++.++|||||||++|||++|+.||...+.. ....|......
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~---~~~~~~~~~~~-- 228 (268)
T cd06624 156 SKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEP---QAAMFKVGMFK-- 228 (268)
T ss_pred heecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccCh---hhhHhhhhhhc--
Confidence 87653221 1122345889999999986643 789999999999999999999998643211 11111111000
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
....++.....++.+++.+||+.+|++||++.||++.
T Consensus 229 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 229 ----------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred ----------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 0111223344678899999999999999999999764
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=326.95 Aligned_cols=251 Identities=26% Similarity=0.448 Sum_probs=201.3
Q ss_pred CcceeeEEeecCcEEEEEEEecCCCEEEEEEeeccc------chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d------~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
+|.+.+.||+|+||.||+|...+|+.+|||.++... ....+.+.+|+++|++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998889999999986321 22335688999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+++|.+++.+ ...+.+..++.++.|++.||+|||+.+ |+|+|||++|||+++++.+||+|||+++...
T Consensus 81 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 153 (265)
T cd06631 81 MEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLA 153 (265)
T ss_pred EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence 999999999999953 235889999999999999999999887 9999999999999999999999999987542
Q ss_pred ccc----cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1124 DEE----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1124 ~~~----~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
... .........|+..|++||++.+..++.++|||||||++|||++|+.||...+... ...... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~----~~~~-- 225 (265)
T cd06631 154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLA--AMFYIG----AHRG-- 225 (265)
T ss_pred hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHH--HHHHhh----hccC--
Confidence 211 1112233568999999999998889999999999999999999999996532111 110000 0000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
............+.+++.+||+.+|++||++.|+++
T Consensus 226 -------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 226 -------LMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred -------CCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 001122234567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=361.69 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=197.7
Q ss_pred HHHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccc------cceeeeeee
Q 000659 962 SEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR------NLVKLIGIC 1034 (1368)
Q Consensus 962 eELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHP------NIVrLlG~~ 1034 (1368)
+++....++|++.++||+|+||+||+|.. .+++.||||+++... ...+++..|++++++++|. +|+.+++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 34555678999999999999999999985 467889999997432 2345567788888877654 588899988
Q ss_pred eec-cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeeecCCC---
Q 000659 1035 IEE-QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDF--- 1109 (1368)
Q Consensus 1035 ~d~-~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILLD~ng--- 1109 (1368)
..+ +..|+|||++ +++|.+++.. ...+.+.+++.|+.||+.||+|||. .+ ||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccc
Confidence 754 5678999988 7889888853 2468999999999999999999997 46 99999999999998765
Q ss_pred -------------CcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCC
Q 000659 1110 -------------TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1176 (1368)
Q Consensus 1110 -------------~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~ 1176 (1368)
.+||+|||++.... ......+||..|||||++.+..++.++|||||||+||||++|+.||+.
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~ 347 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT 347 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 49999999886432 123456799999999999999999999999999999999999999976
Q ss_pred CCCCcchhHH---------Hhhhh--------hcccccccceeecCC-----CCCC--CChhhHHHHHHHHHHhcCcCcC
Q 000659 1177 TQPPGQENLV---------AWARP--------LLTSREGLERIIDPS-----LGND--VPFDSVAKVAAIASMCVQPEVQ 1232 (1368)
Q Consensus 1177 s~~~~~~nLv---------~Wa~p--------lls~~e~L~eIvDp~-----L~~~--~~~ee~~eLl~La~~CL~pDPk 1232 (1368)
.+..+...+. .|... ++.....+....++. .... ........+.+|+.+||+.||+
T Consensus 348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~ 427 (467)
T PTZ00284 348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427 (467)
T ss_pred CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence 5432211111 11110 000000000000000 0000 0011234678999999999999
Q ss_pred CCCCHHHHHHHH
Q 000659 1233 HRPFMGEVVQAL 1244 (1368)
Q Consensus 1233 eRPTMsEVLq~L 1244 (1368)
+|++++|+++.-
T Consensus 428 ~R~ta~e~L~Hp 439 (467)
T PTZ00284 428 KRLNARQMTTHP 439 (467)
T ss_pred hCCCHHHHhcCc
Confidence 999999998753
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=335.01 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.+|++.+.||+|+||.||+|+. .+++.|++|.+........+.+.+|++++++++|+||+++++++.++...|+||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 5789999999999999999984 578999999997655556678899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++.+ ..+++.+++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++.......
T Consensus 100 ~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred CCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 99999999842 34789999999999999999999887 99999999999999999999999999886533221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+. ... .. .+
T Consensus 172 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~--~~~~~~~----~~~--~~-----~~ 236 (296)
T cd06654 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIA----TNG--TP-----EL 236 (296)
T ss_pred --ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHH--HhHHHHh----cCC--CC-----CC
Confidence 123346889999999999888999999999999999999999999654321 1111111 000 00 00
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+++.+||..+|++||++.||++.
T Consensus 237 --~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 --QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred --CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 1112234568899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=323.12 Aligned_cols=250 Identities=26% Similarity=0.412 Sum_probs=204.0
Q ss_pred CCcceeeEEeecCcEEEEEEEecC-CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||+|...+ ++.|++|.++.... .+++.+|++++++++|+||+++++++.++...|++|||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578899999999999999999764 78999999875432 678999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++... ...++|.+++.++.|+++||.|||+.+ |+||||+++||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 81 GAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999998532 346899999999999999999999887 99999999999999999999999999986643221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......|+..|++||++.+..++.++|||||||++|||++|+.||....... ...... .. ....+
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~--~~~~~~------~~-----~~~~~ 219 (256)
T cd06612 155 --KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMR--AIFMIP------NK-----PPPTL 219 (256)
T ss_pred --ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhh--hhhhhc------cC-----CCCCC
Confidence 2233458899999999998899999999999999999999999997543211 000000 00 00000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+++.+||+.+|++||++.||++.
T Consensus 220 --~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 220 --SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred --CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 1112233578999999999999999999999763
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=341.41 Aligned_cols=238 Identities=26% Similarity=0.335 Sum_probs=192.6
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|..+ +++.||||+++.. .....+.+.+|++++..+ +|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 6889999999743 233456678899999877 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.+++.++.|++.||+|||+++ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~ 151 (320)
T cd05590 81 GDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--K 151 (320)
T ss_pred chHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--C
Confidence 999998853 235899999999999999999999887 9999999999999999999999999987542211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.... .....
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~---~~~~~~i---~~~~~------------ 213 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAI---LNDEV------------ 213 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH---HHHHHHH---hcCCC------------
Confidence 22346799999999999999999999999999999999999999975432 1111111 11100
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1239 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsE 1239 (1368)
.++.....++.+++.+||+.||++|+++.+
T Consensus 214 ~~~~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 214 VYPTWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 111223457889999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=343.74 Aligned_cols=266 Identities=24% Similarity=0.310 Sum_probs=199.3
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeecc-----
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----- 1038 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~----- 1038 (1368)
..++|++.+.||+|+||.||++.. .+|+.||||+++.. .....+++.+|+.+++.++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999985 46899999999643 3344567889999999999999999999986543
Q ss_pred -ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1039 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1039 -~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
..|+||||+++ +|.++++ ..+++.++..++.||+.||+|||+++ |+|||||++||||+.++.+||+|||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46999999965 5666653 23788999999999999999999888 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh------------H
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN------------L 1185 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n------------L 1185 (1368)
+++..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+..+... +
T Consensus 169 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 169 LARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 99754321 22234568999999999999999999999999999999999999997543211000 0
Q ss_pred ----HHhhhhhcccccc-----cceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1186 ----VAWARPLLTSREG-----LERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1186 ----v~Wa~plls~~e~-----L~eIvDp~L~---~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
............. +.+++..... ..........+.+|+.+||+.||++|+++.|+++.-+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 317 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPY 317 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCch
Confidence 0000000000000 0000000000 0011122456889999999999999999999988644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=328.31 Aligned_cols=257 Identities=26% Similarity=0.431 Sum_probs=204.6
Q ss_pred CCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
++|++.+.||+|+||.||+|..+ +.+.|++|.+...... ..++|.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 57889999999999999999954 3467999998654433 4568999999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccC-----CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKE-----SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~-----~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
+||||+++|+|.++++..... ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999644321 125899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
|+++....... .......++..|++||.+.+...+.++|||||||++|||++ |..||..... ...+.+...
T Consensus 162 ~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~---~~~~~~~~~---- 233 (275)
T cd05046 162 SLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD---EEVLNRLQA---- 233 (275)
T ss_pred ccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccch---HHHHHHHHc----
Confidence 99875432211 11223356788999999988889999999999999999999 7888854321 122222110
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..+. ..........+.+++.+||+.+|++||++.|+++.|+
T Consensus 234 -~~~~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKLE--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCcC--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 0111234467999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=350.93 Aligned_cols=263 Identities=23% Similarity=0.381 Sum_probs=209.1
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.++|++.+.||.|..+.||+|+ ...++.||||++.-. +....+.+.+|+..|+.++||||+.++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4679999999999999999999 557899999999643 23335789999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||.+|++.+.++.+-.. .|++..+..|++++++||.|||.+| .||||||+.|||||.+|.|||+|||.+..+.+.
T Consensus 105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999765443 4999999999999999999999998 999999999999999999999999988766543
Q ss_pred ccccc-c-ccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1126 ESRHI-S-TRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1126 ~~~~~-s-t~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
..+.. . .+.+||+.|||||+++. .-|+.|+||||||++.+||.+|..||...-.- ..+..-.. . ....
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm--kvLl~tLq---n---~pp~ 251 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM--KVLLLTLQ---N---DPPT 251 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH--HHHHHHhc---C---CCCC
Confidence 32221 1 55789999999999654 46899999999999999999999999754221 11111111 1 0000
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+-..+..+........|.+++..||+.||++|||++++++.
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 000111111112233579999999999999999999999865
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.79 Aligned_cols=254 Identities=24% Similarity=0.401 Sum_probs=203.1
Q ss_pred CcceeeEEeecCcEEEEEEEecC--CCEEEEEEeecc----------cchhhHHHHHHHHHHhh-cccccceeeeeeeee
Q 000659 970 NFDASRILGEGGFGLVYSGVLDD--GTKVAVKVLKRV----------DQQGGREFLAEVEMLSR-LHHRNLVKLIGICIE 1036 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkd--Gr~VAVKvLk~~----------d~~~~keFlrEIeILsr-LrHPNIVrLlG~~~d 1036 (1368)
+|++.+.||+|+||.||+|..+. ++.+++|+++.. .....+++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999764 688999987532 22334567889998875 799999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeeecCCCCccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSD 1115 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILLD~ng~VKLsD 1115 (1368)
++..++||||+++++|.+++.........+++..+++++.|++.||.|||+ .+ |+|||||++|||++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 999999999999999999986544445578999999999999999999996 45 99999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1116 FGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
||++....... ......|+..|++||++.++.++.++||||||+++|||++|+.||...+. ...... ....
T Consensus 158 fg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~---~~~~~~---~~~~ 228 (269)
T cd08528 158 FGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATK---IVEA 228 (269)
T ss_pred ccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH---HHHHHH---Hhhc
Confidence 99998654322 22345689999999999988899999999999999999999999864321 111111 1110
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
... + .........+.+++.+||+.||++||++.||.++++
T Consensus 229 --~~~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 229 --VYE----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred --cCC----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000 0 001123467899999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=325.39 Aligned_cols=249 Identities=23% Similarity=0.410 Sum_probs=200.1
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccc---------hhhHHHHHHHHHHhhcccccceeeeeeeeeccc
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~---------~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~ 1039 (1368)
+|.+.+.||+|+||.||+|.. .+++.|++|.+..... ...+.+.+|++++++++|+||+++++++.+++.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467788999999999999985 4688999998854321 123568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+ |+|||||++||||++++.+||+|||++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~ 153 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGIS 153 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCC
Confidence 99999999999999999532 35889999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccc----cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1120 RSAMDEESR----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1120 rll~~~~~~----~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
+........ .......|+..|++||++.+..++.++|||||||++|||++|+.||...+.. ..+... .
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~-- 225 (267)
T cd06628 154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--QAIFKI----G-- 225 (267)
T ss_pred cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--HHHHHH----h--
Confidence 866421111 1112345889999999999888999999999999999999999999753211 111000 0
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
. ......+......+.+++.+||+.+|++||++.||++
T Consensus 226 -----~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 226 -----E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred -----c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 0 0111222334567899999999999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=322.04 Aligned_cols=247 Identities=27% Similarity=0.446 Sum_probs=201.7
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
+|+..+.||+|+||.||+|... +++.|++|++.... .+..+++.+|++++++++|+||+++++++.+++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999976 78999999986433 23456789999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+++++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||||++||+++.++.+||+|||++....
T Consensus 81 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~ 153 (258)
T cd06632 81 LELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVV 153 (258)
T ss_pred EEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecc
Confidence 999999999999853 235889999999999999999999887 9999999999999999999999999988654
Q ss_pred ccccccccccccccccccCcchhccCC-CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~-~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
... ......|+..|++||.+.... ++.++|||||||++|||++|+.||+.... ......+.. ....
T Consensus 154 ~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~-----~~~~--- 220 (258)
T cd06632 154 EFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG--VAAVFKIGR-----SKEL--- 220 (258)
T ss_pred ccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH--HHHHHHHHh-----cccC---
Confidence 322 223456889999999988776 89999999999999999999999965431 111111110 0000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
..+.......+.+++.+||+.+|++||++.|+++
T Consensus 221 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 221 ------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 1122233467889999999999999999999976
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=331.33 Aligned_cols=252 Identities=25% Similarity=0.372 Sum_probs=199.7
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.|+..+.||+|+||+||+|.. .+++.||+|+++... ....+.+.+|+++|++++|+||+.+++++.+++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 377889999999999999985 478999999986432 2234457889999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+|+|.+++... ....+++..++.++.|++.||.|||+.+ |+|||||++|||+++++.+||+|||+++.....
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 155 (285)
T cd05632 81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG 155 (285)
T ss_pred eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence 99999999888532 2336999999999999999999999887 999999999999999999999999998754322
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....... ....+........
T Consensus 156 ~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~--~~~~~~~~~~~~~--------- 221 (285)
T cd05632 156 E---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV--KREEVDRRVLETE--------- 221 (285)
T ss_pred C---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhhhccc---------
Confidence 1 1123468999999999998999999999999999999999999997542211 1111111111100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-----MsEVLq~ 1243 (1368)
..+.......+.+|+..||+.||++|++ ++|+++.
T Consensus 222 ---~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 222 ---EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ---cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 0112233456889999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-37 Score=344.01 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=199.5
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec-----
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE----- 1037 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~----- 1037 (1368)
...++|++.+.||+|+||.||++.. .+++.||||+++.. .....+++.+|+.+++.++|+||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999985 46889999999643 333456788999999999999999999988643
Q ss_pred -cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1038 -QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1038 -~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
...|+||||+++ +|.+++. ..+++..++.++.|+++||+|||+.+ |+||||||+||||+.++.+||+||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Df 163 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 163 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeC
Confidence 346999999965 6666663 24788999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HH--------H
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LV--------A 1187 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv--------~ 1187 (1368)
|+++..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+..+... .. +
T Consensus 164 g~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 164 GLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred cccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 999865321 12234568999999999999899999999999999999999999997543211100 00 0
Q ss_pred -------hhhhhcccccccceee------cCCC--CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1188 -------WARPLLTSREGLERII------DPSL--GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1188 -------Wa~plls~~e~L~eIv------Dp~L--~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..............+. +..+ ..........++.+|+.+||+.||++|||+.|+++.-
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp 312 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHP 312 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCc
Confidence 0000000000000000 0000 0011112345789999999999999999999998863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=345.07 Aligned_cols=242 Identities=25% Similarity=0.325 Sum_probs=191.8
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHH-HHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||+||+|.. .+|+.||||+++.. .....+++.+|.. +++.++|+||+++++++.+++..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 47899999999643 2233455666665 46778999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.+++.++.||++||+|||+.+ |+|||||++||||++++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 151 (325)
T cd05604 81 GELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SD 151 (325)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CC
Confidence 999988853 346899999999999999999999887 999999999999999999999999998754221 11
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. .+ .+..+.. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~---~~~~~~~----------~~-- 213 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA---EM---YDNILHK----------PL-- 213 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH---HH---HHHHHcC----------Cc--
Confidence 224467999999999999999999999999999999999999999653211 11 1111110 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+++.+|++.+|.+|+++++.+++
T Consensus 214 ~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 214 VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 0111234568899999999999999998754443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=327.64 Aligned_cols=254 Identities=26% Similarity=0.359 Sum_probs=191.2
Q ss_pred eEEeecCcEEEEEEEecC---CCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 975 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd---Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+.||+|+||.||+|...+ ...+++|.++... ....++|++|+++++.++|+||++++++|.+.+..++||||+.+|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 368999999999998543 3467888775432 334567899999999999999999999999999999999999999
Q ss_pred ChhhcccccccC-CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1051 SL~d~L~~~~~~-~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
+|.++|...... ....++...++++.||+.||+|||+.+ |+|||||++||||++++++||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 999999654321 234578889999999999999999887 9999999999999999999999999987543322222
Q ss_pred ccccccccccccCcchhcc-------CCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1130 ISTRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~-------~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
......++..|+|||++.. ..++.++|||||||++|||++ |+.||...... +.+... .. +...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~~~----~~--~~~~~ 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE--QVLKQV----VR--EQDIK 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHH----hh--ccCcc
Confidence 2233446778999998753 356789999999999999999 78888643211 111111 00 01111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+.++. ........+.+++..|| .||++||+++||++.|
T Consensus 230 ~~~~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 230 LPKPQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred CCCCc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11222 22234456778889998 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=321.79 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=205.1
Q ss_pred CcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|+..+.||+|+||.||.+. .++++.|++|.+... .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58899999999999999988 456889999997643 345566789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+|+|.+++.... ...+++.+++.++.|++++|+|||+.+ |+|||||++||++++++.+||+|||+++......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~ 155 (256)
T cd08221 81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY 155 (256)
T ss_pred cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence 99999999996432 346899999999999999999999887 9999999999999999999999999998664322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
. ......|+..|+|||++.+..++.++||||||+++|||++|+.+|+..+.. +........ ...
T Consensus 156 ~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~------~~~~~~~~~--~~~------ 219 (256)
T cd08221 156 S--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL------NLVVKIVQG--NYT------ 219 (256)
T ss_pred c--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcC--CCC------
Confidence 1 223456899999999998888999999999999999999999999653321 111111110 000
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
........++.+++.+||+.+|++||++.|+++.+
T Consensus 220 ---~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 220 ---PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11123346788999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=331.12 Aligned_cols=248 Identities=24% Similarity=0.328 Sum_probs=195.5
Q ss_pred EeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||.||++.. .+|+.||+|++.... ....+.+..|++++++++|+||+++++++.++...++||||+.+|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999985 468999999986421 22334567799999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++.... ...+++..++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||++....... ...
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~ 152 (277)
T cd05607 81 KYHIYNVG--ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TIT 152 (277)
T ss_pred HHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eee
Confidence 98885432 335889999999999999999999887 9999999999999999999999999997654321 123
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
...|+..|+|||++.+..++.++|||||||+||||++|+.||....... ....+.+..+. ..+.. ..
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~--~~~~~~~~~~~----------~~~~~-~~ 219 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKV--AKEELKRRTLE----------DEVKF-EH 219 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchh--hHHHHHHHhhc----------ccccc-cc
Confidence 3568999999999999899999999999999999999999997543221 11111111111 00000 00
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.....++.+|+.+||+.||++|+++.|+++.+.
T Consensus 220 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 220 QNFTEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred ccCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 123457899999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.61 Aligned_cols=264 Identities=23% Similarity=0.294 Sum_probs=195.1
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhc---ccccceeeeeeeee-----cc
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICIE-----EQ 1038 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrL---rHPNIVrLlG~~~d-----~~ 1038 (1368)
+|++.+.||+|+||.||+|... +|+.||+|+++... ......+.+|+++++++ +|+||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5889999999999999999854 68899999986432 22234567788887766 69999999999864 34
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGL 1118 (1368)
..++||||+. ++|.+++.... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~ 154 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGL 154 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCc
Confidence 5789999996 58888886432 235899999999999999999999888 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhccccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSRE 1197 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~e 1197 (1368)
++...... ......|+..|+|||++.+..++.++|||||||++|||++|+.+|......+. ..+..+.........
T Consensus 155 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 155 ARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW 231 (288)
T ss_pred cccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhC
Confidence 98653221 12335689999999999988999999999999999999999999965432211 111111100000000
Q ss_pred ----cc-ceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1198 ----GL-ERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1198 ----~L-~eIvDp~L~---~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.+ ...+..... .....+....+.+++.+||+.||++|+++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00 000000000 0011123456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=322.56 Aligned_cols=237 Identities=26% Similarity=0.479 Sum_probs=189.9
Q ss_pred eEEeecCcEEEEEEEecCCC-----------EEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 975 RILGEGGFGLVYSGVLDDGT-----------KVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr-----------~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
+.||+|+||.||+|.+.+.. .|++|+++..... .++|.+|+.+|++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 5788887644333 6789999999999999999999999988 788999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-------Ccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-------TPKVSDF 1116 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-------~VKLsDF 1116 (1368)
|||+.+|+|.++++... ..+++..+++++.||+.||+|||+.+ |+|||||++|||++.++ .+||+||
T Consensus 79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence 99999999999996422 26899999999999999999999887 99999999999999887 7999999
Q ss_pred cccccccccccccccccccccccccCcchhccC--CCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~--~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
|+++.... .....++..|+|||++... .++.++|||||||++|||++ |..||...... ....+..
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~--- 220 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQ--- 220 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHh---
Confidence 99986533 1223467789999998876 78999999999999999999 57777554311 1111111
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1194 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
. .. .........+.+++.+||..+|++||++.||++.|
T Consensus 221 ~-~~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 D-QH------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred c-CC------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 00 01111126789999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=347.31 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=200.3
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeecc-----ceE
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 1041 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-----~~~ 1041 (1368)
+|++.+.||+|+||.||++.. .+|+.||||++... +....+++.+|+++|+.++|+||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 588899999999999999995 57899999998643 2334567899999999999999999999998766 789
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
+||||+. ++|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++.
T Consensus 81 lv~e~~~-~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~ 152 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARV 152 (372)
T ss_pred EEeeccc-cCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceee
Confidence 9999995 678777742 346899999999999999999999887 99999999999999999999999999986
Q ss_pred ccccccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh------------
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW------------ 1188 (1368)
Q Consensus 1122 l~~~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W------------ 1188 (1368)
...... .......++..|+|||++.+. .++.++|||||||+||||++|+.||...+..........
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 153 EEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred cccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 533221 222334688999999998764 578999999999999999999999976543221111100
Q ss_pred ----hhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1189 ----ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1189 ----a~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.+..+............ ..........++.+|+.+||+.||++|+++.|+++.-+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPV--LYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHH--hcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 00000000000000000 00111223467889999999999999999999987643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=335.14 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=203.3
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCC----EEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr----~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
++|+..+.||+|+||.||+|.+ .+|+ .||+|+++.... ....++.+|+.++++++|+||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4678889999999999999985 3454 478888865332 3345788999999999999999999999754 5679
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
++||+.+|+|.+++... ...+++..+++++.|++.||+|||+++ |+|||||++||||++++.+||+|||+++..
T Consensus 86 v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999998532 235889999999999999999999887 999999999999999999999999999866
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.............++..|++||++.+..++.++|||||||++|||++ |+.||.... ...+.++... ....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~~----~~~~-- 230 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLEK----GERL-- 230 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHC----CCCC--
Confidence 43222222223345778999999998999999999999999999997 899986532 1223333211 1100
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.....+...+.+++.+||..+|++||+++|+++.|+.+...
T Consensus 231 --------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 --------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred --------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 01112345789999999999999999999999999877554
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=340.54 Aligned_cols=240 Identities=23% Similarity=0.321 Sum_probs=192.7
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|... +|+.||||+++... ....+.+..|++++.++ +|+||+++++++.+++..|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999965 68899999997532 23345677888888765 899999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.+++.++.||++||+|||+++ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~ 151 (316)
T cd05620 81 GDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG--DN 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC--CC
Confidence 999998853 235889999999999999999999887 999999999999999999999999998743221 12
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.+... .. . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~---~~~~~~~~---~~--------~----~ 213 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESIR---VD--------T----P 213 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hC--------C----C
Confidence 23446799999999999999999999999999999999999999965421 11111111 00 0 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH-HHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVV 1241 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMs-EVL 1241 (1368)
.++.....++.+++.+||+.||++|+++. ++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 HYPRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11222345788999999999999999984 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=338.81 Aligned_cols=255 Identities=21% Similarity=0.267 Sum_probs=196.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||++... +++.||||++++. .....+.|.+|+.++++++|+||+.+++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999954 6899999999642 2233456889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+|+|.+++.+. ...+.+.++..++.||+.||+|||+++ |+|||||++||||+.++++||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 999999999999532 235889999999999999999999888 99999999999999999999999999876543
Q ss_pred cccccccccccccccccCcchhcc-----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~-----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
... ......+||..|||||++.. ..++.++|||||||+||||++|+.||..... .+...........
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~------~~~~~~i~~~~~~- 226 (331)
T cd05597 155 DGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKEH- 226 (331)
T ss_pred CCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH------HHHHHHHHcCCCc-
Confidence 221 12233569999999999863 4678899999999999999999999965321 1111111111110
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCc--CcCCCCCHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQP--EVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~p--DPkeRPTMsEVLq~ 1243 (1368)
..+. .........+.+++.+|+.. ++..|+++.++++.
T Consensus 227 ~~~~------~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 227 FQFP------PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred ccCC------CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0000 00112345677788876654 33448899998776
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=331.26 Aligned_cols=252 Identities=25% Similarity=0.381 Sum_probs=201.0
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.|+..++||+|+||.||++.. .+++.||||.+.... ....+.+.+|+.++++++|+||+.+++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 378889999999999999995 478899999986432 2223567889999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+|+|.+++.... ...+.+.+++.++.|++.||.|||+.+ |+|||||++|||+++++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 155 (285)
T cd05630 81 LMNGGDLKFHIYHMG--EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 155 (285)
T ss_pred ecCCCcHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence 999999999985422 235899999999999999999999887 999999999999999999999999998755322
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||.............. ....
T Consensus 156 ~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~---~~~~---------- 219 (285)
T cd05630 156 QT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER---LVKE---------- 219 (285)
T ss_pred cc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh---hhhh----------
Confidence 11 1234689999999999999999999999999999999999999975432111110000 0000
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-----MsEVLq~ 1243 (1368)
....+.......+.+|+..||+.||++|++ +.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h 261 (285)
T cd05630 220 -VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH 261 (285)
T ss_pred -hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence 001112233456889999999999999999 7888765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=347.10 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=196.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||++... +++.||||+++.. .....+.+.+|++++.+++|+||+++++++.+++..||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999954 6899999999743 2334557889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~ 153 (360)
T cd05627 81 EFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK 153 (360)
T ss_pred eCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence 99999999999853 345899999999999999999999887 99999999999999999999999999875422
Q ss_pred ccc---------------------------------ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCC
Q 000659 1125 EES---------------------------------RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR 1171 (1368)
Q Consensus 1125 ~~~---------------------------------~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr 1171 (1368)
... .......+||..|+|||++.+..++.++|||||||+||||++|+
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~ 233 (360)
T cd05627 154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY 233 (360)
T ss_pred ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence 110 00112357999999999999999999999999999999999999
Q ss_pred CCCCCCCCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC---HHHHHHH
Q 000659 1172 KPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF---MGEVVQA 1243 (1368)
Q Consensus 1172 ~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT---MsEVLq~ 1243 (1368)
.||........ ..+..| ...+ .+. .. .....++.+++.+|+. +|++|++ +.|+++.
T Consensus 234 ~Pf~~~~~~~~~~~i~~~-------~~~~--~~p----~~--~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h 293 (360)
T cd05627 234 PPFCSETPQETYRKVMNW-------KETL--VFP----PE--VPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH 293 (360)
T ss_pred CCCCCCCHHHHHHHHHcC-------CCce--ecC----CC--CCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence 99975432111 011111 0000 000 00 1123467777777664 9999985 5665544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=346.99 Aligned_cols=262 Identities=19% Similarity=0.254 Sum_probs=203.3
Q ss_pred HHHHHHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 961 ASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 961 leELe~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
..+++...++|++.+.||+|+||.||++..+ +++.||+|+++.. .....+.+.+|+++++.++|+||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445555689999999999999999999955 6889999998642 22334567899999999999999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
++..|+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+++ |+|||||++||||+.++.+||+||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~Df 186 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADF 186 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeC
Confidence 9999999999999999999853 24788889999999999999999888 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccC----CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~----~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
|+++....... ......+||..|||||++... .++.++|||||||+||||++|+.||...+.. ......
T Consensus 187 G~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~------~~~~~i 259 (371)
T cd05622 187 GTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV------GTYSKI 259 (371)
T ss_pred CceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH------HHHHHH
Confidence 99986643221 122346799999999998754 3789999999999999999999999753211 111111
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQALK 1245 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPke--RPTMsEVLq~Le 1245 (1368)
......+ .+ .........+.+++.+|+..++.+ |+++.|+++..+
T Consensus 260 ~~~~~~~-~~-------~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 260 MNHKNSL-TF-------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred HcCCCcc-cC-------CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 1111000 00 011134567888999999854443 789999887653
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=361.97 Aligned_cols=265 Identities=27% Similarity=0.421 Sum_probs=224.7
Q ss_pred HHHHHHhCCcceeeEEeecCcEEEEEEEecC-CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccce
Q 000659 962 SEIEKATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 962 eELe~aT~nFei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~ 1040 (1368)
++++....++.+..+||-|.||.||.|+|+. .-.||||.|+. +....++|+.|..+|+.++|+|+|+|+|+|..+--.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKE-DtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhh-cchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4445555678889999999999999999874 45799999985 556788999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
|||.|||..|+|.|||++.++. .+.--.++.++.||+.||+||..++ +|||||..+|+||.++..+||+||||++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~--ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS--EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh--hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence 9999999999999999876543 4667778999999999999999887 9999999999999999999999999999
Q ss_pred cccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
++..+.+..- ....-...|.|||.+....++.|+|||+|||+|||+.| |..||-..+ ...+
T Consensus 414 lMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqV 475 (1157)
T KOG4278|consen 414 LMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQV 475 (1157)
T ss_pred hhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHH
Confidence 8865433211 11122468999999999999999999999999999999 888885432 1223
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
..+++..++.+.++.|..++++||++||+..|.+||++.|+-+.|+.+..+
T Consensus 476 Y~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~ 526 (1157)
T KOG4278|consen 476 YGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS 526 (1157)
T ss_pred HHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence 345556667778889999999999999999999999999999999876654
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=325.95 Aligned_cols=257 Identities=26% Similarity=0.441 Sum_probs=201.2
Q ss_pred cceeeEEeecCcEEEEEEEec----CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeecc------
Q 000659 971 FDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 1038 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk----dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~------ 1038 (1368)
|.+.+.||+|+||.||+|.+. +++.||||+++.. .....+++.+|++++++++|+||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3688999998643 3345667899999999999999999999886532
Q ss_pred ceEEEEeecCCCChhhccccc--ccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGV--DKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~--~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
..++++||+.+|+|.+++... ..+...+++..+++++.|++.||+|||+.+ |+|||||++|||++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 237889999999999887432 122335889999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
|+++...............++..|++||.+....++.++|||||||++|||++ |+.||..... ..+..+...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~---~~~~~~~~~---- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN---SEIYNYLIK---- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH---HHHHHHHHc----
Confidence 99986643322222223345678999999998899999999999999999999 8888864321 222222211
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
...+ .........+.+++.+||+.+|++||++.|+++.|+.+
T Consensus 231 ~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 11123446899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=352.22 Aligned_cols=262 Identities=20% Similarity=0.279 Sum_probs=197.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
.++|++.+.||+|+||.||++.. .+++.||||+.+. +.+.+|+++|++|+|+|||++++++..+...++||||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 46799999999999999999995 5788999997542 3567899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+ +++|.+++.. ...+++.+++.|+.||+.||+|||+++ ||||||||+||||+.++.+||+|||+++......
T Consensus 165 ~-~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~ 236 (391)
T PHA03212 165 Y-KTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236 (391)
T ss_pred C-CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence 9 5788888743 235889999999999999999999887 9999999999999999999999999997543211
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCc-c----hhHHHhhhhhc--------
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-Q----ENLVAWARPLL-------- 1193 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~-~----~nLv~Wa~pll-------- 1193 (1368)
.......+||..|+|||++.+..++.++|||||||+||||++|+.||-.....+ . ..+........
T Consensus 237 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~ 315 (391)
T PHA03212 237 -ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI 315 (391)
T ss_pred -ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc
Confidence 122234679999999999999999999999999999999999998764322111 0 00000000000
Q ss_pred ccccccceee---------cCCCCCCC--ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1194 TSREGLERII---------DPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1194 s~~e~L~eIv---------Dp~L~~~~--~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.....+..++ ....+... ..+...++.+|+.+||+.||++|||+.|+++.-
T Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp 377 (391)
T PHA03212 316 DAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA 377 (391)
T ss_pred chhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence 0000000000 00000000 012345788999999999999999999998643
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=339.41 Aligned_cols=237 Identities=24% Similarity=0.325 Sum_probs=188.9
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHH-HHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||.||+|+.. +|+.||||++.... ....+++.+|+. +++.++|+||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999964 68899999996432 223345566654 57889999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+.+.++..|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~ 151 (321)
T cd05603 81 GELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--EE 151 (321)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC--CC
Confidence 999988843 335888999999999999999999887 999999999999999999999999998753221 12
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.+. .... . .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~---i~~~----------~--~ 213 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV---SQMYDN---ILHK----------P--L 213 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH---HHHHHH---HhcC----------C--C
Confidence 23446799999999999998999999999999999999999999965421 111111 1110 0 1
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMG 1238 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMs 1238 (1368)
.++......+.+++.+||+.+|++|++..
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 214 QLPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 12223456789999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-37 Score=326.10 Aligned_cols=253 Identities=23% Similarity=0.357 Sum_probs=201.2
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||+|.. .+++.|++|+++.........+.+|+.+++.++|+||+++++++.+.+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 4678888999999999999985 468899999997655555567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06645 89 GGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI- 160 (267)
T ss_pred CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-
Confidence 99999999853 235899999999999999999999887 9999999999999999999999999987653221
Q ss_pred ccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1128 RHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.......|+..|+|||++. ...++.++|||||||++|||++|+.||....... .+..... .. ...
T Consensus 161 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~--~~~~~~~------~~---~~~ 228 (267)
T cd06645 161 -AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR--ALFLMTK------SN---FQP 228 (267)
T ss_pred -cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchh--hHHhhhc------cC---CCC
Confidence 1123356899999999874 4568899999999999999999999985433211 1111000 00 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+.. .......+.+++.+||..+|++||++++|++.
T Consensus 229 ~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 229 PKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred Ccccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 01100 01223568899999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=340.82 Aligned_cols=242 Identities=24% Similarity=0.315 Sum_probs=195.6
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
++||+|+||+||+|... +++.||||+++.. .....+.+.+|++++..+ +|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999865 5789999999753 233455678899999888 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||++++.+||+|||+++...... .
T Consensus 81 ~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~ 151 (318)
T cd05570 81 GDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--V 151 (318)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--C
Confidence 999988853 236899999999999999999999887 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+|+..|+|||++.+..++.++|||||||++|||++|+.||..... ..+.... .... .
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~---~~~~~~i---~~~~------------~ 213 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSI---LEDE------------V 213 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH---HHHHHHH---HcCC------------C
Confidence 22345699999999999999999999999999999999999999965431 1111111 1100 0
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCH-----HHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFM-----GEVVQA 1243 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTM-----sEVLq~ 1243 (1368)
.++......+.+|+.+||+.||++|+++ .++++.
T Consensus 214 ~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~ 252 (318)
T cd05570 214 RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH 252 (318)
T ss_pred CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence 1122334678999999999999999999 777654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=340.04 Aligned_cols=243 Identities=23% Similarity=0.298 Sum_probs=191.3
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHH-HHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVE-MLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIe-ILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+.||+|+||+||+|... +++.||+|+++... ....+++.+|.. +++.++|+||+++++++.+.+..|+||||+.+
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999955 67889999996432 222344555544 56788999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+.+.++..++.||++||+|||+.+ |+|||||++||||+.++.+||+|||+++..... ..
T Consensus 81 ~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--~~ 151 (325)
T cd05602 81 GELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--NG 151 (325)
T ss_pred CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC--CC
Confidence 999999853 235778888999999999999999888 999999999999999999999999999754321 12
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+..+. ... .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i---~~~----------~~-- 213 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT---AEMYDNI---LNK----------PL-- 213 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH---HHHHHHH---HhC----------Cc--
Confidence 23446799999999999999999999999999999999999999965321 1111111 110 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.........+.+++.+||+.+|++|+++.+.++++
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i 248 (325)
T cd05602 214 QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEI 248 (325)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHH
Confidence 11123345788999999999999999987654433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=326.08 Aligned_cols=253 Identities=28% Similarity=0.392 Sum_probs=197.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHH-HhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEM-LSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeI-LsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|+.. +|+.||||+++... .....++..|+++ ++.++|+||+++++++.+++..|+|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 47999999999999999999964 69999999987532 3344567777776 556689999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhcc-CCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~-gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
|++ |+|.+++.........+++.++++++.||+.||+|||++ + ++|||||++|||++.++++||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 995 788888865433445799999999999999999999986 5 99999999999999999999999999986532
Q ss_pred cccccccccccccccccCcchhcc----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
. ...+...|+..|++||++.. ..++.++|||||||+||||++|+.||+..... .+.+..... ....
T Consensus 157 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~------~~~~ 226 (283)
T cd06617 157 S---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQLKQVVE------EPSP 226 (283)
T ss_pred c---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHHHHHHh------cCCC
Confidence 2 11233468899999998764 45688999999999999999999999643211 111111110 0000
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+ .......++.+++.+||..+|++||++.||++.
T Consensus 227 -----~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 261 (283)
T cd06617 227 -----QL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH 261 (283)
T ss_pred -----CC---CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011234578999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=330.17 Aligned_cols=264 Identities=27% Similarity=0.387 Sum_probs=208.4
Q ss_pred CCHHHHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeee
Q 000659 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 1036 (1368)
Q Consensus 959 fsleELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d 1036 (1368)
+...++..++++|++.+.||+|+||.||++.. ++++.+++|++.... ...+++.+|+.+++++ +|+||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 55667778899999999999999999999995 578899999986432 3346788999999999 79999999999875
Q ss_pred c-----cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCc
Q 000659 1037 E-----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111 (1368)
Q Consensus 1037 ~-----~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~V 1111 (1368)
. +..++||||+++|+|.++++........+.|..+++++.|++.||+|||+.+ |+|||||++|||+++++++
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 3 3579999999999999998654444456899999999999999999999887 9999999999999999999
Q ss_pred ccccccccccccccccccccccccccccccCcchhccC-----CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 000659 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1186 (1368)
Q Consensus 1112 KLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~-----~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv 1186 (1368)
||+|||+++....... ......|+..|++||++... .++.++|||||||++|||++|+.||..... ...+.
T Consensus 168 kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~--~~~~~ 243 (291)
T cd06639 168 KLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP--VKTLF 243 (291)
T ss_pred EEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH--HHHHH
Confidence 9999999986543221 12234688999999987643 368999999999999999999999965321 12222
Q ss_pred HhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1187 AWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1187 ~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.+. ....+. ...+....+.+++.+||+.+|++||++.|+++.
T Consensus 244 ~~~~~------~~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 244 KIPRN------PPPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHhcC------CCCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 22111 001111 112233568999999999999999999999864
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=320.08 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=205.3
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||+|.. .+++.+++|++........+.+.+|++++++++|+||+++++++.+++..|++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 6799999999999999999995 467889999998665556778999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++... ...+++.+++.++.|++.||+|||+.+ |+|||||++||+|++++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 83 GGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 999999988532 246899999999999999999999887 9999999999999999999999999997654321
Q ss_pred ccccccccccccccCcchhccC---CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~---~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.......++..|++||++... .++.++|||||||++|||++|+.||...... ........ ..+. .
T Consensus 156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~--~~~~~~~~------~~~~---~ 223 (262)
T cd06613 156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPM--RALFLISK------SNFP---P 223 (262)
T ss_pred -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh------ccCC---C
Confidence 112335688899999998776 8899999999999999999999999653311 11111110 0000 0
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
..+ .........+.+++.+||..+|.+||++.+|++
T Consensus 224 ~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKL--KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccc--cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000 112234567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=339.58 Aligned_cols=241 Identities=25% Similarity=0.350 Sum_probs=192.9
Q ss_pred eEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+.||+|+||+||+|... +++.||||+++... ....+.+..|..+++.+ +|+||+++++++.+.+..++||||+.+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999965 57899999997532 23345677788888765 899999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.++..++.|+++||+|||+.+ |+|||||++||||+.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~ 151 (316)
T cd05619 81 GDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--A 151 (316)
T ss_pred CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--C
Confidence 999999853 235889999999999999999999887 9999999999999999999999999987532211 1
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....+||..|+|||++.+..++.++|||||||+||||++|+.||..... ..+...+. . . ..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~---~~~~~~i~---~-~-------~~---- 213 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIR---M-D-------NP---- 213 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH---HHHHHHHH---h-C-------CC----
Confidence 22345799999999999999999999999999999999999999975431 11111111 0 0 00
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHH-HHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQ 1242 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMs-EVLq 1242 (1368)
.++.....++.+++.+||+.||++|+++. ++.+
T Consensus 214 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 247 (316)
T cd05619 214 CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQ 247 (316)
T ss_pred CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence 11112345688999999999999999997 5543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=339.72 Aligned_cols=255 Identities=21% Similarity=0.276 Sum_probs=197.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.++||+|+||.||++.++ +++.||+|++.+. .....+.|.+|+.++..++|+||+.+++++.+.+..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999965 5788999998642 2223345889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+|+|.++|++. ...+++..++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~ 154 (332)
T cd05623 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME 154 (332)
T ss_pred eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence 999999999999642 235899999999999999999999887 99999999999999999999999999976533
Q ss_pred cccccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
.. .......+||..|+|||++. ...++.++|||||||+||||++|+.||..... .+............
T Consensus 155 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~------~~~~~~i~~~~~~~ 227 (332)
T cd05623 155 DG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESL------VETYGKIMNHKERF 227 (332)
T ss_pred CC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCH------HHHHHHHhCCCccc
Confidence 22 12223457999999999886 34688999999999999999999999965321 11111111111000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 1243 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPke--RPTMsEVLq~ 1243 (1368)
. + ..........+.+|+.+|+..++++ |+++.|+++.
T Consensus 228 ~------~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 Q------F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred c------C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 0 0011233466788888887654444 6889998776
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=356.93 Aligned_cols=265 Identities=24% Similarity=0.312 Sum_probs=197.1
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeec--------
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-------- 1037 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~-------- 1037 (1368)
..++|++.++||+|+||.||+|+. .+++.||||++.... ....+|+.+|++++|+|||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 356899999999999999999995 468899999885422 2345799999999999999999986432
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Ccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDF 1116 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsDF 1116 (1368)
..+++||||+. ++|.+++.........+++..++.|+.||++||+|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 24578999996 5787777544444567999999999999999999999888 99999999999999665 6999999
Q ss_pred cccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
|+++...... ......||..|+|||++.+ ..++.++|||||||+||||++|+.||...... +.+......+...
T Consensus 216 Gla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~--~~~~~i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSV--DQLVRIIQVLGTP 290 (440)
T ss_pred ccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCC
Confidence 9998654322 1223568999999998875 46899999999999999999999999754322 1111111100000
Q ss_pred --------ccccc-----eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1196 --------REGLE-----RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1196 --------~e~L~-----eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..... .+....+...++.....++.+|+.+||+.||++|+++.|+++.-
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 00000 00001111112223446789999999999999999999998663
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=333.54 Aligned_cols=268 Identities=21% Similarity=0.295 Sum_probs=200.6
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|.+.+.||+|+||.||+|+.+ +++.||||+++... ......+.+|++++++++|+||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56999999999999999999954 67889999987432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+ +|.+++... ...+++.+++.++.||++||+|||+.+ |+|||||++||||+.++.+||+|||+++......
T Consensus 86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 964 888887532 335889999999999999999999887 9999999999999999999999999997543221
Q ss_pred cccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhh--------hhccccc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR--------PLLTSRE 1197 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~--------plls~~e 1197 (1368)
.......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+......... +.+....
T Consensus 159 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 --KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred --cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 11223457899999998865 568899999999999999999999997654322111111000 0000000
Q ss_pred ccceeecCCCCC----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1198 GLERIIDPSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1198 ~L~eIvDp~L~~----~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.....-.+.... ........++.+++.+||+.||++|+|+.|+++.-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 288 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChh
Confidence 000000000000 000123456789999999999999999999987533
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.23 Aligned_cols=264 Identities=20% Similarity=0.287 Sum_probs=199.4
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|+.. +++.|+||+++.. +....+.+.+|++++++++|+||+++++++.+++..|+||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 5888999999999999999964 6899999998643 223346788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. ++|.+++..... ...+++.+++.++.||+.||+|||+.+ |+|||||++|||++.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 81 LS-MDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV 155 (285)
T ss_pred CC-CCHHHHHhcCCC-CCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence 96 689888864332 346899999999999999999999887 9999999999999999999999999997553221
Q ss_pred cccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh----------ccc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL----------LTS 1195 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl----------ls~ 1195 (1368)
.......++..|+|||++.+. .++.++|||||||++|||++|+.||....... .+....... ...
T Consensus 156 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEID--QLFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred --ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhcchh
Confidence 122334578899999988654 57899999999999999999999997543211 111110000 000
Q ss_pred ccccceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1196 REGLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~---~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.......++.... .........++.+++.+||+.||++||++.||++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0000000000000 0011123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=340.58 Aligned_cols=255 Identities=19% Similarity=0.248 Sum_probs=197.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+.+|+.++.+++|+||+++++++.+++..||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999954 6788999998642 2233445788999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+|+|.++++.. ...+++..+..++.|++.||+|||+++ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 154 (331)
T cd05624 81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ 154 (331)
T ss_pred eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence 999999999999642 235889999999999999999999887 99999999999999999999999999986543
Q ss_pred cccccccccccccccccCcchhcc-----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~-----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
... ......+||..|+|||++.. +.++.++|||||||+||||++|+.||...+.. +...........+
T Consensus 155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~------~~~~~i~~~~~~~ 227 (331)
T cd05624 155 DGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLV------ETYGKIMNHEERF 227 (331)
T ss_pred CCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHH------HHHHHHHcCCCcc
Confidence 221 12233569999999999875 56789999999999999999999999653211 1111111111000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCC--CCCHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQH--RPFMGEVVQA 1243 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPke--RPTMsEVLq~ 1243 (1368)
. +. ....+...++.+++.+|+..++++ |.+++++++.
T Consensus 228 ~------~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 228 Q------FP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred c------CC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 0 00 011123467888999988865544 4677777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=323.24 Aligned_cols=257 Identities=31% Similarity=0.480 Sum_probs=203.0
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeeecc-----
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ----- 1038 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~----- 1038 (1368)
..+++|++.+.||+|+||.||+|..+ +++.|++|++.... ...++|.+|+++++++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45688999999999999999999964 67889999987543 3456799999999999 6999999999997644
Q ss_pred -ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1039 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1039 -~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
..++||||+++++|.++++........+++..++.++.|++.||.|||+.+ |+||||+++||+|++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 479999999999999998654433457899999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhcc-----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~-----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
++....... .......|+..|+|||++.. ..++.++|||||||+||||++|+.||..... ...+.....
T Consensus 159 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-- 232 (275)
T cd06608 159 VSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRALFKIPR-- 232 (275)
T ss_pred cceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccch--HHHHHHhhc--
Confidence 987653321 11233458899999998753 3567899999999999999999999964321 111111110
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.... .+ .........+.+++.+||..||++||++.||++.
T Consensus 233 ----~~~~-----~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 233 ----NPPP-----TL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred ----cCCC-----CC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 0000 01 1112245678999999999999999999999763
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=339.80 Aligned_cols=242 Identities=22% Similarity=0.311 Sum_probs=195.1
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVm 1044 (1368)
+|+..+.||+|+||.||+|.. .+|+.||||+++.. .....+.+..|++++..+. |++|+.+++++.+.+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 478899999999999999985 46899999999753 2233456788999998885 577888999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+++.+++.|+.||+.||+|||+++ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~ 153 (323)
T cd05615 81 EYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV 153 (323)
T ss_pred cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence 99999999999853 235899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.. ......+||..|+|||++.+..++.++|||||||+||||++|+.||..... ..+..... ..
T Consensus 154 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~---~~~~~~i~---~~--------- 216 (323)
T cd05615 154 DG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM---EH--------- 216 (323)
T ss_pred CC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH---HHHHHHHH---hC---------
Confidence 11 122345699999999999999999999999999999999999999975431 11211111 10
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1238 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMs 1238 (1368)
. ..++.....++.+++.+||+.+|++|++..
T Consensus 217 -~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 -N--VSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred -C--CCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0 012223345788999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=356.48 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=205.3
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
..++|++++.||+|+||.||+|+ .++|..+|+|+|++.. ....+.++.|-++|...++++||+|+..|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999 5579999999998743 3344567899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||++||++..+|. ..+.|+++....++.+++.|++-||+.| +|||||||+|+|||.+|.+||+||||+.-+
T Consensus 219 iMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999994 3457999999999999999999999998 999999999999999999999999998532
Q ss_pred ccc----------------------cccc----c-------------------cccccccccccCcchhccCCCCcccce
Q 000659 1123 MDE----------------------ESRH----I-------------------STRVMGTFGYVAPEYAMTGHLLVKSDV 1157 (1368)
Q Consensus 1123 ~~~----------------------~~~~----~-------------------st~v~GT~gYmAPEvL~~~~~T~KSDV 1157 (1368)
... +... . ....+||+.|||||++++..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 110 0000 0 012579999999999999999999999
Q ss_pred eeHHHHHHHHHhCCCCCCCCCCCc-chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000659 1158 YSYGVVILELLSGRKPVDMTQPPG-QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1236 (1368)
Q Consensus 1158 WSLGVILyELLTGr~PFd~s~~~~-~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT 1236 (1368)
||||||+||||.|..||...+... ..+++.|-..+.... ...+..+..+||.+|+. |+++|.-
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~---------------~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPE---------------EVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCC---------------cCcccHHHHHHHHHHhc-CHHHhcC
Confidence 999999999999999998876543 456777743222111 11223678899999999 9999986
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=319.51 Aligned_cols=251 Identities=31% Similarity=0.527 Sum_probs=201.8
Q ss_pred cceeeEEeecCcEEEEEEEecC-----CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 971 FDASRILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkd-----Gr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
|++.+.||+|+||.||++...+ +..||+|+++..... ..+.+.+|++++++++|+||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 4567899999999999999653 488999999754433 5678999999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+++|.+++..... ..+++.+++.++.|++.||+|||+.+ ++|||||++||++++++.++|+|||+++....
T Consensus 81 e~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 81 EYMEGGDLLDYLRKNRP--KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred eccCCCCHHHHHHhhhh--ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999964321 12899999999999999999999887 99999999999999999999999999986654
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
..... .....++..|++||.+.+..++.++||||||+++|||++ |+.||+... ...+..+.. . ...
T Consensus 156 ~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~---~~~~~~~~~---~-~~~----- 222 (258)
T smart00219 156 DDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMS---NEEVLEYLK---K-GYR----- 222 (258)
T ss_pred ccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHh---c-CCC-----
Confidence 32211 112336789999999988899999999999999999998 888886532 122222211 1 000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.........++.+++.+||..+|++||++.|+++.|
T Consensus 223 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 -----LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred -----CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 011122456789999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=328.64 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=200.8
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
|++.+.||+|+||.||+|... ++..+++|.+........+.+.+|++++++++|+||+++++++.+++..++||||+.+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 567789999999999999965 5778899998765556667899999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.+. ...+++.+++.++.|++.||+|||+.+ |+|||||++|||++.++++||+|||+++...... .
T Consensus 87 ~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~--~ 158 (282)
T cd06643 87 GAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI--Q 158 (282)
T ss_pred CcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc--c
Confidence 9999988532 246899999999999999999999887 9999999999999999999999999987553221 1
Q ss_pred ccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1130 ISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
......|+..|+|||++. ...++.++|||||||++|||++|+.||..... .......... . ...+
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~----~--~~~~-- 228 (282)
T cd06643 159 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP--MRVLLKIAKS----E--PPTL-- 228 (282)
T ss_pred ccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH--HHHHHHHhhc----C--CCCC--
Confidence 223356899999999874 34577899999999999999999999865331 1111111110 0 0000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..+.....++.+++.+||+.+|++||++.++++.-
T Consensus 229 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~ 263 (282)
T cd06643 229 -----AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP 263 (282)
T ss_pred -----CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence 01112345789999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=329.87 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=202.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||+|... +++.|++|++...+....+++.+|++++++++|+||+++++++..++..++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 56888999999999999999965 58999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++++|.+++.+. ...+++.+++.++.|++++|+|||+.+ |+|||||++|||++.++++||+|||++......
T Consensus 92 ~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-- 163 (292)
T cd06644 92 PGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-- 163 (292)
T ss_pred CCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccc--
Confidence 999998887532 235899999999999999999999887 999999999999999999999999998754321
Q ss_pred ccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1128 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
........++..|++||++. ...++.++|||||||++|||++|+.||..... ......+. ...
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~--~~~~~~~~----~~~------ 231 (292)
T cd06644 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP--MRVLLKIA----KSE------ 231 (292)
T ss_pred ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH--HHHHHHHh----cCC------
Confidence 11123345889999999884 34568899999999999999999999865321 11111111 000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.+ ........++.+++.+||+.+|++||++.|+++.
T Consensus 232 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 269 (292)
T cd06644 232 -PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH 269 (292)
T ss_pred -CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000 1112334578899999999999999999999764
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=327.31 Aligned_cols=260 Identities=27% Similarity=0.397 Sum_probs=204.8
Q ss_pred CCHHHHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeee
Q 000659 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 1036 (1368)
Q Consensus 959 fsleELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d 1036 (1368)
.++.++....+.|++.+.||+|+||.||+|.. ++++.|++|++... .....++.+|+.+++++ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 46677777889999999999999999999995 56889999998643 33446788999999998 69999999999853
Q ss_pred ------ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC
Q 000659 1037 ------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110 (1368)
Q Consensus 1037 ------~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~ 1110 (1368)
.+..|+||||+.+|+|.+++.... ...+.+..++.++.||+.||+|||+.+ |+|||||++||||++++.
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~ 159 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE 159 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence 457799999999999999986432 335888899999999999999999887 999999999999999999
Q ss_pred cccccccccccccccccccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhH
Q 000659 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1185 (1368)
Q Consensus 1111 VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nL 1185 (1368)
++|+|||+++...... .......|+..|+|||++. ...++.++|||||||++|||++|+.||...........
T Consensus 160 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 160 VKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred EEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 9999999987553211 1123356899999999876 34678899999999999999999999964321111000
Q ss_pred HHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1186 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1186 v~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
+.+..... .........+.+++.+||+.||++||++.||++
T Consensus 238 -------------~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 -------------IPRNPPPK---LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -------------HhhCCCCC---CcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00000000 011123467999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=319.68 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=201.3
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeee-ccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d-~~~~~LVmE 1045 (1368)
+|++.+.||+|+||.||++..+ +++.|++|++... .....+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5889999999999999999954 5788999998643 23445678899999999999999999998764 446789999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+++++|.+++... ....+++.++++++.|++.||+|||+.+ |+|||||++|||++.++.++|+|||++......
T Consensus 81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~ 155 (257)
T cd08223 81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ 155 (257)
T ss_pred ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence 99999999999642 2345899999999999999999999887 999999999999999999999999999865332
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. .......|+..|+|||++.+..++.++|||||||++|||++|+.||+..+. ..+....... .+
T Consensus 156 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~------~~~~~~~~~~--~~------ 219 (257)
T cd08223 156 C--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM------NSLVYRIIEG--KL------ 219 (257)
T ss_pred C--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH------HHHHHHHHhc--CC------
Confidence 1 222345688999999999999999999999999999999999999864321 1111111110 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........++.+++.+||+.+|++||++.|+++.
T Consensus 220 ---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 220 ---PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ---CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 11122344679999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=331.40 Aligned_cols=251 Identities=24% Similarity=0.349 Sum_probs=205.2
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..+|++.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.++++++|+||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 36799999999999999999995 57999999999765555567789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.+++.. ..+++.++++++.|++.||.|||+.+ |+|||||++||||+.++.+||+|||++.......
T Consensus 98 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~ 169 (297)
T cd06656 98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 169 (297)
T ss_pred cCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCc
Confidence 999999999842 35889999999999999999999887 9999999999999999999999999987653322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......++..|++||++.+..++.++|||||||++|+|++|+.||...+..... .. ... . ..
T Consensus 170 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~--~~----~~~--~-------~~ 232 (297)
T cd06656 170 --SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL----IAT--N-------GT 232 (297)
T ss_pred --cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhe--ee----ecc--C-------CC
Confidence 1123356889999999999988999999999999999999999999654321100 00 000 0 00
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
............+.+++.+||+.+|++||++.+|++.
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH 269 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0001122334567899999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=325.82 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=203.1
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||.|+||.||+|... +++.|++|++.... ....+.+.+|++++++++|+||+++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888899999999999999954 68899999986533 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+++|.++++.. .+++.+++.++.|++.||.|||+.+ |+||||+++||+|++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 152 (274)
T cd06609 81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM 152 (274)
T ss_pred eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence 9999999998532 6899999999999999999999887 9999999999999999999999999998764322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......|+..|++||++.+..++.++|||||||+||||++|+.||+..+... ....... . ..+.
T Consensus 153 --~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~~~~~~--~-----~~~~ 217 (274)
T cd06609 153 --SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VLFLIPK--N-----NPPS 217 (274)
T ss_pred --cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HHHHhhh--c-----CCCC
Confidence 12233568889999999998889999999999999999999999996543111 1000000 0 0011
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+... .....+.+++.+||..+|++||+++++++.
T Consensus 218 ~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~ 251 (274)
T cd06609 218 LEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLKH 251 (274)
T ss_pred Cccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 1111 134568899999999999999999999875
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=323.03 Aligned_cols=266 Identities=24% Similarity=0.290 Sum_probs=201.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|+.. +|+.|++|++.... ....+.+.+|++++++++|+||+++++++.+....++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47899999999999999999965 68999999986432 2334568899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+++++|..++.. ...++|.++++++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887642 235899999999999999999999887 999999999999999999999999999876432
Q ss_pred ccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhccc-------c
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTS-------R 1196 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls~-------~ 1196 (1368)
.. ......++..|++||++.+ ..++.++|||||||++|||++|+.||......+.. .+.......... .
T Consensus 154 ~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 154 GD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred cc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 21 1223457889999999875 56789999999999999999999999754322111 111111110000 0
Q ss_pred cccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~-----~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.-...+..+....... ......+.+|+.+||+.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000011000000 1224578899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=326.01 Aligned_cols=266 Identities=26% Similarity=0.355 Sum_probs=202.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|..+ +++.|+||+++.. .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 47999999999999999999965 6889999998643 33345678999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.++.|..++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 9998777666532 235899999999999999999999887 999999999999999999999999999876443
Q ss_pred ccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HHHhhhhh-------cccc
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPL-------LTSR 1196 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv~Wa~pl-------ls~~ 1196 (1368)
.. .......++..|+|||++... .++.++||||||++||||++|+.+|......+... +..+...+ +...
T Consensus 154 ~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07833 154 PA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSN 232 (288)
T ss_pred cc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccC
Confidence 22 122345688999999999888 88999999999999999999999997543211100 00100000 0000
Q ss_pred cccc--eeecCC----CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1197 EGLE--RIIDPS----LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1197 e~L~--eIvDp~----L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.... ++.+.. +...+......++.+++++||+.+|++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 233 PRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000 000000 000112223577999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=328.95 Aligned_cols=249 Identities=23% Similarity=0.355 Sum_probs=202.3
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.|+..+.||+|+||.||+|.+ .+++.||+|+++... ....+++.+|++++++++|+||+++++++..++..|+||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 366677899999999999985 467889999986432 344567899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++.. ..+.+..++.++.|+++||.|||+.+ |+|+||+++||++++++.+||+|||+++......
T Consensus 85 ~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06642 85 GGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ- 155 (277)
T ss_pred CCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-
Confidence 99999998842 35889999999999999999999887 9999999999999999999999999997654321
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.......|+..|++||++.+..++.++|||||||++|||++|+.||....... ...+. ....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~~~--------------~~~~ 217 (277)
T cd06642 156 -IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR---VLFLI--------------PKNS 217 (277)
T ss_pred -hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh---HHhhh--------------hcCC
Confidence 11223458899999999999899999999999999999999999986432211 11110 0001
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
...........+.+++.+||+.+|++||+|.||++.-.
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 11122234567899999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=326.07 Aligned_cols=239 Identities=23% Similarity=0.435 Sum_probs=189.6
Q ss_pred eEEeecCcEEEEEEEecC-------------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 975 RILGEGGFGLVYSGVLDD-------------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd-------------Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
+.||+|+||.||+|.+.+ ...|++|++..........|.+|+.++++++|+||+++++++.++...+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 368999999999998532 2358899887655555667899999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC-------cccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT-------PKVS 1114 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~-------VKLs 1114 (1368)
+||||+++|+|..+++.. ...+++..+++|+.||++||+|||+.+ |+|||||++||||+.++. +|++
T Consensus 81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~ 154 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLS 154 (262)
T ss_pred EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeC
Confidence 999999999999888532 345899999999999999999999887 999999999999987664 8999
Q ss_pred cccccccccccccccccccccccccccCcchhc-cCCCCcccceeeHHHHHHHHH-hCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~-~~~~T~KSDVWSLGVILyELL-TGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
|||++...... ....++..|+|||++. ...++.++|||||||+||||+ .|+.||........ .+.
T Consensus 155 d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~~~--- 221 (262)
T cd05077 155 DPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----ERF--- 221 (262)
T ss_pred CCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----HHH---
Confidence 99998754321 2235788999999887 567899999999999999998 58888754321111 110
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.... .. ........+.+|+.+||+.||++||++.||++.|
T Consensus 222 ~~~~---~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 YEGQ---CM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred HhcC---cc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0000 00 0112235688999999999999999999998876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=327.05 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=191.1
Q ss_pred EEeecCcEEEEEEEecCCC---EEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCC
Q 000659 976 ILGEGGFGLVYSGVLDDGT---KVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 1051 (1368)
Q Consensus 976 lLGeGgFGtVYKAvlkdGr---~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGS 1051 (1368)
.||+|+||.||+|...++. .+++|.++... ....++|.+|++++++++|+||++++++|.+....|+||||+.+|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 6999999999999855443 45566665332 3445789999999999999999999999999999999999999999
Q ss_pred hhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccc
Q 000659 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131 (1368)
Q Consensus 1052 L~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~s 1131 (1368)
|.+++++.......+.+..+++++.||++||+|||+.+ |+|||||++|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 99999754333345677788999999999999999887 999999999999999999999999998643222211222
Q ss_pred ccccccccccCcchhcc-------CCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1132 TRVMGTFGYVAPEYAMT-------GHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1132 t~v~GT~gYmAPEvL~~-------~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
....|+..|+|||++.. ..++.++|||||||++|||++ |..||..... .. +....+. +....+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~---~~~~~~~--~~~~~~~ 230 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD---RE---VLNHVIK--DQQVKLF 230 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH---HH---HHHHHHh--hcccccC
Confidence 34568899999998753 245789999999999999997 5667754321 11 1111111 1112233
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
++.+.. ....++.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 333322 23456788999999 67999999999988763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=346.86 Aligned_cols=264 Identities=21% Similarity=0.267 Sum_probs=201.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEec---CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk---dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
..+|++.+.||+|+||.||++... .++.|+||.+... +.+.+|+++|++|+|+|||++++++..+...|+||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 467999999999999999999753 3578999988642 24568999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+. ++|.+++. ....+++.+++.|+.||+.||+|||+.+ |||||||++||||+.++.+||+|||+++....
T Consensus 166 e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 166 PKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred hhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 9994 68888883 2346899999999999999999999887 99999999999999999999999999986654
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhcccc------c
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTSR------E 1197 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls~~------e 1197 (1368)
...........||..|+|||++....++.++|||||||+||||++|+.||......... .+..-.+ .+... .
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~-~~~~~~~~~~~~ 316 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIR-CMQVHPLEFPQN 316 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHH-HhccCccccCCc
Confidence 33333334567999999999999999999999999999999999999999655432211 1111100 00000 0
Q ss_pred ---cccee---ecCCCCCCCC-------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1198 ---GLERI---IDPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1198 ---~L~eI---vDp~L~~~~~-------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.+.+. +....+..+. .....++.+++.+||..||++||++.|+++.-.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~ 377 (392)
T PHA03207 317 GSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377 (392)
T ss_pred cchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCch
Confidence 00000 0000000000 112346788999999999999999999987643
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=329.02 Aligned_cols=238 Identities=24% Similarity=0.417 Sum_probs=188.6
Q ss_pred EEeecCcEEEEEEEecC-------------------------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceee
Q 000659 976 ILGEGGFGLVYSGVLDD-------------------------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 1030 (1368)
Q Consensus 976 lLGeGgFGtVYKAvlkd-------------------------Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrL 1030 (1368)
+||+|+||.||+|.+.. ...|++|+++.......++|.+|++++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999998421 13588999876555556788999999999999999999
Q ss_pred eeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-
Q 000659 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF- 1109 (1368)
Q Consensus 1031 lG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng- 1109 (1368)
+++|.+.+..++||||+++|+|.+++.. ....+++..+++|+.||++||+|||+.+ |+|||||++||||+.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~ 155 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK---EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL 155 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence 9999999999999999999999999853 2346889999999999999999999887 99999999999997654
Q ss_pred ------CcccccccccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHH-hCCCCCCCCCCCc
Q 000659 1110 ------TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPG 1181 (1368)
Q Consensus 1110 ------~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELL-TGr~PFd~s~~~~ 1181 (1368)
.+||+|||++...... ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||.......
T Consensus 156 ~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 229 (274)
T cd05076 156 AEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE 229 (274)
T ss_pred ccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence 3799999998644221 12347788999998865 56899999999999999995 6999886543211
Q ss_pred chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1182 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1182 ~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
...+.. ... .........+.+++.+||+.+|++||+|.||++.|
T Consensus 230 ---~~~~~~----~~~------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 230 ---KERFYE----KKH------------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ---HHHHHH----hcc------------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 111111 000 01111224688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.60 Aligned_cols=258 Identities=26% Similarity=0.398 Sum_probs=206.6
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||+||+|.. .++..|++|++.... ....+++.+|+++|+.++|+||+++++.+.+++..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 4799999999999999999995 468899999986432 33567899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.++++.... ...+++..++.++.|++.||+|||+.+ |+|||||++||++++++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999964322 235899999999999999999999887 9999999999999999999999999998665432
Q ss_pred cc--cccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1127 SR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1127 ~~--~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.. .......|+..|++||++... .++.++|||||||++|||++|+.||+..... ..+..+... .
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~--~~~~~~~~~----~------- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPM--KVLMLTLQN----D------- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChh--hhHHHHhcC----C-------
Confidence 22 123345689999999998877 7899999999999999999999999754321 112222111 0
Q ss_pred cCCCCCCC-ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1204 DPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~-~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...+.... .......+.+++.+||+.||++||++.||++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 224 PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 00111111 11334678999999999999999999999763
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.24 Aligned_cols=252 Identities=25% Similarity=0.365 Sum_probs=209.0
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|++|.||+|... +++.|+||++..... ...+++.+|++++.+++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 47899999999999999999966 589999999875443 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
+++++|.+++... ..+++..+++++.|+++||+|||+ .+ ++||||+++||+|+.++.++|+|||++......
T Consensus 81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 9999999999532 468999999999999999999998 77 999999999999999999999999999866432
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
.. ......++..|++||++.+..++.++|||+||+++|||++|+.||...+......+..+.... ..
T Consensus 154 ~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~------ 220 (264)
T cd06623 154 LD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDG-----PP------ 220 (264)
T ss_pred CC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcC-----CC------
Confidence 22 122456889999999999999999999999999999999999999765432222333332210 00
Q ss_pred CCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1206 SLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~e-e~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...... ....+.+++.+||+.+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 ---PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred ---CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 011122 45689999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=331.15 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=205.5
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.+|++.+.||.|+||.||+|+. .+|+.|+||.+........+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 4699999999999999999984 578999999997655556678899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+++|.+++.. ..+++.++++++.|+++||+|||+.+ |+|||||++|||++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 99 AGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred CCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 99999998842 35899999999999999999999887 99999999999999999999999999886543221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......|+..|++||.+.+..++.++|||||||++|||++|+.||...+... .+..+ .... ...
T Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~--~~~~~----~~~~--~~~------ 234 (296)
T cd06655 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR--ALYLI----ATNG--TPE------ 234 (296)
T ss_pred --cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH----HhcC--Ccc------
Confidence 1233568899999999998889999999999999999999999997643211 11111 0000 000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..........+.+++.+||..||++||++.+|++.
T Consensus 235 -~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~ 269 (296)
T cd06655 235 -LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH 269 (296)
T ss_pred -cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence 01112334578899999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=351.90 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=205.7
Q ss_pred HHHHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeeccc--------------chhhHHHHHHHHHHhhcccccc
Q 000659 963 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD--------------QQGGREFLAEVEMLSRLHHRNL 1027 (1368)
Q Consensus 963 ELe~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d--------------~~~~keFlrEIeILsrLrHPNI 1027 (1368)
+=.+..++|++.+.||+|.||.|-+|+ ..+++.||||++.+.. ....+++++||.||++|+|+||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 334566889999999999999999999 4579999999995321 1123578999999999999999
Q ss_pred eeeeeeeee--ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee
Q 000659 1028 VKLIGICIE--EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1028 VrLlG~~~d--~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL 1105 (1368)
|+|+++..+ .+.+|||+|||..|.+...= .....|++.+.++|+.+++.||+|||.+| ||||||||+|+||
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl 243 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLL 243 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEE
Confidence 999999876 57889999999998875543 12223999999999999999999999998 9999999999999
Q ss_pred cCCCCccccccccccccccc---ccccccccccccccccCcchhccCC----CCcccceeeHHHHHHHHHhCCCCCCCCC
Q 000659 1106 EHDFTPKVSDFGLARSAMDE---ESRHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVILELLSGRKPVDMTQ 1178 (1368)
Q Consensus 1106 D~ng~VKLsDFGLArll~~~---~~~~~st~v~GT~gYmAPEvL~~~~----~T~KSDVWSLGVILyELLTGr~PFd~s~ 1178 (1368)
+++|++||+|||.+..+..+ +......+..||+.|||||...++. .+.+.||||+||+||.|+.|+.||-...
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 99999999999998765221 1222233467999999999887633 3578899999999999999999996432
Q ss_pred CCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1179 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1179 ~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
..+. ..+|++..+.-....++...+.+|+.++|..||++|.++.+|....+.
T Consensus 324 ------~~~l----------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwv 375 (576)
T KOG0585|consen 324 ------ELEL----------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWV 375 (576)
T ss_pred ------HHHH----------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheeccee
Confidence 1111 222333333222222456788999999999999999999999887764
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=322.37 Aligned_cols=247 Identities=31% Similarity=0.488 Sum_probs=198.9
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
++|++.+.||+|+||.||++.. +++.|++|+++.. ...+.|.+|+.++++++|+||+++++++..+ ..++||||+.
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588999999999999999975 4788999998643 2346789999999999999999999998764 5799999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.+++.... ...+++.++++++.|++.||.|||+.+ ++|||||++|||++.++.+||+|||+++.....
T Consensus 82 ~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 82 KGNLVNFLRTRG--RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999996432 235889999999999999999999887 999999999999999999999999998754321
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......+..|++||++.++.++.++|||||||++|||++ |+.||...... .+.... .. ..
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~----~~----------~~ 214 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLK---EVKECV----EK----------GY 214 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHH---HHHHHH----hC----------CC
Confidence 112234578999999998899999999999999999998 99998653221 111111 10 01
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
...........+.+++.+||+.+|++||++++|++.|++
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 111122345678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=323.59 Aligned_cols=255 Identities=25% Similarity=0.407 Sum_probs=200.3
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccc----------hhhHHHHHHHHHHhhcccccceeeeeeeeecc
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ----------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~----------~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~ 1038 (1368)
+|.+.+.||+|+||.||+|.. .+|+.||||.++.... ...+.+.+|++++++++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 577889999999999999984 4689999998853211 12346788999999999999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGL 1118 (1368)
..++||||+.+|+|.+++++. ..+++..+..++.||+.||.|||+.+ ++|||||++||+++.++.+||+|||+
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~ 154 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGI 154 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccc
Confidence 999999999999999999643 46899999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcchhccCC--CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~~~--~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
++...............|+..|++||++.... ++.++||||||+++|||++|+.||..... ...+.+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~--~~~~~~~~----~-- 226 (272)
T cd06629 155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA--IAAMFKLG----N-- 226 (272)
T ss_pred cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch--HHHHHHhh----c--
Confidence 98654322222223456889999999987654 88999999999999999999999964321 11111110 0
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+. ..........+.+++.+||+.+|++||++.||++.
T Consensus 227 ~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 227 KRSAPPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cccCCcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 00011111 11112345678999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=312.01 Aligned_cols=252 Identities=26% Similarity=0.392 Sum_probs=206.6
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~LVm 1044 (1368)
+|++.+.||+|++|.||+|... +++.|++|+++.... ...+.+.+|++++++++|+||+++++++.+. +..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4788899999999999999966 789999999875432 4567899999999999999999999999988 8899999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+++|.+++... ..+++.+++.++.|++++|+|||+.+ ++||||+++||+++.++.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 153 (260)
T cd06606 81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGD 153 (260)
T ss_pred EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence 999999999999643 26899999999999999999999887 99999999999999999999999999987654
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
...........++..|++||++.....+.++||||||++||+|++|+.||+.... .....|. +.+
T Consensus 154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~------------~~~ 218 (260)
T cd06606 154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYK------------IGS 218 (260)
T ss_pred ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHh------------ccc
Confidence 3321113345688999999999988899999999999999999999999976541 1111110 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+.......+.+++.+|++.+|++||++.|+++.
T Consensus 219 ~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 219 SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 111112233345789999999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=323.15 Aligned_cols=251 Identities=25% Similarity=0.375 Sum_probs=194.7
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeeeeeeee--ccce
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQAR 1040 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~ 1040 (1368)
.+|+..+.||+|+||.||+|.. .+++.|++|+++... ....+.+.+|+.++++++|+||+++++++.+ +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 4789999999999999999985 468999999986321 2234568899999999999999999998865 3567
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
+++|||+.+++|.+++.. ...+++..++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+++
T Consensus 82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~ 154 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (266)
T ss_pred EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence 899999999999999853 235889999999999999999999887 9999999999999999999999999997
Q ss_pred ccccccc-ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1121 SAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ll~~~~~-~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
....... ........++..|+|||++.+..++.++|||||||++|||++|+.||...... ... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~-----~~~-~~~~~~---- 224 (266)
T cd06651 155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAM-----AAI-FKIATQ---- 224 (266)
T ss_pred ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchH-----HHH-HHHhcC----
Confidence 5532111 11112345889999999999889999999999999999999999999643211 111 000000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.....++......+.+++ +||..+|++||+++||++.
T Consensus 225 ------~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 225 ------PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred ------CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 001112222334455566 7888999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=328.99 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=205.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||+||++... +|+.||+|++.... ....++|.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 46788899999999999999954 68899999886532 34467899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++|+|.+++.. ...+.+..+.+++.+++.+|.|||+.. +|+|||||++|||+++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 85 MDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS- 157 (284)
T ss_pred CCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh-
Confidence 999999998853 235899999999999999999999742 3999999999999999999999999998754221
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCc-----chhHHHhhhhhcccccccce
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-----QENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~-----~~nLv~Wa~plls~~e~L~e 1201 (1368)
.....+|+..|++||++.+..++.++|||||||++|||++|+.||+...... ...+.++........
T Consensus 158 ---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd06620 158 ---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP----- 229 (284)
T ss_pred ---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc-----
Confidence 1224568999999999988899999999999999999999999998654321 111222222221110
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
...+ ...+....+.+++.+||+.||++||++.|++++..
T Consensus 230 --~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 230 --PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred --CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 01123457899999999999999999999988754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=346.88 Aligned_cols=250 Identities=22% Similarity=0.358 Sum_probs=211.8
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
...+|++.+.||+|.||+|-+|+ ...|+.||||.+++.. ++..-.+.+||+||+.|+|+||+.++++|+..+.+.|
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 34578999999999999999999 5789999999997643 3444467899999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||..+|.|+||+. +.+.|++.+...|+.||..|+.|||.++ |+|||||.+|||||+|+++||+||||+.++
T Consensus 131 vMEYaS~GeLYDYiS----er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly 203 (668)
T KOG0611|consen 131 VMEYASGGELYDYIS----ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLY 203 (668)
T ss_pred EEEecCCccHHHHHH----HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhh
Confidence 999999999999995 3457999999999999999999999887 999999999999999999999999999877
Q ss_pred cccccccccccccccccccCcchhccCCCC-cccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T-~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.+ ..+.+++||.+.|.+||++.+..|. ..+|-|||||+||.|+.|..|||..+ ..+++..+. ++.+.+
T Consensus 204 ~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs-----~GaYrE 272 (668)
T KOG0611|consen 204 AD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQIS-----RGAYRE 272 (668)
T ss_pred cc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhh-----cccccC
Confidence 43 3456778999999999999988875 78999999999999999999998753 334444322 111111
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.+......-||++||..+|++|.|+.+|....+
T Consensus 273 -----------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW 305 (668)
T KOG0611|consen 273 -----------PETPSDASGLIRWMLMVNPERRATIEDIASHWW 305 (668)
T ss_pred -----------CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence 122334667999999999999999999988876
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=321.31 Aligned_cols=251 Identities=23% Similarity=0.349 Sum_probs=197.0
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-----chhhHHHHHHHHHHhhcccccceeeeeeeeec--cce
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 1040 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-----~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~ 1040 (1368)
.+|++.++||+|+||.||+|.. ++|+.|+||+++... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5799999999999999999995 468999999885321 22345788999999999999999999988663 467
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+.+|+|.+++... ..+++..+++++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~ 154 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASK 154 (265)
T ss_pred EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccc
Confidence 8999999999999998532 34788999999999999999999887 9999999999999999999999999998
Q ss_pred ccccccc-ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1121 SAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ll~~~~~-~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
....... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+. . ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~---~-~~~----- 223 (265)
T cd06652 155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM--AAIF---K-IAT----- 223 (265)
T ss_pred ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH--HHHH---H-Hhc-----
Confidence 6532111 11123356899999999998888999999999999999999999999643111 1110 0 000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.......+......+.+++.+|+. +|++||+++||++.
T Consensus 224 -----~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 224 -----QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred -----CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 000112233344678889999985 89999999999764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=340.59 Aligned_cols=263 Identities=22% Similarity=0.293 Sum_probs=198.7
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec------
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------ 1037 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~------ 1037 (1368)
..++|++.+.||+|+||.||++.. ..++.||||+++.. +....+++.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999995 46889999999643 334456788999999999999999999987543
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
...|+||||+++ +|.+++. ..+++.+++.++.|+++||+|||+++ |+|||||++||||+.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 356999999964 6777663 24788999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhh-------
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR------- 1190 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~------- 1190 (1368)
+++..... .......||..|+|||++.+..++.++|||||||+||||++|+.||...+..+. +...+.
T Consensus 172 ~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~ 246 (364)
T cd07875 172 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP 246 (364)
T ss_pred CccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence 99865321 122345689999999999999999999999999999999999999975432111 110000
Q ss_pred -----------hhccccccc-----ceeecCCC---CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1191 -----------PLLTSREGL-----ERIIDPSL---GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1191 -----------plls~~e~L-----~eIvDp~L---~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
......... .++..... ..........++.+|+.+||+.||++|||+.|+++.-
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp 319 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP 319 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence 000000000 00000000 0011112235788999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=360.86 Aligned_cols=244 Identities=24% Similarity=0.351 Sum_probs=206.2
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccce
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~ 1040 (1368)
...++|.+.++||+|.||+|+++.++ +++.+|||++++.. .+..+..+.|.+|+.... ||.|+.|+..+..++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34578999999999999999999965 68899999998753 445567788999988875 99999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
|+||||+.||++..+.+ ...+++..+.-++..|+.||.|||+++ ||+||||.+|||||.+|.+||+||||++
T Consensus 445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999555543 346899999999999999999999998 9999999999999999999999999999
Q ss_pred cccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
.... ......+.|||+.|||||++.+..|+..+|.|+|||+|||||.|+.||...++++ +.+
T Consensus 517 e~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee---~Fd------------- 578 (694)
T KOG0694|consen 517 EGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE---VFD------------- 578 (694)
T ss_pred ccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH-------------
Confidence 6643 2234577999999999999999999999999999999999999999997654321 111
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
.|+.. .-.++.....+.++|+++++..+|++|.-+
T Consensus 579 sI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 579 SIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 11111 124566777899999999999999999987
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=325.74 Aligned_cols=266 Identities=22% Similarity=0.338 Sum_probs=201.4
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 47899999999999999999975 589999999864322 234578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+++++|.++... ...++|.+++.++.||++||+|||+.+ |+||||+++||++++++.+||+|||++......
T Consensus 81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07846 81 FVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 153 (286)
T ss_pred cCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence 9999999887642 234899999999999999999999887 999999999999999999999999999865432
Q ss_pred ccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhcccc-------
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLLTSR------- 1196 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~Wa~plls~~------- 1196 (1368)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.+|........ ..+..+...+....
T Consensus 154 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 154 G--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred c--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 2 22233558899999998875 4578899999999999999999999865432111 11111111111000
Q ss_pred cccceeecCCCCC-----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSLGN-----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L~~-----~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.....+..+.... .........+.+++.+||+.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000000 0011234678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.80 Aligned_cols=264 Identities=25% Similarity=0.328 Sum_probs=207.0
Q ss_pred CCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccch--hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~--~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.+|...++||+|.||.||+|+ .++|+.||||+++..+.. .....+|||+.|+.++|+||+.|++++-..+.+-||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 467788899999999999999 668999999999754332 23457899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||+ -+|+..++. +...|.-.++..++.++++||+|||++. |+||||||.|+||+.+|.+||+|||||+.+...
T Consensus 82 fm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p 154 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSP 154 (318)
T ss_pred ecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence 994 589988853 4557899999999999999999999998 999999999999999999999999999988653
Q ss_pred ccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc----ccccc
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS----REGLE 1200 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~----~e~L~ 1200 (1368)
+.. .+..+-|.+|+|||++.+ +.|+...||||.|||+.||+-|..-|....+-+ .+..-++.+-+- .-.+.
T Consensus 155 ~~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDid--QL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 155 NRI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID--QLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred Ccc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHH--HHHHHHHHcCCCCcccCcccc
Confidence 332 233467999999998875 579999999999999999999987776544333 232222222111 11111
Q ss_pred eeec--------CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1201 RIID--------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1201 eIvD--------p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+-| .......-..+..+.++|+..+|..||.+|.++.|++++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 1111 111111223445677999999999999999999999765
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=338.82 Aligned_cols=192 Identities=24% Similarity=0.355 Sum_probs=164.6
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
...+|++.+.||+|+||.||+|... +++.||+|+.... .+..|+.++++++|+||+++++++.+.+..++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 3467999999999999999999965 5678999975432 23569999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+ .|+|.+++.. ....++|.++++|+.||+.||.|||+++ |||||||++||||+.++.+||+|||+++.....
T Consensus 138 ~~-~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 138 HY-SSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred cc-CCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 99 5688888853 2346899999999999999999999887 999999999999999999999999999754221
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1174 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PF 1174 (1368)
.......||..|+|||++.+..++.++|||||||+||||+++..++
T Consensus 211 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 ---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred ---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1123456999999999999999999999999999999999855444
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=325.55 Aligned_cols=253 Identities=26% Similarity=0.393 Sum_probs=204.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||+|... +++.|++|+++.......++|.+|++++++++|+||+++++++.+++..|+||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56888999999999999999964 68899999998666666778999999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++++|.+++... ...+++.++++++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++........
T Consensus 85 ~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 85 DGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred CCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999998532 235899999999999999999999888 99999999999999999999999999876533211
Q ss_pred ccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1128 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
......|+..|++||++. ...++.++|||||||++|||++|+.||..... ...+..+.. .. .
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~----~~--~--- 225 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP--MRVLLKILK----SE--P--- 225 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH--HHHHHHHhc----CC--C---
Confidence 123356899999999875 34567899999999999999999999965421 111111111 00 0
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+.+ .........+.+++.+||+.+|++||++.++++.-
T Consensus 226 --~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 263 (280)
T cd06611 226 --PTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHP 263 (280)
T ss_pred --CCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcCh
Confidence 000 11122345788999999999999999999998763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=316.41 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=202.0
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|+..+.||+|+||.||++.. .+++.++||++... .....+.+.+|+++|++++|+||+++++++..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588999999999999999985 46889999998643 334466889999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Cccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsDFGLArll~~~ 1125 (1368)
+++++|.+++.... ...+++..+++++.|++++|+|||+++ |+|||||++||||++++ .+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (256)
T cd08220 81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK 155 (256)
T ss_pred CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence 99999999996432 345899999999999999999999887 99999999999998654 5799999999866432
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......|+..|+|||++....++.++||||||+++|+|++|+.+|+..+.. ....+. ... ..
T Consensus 156 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~---~~~~~~---~~~--~~------ 218 (256)
T cd08220 156 S---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLP---ALVLKI---MSG--TF------ 218 (256)
T ss_pred c---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchH---HHHHHH---Hhc--CC------
Confidence 2 122356889999999999888999999999999999999999999654321 111111 110 00
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..........+.+++.+||+.+|++||++.|+++.
T Consensus 219 ---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 219 ---APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred ---CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 01122345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=323.49 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=205.0
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..|+..+.||+|+||.||+|... +++.||||+++... ....+++.+|++++++++|+||+++++++.+++..++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999964 68899999987432 34456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++|+|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+++|||++.+++++|+|||++.......
T Consensus 84 ~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 155 (277)
T cd06640 84 LGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ 155 (277)
T ss_pred CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc
Confidence 999999999852 35889999999999999999999887 9999999999999999999999999997654322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......++..|+|||++.+..++.++|||||||++|||++|+.||....... ... .+...
T Consensus 156 --~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~---~~~--------------~~~~~ 216 (277)
T cd06640 156 --IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR---VLF--------------LIPKN 216 (277)
T ss_pred --cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh---Hhh--------------hhhcC
Confidence 12233468889999999998889999999999999999999999986432111 000 00011
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
............+.+++.+||+.+|++||++.++++.-.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06640 217 NPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255 (277)
T ss_pred CCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence 112233345678999999999999999999999987744
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.88 Aligned_cols=262 Identities=25% Similarity=0.333 Sum_probs=207.1
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~LVm 1044 (1368)
++|+..+.||.|++|.||++... +++.||+|++.... ....+++.+|++++++++|+||++++++|.+. +..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 47899999999999999999964 68899999987432 24567799999999999999999999998653 4689999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++++|.+++.........+++..+++|+.||+.||+|||+.+ ++||||+++||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999988654444556899999999999999999999887 99999999999999999999999999875532
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCC--CcchhHHHhhhhhccccccccee
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP--PGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~--~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.. .....++..|++||.+.+..++.++|||+|||++|||++|+.||+.... .....+..|..... . ..+
T Consensus 158 ~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~---~~~ 228 (287)
T cd06621 158 SL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP--N---PEL 228 (287)
T ss_pred cc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC--c---hhh
Confidence 21 1234578899999999999999999999999999999999999976532 11122333322110 0 000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.... .........+.+++.+||+.+|.+||++.||++.-+
T Consensus 229 -~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~ 268 (287)
T cd06621 229 -KDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268 (287)
T ss_pred -ccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcc
Confidence 0011 011123567899999999999999999999988543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=317.02 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=202.0
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|... +++.|++|+++.... ...+++.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999854 789999999875443 3667899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.++++. ...+++..+++|+.|+++||+|||+.+ |+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~ 153 (264)
T cd06626 81 CSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT 153 (264)
T ss_pred CCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence 999999999853 235889999999999999999999887 9999999999999999999999999998664322
Q ss_pred cccc--cccccccccccCcchhccCC---CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1127 SRHI--STRVMGTFGYVAPEYAMTGH---LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1127 ~~~~--st~v~GT~gYmAPEvL~~~~---~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.... .....++..|++||++.... ++.++||||||+++|||++|+.||...... .....+.. . ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~--~~~~~~~~---~--~~--- 223 (264)
T cd06626 154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--FQIMFHVG---A--GH--- 223 (264)
T ss_pred CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch--HHHHHHHh---c--CC---
Confidence 2111 11346788999999988766 889999999999999999999999653211 11111110 0 00
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
...+. ........+.+++.+||+.+|++||++.|+++
T Consensus 224 --~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 --KPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00010 01123466789999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=330.23 Aligned_cols=199 Identities=24% Similarity=0.333 Sum_probs=161.6
Q ss_pred eeEEeecCcEEEEEEEec---CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeee--ccceEEEEeecC
Q 000659 974 SRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIP 1048 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlk---dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~~LVmEYm~ 1048 (1368)
.++||+|+||.||+|+.. +++.||+|+++... ....+.+|+++|++++|+||+++++++.+ +...|+||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999854 46789999986432 23567899999999999999999999854 456789999995
Q ss_pred CCChhhcccccc-----cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee----cCCCCccccccccc
Q 000659 1049 NGSVESHLHGVD-----KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1049 gGSL~d~L~~~~-----~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL----D~ng~VKLsDFGLA 1119 (1368)
++|.+++.... .....+++..+..|+.||+.||+|||+.+ |+|||||++|||| +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58877764221 11235889999999999999999999888 9999999999999 45678999999999
Q ss_pred cccccccc-ccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCC
Q 000659 1120 RSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1178 (1368)
Q Consensus 1120 rll~~~~~-~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~ 1178 (1368)
+....... ........||..|+|||++.+ ..++.++|||||||++|||++|+.||...+
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 86643221 112234678999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=356.00 Aligned_cols=263 Identities=21% Similarity=0.258 Sum_probs=197.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..+|.+.+.||+|+||.||+|+.. +++.||||.... ..+.+|+++|++|+|+|||++++++..++..+|||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457999999999999999999965 578899996432 3467899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+ .++|.+++... ...++|.++++|+.||++||+|||+++ |||||||++||||+.++.+||+|||+++......
T Consensus 242 ~-~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 242 Y-RSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 9 57888888532 236999999999999999999999887 9999999999999999999999999998664332
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCC-CCc----chhHHHhhhhhcccccccce
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ-PPG----QENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~-~~~----~~nLv~Wa~plls~~e~L~e 1201 (1368)
........+||..|||||++.+..++.++|||||||+||||++|..++-... ... ...+...++........+..
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~ 394 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ 394 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence 2223334679999999999999999999999999999999999876543221 111 11111111110000000000
Q ss_pred -----ee-------cCCCCCCCC-------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1202 -----II-------DPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 -----Iv-------Dp~L~~~~~-------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+. ......... ......+.+|+.+||+.||++||++.|+++.
T Consensus 395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 00 000000000 0112368889999999999999999999875
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=318.23 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=202.1
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc------chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d------~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
+|+..++||+|+||.||+|.. .+++.|++|+++... ....+++.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999984 678999999986422 1234678999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Cccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 1121 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsDFGLArl 1121 (1368)
||||+.+++|.++|.+ ...+++..+++++.|++.||.|||+.+ |+|||||++||+++.++ .+||+|||++..
T Consensus 81 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~ 153 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAAR 153 (268)
T ss_pred EEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence 9999999999999853 236889999999999999999999887 99999999999998776 599999999876
Q ss_pred ccccccc--cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1122 AMDEESR--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1122 l~~~~~~--~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
....... .......|+..|++||++.+..++.++||||||+++|||++|+.||........... + .....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~--~-~~~~~----- 225 (268)
T cd06630 154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL--I-FKIAS----- 225 (268)
T ss_pred cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH--H-HHHhc-----
Confidence 6432111 112335688999999999888899999999999999999999999965432211111 1 00000
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.......+.....++.+++.+||+.+|++||++.|+++
T Consensus 226 -----~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 226 -----ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred -----cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 00111223334567899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=317.76 Aligned_cols=250 Identities=22% Similarity=0.321 Sum_probs=203.4
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||++.. .+|+.|++|+++.. .....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999984 47899999998642 334456889999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+.+++|.+++.... ...+++.++++|+.|++.||+|||+.+ ++|+||+++||||+.++.++|+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~ 155 (256)
T cd08218 81 CEGGDLYKKINAQR--GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV 155 (256)
T ss_pred CCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence 99999999985322 235789999999999999999999887 9999999999999999999999999998654322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
. ......|+..|++||++.++.++.++|||||||++|||++|+.||...+. .+.....+... .
T Consensus 156 ~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~------~~~~~~~~~~~--~------- 218 (256)
T cd08218 156 E--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM------KNLVLKIIRGS--Y------- 218 (256)
T ss_pred h--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH------HHHHHHHhcCC--C-------
Confidence 1 12234588899999999988999999999999999999999999864321 11111111110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........++.+++.+||+.+|++||+|.||++.
T Consensus 219 --~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 219 --PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred --CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 11222345678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=336.65 Aligned_cols=263 Identities=24% Similarity=0.310 Sum_probs=198.3
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeec----
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE---- 1037 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~---- 1037 (1368)
....++|++.+.||+|+||.||+|.. .+++.||||+++... ....+++.+|+++|++++|+||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIE 90 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccc
Confidence 34568899999999999999999985 578899999986432 23345688999999999999999999987543
Q ss_pred --cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccc
Q 000659 1038 --QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 1115 (1368)
Q Consensus 1038 --~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsD 1115 (1368)
...|+++|++ +++|.+++. ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|
T Consensus 91 ~~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~D 161 (343)
T cd07878 91 NFNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILD 161 (343)
T ss_pred ccCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcC
Confidence 3568999998 889988874 235899999999999999999999888 99999999999999999999999
Q ss_pred ccccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcc
Q 000659 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194 (1368)
Q Consensus 1116 FGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls 1194 (1368)
||+++..... .....||..|+|||++.+ ..++.++|||||||+||||++|+.||...+.. ..+..+......
T Consensus 162 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~ 234 (343)
T cd07878 162 FGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGT 234 (343)
T ss_pred CccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCC
Confidence 9999865321 233568999999999876 57889999999999999999999999654321 111111110000
Q ss_pred c---------ccccceeec-------CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1195 S---------REGLERIID-------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1195 ~---------~e~L~eIvD-------p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
. .+...+.+. ..+.. ........+.+|+.+||+.||++|+++.|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp 299 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAHP 299 (343)
T ss_pred CCHHHHHhcchhhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0 000000000 00000 0011223578999999999999999999998753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=309.76 Aligned_cols=250 Identities=27% Similarity=0.459 Sum_probs=205.1
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
+|+..+.||+|+||.||++... +++.|++|+++.......+++.+|++++++++|+||+++++++..++..++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4788999999999999999965 788999999976555566789999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+++|.+++.... ..+++.++..++.|++.+|+|||+.+ ++||||+++||++++++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~- 153 (253)
T cd05122 81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA- 153 (253)
T ss_pred CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence 999999985432 46899999999999999999999887 99999999999999999999999999986644321
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
.....|+..|++||++....++.++||||||++||||++|+.||...... ..+... .. .....+.+
T Consensus 154 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~-~~-----~~~~~~~~---- 219 (253)
T cd05122 154 --RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM--KALFKI-AT-----NGPPGLRN---- 219 (253)
T ss_pred --ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH--HHHHHH-Hh-----cCCCCcCc----
Confidence 23456889999999999888999999999999999999999999654211 111111 00 00111100
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.......+.+++.+||+.||++||++.|+++.
T Consensus 220 ---~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 220 ---PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred ---ccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 11124678999999999999999999999763
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=326.29 Aligned_cols=240 Identities=24% Similarity=0.454 Sum_probs=190.6
Q ss_pred eEEeecCcEEEEEEEecC--------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 975 RILGEGGFGLVYSGVLDD--------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd--------Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+.||+|+||.||+|.... ...|++|++........++|.+|+.++++++|+||+++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998532 234888888665555567889999999999999999999999998999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC--------cccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT--------PKVSDFGL 1118 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~--------VKLsDFGL 1118 (1368)
+.+|+|.++++.. ...+++..+++++.||+.||+|||+.+ |+|||||++|||++.++. +|++|||+
T Consensus 81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~ 154 (258)
T cd05078 81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI 154 (258)
T ss_pred CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccc
Confidence 9999999999643 235899999999999999999999887 999999999999987765 58999998
Q ss_pred cccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCC-CCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr-~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+..... .....++..|+|||++.+ ..++.++|||||||++|||++|. .||...... ..... ....
T Consensus 155 ~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~---~~~~~----~~~~ 221 (258)
T cd05078 155 SITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ---KKLQF----YEDR 221 (258)
T ss_pred ccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHH---HHHHH----HHcc
Confidence 865432 123457889999999876 45899999999999999999985 555432211 11111 0000
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..++.....++.+++.+||+.+|++||+++|+++.|+
T Consensus 222 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 222 ------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1122233467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=326.94 Aligned_cols=268 Identities=23% Similarity=0.290 Sum_probs=200.5
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||.||+|..+ +++.||+|.++... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 57999999999999999999864 68899999986432 23345678999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. ++|.+++... ...+++..++.++.||++||+|||+.+ |+|||||++||||+.++.+||+|||+++......
T Consensus 86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 96 6898888532 235889999999999999999999887 9999999999999999999999999997543221
Q ss_pred cccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HHHhhh-------hhccccc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWAR-------PLLTSRE 1197 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv~Wa~-------plls~~e 1197 (1368)
.......++..|++||++.+ ..++.++|||||||+||||++|+.||...+..+... ...... ..+...+
T Consensus 159 --~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 --KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred --CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 11223457889999998865 457889999999999999999999997543221110 000000 0000000
Q ss_pred ccceeecCCCCC----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1198 GLERIIDPSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1198 ~L~eIvDp~L~~----~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.......+.... .........+.+|+.+||+.||.+|+|+.|+++.-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~ 288 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPY 288 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 000000000000 011123456889999999999999999999987533
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=323.03 Aligned_cols=255 Identities=24% Similarity=0.409 Sum_probs=202.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||.||++... +|+.||+|.++.. .....+++.+|++++++++|+||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 36888999999999999999965 7899999998643 333456789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhcc-CCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~-gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
+++++|.++++... ....+++..+++++.|++.||.|||+. + |+|||||++|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 81 MDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS 156 (286)
T ss_pred cCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence 99999999986432 133689999999999999999999964 5 999999999999999999999999998765321
Q ss_pred ccccccccccccccccCcchhccC------CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~------~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
......|+..|++||++.+. .++.++|||||||+||||++|+.||...... ....-..
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~--------- 220 (286)
T cd06622 157 ----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA---NIFAQLS--------- 220 (286)
T ss_pred ----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh---hHHHHHH---------
Confidence 22334588899999988544 3588999999999999999999999653211 1111111
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.+.+.. ......+...++.+++.+||+.+|++||++.++++.-+
T Consensus 221 -~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~ 264 (286)
T cd06622 221 -AIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPW 264 (286)
T ss_pred -HHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChh
Confidence 011100 11122234567889999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=321.40 Aligned_cols=263 Identities=23% Similarity=0.302 Sum_probs=202.2
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|.. .+|+.|+||++.... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999995 478999999987543 33456799999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+ +++|.+++.... ..+++.++++++.||+++|+|||+.+ |+|+|||++||+++.++.++|+|||++.......
T Consensus 81 ~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (286)
T cd07832 81 M-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEE 153 (286)
T ss_pred c-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence 9 999999986432 46899999999999999999999887 9999999999999999999999999998664432
Q ss_pred cccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh-----------cc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL-----------LT 1194 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl-----------ls 1194 (1368)
. .......|+..|+|||++.+. .++.++|||||||++|||++|+.+|....... ...+.... +.
T Consensus 154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 154 P-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred C-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhcc
Confidence 1 122335689999999988654 46899999999999999999988775433211 11111100 00
Q ss_pred cccccceeecCCCC----CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1195 SREGLERIIDPSLG----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1195 ~~e~L~eIvDp~L~----~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+......+...... .....+....+.+++.+||+.+|++||+++++++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000000 00111234788999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=320.17 Aligned_cols=253 Identities=25% Similarity=0.407 Sum_probs=204.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|+..+.||+|+||.||++..+ +++.|++|++.... ....+++.+|++++++++|+||+++++++..++..++|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 46788899999999999999965 68899999986543 34556799999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
+.+++|.+++.... ..+++..+.+++.|++.+|+|||+ .+ ++|||||++||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~ 154 (265)
T cd06605 81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS 154 (265)
T ss_pred cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence 99999999996432 468899999999999999999998 66 999999999999999999999999998765332
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
.. ....++..|++||++.+..++.++||||||+++|+|++|+.||...... .....+.+.......
T Consensus 155 ~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~--------- 220 (265)
T cd06605 155 LA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP--------- 220 (265)
T ss_pred Hh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC---------
Confidence 11 1256889999999999999999999999999999999999999654321 112222222111110
Q ss_pred CCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1206 SLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~e-e~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
. ...... ...++.+++.+||..+|++||++.|+++.
T Consensus 221 -~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 257 (265)
T cd06605 221 -P-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH 257 (265)
T ss_pred -C-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence 0 011111 44678999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=323.81 Aligned_cols=263 Identities=24% Similarity=0.285 Sum_probs=200.1
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccch-----hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQ-----GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~-----~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
+|++.+.||+|+||.||+|... +|+.|+||+++..... ..+.+.+|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4888999999999999999954 6899999999754322 345677899999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+ +|+|.++++... ..+++.++++++.||++||.|||+++ |+|||||++||||+.++.+||+|||+++...
T Consensus 81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 153 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153 (298)
T ss_pred Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence 9999 999999996422 36999999999999999999999888 9999999999999999999999999998664
Q ss_pred ccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcc-------c
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT-------S 1195 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls-------~ 1195 (1368)
.... ......++..|+|||++.+ ..++.++|||||||++|||++|..+|......+ .+......... .
T Consensus 154 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 154 SPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID--QLGKIFEALGTPTEENWPG 229 (298)
T ss_pred CCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH--HHHHHHHHcCCCchhhhhh
Confidence 3221 1123346788999998864 467899999999999999999987776543211 11111100000 0
Q ss_pred ccccceeecCCCCCC-----CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 REGLERIIDPSLGND-----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~-----~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...+........... ........+.+++.+||+.+|++||++.||++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000001111000001 112234678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=328.04 Aligned_cols=264 Identities=20% Similarity=0.255 Sum_probs=188.9
Q ss_pred eeEEeecCcEEEEEEEec---CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeee--ccceEEEEeecC
Q 000659 974 SRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLVYELIP 1048 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlk---dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~~LVmEYm~ 1048 (1368)
.++||+|+||.||+|+.. +++.||+|.++... ....+.+|+++|++++|+||+++++++.. +...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999965 45789999986432 23467899999999999999999999854 556789999996
Q ss_pred CCChhhcccccc-----cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee----cCCCCccccccccc
Q 000659 1049 NGSVESHLHGVD-----KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1049 gGSL~d~L~~~~-----~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL----D~ng~VKLsDFGLA 1119 (1368)
++|.+++.... .....+.+..+++|+.||+.||.|||+.+ |+|||||++|||| +.++++||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 57777764221 12235889999999999999999999887 9999999999999 56678999999999
Q ss_pred ccccccccc-cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-------hhHHHhhh
Q 000659 1120 RSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-------ENLVAWAR 1190 (1368)
Q Consensus 1120 rll~~~~~~-~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-------~nLv~Wa~ 1190 (1368)
+........ .......||..|+|||++.+ ..++.++|||||||+||||++|+.||........ ..+..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS 239 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence 866432211 11234568999999999876 4588999999999999999999999975432211 00111100
Q ss_pred hh----------cccccccceeec---CC------C---CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1191 PL----------LTSREGLERIID---PS------L---GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1191 pl----------ls~~e~L~eIvD---p~------L---~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+ .........+.. .. + ...........+.+|+.+||+.||++|+|+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h 314 (317)
T cd07867 240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD 314 (317)
T ss_pred hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence 00 000000000000 00 0 000011123468889999999999999999999763
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.77 Aligned_cols=236 Identities=28% Similarity=0.367 Sum_probs=198.1
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|+..+.||.|+||+|.+++.+ +|..+|+|++++.+ ....+...+|..+|+.+.||++++|++.|.+.+.+||||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 46888899999999999999954 68899999997543 334455789999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||++||.|..+|++ .+++++...+-++.||+.||+|||..+ |++|||||+|||||++|.+||+|||+|+...+
T Consensus 124 eyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred eccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999964 346899999999999999999999888 99999999999999999999999999997643
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
...++|||+.|+|||++..+.+...+|-|+|||++|||+.|+.||...+... ..++|+.
T Consensus 197 -----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~----------------iY~KI~~ 255 (355)
T KOG0616|consen 197 -----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ----------------IYEKILE 255 (355)
T ss_pred -----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH----------------HHHHHHh
Confidence 2456899999999999999999999999999999999999999997654311 1122222
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCC
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHR 1234 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeR 1234 (1368)
..+ .++.....++.+|+...++.|-.+|
T Consensus 256 ~~v--~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 256 GKV--KFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred Ccc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence 221 2333344567788888888877777
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=321.71 Aligned_cols=265 Identities=23% Similarity=0.325 Sum_probs=197.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
++|++.+.||+|+||.||+|..+ +++.|+||.++.... .....+.+|++++++++|+||+++++++.+++..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67999999999999999999965 689999999864322 2234577899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. ++|.+++.... ..+++..++.++.|++.||.|||+.+ |+|||||++|||++.++++||+|||+++......
T Consensus 85 ~~-~~L~~~~~~~~---~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 85 LD-TDLKQYMDDCG---GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred CC-CCHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 97 58999885432 36889999999999999999999887 9999999999999999999999999987543211
Q ss_pred cccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh-hh--------hhcccc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-AR--------PLLTSR 1196 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W-a~--------plls~~ 1196 (1368)
. ......++..|+|||++.+ ..++.++|||||||++|||++|+.+|.............| .. ......
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1122346889999998865 4588999999999999999999999965432111100000 00 000000
Q ss_pred cccce----ee-cCCCCCCC-ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1197 EGLER----II-DPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1197 e~L~e----Iv-Dp~L~~~~-~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
..... .. ...+.... .......+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00000 00 00000000 0112267789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=350.16 Aligned_cols=249 Identities=25% Similarity=0.358 Sum_probs=208.9
Q ss_pred CCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeec-ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~-~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..|...++||+|.||.||||. .++++.||||++.- ......+++.+|+.+|..++++||.+++|.+..+..++++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346677899999999999999 55789999999964 3455567899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
|.||++.+.|.. ...+++.++.-|+.++..||.|||.++ .+|||||+.||||..+|.+||+|||.+.......
T Consensus 93 ~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~ 165 (467)
T KOG0201|consen 93 CGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTV 165 (467)
T ss_pred hcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechh
Confidence 999999999953 334588888899999999999999887 9999999999999999999999999998775533
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.. ..+.+||+.|||||++....|+.|+||||||++.+||++|..|+...... ..+. ++-+.
T Consensus 166 ~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm----------------rvlf-lIpk~ 226 (467)
T KOG0201|consen 166 KR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM----------------RVLF-LIPKS 226 (467)
T ss_pred hc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc----------------eEEE-eccCC
Confidence 32 26678999999999999889999999999999999999999999654321 1111 12222
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
............|.+++..||+.||+.||++.++++.
T Consensus 227 ~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 227 APPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 2222333556679999999999999999999999864
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=318.77 Aligned_cols=249 Identities=25% Similarity=0.391 Sum_probs=200.7
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcc---cccceeeeeeeeeccceEEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~-d~~~~keFlrEIeILsrLr---HPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.|+..+.||+|+||.||+|.. .+++.|+||+++.. .....+++.+|++++++++ |+||+++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 577888999999999999995 57899999998643 3344567889999999997 999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+++|.++++. ..+++..++.++.|++.||.|||+.+ |+||||+++||++++++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 82 EYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred ecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999853 25899999999999999999999887 99999999999999999999999999986644
Q ss_pred cccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
... ......|+..|+|||++.++ .++.++|||||||++|||++|+.||+..... ....+. . ...
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~---~~~~~~----~------~~~ 218 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF---RAMMLI----P------KSK 218 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh---hhhhcc----c------cCC
Confidence 321 12334688999999988754 4689999999999999999999999654221 111110 0 000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.+.+.. .....++.+++.+||+.||++||++.|+++.-
T Consensus 219 ~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~ 256 (277)
T cd06917 219 PPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKSK 256 (277)
T ss_pred CCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhCh
Confidence 011111 11446789999999999999999999998753
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=321.95 Aligned_cols=263 Identities=21% Similarity=0.287 Sum_probs=196.7
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|+.. +|+.|++|+++.. .....+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888999999999999999964 7899999998643 222345678899999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. ++|.+++... ...+++..++.++.||++||.|||+.+ |+|||||++|||++.++++||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 153 (284)
T cd07839 81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV 153 (284)
T ss_pred CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence 96 5788877532 235899999999999999999999887 9999999999999999999999999998653221
Q ss_pred cccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc--c---cccc
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS--R---EGLE 1200 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~--~---e~L~ 1200 (1368)
.......++..|+|||++.+. .++.++|||||||++|||++|+.|+...... ...+ +.....+.. . ..+.
T Consensus 154 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 154 --RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQL-KRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred --CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH-HHHH-HHHHHHhCCCChHHhHHhh
Confidence 112234578899999988764 4689999999999999999999886433211 1111 100000000 0 0000
Q ss_pred eeecC----CCCC-----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1201 RIIDP----SLGN-----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1201 eIvDp----~L~~-----~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.+. .... ........++.+++.+||+.||.+|||+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000 0000 0111234678899999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=330.67 Aligned_cols=265 Identities=19% Similarity=0.221 Sum_probs=195.8
Q ss_pred eeeEEeec--CcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 973 ASRILGEG--GFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 973 i~klLGeG--gFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
+.++||+| +|++||++.. .+|+.||||+++.. .....+.+.+|+++++.++|+||++++++|.+++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6889999985 57899999999643 2233456778999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++|+|.+++.... ...+++.++++|+.|++.||+|||+.+ |+|||||++||||+.+++++++||+..........
T Consensus 82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~ 156 (327)
T cd08227 82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ 156 (327)
T ss_pred CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence 9999999985422 235899999999999999999999887 99999999999999999999999987654322111
Q ss_pred c-----cccccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc----
Q 000659 1128 R-----HISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR---- 1196 (1368)
Q Consensus 1128 ~-----~~st~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~---- 1196 (1368)
. .......++..|+|||++.+ ..++.++|||||||++|||++|+.||+..... ..............
T Consensus 157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 234 (327)
T cd08227 157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNGTVPCLLDTT 234 (327)
T ss_pred cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcCCcccccccc
Confidence 0 01122356788999999876 45889999999999999999999999753221 11111110000000
Q ss_pred ----ccc-----ceeecCC-----------------CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1197 ----EGL-----ERIIDPS-----------------LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1197 ----e~L-----~eIvDp~-----------------L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+.+ ....+.. ....+.......+.+|+.+||+.||++|||++|+++.-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p 308 (327)
T cd08227 235 TIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308 (327)
T ss_pred chhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcCh
Confidence 000 0000000 00011122345789999999999999999999998753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=327.15 Aligned_cols=253 Identities=25% Similarity=0.316 Sum_probs=201.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc---hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||+|... +++.||||.+..... ...+++.+|++++++++|+||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999965 589999999865332 24567899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+++|.+++... ....+++..++.++.|++.||+|||+.+ |+|||||++||||+.+++++|+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 155 (316)
T cd05574 81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDV 155 (316)
T ss_pred EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence 999999999998632 2346899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccc---------------------------cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCC
Q 000659 1125 EESR---------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMT 1177 (1368)
Q Consensus 1125 ~~~~---------------------------~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s 1177 (1368)
.... .......|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 235 (316)
T cd05574 156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS 235 (316)
T ss_pred cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence 1110 0112346889999999999888999999999999999999999999654
Q ss_pred CCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC----HHHHHH
Q 000659 1178 QPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF----MGEVVQ 1242 (1368)
Q Consensus 1178 ~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT----MsEVLq 1242 (1368)
+.. ..+.. +++....-.........+.+++.+||+.+|++|++ ++|+++
T Consensus 236 ~~~--~~~~~--------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 236 NRD--ETFSN--------------ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred chH--HHHHH--------------HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 321 11111 01111100111114568999999999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=324.74 Aligned_cols=270 Identities=20% Similarity=0.263 Sum_probs=200.0
Q ss_pred CcceeeEEeecCcEEEEEEEec---CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeec--cceE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD---DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARC 1041 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk---dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~ 1041 (1368)
+|++.++||+|+||.||+|... +++.||||+++... ....+.+.+|++++++++|+||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4888999999999999999964 47899999997632 34456788999999999999999999999887 7899
Q ss_pred EEEeecCCCChhhcccccccC-CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC----CCCcccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH----DFTPKVSDF 1116 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~-~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~----ng~VKLsDF 1116 (1368)
+||||+++ +|.+++...... ...+++..++.|+.||+.||.|||+.+ |+|||||++||||+. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999964 677666433222 236899999999999999999999887 999999999999999 999999999
Q ss_pred ccccccccccc-ccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-------hhHHH
Q 000659 1117 GLARSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-------ENLVA 1187 (1368)
Q Consensus 1117 GLArll~~~~~-~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-------~nLv~ 1187 (1368)
|+++....... ........++..|+|||++.+ ..++.++|||||||+||||++|+.+|........ ..+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986643222 112233568899999998776 4578999999999999999999999976543320 01111
Q ss_pred hhhhh----------cccccccceeecCCCCCCCC-----------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1188 WARPL----------LTSREGLERIIDPSLGNDVP-----------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1188 Wa~pl----------ls~~e~L~eIvDp~L~~~~~-----------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
++..+ +..........+......+. .....++.+++.+||+.||++||++.|+++.
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 11000 00000000000000000111 0234578999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=310.57 Aligned_cols=252 Identities=26% Similarity=0.429 Sum_probs=207.2
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||++... +++.|++|++.... ....+++.+|++++++++|+|++++++.+.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5889999999999999999965 68899999987543 35567789999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.+++.........+++.+++.|+.+++.||.|||+.+ ++|+||+++|||++++++++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999754333467999999999999999999999887 9999999999999999999999999998664322
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.......|+..|++||++....++.++||||||+++|+|++|+.||+.... . ......... .
T Consensus 158 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~---~~~~~~~~~--~-------- 219 (258)
T cd08215 158 --DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL---L---ELALKILKG--Q-------- 219 (258)
T ss_pred --ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH---H---HHHHHHhcC--C--------
Confidence 223345688999999999988999999999999999999999999965431 1 111111110 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...........+.+++.+||..+|++||++.|+++.
T Consensus 220 -~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 220 -YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred -CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 011222345678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=314.49 Aligned_cols=250 Identities=23% Similarity=0.361 Sum_probs=205.6
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||++.. .+++.+++|+++.. ......++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 588999999999999999984 47889999998753 234456788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.+++.+.......+++.+++.++.|++.||+|||+.+ ++||||+++||++++++++||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998654433457899999999999999999999887 999999999999999999999999999876443
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
......|+..|++||++.+..++.++|+||||+++|||++|+.||+..+. ..+..... . .
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~-----~---------~ 216 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM---QDLRYKVQ-----R---------G 216 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHh-----c---------C
Confidence 22234588999999999998999999999999999999999999965432 11111110 0 0
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...........++.+++.+||+.+|++||++.|+++.
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 217 KYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 0111222345679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=336.56 Aligned_cols=240 Identities=23% Similarity=0.289 Sum_probs=186.3
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc---ccccceeeeeeeeeccceEEEEeecCC
Q 000659 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL---HHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 977 LGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrL---rHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
||+|+||+||+|... +|+.||||++.... .....++.+|.+++.++ +|+||+.+++++.+.+..|+||||+.+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999954 68999999996432 22234456677777765 699999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.+++.. ...+++.+++.|+.||++||+|||+.+ |+|||||++||||+.++++||+|||+++...... .
T Consensus 81 g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~ 151 (330)
T cd05586 81 GELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--K 151 (330)
T ss_pred ChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--C
Confidence 999998853 345899999999999999999999887 9999999999999999999999999987543221 2
Q ss_pred ccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
.....+||..|+|||++.+. .++.++|||||||+||||++|+.||...+.. .+ ......... .+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~---~~---~~~i~~~~~--------~~~ 217 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQ---QM---YRNIAFGKV--------RFP 217 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHH---HH---HHHHHcCCC--------CCC
Confidence 23346799999999998764 4789999999999999999999999653211 11 111111000 000
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCC----HHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPF----MGEVVQ 1242 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPT----MsEVLq 1242 (1368)
. ......+.+++.+||+.||++|++ +.|+++
T Consensus 218 ~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 K---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred C---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 0 112456789999999999999985 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=347.12 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=212.4
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccc-eEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA-RCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~-~~LV 1043 (1368)
.++|+.+++||+|+||.++..+.+ +++.|++|.+.. ......+...+|+.++++++|||||.+.+.+++++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 367889999999999999998844 678899999854 334444567899999999999999999999999888 8999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|+||+||+|.+.+.+.. ...+.++.+++|+.|++.||.|||+.. |+|||||+.|||++.++.|||+|||+|+...
T Consensus 83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcC
Confidence 99999999999996543 456889999999999999999999776 9999999999999999999999999999886
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
... .....++||+.||+||++.+..|..|+|||||||++|||++-+.+|+..+. ..++.... ..+
T Consensus 158 ~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~ki~---------~~~- 222 (426)
T KOG0589|consen 158 PED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELILKIN---------RGL- 222 (426)
T ss_pred Cch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHHHHh---------hcc-
Confidence 533 244567899999999999999999999999999999999999999976432 22222111 111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..-.+..+..++..++..|++.+|+.||++.+++.+.
T Consensus 223 ----~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 223 ----YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred ----CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 1233445677899999999999999999999999873
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=347.22 Aligned_cols=258 Identities=31% Similarity=0.459 Sum_probs=216.5
Q ss_pred hCCcceeeEEeecCcEEEEEEEec---CCC--EEEEEEeec-ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD---DGT--KVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk---dGr--~VAVKvLk~-~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
.+.+.+.++||+|.||.||+|++. .|+ .||||..|. .+.+..+.|++|..+|++++|+|||+|+|+|.+ .-.|
T Consensus 388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 344556789999999999999954 233 588898876 445567889999999999999999999999986 5679
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
||||.+.-|.|.+||+. ++..|+..+...+++||+.+|+|||+.. +|||||..+||||....-+||+||||+|.
T Consensus 467 ivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred EEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhh
Confidence 99999999999999964 3456889999999999999999999776 99999999999999999999999999998
Q ss_pred ccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1122 l~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
+.++...+.+ +..-...|||||.+.-+.++.++|||-|||++||+|. |.+||..... .+.+
T Consensus 541 ~ed~~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI- 602 (974)
T KOG4257|consen 541 LEDDAYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVI- 602 (974)
T ss_pred ccccchhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceE-
Confidence 8765554433 4456789999999999999999999999999999988 9999975432 1112
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
..++..-+-..+..|...++.|+.+||..||.+||.+.|+...|.+++++
T Consensus 603 ~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qe 652 (974)
T KOG4257|consen 603 GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQE 652 (974)
T ss_pred EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHH
Confidence 22233333456678889999999999999999999999999999988773
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=325.15 Aligned_cols=255 Identities=21% Similarity=0.316 Sum_probs=200.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||++... +++.|+||.++... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 47899999999999999999954 57899999987543 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+++|+|.+++.. ...+.+..+.+++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~ 153 (305)
T cd05609 81 EYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM 153 (305)
T ss_pred ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence 99999999999953 235899999999999999999999887 99999999999999999999999999874211
Q ss_pred cc-------------cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhh
Q 000659 1125 EE-------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191 (1368)
Q Consensus 1125 ~~-------------~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~p 1191 (1368)
.. .........|+..|+|||++....++.++|||||||+||||++|+.||...... ++...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~ 227 (305)
T cd05609 154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ 227 (305)
T ss_pred CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence 00 001112345788999999998889999999999999999999999999643211 11111
Q ss_pred hcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1192 LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1192 lls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..... +..+.. .......+.+++.+||+.+|++||++.++.+.|+
T Consensus 228 ~~~~~-----~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 VISDD-----IEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHhcc-----cCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 11100 000000 0123456899999999999999999766665555
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.86 Aligned_cols=246 Identities=24% Similarity=0.385 Sum_probs=201.1
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
|++.+.||+|+||.||+|.. .+++.||||++.... ....++|.+|++++++++|+||+++++++.+++..++||||+.
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 66788999999999999985 468899999986432 3345678899999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.+++.. ..+++..++.++.|++.+|.|||+.+ |+|+|||++||+++.++.++|+|||++........
T Consensus 86 ~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 86 GGSALDLLEP-----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999999852 35889999999999999999999887 99999999999999999999999999876543221
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
......|+..|++||++.+..++.++|||||||++|||++|+.||..... ....... .. .. .
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~~~~~~~---~~--~~---------~ 218 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP---MKVLFLI---PK--NN---------P 218 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch---HHHHHHH---hc--CC---------C
Confidence 12334688899999999988899999999999999999999999964321 1111110 00 00 0
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..........+.+++.+||+.+|++||++.++++.
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 11222344678899999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=318.84 Aligned_cols=267 Identities=21% Similarity=0.267 Sum_probs=197.9
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++++|.+.+.||+|+||.||+|.. .+|+.|+||+++... ......+.+|++++++++|+||+++++++.+++..|+||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999985 468899999986433 233346789999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+. ++|.+++... ...+.+.++..++.|++.||+|||+.+ |+|||||++||||+.++++||+|||+++....
T Consensus 83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 155 (291)
T cd07870 83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSI 155 (291)
T ss_pred eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence 9995 6777776422 235788899999999999999999887 99999999999999999999999999975432
Q ss_pred cccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc------cc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS------RE 1197 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~------~e 1197 (1368)
.. .......++..|+|||++.+. .++.++|||||||+||||++|+.||+............|....... ..
T Consensus 156 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 156 PS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhh
Confidence 11 112234578999999988754 5788999999999999999999999754322111111111000000 00
Q ss_pred ccceeecCCC----CCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1198 GLERIIDPSL----GNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1198 ~L~eIvDp~L----~~~~-----~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.+.+..+... .... .......+.+++.+|+..||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000 0000 0112457889999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=327.69 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=199.2
Q ss_pred eeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCC
Q 000659 973 ASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 1051 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGS 1051 (1368)
....||+|+||.||++.. .+++.||||+++.......+.+.+|+.++++++|+||+++++.+...+..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 345799999999999985 4688999999876555666779999999999999999999999999999999999999999
Q ss_pred hhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccc
Q 000659 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131 (1368)
Q Consensus 1052 L~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~s 1131 (1368)
|.+++.. ..+++.+++.++.||+.||+|||+.+ |+|||||++||||++++.+||+|||++........ ..
T Consensus 106 L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~ 175 (292)
T cd06658 106 LTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KR 175 (292)
T ss_pred HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cC
Confidence 9998842 24889999999999999999999887 99999999999999999999999999876533221 12
Q ss_pred ccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCC
Q 000659 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1211 (1368)
Q Consensus 1132 t~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~ 1211 (1368)
....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ..+... . ..+...+..
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~--~~~~~~-~----------~~~~~~~~~-- 240 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL--QAMRRI-R----------DNLPPRVKD-- 240 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-H----------hcCCCcccc--
Confidence 3356899999999998888999999999999999999999999653211 111110 0 011111111
Q ss_pred ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1212 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1212 ~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.......+.+++.+||..||++||+++|+++.
T Consensus 241 ~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 241 SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 11234468889999999999999999999875
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.80 Aligned_cols=253 Identities=27% Similarity=0.340 Sum_probs=211.0
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
.++|++++.||+|.||.||.|+. +++-.||+|++.+. ..+..+++.+|++|-+.|+|+||+++++++.++...||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 35689999999999999999994 46788999998542 233456889999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
+||..+|+|+..|... ....+++.....++.|+|.||.|||..+ ||||||||+|+|++.++.+||+|||.+....
T Consensus 101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 9999999999999643 2346888899999999999999999887 9999999999999999999999999997653
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.....+.|||+.|++||+..+...+.++|+|++|++.||++.|..||+..... .... +|.
T Consensus 176 ----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYk-------------rI~ 235 (281)
T KOG0580|consen 176 ----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYK-------------RIR 235 (281)
T ss_pred ----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHH-------------HHH
Confidence 22345689999999999999999999999999999999999999999765411 1111 111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
.- +-.++........+++.+|+..+|.+|....|+++.-+..
T Consensus 236 k~--~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~ 277 (281)
T KOG0580|consen 236 KV--DLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIV 277 (281)
T ss_pred Hc--cccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHH
Confidence 10 1122234456788999999999999999999998876643
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=323.16 Aligned_cols=251 Identities=25% Similarity=0.362 Sum_probs=204.5
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
++|++.+.||+|+||.||++.. .+++.|++|.+........+.+.+|+.++++++|+||+++++++...+..|+||||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 6789999999999999999984 468899999987555555678899999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
++++|.+++.+ ..+++.+++.++.|+++||.|||+.+ |+|||||++||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 99 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 99999999853 24789999999999999999999887 99999999999999999999999999876543221
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
......|+..|++||++....++.++|||||||++|||++|+.||...+.... +..+ .. ....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~----~~---------~~~~ 233 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI----AT---------NGTP 233 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh----hc---------CCCC
Confidence 12334688999999999888899999999999999999999999975432111 0000 00 0000
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
...........+.+++.+||+.+|++||++.|++++-
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~ 270 (293)
T cd06647 234 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP 270 (293)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence 0011122345688999999999999999999998763
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=312.57 Aligned_cols=250 Identities=22% Similarity=0.352 Sum_probs=201.7
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|..+ +|..|++|.+... .....+.+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5889999999999999999965 6889999998643 223456788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC-ccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT-PKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~-VKLsDFGLArll~~~ 1125 (1368)
+.+++|.+++... ....++|..+++++.|++.||+|||+.+ |+|||||++|||+++++. +||+|||++......
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~ 155 (257)
T cd08225 81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS 155 (257)
T ss_pred CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence 9999999998642 2235899999999999999999999887 999999999999998864 699999999866432
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. .......|+..|+|||++....++.++|||||||++|||++|+.||...+ ..++....... ...
T Consensus 156 ~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~------~~~~~~~~~~~--~~~----- 220 (257)
T cd08225 156 M--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN------LHQLVLKICQG--YFA----- 220 (257)
T ss_pred c--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHhcc--cCC-----
Confidence 2 11223458899999999988889999999999999999999999986432 12222211111 010
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+++.+||+.+|++||++.||++.
T Consensus 221 ----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 221 ----PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred ----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 1111234578999999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=321.89 Aligned_cols=245 Identities=26% Similarity=0.362 Sum_probs=200.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|+||.||++... +++.||+|+++... ....+.+.+|+++|++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47899999999999999999954 68999999986432 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+.+++|.+++... ..+++.+++.++.|++.||+|||+.+ |+|||||++||||++++.+||+|||+++....
T Consensus 81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 153 (290)
T cd05580 81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153 (290)
T ss_pred ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence 999999999998532 46899999999999999999999887 99999999999999999999999999986643
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
. ....+|+..|++||.+.+...+.++||||||+++|||++|+.||..... ....... ...
T Consensus 154 ~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~~~~~---~~~--------- 213 (290)
T cd05580 154 R-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP---IQIYEKI---LEG--------- 213 (290)
T ss_pred C-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---hcC---------
Confidence 2 2345689999999999888899999999999999999999999965431 1111110 000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
. ..++......+.+++.+||..+|++|+ +++|+++.
T Consensus 214 -~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~ 254 (290)
T cd05580 214 -K--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH 254 (290)
T ss_pred -C--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence 0 011222346788999999999999998 66666543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=360.04 Aligned_cols=257 Identities=26% Similarity=0.450 Sum_probs=212.7
Q ss_pred ceeeEEeecCcEEEEEEEe-cCCC----EEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 972 DASRILGEGGFGLVYSGVL-DDGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvl-kdGr----~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
..+++||+|+||+||||.+ .+|+ .||||++... ..+..++|++|+.+|.+|+|+||++|+|+|.... ..||++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 3467999999999999994 4455 4788888643 3445678999999999999999999999998765 789999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||+.|+|.||++. ++..+.-+..+.|.+|||+||.|||++. +|||||..+||||..-..+||.|||+++....+
T Consensus 778 ~mP~G~LlDyvr~---hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 778 LMPLGCLLDYVRE---HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred hcccchHHHHHHH---hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999975 3456889999999999999999999887 999999999999999999999999999988665
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
..........-...|||-|.++...|+.++|||||||.+||||| |..|++..... .+.++++
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle 914 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLE 914 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHh
Confidence 54443333444678999999999999999999999999999999 99999764321 1222222
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhh
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
...+-..+..+..++..++.+||..|.+.||+++|+..++.+..++..
T Consensus 915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpq 962 (1177)
T KOG1025|consen 915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQ 962 (1177)
T ss_pred ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcc
Confidence 222234455678889999999999999999999999999987776543
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=367.64 Aligned_cols=264 Identities=23% Similarity=0.304 Sum_probs=206.9
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.++||+|+||.||+|+.. +|+.||||+++.. .....++|.+|++++++++|+||+++++++.+.+..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999954 6899999998642 2233567999999999999999999999999999999999
Q ss_pred eecCCCChhhccccccc-------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1045 ELIPNGSVESHLHGVDK-------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~-------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
||++||+|.++++.... ....+++.++++|+.||++||+|||+.+ |+||||||+||||+.++++||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 1234678889999999999999999887 9999999999999999999999999
Q ss_pred ccccccccccc----------------cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCc
Q 000659 1118 LARSAMDEESR----------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG 1181 (1368)
Q Consensus 1118 LArll~~~~~~----------------~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~ 1181 (1368)
+++........ ......+||..|||||++.+..++.++|||||||+||||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99865211100 01123569999999999999999999999999999999999999996532111
Q ss_pred chhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-CHHHHHHHHHHHHHh
Q 000659 1182 QENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1182 ~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRP-TMsEVLq~Le~I~~e 1250 (1368)
+... ... .++... ....+....+.+++.+|++.||++|+ +++++++.|+...+.
T Consensus 239 ---i~~~--~~i---------~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~ 293 (932)
T PRK13184 239 ---ISYR--DVI---------LSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG 293 (932)
T ss_pred ---hhhh--hhc---------cChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence 1000 000 000000 00112345688999999999999995 677788888877654
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=322.22 Aligned_cols=265 Identities=23% Similarity=0.329 Sum_probs=216.2
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeecc-----ce
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----AR 1040 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-----~~ 1040 (1368)
-.++|++.++||+|||+.||++. +.+++.||+|++.....++.++.++|++..++++|+||+++++++..+. ..
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 35689999999999999999999 7789999999998877788889999999999999999999999986543 48
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
||++.|...|+|.+.+.....++..+++.+.++|+.+|++||++||+.. +.++||||||.|||+.+.+.++|.|||.++
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 9999999999999999877777778999999999999999999999884 679999999999999999999999999987
Q ss_pred ccccccc---c----cccccccccccccCcchhcc---CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhh
Q 000659 1121 SAMDEES---R----HISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1121 ll~~~~~---~----~~st~v~GT~gYmAPEvL~~---~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~ 1190 (1368)
...-.-. . ........|.-|+|||++.- ...++++|||||||+||+||.|..||+.....+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G--------- 248 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG--------- 248 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC---------
Confidence 6532111 0 01122457899999998863 467899999999999999999999997643221
Q ss_pred hhcccccccceee-cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1191 PLLTSREGLERII-DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1191 plls~~e~L~eIv-Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
+.+.-.+ ...+.-.-.....+.+.+++..|++.||.+||++.|++..+..+
T Consensus 249 ------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 249 ------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111 11111111112567899999999999999999999999888765
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=313.67 Aligned_cols=247 Identities=26% Similarity=0.322 Sum_probs=203.1
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
+|++.+.||+|+||.||+|..+ +++.|++|++.... ....+++.+|++++++++|+||+++++++.+.+..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5889999999999999999965 68999999996432 2446789999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+.+++|.+++... ..+++.+++.|+.|+++||.|||+.+ |+|+|||++|||+++++.++|+|||++......
T Consensus 81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 153 (258)
T cd05578 81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153 (258)
T ss_pred CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence 99999999998532 46899999999999999999999887 999999999999999999999999998866432
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
. ......|+..|++||++.+..++.++||||||+++|+|++|+.||....... .++.......
T Consensus 154 ~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~---------- 216 (258)
T cd05578 154 T---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET---------- 216 (258)
T ss_pred c---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc----------
Confidence 2 1233558889999999998889999999999999999999999997654321 1111111110
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH--HHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM--GEVV 1241 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM--sEVL 1241 (1368)
.....+......+.+++.+||+.+|++|+++ +|++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 -ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0111222334788999999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.80 Aligned_cols=265 Identities=22% Similarity=0.289 Sum_probs=198.0
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||+|+.. +|+.|+||+++... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5889999999999999999854 68999999986432 22345788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. ++|.++++... ...+++..+++++.|++.||+|||+.+ ++|||||++||||+.++.+||+|||+++......
T Consensus 81 ~~-~~l~~~~~~~~--~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~ 154 (284)
T cd07860 81 LH-QDLKKFMDASP--LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 154 (284)
T ss_pred cc-cCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence 95 68988885432 346899999999999999999999887 9999999999999999999999999987653321
Q ss_pred cccccccccccccccCcchhccCC-CCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHHhhhhhc-------cc--
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVAWARPLL-------TS-- 1195 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~-~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~Wa~pll-------s~-- 1195 (1368)
.......++..|+|||++.+.. ++.++|||||||++|||+||+.||........ ..+..+..... ..
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 155 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHH
Confidence 1123345788999999876644 68899999999999999999999965432110 01111111000 00
Q ss_pred --ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 --REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 --~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+....+. .........+.+++.+||+.||++||+++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000000 0001123467899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=325.50 Aligned_cols=247 Identities=24% Similarity=0.360 Sum_probs=199.7
Q ss_pred ceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 972 DASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+....||+|+||.||+|... +++.|+||+++.......+.+.+|+.++++++|+||+++++++..++..|+||||++++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 33457999999999999854 68999999997655555677899999999999999999999999999999999999999
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~ 1130 (1368)
+|.+++.. ..+++.+++.++.|++.||+|||+.+ |+|||||++||||+.++.+||+|||++........ .
T Consensus 104 ~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~ 173 (297)
T cd06659 104 ALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--K 173 (297)
T ss_pred CHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--c
Confidence 99988742 35889999999999999999999887 99999999999999999999999999875533211 1
Q ss_pred cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1210 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~ 1210 (1368)
.....|+..|+|||++.+..++.++|||||||+||||++|+.||..... ........... .... .
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~----------~~~~--~ 238 (297)
T cd06659 174 RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQAMKRLRDSP----------PPKL--K 238 (297)
T ss_pred ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHhccC----------CCCc--c
Confidence 2335689999999999988999999999999999999999999964321 11111111000 0000 0
Q ss_pred CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1211 VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1211 ~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
........+.+++.+||+.+|++||++.||++.
T Consensus 239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 NAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 111233568899999999999999999999885
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=354.44 Aligned_cols=252 Identities=29% Similarity=0.445 Sum_probs=208.4
Q ss_pred ceeeEEeecCcEEEEEEEec--CCC--EEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 972 DASRILGEGGFGLVYSGVLD--DGT--KVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlk--dGr--~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
.+.++||+|.||.|++|.|. .|+ .||||+++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....||||+
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 35679999999999999976 344 5899999865443 56799999999999999999999999987 677899999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
++.|+|.+.|+. .....|-...+..++.|||.||.||..++ +|||||..+||||-....|||+||||.|.+..++
T Consensus 192 aplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 192 APLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred cccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 999999999986 33456888899999999999999999877 9999999999999999999999999999887655
Q ss_pred cccccc-cccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1127 SRHIST-RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1127 ~~~~st-~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
..+... ...-.+.|+|||.++.++++.++|||+|||+||||++ |+.||-..... . +-+.+|
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------q-IL~~iD 329 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------Q-ILKNID 329 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------H-HHHhcc
Confidence 443322 2334689999999999999999999999999999999 88998653211 0 111222
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
..-+-.-+..|.+++++++..||..+|.+||+|..|.+.+-.
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 222233456789999999999999999999999999866543
|
|
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=313.91 Aligned_cols=265 Identities=22% Similarity=0.293 Sum_probs=199.4
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEEEEe
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLVYE 1045 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~LVmE 1045 (1368)
|++.+.||+|+||.||+|+.. +|+.|++|+++... ....+++.+|++++++++|+||+++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999965 58899999997642 33446788999999999999999999999887 88999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|++ ++|.+++... ...+++.++++++.||++||+|||+.+ ++|+|||++||||++++.+||+|||++......
T Consensus 81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 996 4888888532 246899999999999999999999887 999999999999999999999999999866443
Q ss_pred ccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HHHhhhhhccc-ccccce-
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLLTS-REGLER- 1201 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv~Wa~plls~-~e~L~e- 1201 (1368)
.. .......++..|++||.+.+ ..++.++||||||+++|||++|+.||+..+...... +.+........ ...+.+
T Consensus 154 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 154 NS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred Cc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence 21 11233457889999997764 467899999999999999999999997654322111 11110000000 000000
Q ss_pred ----------eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1202 ----------IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 ----------IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.....+...+...+...+.+++.+||+.+|++||++.++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 000000011111125678999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=317.88 Aligned_cols=255 Identities=25% Similarity=0.363 Sum_probs=206.2
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.+++|+..+.||+|+||.||+|..+ +++.|++|+++.... ..+++.+|++++++++|+||+++++++...+..++|||
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4567888899999999999999976 688999999975444 56788999999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+++++|.+++.... ..+++.+++.++.|++.||+|||+.+ |+|+|||++||+|+.++.+||+|||++......
T Consensus 96 ~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 96 YMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred ccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 999999999996432 36999999999999999999999887 999999999999999999999999998755332
Q ss_pred ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecC
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp 1205 (1368)
.. ......++..|++||++.+..++.++|||||||+||||++|+.||...... .....+.. .....+
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~--~~~~~~~~------~~~~~~--- 236 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--RALFLITT------KGIPPL--- 236 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHh------cCCCCC---
Confidence 11 123345788999999998888999999999999999999999998643211 11111110 000100
Q ss_pred CCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.........+.+++.+||+.+|.+||++.||++...
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 272 (286)
T cd06614 237 ----KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272 (286)
T ss_pred ----cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChH
Confidence 011113457889999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=317.31 Aligned_cols=269 Identities=21% Similarity=0.278 Sum_probs=195.9
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeecc------
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 1038 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~------ 1038 (1368)
.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|++++++++|+||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999954 68999999986432 222345678999999999999999999987644
Q ss_pred --ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1039 --ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1039 --~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
..++||||+. ++|.+++... ...+++.++++++.||+.||+|||+++ |+|||||++||||+.++.+||+||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcC
Confidence 3499999995 5788877532 235899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccc--cccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1117 GLARSAMDEESR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1117 GLArll~~~~~~--~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
|++......... .......++..|+|||++.+. .++.++||||||+++|||++|+.+|...+..............+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 999865432221 112234578899999988654 47889999999999999999999997654322211111111000
Q ss_pred c-----cc---cccceeec-CCC----CCCC-ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1194 T-----SR---EGLERIID-PSL----GNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1194 s-----~~---e~L~eIvD-p~L----~~~~-~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
. .. .....+.. ... .... .......+.+|+.+||+.||++||+++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 0 00 00000000 000 0000 00123467899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=318.65 Aligned_cols=265 Identities=22% Similarity=0.307 Sum_probs=199.6
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|... +++.|+||.++... ......+.+|++++++++|+||+++++++... +..|+|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46888999999999999999965 68899999997433 22234678899999999999999999998877 889999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+. ++|.+++.... ..+++.++++|+.||+.||+|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 157 (293)
T cd07843 85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG 157 (293)
T ss_pred ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence 99996 58988885422 35899999999999999999999887 9999999999999999999999999998664
Q ss_pred ccccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHH---------hhh--
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVA---------WAR-- 1190 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~---------Wa~-- 1190 (1368)
.... ......++..|+|||++.+. .++.++|||||||++|||++|+.+|........ ..+.. |..
T Consensus 158 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (293)
T cd07843 158 SPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFS 235 (293)
T ss_pred CCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhh
Confidence 4221 12234578899999988754 468999999999999999999999975432111 00110 100
Q ss_pred hhcc-cccccceeecCCCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1191 PLLT-SREGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1191 plls-~~e~L~eIvDp~L~~~~~~e-e~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.+.. ......+.....+...+... ....+.+++.+||+.+|++||++.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 236 ELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred ccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0000 00001111111111222222 3567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=318.14 Aligned_cols=248 Identities=24% Similarity=0.373 Sum_probs=201.0
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
|...+.||+|++|.||++.. .+++.|++|+++.......+.+.+|+.++++++|+||+++++++...+..++|+||+.+
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457999999999999995 57889999998765555566789999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
++|.+++.. ..+++.+++.|+.|++.||+|||+.+ |+|||||++||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-- 170 (285)
T cd06648 101 GALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-- 170 (285)
T ss_pred CCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--
Confidence 999999853 35899999999999999999999887 99999999999999999999999999875533211
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
......|+..|++||++.+..++.++|||||||++|||++|+.||...+. ..+....... ....+.
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~------~~~~~~~~~~-------~~~~~~- 236 (285)
T cd06648 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRIRDN-------LPPKLK- 236 (285)
T ss_pred ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH------HHHHHHHHhc-------CCCCCc-
Confidence 12234689999999999988899999999999999999999999865321 1111111110 000110
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
........+.+++.+||+.+|++||++.|+++.
T Consensus 237 -~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 237 -NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred -ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 111234679999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=311.46 Aligned_cols=246 Identities=26% Similarity=0.409 Sum_probs=196.1
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeecccc---hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||.||+++.. +|+.|++|++..... ...+.+.+|++++++++|+||+++++.+.+++..|+||||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999976 489999999865332 4556789999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc-----
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES----- 1127 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~----- 1127 (1368)
.+++++. ..+++.++++|+.||++||+|||+.+ |+||||+++|||+++++.+||+|||++........
T Consensus 81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 153 (265)
T cd05579 81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND 153 (265)
T ss_pred HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence 9999642 26899999999999999999999887 99999999999999999999999999875533211
Q ss_pred -ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1128 -RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1128 -~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
........++..|++||++....++.++||||||+++|||++|+.||+.... ....... .... ..
T Consensus 154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~---~~~~~~~---~~~~--~~------ 219 (265)
T cd05579 154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP---EEIFQNI---LNGK--IE------ 219 (265)
T ss_pred ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH---hcCC--cC------
Confidence 1122345688899999999988899999999999999999999999965431 1111111 1100 00
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
... .......+.+++.+||+.+|++||++.++.+.|+
T Consensus 220 ~~~--~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 220 WPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred CCc--cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 000 0012467899999999999999999966655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=313.83 Aligned_cols=266 Identities=21% Similarity=0.278 Sum_probs=199.4
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
+|++.+.||+|++|.||+|+.. +|+.|+||+++.... ...+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5889999999999999999964 688999999875432 23467789999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+ +|.+++..... ...+++..+++++.|++.||+|||+.+ |+|||||++||++++++.+||+|||+++......
T Consensus 81 ~~-~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 81 DK-DLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred Cc-cHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 74 88888754332 346899999999999999999999887 9999999999999999999999999997553221
Q ss_pred ccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhcc-ccc---ccce
Q 000659 1128 RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLT-SRE---GLER 1201 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls-~~e---~L~e 1201 (1368)
.......++..|++||++.+ ..++.++|||+|||++|||++|+.||......+.. .+.+....... ..+ .+..
T Consensus 155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd07836 155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233 (284)
T ss_pred -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence 11233457889999998765 45789999999999999999999999765432111 11111000000 000 0000
Q ss_pred eecCCCC------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1202 IIDPSLG------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1202 IvDp~L~------~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
+...... ..+.......+.+++.+|++.||++|+++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0011122456889999999999999999999975
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.80 Aligned_cols=256 Identities=26% Similarity=0.384 Sum_probs=196.4
Q ss_pred CcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|+..+.||+|+||.||++.. .+++.||||++.... .....++.+|+.++.++. |+||+++++++.+++..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 455667899999999999995 468999999986432 344567899999999996 99999999999999999999999
Q ss_pred cCCCChhhccccc-ccCCCCCChHHHHHHHHHHHHHHhhhhcc-CCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1047 IPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1047 m~gGSL~d~L~~~-~~~~~pLsw~erlkIA~QIA~GLaYLHs~-gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
+. ++|.++.... ......+++..+.+++.|++.||+|||+. + |+|||||++|||++.++.+||+|||+++....
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 85 4555543211 11234689999999999999999999975 5 99999999999999999999999999976533
Q ss_pred cccccccccccccccccCcchhccC---CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~---~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.. ......|+..|+|||++.+. .++.++|||||||++|||++|+.||.... ....-.......
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-----~~~~~~~~~~~~------ 226 (288)
T cd06616 161 SI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN-----SVFDQLTQVVKG------ 226 (288)
T ss_pred CC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc-----hHHHHHhhhcCC------
Confidence 21 11234588999999998766 68899999999999999999999996532 111111111100
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..+.+..........++.+|+.+||+.+|++||++.||++.-
T Consensus 227 -~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~ 268 (288)
T cd06616 227 -DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHP 268 (288)
T ss_pred -CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence 011111222234556899999999999999999999998763
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.88 Aligned_cols=259 Identities=23% Similarity=0.299 Sum_probs=194.6
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeeeeeeeec--cceEEEEe
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLVYE 1045 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~--~~~~LVmE 1045 (1368)
|++.+.||+|+||.||+|.. .+++.||+|+++... .....+..+|+.++.++. |+||+++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 67789999999999999995 468999999987532 223345568999999985 99999999999887 88999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+. |+|.+++... ...++|.++++++.|++.||+|||+.+ |+|||||++||||+. +.+||+|||+++.....
T Consensus 81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 996 5888887532 246899999999999999999999887 999999999999999 99999999999866432
Q ss_pred ccccccccccccccccCcchhc-cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc-c------
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR-E------ 1197 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~-~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~-e------ 1197 (1368)
.. .....++..|+|||++. .+.++.++|||||||+||||++|+.||...+.. ..+.+....+... .
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL---DQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH---HHHHHHHHHcCCCCHHHHHhh
Confidence 11 12345789999999765 456789999999999999999999999664321 1222221111000 0
Q ss_pred ccceeecCCCCC-------CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1198 GLERIIDPSLGN-------DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1198 ~L~eIvDp~L~~-------~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+..+.. .........+.+|+.+||+.+|++||+++|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 000000000000 0011335789999999999999999999999763
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-35 Score=321.20 Aligned_cols=248 Identities=29% Similarity=0.367 Sum_probs=197.2
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
..|++.+.||+|+||.||+|... +|+.|++|++.... ....+++.+|++++++++|+||++++++|.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45888899999999999999954 68999999986432 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+. |+|.+++... ...+++.++..++.|++.||.|||+.+ |+||||+++||++++++.+||+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 95 EYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 9996 6777766422 235899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
. ....|+..|+|||++. .+.++.++||||||+++|||++|+.||...+.. ...... .. .+ .
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~---~~~~~~---~~-~~-~-- 231 (307)
T cd06607 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI---AQ-ND-S-- 231 (307)
T ss_pred C------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHH---HHHHHH---hc-CC-C--
Confidence 1 2345788999999874 456889999999999999999999998643211 111110 00 00 0
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.. .........+.+++.+||+.+|++||++.+|++..+
T Consensus 232 ---~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 269 (307)
T cd06607 232 ---PT---LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF 269 (307)
T ss_pred ---CC---CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 00 011224467899999999999999999999988644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=338.78 Aligned_cols=255 Identities=27% Similarity=0.302 Sum_probs=213.0
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccch---hhHHHHHHHHHHhhcc-cccceeeeeeeeeccce
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQ---GGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~---~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~ 1040 (1368)
.....|++.+.||+|.||.||+++.+ +|+.+|+|++.+.... ..+.+.+|+.+|++|. |+|||.+++++++.+.+
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567999999999999999999965 5999999999654332 3468899999999998 99999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC----CCcccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD----FTPKVSDF 1116 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n----g~VKLsDF 1116 (1368)
++|||++.||.|.+.+... .+++.+...++.|++.++.|||+.| |+||||||+|||+... +.+|++||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 9999999999999999543 2899999999999999999999987 9999999999999543 57999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
|++..... .......+||+.|+|||++....|+...||||+||++|.|++|..||...+...... . ....
T Consensus 184 Gla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--~----i~~~- 253 (382)
T KOG0032|consen 184 GLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--A----ILRG- 253 (382)
T ss_pred CCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--H----HHcC-
Confidence 99997754 334567899999999999999999999999999999999999999997754322111 1 0110
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
+..+...........+.+++..|+..||.+|.++.++++.-|
T Consensus 254 -------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 -------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred -------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 012233344455678999999999999999999999998644
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=317.30 Aligned_cols=267 Identities=20% Similarity=0.245 Sum_probs=197.0
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccc-----
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA----- 1039 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~----- 1039 (1368)
++|++.+.||+|+||.||+|... +|+.||||+++... ....+.+.+|++++++++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999954 68999999986432 223467889999999995 6999999999887665
Q ss_pred eEEEEeecCCCChhhcccccccC-CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKE-SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFG 1117 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~-~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~VKLsDFG 1117 (1368)
.|+||||+++ +|.+++...... ...+++.+++.++.||++||+|||+.+ |+|||||++||||+. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 888888643332 346899999999999999999999887 999999999999998 8899999999
Q ss_pred ccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc-
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 1195 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~- 1195 (1368)
+++....... ......++..|+|||++.+ ..++.++|||||||+||||++|+.||....... .+..........
T Consensus 157 ~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPT 232 (295)
T ss_pred cceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence 9875532111 1122356889999998765 457899999999999999999999996532211 111111000000
Q ss_pred ccccceeec-------CCCC----CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 REGLERIID-------PSLG----NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 ~e~L~eIvD-------p~L~----~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+.+ .... .........++.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 000000000 0000 00011234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=304.91 Aligned_cols=247 Identities=28% Similarity=0.452 Sum_probs=203.1
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|++.+.||+|+||.||++... +++.|++|.+..... ...+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5888999999999999999854 678999999976543 4557899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+++++|.+++... ..+++..++.++.|++.+|.|||+.+ |+|||||++||+|+.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 153 (254)
T cd06627 81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVS 153 (254)
T ss_pred CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence 9999999998532 46899999999999999999999887 9999999999999999999999999998765432
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~ 1206 (1368)
.. .....++..|++||++.+..++.++|||+||+++|||++|+.||..... ....|.. .. ..
T Consensus 154 ~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~--~~--~~-------- 215 (254)
T cd06627 154 KD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRI--VQ--DD-------- 215 (254)
T ss_pred cc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHH--hc--cC--------
Confidence 21 2335688999999999888889999999999999999999999965321 1111110 00 00
Q ss_pred CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1207 L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
...........+.+++.+||..+|++||++.|+++
T Consensus 216 -~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 216 -HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred -CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 01122233467889999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=313.86 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=198.0
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
|++.+.||+|++|.||+|.. .+|+.|+||++.... ....+.+.+|++++++++|+||+++++++.+++..|+||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999985 479999999986432 223457889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
+++|.+++.... ...+++.++++++.|+++||+|||+.+ ++||||+++|||++.++.+||+|||+++.......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~ 154 (283)
T cd07835 81 -DLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR 154 (283)
T ss_pred -CcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence 578999885432 135899999999999999999999887 99999999999999999999999999975532211
Q ss_pred ccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc----------
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR---------- 1196 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~---------- 1196 (1368)
......++..|+|||++.+. .++.++|||||||++|||++|+.||...... ..+.+..+......
T Consensus 155 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 155 --TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEI--DQLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred --ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCChHHhhhhhhc
Confidence 11223568899999987654 5789999999999999999999999654321 11111111100000
Q ss_pred cc----cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EG----LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~----L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.. ..+...... ..........+.+++.+||+.+|++||+++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 231 PDYKPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hhhhhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 000000000 01112234678899999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=325.78 Aligned_cols=266 Identities=23% Similarity=0.309 Sum_probs=200.4
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec-----
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE----- 1037 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~----- 1037 (1368)
...++|++.+.||+|+||.||+|.. .+|+.||||+++.. +....+++.+|++++++++|+||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 3557899999999999999999995 47899999998642 334456788999999999999999999988643
Q ss_pred -cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1038 -QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1038 -~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
...|+||||+. ++|.+++.. .+++.++..++.|++.||+|||..+ |+|||||++|||++.++++||+||
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Df 162 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDF 162 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccC
Confidence 34699999995 588887742 2888999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHH--------
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVA-------- 1187 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~-------- 1187 (1368)
|+++...... ......|+..|+|||++.+..++.++|||||||+||+|++|+.||...+..+.. .+..
T Consensus 163 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 163 GLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred ccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 9998653321 123345889999999999999999999999999999999999999654321100 0000
Q ss_pred hh-------hhhcccc-----cccceeecCCC----CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1188 WA-------RPLLTSR-----EGLERIIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1188 Wa-------~plls~~-----e~L~eIvDp~L----~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
|. ....... ..+.+++...+ ..........++.+++.+||+.||++||++.|+++.-
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~ 312 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHP 312 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcCh
Confidence 00 0000000 00011111110 0111123456788999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.05 Aligned_cols=250 Identities=22% Similarity=0.317 Sum_probs=198.0
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc-----cchhhHHHHHHHHHHhhcccccceeeeeeeeec--cce
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QAR 1040 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~-----d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~ 1040 (1368)
.+|++.+.||+|+||.||+|.. .+++.|++|++... .....+.|.+|++++++++|+||+++++++.+. +..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4799999999999999999995 46899999987421 223446788999999999999999999998764 457
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+.+++|.+++.. ...+++..+++|+.|++.||.|||+.+ |+|||||++||+++.++.++|+|||+++
T Consensus 82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~ 154 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 154 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccc
Confidence 899999999999999853 235889999999999999999999887 9999999999999999999999999998
Q ss_pred ccccccc-ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccc
Q 000659 1121 SAMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ll~~~~~-~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L 1199 (1368)
....... ........|+..|+|||++.+..++.++|||||||+||||++|+.||...... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~----------- 221 (264)
T cd06653 155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM--AAIFKI----------- 221 (264)
T ss_pred ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH--HHHHHH-----------
Confidence 6532111 11112356889999999999888999999999999999999999999643211 111111
Q ss_pred ceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1200 ~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
........++......+.+++.+||+ ++++||+..++++
T Consensus 222 ---~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 222 ---ATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred ---HcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 00011122333455779999999999 4699999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.36 Aligned_cols=242 Identities=23% Similarity=0.296 Sum_probs=196.1
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||.||+++.. +++.|++|++.... ....+.+.+|++++++++|+||+++++++.+++..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999965 58999999986432 23456799999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++.+. ..+++.+++.++.||+.||+|||+.+ ++|+|||++||+|+.++.+||+|||+++...... ...
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~ 150 (262)
T cd05572 81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTW 150 (262)
T ss_pred HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccc
Confidence 9999542 34889999999999999999999887 9999999999999999999999999998764432 122
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
...|+..|++||++....++.++||||||+++|||++|+.||.....+. .++...... ......++
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~----------~~~~~~~~ 216 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILK----------GNGKLEFP 216 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhc----------cCCCCCCC
Confidence 3468899999999988889999999999999999999999997654211 111111111 01111222
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCC-----HHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQ 1242 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPT-----MsEVLq 1242 (1368)
......+.+++.+||+.+|++|++ ++|+++
T Consensus 217 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 217 NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 233567999999999999999999 666655
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=308.49 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=196.4
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhc---ccccceeeeeeeeeccc-----
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRL---HHRNLVKLIGICIEEQA----- 1039 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrL---rHPNIVrLlG~~~d~~~----- 1039 (1368)
|++.+.||+|+||.||+|..+ +++.||||+++... ....+.+.+|+++++++ +|+||+++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999976 48999999996422 22234577888888776 59999999999988776
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.+++|||+. ++|.+++.... ...+++..+++++.|+++||+|||+.+ |+|+|||++|||++.++++||+|||++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~ 154 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLA 154 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcc
Confidence 899999996 58988885432 235899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc---c
Q 000659 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS---R 1196 (1368)
Q Consensus 1120 rll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~---~ 1196 (1368)
....... ......++..|++||++.+..++.++|||||||++|||++|+.+|+..... +.+..+....... .
T Consensus 155 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 155 RIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA--DQLDKIFDVIGLPSEEE 229 (287)
T ss_pred eeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH--HHHHHHHHHcCCCChHh
Confidence 8663321 112345788999999999999999999999999999999999998754322 2222221111000 0
Q ss_pred cccc-----eeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1197 EGLE-----RIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1197 e~L~-----eIvDp~L~---~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
.... ..+..... .....+....+.+++.+||+.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 00000000 0111123467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=365.80 Aligned_cols=259 Identities=23% Similarity=0.341 Sum_probs=201.8
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeee--ccc
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQA 1039 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--~~~ 1039 (1368)
+...++|++.+.||+|+||+||+|... +++.||+|+++.. .......|.+|+.+|++|+|+|||++++++.+ ...
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 445678999999999999999999954 5778999988642 33445678999999999999999999998854 356
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCC----CCccccCCcccCeeecCC-------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS----PRVIHRDFKSSNILLEHD------- 1108 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gs----p~IVHRDIKPsNILLD~n------- 1108 (1368)
+||||||+.+|+|.++|.........+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999997544444579999999999999999999998531 349999999999999642
Q ss_pred ----------CCcccccccccccccccccccccccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCC
Q 000659 1109 ----------FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDM 1176 (1368)
Q Consensus 1109 ----------g~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~ 1176 (1368)
+.+||+|||+++..... ......+||..|+|||++.. ..++.++||||||||||||++|+.||..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred cccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 34899999999865332 12234569999999999864 4588999999999999999999999965
Q ss_pred CCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1177 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1177 s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
... ...++.. +.... .+ .......++.+|+..||+.+|++||++.|+++.
T Consensus 246 ~~~-----~~qli~~-lk~~p--------~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h 295 (1021)
T PTZ00266 246 ANN-----FSQLISE-LKRGP--------DL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGY 295 (1021)
T ss_pred CCc-----HHHHHHH-HhcCC--------CC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence 321 1111111 11000 00 001234678999999999999999999999864
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=320.47 Aligned_cols=247 Identities=29% Similarity=0.387 Sum_probs=197.1
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
|+..+.||+|+||.||+|.. .+++.|++|++.... ....+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 77788999999999999995 468899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. |+|.+++.. ....++|.+++.++.|++.||.|||+.+ |+||||+++||+++.++.+||+|||++.....
T Consensus 107 ~~-g~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 107 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CC-CCHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 96 577777642 2345899999999999999999999887 99999999999999999999999999875432
Q ss_pred cccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1127 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.....|+..|+|||++. .+.++.++|||||||++|||++|+.||...+. ...+..+....
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~--~~~~~~~~~~~----------- 240 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQNE----------- 240 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccH--HHHHHHHHhcc-----------
Confidence 12345888999999874 45788999999999999999999999864321 11111111100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
............+.+++.+||+.+|++||++.||++.+..
T Consensus 241 ---~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 ---SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred ---CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 0001112334568999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=325.37 Aligned_cols=265 Identities=26% Similarity=0.354 Sum_probs=197.9
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeecc-----c
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----A 1039 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-----~ 1039 (1368)
..++|++.++||+|+||.||+|.. .+|+.||||+++.. .....+++.+|+.++++++|+||+++++++...+ .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 357899999999999999999984 57899999998643 2334567889999999999999999999876543 4
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.|+||||+. ++|.+++.. ..+++..++.++.|+++||+|||+.+ |+|||||++||||+.++.+||+|||++
T Consensus 83 ~~lv~e~~~-~~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~ 153 (336)
T cd07849 83 VYIVQELME-TDLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLA 153 (336)
T ss_pred EEEEehhcc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccce
Confidence 799999996 578777742 35899999999999999999999887 999999999999999999999999999
Q ss_pred cccccccc-ccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc--
Q 000659 1120 RSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS-- 1195 (1368)
Q Consensus 1120 rll~~~~~-~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~-- 1195 (1368)
+....... ........|+..|+|||++.+ ..++.++|||||||++|||++|+.+|...+.. ....++...+..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~---~~~~~~~~~~~~~~ 230 (336)
T cd07849 154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL---HQLNLILGVLGTPS 230 (336)
T ss_pred eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHHHcCCCC
Confidence 86543221 111233568999999998754 56889999999999999999999999653211 111111111100
Q ss_pred ccccceeecCCC---------CCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 REGLERIIDPSL---------GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 ~e~L~eIvDp~L---------~~~~~-----~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.+..+.+... ..... .....++.+++.+||+.+|++||++.|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000010000000 00000 1124568899999999999999999999876
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=327.01 Aligned_cols=268 Identities=24% Similarity=0.299 Sum_probs=203.6
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccch--hhHHHHHHHHHHhhccccc-ceeeeeeeeecc-----
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRN-LVKLIGICIEEQ----- 1038 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~--~~keFlrEIeILsrLrHPN-IVrLlG~~~d~~----- 1038 (1368)
...|+..++||+|+||+||+|+ ..+|+.||+|+++...++ .-....+|+.+|++|+|.| ||+|++++..++
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3446667789999999999999 557899999999754332 2235689999999999999 999999998877
Q ss_pred -ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1039 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1039 -~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
..+|||||+ .-+|..++.........++...+.++++||++||+|||+++ |+||||||.||||+++|.+||+|||
T Consensus 90 ~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 789999999 56999999765433245777889999999999999999988 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc-
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 1195 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~- 1195 (1368)
+|+...-. ....+..++|..|+|||++.+. .|+...||||+|||++||++++.-|....+.+ .+..-++.+-+.
T Consensus 166 lAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~--ql~~If~~lGtP~ 241 (323)
T KOG0594|consen 166 LARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID--QLFRIFRLLGTPN 241 (323)
T ss_pred hHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH--HHHHHHHHcCCCC
Confidence 99965421 2224567799999999998876 78999999999999999999999887655422 222222211111
Q ss_pred ---ccccceeecCC--CCCCC-C-------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 ---REGLERIIDPS--LGNDV-P-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 ---~e~L~eIvDp~--L~~~~-~-------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...+..+.+-. +.... . ........+++.+|++.+|.+|.+++.++++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 11111111111 00000 0 0111468899999999999999999999875
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=317.01 Aligned_cols=269 Identities=24% Similarity=0.291 Sum_probs=198.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeec--cceEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEE--QARCL 1042 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--~~~~L 1042 (1368)
.++|++.+.||+|+||.||+|... +|+.||+|+++.... .....+.+|++++++++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 467999999999999999999964 689999999864322 2233567899999999999999999998764 56799
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+. ++|.+++... ...+++.+++.++.|+++||+|||+.+ |+|||||++|||++.++.+||+|||+++..
T Consensus 86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 999996 5888888543 246899999999999999999999988 999999999999999999999999999866
Q ss_pred cccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhh-------hhc
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWAR-------PLL 1193 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~-------pll 1193 (1368)
..... ......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.. .+..+.. +.+
T Consensus 159 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 159 GLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhh
Confidence 43221 1223346788999998865 56789999999999999999999999754322111 1111110 000
Q ss_pred ccccccceee-cCCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1194 TSREGLERII-DPSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1194 s~~e~L~eIv-Dp~L~~~~---~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
........+. ........ .......+.+++.+||+.||++||++.|+++.-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~ 292 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence 0000000000 00000000 0112456789999999999999999999987533
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=344.42 Aligned_cols=264 Identities=23% Similarity=0.278 Sum_probs=204.6
Q ss_pred CcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-c-----ccceeeeeeeeeccceEE
Q 000659 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-H-----RNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-H-----PNIVrLlG~~~d~~~~~L 1042 (1368)
+|+++++||+|.||.|.||. .++++.||||+++. .....++-+.|+.+|.+|+ | -|+|++++++...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 79999999999999999999 56799999999985 4455567788999999997 4 389999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC--CCCcccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH--DFTPKVSDFGLAR 1120 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~--ng~VKLsDFGLAr 1120 (1368)
|+|.+ .-+|+++|+.... ..|+...+..|+.||+.||.+||+.+ |||+||||+||||.+ ..++||+|||.++
T Consensus 266 VfELL-~~NLYellK~n~f--~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF--RGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred eehhh-hhhHHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence 99999 6799999975443 35889999999999999999999888 999999999999965 3479999999998
Q ss_pred cccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHH--------Hhhh--
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV--------AWAR-- 1190 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv--------~Wa~-- 1190 (1368)
....... ..+-+..|+|||++.+..|+.+.|||||||||+||++|..-|-..++.++..+. .|+.
T Consensus 340 ~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~ 414 (586)
T KOG0667|consen 340 FESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT 414 (586)
T ss_pred ccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 6643222 334577899999999999999999999999999999998888766544432211 1110
Q ss_pred -----hhccc-cccccee---------------------ecCCCC--------CCCChhhHHHHHHHHHHhcCcCcCCCC
Q 000659 1191 -----PLLTS-REGLERI---------------------IDPSLG--------NDVPFDSVAKVAAIASMCVQPEVQHRP 1235 (1368)
Q Consensus 1191 -----plls~-~e~L~eI---------------------vDp~L~--------~~~~~ee~~eLl~La~~CL~pDPkeRP 1235 (1368)
.++.. .+..... .+.... .......-..|++++++|++.||.+|+
T Consensus 415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~ 494 (586)
T KOG0667|consen 415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI 494 (586)
T ss_pred ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence 11111 0000000 000000 001113346789999999999999999
Q ss_pred CHHHHHHHHH
Q 000659 1236 FMGEVVQALK 1245 (1368)
Q Consensus 1236 TMsEVLq~Le 1245 (1368)
|..|.++.-+
T Consensus 495 tp~qal~Hpf 504 (586)
T KOG0667|consen 495 TPAQALNHPF 504 (586)
T ss_pred CHHHHhcCcc
Confidence 9999987644
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=313.21 Aligned_cols=243 Identities=26% Similarity=0.362 Sum_probs=188.6
Q ss_pred EEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhh---cccccceeeeeeeeeccceEEEEeecC
Q 000659 976 ILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSR---LHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 976 lLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsr---LrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
+||+|+||.||++.. .+++.||||++.... ....+.+.+|..+++. .+|+||+.+++++.+++..++||||+.
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 468999999986432 1222344555554444 369999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+|+|.+++.. ...+.|.++..|+.|++.||+|||+.+ |+|||||++|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-- 151 (279)
T cd05633 81 GGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (279)
T ss_pred CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence 9999998853 235999999999999999999999887 9999999999999999999999999987553221
Q ss_pred cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.....|+..|+|||++.+ ..++.++|||||||+||||++|+.||..........+.... .. .
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~---~~------------~ 214 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT------------V 214 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh---hc------------C
Confidence 123468999999998864 55789999999999999999999999754332211111110 00 0
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQAL 1244 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~L 1244 (1368)
....+.....++.+++.+||+.||++|+ +++|+++..
T Consensus 215 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~ 256 (279)
T cd05633 215 NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV 256 (279)
T ss_pred CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence 1112223456789999999999999999 588887754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.71 Aligned_cols=267 Identities=25% Similarity=0.303 Sum_probs=198.8
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeecc----
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ---- 1038 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~---- 1038 (1368)
...++|++.+.||+|+||.||+|..+ +|+.|+||+++... ......+.+|++++++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999965 68899999996432 233356788999999999999999999987654
Q ss_pred ------ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcc
Q 000659 1039 ------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1112 (1368)
Q Consensus 1039 ------~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VK 1112 (1368)
..++||||+++ +|.+++... ...+++.+++.|+.||+.||+|||+.+ |+|||||++||||++++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999975 677776432 336899999999999999999999887 99999999999999999999
Q ss_pred cccccccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhh
Q 000659 1113 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191 (1368)
Q Consensus 1113 LsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~p 1191 (1368)
|+|||++........ .......++..|++||++.+ ..++.++|||||||++|||++|+.+|+..... ..+......
T Consensus 157 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~--~~~~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL--AQLELISRL 233 (302)
T ss_pred eCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHH
Confidence 999999986643222 11122346788999998764 45789999999999999999999999754321 111111110
Q ss_pred hccc-cccccee--------ec------CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1192 LLTS-REGLERI--------ID------PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 lls~-~e~L~eI--------vD------p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.... ......+ .+ ..++... ......+.+++.+||+.+|++||++.++++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 0000000 00 0000001 1234678999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=309.80 Aligned_cols=264 Identities=23% Similarity=0.300 Sum_probs=197.6
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~-~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
|++.+.||+|+||.||+|... +++.|+||+++.... .......+|++.+++++ |+||+++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 677899999999999999975 578899999865322 22334567999999999 999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
+|+|.+++.... ...+++.+++.++.|++.+|.|||+.+ |+|+|||++||||++++.++|+|||+++......
T Consensus 81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~- 153 (283)
T cd07830 81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP- 153 (283)
T ss_pred -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence 889999886432 246899999999999999999999887 9999999999999999999999999998653321
Q ss_pred ccccccccccccccCcchhc-cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhcc----cccccce
Q 000659 1128 RHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLT----SREGLER 1201 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~-~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls----~~e~L~e 1201 (1368)
......++..|+|||++. ...++.++||||||+++|||++|+.+|......+.. ....+...... +...+..
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd07830 154 --PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231 (283)
T ss_pred --CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence 123345888999999875 456789999999999999999999999654322111 01111000000 0000000
Q ss_pred eecCCCC-------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1202 IIDPSLG-------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 IvDp~L~-------~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.++..+. ..........+.+++++||+.+|++||+++|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 232 KLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred cccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 0110000 00111124678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.98 Aligned_cols=264 Identities=23% Similarity=0.291 Sum_probs=203.7
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhh--HHHHHHHHHHhhcccccceeeeeeeee--ccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~--keFlrEIeILsrLrHPNIVrLlG~~~d--~~~~~LV 1043 (1368)
++|+.++.|++|+||.||+|+. ++++.||+|+++....... -.-+|||.+|.+++|+|||.+.++... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 3477889999999999999995 4789999999975432211 134799999999999999999998764 4678999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
||||+. +|..+|+... .++...++..++.|+++||+|||.+. |+|||||++|+|+...|.+||+||||||.+.
T Consensus 156 Me~~Eh-DLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHHh-hHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 999965 8888886543 57889999999999999999999998 9999999999999999999999999999875
Q ss_pred ccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccc----c
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE----G 1198 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e----~ 1198 (1368)
.. ....+..+-|.+|+|||++.+ ..|+...|+||+|||+.||++++.-|....+.++.+.. ++-+-...+ +
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~llGtPte~iwpg 304 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKLLGTPSEAIWPG 304 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHHhCCCccccCCC
Confidence 43 233466778999999998875 57999999999999999999999988776554433222 111111100 0
Q ss_pred cce-----------eecCCCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1199 LER-----------IIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1199 L~e-----------IvDp~L~~~~~~e-e~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+.+ ---..++..+... ....-.+|+..++..||++|-|+.|.++.
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h 361 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH 361 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence 110 0011122233222 33567889999999999999999998764
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=310.25 Aligned_cols=249 Identities=26% Similarity=0.361 Sum_probs=202.8
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LV 1043 (1368)
++|++.+.||+|+||.||+|... +|+.|++|+++.. .....+.+.+|++++++++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47899999999999999999964 7899999998642 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+++|.+++... ..+++.+++.|+.|++.||+|||+.+ ++|+|||++||+|+.+++++|+|||++....
T Consensus 81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~ 153 (280)
T cd05581 81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLD 153 (280)
T ss_pred EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccC
Confidence 9999999999999542 36999999999999999999999887 9999999999999999999999999998654
Q ss_pred ccccc------------------cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhH
Q 000659 1124 DEESR------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL 1185 (1368)
Q Consensus 1124 ~~~~~------------------~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nL 1185 (1368)
..... .......|+..|++||++....++.++||||||+++|||++|+.||..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~---~~~ 230 (280)
T cd05581 154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE---YLT 230 (280)
T ss_pred CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH---HHH
Confidence 32211 112234578999999999888899999999999999999999999975431 111
Q ss_pred HHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH----HHHHH
Q 000659 1186 VAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM----GEVVQ 1242 (1368)
Q Consensus 1186 v~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM----sEVLq 1242 (1368)
..... . ....+.......+.+++.+||+.+|++||++ +|+++
T Consensus 231 ~~~~~---~------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 FQKIL---K------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHHH---h------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 11110 0 0111222335678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=309.69 Aligned_cols=241 Identities=24% Similarity=0.348 Sum_probs=190.7
Q ss_pred EeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||+||++.. .+|+.|++|++.... ....+.+.+|+++|++++|+||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 468999999986422 23345678899999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++.... ...+++.+++.++.|++.||.|||+.+ |+|||||++|||+++++.+||+|||+++..... ....
T Consensus 81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~ 152 (277)
T cd05577 81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIK 152 (277)
T ss_pred HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Cccc
Confidence 99986432 235899999999999999999999887 999999999999999999999999998765331 1122
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
...++..|++||++.++.++.++|||||||++|||++|+.||.......... ........ ......
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~------------~~~~~~ 218 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLE------------MAVEYP 218 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhcccc------------ccccCC
Confidence 3457889999999988889999999999999999999999996543311110 00000000 011122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGE 1239 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsE 1239 (1368)
......+.+++.+||+.+|++|+++.|
T Consensus 219 ~~~~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 219 DKFSPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred ccCCHHHHHHHHHHccCChhHccCCCc
Confidence 233567899999999999999994444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=312.77 Aligned_cols=268 Identities=23% Similarity=0.282 Sum_probs=195.1
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeecc------
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 1038 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~------ 1038 (1368)
.++|++.+.||+|+||.||+|... +++.|+||++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999954 689999999864322 22346789999999999999999999875433
Q ss_pred --ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1039 --ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1039 --~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
..++||||+. ++|.+++... ...+++.+++.++.|+++||+|||+.+ |+|||||++|||+++++.+||+||
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~df 159 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADF 159 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcC
Confidence 4699999996 4677766432 336999999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccc---------cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHH
Q 000659 1117 GLARSAMDEESR---------HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1186 (1368)
Q Consensus 1117 GLArll~~~~~~---------~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv 1186 (1368)
|+++........ ...+...|+..|+|||++.+ ..++.++|||||||++|||++|+.+|............
T Consensus 160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~ 239 (311)
T cd07866 160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI 239 (311)
T ss_pred ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999865432211 11123467889999998765 45889999999999999999999999754432211110
Q ss_pred -Hhhhhh----cccccccceeecCCCCCCCC-------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1187 -AWARPL----LTSREGLERIIDPSLGNDVP-------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1187 -~Wa~pl----ls~~e~L~eIvDp~L~~~~~-------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
...... ......+....+........ ......+.+++.+||+.+|++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 000000 00000000000000000000 112257889999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=312.05 Aligned_cols=267 Identities=20% Similarity=0.275 Sum_probs=196.8
Q ss_pred CCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|... +|+.|+||+++... ....+.+.+|++++++++|+||+++++++.+.+..|+|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999965 78899999986432 2334578899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCcccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~VKLsDFGLArll~~ 1124 (1368)
|+. ++|.+++.... ...+++..++.++.||+.||+|||+++ |+|||||++||||+. ++.+||+|||+++....
T Consensus 82 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~ 155 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGI 155 (294)
T ss_pred ccc-ccHHHHHHhCC--CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence 995 57888774322 224678888999999999999999887 999999999999985 56799999999975532
Q ss_pred cccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhcccc----cc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLTSR----EG 1198 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls~~----e~ 1198 (1368)
.. .......++..|++||++.+ ..++.++|||||||++|||++|+.||......+.. ....+........ ..
T Consensus 156 ~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 156 PV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred Cc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence 21 11233457889999998866 45789999999999999999999999754322111 1111100000000 00
Q ss_pred cceeec--CCCCC----CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1199 LERIID--PSLGN----DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1199 L~eIvD--p~L~~----~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+..... ..... ........++.+++.+|++.+|++||++.|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~ 284 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH 284 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000 00000 0111234568899999999999999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=327.32 Aligned_cols=270 Identities=25% Similarity=0.315 Sum_probs=206.9
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeeeeeeee-----c
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-----E 1037 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d-----~ 1037 (1368)
.+...|...+.||+|+||.|+.+.. .+|+.||||++.+ .+....++.+||+++|+.++|+||+.+++++.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 3445666678999999999999994 5789999999873 455567788999999999999999999999865 3
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
+.+|+|+|+| +-+|...++. +..|+.+....+++|+++||+|+|+.+ |+||||||+|+|++.+..+||+|||
T Consensus 99 ~DvYiV~elM-etDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 5679999999 6688888843 345999999999999999999999888 9999999999999999999999999
Q ss_pred ccccccccccccccccccccccccCcchhc-cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~-~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
|||...........+..+.|.+|.|||++. ...|+...||||.||||.|||+|+.-|-+.+.-.+..+.-.....-. .
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~-~ 249 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS-E 249 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC-H
Confidence 999875432333445667899999999776 46799999999999999999999999977654433322211111000 0
Q ss_pred cccce--------eecCCC-CCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1197 EGLER--------IIDPSL-GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1197 e~L~e--------IvDp~L-~~~~~-----~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+.+.. .+.... ....+ .......++|+.+||..||++|.|++|.++.-
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hP 311 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHP 311 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence 00111 111000 00111 12345788999999999999999999998763
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.33 Aligned_cols=251 Identities=22% Similarity=0.358 Sum_probs=198.4
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-----cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-----d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
+|.+.+.||+|+||.||++... .+..+++|+++.. ......++.+|+.++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5888999999999999999854 3455666666532 223344677899999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||+.+++|.++++........+++.+++.++.|++.||.|||+.+ |+|+|||++||++++ +.+||+|||+++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999998754444567999999999999999999999887 999999999999975 569999999998664
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.... ......|+..|++||++....++.++||||||+++|+|++|+.+|+... ...........
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~------~~~~~~~~~~~-------- 220 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN------FLSVVLRIVEG-------- 220 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc------HHHHHHHHHcC--------
Confidence 3221 2233558889999999988888999999999999999999999986432 11111111110
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...........++.+++.+||+.+|++||++.|+++.
T Consensus 221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 221 ---PTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred ---CCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 0011223445678999999999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=308.88 Aligned_cols=264 Identities=23% Similarity=0.270 Sum_probs=199.8
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
|++.+.||+|++|.||+|... +|+.+++|+++.... ...+++.+|++++++++|+||+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999854 788999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.+ +|.+++... ...+++.+++.++.|++.||+|||+.+ |+|||||++|||++.++.+||+|||++.......
T Consensus 81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~- 152 (283)
T cd05118 81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV- 152 (283)
T ss_pred CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence 64 888888532 246899999999999999999999887 9999999999999999999999999998664432
Q ss_pred ccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HHHhh-------hhhccc--c
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWA-------RPLLTS--R 1196 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv~Wa-------~plls~--~ 1196 (1368)
.......++..|++||.+.+. .++.++||||||+++|+|++|+.+|...+..+... +.+.. ...+.. .
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhh
Confidence 112234578899999998876 78999999999999999999999996543211110 00000 000000 0
Q ss_pred cccceeecCCC--CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSL--GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L--~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.....+.+... ..........++.+++.+||+.||.+||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 00000000000 001112345689999999999999999999999763
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=321.61 Aligned_cols=269 Identities=24% Similarity=0.312 Sum_probs=199.6
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhc-ccccceeeeeeeeec--cc
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE--QA 1039 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~--~~ 1039 (1368)
...++|++.+.||+|+||.||+|... +|+.|+||++... .......+.+|+.+++++ +|+||++++++|... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34678999999999999999999965 6889999988532 233445678899999999 999999999998653 35
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.|+||||+. ++|.+++.. ..++|..++.++.||+.||+|||+.+ |+|||||++||||+.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~ 154 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLA 154 (337)
T ss_pred EEEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccch
Confidence 799999996 589888843 26889999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccc---cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1120 RSAMDEESR---HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1120 rll~~~~~~---~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
+........ .......|+..|++||++.. ..++.++|||||||++|||++|+.+|.............+.......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07852 155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA 234 (337)
T ss_pred hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 866443221 12234568999999998764 56789999999999999999999999654322111100000000000
Q ss_pred -------ccccceeecCCC------CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 -------REGLERIIDPSL------GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 -------~e~L~eIvDp~L------~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+++... ..........++.+++.+||+.+|++||++.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 235 EDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000111000 000111235678999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=345.07 Aligned_cols=273 Identities=21% Similarity=0.240 Sum_probs=192.1
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEecC--CCEEEEE------------------EeecccchhhHHHHHHHHHHhhcccc
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLDD--GTKVAVK------------------VLKRVDQQGGREFLAEVEMLSRLHHR 1025 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlkd--Gr~VAVK------------------vLk~~d~~~~keFlrEIeILsrLrHP 1025 (1368)
...++|++.+.||+|+||+||++.++. ++.+++| .++ ......++|.+|+++|++++|+
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence 346789999999999999999987542 2222222 111 1223345688999999999999
Q ss_pred cceeeeeeeeeccceEEEEeecCCCChhhccccccc-CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCee
Q 000659 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK-ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 1104 (1368)
Q Consensus 1026 NIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~-~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNIL 1104 (1368)
|||++++++.+.+..|+|+|++ +++|.+++..... ......+.++++|+.||+.||+|||+++ |||||||++|||
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NIL 299 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIF 299 (501)
T ss_pred CcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEE
Confidence 9999999999999999999999 5677777643221 1222345677889999999999999887 999999999999
Q ss_pred ecCCCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCC-CCCCCCCCcch
Q 000659 1105 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK-PVDMTQPPGQE 1183 (1368)
Q Consensus 1105 LD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~-PFd~s~~~~~~ 1183 (1368)
|+.++.+||+|||+++.+.... .......+||..|+|||++.+..++.++|||||||+||||++|.. ||.........
T Consensus 300 l~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 300 LNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred ECCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 9999999999999998664322 222234679999999999999999999999999999999999875 44433222222
Q ss_pred hHHHhhhhhccccc-------ccceeecCC-CC---CCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1184 NLVAWARPLLTSRE-------GLERIIDPS-LG---NDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1184 nLv~Wa~plls~~e-------~L~eIvDp~-L~---~~~-----~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.+.+.........+ .+.+.++.. +. ..+ .......+.+++.+||+.||++||++.|+++.-
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 22221111000000 000000000 00 000 001224577889999999999999999998753
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-34 Score=309.03 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=198.1
Q ss_pred CcceeeEEeecCcEEEEEEEe----cCCCEEEEEEeeccc----chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccce
Q 000659 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl----kdGr~VAVKvLk~~d----~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~ 1040 (1368)
+|++.+.||+|+||.||++.. .+|+.||+|+++... ....+++.+|+++++++ +|+||+.+++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 588899999999999999985 378999999997532 22346788999999999 599999999999998999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+++++|.++|.. ...+.+.++..++.|+++||.|||+.+ |+|||||++||||++++++||+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~ 153 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 153 (290)
T ss_pred EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccce
Confidence 999999999999999853 235889999999999999999999887 9999999999999999999999999998
Q ss_pred cccccccccccccccccccccCcchhccC--CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~--~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~ 1198 (1368)
....... .......|+..|++||++... .++.++||||||++||||++|+.||+..... ....++........
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~--~~~~~~~~~~~~~~-- 228 (290)
T cd05613 154 EFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK--NSQAEISRRILKSE-- 228 (290)
T ss_pred ecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc--ccHHHHHHHhhccC--
Confidence 6543221 112235689999999998753 4678999999999999999999999653221 11222222111110
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1199 L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
..++......+.+++.+||+.+|++|+ +++++++.
T Consensus 229 ----------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 229 ----------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 112223446788999999999999997 56666543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=313.66 Aligned_cols=253 Identities=26% Similarity=0.424 Sum_probs=196.4
Q ss_pred CCcceeeEEeecCcEEEEEEEecC-CCEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d-~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
++|++.+.||+|+||.||+|..++ ++.||||+++... ....+++.+|++++.++. |+||++++++|.++...|+|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 568889999999999999999764 8999999997543 234456778888777775 9999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhcc-CCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~-gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
|+ +++|.+++... ...+++.++.+|+.|+++||+|||+. + |+|||||++|||+++++.+||+|||++.....
T Consensus 95 ~~-~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 95 LM-STCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred cc-CcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 98 45777766432 23689999999999999999999974 5 99999999999999999999999999876533
Q ss_pred cccccccccccccccccCcchhccCC----CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGH----LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~----~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
... .....++..|+|||++.... ++.++||||||++||||++|+.||...... .+.+..+. ... ..
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~----~~~--~~ 237 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTKIL----QEE--PP 237 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHHHh----cCC--CC
Confidence 221 12345788999999987554 789999999999999999999999643211 11111111 110 00
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
. + ........++.+++.+||+.||++||++.++++...
T Consensus 238 ~-----~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~ 275 (296)
T cd06618 238 S-----L--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF 275 (296)
T ss_pred C-----C--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence 0 0 001123467899999999999999999999987754
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=349.87 Aligned_cols=267 Identities=25% Similarity=0.426 Sum_probs=214.2
Q ss_pred HHHHhCCcceeeEEeecCcEEEEEEEec--------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhc-ccccceeeeee
Q 000659 964 IEKATGNFDASRILGEGGFGLVYSGVLD--------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGI 1033 (1368)
Q Consensus 964 Le~aT~nFei~klLGeGgFGtVYKAvlk--------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrL-rHPNIVrLlG~ 1033 (1368)
++.-.+++.+.+.||+|.||.||+|.+. ....||||.++.. .....+.+..|+++|+.+ +|+||+.++|+
T Consensus 291 ~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 291 WEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred eeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 3444455566779999999999999844 1457999999753 345667899999999999 59999999999
Q ss_pred eeeccceEEEEeecCCCChhhcccccc---c-------CC--CCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCccc
Q 000659 1034 CIEEQARCLVYELIPNGSVESHLHGVD---K-------ES--APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSS 1101 (1368)
Q Consensus 1034 ~~d~~~~~LVmEYm~gGSL~d~L~~~~---~-------~~--~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPs 1101 (1368)
|.+++..++|+||+..|+|.++|+..+ . .. ..|...+++.+++|||+||+||++.. +|||||..+
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaR 447 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAAR 447 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhh
Confidence 999999999999999999999997654 0 01 23899999999999999999999886 999999999
Q ss_pred CeeecCCCCccccccccccccccccccccccccc--ccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCC
Q 000659 1102 NILLEHDFTPKVSDFGLARSAMDEESRHISTRVM--GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQ 1178 (1368)
Q Consensus 1102 NILLD~ng~VKLsDFGLArll~~~~~~~~st~v~--GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~ 1178 (1368)
||||.++..+||+|||||+............ .. -...|||||.+....|+.|+|||||||+||||++ |..||....
T Consensus 448 NVLi~~~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 448 NVLITKNKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hEEecCCCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 9999999999999999999765433322111 11 2456999999999999999999999999999999 888885421
Q ss_pred CCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1179 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1179 ~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
....+.++ +....+...+..+..++++||+.||+.+|++||++.|+++.|+..+.+
T Consensus 527 --~~~~l~~~--------------l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~~ 582 (609)
T KOG0200|consen 527 --PTEELLEF--------------LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQD 582 (609)
T ss_pred --cHHHHHHH--------------HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHHH
Confidence 11222222 222223345566788999999999999999999999999999986543
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=320.28 Aligned_cols=268 Identities=23% Similarity=0.326 Sum_probs=201.0
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeee----ccce
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQAR 1040 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d----~~~~ 1040 (1368)
.++|++.+.||+|+||.||+|.. .+|+.|++|++.... ....+.+.+|+.+|++++|+||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999995 469999999986532 2345678899999999999999999998753 3467
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+. |+|.+++.. ...+++.++++++.||+.||+|||+.+ |+|||||++|||+++++.+||+|||+++
T Consensus 84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~ 155 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155 (334)
T ss_pred EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccce
Confidence 99999995 689888853 234899999999999999999999887 9999999999999999999999999997
Q ss_pred cccccccc--cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcc---
Q 000659 1121 SAMDEESR--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT--- 1194 (1368)
Q Consensus 1121 ll~~~~~~--~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls--- 1194 (1368)
........ .......|+..|++||++.. ..++.++|||||||++|||++|+.||......... ......+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~~ 232 (334)
T cd07855 156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSPS 232 (334)
T ss_pred eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCCh
Confidence 65432211 11234568999999998765 46889999999999999999999999654321110 00000000
Q ss_pred -------cccccceeecCC-CCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1195 -------SREGLERIIDPS-LGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1195 -------~~e~L~eIvDp~-L~~~~-----~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
..+.+.+.++.. ..... ......++.+++.+||+.+|++||++.|+++.-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~ 297 (334)
T cd07855 233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297 (334)
T ss_pred hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhh
Confidence 000011111100 00001 11235679999999999999999999999886543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=312.44 Aligned_cols=256 Identities=15% Similarity=0.196 Sum_probs=184.5
Q ss_pred hCCcceeeEEeecCcEEEEEEEecC----CCEEEEEEeecccchhh-----------HHHHHHHHHHhhcccccceeeee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGG-----------REFLAEVEMLSRLHHRNLVKLIG 1032 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~d~~~~-----------keFlrEIeILsrLrHPNIVrLlG 1032 (1368)
.++|++.++||+|+||.||+|...+ ++.+++|+......... .....++..+..++|.||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4679999999999999999999654 34566665432221110 11223334455678999999999
Q ss_pred eeeecc----ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC
Q 000659 1033 ICIEEQ----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1108 (1368)
Q Consensus 1033 ~~~d~~----~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n 1108 (1368)
++.... ..++++|++. .++.+.+... ....+..++.|+.|+++||+|||+.+ |+||||||+||||+.+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 766543 3367778763 4565555322 23568889999999999999999887 9999999999999999
Q ss_pred CCcccccccccccccccccc-----cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch
Q 000659 1109 FTPKVSDFGLARSAMDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE 1183 (1368)
Q Consensus 1109 g~VKLsDFGLArll~~~~~~-----~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~ 1183 (1368)
+++||+|||+++........ .......||..|+|||++.+..++.++|||||||+||||++|+.||.........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999866432111 1112346999999999999999999999999999999999999999765322211
Q ss_pred h---HHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1184 N---LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1184 n---Lv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
. ..++...... ..+ ....+...+.+++..|+..++++||++.++++.|
T Consensus 243 ~~~~~~~~~~~~~~----------~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKRLHE----------GKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHHhhh----------hhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 1122211111 000 0112346789999999999999999999998876
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=304.32 Aligned_cols=243 Identities=24% Similarity=0.302 Sum_probs=188.9
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecccc---hhhHHHHHHHHHH-hhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---QGGREFLAEVEML-SRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~---~~~keFlrEIeIL-srLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+.||+|+||.||+|.. .+|+.||||+++.... .....+..|..++ ..++|+||+++++++.+++..|+||||+.+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999985 4689999999865322 2233455565554 445899999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
++|.+++.. ...+++..+.+|+.|++.||.|||+.+ |+||||+++||||++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----- 149 (260)
T cd05611 82 GDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE----- 149 (260)
T ss_pred CCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence 999999853 235889999999999999999999887 99999999999999999999999999875432
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.....|+..|++||++.+..++.++||||||++||||++|..||...+.. ...... .... . ....
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~----~~~~--~------~~~~ 214 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPD--AVFDNI----LSRR--I------NWPE 214 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH----Hhcc--c------CCCC
Confidence 22345888999999998888999999999999999999999999653321 111111 0000 0 0011
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
.....+...+.+++.+||+.+|++|+++.++.+.|
T Consensus 215 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 215 EVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred cccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 11123456789999999999999999776554443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=307.93 Aligned_cols=255 Identities=25% Similarity=0.320 Sum_probs=200.3
Q ss_pred CcceeeEEeecCcEEEEEEEe----cCCCEEEEEEeeccc----chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccce
Q 000659 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVD----QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvl----kdGr~VAVKvLk~~d----~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~ 1040 (1368)
+|++.+.||+|+||.||++.. .+++.||||+++... ....+++.+|++++.++ +|+||+.+++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 488899999999999999984 357889999987432 22345688999999999 599999999999998999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
++||||+.+|+|.+++.. ...+.+.+++.++.|++++|+|||+.+ ++|||||++|||++.++.++|+|||+++
T Consensus 81 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~ 153 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSK 153 (288)
T ss_pred EEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccc
Confidence 999999999999999853 235889999999999999999999887 9999999999999999999999999988
Q ss_pred cccccccccccccccccccccCcchhccCC--CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGH--LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~~--~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~ 1198 (1368)
....... .......|+..|++||++.+.. .+.++||||||+++|||++|+.||....... ...++.+......
T Consensus 154 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~-- 228 (288)
T cd05583 154 EFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSK-- 228 (288)
T ss_pred ccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccC--
Confidence 6543221 1122356889999999987665 7889999999999999999999996432111 1111111111110
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1199 L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
..........+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 229 ----------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 229 ----------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ----------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 11122233568899999999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=320.23 Aligned_cols=265 Identities=24% Similarity=0.330 Sum_probs=198.6
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec-----cc
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QA 1039 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~-----~~ 1039 (1368)
.++|.+.+.||+|+||.||+|+. .+++.||||+++.. .....+++.+|+.++++++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999994 47899999998642 233455778999999999999999999988654 34
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.|+||||+. ++|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~ 155 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLA 155 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccc
Confidence 799999995 788888843 246899999999999999999999887 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhhhcc---
Q 000659 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARPLLT--- 1194 (1368)
Q Consensus 1120 rll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~plls--- 1194 (1368)
+...... .......++..|+|||++.. ..++.++|||||||++|||++|+.||...+..... .+.........
T Consensus 156 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07858 156 RTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL 233 (337)
T ss_pred cccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence 8654321 12233457889999998765 56889999999999999999999999654311100 00100000000
Q ss_pred ---cccccceee-------cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1195 ---SREGLERII-------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1195 ---~~e~L~eIv-------Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
......+.+ +..+. ........++.+++.+||+.+|++||+++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 234 GFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 000000000 00000 0111345678999999999999999999999877
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=304.51 Aligned_cols=263 Identities=26% Similarity=0.337 Sum_probs=199.6
Q ss_pred cceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
|+..+.||+|+||.||+|... +++.|++|+++... ....+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 567789999999999999965 58999999997542 334567889999999999999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
. ++|.+++.... ..+++.++++++.|+++||+|||+.+ |+||||+++||++++++.+||+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~ 153 (282)
T cd07829 81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR 153 (282)
T ss_pred C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence 7 58999996432 36899999999999999999999987 99999999999999999999999999986643221
Q ss_pred ccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhh-------hhccc---
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWAR-------PLLTS--- 1195 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~-------plls~--- 1195 (1368)
......++..|+|||++.+. .++.++|||||||++|||++|+.+|......+.. .+..... .....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07829 154 --TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231 (282)
T ss_pred --ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccc
Confidence 12234467889999998776 8899999999999999999999999654321110 0000000 00000
Q ss_pred -ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1196 -REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 -~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...............+ ......+.+++.+||+.+|++||++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 232 YKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred ccccccccCccchHHhc-ccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000110000000001 1124579999999999999999999999763
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=311.45 Aligned_cols=266 Identities=20% Similarity=0.225 Sum_probs=196.1
Q ss_pred ceeeEEeecCcEEEEEEEecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 972 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
.+.+.+|.|+++.||++.. +++.||||+++.. .....+.+.+|++++++++|+||+++++++.+++..+++|||+.+
T Consensus 5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 3445556666666666655 6899999998653 345567899999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc--
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES-- 1127 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~-- 1127 (1368)
|+|.++++... ...+++..+.+++.|+++||+|||+++ |+|||||++||||+.++.+||+|||++........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 84 GSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 99999996432 235889999999999999999999887 99999999999999999999999999875532211
Q ss_pred ---ccccccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh----ccc---
Q 000659 1128 ---RHISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL----LTS--- 1195 (1368)
Q Consensus 1128 ---~~~st~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl----ls~--- 1195 (1368)
........++..|+|||++.. ..++.++|||||||++|||++|+.||...... ..+.+..... +..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhccCccccccCch
Confidence 111223457789999999876 35789999999999999999999999754321 1111111100 000
Q ss_pred ---ccccce----eecCCC----CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1196 ---REGLER----IIDPSL----GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1196 ---~e~L~e----IvDp~L----~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
...... ..+... ..........++.+++.+||+.||++||++.|+++.-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~ 297 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSF 297 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCch
Confidence 000000 000000 01111223457889999999999999999999988644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=318.66 Aligned_cols=260 Identities=23% Similarity=0.334 Sum_probs=193.2
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeecc------
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ 1038 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~------ 1038 (1368)
.++|.+.+.||+|+||.||+|+. .+|+.||||+++.. .....+.+.+|++++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999995 47899999998643 2233456889999999999999999999987542
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGL 1118 (1368)
..++|+||+. ++|.+++. ..+.+.++..++.|+++||+|||+.+ |+|||||++|||++.++.+||+|||+
T Consensus 94 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred eEEEEecccc-cCHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCC
Confidence 4589999995 46766552 25889999999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhh-------
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR------- 1190 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~------- 1190 (1368)
++..... .....++..|+|||++.+ ..++.++|||||||+||||++|+.||...+.........+..
T Consensus 164 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 164 ARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEF 238 (342)
T ss_pred CcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 8754221 123457889999999876 468899999999999999999999997543211100000000
Q ss_pred -hhcccccccceeec---CCCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1191 -PLLTSREGLERIID---PSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1191 -plls~~e~L~eIvD---p~L~~~~---~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+.. ......++ ....... .......+.+++.+||+.||++|+++.|+++.
T Consensus 239 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h 297 (342)
T cd07879 239 VQKLED-KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEH 297 (342)
T ss_pred HHHhcc-cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000 00000000 0000000 01233568899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=312.88 Aligned_cols=244 Identities=25% Similarity=0.370 Sum_probs=197.5
Q ss_pred eEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChh
Q 000659 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 1053 (1368)
Q Consensus 975 klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~ 1053 (1368)
..||+|+||.||++.. .+|+.|+||++........+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999986 478999999986555556677999999999999999999999999999999999999999999
Q ss_pred hcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccccc
Q 000659 1054 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1133 (1368)
Q Consensus 1054 d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~ 1133 (1368)
+++.. ..+++..++.++.|++.+|+|||+.+ |+|||||++||+|+.++.++|+|||++........ ....
T Consensus 106 ~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~ 175 (292)
T cd06657 106 DIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKS 175 (292)
T ss_pred HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--cccc
Confidence 98742 24889999999999999999999887 99999999999999999999999999876543221 1233
Q ss_pred ccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCCh
Q 000659 1134 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPF 1213 (1368)
Q Consensus 1134 v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ 1213 (1368)
..|+..|++||++.+..++.++|||||||++|||++|+.||..... ..........+ . ..+. ...
T Consensus 176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~~------~----~~~~--~~~ 240 (292)
T cd06657 176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNL------P----PKLK--NLH 240 (292)
T ss_pred cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhC------C----cccC--Ccc
Confidence 5688999999999888899999999999999999999999864321 11111111101 0 0000 011
Q ss_pred hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1214 DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1214 ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.....+.+++.+||+.+|.+|+++.|+++.
T Consensus 241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~~ 270 (292)
T cd06657 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKH 270 (292)
T ss_pred cCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence 234567889999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.98 Aligned_cols=242 Identities=26% Similarity=0.358 Sum_probs=187.6
Q ss_pred EEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHH---hhcccccceeeeeeeeeccceEEEEeecC
Q 000659 976 ILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEML---SRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 976 lLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeIL---srLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
+||+|+||.||+|.. .+++.||||++.... ......+..|..++ +..+|+||+.+++++.+.+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999985 468899999986432 12222344554444 44579999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
||+|.+++.. ...++|.+++.|+.|+++||+|||+.+ |+|||||++|||++.++.+||+|||+++......
T Consensus 81 g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~-- 151 (278)
T cd05606 81 GGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-- 151 (278)
T ss_pred CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence 9999998842 346999999999999999999999887 9999999999999999999999999987553221
Q ss_pred cccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.....|+..|++||++.++ .++.++|||||||+||||++|+.||........... .+.. .. .+
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-~~~~--~~--------~~--- 215 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-DRMT--LT--------MA--- 215 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-HHHh--hc--------cC---
Confidence 1234689999999998754 688999999999999999999999976432221111 0000 00 01
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCC-----CHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRP-----TMsEVLq~ 1243 (1368)
...+.....++.+++.+|+..+|.+|+ ++.|+++.
T Consensus 216 -~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~ 255 (278)
T cd05606 216 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH 255 (278)
T ss_pred -CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence 112222356799999999999999999 88888753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=324.52 Aligned_cols=262 Identities=24% Similarity=0.303 Sum_probs=199.7
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeec---c--ceEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE---Q--ARCL 1042 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~---~--~~~L 1042 (1368)
-.|+..+++|.|.||.||+|.+ ++++.||||++-.... .-.+|+++|++++|+|||+|+-++... + ...|
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl 99 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL 99 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence 3477789999999999999994 4679999998743222 123799999999999999999987642 2 3358
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC-CCccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARS 1121 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n-g~VKLsDFGLArl 1121 (1368)
|||||+ .+|.++++.+...+..++..++.-+.+||++||+|||+.+ |+||||||.|||||.+ |.+||||||.|+.
T Consensus 100 VleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 100 VLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence 999995 5999999876666677888899999999999999999987 9999999999999976 9999999999998
Q ss_pred ccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc----
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR---- 1196 (1368)
Q Consensus 1122 l~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~---- 1196 (1368)
+..++.. .....+..|+|||++.+ ..|+.+.||||.|||+.||+-|+.-|.+... .+.++..++-+-...
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~--~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS--VDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH--HHHHHHHHHHhCCCCHHHH
Confidence 7554332 22346889999998876 5799999999999999999999999976433 233333332221110
Q ss_pred ---------cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 ---------EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 ---------e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
....++....+..-+......+.++|+.+++..+|++|-+..|+++.
T Consensus 251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h 306 (364)
T KOG0658|consen 251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH 306 (364)
T ss_pred hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence 01111111111111233455789999999999999999999999764
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-34 Score=314.57 Aligned_cols=267 Identities=25% Similarity=0.338 Sum_probs=202.5
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcccccceeeeeeeeecc-----ceE
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-----ARC 1041 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-----~~~ 1041 (1368)
+|++.+.||+|+||.||+|... +++.|+||++.... ....+.+.+|++++++++|+||+++++++.+.+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5889999999999999999965 58999999987543 445568999999999999999999999998765 789
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
+||||+. ++|.++++. ...+++..++.++.||+.||+|||+.+ |+|||||++||||+.++.++|+|||++..
T Consensus 81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~ 152 (330)
T cd07834 81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARG 152 (330)
T ss_pred EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence 9999997 588888853 236999999999999999999999887 99999999999999999999999999987
Q ss_pred ccccccc-cccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HHHhhhhhcc----
Q 000659 1122 AMDEESR-HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LVAWARPLLT---- 1194 (1368)
Q Consensus 1122 l~~~~~~-~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv~Wa~plls---- 1194 (1368)
....... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...+...... +..+......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 232 (330)
T cd07834 153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLK 232 (330)
T ss_pred ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhh
Confidence 6443210 112334578899999999887 88999999999999999999999997654221110 1110000000
Q ss_pred --cccccceeecC-CCCCC-----CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1195 --SREGLERIIDP-SLGND-----VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1195 --~~e~L~eIvDp-~L~~~-----~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
......+.+.. ..... ........+.+++.+||+.+|++||++.++++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~ 290 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHP 290 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCc
Confidence 00000000000 00000 0112346789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=331.07 Aligned_cols=249 Identities=25% Similarity=0.373 Sum_probs=212.2
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.+-|++.+.||+|.|+.|-+|+ .-+|+.||||++.+. +......+++|++.|+.++|+|||+||++......+|||+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 4557788899999999999998 558999999999654 3444567899999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec-CCCCccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD-~ng~VKLsDFGLArll~ 1123 (1368)
|+-++|+|+||+-.. ...+.++...+++.||+.|+.|||+.. ||||||||+||.+- .-|-+||.|||++..+.
T Consensus 97 ELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 999999999999543 345899999999999999999999887 99999999999885 45789999999998775
Q ss_pred ccccccccccccccccccCcchhccCCCC-cccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T-~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.+. ..++.||.+.|-|||++.+..|+ .++||||||||||.|++|+.||+..+. .+.+..|
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeAND----------------SETLTmI 231 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEAND----------------SETLTMI 231 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccc----------------hhhhhhh
Confidence 543 34567999999999999988886 678999999999999999999976542 3445566
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+|-.. .++.....+..+||..||..||++|.+.+||+..
T Consensus 232 mDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~ 270 (864)
T KOG4717|consen 232 MDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST 270 (864)
T ss_pred hcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence 66443 4555667889999999999999999999998654
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.37 Aligned_cols=264 Identities=20% Similarity=0.265 Sum_probs=195.2
Q ss_pred eEEeec--CcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEG--GFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeG--gFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
..||+| +||+||++.. .+|+.||||+++.. .....+.+.+|+.+++.++|+||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 8999999995 47999999998643 223346788999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc-
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 1128 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~- 1128 (1368)
|+|.+++.+.. ...+++..++.++.|++.||+|||+.+ |+|||||++||||+.++.+|++||+.+.........
T Consensus 84 ~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~ 158 (328)
T cd08226 84 GSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKA 158 (328)
T ss_pred CCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccc
Confidence 99999986543 235889999999999999999999887 999999999999999999999999866433221110
Q ss_pred c----ccccccccccccCcchhccC--CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc---------
Q 000659 1129 H----ISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL--------- 1193 (1368)
Q Consensus 1129 ~----~st~v~GT~gYmAPEvL~~~--~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll--------- 1193 (1368)
. ......++..|++||++.+. .++.++|||||||++|||++|+.||...... ..+........
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 236 (328)
T cd08226 159 KVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRT--QMLLQKLKGPPYSPLDITTF 236 (328)
T ss_pred cccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChH--HHHHHHhcCCCCCCcccccc
Confidence 0 01112356679999998764 4789999999999999999999999754321 11111110000
Q ss_pred cc------------c----------cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1194 TS------------R----------EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1194 s~------------~----------e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.. . .....+.+..+.......+...+.+|+.+||+.||++|||+.|+++.-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 00 0 0000111111122222345678999999999999999999999987644
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=337.64 Aligned_cols=254 Identities=21% Similarity=0.333 Sum_probs=209.3
Q ss_pred HhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEee--cccchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk--~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LV 1043 (1368)
....|+++++||+||.++||++...+.+.||+|++. ..+.+...-|.+||++|.+|+ |.+||+|++|-..++.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 345688899999999999999998888899998864 356666778999999999996 99999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|||- ..+|..+|++.. ....+| .++.+..|++.++.++|++| |||.||||.|+|+- .|++||+|||+|..+.
T Consensus 439 mE~G-d~DL~kiL~k~~--~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK--SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred eecc-cccHHHHHHhcc--CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 9986 679999996543 233456 77888999999999999998 99999999999996 4689999999999887
Q ss_pred ccccccccccccccccccCcchhccC-----------CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~-----------~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
.+...-.....+||+.||+||.+... +.++++||||||||||+|+.|+.||... ...|
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-------~n~~---- 579 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-------INQI---- 579 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-------HHHH----
Confidence 76666666778999999999987532 3568999999999999999999999542 1122
Q ss_pred cccccccceeecCCCCCCCChh-hHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~e-e~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+..|.|++..-.++.- .-.++.++|..||..||++||++.||++.
T Consensus 580 ----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 580 ----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 234556666554444432 22339999999999999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=313.68 Aligned_cols=266 Identities=22% Similarity=0.298 Sum_probs=193.8
Q ss_pred CcceeeEEeecCcEEEEEEEec-C--CCEEEEEEeecc--cchhhHHHHHHHHHHhhc-ccccceeeeeeeeec----cc
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-D--GTKVAVKVLKRV--DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE----QA 1039 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-d--Gr~VAVKvLk~~--d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~----~~ 1039 (1368)
+|++.+.||+|+||.||+++.. + ++.||||++... .....+.+.+|+++++++ +|+||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 5889999999999999999954 3 778999998642 223356788999999999 599999999975432 45
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.|+++||+. ++|.+++.. ...+++.+++.++.||+.||+|||+.+ |+|||||++|||++.++.+||+|||++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a 152 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLA 152 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence 688889885 689888843 346899999999999999999999888 999999999999999999999999999
Q ss_pred ccccccccc--cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh-HH--------H
Q 000659 1120 RSAMDEESR--HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN-LV--------A 1187 (1368)
Q Consensus 1120 rll~~~~~~--~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n-Lv--------~ 1187 (1368)
+........ .......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||...+...... .. +
T Consensus 153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 232 (332)
T cd07857 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE 232 (332)
T ss_pred eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 865432211 11233568999999998765 468899999999999999999999997543211000 00 0
Q ss_pred hhhhhcccc-cccceeecCCCC---CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1188 WARPLLTSR-EGLERIIDPSLG---NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1188 Wa~plls~~-e~L~eIvDp~L~---~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+........ ....+.++.... ..........+.+++.+||+.+|++||++.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~ 292 (332)
T cd07857 233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292 (332)
T ss_pred HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 000000000 000000000000 00111224578999999999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.69 Aligned_cols=250 Identities=21% Similarity=0.260 Sum_probs=194.3
Q ss_pred HHHHHHHhCCcceeeEE--eecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeee
Q 000659 961 ASEIEKATGNFDASRIL--GEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE 1036 (1368)
Q Consensus 961 leELe~aT~nFei~klL--GeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d 1036 (1368)
..++....++|++.+.+ |+|+||.||++.. .+++.+++|+++...... .|+.+...+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34455556777877776 9999999999995 468889999986432211 133333323 69999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Cccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSD 1115 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsD 1115 (1368)
.+..|+||||+++|+|.+++... ..++|++++.++.|+++||.|||+.+ |+|||||++|||++.++ .++|+|
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~d 153 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCD 153 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEec
Confidence 99999999999999999999532 26899999999999999999999887 99999999999999988 999999
Q ss_pred ccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc
Q 000659 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1116 FGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~ 1195 (1368)
||+++..... ....|+..|+|||++.+..++.++|||||||++|||++|+.||...... ......|.... ..
T Consensus 154 fg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~~ 225 (267)
T PHA03390 154 YGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-QK 225 (267)
T ss_pred CccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-cc
Confidence 9998755321 2235889999999999989999999999999999999999999744322 11222332211 10
Q ss_pred ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC-HHHHHH
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-MGEVVQ 1242 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT-MsEVLq 1242 (1368)
. . .........+.+++.+||+.+|.+|++ ++|+++
T Consensus 226 ~--~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 226 K--L----------PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred c--C----------CcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 0 111134467899999999999999995 688875
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.49 Aligned_cols=247 Identities=28% Similarity=0.362 Sum_probs=195.7
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.|+..+.||+|+||.||+|+.. +++.|+||.+... .....+++.+|++++++++|+|++++++++.+.+..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3667788999999999999954 6788999998632 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
|+. |+|.+++... ...+++.+++.++.|++.||.|||+.+ ++|||||++|||++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 96 YCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred ccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 996 6887777422 235889999999999999999999887 999999999999999999999999998765321
Q ss_pred ccccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||...+.. ..+..+... ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~------~~--- 231 (308)
T cd06634 169 ------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHIAQN------ES--- 231 (308)
T ss_pred ------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH--HHHHHHhhc------CC---
Confidence 2345888999999875 356788999999999999999999998543211 111111110 00
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.. .........+.+|+.+||+.+|++||++.++++..+
T Consensus 232 --~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~ 269 (308)
T cd06634 232 --PA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF 269 (308)
T ss_pred --CC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcc
Confidence 00 011233466889999999999999999999987755
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=315.60 Aligned_cols=256 Identities=24% Similarity=0.349 Sum_probs=206.7
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc--------chhhHHHHHHHHHHhhc-ccccceeeeeee
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--------QQGGREFLAEVEMLSRL-HHRNLVKLIGIC 1034 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d--------~~~~keFlrEIeILsrL-rHPNIVrLlG~~ 1034 (1368)
...-++|+..++||+|..+.|.++.. .+|..+|+|++.... ....+.-.+|++||+++ .||||+.|.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 34556788889999999999998884 578899999985321 11123456899999998 599999999999
Q ss_pred eeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccc
Q 000659 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1114 (1368)
Q Consensus 1035 ~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLs 1114 (1368)
..+...++|+|.|+.|.|+|+|.. .-.+++++..+|+.|+..|++|||.++ |||||||++|||+|+|.++||+
T Consensus 93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~is 165 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKIS 165 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEe
Confidence 999999999999999999999953 446999999999999999999999998 9999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcchhccC------CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1188 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~------~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W 1188 (1368)
|||+++.+..+.. ...+|||++|+|||.+... .|+...|+|++|||||.||.|..||-..
T Consensus 166 DFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR----------- 231 (411)
T KOG0599|consen 166 DFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR----------- 231 (411)
T ss_pred ccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH-----------
Confidence 9999998865432 3568999999999988743 4678899999999999999999999432
Q ss_pred hhhhcccccccceeecCC--CCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1189 ARPLLTSREGLERIIDPS--LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~--L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
..+. .+..++... +...-..+......+|+.+||+.||.+|-|.+|+++.-..
T Consensus 232 --kQml---MLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 232 --KQML---MLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred --HHHH---HHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 1110 011111111 2222334566789999999999999999999999987443
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=314.52 Aligned_cols=266 Identities=21% Similarity=0.257 Sum_probs=195.6
Q ss_pred CCcc-eeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchh--------------hHHHHHHHHHHhhcccccceeeee
Q 000659 969 GNFD-ASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQG--------------GREFLAEVEMLSRLHHRNLVKLIG 1032 (1368)
Q Consensus 969 ~nFe-i~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~--------------~keFlrEIeILsrLrHPNIVrLlG 1032 (1368)
++|. +.+.||+|+||.||+|... +++.||||+++...... ...+.+|++++++++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 4554 3578999999999999954 68999999986432221 125789999999999999999999
Q ss_pred eeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcc
Q 000659 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1112 (1368)
Q Consensus 1033 ~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VK 1112 (1368)
++..++..++||||+. |+|.+++.. ...+++...+.++.|++.||+|||+.+ |+|||||++||||+.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 9999999999999996 689988843 335889999999999999999999887 99999999999999999999
Q ss_pred cccccccccccccc------------cccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCC
Q 000659 1113 VSDFGLARSAMDEE------------SRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQP 1179 (1368)
Q Consensus 1113 LsDFGLArll~~~~------------~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~ 1179 (1368)
|+|||+++...... .........++..|++||++.+. .++.++|||||||++|||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654110 01111223468899999988764 468999999999999999999999976543
Q ss_pred Ccch-hHHHhhhhhccc----ccccc------eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1180 PGQE-NLVAWARPLLTS----REGLE------RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1180 ~~~~-nLv~Wa~plls~----~e~L~------eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.. .+..+....... ...+. ......+. ........++.+++.+||+.+|++|+++.|++..
T Consensus 240 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~ 313 (335)
T PTZ00024 240 IDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKH 313 (335)
T ss_pred HHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence 2111 111111000000 00000 00000000 0011234678899999999999999999999864
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=317.02 Aligned_cols=271 Identities=24% Similarity=0.326 Sum_probs=202.9
Q ss_pred CCHHHHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeee
Q 000659 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035 (1368)
Q Consensus 959 fsleELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~ 1035 (1368)
....++..+.++|++.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|++++++++|+||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 44567778899999999999999999999984 57899999998653 2233467889999999999999999999886
Q ss_pred ec------cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC
Q 000659 1036 EE------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1109 (1368)
Q Consensus 1036 d~------~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng 1109 (1368)
.. ...|++++++ +++|.+++.. ..+++..++.++.|+++||+|||+.+ |+|||||++||+++.++
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 43 3467888887 8899888742 25899999999999999999999887 99999999999999999
Q ss_pred CcccccccccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHH
Q 000659 1110 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVA 1187 (1368)
Q Consensus 1110 ~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~ 1187 (1368)
.+||+|||+++..... .....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...+..... .+..
T Consensus 158 ~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 232 (345)
T cd07877 158 ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 232 (345)
T ss_pred CEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999998754321 223468899999998866 56889999999999999999999999654321110 1111
Q ss_pred hh-------hhhcccc------cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1188 WA-------RPLLTSR------EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1188 Wa-------~plls~~------e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+. ...+... ..+..+.+..+. +.......++.+++.+|++.||++|+++.|+++.-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~ 301 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA 301 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchh-hhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence 10 0000000 000000000000 00112345688999999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=337.53 Aligned_cols=244 Identities=31% Similarity=0.428 Sum_probs=199.5
Q ss_pred cceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
|..++.||.|.||.||-|+ ..+.+.||||++... ....+.+++.||.+|++|+|||+|.+.|+|..+...||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 5667789999999999999 557889999998543 334467899999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
| -|+-.|+|.- .+.+|-+.++..|+.|.+.||+|||+++ .||||||..||||++.|.|||+|||.|......
T Consensus 108 C-lGSAsDlleV---hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred H-hccHHHHHHH---HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 9 5677777642 3457999999999999999999999988 999999999999999999999999999866442
Q ss_pred cccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1127 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
..++||+.|||||++. .+.|+-|+||||||++..||.-++.|+-..+. ...+...+. ++
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA--MSALYHIAQ-----Ne------ 241 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA--MSALYHIAQ-----NE------ 241 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH--HHHHHHHHh-----cC------
Confidence 3467999999999875 57899999999999999999999988743221 111111111 10
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.+. ..+....|.+|+..||+.-|.+|||..++++.
T Consensus 242 sPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 11111 23566789999999999999999999998754
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=309.70 Aligned_cols=244 Identities=28% Similarity=0.391 Sum_probs=193.2
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
|...+.||+|+||.||+|+. .+|+.|+||++... .....+++.+|++++++++|+|++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 55567899999999999985 46889999998643 223345788999999999999999999999999999999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
+. |+|.+++.. ....+++.+++.++.|++.+|.|||+.+ |+|||||++||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~-- 173 (313)
T cd06633 103 CL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP-- 173 (313)
T ss_pred CC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC--
Confidence 95 677777743 2346899999999999999999999887 99999999999999999999999999864321
Q ss_pred cccccccccccccccCcchhc---cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1127 SRHISTRVMGTFGYVAPEYAM---TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~---~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.....|+..|++||++. ...++.++|||||||++|||++|+.||...+.. ....+. .. .....
T Consensus 174 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~---~~~~~~---~~--~~~~~-- 239 (313)
T cd06633 174 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM---SALYHI---AQ--NDSPT-- 239 (313)
T ss_pred ----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH---HHHHHH---Hh--cCCCC--
Confidence 12356889999999874 466889999999999999999999998654321 111111 00 00000
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.........+.+++.+||+.+|++||++.++++.
T Consensus 240 ------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111223468899999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=314.88 Aligned_cols=265 Identities=22% Similarity=0.345 Sum_probs=198.7
Q ss_pred HHHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeecc--
Q 000659 964 IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-- 1038 (1368)
Q Consensus 964 Le~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-- 1038 (1368)
+....++|++.+.||+|+||.||+|. ..+|+.||||+++.. .....+++.+|+++|++++|+||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 44567889999999999999999998 457899999998542 2233456889999999999999999999987543
Q ss_pred ----ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccc
Q 000659 1039 ----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1114 (1368)
Q Consensus 1039 ----~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLs 1114 (1368)
..++||||+ +++|.+++.. ..+++..++.++.||++||+|||+.+ |+|||||++|||++.++.+||+
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 358999999 7899888742 35899999999999999999999887 9999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHH------
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLV------ 1186 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv------ 1186 (1368)
|||+++..... .....++..|++||++.+ ..++.++|||||||++|+|++|+.||...+..... .+.
T Consensus 161 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07880 161 DFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTP 235 (343)
T ss_pred ecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999865321 123457889999998876 45889999999999999999999999754321100 000
Q ss_pred --Hhhhhhcccc-----cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1187 --AWARPLLTSR-----EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1187 --~Wa~plls~~-----e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.|........ ..+..+....+ ..........+.+++.+|++.||++|+++.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~ 298 (343)
T cd07880 236 SKEFVQKLQSEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH 298 (343)
T ss_pred CHHHHHhhcchhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 0100000000 00000000000 00112234568899999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=315.01 Aligned_cols=267 Identities=23% Similarity=0.316 Sum_probs=196.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeec---------
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE--------- 1037 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~--------- 1037 (1368)
.++|++.+.||+|+||.||+|.. .+|+.|++|++........+.+.+|++++++++|+||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 47899999999999999999995 46899999999766666667889999999999999999999876543
Q ss_pred -----cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCc
Q 000659 1038 -----QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTP 1111 (1368)
Q Consensus 1038 -----~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~V 1111 (1368)
...|+||||+. ++|.+++.. ..+.+..++.++.||+.||.|||+.+ |+|||||++||||+. ++.+
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceE
Confidence 35789999996 588888742 35889999999999999999999887 999999999999974 5678
Q ss_pred cccccccccccccccc-ccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhh
Q 000659 1112 KVSDFGLARSAMDEES-RHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA 1189 (1368)
Q Consensus 1112 KLsDFGLArll~~~~~-~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa 1189 (1368)
||+|||+++....... ........|+..|+|||++.. ..++.++|||||||++|||++|+.||...+...........
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~ 234 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES 234 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9999999976532111 111123457889999997654 56788999999999999999999999754322111110000
Q ss_pred hhhccc--ccc----cceeec-CCCCCCC-----ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1190 RPLLTS--REG----LERIID-PSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1190 ~plls~--~e~----L~eIvD-p~L~~~~-----~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+.... ... +...+. ....... ......++.+++.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h 300 (342)
T cd07854 235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH 300 (342)
T ss_pred cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence 000000 000 000000 0000000 01233578899999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=311.66 Aligned_cols=266 Identities=25% Similarity=0.329 Sum_probs=199.9
Q ss_pred HHHHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeee-cc
Q 000659 963 EIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQ 1038 (1368)
Q Consensus 963 ELe~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d-~~ 1038 (1368)
++..++++|++.+.||+|+||.||+|.. .+|+.||||++... .....+.+.+|++++++++|+||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 3455788999999999999999999984 47899999988532 23345678899999999999999999999865 56
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGL 1118 (1368)
..++||||+ +++|.++++. ..+.+..+..++.|++.||+|||+.+ |+|||||++|||+++++.+||+|||+
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccc
Confidence 789999999 6789888742 34788889999999999999999887 99999999999999999999999999
Q ss_pred cccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc-hhHHH--------h
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-ENLVA--------W 1188 (1368)
Q Consensus 1119 Arll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-~nLv~--------W 1188 (1368)
++..... .....++..|++||++.+ ..++.++|||||||++|||++|+.+|........ ..+.+ |
T Consensus 155 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~ 229 (328)
T cd07856 155 ARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDV 229 (328)
T ss_pred ccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 8754221 123457889999998766 5689999999999999999999999965432110 01111 1
Q ss_pred hhhhcccccccceeecCCCCCCCC-----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~L~~~~~-----~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
....... ..+..+.+-......+ ......+.+++.+||+.+|++||++.|++..
T Consensus 230 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 230 INTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 1111100 0000000000001111 1234678999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-33 Score=291.92 Aligned_cols=236 Identities=30% Similarity=0.348 Sum_probs=193.0
Q ss_pred EeecCcEEEEEEEec-CCCEEEEEEeecccc---hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
||+|+||.||++... +++.|++|+++.... ...+.+.+|++++++++|+||+++++.+.+++..++||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999965 589999999865322 2456789999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st 1132 (1368)
.+++... ..+++.+++.++.|++.||.|||+.+ ++|+|||++||+++.++.++|+|||++....... ....
T Consensus 81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~ 151 (250)
T cd05123 81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTN 151 (250)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--Cccc
Confidence 9999532 35899999999999999999999887 9999999999999999999999999998664321 1223
Q ss_pred cccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1133 ~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
...++..|++||.+.+...+.++|+|+||+++|||++|+.||..... ..+..... .. ...++
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~---~~------------~~~~~ 213 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKIL---KD------------PLRFP 213 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHh---cC------------CCCCC
Confidence 45688999999999888899999999999999999999999965422 11112111 10 01122
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGE 1239 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsE 1239 (1368)
......+.+++.+||..||++||++.+
T Consensus 214 ~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 214 EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 223467899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=333.36 Aligned_cols=245 Identities=27% Similarity=0.454 Sum_probs=203.9
Q ss_pred EEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChhh
Q 000659 976 ILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES 1054 (1368)
Q Consensus 976 lLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~d 1054 (1368)
+||+|.||+||-|+. .+...+|||.+...+.+..+-+..||.+.++|+|.|||+++|.|.+++..-|.||.++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 799999999999994 4567899999977777777778899999999999999999999999999999999999999999
Q ss_pred cccccccCCCCC--ChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec-CCCCccccccccccccccccccccc
Q 000659 1055 HLHGVDKESAPL--GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHIS 1131 (1368)
Q Consensus 1055 ~L~~~~~~~~pL--sw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD-~ng~VKLsDFGLArll~~~~~~~~s 1131 (1368)
+|+. ..++| .+.+.-.+.+||+.||.|||+.. |||||||-+||||+ -.|.+||+|||-++.+.. -....
T Consensus 662 LLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 662 LLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 9963 34456 67788889999999999999987 99999999999996 578999999999986643 23344
Q ss_pred ccccccccccCcchhccC--CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1132 TRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1132 t~v~GT~gYmAPEvL~~~--~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
.+..||+.|||||++..+ .|+.++|||||||.+.||.||+.||...+...... ++ -++. ....
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAM--------Fk--VGmy-----KvHP 798 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAM--------FK--VGMY-----KVHP 798 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhh--------hh--hcce-----ecCC
Confidence 567799999999999865 58899999999999999999999996544321110 00 0111 1123
Q ss_pred CCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1210 ~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.++.+...+...++.+|+.+||.+||++.++++-
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 5667888899999999999999999999999764
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=315.06 Aligned_cols=263 Identities=24% Similarity=0.344 Sum_probs=198.8
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccc---
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--- 1039 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~--- 1039 (1368)
...++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++++++|+||+++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 45678999999999999999999965 6789999998642 23344678899999999999999999998876554
Q ss_pred ---eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1040 ---RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1040 ---~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
.++|+||+ +++|.+++.. ..+++.++++++.|+++||.|||+.+ |+|||||++|||+++++++||+||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 6799998853 35899999999999999999999887 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHhhhh---
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAWARP--- 1191 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~Wa~p--- 1191 (1368)
|++...... .....++..|++||++.+ ..++.++|||||||++|||++|+.||......... .+.+....
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~ 237 (343)
T cd07851 163 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDE 237 (343)
T ss_pred ccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCH
Confidence 999865332 223457889999998865 46789999999999999999999999654321110 00000000
Q ss_pred ----hcccccccceeecC---CCCCCC---ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1192 ----LLTSREGLERIIDP---SLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 ----lls~~e~L~eIvDp---~L~~~~---~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+. .+....+++. .....+ ......++.+++.+||+.+|++|||+.||++.
T Consensus 238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h 298 (343)
T cd07851 238 ELLQKIS-SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH 298 (343)
T ss_pred HHHhhcc-chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence 000 0000001000 000000 01235678999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=313.63 Aligned_cols=255 Identities=23% Similarity=0.320 Sum_probs=205.9
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEee--cccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk--~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
.+++|++.+.||+|.|+.||++. ..+|+.+|+|++. +......+++.+|++|.+.|+|||||+|.+.+.++...|||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 34678888999999999999998 4578999999874 33445678899999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC---CCCcccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLAR 1120 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~---ng~VKLsDFGLAr 1120 (1368)
+|+|+||+|..-+-. ....++..+-.+++||+++|.|+|.++ |||||+||+|+||-. ..-+||+|||+|.
T Consensus 89 Fe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999999876632 134677888899999999999999988 999999999999943 3458999999999
Q ss_pred cccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccc
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~ 1200 (1368)
.+.++ .......||++|||||+++...|+..+|||++|||||-||.|+.||.... +..+.+.+..-
T Consensus 162 ~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~---~~rlye~I~~g-------- 227 (355)
T KOG0033|consen 162 EVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYEQIKAG-------- 227 (355)
T ss_pred EeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhcc--------
Confidence 87632 22345679999999999999999999999999999999999999996532 22333222100
Q ss_pred eeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1201 eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.+ .+..........+..+|+++||..||.+|.|+.|.++.-+
T Consensus 228 -~y--d~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpW 269 (355)
T KOG0033|consen 228 -AY--DYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPW 269 (355)
T ss_pred -cc--CCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCch
Confidence 00 1112223344567889999999999999999999987644
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=317.09 Aligned_cols=254 Identities=24% Similarity=0.288 Sum_probs=203.2
Q ss_pred CCcceeeEEeecCcEEEEEEEecC-CCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
++|++.+.||+|.-|+||++.+++ +..+|+|++.+.. .....+.+.|-+||+.++||.+..|+..++.++..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 357778899999999999999764 5889999997643 333456678999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
|||.||+|..++++.. ...+++..+.-++..|+.||+|||..| ||.|||||+||||.++|.+.|+||.|+.....
T Consensus 157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~ 231 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPV 231 (459)
T ss_pred ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence 9999999999987543 457999999999999999999999888 99999999999999999999999999743210
Q ss_pred ---------------------------------ccc---------------------ccccccccccccccCcchhccCC
Q 000659 1125 ---------------------------------EES---------------------RHISTRVMGTFGYVAPEYAMTGH 1150 (1368)
Q Consensus 1125 ---------------------------------~~~---------------------~~~st~v~GT~gYmAPEvL~~~~ 1150 (1368)
... ...+...+||-.|+|||++.+.-
T Consensus 232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G 311 (459)
T KOG0610|consen 232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG 311 (459)
T ss_pred CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence 000 01112367999999999999999
Q ss_pred CCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcC
Q 000659 1151 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 1230 (1368)
Q Consensus 1151 ~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pD 1230 (1368)
.+.++|.|.|||+|||||.|.-||...+... .+..++-..+.--........+.+||++.|.+|
T Consensus 312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~----------------Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE----------------TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCchhhHHHHHHHHHHHHhCCCCcCCCCchh----------------hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 9999999999999999999999998764321 122222222211111245678899999999999
Q ss_pred cCCCCC----HHHHHHH
Q 000659 1231 VQHRPF----MGEVVQA 1243 (1368)
Q Consensus 1231 PkeRPT----MsEVLq~ 1243 (1368)
|.+|.. +.||.+.
T Consensus 376 P~kRlg~~rGA~eIK~H 392 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKRH 392 (459)
T ss_pred hhhhhccccchHHhhcC
Confidence 999998 5555443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=313.06 Aligned_cols=271 Identities=23% Similarity=0.355 Sum_probs=223.2
Q ss_pred HHHHHHHhCCcceeeEEeecCcEEEEEEEec------CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeee
Q 000659 961 ASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033 (1368)
Q Consensus 961 leELe~aT~nFei~klLGeGgFGtVYKAvlk------dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~ 1033 (1368)
..+|.....+|+...++-+|.||+||+|.+. +.+.|.+|.++.. .+.....|+.|.-+|..+.|+|++.+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455556677888999999999999999654 3456788888654 34445678899999999999999999999
Q ss_pred eeec-cceEEEEeecCCCChhhccccccc----CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC
Q 000659 1034 CIEE-QARCLVYELIPNGSVESHLHGVDK----ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1108 (1368)
Q Consensus 1034 ~~d~-~~~~LVmEYm~gGSL~d~L~~~~~----~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n 1108 (1368)
+.++ +..+++|.++.-|+|..||...+. ..+.++..+...++.|++.||+|||+++ |||.||..+|++||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 9765 456889999999999999973322 2345778889999999999999999988 9999999999999999
Q ss_pred CCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHH
Q 000659 1109 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVA 1187 (1368)
Q Consensus 1109 g~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~ 1187 (1368)
.++||+|-.|+|.+...++............||++|.+.+..|+.++|||||||+||||+| |+.|+-..+..+ +
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---m-- 507 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---M-- 507 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH---H--
Confidence 9999999999999988888888888888899999999999999999999999999999999 999986543221 1
Q ss_pred hhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1188 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1188 Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
...+++ ..+-..+..|..++..+|.-||...|++||++.|++.-|.+.....
T Consensus 508 --~~ylkd----------GyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 --EHYLKD----------GYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred --HHHHhc----------cceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 111222 2223345678899999999999999999999999999888765443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=327.93 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=209.5
Q ss_pred HHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 966 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
.-.+.|.+.+.||+|.|+.|.+|+ ..++..||||.+++. +....+.+.+|+++|+.|+|||||+|+.+...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 446789999999999999999999 447999999999764 33334568999999999999999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.+|.+++||... ..+.+.+...++.|+.++++|||.++ |||||||.+|||||.+.++||+|||++..+
T Consensus 133 V~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999643 34666888999999999999999998 999999999999999999999999999877
Q ss_pred cccccccccccccccccccCcchhccCCC-CcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~-T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
. ........||++-|.|||++.+..| +.++|+|++|++||-|+.|..||+..+... +. .+
T Consensus 206 ~---~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-----------Lr-----~r 266 (596)
T KOG0586|consen 206 D---YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-----------LR-----PR 266 (596)
T ss_pred c---ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-----------cc-----ch
Confidence 4 3445567899999999999998766 589999999999999999999998643211 00 11
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
.+...+ .++.-...+..+++++++-.+|.+|.+++++.+.-+
T Consensus 267 vl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 267 VLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred heeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 111111 233344556788999999999999999999977654
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=356.99 Aligned_cols=256 Identities=27% Similarity=0.378 Sum_probs=205.0
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceE
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~ 1041 (1368)
...+-+++...+||.|.||.||-|+ +++|+-.|+|.++. .+....+.+.+|+.+|..|+|+|||+.+|+-.+++..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3455677788899999999999999 77899999998753 33445567889999999999999999999999999999
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
|.||||++|+|.+.+.. .+.+++.....+..|++.||+|||++| |||||||+.|||||.+|-+|++|||.|+.
T Consensus 1311 IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999953 334666667778899999999999998 99999999999999999999999999987
Q ss_pred ccccc--cccccccccccccccCcchhccC---CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1122 AMDEE--SRHISTRVMGTFGYVAPEYAMTG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1122 l~~~~--~~~~st~v~GT~gYmAPEvL~~~---~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+.... ........+||+.|||||++.+. .-..+.||||||||++||+||+.||...+. +|+--+-
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~--- 1453 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYH--- 1453 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhH---
Confidence 75432 11222346799999999998753 345789999999999999999999965432 2211100
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+--.-...++.....+-.+++.+||..||++|.++.|+++.
T Consensus 1454 ------V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1454 ------VAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ------HhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 00111234555566778899999999999999888777553
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-34 Score=312.48 Aligned_cols=247 Identities=25% Similarity=0.382 Sum_probs=207.5
Q ss_pred cceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCC
Q 000659 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~g 1049 (1368)
|+++++||+|.||.||||.+ +.|..||||.+-. ....+++..||.||++++.+++|+++|.|.....+|+|||||..
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 67788999999999999994 5799999999863 33457899999999999999999999999999999999999999
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|++.|.++. ++.+|.++++..|+...++||+|||... -||||||..||||+.+|.+||+|||.|..+.+. -.
T Consensus 113 GSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT--MA 184 (502)
T KOG0574|consen 113 GSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT--MA 184 (502)
T ss_pred CcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhh--HH
Confidence 999999963 3457999999999999999999999776 899999999999999999999999999877542 22
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee-cCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII-DPSLG 1208 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv-Dp~L~ 1208 (1368)
..+++.||+.|||||++..-.|..++||||||+...||..|+.||.+-.. ...+.-+- ++-.-
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHP----------------MRAIFMIPT~PPPT 248 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHP----------------MRAIFMIPTKPPPT 248 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccc----------------cceeEeccCCCCCC
Confidence 23567899999999999999999999999999999999999999965321 11111111 11111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
-..++....+|.++++.||-..|++|-|+.++++.
T Consensus 249 F~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 249 FKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 12345667899999999999999999999999875
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.4e-34 Score=330.57 Aligned_cols=251 Identities=24% Similarity=0.399 Sum_probs=202.3
Q ss_pred CcceeeEEeecCcEEEEEEEecC-CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 970 NFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
.|++...||.|+||.||||+.++ +-..|.|++........++|+-||+||..++||+||+|++.|.-++.+||+.|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 35566789999999999999664 44456788877777788899999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
||-++..+-.. ...|.++++.-+++|+++||.|||+.+ |||||||..|||++-+|.++|+|||.+..... ..
T Consensus 113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~ 184 (1187)
T KOG0579|consen 113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TR 184 (1187)
T ss_pred CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh--HH
Confidence 99998887433 347999999999999999999999887 99999999999999999999999999865432 22
Q ss_pred cccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1129 HISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.....+.||+.|||||+.+ ...|+.++||||||+.|.||..+..|....+. ...+....+.+ -..++
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------MRVllKiaKSe--PPTLl 256 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------MRVLLKIAKSE--PPTLL 256 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------HHHHHHHhhcC--CCccc
Confidence 2334578999999999876 45789999999999999999999988754332 11111111100 11111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.+......|.+|+.+||..||..||+..++++.
T Consensus 257 -------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 257 -------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred -------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 123456789999999999999999999999754
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-33 Score=332.06 Aligned_cols=245 Identities=23% Similarity=0.385 Sum_probs=190.7
Q ss_pred eeeEEeecCcEEEEEEEec-CCCEEEEEEee--cc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccc--eEEEEe
Q 000659 973 ASRILGEGGFGLVYSGVLD-DGTKVAVKVLK--RV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA--RCLVYE 1045 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvlk-dGr~VAVKvLk--~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~--~~LVmE 1045 (1368)
...+||+|+|-+||||.+. +|..||=-.++ +. +....++|..|+.+|+.|+|+|||++++++.+.+. +.+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3468999999999999954 56666533222 22 33445789999999999999999999999987665 678999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC-CCcccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n-g~VKLsDFGLArll~~ 1124 (1368)
.|..|+|..|+++. ..++.+.+.+|+.||++||.|||.+ .|+|||||||.+||+|+.+ |.|||+|+|||+....
T Consensus 124 L~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred cccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999644 3588899999999999999999998 5899999999999999865 8999999999997743
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
.. ...+.||+.|||||+.. ..|.+.+||||||++|+||+|+..||..=.. ...+..-+..-.+ -..+.++-
T Consensus 199 s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiK-P~sl~kV~- 269 (632)
T KOG0584|consen 199 SH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIK-PAALSKVK- 269 (632)
T ss_pred cc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCC-HHHhhccC-
Confidence 22 23378999999999876 8899999999999999999999999843111 1111111110000 01112211
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..++.+||.+|+.. .++|+++.|+++.
T Consensus 270 -----------dPevr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 270 -----------DPEVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred -----------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence 24688999999999 9999999999764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=333.20 Aligned_cols=146 Identities=31% Similarity=0.411 Sum_probs=131.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+++.+|+++++.++|+||+++++++...+..|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999965 78999999997532 23346788999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
|||+.+++|.++++.. ..+++..+++|+.||+.||+|||..+ ||||||||+||||+.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999998532 35889999999999999999999887 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=328.07 Aligned_cols=272 Identities=25% Similarity=0.366 Sum_probs=210.2
Q ss_pred CcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeeecc------ceE
Q 000659 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ------ARC 1041 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~------~~~ 1041 (1368)
.+...+.||+|+||.||+|+ -++|+.||||.++.. .....+...+|+++|++|+|+|||+++++-.+.. ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 35567899999999999999 668999999999753 3344567889999999999999999999876543 458
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec--CCC--Cccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDF--TPKVSDFG 1117 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD--~ng--~VKLsDFG 1117 (1368)
+|||||.+|+|+..|++-.. ...|.+.+.+.++.+++.||.|||+++ ||||||||.||++- ++| -.||+|||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN-~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN-AYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred EEEeecCCCcHHHHhcCccc-ccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 99999999999999976433 346999999999999999999999888 99999999999993 234 36999999
Q ss_pred ccccccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc-
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS- 1195 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~- 1195 (1368)
+|+...++. ....++||..|++||+... +.|+..+|.|||||++||+.||..||..........-+.|.. .++
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~--~tkk 244 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI--ITKK 244 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh--hccC
Confidence 999875433 5567889999999999984 889999999999999999999999997665443222222321 221
Q ss_pred ccccceeecCCCCCC------------CChhhHHHHHHHHHHhcCcCcCCCC--CHHHHHHHHHHHHHh
Q 000659 1196 REGLERIIDPSLGND------------VPFDSVAKVAAIASMCVQPEVQHRP--FMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1196 ~e~L~eIvDp~L~~~------------~~~ee~~eLl~La~~CL~pDPkeRP--TMsEVLq~Le~I~~e 1250 (1368)
...+....+....+. .......++.+.+..++..++++|. .+.+.+..+..+++.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~ 313 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL 313 (732)
T ss_pred CCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence 111111122221111 1123345677788888888999999 888888888877763
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.1e-32 Score=279.50 Aligned_cols=238 Identities=29% Similarity=0.389 Sum_probs=193.7
Q ss_pred CcEEEEEEEec-CCCEEEEEEeecccchh-hHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccc
Q 000659 981 GFGLVYSGVLD-DGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG 1058 (1368)
Q Consensus 981 gFGtVYKAvlk-dGr~VAVKvLk~~d~~~-~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~ 1058 (1368)
+||.||+|+.. +|+.|++|++....... .+.+.+|++++++++|+||+++++++......+++|||+.+++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999976 48999999997654443 67899999999999999999999999999999999999999999999853
Q ss_pred cccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccc
Q 000659 1059 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138 (1368)
Q Consensus 1059 ~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~ 1138 (1368)
.. .+++..+++++.+++++|.|||+.+ |+|+||+++||++++++.++|+|||++....... ......++.
T Consensus 81 ~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 81 RG----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred cc----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 22 2889999999999999999999887 9999999999999999999999999998764432 223455888
Q ss_pred cccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHH
Q 000659 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 1218 (1368)
Q Consensus 1139 gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~e 1218 (1368)
.|++||.+....++.++|||+||+++|||++|..||+... +...+.++....... . .........+
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~------~------~~~~~~~~~~ 216 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPP------F------PPPEWKISPE 216 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCC------C------ccccccCCHH
Confidence 9999999988889999999999999999999999986531 122233322211100 0 0000003467
Q ss_pred HHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1219 VAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1219 Ll~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
+.+++.+||..+|++||++.++++
T Consensus 217 ~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 217 AKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHccCCchhccCHHHHhh
Confidence 899999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-33 Score=342.84 Aligned_cols=256 Identities=26% Similarity=0.389 Sum_probs=192.6
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc-cchhhHHHHHHHHHHhhcccccceeeeeeeee------
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE------ 1036 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d------ 1036 (1368)
.+...+|+..++||+||||.|||++.+ ||+.||||++.-. ......++++|+.+|.+|+|+|||+++..+.+
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 567788999999999999999999965 8999999998532 45556789999999999999999998821100
Q ss_pred --------------------------------------------------------------------------------
Q 000659 1037 -------------------------------------------------------------------------------- 1036 (1368)
Q Consensus 1037 -------------------------------------------------------------------------------- 1036 (1368)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred -------------------------c--------cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHh
Q 000659 1037 -------------------------E--------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083 (1368)
Q Consensus 1037 -------------------------~--------~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLa 1083 (1368)
+ ..+||-||||+..+|.+++++.... -..+..++++.+|+.||+
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~---~~~d~~wrLFreIlEGLa 711 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN---SQRDEAWRLFREILEGLA 711 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc---hhhHHHHHHHHHHHHHHH
Confidence 0 1247889999998888888643221 146788999999999999
Q ss_pred hhhccCCCCccccCCcccCeeecCCCCccccccccccccc------c----------cccccccccccccccccCcchhc
Q 000659 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM------D----------EESRHISTRVMGTFGYVAPEYAM 1147 (1368)
Q Consensus 1084 YLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~------~----------~~~~~~st~v~GT~gYmAPEvL~ 1147 (1368)
|+|+.| ||||||||.||+||+++.|||+|||+|+... + +......+..+||..|+|||++.
T Consensus 712 YIH~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~ 788 (1351)
T KOG1035|consen 712 YIHDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLS 788 (1351)
T ss_pred HHHhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhc
Confidence 999998 9999999999999999999999999998721 0 01111234578999999999987
Q ss_pred cC---CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHH
Q 000659 1148 TG---HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIAS 1224 (1368)
Q Consensus 1148 ~~---~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~ 1224 (1368)
+. .|+.|+|+||||||||||+. ||...- +...... .+. ...+.. ..++.......=.++++
T Consensus 789 ~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~iL~----~LR-~g~iP~------~~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 789 DTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERASILT----NLR-KGSIPE------PADFFDPEHPEEASLIR 852 (1351)
T ss_pred ccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHHHHH----hcc-cCCCCC------CcccccccchHHHHHHH
Confidence 54 59999999999999999985 464321 1111111 111 111110 02233445566778999
Q ss_pred HhcCcCcCCCCCHHHHHH
Q 000659 1225 MCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1225 ~CL~pDPkeRPTMsEVLq 1242 (1368)
++++.||.+|||+.|+++
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999974
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-33 Score=305.72 Aligned_cols=243 Identities=26% Similarity=0.336 Sum_probs=198.9
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
..++|+.+++||+|.||+|.+++ ..+|+.+|||++++.- ++....-+.|-++|+..+||.+..|...+...+.+|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 35789999999999999999998 4579999999998642 3333445789999999999999999988999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.||.|+-+|.+ ...++++...-+-..|+.||.|||+++ ||.||||.+|+|||.+|.+||+||||++.-
T Consensus 246 VMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc
Confidence 9999999999999953 345778877888889999999999887 999999999999999999999999999854
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.. ......+.|||+.|+|||++....|+..+|.|.+||++|||++|+.||...+.+ .+.+.+ +.
T Consensus 319 I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLI---l~-------- 382 (516)
T KOG0690|consen 319 IK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELI---LM-------- 382 (516)
T ss_pred cc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHH---Hh--------
Confidence 32 222345689999999999999999999999999999999999999999754322 111111 00
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1236 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT 1236 (1368)
.. -.++.....+...|+.-.|..||++|..
T Consensus 383 --ed--~kFPr~ls~eAktLLsGLL~kdP~kRLG 412 (516)
T KOG0690|consen 383 --ED--LKFPRTLSPEAKTLLSGLLKKDPKKRLG 412 (516)
T ss_pred --hh--ccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence 00 1234444567788899999999999963
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=311.55 Aligned_cols=249 Identities=23% Similarity=0.325 Sum_probs=202.8
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LV 1043 (1368)
.+.|..-++||+|+||.||-+. ..+|+-+|+|++.+. ...++...++|-.||.+++.+.||.|-..|...+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4668889999999999999998 457999999998432 334445678999999999999999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
+..|.||+|.-+|.+.. +..+++..++-++.+|+.||++||+.. ||.|||||+|||||+.|+++|+|+|||..+.
T Consensus 264 LtlMNGGDLkfHiyn~g--~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~ 338 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG--NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIP 338 (591)
T ss_pred EEeecCCceeEEeeccC--CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecC
Confidence 99999999999986543 356999999999999999999999887 9999999999999999999999999999875
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.+.. ....+||.+|||||++.++.|+...|.|+|||+||||+.|+.||...... +.|- .+++.+
T Consensus 339 ~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK-----vk~e--------Evdrr~ 402 (591)
T KOG0986|consen 339 EGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK-----VKRE--------EVDRRT 402 (591)
T ss_pred CCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh-----hhHH--------HHHHHH
Confidence 5332 22347999999999999999999999999999999999999999654322 2220 011100
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1238 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMs 1238 (1368)
. .....++.....+..+|....|..||++|...+
T Consensus 403 ~-~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr 436 (591)
T KOG0986|consen 403 L-EDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR 436 (591)
T ss_pred h-cchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence 0 001234445566788889999999999997654
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=284.90 Aligned_cols=221 Identities=20% Similarity=0.189 Sum_probs=176.7
Q ss_pred cCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccc
Q 000659 980 GGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG 1058 (1368)
Q Consensus 980 GgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~ 1058 (1368)
|.||.||++.. .+++.||+|+++... ++.+|...+....|+||+++++++.+.+..++||||+.+|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999995 478999999997532 234455555666799999999999999999999999999999999853
Q ss_pred cccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccc
Q 000659 1059 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138 (1368)
Q Consensus 1059 ~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~ 1138 (1368)
. ..+++.++++++.|++.||+|||+.+ |+||||||+|||++.++.++|+|||++...... .....++.
T Consensus 79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~~~~ 146 (237)
T cd05576 79 F----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEAVEN 146 (237)
T ss_pred h----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCCcCc
Confidence 2 35899999999999999999999887 999999999999999999999999988655321 12234677
Q ss_pred cccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHH
Q 000659 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 1218 (1368)
Q Consensus 1139 gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~e 1218 (1368)
.|++||++....++.++|||||||++|||++|+.+++..... + . .... ...+.....+
T Consensus 147 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-------~-----~------~~~~----~~~~~~~~~~ 204 (237)
T cd05576 147 MYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-------I-----N------THTT----LNIPEWVSEE 204 (237)
T ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-------c-----c------cccc----cCCcccCCHH
Confidence 899999998888999999999999999999999877432110 0 0 0000 0112223467
Q ss_pred HHHHHHHhcCcCcCCCCCHHH
Q 000659 1219 VAAIASMCVQPEVQHRPFMGE 1239 (1368)
Q Consensus 1219 Ll~La~~CL~pDPkeRPTMsE 1239 (1368)
+.+++.+|++.||++|+++.+
T Consensus 205 ~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 205 ARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred HHHHHHHHccCCHHHhcCCCc
Confidence 889999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=296.82 Aligned_cols=206 Identities=24% Similarity=0.332 Sum_probs=169.1
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec---C--CCEEEEEEeecccch--hhHHHHHHHHHHhhcccccceeeeeeeee-cc
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD---D--GTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGICIE-EQ 1038 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk---d--Gr~VAVKvLk~~d~~--~~keFlrEIeILsrLrHPNIVrLlG~~~d-~~ 1038 (1368)
....|+..+.||+|+||.||||+-. + .+.+|||+++...+. ......|||.+++.|+|+||+.|+.++.. +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3456889999999999999999733 2 236899999754221 12356799999999999999999999887 78
Q ss_pred ceEEEEeecCCCChhhcccccc-cCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC----CCccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVD-KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD----FTPKV 1113 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~-~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n----g~VKL 1113 (1368)
.++|++||.+. +|.+.++..+ .+...+....+..|++||+.|+.|||++. |+||||||.||||..+ |++||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 89999999965 7777775322 23346888999999999999999999998 9999999999999877 99999
Q ss_pred ccccccccccccccc-cccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCC
Q 000659 1114 SDFGLARSAMDEESR-HISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDM 1176 (1368)
Q Consensus 1114 sDFGLArll~~~~~~-~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~ 1176 (1368)
+||||+|.+...-.- .....++-|..|+|||++.+ ..||.+.|||++|||+.|||+-+.-|..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999999988653322 23456778999999998886 5789999999999999999998776644
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=310.32 Aligned_cols=262 Identities=19% Similarity=0.262 Sum_probs=184.4
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-----------------cCCCEEEEEEeecccchhhHHH--------------HHH
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-----------------DDGTKVAVKVLKRVDQQGGREF--------------LAE 1015 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-----------------kdGr~VAVKvLk~~d~~~~keF--------------lrE 1015 (1368)
..++|++.++||+|+||.||+|.+ .+++.||||+++.......++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999974 2456899999875433333333 447
Q ss_pred HHHHhhcccccc-----eeeeeeeee--------ccceEEEEeecCCCChhhccccccc--------------------C
Q 000659 1016 VEMLSRLHHRNL-----VKLIGICIE--------EQARCLVYELIPNGSVESHLHGVDK--------------------E 1062 (1368)
Q Consensus 1016 IeILsrLrHPNI-----VrLlG~~~d--------~~~~~LVmEYm~gGSL~d~L~~~~~--------------------~ 1062 (1368)
+.++.+++|.++ ++++++|.. ++..+|||||+.+|+|.++|+.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788876654 678888753 3567999999999999999874211 1
Q ss_pred CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccccccC
Q 000659 1063 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142 (1368)
Q Consensus 1063 ~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmA 1142 (1368)
...++|..++.|+.|++.+|+|||+.+ |+|||||++|||++.++.+||+|||+++....... .......+++.|++
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 124578889999999999999999887 99999999999999999999999999976533211 11122335789999
Q ss_pred cchhccCC--------------------C--CcccceeeHHHHHHHHHhCCC-CCCCCCCCc------chhHHHhhhhhc
Q 000659 1143 PEYAMTGH--------------------L--LVKSDVYSYGVVILELLSGRK-PVDMTQPPG------QENLVAWARPLL 1193 (1368)
Q Consensus 1143 PEvL~~~~--------------------~--T~KSDVWSLGVILyELLTGr~-PFd~s~~~~------~~nLv~Wa~pll 1193 (1368)
||.+.... + ..+.||||+|||||||++|.. +|....... ...+..|...
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-- 456 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-- 456 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--
Confidence 99875322 1 135799999999999999875 664321111 1122223210
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCc---CCCCCHHHHHHH
Q 000659 1194 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEV---QHRPFMGEVVQA 1243 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDP---keRPTMsEVLq~ 1243 (1368)
... .++- ...........+|+.+|+..++ .+|+++.|+++.
T Consensus 457 ~~~-----~~~~----~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H 500 (507)
T PLN03224 457 KGQ-----KYDF----SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH 500 (507)
T ss_pred ccc-----CCCc----ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence 000 0000 1112234567888999998765 689999999875
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=293.93 Aligned_cols=245 Identities=26% Similarity=0.435 Sum_probs=196.8
Q ss_pred eeEEeecCcEEEEEEEec-CCCEEEEEEeec-ccchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEeecCCC
Q 000659 974 SRILGEGGFGLVYSGVLD-DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~-~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+..||.|..|.||+++++ +|..+|||.+.+ .+.++.++++..++++.+.+ .++||+.+|||..+...++.||.| .-
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~ 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-ST 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HH
Confidence 457999999999999955 689999999965 45566778889999888775 999999999999999999999999 45
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~ 1130 (1368)
.++.+|++. ..++.+..+-++...+++||.||-++. +|||||+||+|||||+.|++||||||++..+.+. ..
T Consensus 176 C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---kA 247 (391)
T KOG0983|consen 176 CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---KA 247 (391)
T ss_pred HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc---cc
Confidence 666676543 346888888999999999999999875 6999999999999999999999999999866442 22
Q ss_pred cccccccccccCcchhcc---CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec---
Q 000659 1131 STRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID--- 1204 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~---~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD--- 1204 (1368)
.++..|-..|||||.+.- ..|+.++||||||+.|+||.||+.||..-+.+ .+. +.++++
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~--------------ltkvln~eP 312 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEV--------------LTKVLNEEP 312 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHH--------------HHHHHhcCC
Confidence 345568899999998863 47889999999999999999999999753321 111 112222
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+.+.+ .......|.+++..||..|+.+||...++++.-
T Consensus 313 P~L~~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 313 PLLPG--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred CCCCc--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 22221 122457899999999999999999999998764
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=315.80 Aligned_cols=260 Identities=27% Similarity=0.412 Sum_probs=213.2
Q ss_pred CHHHHHHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeee-
Q 000659 960 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE- 1036 (1368)
Q Consensus 960 sleELe~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d- 1036 (1368)
.++.+..-++-|++.+.||+|.+|.||+++ .++|+.+|||++.. +.+..+++..|.+||+.+ +|+|++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~-~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDP-TEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecC-CccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 444455567789999999999999999999 66889999999864 455567888999999988 59999999999864
Q ss_pred ----ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcc
Q 000659 1037 ----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1112 (1368)
Q Consensus 1037 ----~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VK 1112 (1368)
++++|||||||.+|+..|++++.. ...|.|+.+..|++.+++||.+||... ++|||||-.||||+.++.+|
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 578999999999999999998765 567999999999999999999999876 99999999999999999999
Q ss_pred cccccccccccccccccccccccccccccCcchhcc-----CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHH
Q 000659 1113 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT-----GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 1187 (1368)
Q Consensus 1113 LsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~-----~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~ 1187 (1368)
|+|||++..+.. ......+..||+.|||||++.. ..|+.++|+||||++-.||--|..|+.+...
T Consensus 164 LvDFGvSaQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP-------- 233 (953)
T KOG0587|consen 164 LVDFGVSAQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP-------- 233 (953)
T ss_pred Eeeeeeeeeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch--------
Confidence 999999987643 2333455679999999999864 3577899999999999999999999865321
Q ss_pred hhhhhcccccccceee-cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1188 WARPLLTSREGLERII-DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1188 Wa~plls~~e~L~eIv-Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
++. |..+. ++-..-.-+....++|.++|..||..|.++||++.++++.
T Consensus 234 -mra-------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 234 -MRA-------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred -hhh-------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 111 11111 1222223345678899999999999999999999998754
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=314.51 Aligned_cols=262 Identities=19% Similarity=0.212 Sum_probs=172.0
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec-C----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeee------ee
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-D----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI------CI 1035 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk-d----Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~------~~ 1035 (1368)
..++|++.+.||+|+||.||+|++. + ++.||||+++..... +.+..| .+++..+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 4678999999999999999999965 4 689999998643211 111111 1122222222222221 24
Q ss_pred eccceEEEEeecCCCChhhcccccccC----------------CCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCc
Q 000659 1036 EEQARCLVYELIPNGSVESHLHGVDKE----------------SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1099 (1368)
Q Consensus 1036 d~~~~~LVmEYm~gGSL~d~L~~~~~~----------------~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIK 1099 (1368)
++...+|||||+.+++|.++++..... .....+..+..|+.||++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 567889999999999999998642210 011223456689999999999999887 9999999
Q ss_pred ccCeeecC-CCCcccccccccccccccccccccccccccccccCcchhccC----------------------CCCcccc
Q 000659 1100 SSNILLEH-DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG----------------------HLLVKSD 1156 (1368)
Q Consensus 1100 PsNILLD~-ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~----------------------~~T~KSD 1156 (1368)
|+||||++ ++++||+|||+++...... .......+|+..|||||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 5799999999998654322 2233456789999999965321 2445779
Q ss_pred eeeHHHHHHHHHhCCCCCCCCCC-------CcchhHHHhhhhhcccccccceeecCCCCCCC--ChhhHHHHHHHHHHhc
Q 000659 1157 VYSYGVVILELLSGRKPVDMTQP-------PGQENLVAWARPLLTSREGLERIIDPSLGNDV--PFDSVAKVAAIASMCV 1227 (1368)
Q Consensus 1157 VWSLGVILyELLTGr~PFd~s~~-------~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~--~~ee~~eLl~La~~CL 1227 (1368)
|||||||||||+++..+++.... .....+..|....... ....+...+ .........+|+.+||
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHHHHHc
Confidence 99999999999998766542210 0011122332111100 000000000 0111234568999999
Q ss_pred CcCcCCCCCHHHHHHH
Q 000659 1228 QPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1228 ~pDPkeRPTMsEVLq~ 1243 (1368)
+.||++|||+.|+++.
T Consensus 435 ~~dP~kR~ta~e~L~H 450 (566)
T PLN03225 435 RFKGRQRISAKAALAH 450 (566)
T ss_pred cCCcccCCCHHHHhCC
Confidence 9999999999999876
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=301.99 Aligned_cols=259 Identities=25% Similarity=0.369 Sum_probs=198.5
Q ss_pred HHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeec---ccch----hhHHHHHHHHHHhhcccccceeeeeeee-e
Q 000659 966 KATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQ----GGREFLAEVEMLSRLHHRNLVKLIGICI-E 1036 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~---~d~~----~~keFlrEIeILsrLrHPNIVrLlG~~~-d 1036 (1368)
...++|-++.+||+|||+.||||. +...+.||||+-.. +..+ -.+...+|.+|.+.|+|+.||++++|+. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 344668888999999999999998 66688899998532 1111 1234578999999999999999999985 5
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec---CCCCccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKV 1113 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD---~ng~VKL 1113 (1368)
.+.+|-|+|||+|.+|+-||+. ...++++++..|+.||+.||.||.+. +++|||-||||.||||. ..|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 6788999999999999999954 34689999999999999999999998 58899999999999994 4588999
Q ss_pred cccccccccccccccc-----ccccccccccccCcchhccC----CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchh
Q 000659 1114 SDFGLARSAMDEESRH-----ISTRVMGTFGYVAPEYAMTG----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1184 (1368)
Q Consensus 1114 sDFGLArll~~~~~~~-----~st~v~GT~gYmAPEvL~~~----~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~n 1184 (1368)
+||||++.+.++.+.. +.....||.+|++||.+.-+ +.+.|+||||+|||+|+++.|++||+.... ++.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HHH
Confidence 9999999876544332 23456799999999987644 578999999999999999999999976532 222
Q ss_pred HHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHH
Q 000659 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV 1241 (1368)
Q Consensus 1185 Lv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVL 1241 (1368)
+...- .+.+.-+-.+. .......+..++|++||+..-++|-+..|+.
T Consensus 693 ILqeN--------TIlkAtEVqFP--~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 693 ILQEN--------TILKATEVQFP--PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred HHhhh--------chhcceeccCC--CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 22211 11111000010 0112345678899999999999997776653
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=290.84 Aligned_cols=269 Identities=24% Similarity=0.331 Sum_probs=204.8
Q ss_pred CHHHHHHHhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeeeeeec
Q 000659 960 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE 1037 (1368)
Q Consensus 960 sleELe~aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~ 1037 (1368)
.++|+-+.+ .++||+|+|+.|--++ +.+|..||||++.+.......++++|++++.+.+ |+||++|+++++++
T Consensus 74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 356666666 3689999999999888 7889999999998777777889999999999996 99999999999999
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC---Ccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVS 1114 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng---~VKLs 1114 (1368)
+..|||||.|.||.|..++++ ..-+++.++.+++++|+.||.|||.+| |.||||||+|||-.+-. -+||+
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiC 221 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKIC 221 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeee
Confidence 999999999999999999964 235889999999999999999999998 99999999999996543 48999
Q ss_pred cccccccccccc-----cccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcc--
Q 000659 1115 DFGLARSAMDEE-----SRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ-- 1182 (1368)
Q Consensus 1115 DFGLArll~~~~-----~~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~-- 1182 (1368)
||.|..-+.... ......+-+|...|||||+.. ...|+.+.|.||||||||-||+|+.||...-..+.
T Consensus 222 DfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 222 DFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred ccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 999876432211 111223467999999999754 23578899999999999999999999976533221
Q ss_pred ---hhHHHhhhhhccc-ccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1183 ---ENLVAWARPLLTS-REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1183 ---~nLv~Wa~plls~-~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
+.+..-...++.. .++..++-|.. ......+..+++...+..|+.+|.++.++++.-+
T Consensus 302 drGe~Cr~CQ~~LFesIQEGkYeFPdkd-----WahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 302 DRGEVCRVCQNKLFESIQEGKYEFPDKD-----WAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred cCCCccHHHHHHHHHHHhccCCcCChhh-----hHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 1111111111111 01111111111 1123456778888999999999999999987543
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-31 Score=322.86 Aligned_cols=259 Identities=23% Similarity=0.297 Sum_probs=207.5
Q ss_pred HHHHHHHhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecc---cchhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 961 ASEIEKATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 961 leELe~aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~---d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
..+++...++|+++++||+|+||.|..++.+ +++.||+|++.++ ......-|..|-++|..-+.+=|+.|+-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455666789999999999999999999964 6889999999763 23344568889999999899999999999999
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
++++|||||||.||+|..+|..++ .++++.+..++..|+-||.-||+.| +|||||||+|||||.+|.+||+||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~----~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADF 219 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD----RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADF 219 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC----CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccc
Confidence 999999999999999999996443 5889999999999999999999888 999999999999999999999999
Q ss_pred cccccccccccccccccccccccccCcchhc----c-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhh
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAM----T-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~----~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~p 1191 (1368)
|.+-.+..+ ..-.+...+||+.|++||++. + +.|+..+|.||+||++||||.|.-||.. +.++.-...
T Consensus 220 GsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~K 292 (1317)
T KOG0612|consen 220 GSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGK 292 (1317)
T ss_pred hhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHH
Confidence 998766532 333445677999999999986 2 6799999999999999999999999964 344444333
Q ss_pred hcccccccceeecCCCCCCCC--hhhHHHHHHHHHHhcCcCcCCCCC---HHHHHHHH
Q 000659 1192 LLTSREGLERIIDPSLGNDVP--FDSVAKVAAIASMCVQPEVQHRPF---MGEVVQAL 1244 (1368)
Q Consensus 1192 lls~~e~L~eIvDp~L~~~~~--~ee~~eLl~La~~CL~pDPkeRPT---MsEVLq~L 1244 (1368)
.+.-.+ .-.++ .+...+..+||++.+. +++.|.. +.++....
T Consensus 293 Im~hk~----------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp 339 (1317)
T KOG0612|consen 293 IMNHKE----------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP 339 (1317)
T ss_pred Hhchhh----------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence 222111 11222 2355677888887654 5677777 77776554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=250.55 Aligned_cols=210 Identities=37% Similarity=0.592 Sum_probs=183.1
Q ss_pred EeecCcEEEEEEEecC-CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChhh
Q 000659 977 LGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES 1054 (1368)
Q Consensus 977 LGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~d 1054 (1368)
||+|.+|.||++...+ ++.+++|++...... ..+.+.+|++++++++|++|+++++++......+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999764 899999999754332 35689999999999999999999999999899999999999999999
Q ss_pred cccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCccccccccccccccccccccccc
Q 000659 1055 HLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHISTR 1133 (1368)
Q Consensus 1055 ~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~VKLsDFGLArll~~~~~~~~st~ 1133 (1368)
++.... ..+++..++.++.+++++|.|||+.+ ++|+||+++||+++. +++++|+|||++........ ....
T Consensus 81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 81 LLKENE---GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 985432 35899999999999999999999887 999999999999999 89999999999986643221 1233
Q ss_pred ccccccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCC
Q 000659 1134 VMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212 (1368)
Q Consensus 1134 v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~ 1212 (1368)
..+...|++||.+... ..+.+.|+|+||+++++|
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4578899999998877 888999999999999999
Q ss_pred hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1213 ~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+.+++..|++.+|++|+++.++++.
T Consensus 188 ----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 468889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=301.26 Aligned_cols=247 Identities=25% Similarity=0.336 Sum_probs=197.7
Q ss_pred eeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCC
Q 000659 974 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
.++||.|.||+||-|. .++|+.||||++.+. ....+.++++|+.||++++||.||.|-..|+..+.+++|||.+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 5799999999999999 568999999999653 334457889999999999999999999999999999999999954
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC---CCccccccccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD---FTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n---g~VKLsDFGLArll~~~~~ 1127 (1368)
++.+.+- ..+..+|.+..-..++.||+.||.|||.++ |+|+||||+||||... -++||||||+||.+.+.
T Consensus 648 DMLEMIL--SsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-- 720 (888)
T KOG4236|consen 648 DMLEMIL--SSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-- 720 (888)
T ss_pred hHHHHHH--HhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--
Confidence 5544442 345567888888889999999999999998 9999999999999654 36999999999988543
Q ss_pred ccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.....++||+.|+|||+++++.|...-|+||.|||+|.-|+|..||+... ++.+.++ +..-++-
T Consensus 721 -sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----dIndQIQ-------NAaFMyP--- 784 (888)
T KOG4236|consen 721 -SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----DINDQIQ-------NAAFMYP--- 784 (888)
T ss_pred -hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----chhHHhh-------ccccccC---
Confidence 33456889999999999999999999999999999999999999996432 2222111 0111111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
..-..+.....++||...|+..-.+|-+.++.+...+
T Consensus 785 -p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 785 -PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred -CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 1222344566788999999999999999988776544
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=286.22 Aligned_cols=257 Identities=23% Similarity=0.245 Sum_probs=197.6
Q ss_pred HhCCccee-eEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeee----ccc
Q 000659 967 ATGNFDAS-RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE----EQA 1039 (1368)
Q Consensus 967 aT~nFei~-klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d----~~~ 1039 (1368)
++++|.+. ++||-|-.|.|..+.. .+|+.+|+|+|.+. .+.++|+++.-+. .|+|||.++++|.. ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666654 5799999999999984 47899999999743 2456899987777 49999999999863 456
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC---CCCcccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 1116 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~---ng~VKLsDF 1116 (1368)
+++|||.|+||.|+..+... ....+++.++-.|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+||
T Consensus 134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDf 208 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDF 208 (400)
T ss_pred eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccc
Confidence 68899999999999999643 3457999999999999999999999988 999999999999964 456899999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
|+|+.... .....+-|-|+.|+|||++...+|+...|+||+||++|-||+|..||...... .+..-++..+.
T Consensus 209 GFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~---aispgMk~rI~-- 280 (400)
T KOG0604|consen 209 GFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL---AISPGMKRRIR-- 280 (400)
T ss_pred ccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc---cCChhHHhHhh--
Confidence 99986532 23334567899999999999999999999999999999999999999654321 11111110000
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
.+..++ ...-.....+...++++.+|..+|.+|.|+.|++..-+.
T Consensus 281 ~gqy~F-----P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi 325 (400)
T KOG0604|consen 281 TGQYEF-----PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI 325 (400)
T ss_pred ccCccC-----CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence 000001 111112334667889999999999999999999876553
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-31 Score=291.78 Aligned_cols=254 Identities=23% Similarity=0.324 Sum_probs=195.3
Q ss_pred eeEEeecCcEEEEEEEec-CCCEEEEEEeecccc-hhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeecCCC
Q 000659 974 SRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~-~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+..||.|.||+|+|-.++ .|+..|||+++.... .+.++++.|.+...+- +.+|||+++|.+..++.+|+.||.| .-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hh
Confidence 458999999999999854 799999999976443 5667899999887665 6999999999999999999999999 45
Q ss_pred Chhhcccc-cccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1051 SVESHLHG-VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1051 SL~d~L~~-~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
+|+.+... +...+..+.+..+-+|....++||.||-+.- +||||||||+|||||..|.+||||||++..+.+ ..
T Consensus 148 SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---Si 222 (361)
T KOG1006|consen 148 SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---SI 222 (361)
T ss_pred hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH---HH
Confidence 66554321 2223456888889999999999999998764 699999999999999999999999999986633 22
Q ss_pred ccccccccccccCcchhcc--CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMT--GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~--~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
..+...|-.-|||||.+.. ..|+-++||||||++|+|+.||+.|+...+ ++.+.+....... -. ++..
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd--pp-~l~~-- 292 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD--PP-ILLF-- 292 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC--CC-eecC--
Confidence 2344557788999998863 348899999999999999999999996542 2222222222111 11 1111
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
..-..+....|..++..|+..|-.+||.+.+++++-
T Consensus 293 -~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 293 -DKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred -cccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 111133557899999999999999999999997763
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=297.38 Aligned_cols=213 Identities=27% Similarity=0.367 Sum_probs=177.8
Q ss_pred CCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccc---hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ---QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~---~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.-|...+.||-|+||+|.++. .++...||+|.|++.+- .....++.|-+||...+.+-||+|+-.|.+++.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 458889999999999999998 56677899999976433 23345688999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||++||++-.+|-+ .+.+.++.+..++..+.+|+++.|..| +|||||||+|||||.+|.|||+||||+.-+..
T Consensus 709 dYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred eccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999853 346788888888999999999999888 99999999999999999999999999963211
Q ss_pred --------cccc--------------------------------cccccccccccccCcchhccCCCCcccceeeHHHHH
Q 000659 1125 --------EESR--------------------------------HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVI 1164 (1368)
Q Consensus 1125 --------~~~~--------------------------------~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVIL 1164 (1368)
+... .....++||..|+|||++....++.-+|.||.||||
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0000 001135799999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCCCc-chhHHHh
Q 000659 1165 LELLSGRKPVDMTQPPG-QENLVAW 1188 (1368)
Q Consensus 1165 yELLTGr~PFd~s~~~~-~~nLv~W 1188 (1368)
|||+.|+.||......+ +..+..|
T Consensus 862 ~em~~g~~pf~~~tp~~tq~kv~nw 886 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGETQYKVINW 886 (1034)
T ss_pred HHHhhCCCCccCCCCCcceeeeeeh
Confidence 99999999997766544 3344555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-30 Score=303.66 Aligned_cols=244 Identities=23% Similarity=0.251 Sum_probs=197.8
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.++.|+....||.|+|+.|-++. ..+++..++|++.+.. .+-.+|+.++.+. +|+||+.+.++|.+..+.|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 46778888899999999999888 4578899999997542 2334678777776 6999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee-cCCCCccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL-D~ng~VKLsDFGLArll~ 1123 (1368)
|++.||.|.+.+... .....++..|+.+|+.+|.|||++| ||||||||+|||+ ++.++++|+|||.++...
T Consensus 396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~ 467 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELE 467 (612)
T ss_pred hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence 999999988877432 2223778889999999999999988 9999999999999 588999999999998765
Q ss_pred ccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceee
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIv 1203 (1368)
.. ..+-+-|..|.|||++....|++++|+||||++|||||+|+.||...-.. ..+..
T Consensus 468 ~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~---------------- 524 (612)
T KOG0603|consen 468 RS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT---------------- 524 (612)
T ss_pred hh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH----------------
Confidence 43 23345689999999999999999999999999999999999999654221 11111
Q ss_pred cCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
....+.+.........+|+.+||+.||.+|++|+|+...-+.
T Consensus 525 -~i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 525 -RIQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -hhcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 111122334556788999999999999999999999776443
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-30 Score=289.65 Aligned_cols=243 Identities=23% Similarity=0.311 Sum_probs=195.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeeccc---chhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d---~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~L 1042 (1368)
..+|..+.+||+|+||+|.+|..+ +.+.+|||+|++.- .+..+--+.|-++|... +-+.+++|..++..-+.+|+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF 427 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF 427 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence 357899999999999999999854 56789999997532 12222335677777766 57899999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+.||+|--++++.. .+.+..+.-++..||-||-|||++| ||.||||.+|||||.+|.+||+|||+++..
T Consensus 428 VMEyvnGGDLMyhiQQ~G----kFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 428 VMEYVNGGDLMYHIQQVG----KFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEEecCchhhhHHHHhc----ccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999988886554 3667788889999999999999998 999999999999999999999999999854
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
..+ .....+.|||+.|+|||++....|+..+|.|+|||+|||||.|+.||+..++++ ....|
T Consensus 501 i~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI 562 (683)
T KOG0696|consen 501 IFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAI 562 (683)
T ss_pred ccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Confidence 322 223356899999999999999999999999999999999999999998754321 11222
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
++.+. .++.....+.+.+....+...|.+|...
T Consensus 563 ~ehnv--syPKslSkEAv~ickg~ltK~P~kRLGc 595 (683)
T KOG0696|consen 563 MEHNV--SYPKSLSKEAVAICKGLLTKHPGKRLGC 595 (683)
T ss_pred HHccC--cCcccccHHHHHHHHHHhhcCCccccCC
Confidence 23222 3455556778888888899999998643
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=250.55 Aligned_cols=199 Identities=36% Similarity=0.484 Sum_probs=172.6
Q ss_pred cceeeEEeecCcEEEEEEEecC-CCEEEEEEeecccch-hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecC
Q 000659 971 FDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQQ-GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d~~-~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
|++.+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5678899999999999999764 899999999765444 56789999999999999999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
+++|.+++..... .+++..++.++.+++++|.|||+.+ ++|+||+++||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~- 153 (225)
T smart00221 81 GGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA- 153 (225)
T ss_pred CCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-
Confidence 9999999864321 1889999999999999999999887 99999999999999999999999999987654321
Q ss_pred cccccccccccccCcchh-ccCCCCcccceeeHHHHHHHHHhCCCCCCC
Q 000659 1129 HISTRVMGTFGYVAPEYA-MTGHLLVKSDVYSYGVVILELLSGRKPVDM 1176 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL-~~~~~T~KSDVWSLGVILyELLTGr~PFd~ 1176 (1368)
.......++..|++||.+ ....++.++|||+||++++||++|+.||+.
T Consensus 154 ~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 122335678899999998 666778899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=258.97 Aligned_cols=265 Identities=21% Similarity=0.263 Sum_probs=195.4
Q ss_pred CCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccch--hhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQ--GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~--~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
.+|+..++||+|.||+||||+ .++++.||+|+++-.+.+ .-...++||-+|+.|+|+|||+|+++...+...-||+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 356677899999999999999 567899999998643322 23467899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||+ .+|..|... -++.++.+....++.|+++||.|+|+++ +.||||||.|+||+.+|++||+|||+++-+.-.
T Consensus 82 ~cd-qdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 82 FCD-QDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred Hhh-HHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 994 477777643 3456899999999999999999999988 999999999999999999999999999966431
Q ss_pred ccccccccccccccccCcchhccC-CCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhccc--ccccce
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTS--REGLER 1201 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~--~e~L~e 1201 (1368)
.......+-|..|.+|+++.+. -|+...|+||-|||+.||.. |+.-|-..+..++....-|.....++ .-.+.+
T Consensus 155 --vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~ 232 (292)
T KOG0662|consen 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK 232 (292)
T ss_pred --eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence 1122335579999999998865 47788899999999999987 77667655444333333332222211 111222
Q ss_pred eecCCCCCCCCh---------hhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1202 IIDPSLGNDVPF---------DSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1202 IvDp~L~~~~~~---------ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
+-|-....-++. .....=.+++++.+.-+|.+|.++++.++
T Consensus 233 lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 233 LPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 323222222221 11122345666777778888888887765
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=285.03 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=199.8
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-c-c----cceeeeeeeeeccc
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-H-R----NLVKLIGICIEEQA 1039 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-H-P----NIVrLlG~~~d~~~ 1039 (1368)
.+++|.+.+++|+|.||.|.++.. +.+..||||+++..+.. .+.-+-||++|++|. + | -+|.+.+|+.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 378899999999999999999984 45789999999866544 334567999999994 2 2 36788888999999
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH------------ 1107 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~------------ 1107 (1368)
.|||+|.+ |-+++++|.... -.++..+.+..|++|++++|+|||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~--y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENN--YIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred eEEEEecc-ChhHHHHhccCC--ccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence 99999999 779999996533 346788999999999999999999887 999999999999931
Q ss_pred --------CCCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCC
Q 000659 1108 --------DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQP 1179 (1368)
Q Consensus 1108 --------ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~ 1179 (1368)
+..|||+|||.|+...... ..++.|..|.|||++.+..++..+||||+||||+||++|..-|.....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen 314 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHEN 314 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCc
Confidence 3358999999998553321 457789999999999999999999999999999999999998876542
Q ss_pred CcchhHHHhh--------------hhhcccc----------cccceeecCCC----CCCCChhhHHHHHHHHHHhcCcCc
Q 000659 1180 PGQENLVAWA--------------RPLLTSR----------EGLERIIDPSL----GNDVPFDSVAKVAAIASMCVQPEV 1231 (1368)
Q Consensus 1180 ~~~~nLv~Wa--------------~plls~~----------e~L~eIvDp~L----~~~~~~ee~~eLl~La~~CL~pDP 1231 (1368)
.+...+.+.+ ...+... ..+....+... .......+..+|.+|++++|..||
T Consensus 315 ~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP 394 (415)
T KOG0671|consen 315 LEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDP 394 (415)
T ss_pred HHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCc
Confidence 2211111110 0001000 00001111100 011223456789999999999999
Q ss_pred CCCCCHHHHHHH
Q 000659 1232 QHRPFMGEVVQA 1243 (1368)
Q Consensus 1232 keRPTMsEVLq~ 1243 (1368)
.+|.|++|+++.
T Consensus 395 ~~RiTl~EAL~H 406 (415)
T KOG0671|consen 395 ARRITLREALSH 406 (415)
T ss_pred cccccHHHHhcC
Confidence 999999999865
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-30 Score=296.23 Aligned_cols=242 Identities=24% Similarity=0.346 Sum_probs=200.2
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCC-EEEEEEeec---ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGT-KVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr-~VAVKvLk~---~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
.+++....||-|+||+|=++..+..+ .+|+|++++ .+....+.+..|-.||..++.+.||+|+..|.++..+|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34555668999999999998876444 388998875 45556677889999999999999999999999999999999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
|-|-||.|...|+. ...++..+...++.++..|++|||+++ ||.|||||+|+|||.+|-+||.|||+|+.+..
T Consensus 500 EaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~ 572 (732)
T KOG0614|consen 500 EACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS 572 (732)
T ss_pred HhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhcc
Confidence 99999999999953 346888899999999999999999998 99999999999999999999999999998865
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
+.. ..+.|||+.|+|||++.++-.+..+|.|+||+++||||+|..||...+.-...++. ++ +++.+
T Consensus 573 g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------Lk---Gid~i-- 638 (732)
T KOG0614|consen 573 GRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------LK---GIDKI-- 638 (732)
T ss_pred CCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------Hh---hhhhh--
Confidence 433 34689999999999999999999999999999999999999999876543222211 11 11111
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1236 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT 1236 (1368)
.++........+|+++.+..+|.+|..
T Consensus 639 -----~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 639 -----EFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -----hcccccchhHHHHHHHHHhcCcHhhhc
Confidence 233344566788889888999999976
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-29 Score=300.11 Aligned_cols=248 Identities=27% Similarity=0.356 Sum_probs=190.1
Q ss_pred cceeeEEeecCcE-EEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEeecC
Q 000659 971 FDASRILGEGGFG-LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 971 Fei~klLGeGgFG-tVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
|...+++|.|+.| .||+|.++ |+.||||++-. .......+||..|+.-+ |+|||++++.-.+++..||+.|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 4445678999988 67999998 88999999853 33345678999999884 999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-----CCCccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-----ng~VKLsDFGLArll~ 1123 (1368)
..+|+|++.....+.........+.++.|++.||++||..+ ||||||||.||||+. ..+++|+|||+++...
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 77999999763111111222455778899999999999877 999999999999975 3578999999999876
Q ss_pred cccccc-ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhC-CCCCCCCCCCcchhHHHhhhhhcccccccce
Q 000659 1124 DEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1124 ~~~~~~-~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTG-r~PFd~s~~~~~~nLv~Wa~plls~~e~L~e 1201 (1368)
.+.... ......||-||+|||++....-+..+||||||||+|+.++| ..||+..... +.|+ ++.+..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R-~~NI-------l~~~~~L~~ 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER-QANI-------LTGNYTLVH 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh-hhhh-------hcCccceee
Confidence 543322 23446699999999999998888899999999999999995 8999764321 1121 222222222
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+-. ..++ +..+||.+|++.+|..||++.+|+..
T Consensus 735 L~~-------~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 735 LEP-------LPDC--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ecc-------CchH--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 111 0112 78899999999999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.9e-29 Score=274.24 Aligned_cols=249 Identities=22% Similarity=0.335 Sum_probs=199.8
Q ss_pred hCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecc---cchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~---d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~L 1042 (1368)
.++|+++++||+|.|++|..+++ ++.+.+|+|++++. +.+..+=.+.|-.++.+. +||.+|-|..++..+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 47899999999999999999995 46888999999763 222333345677777766 69999999999999999999
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
|.||++||+|--++++ ...|.++.+..+...|.-||.|||++| ||.||||.+|||||.+|.+||+|+|+++.-
T Consensus 329 vieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999888854 335889999999999999999999998 999999999999999999999999999854
Q ss_pred cccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCc-chhHHHhhhhhcccccccce
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPG-QENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~-~~nLv~Wa~plls~~e~L~e 1201 (1368)
.. ......+.|||+.|+|||++++..|+...|.|+|||+++||+.|+.||+....+. .+|-.++.-..+.
T Consensus 402 l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvil------- 472 (593)
T KOG0695|consen 402 LG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVIL------- 472 (593)
T ss_pred CC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHh-------
Confidence 32 2234467899999999999999999999999999999999999999998765332 2333333322221
Q ss_pred eecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1236 (1368)
Q Consensus 1202 IvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT 1236 (1368)
+..+ +++.....+...+++.-|+.||++|..
T Consensus 473 --ekqi--riprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 473 --EKQI--RIPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred --hhcc--cccceeehhhHHHHHHhhcCCcHHhcC
Confidence 1111 233344456677888899999999864
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=272.00 Aligned_cols=269 Identities=21% Similarity=0.323 Sum_probs=193.7
Q ss_pred CCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeec-c-cchhhHHHHHHHHHHhhcccccceeeeeeeee--------c
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR-V-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--------E 1037 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~-~-d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d--------~ 1037 (1368)
+.|+...+||+|.||+||+|+. ++|+.||+|++-. . ....-..-++|+++|..|+|+|++.|+++|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3456677999999999999994 4678888876532 1 22223456899999999999999999999864 2
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
..+||||++|+. +|.-+|.. ....++..++.+++.++..||.|+|+.. |+|||+|+.|+||+.++.+||+|||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccc
Confidence 347999999965 67777732 2346889999999999999999999887 9999999999999999999999999
Q ss_pred ccccccccc--cccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHh------
Q 000659 1118 LARSAMDEE--SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW------ 1188 (1368)
Q Consensus 1118 LArll~~~~--~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~W------ 1188 (1368)
+++.+...+ .....+..+-|+.|+.||.+.+ +.|+.+.|||+-|||+.||+||..-|.......+..+...
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997654321 2222344567999999998775 5789999999999999999999888866543332222211
Q ss_pred --hhhhccccccccee-ecCCCCCCCC--------hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1189 --ARPLLTSREGLERI-IDPSLGNDVP--------FDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1189 --a~plls~~e~L~eI-vDp~L~~~~~--------~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
+++..........+ +.+...+.+. .....+.++|+..++..||.+|++.++++...
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~ 316 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD 316 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence 11111111111111 0111111110 11123678899999999999999999998653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-28 Score=255.90 Aligned_cols=202 Identities=31% Similarity=0.424 Sum_probs=169.0
Q ss_pred cceeeEEeecCcEEEEEEE-ecCCCEEEEEEeec-ccchhhHHHHHHHHHHhhc-ccccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~-~d~~~~keFlrEIeILsrL-rHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
......||+|+||.|-+.+ ..+|...|+|+++. ...+..++.++|+++..+. .++.+|.++|.+.++...++.||.|
T Consensus 48 L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 48 LVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 3345689999999998887 45799999999964 4566677889999997765 6999999999999999999999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~ 1127 (1368)
.-+|+.+.++.-+.+..+.+..+-+|+..+.+||.|||++- .|||||+||+|||||.+|++||||||++..+.+.-.
T Consensus 128 -~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA 204 (282)
T KOG0984|consen 128 -DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA 204 (282)
T ss_pred -hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence 55787776655556678999999999999999999999875 599999999999999999999999999986643211
Q ss_pred ccccccccccccccCcchhcc----CCCCcccceeeHHHHHHHHHhCCCCCCCCC
Q 000659 1128 RHISTRVMGTFGYVAPEYAMT----GHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1178 (1368)
Q Consensus 1128 ~~~st~v~GT~gYmAPEvL~~----~~~T~KSDVWSLGVILyELLTGr~PFd~s~ 1178 (1368)
.+-..|-.-|||||.+.. ..|+.|+||||||+.++||.+++.||+...
T Consensus 205 ---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 205 ---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 122346678999998763 368899999999999999999999997643
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.8e-28 Score=264.84 Aligned_cols=266 Identities=24% Similarity=0.339 Sum_probs=195.5
Q ss_pred CcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecc--cchhhHHHHHHHHHHhhcccccceeeeeeeeec-----cceE
Q 000659 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE-----QARC 1041 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~--d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~-----~~~~ 1041 (1368)
+++.++-||-|+||.||.++ -++|+.|++|++-.. +-...+++.+|+++|.-++|.|++..+++.... .++|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 34557899999999999988 458999999998543 334467899999999999999999999876542 3557
Q ss_pred EEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
+|.|.| ..+|...+ .....|+-+.+.-+++||++||+|||+.+ |.||||||.|+||+.|..+|||||||++.
T Consensus 134 V~TELm-QSDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARv 205 (449)
T KOG0664|consen 134 VLTELM-QSDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLART 205 (449)
T ss_pred HHHHHH-Hhhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccc
Confidence 888887 44554444 44567889999999999999999999887 99999999999999999999999999997
Q ss_pred ccccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccc-----
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS----- 1195 (1368)
Q Consensus 1122 l~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~----- 1195 (1368)
...++..++ +..+-|..|.|||++++ +.|+.+.||||.|||+.|||.++.-|+..+...+..+..-....-..
T Consensus 206 ee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ 284 (449)
T KOG0664|consen 206 WDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKY 284 (449)
T ss_pred cchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHH
Confidence 655444443 44557899999999886 57999999999999999999999888766544433222110000000
Q ss_pred --ccccceeec-----CCCCCCCC----hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHH
Q 000659 1196 --REGLERIID-----PSLGNDVP----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1196 --~e~L~eIvD-----p~L~~~~~----~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~L 1244 (1368)
++.-..++. +.+.--+. .....+.+.+.+.++..||++|.+..+.+..+
T Consensus 285 ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 285 ACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred HhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 000001111 11100011 12234567788899999999999988887654
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=254.09 Aligned_cols=259 Identities=20% Similarity=0.329 Sum_probs=196.1
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeeeeeec--cceEEE
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEE--QARCLV 1043 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~--~~~~LV 1043 (1368)
.++|++.+.+|+|.|++||.|. ..+++.++||+++... .+.+.+|+.||..|+ |+||+.|+++..+. ....||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 4678899999999999999999 6678999999998654 368899999999997 99999999998764 445799
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC-CCcccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSA 1122 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n-g~VKLsDFGLArll 1122 (1368)
+||+++.+...+. ..|+..++..++.++++||.|||++| |+|||+||.|++||.. ..++|+|+|||...
T Consensus 114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 9999998876655 24777788899999999999999888 9999999999999965 56999999999877
Q ss_pred cccccccccccccccccccCcchhcc-CCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc-----
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR----- 1196 (1368)
Q Consensus 1123 ~~~~~~~~st~v~GT~gYmAPEvL~~-~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~----- 1196 (1368)
..+.... ..+.+..|.-||++.. ..|+..-|+|||||+|.+|+..+.||-... ...+.++..++-+-+++
T Consensus 184 Hp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred CCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHHHH
Confidence 5543322 2345667888998875 457788999999999999999999984432 23344554433222210
Q ss_pred cccceeecCCC--------CCC----CC---h-hhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1197 EGLERIIDPSL--------GND----VP---F-DSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1197 e~L~eIvDp~L--------~~~----~~---~-ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
....-.+|+.+ +.. ++ . -...+.++++.+.|..|-.+|+|++|....
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H 322 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH 322 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence 00000112211 100 00 0 112578899999999999999999998764
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=251.95 Aligned_cols=255 Identities=22% Similarity=0.335 Sum_probs=190.0
Q ss_pred HhCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeee-eeeccceEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI-CIEEQARCLV 1043 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~-~~d~~~~~LV 1043 (1368)
..+.|.+.+.||+|.||.+.+++++ ..+.+++|.+.+ .....++|.+|...--.| .|.||+.-+++ +...+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~-p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPR-PQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCc-chhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 3467889999999999999999965 567899998864 344567899998776566 49999998876 5667788899
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec--CCCCccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD--~ng~VKLsDFGLArl 1121 (1368)
+||++.|+|.+.+.. ..+.+....+++.|++.||.|||+++ +||||||.+||||- +..++||||||+.+.
T Consensus 101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k 172 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRK 172 (378)
T ss_pred eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccc
Confidence 999999999988842 34788888999999999999999988 99999999999993 345899999999875
Q ss_pred ccccccccccccccccccccCcchhccC-----CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMTG-----HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1122 l~~~~~~~~st~v~GT~gYmAPEvL~~~-----~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
.+. ...+..-+..|.+||+.... .....+|||.||+|+|.+|||+.||+... ......++|..-+-...
T Consensus 173 ~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~-~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 173 VGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKAS-IMDKPYWEWEQWLKRKN 246 (378)
T ss_pred cCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhh-ccCchHHHHHHHhcccC
Confidence 532 11223346789999976533 34567899999999999999999998432 33344445433222111
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
-.+.+. +. ....+++.+.++-+..++++|=-+.++.++.+
T Consensus 247 ~~~P~~--------F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 PALPKK--------FN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ccCchh--------hc-ccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 111111 11 22356788889999999999966666555544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-27 Score=273.68 Aligned_cols=197 Identities=20% Similarity=0.319 Sum_probs=167.3
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccc--------hhhHHHHHHHHHHhhcc---cccceeeeeeee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQ--------QGGREFLAEVEMLSRLH---HRNLVKLIGICI 1035 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~--------~~~keFlrEIeILsrLr---HPNIVrLlG~~~ 1035 (1368)
..+|...+.||+|+||.|+.|+++ +...|+||.+.+... ...-.+-.||.||..|+ |+||++++++++
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346889999999999999999965 466799999864211 11123457999999997 999999999999
Q ss_pred eccceEEEEeec-CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccc
Q 000659 1036 EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1114 (1368)
Q Consensus 1036 d~~~~~LVmEYm-~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLs 1114 (1368)
+++.+||+||-. ++-+|++++. .+..|++.+...|++||+.|+++||+.+ |||||||-+||+||.+|-+||+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~kli 712 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLI 712 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEe
Confidence 999999999976 5568888884 3456999999999999999999999998 9999999999999999999999
Q ss_pred cccccccccccccccccccccccccccCcchhccCCC-CcccceeeHHHHHHHHHhCCCCCC
Q 000659 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVD 1175 (1368)
Q Consensus 1115 DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~-T~KSDVWSLGVILyELLTGr~PFd 1175 (1368)
|||.+.....+. ....+||.+|.|||++.+..| +..-|||+||++||.++....||.
T Consensus 713 dfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 713 DFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999998664332 345789999999999998876 466899999999999999888874
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.8e-27 Score=275.84 Aligned_cols=254 Identities=24% Similarity=0.327 Sum_probs=203.1
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
-.++|++.+.||.|.||.|||++ ...++..|||+++-...+...-+.+||-+++..+|+|||.++|.|...+..+++||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 35689999999999999999999 45789999999987766667778899999999999999999999999999999999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||.+|+|++.-+. ..+|++.++..+++...+||+|||..+ -+|||||-.|||+++.|.+|++|||.+..+..
T Consensus 93 ycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqita- 164 (829)
T KOG0576|consen 93 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITA- 164 (829)
T ss_pred ecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhh-
Confidence 9999999998763 347999999999999999999999887 79999999999999999999999999876642
Q ss_pred ccccccccccccccccCcchh---ccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1126 ESRHISTRVMGTFGYVAPEYA---MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1126 ~~~~~st~v~GT~gYmAPEvL---~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.........||+.|||||+. +.+-|..++|||++|+.-.||---+.|.-.... .+++ .+.+ .. .
T Consensus 165 -ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l-----~LmT-kS----~ 231 (829)
T KOG0576|consen 165 -TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRAL-----FLMT-KS----G 231 (829)
T ss_pred -hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHH-----HHhh-cc----C
Confidence 11222346799999999976 467789999999999999999766655422111 0111 1111 11 1
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq 1242 (1368)
+++--.+ -.......|-+|++.|+..+|++||+.+.+++
T Consensus 232 ~qpp~lk-Dk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 232 FQPPTLK-DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCCccc-CCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 1211111 12244567889999999999999999998865
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-26 Score=265.85 Aligned_cols=204 Identities=25% Similarity=0.306 Sum_probs=172.8
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeecccchhhHHHHHHHHHHhhcc------cccceeeeeeeeec
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH------HRNLVKLIGICIEE 1037 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr------HPNIVrLlG~~~d~ 1037 (1368)
+....+|.+....|+|-|++|.+|.. ..|..||||+++. +....+.=++|++||++|+ --|+++|+..|...
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRn-NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRN-NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeec-chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 34467899999999999999999984 4578999999975 3444556678999999995 34799999999999
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Ccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDF 1116 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsDF 1116 (1368)
+++|||+|-+ ..+|.+.|..+.. +..|....+..+++|+.-||..|-..+ |+|.||||+||||++.. .+|||||
T Consensus 507 nHLClVFE~L-slNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 507 NHLCLVFEPL-SLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred ceeEEEehhh-hchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 9999999988 6799999987654 345888999999999999999999887 99999999999998764 5799999
Q ss_pred cccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCC
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1178 (1368)
Q Consensus 1117 GLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~ 1178 (1368)
|.|..+.+++.. -..-...|.|||++.+..|+...|+||.||+||||+||+.-|-...
T Consensus 582 GSA~~~~eneit----PYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 582 GSASFASENEIT----PYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred cccccccccccc----HHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999877554332 2234568999999999999999999999999999999999886554
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=257.16 Aligned_cols=132 Identities=27% Similarity=0.431 Sum_probs=113.0
Q ss_pred hCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-----c---ccceeeeeeeee--
Q 000659 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-----H---RNLVKLIGICIE-- 1036 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-----H---PNIVrLlG~~~d-- 1036 (1368)
.++|.+.++||-|.|++||++. ..+.+.||+|+.+. .+.-.+.-+.||++|++++ | ..||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 3789999999999999999998 45678999999984 3444566789999999984 2 469999999875
Q ss_pred --ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee
Q 000659 1037 --EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1037 --~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL 1105 (1368)
+.++|||+|++ |.+|..++.....+ .|....+.+|++||+.||.|||+.+ +|||-||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr--Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR--GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC--CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 56789999999 88899888655443 4888999999999999999999988 79999999999999
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.1e-24 Score=218.80 Aligned_cols=261 Identities=31% Similarity=0.433 Sum_probs=199.7
Q ss_pred cceeeEEeecCcEEEEEEEecCCCEEEEEEeecccch---hhHHHHHHHHHHhhcccc-cceeeeeeeeeccceEEEEee
Q 000659 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ---GGREFLAEVEMLSRLHHR-NLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~---~~keFlrEIeILsrLrHP-NIVrLlG~~~d~~~~~LVmEY 1046 (1368)
|.+.+.||.|+||.||++... ..+++|.+...... ..+.|.+|+.+++.+.|. +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 678899999999999999977 78999998653332 467899999999999988 799999999777778999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC-Cccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng-~VKLsDFGLArll~~~ 1125 (1368)
+.+++|.+++...... ..+.......++.|++.+|+|+|+.+ ++|||||++|||++..+ .++++|||+++.....
T Consensus 80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 9999999776432211 36888999999999999999999988 99999999999999988 6999999999855443
Q ss_pred cccc----ccccccccccccCcchhcc---CCCCcccceeeHHHHHHHHHhCCCCCCCCCCC-cchhHHHhhhhhccccc
Q 000659 1126 ESRH----ISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPP-GQENLVAWARPLLTSRE 1197 (1368)
Q Consensus 1126 ~~~~----~st~v~GT~gYmAPEvL~~---~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~-~~~nLv~Wa~plls~~e 1197 (1368)
.... ......|+..|++||.+.. ..+....|+|++|++++++++|+.||...... ......+.+......
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-- 233 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-- 233 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc--
Confidence 3221 3456779999999999987 57889999999999999999999997654421 011222221111110
Q ss_pred ccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1198 ~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.................+.+++..|+..++..|.++.+....
T Consensus 234 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 ----SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ----ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000002233578899999999999999999888765
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.8e-26 Score=281.91 Aligned_cols=198 Identities=18% Similarity=0.246 Sum_probs=142.2
Q ss_pred hhccc-ccceeeeeee-------eeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCC
Q 000659 1020 SRLHH-RNLVKLIGIC-------IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1091 (1368)
Q Consensus 1020 srLrH-PNIVrLlG~~-------~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp 1091 (1368)
+.++| .||++++++| .+.+..+++|||+ +++|.++|+.. ...+++.+++.|+.||++||+|||+++
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~g-- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQG-- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence 34555 6888888887 2334567888988 67999999632 345999999999999999999999887
Q ss_pred CccccCCcccCeeecC-------------------CCCccccccccccccccccc--------------ccccccccccc
Q 000659 1092 RVIHRDFKSSNILLEH-------------------DFTPKVSDFGLARSAMDEES--------------RHISTRVMGTF 1138 (1368)
Q Consensus 1092 ~IVHRDIKPsNILLD~-------------------ng~VKLsDFGLArll~~~~~--------------~~~st~v~GT~ 1138 (1368)
||||||||+||||+. ++.+||+|||+++....... .......+||.
T Consensus 101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~ 179 (793)
T PLN00181 101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS 179 (793)
T ss_pred -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence 999999999999953 55677788887764321000 00011246889
Q ss_pred cccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHH
Q 000659 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAK 1218 (1368)
Q Consensus 1139 gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~e 1218 (1368)
.|||||++.+..++.++|||||||+||||++|..++.... ..+..+... .+.... .....+
T Consensus 180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~----------~~~~~~-----~~~~~~ 240 (793)
T PLN00181 180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR----------VLPPQI-----LLNWPK 240 (793)
T ss_pred ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh----------hcChhh-----hhcCHH
Confidence 9999999999999999999999999999999988764211 111111000 011110 112334
Q ss_pred HHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1219 VAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1219 Ll~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..+++.+||+.+|++||+|.||++.
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~h 265 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQS 265 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhhc
Confidence 5688899999999999999999753
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.8e-25 Score=246.50 Aligned_cols=261 Identities=23% Similarity=0.278 Sum_probs=194.0
Q ss_pred CCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeec--ccchhhHHHHHHHHHHhhcccccceeeeeeeee------ccc
Q 000659 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE------EQA 1039 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~--~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d------~~~ 1039 (1368)
.+|.-++.+|.|.- .|..+. .-.++.|++|++.. .+....++..+|..++..++|+||++++.++.- ...
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888888 565555 23578999998743 234456778899999999999999999999864 345
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.|+||||| .++|.+.++ -.++-+++.+|++|+++|++|||+.+ |+||||||+||+|..++.+||.|||+|
T Consensus 96 ~y~v~e~m-~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL------MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HHHHHHhh-hhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 69999999 568888775 23777889999999999999999888 999999999999999999999999999
Q ss_pred ccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhH--------------
Q 000659 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENL-------------- 1185 (1368)
Q Consensus 1120 rll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nL-------------- 1185 (1368)
+.... ....+-.+.|..|.|||++.+..+.+.+||||+||++.||++|+.-|...+..++.+.
T Consensus 166 r~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 86533 2345567789999999999988899999999999999999999988865432222111
Q ss_pred --HHhhhhhcccccc-----cce-eecCCCCCCC--ChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1186 --VAWARPLLTSREG-----LER-IIDPSLGNDV--PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1186 --v~Wa~plls~~e~-----L~e-IvDp~L~~~~--~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
..-++..+..... ..+ +-|..+.... .........+++.+||-.+|++|-+++++++.
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 1111111110000 001 1111111111 11234567889999999999999999999875
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.4e-23 Score=235.10 Aligned_cols=262 Identities=24% Similarity=0.277 Sum_probs=200.3
Q ss_pred CcceeeEEeecCcEEEEEEEecCC--CEEEEEEeecccchhhHHHHHHHHHHhhccc----ccceeeeeee-eeccceEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLDDG--TKVAVKVLKRVDQQGGREFLAEVEMLSRLHH----RNLVKLIGIC-IEEQARCL 1042 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkdG--r~VAVKvLk~~d~~~~keFlrEIeILsrLrH----PNIVrLlG~~-~d~~~~~L 1042 (1368)
+|.+.+.||+|+||.||++..... +.+|+|+...........+..|+.+|..+.. .++..+++.. ..++..|+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999996543 4789998765433333378889999999873 6889999988 47788899
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC-----CCccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-----FTPKVSDFG 1117 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n-----g~VKLsDFG 1117 (1368)
||+.+ |.+|.++..... ...++..+.++|+.|++.+|++||+.| ++||||||+|+++... ..++|.|||
T Consensus 99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 99998 889999875443 457999999999999999999999998 9999999999999754 468999999
Q ss_pred ccc--cccccccc---cc---cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcch-hHHHh
Q 000659 1118 LAR--SAMDEESR---HI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-NLVAW 1188 (1368)
Q Consensus 1118 LAr--ll~~~~~~---~~---st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~-nLv~W 1188 (1368)
+++ ........ .. .....||..|++++.+.+...+++.|+||++.++.||+.|..||......... .+...
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 33222211 11 12355999999999999999999999999999999999999999654432211 11111
Q ss_pred hhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhh
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1189 a~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~ 1251 (1368)
..... ... ........+.+++..+-..+..++|....+.+.|+......
T Consensus 253 ~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 253 PRKLL---------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred hhhhc---------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11000 000 11223456677777777789999999999999988776654
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.2e-24 Score=216.58 Aligned_cols=170 Identities=23% Similarity=0.211 Sum_probs=127.9
Q ss_pred CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccc
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129 (1368)
Q Consensus 1050 GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~ 1129 (1368)
|+|.++|+.. +..++|.++++|+.||++||+|||+++ |++|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~---- 62 (176)
T smart00750 1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE---- 62 (176)
T ss_pred CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc----
Confidence 7899998532 346999999999999999999999775 999999999999999 9999865331
Q ss_pred ccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCC
Q 000659 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209 (1368)
Q Consensus 1130 ~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~ 1209 (1368)
...||..|||||++.+..++.++|||||||+||||++|+.||...... ...+..+....... +... .
T Consensus 63 ---~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~-~~~~~~~~~~~~~~--------~~~~-~ 129 (176)
T smart00750 63 ---QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL-SAILEILLNGMPAD--------DPRD-R 129 (176)
T ss_pred ---cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-cHHHHHHHHHhccC--------Cccc-c
Confidence 125899999999999999999999999999999999999999653221 11122221111110 0000 0
Q ss_pred CCChhhH--HHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1210 DVPFDSV--AKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1210 ~~~~ee~--~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
....... .++.+++.+||+.+|++||++.|+++.+..+..+
T Consensus 130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence 0111122 2689999999999999999999999998876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.6e-24 Score=243.05 Aligned_cols=267 Identities=25% Similarity=0.318 Sum_probs=196.4
Q ss_pred HHHHhCCcceeeEEeecCcEEEEEEEec----CCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeeeeeecc
Q 000659 964 IEKATGNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 964 Le~aT~nFei~klLGeGgFGtVYKAvlk----dGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~ 1038 (1368)
+....+.|...++||+|.|+.||++.+. .++.||+|.+...... .++.+|+++|..+. +.||+.+.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4456678899999999999999999944 4678999998754333 46899999999996 999999999999999
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-CCCccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-DFTPKVSDFG 1117 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-ng~VKLsDFG 1117 (1368)
..++|+||++.....+++. .++..++..+++.+++||+++|..| ||||||||+|+|.+. .++-.|+|||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFg 178 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFG 178 (418)
T ss_pred eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEech
Confidence 9999999999999888884 3668899999999999999999998 999999999999975 5678999999
Q ss_pred cccccccc-------c-----------cc------------------------cccccccccccccCcchhc-cCCCCcc
Q 000659 1118 LARSAMDE-------E-----------SR------------------------HISTRVMGTFGYVAPEYAM-TGHLLVK 1154 (1368)
Q Consensus 1118 LArll~~~-------~-----------~~------------------------~~st~v~GT~gYmAPEvL~-~~~~T~K 1154 (1368)
||...... . .. .......||.||.|||++. ....+.+
T Consensus 179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta 258 (418)
T KOG1167|consen 179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA 258 (418)
T ss_pred hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence 99721000 0 00 0001145999999999876 4677899
Q ss_pred cceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhh--------hhh--------cccccc----------ccee-ecCCC
Q 000659 1155 SDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA--------RPL--------LTSREG----------LERI-IDPSL 1207 (1368)
Q Consensus 1155 SDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa--------~pl--------ls~~e~----------L~eI-vDp~L 1207 (1368)
.||||.|||++.+++++.||-....+ ...+.+.+ +.. +.+... ...+ +....
T Consensus 259 iDiws~GVI~Lslls~~~PFf~a~dd-~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 259 IDIWSAGVILLSLLSRRYPFFKAKDD-ADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred cceeeccceeehhhccccccccCccc-cchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999998543221 11111110 000 000000 0011 00000
Q ss_pred C--------CCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1208 G--------NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~--------~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
. ....+.....+++++.+|+..||.+|-+++|.++.
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH 381 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH 381 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence 0 01111122478999999999999999999999865
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.9e-23 Score=238.24 Aligned_cols=169 Identities=21% Similarity=0.152 Sum_probs=131.6
Q ss_pred HHHHhCCcceeeEEeecCcEEEEEEEec--CCCEEEEEEeecc-----cchhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 964 IEKATGNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRV-----DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 964 Le~aT~nFei~klLGeGgFGtVYKAvlk--dGr~VAVKvLk~~-----d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
+....++|++.+.||+|+||+||+|.+. +++.||||++... .....+.|.+|+++|++|+|+|++..+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 4456788999999999999999999864 5778899987532 223356689999999999999998533222
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCC-cccCeeecCCCCccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF-KSSNILLEHDFTPKVSD 1115 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDI-KPsNILLD~ng~VKLsD 1115 (1368)
+..||||||++|++|.... . .. ...++.|++++|+|||+.+ |+|||| ||+||||+.++++||+|
T Consensus 91 -~~~~LVmE~~~G~~L~~~~----~----~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD 155 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLAR----P----HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID 155 (365)
T ss_pred -CCcEEEEEccCCCCHHHhC----c----cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence 4679999999999996321 1 01 1467889999999999887 999999 99999999999999999
Q ss_pred cccccccccccccc------ccccccccccccCcchhccC
Q 000659 1116 FGLARSAMDEESRH------ISTRVMGTFGYVAPEYAMTG 1149 (1368)
Q Consensus 1116 FGLArll~~~~~~~------~st~v~GT~gYmAPEvL~~~ 1149 (1368)
||+|+.+....... ..+..++++.|++||++...
T Consensus 156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99999765422111 11356789999999988643
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=218.40 Aligned_cols=265 Identities=20% Similarity=0.268 Sum_probs=203.1
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVm 1044 (1368)
..-+|.++++||+|.||.++.|. +-+++.||||.--.. ...-++..|.+.++.|. .++|-..+-|..++.+-.||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34579999999999999999999 667999999986432 22346777888888885 788988888877888889999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-----CCCccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLA 1119 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-----ng~VKLsDFGLA 1119 (1368)
|.+ |-+|+|++.- ....++.++++.|++|++.-++|+|++. +|.|||||+|+||.. ...+.|+|||+|
T Consensus 104 dLL-GPSLEDLFD~---CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDL---CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhh-CcCHHHHHHH---hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccch
Confidence 999 8899998743 3456899999999999999999999998 999999999999953 345899999999
Q ss_pred cccccccc-cccc----ccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcc
Q 000659 1120 RSAMDEES-RHIS----TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194 (1368)
Q Consensus 1120 rll~~~~~-~~~s----t~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls 1194 (1368)
+.+.+... .++. ....||.+||+-....+++.+++.|+-+||-|++.+|.|..||+.........
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---------- 246 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---------- 246 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH----------
Confidence 98766432 2222 23669999999999999999999999999999999999999998765432211
Q ss_pred cccccceeecCCCCCCCC---hhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhhh
Q 000659 1195 SREGLERIIDPSLGNDVP---FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1253 (1368)
Q Consensus 1195 ~~e~L~eIvDp~L~~~~~---~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~e 1253 (1368)
..++|-|......+. .....+|...+.-.-..+-++-|+.+-+...+..++....+
T Consensus 247 ---kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 247 ---KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred ---HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 122222221111111 12234566666666667889999998888877777765543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.9e-22 Score=246.10 Aligned_cols=256 Identities=20% Similarity=0.199 Sum_probs=191.2
Q ss_pred eeeEEeecCcEEEEEEE-ecCCCEEEEEEee----cc-cc-hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEe
Q 000659 973 ASRILGEGGFGLVYSGV-LDDGTKVAVKVLK----RV-DQ-QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAv-lkdGr~VAVKvLk----~~-d~-~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
..+++|.|++|.|+... ....+....|.++ .. .. +....+..|+.+-..|+|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 46789999999777776 3334444554432 11 11 111225678888889999999999988888777777799
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~ 1125 (1368)
||++ +|+.++.. ...+...++..++.|+.+||.|||..| |.|||||++|||++.+|.+||+|||.+......
T Consensus 402 ~~~~-Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cccH-HHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 9999 99999843 235888899999999999999999998 999999999999999999999999999876554
Q ss_pred ccc--cccccccccccccCcchhccCCCC-cccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhccccccccee
Q 000659 1126 ESR--HISTRVMGTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1126 ~~~--~~st~v~GT~gYmAPEvL~~~~~T-~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eI 1202 (1368)
... .....++|.-.|+|||++....|. ...||||.|+++..|++|+.||......+..... .......
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---------~~~~~~~ 544 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---------NNYSDQR 544 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---------hcccccc
Confidence 443 566778899999999999988887 5679999999999999999999766544332100 0000000
Q ss_pred ecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1203 vDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
-+..-...+......+...++.++|+.+|.+|-||++|++.=|
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 0000001122234466788999999999999999999987644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-21 Score=211.12 Aligned_cols=264 Identities=21% Similarity=0.290 Sum_probs=206.7
Q ss_pred HhCCcceeeEEeecCcEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhccc-ccceeeeeeeeeccceEEEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrH-PNIVrLlG~~~d~~~~~LVm 1044 (1368)
..++|.+.+.||.|+||.+|.|. ..+|+.||||+-... ...-++..|..+.+.|++ ..|-.+..|..+++.-.|||
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 35789999999999999999999 778999999987532 233467889999999974 57777888888888889999
Q ss_pred eecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC---CCCccccccccccc
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARS 1121 (1368)
Q Consensus 1045 EYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~---ng~VKLsDFGLArl 1121 (1368)
|.+ |-+|++++.-. ...++..+.+.++-|++.-++|+|.++ +|||||||+|+|..- ..++.|+||||++.
T Consensus 91 dLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 91 DLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred ecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 999 88999988543 345888999999999999999999998 999999999999953 45689999999997
Q ss_pred cccccc-ccc----cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1122 AMDEES-RHI----STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1122 l~~~~~-~~~----st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+.+... .++ ...+.||.+|.+-..+.+...+.+.|+-|+|.+|..+..|..||+...........+.
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk-------- 235 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK-------- 235 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH--------
Confidence 765322 122 2346799999998888888889999999999999999999999987654432222221
Q ss_pred cccceeecCCCCCC---CChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhh
Q 000659 1197 EGLERIIDPSLGND---VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~---~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
|.+..+... .-.....+|...+.-|-...-++-|+..-+-+.++.+...+.
T Consensus 236 -----I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln 289 (341)
T KOG1163|consen 236 -----ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLN 289 (341)
T ss_pred -----HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhcc
Confidence 111111111 112334678889999999999999999888888777766544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.6e-22 Score=217.57 Aligned_cols=244 Identities=21% Similarity=0.350 Sum_probs=193.6
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEee--cccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk--~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
.+|.+...|+.|+|+++ |..+++|+++ .......++|..|.-.|+-+.|+||+.++|.|...-...++..||+-|+|
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 46788899999999998 6667888874 34455567899999999999999999999999999999999999999999
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccc--cccccccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS--DFGLARSAMDEESRHI 1130 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLs--DFGLArll~~~~~~~~ 1130 (1368)
+..||+.. +-.++-.+..+++.++|+|++|||+.. +-|----|....|+||++.+++|+ |--++-.
T Consensus 275 ynvlhe~t--~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsfq--------- 342 (448)
T KOG0195|consen 275 YNVLHEQT--SVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------- 342 (448)
T ss_pred HHHHhcCc--cEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeeee---------
Confidence 99998643 446788899999999999999999985 334445788999999999988774 3222110
Q ss_pred cccccccccccCcchhccCCCC---cccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCC
Q 000659 1131 STRVMGTFGYVAPEYAMTGHLL---VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1131 st~v~GT~gYmAPEvL~~~~~T---~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L 1207 (1368)
.....-.+.||+||.+..+..+ +.+|+|||.++||||.|++.||.....-+. -.++.-+.+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmec----------------gmkialegl 406 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMEC----------------GMKIALEGL 406 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhh----------------hhhhhhccc
Confidence 0111235789999998766543 678999999999999999999965432221 122233445
Q ss_pred CCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHH
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1208 ~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I 1247 (1368)
+-.++......+.+|+.-|++.||.+||.++.|+-.|++.
T Consensus 407 rv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 407 RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred cccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 6677778888999999999999999999999999988865
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.8e-20 Score=203.68 Aligned_cols=172 Identities=13% Similarity=0.148 Sum_probs=134.5
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhH---H------HHHHHHHHhhcccccceeeeeeeee
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR---E------FLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~k---e------FlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
...++|+..++||.|+||.||+... ++..+|||+++.......+ . +.+|+..+.+++|++|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999766 5778999999643222222 2 6799999999999999999988654
Q ss_pred c--------cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC
Q 000659 1037 E--------QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1108 (1368)
Q Consensus 1037 ~--------~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n 1108 (1368)
. +..+|||||++|.+|.++.. ++. .+..+++.+|..||+.| |+||||||+|||++.+
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~ 171 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKN 171 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCC
Confidence 3 35789999999999988741 222 24558999999999998 9999999999999998
Q ss_pred CCcccccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHH
Q 000659 1109 FTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1168 (1368)
Q Consensus 1109 g~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELL 1168 (1368)
+ ++|+|||..+......... .+.....+..++|+|+||+.|..+.
T Consensus 172 g-i~liDfg~~~~~~e~~a~d--------------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 172 G-LRIIDLSGKRCTAQRKAKD--------------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred C-EEEEECCCcccccchhhHH--------------HHHHHhHhcccccccceeEeehHHH
Confidence 8 9999999887552211100 0344555668999999999987765
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=196.75 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=108.3
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeecccch--h-------hHH-----------------HHHHHHHHhhcccccc
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--G-------GRE-----------------FLAEVEMLSRLHHRNL 1027 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~--~-------~ke-----------------FlrEIeILsrLrHPNI 1027 (1368)
.+.||+|+||.||+|...+|+.||||+++..... . ..+ ..+|+++|.++.+.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999888999999999753210 0 112 2359999999988876
Q ss_pred eeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhh-hccCCCCccccCCcccCeeec
Q 000659 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL-HEDSSPRVIHRDFKSSNILLE 1106 (1368)
Q Consensus 1028 VrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYL-Hs~gsp~IVHRDIKPsNILLD 1106 (1368)
.....+.. ...+|||||+++++|...+. ....+++.+.++++.|++.+|.|| |+.+ |+||||||+||||+
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~ 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence 44333222 23489999998887765431 123588999999999999999999 6777 99999999999998
Q ss_pred CCCCcccccccccccc
Q 000659 1107 HDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1107 ~ng~VKLsDFGLArll 1122 (1368)
+++++|+|||+|...
T Consensus 153 -~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 -DGKLYIIDVSQSVEH 167 (190)
T ss_pred -CCcEEEEEccccccC
Confidence 578999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=7.3e-21 Score=234.75 Aligned_cols=247 Identities=23% Similarity=0.251 Sum_probs=184.0
Q ss_pred CcceeeEEeecCcEEEEEEEecCCCEEEEEEeec-ccchhhHHHHHHHHHH--hhcccccceeeeeeeeeccceEEEEee
Q 000659 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR-VDQQGGREFLAEVEML--SRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~-~d~~~~keFlrEIeIL--srLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+|...+.||.++|=+|.+|..+.|. |+||++-+ ......+.|.++++-+ ..++++|.+.+..+...+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6788899999999999999999888 88998843 3344455555544444 445899999999888888888999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccc--c
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM--D 1124 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~--~ 1124 (1368)
+ .-+|+|.|. .+.-|...+.+.|+.|+++||.-+|+.| |+|||||.+||||+.-.-+.|+||.--+-.. .
T Consensus 103 v-khnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe 174 (1431)
T KOG1240|consen 103 V-KHNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE 174 (1431)
T ss_pred H-hhhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence 9 458888884 2345778899999999999999999998 9999999999999999899999998665322 1
Q ss_pred ---cccccccccccccccccCcchhccC-----------CCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhh
Q 000659 1125 ---EESRHISTRVMGTFGYVAPEYAMTG-----------HLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWA 1189 (1368)
Q Consensus 1125 ---~~~~~~st~v~GT~gYmAPEvL~~~-----------~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa 1189 (1368)
.+......+-..-.+|+|||.+... .++.+.||||+||+++||++ |+.+|+..+ +..+-
T Consensus 175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aYr 248 (1431)
T KOG1240|consen 175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAYR 248 (1431)
T ss_pred CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhHh
Confidence 1122222233344689999977541 26778999999999999999 788886532 22221
Q ss_pred hh-hcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1190 RP-LLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1190 ~p-lls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+. ....+..+++|-| ..+.+++..|++.||++|.+++++++.
T Consensus 249 ~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 249 SGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence 11 0011111222222 247789999999999999999999887
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=189.34 Aligned_cols=139 Identities=22% Similarity=0.221 Sum_probs=110.6
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeecccch--------------------------hhHHHHHHHHHHhhcccccc
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--------------------------GGREFLAEVEMLSRLHHRNL 1027 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~--------------------------~~keFlrEIeILsrLrHPNI 1027 (1368)
.+.||+|+||.||+|...+|+.||||+++..... ....+.+|++.+.+++|.+|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999998753210 01123578999999999987
Q ss_pred eeeeeeeeeccceEEEEeecCCCChhhc-ccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeee
Q 000659 1028 VKLIGICIEEQARCLVYELIPNGSVESH-LHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1028 VrLlG~~~d~~~~~LVmEYm~gGSL~d~-L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILL 1105 (1368)
.....+... ..+|||||++|+++... +. ...++..+..+|+.|++.+|.+||. .| |+||||||+||||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-----DVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-----hccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence 554444333 34899999988865433 32 2347788999999999999999998 77 9999999999999
Q ss_pred cCCCCccccccccccccc
Q 000659 1106 EHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1106 D~ng~VKLsDFGLArll~ 1123 (1368)
+ +++++|+|||+++...
T Consensus 152 ~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 152 H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred E-CCCEEEEEcccceecC
Confidence 9 8899999999998653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.1e-21 Score=224.84 Aligned_cols=262 Identities=21% Similarity=0.334 Sum_probs=188.9
Q ss_pred HhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCC
Q 000659 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1098 (1368)
Q Consensus 1019 LsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDI 1098 (1368)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.|.+.. +...++|.-...++.+|+.||+|||... -.+|+.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l 75 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGAL 75 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeee
Confidence 4678999999999999999999999999999999999964 3457999999999999999999999764 2399999
Q ss_pred cccCeeecCCCCcccccccccccccccccccccccccccccccCcchhccC-------CCCcccceeeHHHHHHHHHhCC
Q 000659 1099 KSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG-------HLLVKSDVYSYGVVILELLSGR 1171 (1368)
Q Consensus 1099 KPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~-------~~T~KSDVWSLGVILyELLTGr 1171 (1368)
+..|+++|..+.+||+|||+.................-...|.|||.++.. ..+.+.||||||++++|+++.+
T Consensus 76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~ 155 (484)
T KOG1023|consen 76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS 155 (484)
T ss_pred ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence 999999999999999999998766321111111122245689999998763 2467899999999999999999
Q ss_pred CCCCCCCCCcc-hhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHh
Q 000659 1172 KPVDMTQPPGQ-ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1172 ~PFd~s~~~~~-~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e 1250 (1368)
.||+....... ..++.+++. .....+.+.+.... +....+..++..||..+|.+||++++|...++.+...
T Consensus 156 ~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 156 GPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred CccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 99987543322 233333322 01111222221111 3334789999999999999999999999888877664
Q ss_pred hh-hhhhcCCCCCCCCccccccCCCccCCCCCCCCCCcccCCCC
Q 000659 1251 CD-EAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDPLQRHYSVP 1293 (1368)
Q Consensus 1251 ~~-e~~ev~s~s~s~eD~SiDldsk~SegSgq~seskqR~~Sln 1293 (1368)
.. +....+......+.+...++..+.+.+..+.+++++...+.
T Consensus 228 ~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~e~~k~d~LL 271 (484)
T KOG1023|consen 228 GSSKGNLMDSLFRMLESYADNLEKLVDERTAELEEEKKKTDTLL 271 (484)
T ss_pred ccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHHHHHHHHHHH
Confidence 42 22444444455566666666555555555555554544443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-19 Score=225.61 Aligned_cols=258 Identities=21% Similarity=0.237 Sum_probs=184.8
Q ss_pred HHHHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc---cccceeeeeeeeeccc
Q 000659 963 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 963 ELe~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr---HPNIVrLlG~~~d~~~ 1039 (1368)
+++.....|.+.+.||+|+||.||+|...+|+.||+|+-+..... +|.-=.+++.||+ -+.|..+...+.-.+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 445556789999999999999999999888999999998654332 2222223344444 2334555555556678
Q ss_pred eEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec-------CCCCcc
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-------HDFTPK 1112 (1368)
Q Consensus 1040 ~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD-------~ng~VK 1112 (1368)
.+||+||.+.|+|.+++. ....++|...+.|+.|+++.|+.||..+ |||+||||+|+||. ++..++
T Consensus 769 S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 899999999999999996 3457999999999999999999999988 99999999999993 234689
Q ss_pred cccccccccccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1113 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1113 LsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
|+|||.+-.+.--.........++|-++-+.|+..++.++...|.|+|.-+++.||.|+.- ..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~------------q~----- 904 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM------------EV----- 904 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH------------Hh-----
Confidence 9999999765433333334557789999999999999999999999999999999999631 00
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHHHHHhhhh
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDE 1253 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~I~~e~~e 1253 (1368)
..+-...++..+..-+..+.+.+|.+++ |+.|=..=|...++...|+.+..+..+
T Consensus 905 ---~~g~~~~~~~~~~Ry~~~~~W~~~F~~l---LN~~~~~~p~l~~lr~~~~~~~~~~~~ 959 (974)
T KOG1166|consen 905 ---KNGSSWMVKTNFPRYWKRDMWNKFFDLL---LNPDCDTLPNLQELRTELEEVLAEHFT 959 (974)
T ss_pred ---cCCcceeccccchhhhhHHHHHHHHHHH---hCcCcccchhHHHHHHHHHHHHHHHHH
Confidence 1111222222222223334444444444 444444456666776667666655443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-19 Score=198.60 Aligned_cols=234 Identities=21% Similarity=0.347 Sum_probs=152.4
Q ss_pred CcceeeEEeecCcEEEEEEEec-CCCEEEEEEeec---ccchhhHHHHHHHHHHhhcc----------cccceeeeeeee
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH----------HRNLVKLIGICI 1035 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~---~d~~~~keFlrEIeILsrLr----------HPNIVrLlG~~~ 1035 (1368)
.+...+.||.|+|+.||.+++. +|+.++||++.. ......+++++|.-....+. |-.++--++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4567889999999999999954 689999999843 23344567777776665532 222333233221
Q ss_pred ---------ec---c-----ceEEEEeecCCCChhhccccccc---CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccc
Q 000659 1036 ---------EE---Q-----ARCLVYELIPNGSVESHLHGVDK---ESAPLGWDARLKIALGAARALAYLHEDSSPRVIH 1095 (1368)
Q Consensus 1036 ---------d~---~-----~~~LVmEYm~gGSL~d~L~~~~~---~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVH 1095 (1368)
.. . ..+++|.-+ .++|.+++..... ....+....++.+..|+++.+++||..| |||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 236778777 6788887643221 1223556677888899999999999998 999
Q ss_pred cCCcccCeeecCCCCcccccccccccccccccccccccccccccccCcchhcc--------CCCCcccceeeHHHHHHHH
Q 000659 1096 RDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT--------GHLLVKSDVYSYGVVILEL 1167 (1368)
Q Consensus 1096 RDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~--------~~~T~KSDVWSLGVILyEL 1167 (1368)
+|||++|+||+.+|.++|+||+.....+.... . ...+..|.+||.... -.++.+.|.|+||++||.|
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l 243 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----C-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL 243 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----G-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCceee----c-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence 99999999999999999999998765432111 1 234578999997644 2578899999999999999
Q ss_pred HhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCC
Q 000659 1168 LSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR 1234 (1368)
Q Consensus 1168 LTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeR 1234 (1368)
+||+.||+....... .+| .+ ..+. +..+.+..|+..+|+.++.+|
T Consensus 244 WC~~lPf~~~~~~~~---~~~-----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 244 WCGRLPFGLSSPEAD---PEW-----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHSS-STCCCGGGST---SGG-----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHccCCCCCCCcccc---ccc-----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999986532111 111 11 1223 556788999999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.1e-18 Score=186.95 Aligned_cols=187 Identities=19% Similarity=0.130 Sum_probs=139.9
Q ss_pred cceeeEEeecCcEEEEEEEecCCCEEEEEEeecccch----hhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEe
Q 000659 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ----GGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~----~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmE 1045 (1368)
+.+...|++|+||+||.+.. +++.++.+.+.....- ..+.|.+|+++|++|+ |++|.+++++ +..+++||
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred cccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 34567999999999997766 5788888887643221 1225889999999995 5889999886 45699999
Q ss_pred ecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCC-cccCeeecCCCCcccccccccccccc
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF-KSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1046 Ym~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDI-KPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
|+.|.+|.+.+.. ....++.|++++|++||+.| |+|||| |++|||++.++.++|+|||++.....
T Consensus 79 yI~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 79 YLAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred eecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 9999998765411 11357789999999999998 999999 79999999999999999999985433
Q ss_pred cccc----------c-ccccccccccccCcchhccC-CC-CcccceeeHHHHHHHHHhCCCCCCC
Q 000659 1125 EESR----------H-ISTRVMGTFGYVAPEYAMTG-HL-LVKSDVYSYGVVILELLSGRKPVDM 1176 (1368)
Q Consensus 1125 ~~~~----------~-~st~v~GT~gYmAPEvL~~~-~~-T~KSDVWSLGVILyELLTGr~PFd~ 1176 (1368)
.... + .......+..|+.|+...-. .. -.+.+.++.|+.+|.++||+.+.-.
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 2210 0 01223467788888854321 22 2566889999999999999886533
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-19 Score=211.16 Aligned_cols=225 Identities=27% Similarity=0.333 Sum_probs=177.1
Q ss_pred EEeecCcEEEEEEE----ecCCCEEEEEEeecccchh--hHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEeecC
Q 000659 976 ILGEGGFGLVYSGV----LDDGTKVAVKVLKRVDQQG--GREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 976 lLGeGgFGtVYKAv----lkdGr~VAVKvLk~~d~~~--~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmEYm~ 1048 (1368)
.+|+|.||.|+++. .+.|..+++|++++..... ......|..++..++ |+.+|++...+..+...+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999866 3457778999886532211 113456788888887 9999999999999999999999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccc
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~ 1128 (1368)
||.|...+... ..+++.....+...++-++++||..+ |+|||+|++||++|.+|.+++.|||+.+..-.....
T Consensus 81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~ 153 (612)
T KOG0603|consen 81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA 153 (612)
T ss_pred cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence 99999988532 34666777778888999999999998 999999999999999999999999999876543322
Q ss_pred cccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCC
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208 (1368)
Q Consensus 1129 ~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~ 1208 (1368)
|||..|||||+++ ......|.||||++++||+||..||.. +-++. |+...
T Consensus 154 ------cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~----------Il~~~-- 203 (612)
T KOG0603|consen 154 ------CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKR----------ILKAE-- 203 (612)
T ss_pred ------ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHH----------Hhhhc--
Confidence 8999999999988 456689999999999999999999964 11111 11111
Q ss_pred CCCChhhHHHHHHHHHHhcCcCcCCCCCH
Q 000659 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1209 ~~~~~ee~~eLl~La~~CL~pDPkeRPTM 1237 (1368)
-.++.+......+++..++..+|..|.-.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 13444556677788888888999998765
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.3e-17 Score=174.95 Aligned_cols=134 Identities=21% Similarity=0.287 Sum_probs=113.4
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccc--------hhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ--------QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~--------~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
+.||+|++|.||+|.. +|..|+||+...... ...+++.+|++++.+++|.+|.....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 577899998643211 1124578999999999999998888887777888999999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
++|++|.+++... .+ ++..++.+++.+|.+||+.+ ++|||++++|||++ ++.++|+|||+++.
T Consensus 81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999998421 22 88999999999999999888 99999999999999 78999999998864
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.1e-17 Score=180.66 Aligned_cols=137 Identities=17% Similarity=0.265 Sum_probs=106.6
Q ss_pred ceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhc-----ccccceeeeeeeeecc---ce-EE
Q 000659 972 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-----HHRNLVKLIGICIEEQ---AR-CL 1042 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-----rHPNIVrLlG~~~d~~---~~-~L 1042 (1368)
...++||+|+||.||+ .-+++.. +||++........+++.+|+++++++ +|+||++++|++.++. .. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457999999999996 3334444 68988655445567899999999999 5799999999998763 33 37
Q ss_pred EEee--cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHH-hhhhccCCCCccccCCcccCeeecC----CCCccccc
Q 000659 1043 VYEL--IPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL-AYLHEDSSPRVIHRDFKSSNILLEH----DFTPKVSD 1115 (1368)
Q Consensus 1043 VmEY--m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GL-aYLHs~gsp~IVHRDIKPsNILLD~----ng~VKLsD 1115 (1368)
|+|| +.+|+|.+++.+. .+++. ..++.+++.++ +|||+++ ||||||||+|||++. +++++|+|
T Consensus 83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 8999 5579999999531 25444 35677888777 9999988 999999999999974 34799999
Q ss_pred ccccc
Q 000659 1116 FGLAR 1120 (1368)
Q Consensus 1116 FGLAr 1120 (1368)
|+.++
T Consensus 153 g~G~~ 157 (210)
T PRK10345 153 NIGES 157 (210)
T ss_pred CCCCc
Confidence 55443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=4e-17 Score=171.70 Aligned_cols=145 Identities=19% Similarity=0.113 Sum_probs=113.0
Q ss_pred HHHHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccc----------------------hhhHHHHHHHHHHh
Q 000659 963 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ----------------------QGGREFLAEVEMLS 1020 (1368)
Q Consensus 963 ELe~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~----------------------~~~keFlrEIeILs 1020 (1368)
++......|.+.+.||+|+||.||++...+|+.||||+++.... .....+.+|+.++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445888899999999999999988899999998753210 01123678899999
Q ss_pred hccccc--ceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCC
Q 000659 1021 RLHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDF 1098 (1368)
Q Consensus 1021 rLrHPN--IVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDI 1098 (1368)
++.|.+ +...++ ....++||||++|++|.+.... ....+++.+++.++.+||+.+ |+||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl 151 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHG---IIHGDL 151 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCC---CCcCCC
Confidence 998874 444443 2455899999999998765420 335678899999999999987 999999
Q ss_pred cccCeeecCCCCcccccccccccccc
Q 000659 1099 KSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1099 KPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
||+||||+++++++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999975543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.4e-17 Score=177.77 Aligned_cols=147 Identities=17% Similarity=0.127 Sum_probs=113.1
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEE--ecCCCEEEEEEeecccch------------------------hhHHHHHHHHH
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGV--LDDGTKVAVKVLKRVDQQ------------------------GGREFLAEVEM 1018 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAv--lkdGr~VAVKvLk~~d~~------------------------~~keFlrEIeI 1018 (1368)
.+....|++.+.||+|+||.||+|+ ..+|+.||||+++..... ....+.+|+++
T Consensus 24 ~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 103 (237)
T smart00090 24 LNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRN 103 (237)
T ss_pred HhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHH
Confidence 3334458899999999999999998 568999999998643210 11235689999
Q ss_pred Hhhccccc--ceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCcccc
Q 000659 1019 LSRLHHRN--LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHR 1096 (1368)
Q Consensus 1019 LsrLrHPN--IVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHR 1096 (1368)
++++.+.+ +.+++++ ...+|||||+.+++|..++.. ...+...+..+++.|++.+|.+||..+ +|+||
T Consensus 104 L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~ 173 (237)
T smart00090 104 LQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHG 173 (237)
T ss_pred HHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeC
Confidence 99997633 3333432 245899999999888776521 123556677899999999999999775 49999
Q ss_pred CCcccCeeecCCCCcccccccccccc
Q 000659 1097 DFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1097 DIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
||||+||||+ +++++|+|||++...
T Consensus 174 Dikp~NIli~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 174 DLSEYNILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred CCChhhEEEE-CCCEEEEEChhhhcc
Confidence 9999999999 889999999998754
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.7e-17 Score=198.42 Aligned_cols=141 Identities=18% Similarity=0.266 Sum_probs=114.6
Q ss_pred HHHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEE-eecc-c------chhhHHHHHHHHHHhhcccccceeeeeeeee
Q 000659 965 EKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKV-LKRV-D------QQGGREFLAEVEMLSRLHHRNLVKLIGICIE 1036 (1368)
Q Consensus 965 e~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKv-Lk~~-d------~~~~keFlrEIeILsrLrHPNIVrLlG~~~d 1036 (1368)
+.....|...++||+|+||.||+|.+.+.. +++|+ +.+. . ....+++.+|++++++++|.+++..+.++.+
T Consensus 329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~ 407 (535)
T PRK09605 329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD 407 (535)
T ss_pred cccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence 344455667899999999999999876443 44443 2211 1 1123568899999999999999998888887
Q ss_pred ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccc
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDF 1116 (1368)
....++||||++|++|.+++. .+.+++.+++++|.|||+.+ |+||||||+|||| ++++++|+||
T Consensus 408 ~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 408 PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 778899999999999999883 45789999999999999887 9999999999999 6789999999
Q ss_pred cccccc
Q 000659 1117 GLARSA 1122 (1368)
Q Consensus 1117 GLArll 1122 (1368)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.6e-17 Score=170.45 Aligned_cols=130 Identities=20% Similarity=0.320 Sum_probs=106.8
Q ss_pred EEeecCcEEEEEEEecCCCEEEEEEeeccc--------chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeec
Q 000659 976 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 976 lLGeGgFGtVYKAvlkdGr~VAVKvLk~~d--------~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
+||+|+||.||+|.+. |+.|++|+..... ....+++.+|++++++++|.++.....++.+.+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 7889999864321 111356788999999999887766666666677789999999
Q ss_pred CCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1048 ~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
+|++|.+++.... ..++.+++.+|++||+.+ |+|||+|++|||++ +++++|+|||+++.
T Consensus 80 ~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998874210 078999999999999888 99999999999999 88999999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.7e-17 Score=185.66 Aligned_cols=198 Identities=21% Similarity=0.213 Sum_probs=137.0
Q ss_pred ccccceeeeeeeee---------------------------ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHH
Q 000659 1023 HHRNLVKLIGICIE---------------------------EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1075 (1368)
Q Consensus 1023 rHPNIVrLlG~~~d---------------------------~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA 1075 (1368)
+|||||++.++|.+ ...+|+||..+ ..+|.+||.. ...+...+.-|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~-----~~~s~r~~~~~l 347 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWT-----RHRSYRTGRVIL 347 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhc-----CCCchHHHHHHH
Confidence 59999999987653 22358888877 4588888843 235666777899
Q ss_pred HHHHHHHhhhhccCCCCccccCCcccCeee--cCCC--Cccccccccccccccc--cccccc--ccccccccccCcchhc
Q 000659 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILL--EHDF--TPKVSDFGLARSAMDE--ESRHIS--TRVMGTFGYVAPEYAM 1147 (1368)
Q Consensus 1076 ~QIA~GLaYLHs~gsp~IVHRDIKPsNILL--D~ng--~VKLsDFGLArll~~~--~~~~~s--t~v~GT~gYmAPEvL~ 1147 (1368)
.|+++|+.|||.+| |.|||+|.+|||| |+|+ .+.|+|||++--.... .-...+ -..-|...-||||+..
T Consensus 348 aQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t 424 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT 424 (598)
T ss_pred HHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence 99999999999998 9999999999999 3333 4688999987422110 000011 1133778899999876
Q ss_pred cC------CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHH
Q 000659 1148 TG------HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA 1221 (1368)
Q Consensus 1148 ~~------~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~ 1221 (1368)
.. ....|+|.|+.|.+-||++....||........ .... ++ +.-....+..+...+.+
T Consensus 425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~-----------Yq----e~qLPalp~~vpp~~rq 488 (598)
T KOG4158|consen 425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRT-----------YQ----ESQLPALPSRVPPVARQ 488 (598)
T ss_pred cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhh-----------hh----hhhCCCCcccCChHHHH
Confidence 42 234799999999999999999999975321100 0000 11 11112233445567889
Q ss_pred HHHHhcCcCcCCCCCHHHHHHHHH
Q 000659 1222 IASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1222 La~~CL~pDPkeRPTMsEVLq~Le 1245 (1368)
++...++.||.+|++..-....|.
T Consensus 489 lV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 489 LVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHhcCCccccCCccHHHhHHH
Confidence 999999999999999776655554
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.67 E-value=3e-16 Score=151.01 Aligned_cols=135 Identities=21% Similarity=0.213 Sum_probs=115.5
Q ss_pred eeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccc--ccceeeeeeeeeccceEEEEeecCCC
Q 000659 973 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrH--PNIVrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+.+.||+|.++.||++..++ +.++||+.+.... ..++.+|+.+++++++ .++.++++++...+..+++|||+.++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999864 7899999865433 5678999999999986 58999999988888899999999887
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
.+..+ ++.....++.+++++|++||.....+++|||||++|||+++++.++|+|||+++.
T Consensus 79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77544 4567788899999999999986445699999999999999989999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2e-17 Score=194.67 Aligned_cols=239 Identities=23% Similarity=0.285 Sum_probs=155.3
Q ss_pred eeEEeecCcEEEEEEEecC----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeee-----e--ee-----ec
Q 000659 974 SRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG-----I--CI-----EE 1037 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG-----~--~~-----d~ 1037 (1368)
.+.+++.+++.+....... .+.+..|..+..+-.......+++-.+....|-+..-+.+ . .. ..
T Consensus 249 ~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~ 328 (516)
T KOG1033|consen 249 SKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKK 328 (516)
T ss_pred cccccccccCCchhhhhcccchhhhhccchhhhccchhhhhhhhhhhhheeccccCCcccccCCCCchhhhccccccccc
Confidence 3445555555555544222 2334444444333123333444555554444433333333 1 11 12
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
...||.|++|...+|++||.+... ....+|...+.++.|++.|++| ++ .+|||+|+.||+...+..+||.|||
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~-~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRT-GEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCc-ccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhh
Confidence 346899999999999999964332 3457889999999999999999 55 8999999999999999999999999
Q ss_pred ccccccccc----cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhC-CCCCCCCCCCcchhHHHhhhhh
Q 000659 1118 LARSAMDEE----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1118 LArll~~~~----~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTG-r~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
|........ .....+...||..||+||.+.+..|+.|+|||+||+||+||+.- ...|+. ..
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er---------~~----- 467 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER---------IA----- 467 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH---------HH-----
Confidence 998665433 12234567899999999999999999999999999999999972 111110 00
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGE 1239 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsE 1239 (1368)
...+.-..++++....+++ +-..|+.+++...|.+||++.+
T Consensus 468 -t~~d~r~g~ip~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 468 -TLTDIRDGIIPPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -hhhhhhcCCCChHHhhcCc-----HHHHHHHHhcCCCcccCchHHH
Confidence 0001111122222222232 2346899999999999994433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=2e-15 Score=155.71 Aligned_cols=136 Identities=24% Similarity=0.250 Sum_probs=98.8
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeecccch--hhHH----------------------HHHHHHHHhhccccc--c
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ--GGRE----------------------FLAEVEMLSRLHHRN--L 1027 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~--~~ke----------------------FlrEIeILsrLrHPN--I 1027 (1368)
.+.||+|+||.||+|...+|+.||||+++..... .... ...|.+.+.++++.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999888999999998643211 1111 135666666665443 3
Q ss_pred eeeeeeeeeccceEEEEeecCCCChhhc-ccccccCCCCCChHHHHHHHHHHHHHHhhhhc-cCCCCccccCCcccCeee
Q 000659 1028 VKLIGICIEEQARCLVYELIPNGSVESH-LHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1028 VrLlG~~~d~~~~~LVmEYm~gGSL~d~-L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs-~gsp~IVHRDIKPsNILL 1105 (1368)
.+.+++ ...++||||+.++.+... |.... .. .+..+++.+++.++.+||. .+ |+|||||++||||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence 334332 245899999999654322 21110 11 6678899999999999998 76 9999999999999
Q ss_pred cCCCCccccccccccccc
Q 000659 1106 EHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1106 D~ng~VKLsDFGLArll~ 1123 (1368)
+ ++.++|+|||++....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999997553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-16 Score=192.66 Aligned_cols=210 Identities=22% Similarity=0.340 Sum_probs=142.7
Q ss_pred hCCcceeeEEeecCcEEEEEEEec-CCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 T~nFei~klLGeGgFGtVYKAvlk-dGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..+|+..++|..|+||.||..+++ ..+.+|+|+-++. .+++- +|.....+.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence 467999999999999999999865 4566777543321 11111 22222333333
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
|+-...|... ..+..+. +.+++|||+.+ |+|||+|++|+||+.-|.+|+.||||.+......
T Consensus 136 ---gDc~tllk~~----g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ---GDCATLLKNI----GPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ---chhhhhcccC----CCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 4444444321 1232222 67899999888 9999999999999999999999999987432111
Q ss_pred -------------cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhc
Q 000659 1127 -------------SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1127 -------------~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pll 1193 (1368)
.......+|||+.|+|||++..+-|+..+|.|++|+|+||++.|+.||.....++. .. .++
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel---fg---~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL---FG---QVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH---Hh---hhh
Confidence 11112347999999999999999999999999999999999999999987643321 11 111
Q ss_pred ccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCC
Q 000659 1194 TSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF 1236 (1368)
Q Consensus 1194 s~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPT 1236 (1368)
.+. ..+. +.......+..+++...|+.+|.+|--
T Consensus 272 sd~---i~wp------E~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 272 SDD---IEWP------EEDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhh---cccc------ccCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 110 0000 112233467888999999999999963
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.5e-16 Score=191.65 Aligned_cols=257 Identities=21% Similarity=0.259 Sum_probs=194.3
Q ss_pred CCcceeeEEeecCcEEEEEEEec--CCCEEEEEEeeccc--chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEE
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD--DGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlk--dGr~VAVKvLk~~d--~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LV 1043 (1368)
..|.+.+.||+|.|+.|-..... ....+++|.+.... ....+....|..+-+.+. |.|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34666778999999999888753 34456667665432 333344556888888887 99999999999999999999
Q ss_pred EeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhh-ccCCCCccccCCcccCeeecCCC-Cccccccccccc
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH-EDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 1121 (1368)
Q Consensus 1044 mEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLH-s~gsp~IVHRDIKPsNILLD~ng-~VKLsDFGLArl 1121 (1368)
+||..+|++.+.+.. .....++....-.++.|+..+|.|+| +.+ +.||||||+|.+++..+ .++++|||+|..
T Consensus 100 ~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred cCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998831 12224566777889999999999999 777 99999999999999999 999999999998
Q ss_pred ccc-cccccccccccc-cccccCcchhccC-CCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccc
Q 000659 1122 AMD-EESRHISTRVMG-TFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1122 l~~-~~~~~~st~v~G-T~gYmAPEvL~~~-~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~ 1198 (1368)
+.. ..........+| +.-|+|||...+. ......|+||+|+++.-+++|..||+...... +....|.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~~----- 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNKG----- 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccccc-----
Confidence 876 444444556778 9999999988774 55678899999999999999999997654332 22222321110
Q ss_pred cceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1199 L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
...............+++.+++..++..|.+.+++...
T Consensus 249 -------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d 286 (601)
T KOG0590|consen 249 -------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD 286 (601)
T ss_pred -------ccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence 00011222334567788889998999999999887543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.56 E-value=1.6e-14 Score=158.58 Aligned_cols=135 Identities=22% Similarity=0.275 Sum_probs=105.3
Q ss_pred eEEe-ecCcEEEEEEEecCCCEEEEEEeeccc-------------chhhHHHHHHHHHHhhcccccc--eeeeeeeeecc
Q 000659 975 RILG-EGGFGLVYSGVLDDGTKVAVKVLKRVD-------------QQGGREFLAEVEMLSRLHHRNL--VKLIGICIEEQ 1038 (1368)
Q Consensus 975 klLG-eGgFGtVYKAvlkdGr~VAVKvLk~~d-------------~~~~keFlrEIeILsrLrHPNI--VrLlG~~~d~~ 1038 (1368)
.+|| .|+.|+||++... +..++||+++... .....++.+|++++.+|+|.+| +..++++..+.
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 5787 8999999998876 7789999885311 1223467899999999998875 67777754432
Q ss_pred c-e---EEEEeecCC-CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccc
Q 000659 1039 A-R---CLVYELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113 (1368)
Q Consensus 1039 ~-~---~LVmEYm~g-GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKL 1113 (1368)
. . ++||||++| .+|.+++.. ..++.. .+.+|+.+|.+||+.| |+|||||++||||+.++.++|
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L 183 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL 183 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence 2 2 599999997 689888743 134433 3568999999999998 999999999999999999999
Q ss_pred ccccccccc
Q 000659 1114 SDFGLARSA 1122 (1368)
Q Consensus 1114 sDFGLArll 1122 (1368)
+|||.++..
T Consensus 184 IDfg~~~~~ 192 (239)
T PRK01723 184 IDFDRGELR 192 (239)
T ss_pred EECCCcccC
Confidence 999998753
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=2.7e-13 Score=160.99 Aligned_cols=145 Identities=25% Similarity=0.258 Sum_probs=103.4
Q ss_pred CcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchh----------------------------------------h
Q 000659 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG----------------------------------------G 1009 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~----------------------------------------~ 1009 (1368)
.|+ .+.||.|++|.||+|++.+|+.||||+.+..-... +
T Consensus 119 ~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~E 197 (437)
T TIGR01982 119 EFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRE 197 (437)
T ss_pred hCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHH
Confidence 344 36799999999999999999999999985321100 0
Q ss_pred HHHHHHHHHHhhcc----cccceeeeeeeee-ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHH-HHh
Q 000659 1010 REFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR-ALA 1083 (1368)
Q Consensus 1010 keFlrEIeILsrLr----HPNIVrLlG~~~d-~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~-GLa 1083 (1368)
-+|.+|++.+.+++ +.+-+.+-.+|.+ .+..+|||||++|++|.+++.... ..+ .+.+++..+++ .+.
T Consensus 198 ldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~---~~~~ia~~~~~~~l~ 271 (437)
T TIGR01982 198 LDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGL---DRKALAENLARSFLN 271 (437)
T ss_pred HCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCC---CHHHHHHHHHHHHHH
Confidence 12455666665553 3334444444432 355799999999999998764211 112 24556666666 477
Q ss_pred hhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1084 YLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
.+|..| ++|+|+||.||+++.+++++|+|||++..+..
T Consensus 272 ql~~~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 272 QVLRDG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHhCC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 889887 99999999999999999999999999986643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.37 E-value=3.5e-13 Score=163.46 Aligned_cols=148 Identities=21% Similarity=0.229 Sum_probs=96.9
Q ss_pred HhCCcceeeEEeecCcEEEEEEEecC-CCEEEEEEeecccc----------------------------------hhhH-
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDD-GTKVAVKVLKRVDQ----------------------------------QGGR- 1010 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~~d~----------------------------------~~~k- 1010 (1368)
...+|+. +.||.|++|.||+|++++ |+.||||+++..-. +..+
T Consensus 118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~ 196 (537)
T PRK04750 118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT 196 (537)
T ss_pred HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence 3456776 789999999999999887 99999999863210 0011
Q ss_pred -----HHHHHHHHHhhcc----cccceeeeeeeee-ccceEEEEeecCCCChhhc--ccccccCCCCCChHHHHHHHHHH
Q 000659 1011 -----EFLAEVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESH--LHGVDKESAPLGWDARLKIALGA 1078 (1368)
Q Consensus 1011 -----eFlrEIeILsrLr----HPNIVrLlG~~~d-~~~~~LVmEYm~gGSL~d~--L~~~~~~~~pLsw~erlkIA~QI 1078 (1368)
+|.+|+..+.+++ +.+.+.+-.++.+ ....+|||||++|+.|.++ +.....+...+.......++.|+
T Consensus 197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence 2344544444442 3344444444443 3566899999999999874 22111011123333333333443
Q ss_pred HHHHhhhhccCCCCccccCCcccCeeecCCC----Cccccccccccccccc
Q 000659 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDF----TPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1079 A~GLaYLHs~gsp~IVHRDIKPsNILLD~ng----~VKLsDFGLArll~~~ 1125 (1368)
...| ++|+|+||.||||+.++ +++++|||++..+...
T Consensus 277 -------f~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 277 -------FRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred -------HhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 3456 99999999999999888 9999999999876543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-13 Score=152.96 Aligned_cols=207 Identities=22% Similarity=0.293 Sum_probs=144.1
Q ss_pred HHHHhhcccccceeeeeeeeecc-----ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCC
Q 000659 1016 VEMLSRLHHRNLVKLIGICIEEQ-----ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090 (1368)
Q Consensus 1016 IeILsrLrHPNIVrLlG~~~d~~-----~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gs 1090 (1368)
...|-++.|-|||+++.|+.+.. +..++.|||..|+|.++|++..+....+......+|+.||..||.|||.. .
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~ 196 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D 196 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence 34455667999999999987643 46899999999999999988777667788888899999999999999987 6
Q ss_pred CCccccCCcccCeeecCCCCccccccccccc--ccccccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHH
Q 000659 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS--AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1168 (1368)
Q Consensus 1091 p~IVHRDIKPsNILLD~ng~VKLsDFGLArl--l~~~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELL 1168 (1368)
+.|+|+++..+-|++..++-+||.----... ..............+-.+|.+||+-..-..+..+|||+||++.+||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8899999999999999998888742211100 00000111112234678999999887778888999999999999998
Q ss_pred hCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1169 SGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1169 TGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
.|..--... .. ...+ ++.+...+-. +.+ ..-..++..|++.+|..||+|++++..
T Consensus 277 ilEiq~tns--eS-~~~~---------ee~ia~~i~~-len-------~lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 277 ILEIQSTNS--ES-KVEV---------EENIANVIIG-LEN-------GLQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HheeccCCC--cc-eeeh---------hhhhhhheee-ccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence 876421110 00 0000 0011111000 000 011347889999999999999998643
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.6e-12 Score=153.44 Aligned_cols=270 Identities=14% Similarity=0.136 Sum_probs=179.2
Q ss_pred cEEEEEEE-ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeee----eccceEEEEeecCC-CChhhc
Q 000659 982 FGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICI----EEQARCLVYELIPN-GSVESH 1055 (1368)
Q Consensus 982 FGtVYKAv-lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~----d~~~~~LVmEYm~g-GSL~d~ 1055 (1368)
-.+.||+. ..||..|++|+++....+.......-+++++++.|.|||+|.+++. .+..++|||+|+++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 45789998 5589999999995433333334456788999999999999999876 35677999999987 577776
Q ss_pred cccccc-----------CCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1056 LHGVDK-----------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1056 L~~~~~-----------~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
-..... .+..+.+..+|.++.|+..||.++|+.| +.-+-|.+++||++.+.+++|+.+|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 542211 2335778999999999999999999998 88899999999999999999999988766543
Q ss_pred cccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeec
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvD 1204 (1368)
+.. |.+. --.+-|.-.||.+|+-|.||..--...+. .+..-.+.+
T Consensus 446 d~~----------------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~-~~~s~~~~I--------------- 490 (655)
T KOG3741|consen 446 DPT----------------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDS-TQSSHLTRI--------------- 490 (655)
T ss_pred CCC----------------cchh---HHhhhhHHHHHHHHHHHhhcccccccccc-hHHHHHHHh---------------
Confidence 221 1111 11367888999999999999642111100 000000000
Q ss_pred CCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH----------------------HHHHHHhhhhhhhcCCCCC
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA----------------------LKLVCNECDEAKEVGSASS 1262 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~----------------------Le~I~~e~~e~~ev~s~s~ 1262 (1368)
......++.+++......+.++ -++.+++.+ |.+.++..+..+.+.....
T Consensus 491 -------~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE~~Ls~emENGRLfRll~Kln~ 562 (655)
T KOG3741|consen 491 -------TTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVMETELSREMENGRLFRLLLKLNF 562 (655)
T ss_pred -------hhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHhcchHHHHHHHHhh
Confidence 0111122223333333333332 222232222 2233333333344445556
Q ss_pred CCCccccccCCCccCCCCCCCCCCcccCCCCcccc
Q 000659 1263 SQDDMSIDLDSKVSTGSGQLPDPLQRHYSVPNYDL 1297 (1368)
Q Consensus 1263 s~eD~SiDldsk~SegSgq~seskqR~~SlnafDl 1297 (1368)
..+..+...|..|++.+.++.-.+.|+|.+++.+.
T Consensus 563 I~dR~e~~~D~~WSesG~~fmi~LFRDYlFHqvte 597 (655)
T KOG3741|consen 563 IDDRPEYVDDPDWSESGDRFMIKLFRDYLFHQVTE 597 (655)
T ss_pred hccCcccccCCcchhccceehHHHHHHhhheEecc
Confidence 67777788899999999999999999999998887
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.8e-12 Score=131.19 Aligned_cols=131 Identities=18% Similarity=0.067 Sum_probs=98.4
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eeeeeeeeccceEEEEeecCCCCh
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
.+.|+.|.++.||++... ++.|++|+...... ....+.+|+++++.+.+.+++ +++++. .+..++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999999876 77899999864322 233567899999999766654 444433 3345899999999887
Q ss_pred hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccC--CCCccccCCcccCeeecCCCCccccccccccc
Q 000659 1053 ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1053 ~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~g--sp~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
.+.. .....++.+++++|+.||..+ ...++|||++++|||++ ++.++|+|||.+..
T Consensus 79 ~~~~------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 6431 011345678999999999876 22359999999999999 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.7e-12 Score=153.82 Aligned_cols=250 Identities=23% Similarity=0.242 Sum_probs=182.2
Q ss_pred CCcceeeEEee--cCcEEEEEEEe---cCCCEEEEEEeeccc--chhhHHHHHHHHHHhhcc-cccceeeeeeeeeccce
Q 000659 969 GNFDASRILGE--GGFGLVYSGVL---DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 969 ~nFei~klLGe--GgFGtVYKAvl---kdGr~VAVKvLk~~d--~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~ 1040 (1368)
..|.+.+.+|. |.+|.||++.. .++..+|+|+-+... ......=++|+...++++ |.|.++....+.+.+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999986 467889999843221 122233357787778885 99999999999999999
Q ss_pred EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHH----HHhhhhccCCCCccccCCcccCeeecCC-CCccccc
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR----ALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSD 1115 (1368)
Q Consensus 1041 ~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~----GLaYLHs~gsp~IVHRDIKPsNILLD~n-g~VKLsD 1115 (1368)
++-+|++ +.+|.++.+.... -+....++.++.+... ||.++|..+ |+|-|+|+.||++..+ ..++++|
T Consensus 194 fiqtE~~-~~sl~~~~~~~~~---~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPCN---FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred eeeeccc-cchhHHhhhcccc---cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 9999999 5788888764332 3566677777777777 999999887 9999999999999999 8899999
Q ss_pred ccccccccccccccc---cccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhh
Q 000659 1116 FGLARSAMDEESRHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192 (1368)
Q Consensus 1116 FGLArll~~~~~~~~---st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~pl 1192 (1368)
||+...+.+...... ..+..|...|++||.+ ++.++..+|+|+||.+++|-.+|........ ...|..
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~------~~~W~~-- 337 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGK------NSSWSQ-- 337 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCC------CCCccc--
Confidence 999998876543222 2233588899999965 5678889999999999999999876553221 112211
Q ss_pred cccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHH
Q 000659 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1193 ls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~ 1243 (1368)
+..+. +..++......++..++..+++.++..|++..++...
T Consensus 338 ------~r~~~---ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 338 ------LRQGY---IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ------ccccc---CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 11111 1112222233455558889999999999998777543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.25 E-value=2.9e-11 Score=126.43 Aligned_cols=142 Identities=22% Similarity=0.297 Sum_probs=111.6
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccc-hhhHHHHHHHHHHhhcccc--cceeeeeeeeec---cceEEEEeecC
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ-QGGREFLAEVEMLSRLHHR--NLVKLIGICIEE---QARCLVYELIP 1048 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~-~~~keFlrEIeILsrLrHP--NIVrLlG~~~d~---~~~~LVmEYm~ 1048 (1368)
+.|+.|.++.||+++..+|+.+++|+...... ....++.+|+++++.+++. ++.+++.++.+. +..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999988778999999864322 2356789999999999764 457777777654 36689999999
Q ss_pred CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccC---------------------------------------
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--------------------------------------- 1089 (1368)
Q Consensus 1049 gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~g--------------------------------------- 1089 (1368)
|++|.+.+.. ..++..++..++.++++.|.+||+..
T Consensus 84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (223)
T cd05154 84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME 158 (223)
T ss_pred CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence 9988877631 24677788888888888888888531
Q ss_pred --------------CCCccccCCcccCeeecC--CCCccccccccccc
Q 000659 1090 --------------SPRVIHRDFKSSNILLEH--DFTPKVSDFGLARS 1121 (1368)
Q Consensus 1090 --------------sp~IVHRDIKPsNILLD~--ng~VKLsDFGLArl 1121 (1368)
...++|+|++++|||++. ++.+.|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134799999999999998 56689999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.25 E-value=8.1e-12 Score=149.86 Aligned_cols=251 Identities=22% Similarity=0.209 Sum_probs=181.4
Q ss_pred HHHHhCCcceeeEEeecCcEEEEEEEe--cCCCEEEEEEeecccchhhHHH--HHHHHHHhhcc-cccceeeeeeeeecc
Q 000659 964 IEKATGNFDASRILGEGGFGLVYSGVL--DDGTKVAVKVLKRVDQQGGREF--LAEVEMLSRLH-HRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 964 Le~aT~nFei~klLGeGgFGtVYKAvl--kdGr~VAVKvLk~~d~~~~keF--lrEIeILsrLr-HPNIVrLlG~~~d~~ 1038 (1368)
....+.+|.++..||.|.|+.||+... .++..|++|.+.+.......++ +.|+.+...+. |.++++....+...+
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc
Confidence 445677899999999999999999873 4678899999865433333332 56777777774 899999888888888
Q ss_pred ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC-CCccccccc
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFG 1117 (1368)
Q Consensus 1039 ~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n-g~VKLsDFG 1117 (1368)
..|+--|||+++++...+. ...-++++.++++..|++.++.++|+.. ++|+|+|++||++..+ +..++.|||
T Consensus 340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccc
Confidence 8889999999999877662 2335788899999999999999999776 9999999999999876 889999999
Q ss_pred ccccccccccccccccccccccc-cCcchhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccc
Q 000659 1118 LARSAMDEESRHISTRVMGTFGY-VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196 (1368)
Q Consensus 1118 LArll~~~~~~~~st~v~GT~gY-mAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~ 1196 (1368)
+...+.-.. ....-++..| .+++......+..+.|+|+||+-+.|.++|..-- .+.+.|..
T Consensus 413 ~~t~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls--------~~~~~~~~------ 474 (524)
T KOG0601|consen 413 CWTRLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS--------ESGVQSLT------ 474 (524)
T ss_pred cccccceec----ccccccccccccchhhccccccccccccccccccccccccCcccC--------ccccccee------
Confidence 986421111 0111123334 3556666778889999999999999999986422 11222211
Q ss_pred cccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHHHHHHH
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1197 e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVLq~Le~ 1246 (1368)
+....+ ...+..- .++..+...++.++++.|+.+.++....+.
T Consensus 475 -----i~~~~~-p~~~~~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 475 -----IRSGDT-PNLPGLK-LQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred -----eecccc-cCCCchH-HhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 100000 1111122 567778888889999999998888665543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.4e-11 Score=142.72 Aligned_cols=166 Identities=22% Similarity=0.265 Sum_probs=129.3
Q ss_pred ecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChH
Q 000659 990 LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 1069 (1368)
Q Consensus 990 lkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~ 1069 (1368)
..++..|.|+.++...........+-++.|+.||||||+++++.++.++..|||+|.+. -|..+|.+ +...
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------l~~~ 104 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------LGKE 104 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-------hHHH
Confidence 55788899999887665445567888999999999999999999999999999999883 46666642 3456
Q ss_pred HHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccccccCcchhccC
Q 000659 1070 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149 (1368)
Q Consensus 1070 erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~ 1149 (1368)
.....+.||++||.|||+.+ .++|++|.-+.|+|+..|+.||++|.++........ ......--..|..|+.+...
T Consensus 105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 77788999999999999877 699999999999999999999999999875533221 01111122346666654432
Q ss_pred CCCcccceeeHHHHHHHHHhC
Q 000659 1150 HLLVKSDVYSYGVVILELLSG 1170 (1368)
Q Consensus 1150 ~~T~KSDVWSLGVILyELLTG 1170 (1368)
. ...|.|.|||+++|++.|
T Consensus 181 ~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 181 E--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred c--cchhhhhHHHHHHHHhCc
Confidence 2 346999999999999999
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.15 E-value=2.2e-10 Score=123.62 Aligned_cols=136 Identities=19% Similarity=0.209 Sum_probs=98.8
Q ss_pred eEEeecCcEEEEEEEecC-------CCEEEEEEeecc-------------c---------chhhHHHH----HHHHHHhh
Q 000659 975 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRV-------------D---------QQGGREFL----AEVEMLSR 1021 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd-------Gr~VAVKvLk~~-------------d---------~~~~keFl----rEIeILsr 1021 (1368)
..||.|.-+.||.|...+ +..+|||+.+.. + ....+.+. +|++.|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998553 579999997421 0 01122333 79999999
Q ss_pred ccc--ccceeeeeeeeeccceEEEEeecCCCChhh-cccccccCCCCCChHHHHHHHHHHHHHHhhh-hccCCCCccccC
Q 000659 1022 LHH--RNLVKLIGICIEEQARCLVYELIPNGSVES-HLHGVDKESAPLGWDARLKIALGAARALAYL-HEDSSPRVIHRD 1097 (1368)
Q Consensus 1022 LrH--PNIVrLlG~~~d~~~~~LVmEYm~gGSL~d-~L~~~~~~~~pLsw~erlkIA~QIA~GLaYL-Hs~gsp~IVHRD 1097 (1368)
+.. -++-..+++ ...+|||||+.++.+.. .|+ ...++.++...+..+++.+|.+| |+.+ |||||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 864 355556654 46689999997654422 222 11344556778889999999999 7777 99999
Q ss_pred CcccCeeecCCCCccccccccccccc
Q 000659 1098 FKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1098 IKPsNILLD~ng~VKLsDFGLArll~ 1123 (1368)
|++.|||++ ++.++|+|||.+....
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999997 4689999999987553
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.94 E-value=3.7e-09 Score=113.21 Aligned_cols=143 Identities=22% Similarity=0.300 Sum_probs=107.2
Q ss_pred eeeEEeecCcEEEEEEEecCCCEEEEEEe--ec------ccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEE
Q 000659 973 ASRILGEGGFGLVYSGVLDDGTKVAVKVL--KR------VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvlkdGr~VAVKvL--k~------~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVm 1044 (1368)
...+|-+|+-++|+++.+. |+.+.||.- |. ..+-..++.++|+++|.+++--.|..-.-++.+...-+|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 5678999999999999988 788777753 11 11223456789999999998667766666666777778999
Q ss_pred eecCC-CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCC---Ccccccccccc
Q 000659 1045 ELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVSDFGLAR 1120 (1368)
Q Consensus 1045 EYm~g-GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng---~VKLsDFGLAr 1120 (1368)
||++| -++.+++..... ...+......++..|-+.|.-||..+ |||+||..+||||..++ .+.++||||+.
T Consensus 90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~ 164 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSS 164 (229)
T ss_pred EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchh
Confidence 99976 478888754322 12222333678888889999999988 99999999999996544 34899999976
Q ss_pred c
Q 000659 1121 S 1121 (1368)
Q Consensus 1121 l 1121 (1368)
.
T Consensus 165 ~ 165 (229)
T KOG3087|consen 165 V 165 (229)
T ss_pred c
Confidence 3
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=3.4e-09 Score=113.57 Aligned_cols=132 Identities=20% Similarity=0.286 Sum_probs=101.2
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEe-ecc------c-chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEee
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVL-KRV------D-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvL-k~~------d-~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEY 1046 (1368)
..|++|+-+.+|++.+. |..+++|.- .+. + .-..++-.+|+.+|.+++--.|..-+-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 36889999999999876 444666653 221 1 11123467899999999866666666666677788899999
Q ss_pred cCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1047 m~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
++|-.|.++|... +..++..+-.-+.-||..| |||+||..+||+|..++ +.++||||+...
T Consensus 81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999888422 3566777778888999998 99999999999998764 999999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.7e-10 Score=140.15 Aligned_cols=249 Identities=19% Similarity=0.228 Sum_probs=170.3
Q ss_pred HhCCcceeeEEeecCcEEEEEEEe-cCCCEEEEEEeeccc---chhhHHHHHHHHHHhhcccccceeeeeeeeeccceEE
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 967 aT~nFei~klLGeGgFGtVYKAvl-kdGr~VAVKvLk~~d---~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~L 1042 (1368)
..+.|.+.+-+-+|.++.++.+.- ..|-..++|+.+... ....+..+++-.++-..+++-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 445677778888999999988762 233333444443221 1222333344444444456777766655555677899
Q ss_pred EEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
|++|+.+++|...||... .++.+.....+..+...++|||... ++|||+++.|+|+..++..+++|||+....
T Consensus 882 ~~~~~~~~~~~Skl~~~~----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhHHhccCCchhhhhcCC----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999997543 3555555566667888999999776 899999999999999999999999844321
Q ss_pred ccc-----------------------------ccccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCC
Q 000659 1123 MDE-----------------------------ESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173 (1368)
Q Consensus 1123 ~~~-----------------------------~~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~P 1173 (1368)
... +.........||..|.+||.+.+......+|.|++|++++|.++|..|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 100 000112235699999999999999999999999999999999999999
Q ss_pred CCCCCCCcchhHHHhhhhhcccccccceeecCCC-CCCCChhhHHHHHHHHHHhcCcCcCCCCCHH
Q 000659 1174 VDMTQPPGQENLVAWARPLLTSREGLERIIDPSL-GNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1238 (1368)
Q Consensus 1174 Fd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L-~~~~~~ee~~eLl~La~~CL~pDPkeRPTMs 1238 (1368)
|+....... . +.++...+ ......+...+..+++...+..++.+|-.+.
T Consensus 1035 ~na~tpq~~---f-------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1035 FNAETPQQI---F-------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCcchhhh---h-------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 976543211 0 11111100 1122334456677888888889999998876
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=1.6e-08 Score=113.90 Aligned_cols=140 Identities=16% Similarity=0.100 Sum_probs=101.9
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccch-hhH----------HHHHHHHHHhhcccccc--eeeeeeeee-----
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ-GGR----------EFLAEVEMLSRLHHRNL--VKLIGICIE----- 1036 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~-~~k----------eFlrEIeILsrLrHPNI--VrLlG~~~d----- 1036 (1368)
+.+-+.....|++..++ |+.|.||+....... ..+ .+.+|...+.+|...+| ..++++.+.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44554445567787765 788999977432211 111 47899999999864443 445556543
Q ss_pred ccceEEEEeecCCC-ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecC-------C
Q 000659 1037 EQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-------D 1108 (1368)
Q Consensus 1037 ~~~~~LVmEYm~gG-SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~-------n 1108 (1368)
....+||+|++++- +|.+++.... ....+...+..++.+++..+.-||+.| |+|+|++++||||+. +
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~ 181 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREED 181 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCC
Confidence 23468999999886 7988874321 123556778899999999999999998 999999999999975 4
Q ss_pred CCcccccccccc
Q 000659 1109 FTPKVSDFGLAR 1120 (1368)
Q Consensus 1109 g~VKLsDFGLAr 1120 (1368)
+.+.|+||+.++
T Consensus 182 ~~~~LIDl~r~~ 193 (268)
T PRK15123 182 LKLSVIDLHRAQ 193 (268)
T ss_pred ceEEEEECCccc
Confidence 689999999875
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.2e-07 Score=111.03 Aligned_cols=269 Identities=17% Similarity=0.193 Sum_probs=159.8
Q ss_pred ceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhc-ccccceeeeee----ee--ecc-ceEEE
Q 000659 972 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI----CI--EEQ-ARCLV 1043 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrL-rHPNIVrLlG~----~~--d~~-~~~LV 1043 (1368)
...+.||+|+.+.+|-.- .-+..+.|++..-......+ .++.|.+. .|+-+-.-+.+ .. +++ ..-++
T Consensus 14 ~~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecc--hhhchhheeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 346789999999999543 22334667776433332222 22333333 45543321111 11 122 25677
Q ss_pred EeecCCCC-hhhcccc--cccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1044 YELIPNGS-VESHLHG--VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1044 mEYm~gGS-L~d~L~~--~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
|..+.+.. +.+++.- .+..-...+|+-.++++..+|.+.+.||+.| .+-+|++.+|+||.+++.+.|.|-..-.
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 77776642 2222211 1112234789999999999999999999998 8889999999999999999998754332
Q ss_pred cccccccccccccccccccccCcchhc-----cCCCCcccceeeHHHHHHHHHhC-CCCCCCCCCCcch--hHH-Hhhhh
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQE--NLV-AWARP 1191 (1368)
Q Consensus 1121 ll~~~~~~~~st~v~GT~gYmAPEvL~-----~~~~T~KSDVWSLGVILyELLTG-r~PFd~s~~~~~~--nLv-~Wa~p 1191 (1368)
.. . .......-+|...|..||... +-.-+...|.|.|||++|+||.| +.||......... -+. +.+..
T Consensus 166 i~-~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 IN-A--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred ec-c--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 22 1 111223356889999999765 23456778999999999999996 9999765322110 000 11111
Q ss_pred hcccccccceeecCCCCCCCChh-hHHHHHHHHHHhcCcC--cCCCCCHHHHHHHHHHHHHhhh
Q 000659 1192 LLTSREGLERIIDPSLGNDVPFD-SVAKVAAIASMCVQPE--VQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1192 lls~~e~L~eIvDp~L~~~~~~e-e~~eLl~La~~CL~pD--PkeRPTMsEVLq~Le~I~~e~~ 1252 (1368)
.+.....-..-..+. ...++.+ ....+..+..+|+... +.-||+.+.++..|..+.+++.
T Consensus 243 ~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~ 305 (637)
T COG4248 243 RFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK 305 (637)
T ss_pred eeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence 111100000000000 1122222 2246777888888654 5689999999988877666543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=2.7e-08 Score=106.87 Aligned_cols=125 Identities=25% Similarity=0.288 Sum_probs=82.2
Q ss_pred EEEEEEecCCCEEEEEEeecc-------------cch-------------hhHHHHHHHHHHhhcccc--cceeeeeeee
Q 000659 984 LVYSGVLDDGTKVAVKVLKRV-------------DQQ-------------GGREFLAEVEMLSRLHHR--NLVKLIGICI 1035 (1368)
Q Consensus 984 tVYKAvlkdGr~VAVKvLk~~-------------d~~-------------~~keFlrEIeILsrLrHP--NIVrLlG~~~ 1035 (1368)
.||.|...+|+.||||+.+.. ... ......+|.+.|.++..- ++-+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999997421 000 012356899999999765 455555442
Q ss_pred eccceEEEEeecC--CCChhhcccccccCCCCCChHHHHHHHHHHHHHHhh-hhccCCCCccccCCcccCeeecCCCCcc
Q 000659 1036 EEQARCLVYELIP--NGSVESHLHGVDKESAPLGWDARLKIALGAARALAY-LHEDSSPRVIHRDFKSSNILLEHDFTPK 1112 (1368)
Q Consensus 1036 d~~~~~LVmEYm~--gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaY-LHs~gsp~IVHRDIKPsNILLD~ng~VK 1112 (1368)
..+|||||++ |..+.. |... .++.++...++.+++..+.. +|..| |||+||...|||++++ ++.
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~ 146 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVY 146 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEE
T ss_pred ---CCEEEEEecCCCccchhh-HHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEE
Confidence 4579999998 444433 3211 12245567778888886655 56777 9999999999999988 999
Q ss_pred cccccccccc
Q 000659 1113 VSDFGLARSA 1122 (1368)
Q Consensus 1113 LsDFGLArll 1122 (1368)
|+|||.+...
T Consensus 147 iIDf~qav~~ 156 (188)
T PF01163_consen 147 IIDFGQAVDS 156 (188)
T ss_dssp E--GTTEEET
T ss_pred EEecCcceec
Confidence 9999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=6.2e-09 Score=127.23 Aligned_cols=153 Identities=18% Similarity=0.244 Sum_probs=105.6
Q ss_pred HHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccccccccccccccccc-------ccccccccccCcchhc
Q 000659 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS-------TRVMGTFGYVAPEYAM 1147 (1368)
Q Consensus 1075 A~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~s-------t~v~GT~gYmAPEvL~ 1147 (1368)
+.++++||.|||+.- ++||++|.|++|.++.++..||+.|+++............ -...-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345569999999764 7999999999999999999999999998765442221111 1123457899999999
Q ss_pred cCCCCcccceeeHHHHHHHHHh-CCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHh
Q 000659 1148 TGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMC 1226 (1368)
Q Consensus 1148 ~~~~T~KSDVWSLGVILyELLT-Gr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~C 1226 (1368)
....+.++|+|||||++|.+.. |+.-+...+....... ....+..-.-.+..+...++.+-+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHH
Confidence 9899999999999999999994 5554443321111100 000111111122234456788888899
Q ss_pred cCcCcCCCCCHHHHHHH
Q 000659 1227 VQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1227 L~pDPkeRPTMsEVLq~ 1243 (1368)
+..+..-||++.++...
T Consensus 249 l~~~~~~rp~~~~l~~~ 265 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLSI 265 (700)
T ss_pred hcCCcccCcchhhhhcc
Confidence 99999999988777543
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.58 E-value=1.9e-07 Score=100.52 Aligned_cols=107 Identities=22% Similarity=0.253 Sum_probs=84.5
Q ss_pred hHHHHHHHHHHhhcccc--cceeeeeeeeecc----ceEEEEeecCCC-ChhhcccccccCCCCCChHHHHHHHHHHHHH
Q 000659 1009 GREFLAEVEMLSRLHHR--NLVKLIGICIEEQ----ARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARA 1081 (1368)
Q Consensus 1009 ~keFlrEIeILsrLrHP--NIVrLlG~~~d~~----~~~LVmEYm~gG-SL~d~L~~~~~~~~pLsw~erlkIA~QIA~G 1081 (1368)
..+..+|.+.+.+|+.. .+...+++.+... ..+||+|++++. +|.+++.+.. .++...+..++.++++.
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~----~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE----QLDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc----ccchhhHHHHHHHHHHH
Confidence 34678899999888643 3456666665422 348999999884 7999885422 25667788999999999
Q ss_pred HhhhhccCCCCccccCCcccCeeecCCC---Ccccccccccccc
Q 000659 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDF---TPKVSDFGLARSA 1122 (1368)
Q Consensus 1082 LaYLHs~gsp~IVHRDIKPsNILLD~ng---~VKLsDFGLArll 1122 (1368)
++-||+.| |+|+|+++.||||+.+. ++.|+||+.++..
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 99999998 99999999999998887 8999999987643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.8e-07 Score=102.85 Aligned_cols=136 Identities=23% Similarity=0.165 Sum_probs=95.7
Q ss_pred cceeeEEeecCcEEEEEEEecCCCEEEEEEeecc----------cc------------hhhHHHHHHHHHHhhcccc--c
Q 000659 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV----------DQ------------QGGREFLAEVEMLSRLHHR--N 1026 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~----------d~------------~~~keFlrEIeILsrLrHP--N 1026 (1368)
..+++.||.|.-+.||.|....|+.++||.=+.. .. .......+|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999974211 00 0112346789999988754 5
Q ss_pred ceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeec
Q 000659 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE 1106 (1368)
Q Consensus 1027 IVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD 1106 (1368)
|-+-+++ +...+||||++|-.|...- ++.+..-.|+..|++-+.-+-+.| |||+|+..-||||+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~ 236 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVT 236 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEe
Confidence 5555443 4668999999886554332 122333344444445454444555 99999999999999
Q ss_pred CCCCcccccccccccc
Q 000659 1107 HDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1107 ~ng~VKLsDFGLArll 1122 (1368)
+||.+.|+||--+...
T Consensus 237 ~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 237 EDGDIVVIDWPQAVPI 252 (304)
T ss_pred cCCCEEEEeCcccccC
Confidence 9999999999876543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.2e-06 Score=91.78 Aligned_cols=145 Identities=22% Similarity=0.247 Sum_probs=87.1
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeeeeeeee---ccceEEEEeecC
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGICIE---EQARCLVYELIP 1048 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~~~d---~~~~~LVmEYm~ 1048 (1368)
.+.|+.|..+.||+....+ +.+++|+.... ....++.+|+++++.|.... +.+++.++.. ....+++|+|++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 4689999999999999887 68999997643 45667889999999986443 4566665432 234689999999
Q ss_pred CCChhh----------------cc---cccccCCCCCChHH---------HHHH------------HHHHHH-HHhhhhc
Q 000659 1049 NGSVES----------------HL---HGVDKESAPLGWDA---------RLKI------------ALGAAR-ALAYLHE 1087 (1368)
Q Consensus 1049 gGSL~d----------------~L---~~~~~~~~pLsw~e---------rlkI------------A~QIA~-GLaYLHs 1087 (1368)
|..+.+ .| |........+.+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 11111111111111 0000 111222 2333332
Q ss_pred ----cCCCCccccCCcccCeeec-CCCCccccccccccc
Q 000659 1088 ----DSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1088 ----~gsp~IVHRDIKPsNILLD-~ng~VKLsDFGLArl 1121 (1368)
.....++|+|+.++|||++ +++++.|+||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 1234599999999999999 666778999998753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-06 Score=96.14 Aligned_cols=138 Identities=19% Similarity=0.218 Sum_probs=86.0
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeeeeeeeeccceEEEEeecCCCC-
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGICIEEQARCLVYELIPNGS- 1051 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~~~d~~~~~LVmEYm~gGS- 1051 (1368)
..||+|..+.||+.. |..+++|...... ...+..+|.++++.+..-+ +.+.++++.+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 478999999999842 5567888876432 3345789999999997544 4677777777777889999998863
Q ss_pred hhhc---------------------ccccccCCCCCChHHHHH-HHH----------HHHH-HHhhhhcc-CCCCccccC
Q 000659 1052 VESH---------------------LHGVDKESAPLGWDARLK-IAL----------GAAR-ALAYLHED-SSPRVIHRD 1097 (1368)
Q Consensus 1052 L~d~---------------------L~~~~~~~~pLsw~erlk-IA~----------QIA~-GLaYLHs~-gsp~IVHRD 1097 (1368)
+.+. ||........+ ..+.. +.. .+.. ..++|... ....++|+|
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l--~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTF--QSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcH--HHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 2111 12111111111 11000 000 0000 11222211 133578999
Q ss_pred CcccCeeecCCCCcccccccccc
Q 000659 1098 FKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1098 IKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
+.+.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999876
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.41 E-value=1.3e-06 Score=95.80 Aligned_cols=138 Identities=18% Similarity=0.163 Sum_probs=103.2
Q ss_pred EeecCcEEEEEEEecCCCEEEEEEeecc-----c-chhhHHHHHHHHHHhhccccc--ceeeeeeee-e----ccceEEE
Q 000659 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRV-----D-QQGGREFLAEVEMLSRLHHRN--LVKLIGICI-E----EQARCLV 1043 (1368)
Q Consensus 977 LGeGgFGtVYKAvlkdGr~VAVKvLk~~-----d-~~~~keFlrEIeILsrLrHPN--IVrLlG~~~-d----~~~~~LV 1043 (1368)
-|+||.+-|++-.++ |+.+-+|+-... . ......|.+|+..|.+|...+ +.+.+ ++. . .-.-+||
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 467999999998877 457888886411 1 335678999999999996433 44444 332 1 1234799
Q ss_pred EeecCC-CChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCC--cccccccccc
Q 000659 1044 YELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT--PKVSDFGLAR 1120 (1368)
Q Consensus 1044 mEYm~g-GSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~--VKLsDFGLAr 1120 (1368)
+|-+.| -+|.+++.+. .....+..++..++.+|++.|+-||+.| +.|+|+.+.|||++.++. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998854 5888887432 1234677888999999999999999998 999999999999986666 9999998765
Q ss_pred c
Q 000659 1121 S 1121 (1368)
Q Consensus 1121 l 1121 (1368)
.
T Consensus 179 ~ 179 (216)
T PRK09902 179 R 179 (216)
T ss_pred h
Confidence 3
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.37 E-value=8.7e-07 Score=108.05 Aligned_cols=142 Identities=23% Similarity=0.212 Sum_probs=93.3
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccchh------------------------------hH----------HHHH
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG------------------------------GR----------EFLA 1014 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~------------------------------~k----------eFlr 1014 (1368)
+-|+.++-|.||+|++.+|+.||||+.+..-... .+ ++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 5788999999999999999999999974210000 01 2344
Q ss_pred HHHHHhhcc----cccceeeeeeeee-ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccC
Q 000659 1015 EVEMLSRLH----HRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089 (1368)
Q Consensus 1015 EIeILsrLr----HPNIVrLlG~~~d-~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~g 1089 (1368)
|...+.+++ ...-+++=.+|++ .+...|+|||++|-.+.+...-. ...++.+.+.....++. +..+-..|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~ia~~~~~~f--~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKELAELLVRAF--LRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHHHHHHHHHHH--HHHHHhcC
Confidence 555555542 2333444444543 46678999999999988874211 12344333333222222 23333345
Q ss_pred CCCccccCCcccCeeecCCCCcccccccccccccc
Q 000659 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1090 sp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~ 1124 (1368)
++|+|..|.||+|+.+|++.+.|||+......
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999876644
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.5e-06 Score=93.11 Aligned_cols=138 Identities=15% Similarity=0.183 Sum_probs=97.1
Q ss_pred HHhCCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHH---------HHHHHHHhhcccccceee---eee
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREF---------LAEVEMLSRLHHRNLVKL---IGI 1033 (1368)
Q Consensus 966 ~aT~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keF---------lrEIeILsrLrHPNIVrL---lG~ 1033 (1368)
...++|...+++-......|.+-..+ |+.+++|..+......++.| .+++..+.+++...+..+ +.+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 34678999999988888888777666 78899999876544444433 345555566654333332 222
Q ss_pred eee-----ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCC
Q 000659 1034 CIE-----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD 1108 (1368)
Q Consensus 1034 ~~d-----~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~n 1108 (1368)
... ....+|||||++|..|.++.. ++. .++..+..+|.-||+.| ++|+|..+.|++|+++
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC
Confidence 221 234468999999998877652 222 24456677899999998 9999999999999865
Q ss_pred CCcccccccccc
Q 000659 1109 FTPKVSDFGLAR 1120 (1368)
Q Consensus 1109 g~VKLsDFGLAr 1120 (1368)
.++++||+..+
T Consensus 172 -~i~iID~~~k~ 182 (229)
T PF06176_consen 172 -GIRIIDTQGKR 182 (229)
T ss_pred -cEEEEECcccc
Confidence 49999998765
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.23 E-value=5e-06 Score=90.55 Aligned_cols=141 Identities=21% Similarity=0.186 Sum_probs=86.8
Q ss_pred EEeecCc-EEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-cccceeeeeeeeeccceEEEEeecCCCChh
Q 000659 976 ILGEGGF-GLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQARCLVYELIPNGSVE 1053 (1368)
Q Consensus 976 lLGeGgF-GtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-HPNIVrLlG~~~d~~~~~LVmEYm~gGSL~ 1053 (1368)
.|-.|.. ..||+...+ +..++||+..... ..++.+|+++++.+. +--+.++++++...+..++||||++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3445555 789999865 4788888876432 346778999998885 434557777776666789999999998776
Q ss_pred hcc-------------------cccccCCCCCCh--HHHHHHHH--------------------HHHHHHhhhhc----c
Q 000659 1054 SHL-------------------HGVDKESAPLGW--DARLKIAL--------------------GAARALAYLHE----D 1088 (1368)
Q Consensus 1054 d~L-------------------~~~~~~~~pLsw--~erlkIA~--------------------QIA~GLaYLHs----~ 1088 (1368)
+.. |........+.. ..++.... .+...+.+|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 432 111111111110 01110000 01111122211 1
Q ss_pred CCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1089 gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
..+.++|+|+.+.|||++++..+.|+||+.+.
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 23458999999999999997778899999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.19 E-value=8.9e-07 Score=110.24 Aligned_cols=93 Identities=13% Similarity=0.041 Sum_probs=65.2
Q ss_pred hhHHHHhhhhccCcccccccCCCCCceEEEeeCCCCCCCCCCCCCCCC-cCCCCCCCCCCCCCCCCCcccCCccccccCC
Q 000659 797 NTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIG-IIDDGPYSGNNGRATKPEGVDVPKRRQKYGL 875 (1368)
Q Consensus 797 ~sEaldLssnlLsGeIP~qls~LgrL~vLNVS~N~LsGpIPs~lq~is-Tf~assFsGN~GLCG~PL~vd~~ssrskkgl 875 (1368)
.=+.++|++|.|+|.||..++.|.+|+.|+|++|+|+|.+|..+.... ......+.||.++|+.+....| ... .
T Consensus 467 ~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C-~~~----~ 541 (623)
T PLN03150 467 SLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRAC-GPH----L 541 (623)
T ss_pred CCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCccccCCCCCCCC-ccc----C
Confidence 345689999999999999999999999999999999999998765410 1123457999999998754333 221 2
Q ss_pred CCceeeehhhHHHHHHHHH
Q 000659 876 SGGMIAIVVLSAFVAVVLC 894 (1368)
Q Consensus 876 SggiIa~IVVgavVaVVLv 894 (1368)
+.+.+++++++++++++++
T Consensus 542 ~~~~~i~~~~~~~~~~l~~ 560 (623)
T PLN03150 542 SVGAKIGIAFGVSVAFLFL 560 (623)
T ss_pred CCceEEEEEhHHHHHHHHH
Confidence 2344555555554443333
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.17 E-value=5.5e-06 Score=101.31 Aligned_cols=142 Identities=18% Similarity=0.187 Sum_probs=93.8
Q ss_pred eEEeecCcEEEEEEEecCCCEEEEEEeecccch-------------------------------hhH------HHHHHHH
Q 000659 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQ-------------------------------GGR------EFLAEVE 1017 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~-------------------------------~~k------eFlrEIe 1017 (1368)
+-||.-..|.||+|++++|+.||||+-+..-+. ..+ +|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 579999999999999999999999996421100 011 2455555
Q ss_pred HHhhc----cccc---ceeeeeeeee-ccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccC
Q 000659 1018 MLSRL----HHRN---LVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089 (1368)
Q Consensus 1018 ILsrL----rHPN---IVrLlG~~~d-~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~g 1089 (1368)
-..++ +|-+ -|.+=.++++ .....|+||||+|..+.|... . ++..++-..+..-+.++..-+-+.| |
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~-i--~~~gi~~~~i~~~l~~~~~~qIf~~--G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA-I--DKRGISPHDILNKLVEAYLEQIFKT--G 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH-H--HHcCCCHHHHHHHHHHHHHHHHHhc--C
Confidence 54443 3444 1223333333 356789999999998887642 1 1223555555554444433333333 4
Q ss_pred CCCccccCCcccCeeecC----CCCcccccccccccccc
Q 000659 1090 SPRVIHRDFKSSNILLEH----DFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1090 sp~IVHRDIKPsNILLD~----ng~VKLsDFGLArll~~ 1124 (1368)
++|+|=.|.||||+. ++++.+.|||+.+.+..
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 999999999999983 67899999999986644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.16 E-value=7.6e-06 Score=91.72 Aligned_cols=152 Identities=22% Similarity=0.275 Sum_probs=98.4
Q ss_pred CCHHHHHHHhCCcceeeEEe---ecCcEEEEEEEecCCCEEEEEEeecccchhhH---------HH--------------
Q 000659 959 FSASEIEKATGNFDASRILG---EGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGR---------EF-------------- 1012 (1368)
Q Consensus 959 fsleELe~aT~nFei~klLG---eGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~k---------eF-------------- 1012 (1368)
.+++.|.....+..+..+.| .|.-+.||+|...++..+|||+++.......+ +|
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 45666777777777666555 67777999999888999999998643221111 11
Q ss_pred -HHHHHHHhhccc--ccceeeeeeeeeccceEEEEeecCCC-ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhcc
Q 000659 1013 -LAEVEMLSRLHH--RNLVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088 (1368)
Q Consensus 1013 -lrEIeILsrLrH--PNIVrLlG~~~d~~~~~LVmEYm~gG-SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~ 1088 (1368)
..|+.-|+++.. -.+-+-+++ ..-.|||||+... .-.-.|. .-.+..++...+..++++.+.-|-..
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~Lk-----Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPRLK-----DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCCcc-----cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 234444444431 122222222 2346999999543 1111221 11233336677778888888888763
Q ss_pred CCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1089 gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
+ ++||+||.--|||+. ++.+.|+|||-|...
T Consensus 186 a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~ 216 (268)
T COG1718 186 A--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTI 216 (268)
T ss_pred c--CcccccchhhheEEE-CCeEEEEECcccccc
Confidence 3 499999999999999 889999999998755
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.1e-05 Score=88.33 Aligned_cols=80 Identities=14% Similarity=0.120 Sum_probs=60.2
Q ss_pred CcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccc---ccceeeeeeeee---ccceEEE
Q 000659 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH---RNLVKLIGICIE---EQARCLV 1043 (1368)
Q Consensus 970 nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrH---PNIVrLlG~~~d---~~~~~LV 1043 (1368)
.....+.||+|..+.||+....+++ +++|..+.. .....|.+|.+.|+.|.- -.+.+++++|.. .+..+||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV 91 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL 91 (297)
T ss_pred hhheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence 4455678999999999998876664 777775431 123578899999999853 357788888754 3668999
Q ss_pred EeecCCCCh
Q 000659 1044 YELIPNGSV 1052 (1368)
Q Consensus 1044 mEYm~gGSL 1052 (1368)
||+++++++
T Consensus 92 mE~i~G~~~ 100 (297)
T PRK10593 92 LERLRGVSV 100 (297)
T ss_pred EeccCCEec
Confidence 999998765
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.8e-05 Score=101.56 Aligned_cols=148 Identities=16% Similarity=0.253 Sum_probs=93.0
Q ss_pred eeEEeecCcEEEEEEEecCC---CEEEEEEeeccc-chhhHHHHHHHHHHhhcc-cccc--eeeeeeeeec---cceEEE
Q 000659 974 SRILGEGGFGLVYSGVLDDG---TKVAVKVLKRVD-QQGGREFLAEVEMLSRLH-HRNL--VKLIGICIEE---QARCLV 1043 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdG---r~VAVKvLk~~d-~~~~keFlrEIeILsrLr-HPNI--VrLlG~~~d~---~~~~LV 1043 (1368)
.+.|+.|.++.+|+....++ ..+++|+..... ......+.+|+++|+.|. |.+| .+++++|.+. +..|+|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 56789999999999887654 367777754322 123357889999999996 6665 7788888764 467899
Q ss_pred EeecCCCChhhc-----------------------ccccccCC-------CCCChH--HHHHHH---------------H
Q 000659 1044 YELIPNGSVESH-----------------------LHGVDKES-------APLGWD--ARLKIA---------------L 1076 (1368)
Q Consensus 1044 mEYm~gGSL~d~-----------------------L~~~~~~~-------~pLsw~--erlkIA---------------~ 1076 (1368)
|||++|..+.+. ||..+... ...++. ++.++. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988654321 22211110 011111 111111 1
Q ss_pred HHHHHHhhhhccC--------CCCccccCCcccCeeecC-CCC-ccccccccccc
Q 000659 1077 GAARALAYLHEDS--------SPRVIHRDFKSSNILLEH-DFT-PKVSDFGLARS 1121 (1368)
Q Consensus 1077 QIA~GLaYLHs~g--------sp~IVHRDIKPsNILLD~-ng~-VKLsDFGLArl 1121 (1368)
.+.+.++||..+- ...+||+|+++.|||++. +++ +-|.||+++..
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 1333456664321 134999999999999985 334 47899998864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.07 E-value=7.6e-07 Score=108.56 Aligned_cols=187 Identities=18% Similarity=0.125 Sum_probs=134.4
Q ss_pred CCcceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc-ceeeeeeeeeccceEEEEeec
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN-LVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN-IVrLlG~~~d~~~~~LVmEYm 1047 (1368)
..++.-.-+++|+++++||.+---.+.+..+++... ....-++++|.+++|+| .++.++-+..++..+++++|+
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~ 316 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRIC 316 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhh
Confidence 333344567899999999987433344446655432 34556899999999999 777777788888899999999
Q ss_pred CCC-ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccc
Q 000659 1048 PNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1048 ~gG-SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~ 1126 (1368)
.+| +..+... .....+..-+...+...-+++|+|||+.. =+||| |||..+ +..|..||+....+....
T Consensus 317 s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~ 385 (829)
T KOG0576|consen 317 STGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTM 385 (829)
T ss_pred cCCccccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCccc
Confidence 887 2222221 11223444445566667788999999774 48999 887766 678999999987664422
Q ss_pred cccccccccccccccCcchhccCCCCcccceeeHHHHHHHHHhCCCCC
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1174 (1368)
Q Consensus 1127 ~~~~st~v~GT~gYmAPEvL~~~~~T~KSDVWSLGVILyELLTGr~PF 1174 (1368)
......++..|++||+...+.+..+.|+|++|+--.++--|-.|-
T Consensus 386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 234466899999999999999999999999998766766665543
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=3.2e-05 Score=83.19 Aligned_cols=105 Identities=24% Similarity=0.241 Sum_probs=82.1
Q ss_pred HHHHHHHhhccc-ccceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCC
Q 000659 1013 LAEVEMLSRLHH-RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1091 (1368)
Q Consensus 1013 lrEIeILsrLrH-PNIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp 1091 (1368)
..|.-+|+.+++ +++.+++|+| ..++|.||+..+++...-... ..-..-.|.+|.+|+.++++.+++|++.-..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~ 81 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPLG 81 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence 358888999975 6999999999 347899999877664210000 0112368999999999999999999986444
Q ss_pred CccccCCcccCeeecCCCCcccccccccccc
Q 000659 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1092 ~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
.+.-.|++++|+-|++++++|++|...+...
T Consensus 82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 5888999999999999999999999876543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=4.1e-05 Score=83.51 Aligned_cols=74 Identities=15% Similarity=0.179 Sum_probs=47.6
Q ss_pred eEEeecCcE-EEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccc---cceeeeeeeeec---cceEEEEeec
Q 000659 975 RILGEGGFG-LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR---NLVKLIGICIEE---QARCLVYELI 1047 (1368)
Q Consensus 975 klLGeGgFG-tVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHP---NIVrLlG~~~d~---~~~~LVmEYm 1047 (1368)
+.|+.|+.. .||+. +..+++|+.+.. ....++.+|+++|+.|... -+.++++.+... ...++|||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 467767666 59975 345778876542 2345788999999888632 234444444332 2348899999
Q ss_pred CCCChhh
Q 000659 1048 PNGSVES 1054 (1368)
Q Consensus 1048 ~gGSL~d 1054 (1368)
+|.++.+
T Consensus 77 ~G~~l~~ 83 (235)
T cd05155 77 EGETATA 83 (235)
T ss_pred cCCCCCc
Confidence 9987753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00021 Score=85.36 Aligned_cols=76 Identities=21% Similarity=0.179 Sum_probs=54.8
Q ss_pred eeEEeecCcEEEEEEEecCC-CEEEEEEeecc-----c--chhhHHHHHHHHHHhhcc---cccceeeeeeeeeccceEE
Q 000659 974 SRILGEGGFGLVYSGVLDDG-TKVAVKVLKRV-----D--QQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdG-r~VAVKvLk~~-----d--~~~~keFlrEIeILsrLr---HPNIVrLlG~~~d~~~~~L 1042 (1368)
.+.||.|.+..||++...+| +.|+||.-... . ....+++..|.+.|+.+. -.++.+++.+. .+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--EELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCCCEE
Confidence 35799999999999998877 58999984311 1 123456788889888873 23466666663 356789
Q ss_pred EEeecCCCC
Q 000659 1043 VYELIPNGS 1051 (1368)
Q Consensus 1043 VmEYm~gGS 1051 (1368)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.90 E-value=5.1e-05 Score=82.00 Aligned_cols=142 Identities=20% Similarity=0.219 Sum_probs=83.4
Q ss_pred eeEEeecCcEEEEEEEecC--CCEEEEEEeecccchhhHHHHHHHHHHhhcccccc-eeeeeeeeeccceEEEEeecCCC
Q 000659 974 SRILGEGGFGLVYSGVLDD--GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkd--Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNI-VrLlG~~~d~~~~~LVmEYm~gG 1050 (1368)
.+.|..|-...+|+....+ ++.|++|+....... .-+..+|+.+++.+...++ .++++.+. + .+||||++|.
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~ 77 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGR 77 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCC
Confidence 3567888899999998764 678999987643221 1233579999998864444 34443322 2 4899999997
Q ss_pred Chhhc-----------------ccccccCC-------CCC-ChHHHHHHHH----------------------HHHHHHh
Q 000659 1051 SVESH-----------------LHGVDKES-------APL-GWDARLKIAL----------------------GAARALA 1083 (1368)
Q Consensus 1051 SL~d~-----------------L~~~~~~~-------~pL-sw~erlkIA~----------------------QIA~GLa 1083 (1368)
++... ||...... ... -|+.+..+.. .+.+.+.
T Consensus 78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 157 (235)
T cd05157 78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS 157 (235)
T ss_pred cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence 76321 11111111 011 1222212111 1111111
Q ss_pred h----hhcc-CCCCccccCCcccCeeecC-CCCcccccccccc
Q 000659 1084 Y----LHED-SSPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 1120 (1368)
Q Consensus 1084 Y----LHs~-gsp~IVHRDIKPsNILLD~-ng~VKLsDFGLAr 1120 (1368)
. +-.. ....++|+|+.+.|||+++ ++.+.|+||..|.
T Consensus 158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 1 1111 1235899999999999998 5789999998775
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.88 E-value=4.3e-05 Score=85.48 Aligned_cols=143 Identities=20% Similarity=0.166 Sum_probs=87.2
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeeeeee------eeccceEEEEe
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGIC------IEEQARCLVYE 1045 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~~------~d~~~~~LVmE 1045 (1368)
.+.|..|....+|+...++ ..+++|+... ...+++..|++++..|++.+ +.+++... ...+..++||+
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987664 4688898764 23356778888888886433 44444321 22456689999
Q ss_pred ecCCCChhhc--------------ccccc----cC---CCCCChHHHHH----------HHHHHHHHHhhhhcc----CC
Q 000659 1046 LIPNGSVESH--------------LHGVD----KE---SAPLGWDARLK----------IALGAARALAYLHED----SS 1090 (1368)
Q Consensus 1046 Ym~gGSL~d~--------------L~~~~----~~---~~pLsw~erlk----------IA~QIA~GLaYLHs~----gs 1090 (1368)
|++|..+... ||... .. .....|..... ....+.+.+.++.+. ..
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 9998876430 11110 00 01123322210 111123344444431 12
Q ss_pred CCccccCCcccCeeecCCCCcccccccccc
Q 000659 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1091 p~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
..++|+|+.+.|||+++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 359999999999999988777899999875
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.85 E-value=9e-05 Score=80.79 Aligned_cols=128 Identities=20% Similarity=0.271 Sum_probs=91.3
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeeccc----------------chhhHHHHHHHHHHhhcc------cccceeee
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD----------------QQGGREFLAEVEMLSRLH------HRNLVKLI 1031 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d----------------~~~~keFlrEIeILsrLr------HPNIVrLl 1031 (1368)
...||+|+.-.||. +.++....||+++... ....+++.+|+..+..+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46899999999995 5566778999986544 223467778888877776 78899999
Q ss_pred eeeeeccceEEEEeecCCC------ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee
Q 000659 1032 GICIEEQARCLVYELIPNG------SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1032 G~~~d~~~~~LVmEYm~gG------SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL 1105 (1368)
|+..++...-+|+|.+.+. +|.+++. ...++. +..+.+.++ ..||-+.+ |+.+||++.||++
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~~L~~f---~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQALDEF---KRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHHHHHHH---HHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999987543 4666663 123444 444444444 45555554 9999999999999
Q ss_pred cCCC----Cccccc
Q 000659 1106 EHDF----TPKVSD 1115 (1368)
Q Consensus 1106 D~ng----~VKLsD 1115 (1368)
..+. .+.|+|
T Consensus 152 ~~~~~~~~~lvlID 165 (199)
T PF10707_consen 152 QRRDSGEFRLVLID 165 (199)
T ss_pred EecCCCceEEEEEe
Confidence 5432 466666
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.82 E-value=7.4e-05 Score=82.42 Aligned_cols=140 Identities=19% Similarity=0.161 Sum_probs=81.7
Q ss_pred EEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eeeeeeeeccceEEEEeecCCCChhh
Q 000659 976 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIPNGSVES 1054 (1368)
Q Consensus 976 lLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~d~~~~~LVmEYm~gGSL~d 1054 (1368)
.+..|-.+.+|+... +++.+++|+.........-+..+|.++++.+....++ ++++++. -++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355688889999874 4778889886543222212457899999998654443 3443332 369999999877643
Q ss_pred c-----------------ccccccCCCCCChHHHH-HHHHH---------HHHHHhhhhcc-----CCCCccccCCcccC
Q 000659 1055 H-----------------LHGVDKESAPLGWDARL-KIALG---------AARALAYLHED-----SSPRVIHRDFKSSN 1102 (1368)
Q Consensus 1055 ~-----------------L~~~~~~~~pLsw~erl-kIA~Q---------IA~GLaYLHs~-----gsp~IVHRDIKPsN 1102 (1368)
. ||........++...++ .+..+ +.+.++.+-.. ....++|+|+.+.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 2 22222212222222211 11111 11112222111 12348999999999
Q ss_pred eeecCCCCccccccccccc
Q 000659 1103 ILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1103 ILLD~ng~VKLsDFGLArl 1121 (1368)
||+++++ ++|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 88999998763
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.74 E-value=6.7e-05 Score=80.89 Aligned_cols=128 Identities=20% Similarity=0.204 Sum_probs=86.9
Q ss_pred ceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccccee-eeeeeeeccceEEEEeecCCC
Q 000659 972 DASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK-LIGICIEEQARCLVYELIPNG 1050 (1368)
Q Consensus 972 ei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVr-LlG~~~d~~~~~LVmEYm~gG 1050 (1368)
+..+.|++|++|.||+|.+. |..+|+|+-+.. ...+.+..|+++|..+.-.++.. ++.|. ..++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence 34568999999999999998 567899887643 33467889999999998776654 33332 334569999998
Q ss_pred ChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCc-ccCeeecCCCCcccccccccc
Q 000659 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK-SSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1051 SL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIK-PsNILLD~ng~VKLsDFGLAr 1120 (1368)
.|.++-... +-+++++ ++..---|-..| |-|+.|. +..++|-.++++.|+||.-|+
T Consensus 98 ~L~~~~~~~-------~rk~l~~----vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 98 PLGKLEIGG-------DRKHLLR----VLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred chhhhhhcc-------cHHHHHH----HHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchh
Confidence 887765321 2233333 333333344445 8888887 344444444499999999887
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00019 Score=78.85 Aligned_cols=125 Identities=26% Similarity=0.427 Sum_probs=89.7
Q ss_pred CCcceeeEEeecCc-EEEEEEEecCCCEEEEEEeecc------------cc---------hhhHHHHHHHHHHhhcc---
Q 000659 969 GNFDASRILGEGGF-GLVYSGVLDDGTKVAVKVLKRV------------DQ---------QGGREFLAEVEMLSRLH--- 1023 (1368)
Q Consensus 969 ~nFei~klLGeGgF-GtVYKAvlkdGr~VAVKvLk~~------------d~---------~~~keFlrEIeILsrLr--- 1023 (1368)
.+|+..+.||.|.. |.|||+... |+.+|+|+++.. .. ....-|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78999999999999 999999988 789999994321 00 11224788999988885
Q ss_pred cccc--eeeeeeeeec-c-----------------ceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHh
Q 000659 1024 HRNL--VKLIGICIEE-Q-----------------ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083 (1368)
Q Consensus 1024 HPNI--VrLlG~~~d~-~-----------------~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLa 1083 (1368)
+.++ |+++||..-. + .+.||.||+.... .+ ..+-+.+|.+-|.
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~----~~~~~~~~~~dl~ 178 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PL----QIRDIPQMLRDLK 178 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------cc----chhHHHHHHHHHH
Confidence 4466 9999987321 0 1246777664432 11 2334556777788
Q ss_pred hhhccCCCCccccCCcccCeeecCCCCccccccccc
Q 000659 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1084 YLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLA 1119 (1368)
.||..| |+-+|+|..|.. +-||+|||.+
T Consensus 179 ~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 179 ILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 899888 999999999985 3489999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00038 Score=79.07 Aligned_cols=159 Identities=20% Similarity=0.230 Sum_probs=92.7
Q ss_pred CCHHHHHHHhCCcce-----eeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeee
Q 000659 959 FSASEIEKATGNFDA-----SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI 1031 (1368)
Q Consensus 959 fsleELe~aT~nFei-----~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN--IVrLl 1031 (1368)
.+.++|....++|.+ .+.|+.|....+|+...++| .+++|+.+... ..+++..|++++..|...+ +.+++
T Consensus 7 ~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i 83 (307)
T TIGR00938 7 VSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPV 83 (307)
T ss_pred CCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 445666666556655 34566777789999876655 57788775422 2345567788888875322 34444
Q ss_pred eee------eeccceEEEEeecCCCChhhc--------------ccccccC----C----CCCChHHHHH----------
Q 000659 1032 GIC------IEEQARCLVYELIPNGSVESH--------------LHGVDKE----S----APLGWDARLK---------- 1073 (1368)
Q Consensus 1032 G~~------~d~~~~~LVmEYm~gGSL~d~--------------L~~~~~~----~----~pLsw~erlk---------- 1073 (1368)
... ...+..++||||++|..+... ||..... . ..-.|.....
T Consensus 84 ~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~ 163 (307)
T TIGR00938 84 KSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLE 163 (307)
T ss_pred cCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccC
Confidence 422 124567899999998654311 1211100 0 0111221110
Q ss_pred --HHHHHHHHHhhhhc----cCCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1074 --IALGAARALAYLHE----DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1074 --IA~QIA~GLaYLHs----~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
....+.+.+++|.. .....++|+|++..||++++++...|+||+.+.
T Consensus 164 ~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 164 AHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 01123334555532 123459999999999999988767899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00036 Score=79.23 Aligned_cols=158 Identities=17% Similarity=0.208 Sum_probs=87.9
Q ss_pred CCHHHHHHHhCCcce-----eeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeee
Q 000659 959 FSASEIEKATGNFDA-----SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLI 1031 (1368)
Q Consensus 959 fsleELe~aT~nFei-----~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN--IVrLl 1031 (1368)
++.+++......|.+ .+.|+.|....+|+...++| .+++|++... ..+++..|++++..|...+ +.+.+
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~---~~~~l~~~~~~l~~L~~~glpvP~~i 82 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERL---TAEDLPFFLGLMQHLAARGVPVPAPV 82 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccC---ChHHhHHHHHHHHHHHHCCCCCCcce
Confidence 456666666566655 34566777789999887755 5888887522 2234455666666664222 23333
Q ss_pred ee------eeeccceEEEEeecCCCChhhc--------------ccccccC-------CCCCCh-HHHHH----------
Q 000659 1032 GI------CIEEQARCLVYELIPNGSVESH--------------LHGVDKE-------SAPLGW-DARLK---------- 1073 (1368)
Q Consensus 1032 G~------~~d~~~~~LVmEYm~gGSL~d~--------------L~~~~~~-------~~pLsw-~erlk---------- 1073 (1368)
.. ....+..+++|||++|..+... ||..... ...+.| ...+.
T Consensus 83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (319)
T PRK05231 83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ 162 (319)
T ss_pred eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence 21 1224567899999998754221 1111100 011222 21111
Q ss_pred --HHHH-HHHHHhhhhcc----CCCCccccCCcccCeeecCCCCcccccccccc
Q 000659 1074 --IALG-AARALAYLHED----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1074 --IA~Q-IA~GLaYLHs~----gsp~IVHRDIKPsNILLD~ng~VKLsDFGLAr 1120 (1368)
.+.+ +...++.+... -...+||+|+++.|||++++...-|+||+.+.
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11122333211 12359999999999999966555899999876
|
|
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.97 Score=63.73 Aligned_cols=7 Identities=29% Similarity=0.724 Sum_probs=3.3
Q ss_pred CCccccC
Q 000659 451 GNFHRHS 457 (1368)
Q Consensus 451 ~~~~~~~ 457 (1368)
|.|-|+-
T Consensus 2860 ~~~~r~p 2866 (3151)
T PHA03247 2860 GDVRRRP 2866 (3151)
T ss_pred CccccCC
Confidence 4454443
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00057 Score=77.03 Aligned_cols=141 Identities=28% Similarity=0.318 Sum_probs=85.7
Q ss_pred eEEeecCcEEEEEEEecC-------CCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eeeeeeeeccceEEEEee
Q 000659 975 RILGEGGFGLVYSGVLDD-------GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd-------Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~d~~~~~LVmEY 1046 (1368)
+.|..|-...||+....+ ++.+++|+..... ....+..+|+++++.+...++. ++++++. + .+||||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~--~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N--GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C--Cchhhe
Confidence 466677788999998765 5789999976532 2234567899999988644443 4454443 2 368999
Q ss_pred cCCCChhhc-----------------ccccccCC-------CCCChHHHHH--------------------------HHH
Q 000659 1047 IPNGSVESH-----------------LHGVDKES-------APLGWDARLK--------------------------IAL 1076 (1368)
Q Consensus 1047 m~gGSL~d~-----------------L~~~~~~~-------~pLsw~erlk--------------------------IA~ 1076 (1368)
++|..+... ||...... ...-|..+.+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998876531 12211110 0111111111 111
Q ss_pred HHHHHHhhhhc------cCCCCccccCCcccCeeecCC----CCcccccccccc
Q 000659 1077 GAARALAYLHE------DSSPRVIHRDFKSSNILLEHD----FTPKVSDFGLAR 1120 (1368)
Q Consensus 1077 QIA~GLaYLHs------~gsp~IVHRDIKPsNILLD~n----g~VKLsDFGLAr 1120 (1368)
.+.+-+.+|-. .....++|+|+.+.|||++++ +.++|+||..|.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22222334432 123458999999999999985 889999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.26 E-value=0.0017 Score=73.81 Aligned_cols=73 Identities=15% Similarity=0.112 Sum_probs=41.0
Q ss_pred EeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeeccceEEEEeecCCCCh
Q 000659 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 977 LGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~~~~LVmEYm~gGSL 1052 (1368)
.++|-...||.....+|+.+++|+-+. ......+.+|+++|+.|+..--+..-.+... +.-+++|+++.|..+
T Consensus 19 ~~~g~~~~v~~i~~~~g~~~VlR~p~~--~~~~~~l~rE~~vL~~L~~~l~vpvP~~~~~-~~~~~~y~~i~G~p~ 91 (276)
T cd05152 19 NESGLDFQVVFAKDTDGVPWVLRIPRR--PDVSERAAAEKRVLALVRKHLPVQVPDWRVH-TPELIAYPKLPGVPA 91 (276)
T ss_pred cCCcceeEEEEEEcCCCCeEEEEecCC--HHHHHHHHHHHHHHHHHHhcCCCCCCceeee-cCceEEEeccCCCcc
Confidence 344545566665555688899988753 2234567899999999863100111111111 122567777766544
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0015 Score=74.92 Aligned_cols=143 Identities=24% Similarity=0.284 Sum_probs=75.2
Q ss_pred cceeeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc---cccceeeeeeeeeccceEEEEeec
Q 000659 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 971 Fei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr---HPNIVrLlG~~~d~~~~~LVmEYm 1047 (1368)
.+..+.|+.|....+|+.. .+++.+.||+-.. .....|..|.+-|+.|. --.+.+.+++...++..+|||||+
T Consensus 19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 4556789999999999987 6688899998762 33357888999999884 345778888877777789999999
Q ss_pred CCCChh--h---------cccc-cccC-----------------CCCCChHH-----HHHHHHHHH--------------
Q 000659 1048 PNGSVE--S---------HLHG-VDKE-----------------SAPLGWDA-----RLKIALGAA-------------- 1079 (1368)
Q Consensus 1048 ~gGSL~--d---------~L~~-~~~~-----------------~~pLsw~e-----rlkIA~QIA-------------- 1079 (1368)
+.+... + .||+ .... .-.-+|.+ |+....+++
T Consensus 95 ~~~~~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~ 174 (288)
T PF03881_consen 95 EMGSPSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLV 174 (288)
T ss_dssp ------CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHH
Confidence 887110 0 1232 1000 00122321 112111111
Q ss_pred H-HHhhhhccC-CCCccccCCcccCeeecCCCCccccccc
Q 000659 1080 R-ALAYLHEDS-SPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1080 ~-GLaYLHs~g-sp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
+ -...|+... .+.++|+||...|++++.+|+..|.|=.
T Consensus 175 ~~~~~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 175 ERLPSLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HHHHHCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHHHHHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 1 122233221 4569999999999999999989888854
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.22 E-value=4.8e-05 Score=99.55 Aligned_cols=177 Identities=12% Similarity=-0.009 Sum_probs=124.9
Q ss_pred EEEEEeecccchhhH-----HHHHHHHHHhhcccccceeeeeeee--eccceEEEEeecCCCChhhcccccccCCCCCCh
Q 000659 996 VAVKVLKRVDQQGGR-----EFLAEVEMLSRLHHRNLVKLIGICI--EEQARCLVYELIPNGSVESHLHGVDKESAPLGW 1068 (1368)
Q Consensus 996 VAVKvLk~~d~~~~k-----eFlrEIeILsrLrHPNIVrLlG~~~--d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw 1068 (1368)
+-+|+.+..+-+..- ..+.|.+.++.+.|.++.....-.. +....+.+++|+.+|.+.+.|-....+...++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 345555544333322 2344555555667888776554443 345668999999999999998766666666666
Q ss_pred HHHHHHHHHHHHHHhhhhccC--CCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccccccCcchh
Q 000659 1069 DARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146 (1368)
Q Consensus 1069 ~erlkIA~QIA~GLaYLHs~g--sp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAPEvL 1146 (1368)
.-+.....+......-+|... ..-.+|++||.-|.+|+.+.++|++++|+.+.... .........++..|+.+++.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHH
Confidence 665555555455555555442 23479999999999999999999999999983221 22223345678899999999
Q ss_pred ccCCCCcccceeeHHHHHHHHHhCCCCC
Q 000659 1147 MTGHLLVKSDVYSYGVVILELLSGRKPV 1174 (1368)
Q Consensus 1147 ~~~~~T~KSDVWSLGVILyELLTGr~PF 1174 (1368)
..-.++.|+|+|..|+.+|++..|..+|
T Consensus 1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence 9889999999999999999998776554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.13 E-value=0.00074 Score=87.77 Aligned_cols=196 Identities=19% Similarity=0.185 Sum_probs=132.7
Q ss_pred HHHHHHHhhcccccceeeeeeeeeccce----EEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhcc
Q 000659 1013 LAEVEMLSRLHHRNLVKLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088 (1368)
Q Consensus 1013 lrEIeILsrLrHPNIVrLlG~~~d~~~~----~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~ 1088 (1368)
.-|++.+.++.|.|++.+++|..++... .+..||+...++...+.. ...+...+.+.+..++.+||+|+|..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 4566777888999999999997654333 234578888888777743 34578888999999999999999987
Q ss_pred CCCCccccCCccc---CeeecCCCCcccc--cccccccccccccccccccccccccccCcchhccCCCC--cccceeeHH
Q 000659 1089 SSPRVIHRDFKSS---NILLEHDFTPKVS--DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL--VKSDVYSYG 1161 (1368)
Q Consensus 1089 gsp~IVHRDIKPs---NILLD~ng~VKLs--DFGLArll~~~~~~~~st~v~GT~gYmAPEvL~~~~~T--~KSDVWSLG 1161 (1368)
. +.|.=|..+ +-.++.++.+.++ ||+..+...+.... ....-...|.++|......+. ...|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 555555554 4555666666666 88888766443221 112235567788877665554 457999999
Q ss_pred HHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHHHHhcCcCcCCCCCHHHHH
Q 000659 1162 VVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVV 1241 (1368)
Q Consensus 1162 VILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La~~CL~pDPkeRPTMsEVL 1241 (1368)
.++..+..|...-... .....+++.. ....+.+...+|+..+.++|....+++
T Consensus 380 ll~~~~~~~~~i~~~~-------------------~~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~~~~ll 432 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISEKS-------------------AVPVSLLDVL--------STSELLDALPKCLDEDSEERLSALELL 432 (1351)
T ss_pred HHHhhhhhcCcccccc-------------------cchhhhhccc--------cchhhhhhhhhhcchhhhhccchhhhh
Confidence 9999999876432110 0011111111 111467788899999999999999998
Q ss_pred HHHH
Q 000659 1242 QALK 1245 (1368)
Q Consensus 1242 q~Le 1245 (1368)
....
T Consensus 433 ~~~f 436 (1351)
T KOG1035|consen 433 THPF 436 (1351)
T ss_pred hchh
Confidence 7654
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.001 Score=78.45 Aligned_cols=139 Identities=22% Similarity=0.285 Sum_probs=94.9
Q ss_pred eeeEEeecCcEEEEEEEecCCCEEEEEEeecc-------cc--hhhHH-----------------HHHHHHHHhhccccc
Q 000659 973 ASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV-------DQ--QGGRE-----------------FLAEVEMLSRLHHRN 1026 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~-------d~--~~~ke-----------------FlrEIeILsrLrHPN 1026 (1368)
+-.+|..|.-+.||.++-.+|+.+|||+++.. +. .+..+ ...|++-|++|+.-.
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 34578889999999999999999999998531 00 00001 124666677776444
Q ss_pred ceeeeeeeeeccceEEEEeecCCCCh-hhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeee
Q 000659 1027 LVKLIGICIEEQARCLVYELIPNGSV-ESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1027 IVrLlG~~~d~~~~~LVmEYm~gGSL-~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILL 1105 (1368)
|-.---+.. ....|||+|+..... .-.| ....|+...+..+..|+++-|.-|.+.| ++||.||.--|+|+
T Consensus 228 IP~PePIlL--k~hVLVM~FlGrdgw~aPkL-----Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly 298 (520)
T KOG2270|consen 228 IPCPEPILL--KNHVLVMEFLGRDGWAAPKL-----KDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY 298 (520)
T ss_pred CCCCCceee--ecceEeeeeccCCCCcCccc-----ccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence 321111111 244699999943221 1122 2345777788889999999999999887 79999999999998
Q ss_pred cCCCCccccccccccc
Q 000659 1106 EHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1106 D~ng~VKLsDFGLArl 1121 (1368)
. +|.++|+|.+-+..
T Consensus 299 h-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 299 H-DGKLYIIDVSQSVE 313 (520)
T ss_pred E-CCEEEEEEcccccc
Confidence 5 56899999987753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00055 Score=79.57 Aligned_cols=151 Identities=17% Similarity=0.191 Sum_probs=101.4
Q ss_pred CCcCCCHHHHHHHhCC---cceeeEEeecCcEEEEEEEecCCCEEEEEEeec--cc---------------chhh-----
Q 000659 955 SAKTFSASEIEKATGN---FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKR--VD---------------QQGG----- 1009 (1368)
Q Consensus 955 S~~~fsleELe~aT~n---Fei~klLGeGgFGtVYKAvlkdGr~VAVKvLk~--~d---------------~~~~----- 1009 (1368)
...-+++..|....++ +.+++.||-|.-+.||.+...+|+..++|.-+- .. ...+
T Consensus 75 Ty~GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSR 154 (465)
T KOG2268|consen 75 TYAGYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSR 154 (465)
T ss_pred eeccchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHH
Confidence 3344666666655544 567899999999999999999999999986321 00 0000
Q ss_pred HHHHHHHHHHhhccc-c-cceeeeeeeeeccceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhc
Q 000659 1010 REFLAEVEMLSRLHH-R-NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087 (1368)
Q Consensus 1010 keFlrEIeILsrLrH-P-NIVrLlG~~~d~~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs 1087 (1368)
-...+|...|+.|.. - -|.+.++ -+..++|||++.+..|.+.-+- .+.. .|...+..-+.-|.+
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v-------~d~~---~ly~~lm~~Iv~la~ 220 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPID----HNRHCVVMELVDGYPLRQVRHV-------EDPP---TLYDDLMGLIVRLAN 220 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCccc----ccceeeHHHhhcccceeeeeec-------CChH---HHHHHHHHHHHHHHH
Confidence 013468888888753 2 2333333 3466899999998887665421 1222 233334444555666
Q ss_pred cCCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1088 ~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
+| +||+|+.-=||+|++++.++++||--....
T Consensus 221 ~G---lIHgDFNEFNimv~dd~~i~vIDFPQmvS~ 252 (465)
T KOG2268|consen 221 HG---LIHGDFNEFNIMVKDDDKIVVIDFPQMVST 252 (465)
T ss_pred cC---ceecccchheeEEecCCCEEEeechHhhcc
Confidence 77 999999999999999999999999766543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.04 E-value=0.0033 Score=73.39 Aligned_cols=149 Identities=19% Similarity=0.262 Sum_probs=85.9
Q ss_pred eeeEEeecCcEEEEEEEecCCCEEEEEEee-cccchhhHHHHHHHHHHhhccc--ccceeeeeeeeecc--ceEEEEeec
Q 000659 973 ASRILGEGGFGLVYSGVLDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHH--RNLVKLIGICIEEQ--ARCLVYELI 1047 (1368)
Q Consensus 973 i~klLGeGgFGtVYKAvlkdGr~VAVKvLk-~~d~~~~keFlrEIeILsrLrH--PNIVrLlG~~~d~~--~~~LVmEYm 1047 (1368)
+.+.+..|..-.+|+.... ++.+++++=. ........+..+|.++|+.+.- --+-..+++|.++. ..|.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 3444434444455554444 7778887211 1233445566788888888753 33455667777665 669999999
Q ss_pred CCCChhhccc---------------------ccccC-------------CCCCChHHHHHHHH--------HHHHHHhhh
Q 000659 1048 PNGSVESHLH---------------------GVDKE-------------SAPLGWDARLKIAL--------GAARALAYL 1085 (1368)
Q Consensus 1048 ~gGSL~d~L~---------------------~~~~~-------------~~pLsw~erlkIA~--------QIA~GLaYL 1085 (1368)
+|..+.+.+. +.+.. .....|...++.+. ...+-..||
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 8854433322 11100 00111222221111 122234444
Q ss_pred hcc-----CCCCccccCCcccCeeecCCCCcccccccccccc
Q 000659 1086 HED-----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1086 Hs~-----gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll 1122 (1368)
+.+ +...++|+|+++.||||+.++.+=|.||+++..-
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 433 2346999999999999999888999999998754
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0041 Score=72.70 Aligned_cols=141 Identities=18% Similarity=0.190 Sum_probs=83.5
Q ss_pred eEEeecCcEEEEEEEecC-----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eeeeeeeeccceEEEEeecC
Q 000659 975 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd-----Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~d~~~~~LVmEYm~ 1048 (1368)
+.|-.|-...+|+..+.+ ++.|++|+......... +..+|+.+++.+..-++. ++++.+.. + .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence 345557788999987542 36899998865433222 236799999998755554 45554422 2 5899998
Q ss_pred CCChhhc-----------------ccccccC--CCCCChHHHHHHHHHH-----------------HHHHhhh----hc-
Q 000659 1049 NGSVESH-----------------LHGVDKE--SAPLGWDARLKIALGA-----------------ARALAYL----HE- 1087 (1368)
Q Consensus 1049 gGSL~d~-----------------L~~~~~~--~~pLsw~erlkIA~QI-----------------A~GLaYL----Hs- 1087 (1368)
+.+|... ||+.... ....-|+++.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7776421 2222211 1112233333333221 1112222 21
Q ss_pred cCCCCccccCCcccCeeecC-CCCcccccccccc
Q 000659 1088 DSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 1120 (1368)
Q Consensus 1088 ~gsp~IVHRDIKPsNILLD~-ng~VKLsDFGLAr 1120 (1368)
.....++|+|+++.|||+++ ++.++|+||..+.
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 11235899999999999986 4689999998876
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.0081 Score=67.65 Aligned_cols=65 Identities=15% Similarity=0.170 Sum_probs=40.6
Q ss_pred EEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhccccc--ceeeeee------eeeccceEEEEeecCCCChh
Q 000659 984 LVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN--LVKLIGI------CIEEQARCLVYELIPNGSVE 1053 (1368)
Q Consensus 984 tVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPN--IVrLlG~------~~d~~~~~LVmEYm~gGSL~ 1053 (1368)
.||+...++| .+++|++... .+++..|+.++..|...+ +.+++.. ...++..++||||++|..+.
T Consensus 11 ~v~~v~t~~g-~~~LK~~~~~----~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~~ 83 (313)
T TIGR02906 11 NVYKVETDSG-NKCLKKINYP----PERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGRECD 83 (313)
T ss_pred cEEEEEeCCC-CeEEEEcCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCCC
Confidence 4898876655 5788887521 234566777777775333 3343332 12345678999999986653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.60 E-value=0.017 Score=67.83 Aligned_cols=140 Identities=24% Similarity=0.330 Sum_probs=84.5
Q ss_pred EeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccc------eeeeeee--eecc--ceEEEEee
Q 000659 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL------VKLIGIC--IEEQ--ARCLVYEL 1046 (1368)
Q Consensus 977 LGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNI------VrLlG~~--~d~~--~~~LVmEY 1046 (1368)
|.+ .-..||+...++|+. ++|+.... ....++.-|+++|..|.-.+| ..+-|-. .-.+ ..+-|++|
T Consensus 34 l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 34 LNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 444 567899999887776 88888754 445677778888888853332 2222221 1133 67889999
Q ss_pred cCCCChhh-c--------------cc----ccc----cCCCCCChHH---H----------HHHHHHHHHHHhhhhcc--
Q 000659 1047 IPNGSVES-H--------------LH----GVD----KESAPLGWDA---R----------LKIALGAARALAYLHED-- 1088 (1368)
Q Consensus 1047 m~gGSL~d-~--------------L~----~~~----~~~~pLsw~e---r----------lkIA~QIA~GLaYLHs~-- 1088 (1368)
++|..+.. . || +.. .......|+. + .....++...++.+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99988873 1 11 111 0111344541 0 11222333333333332
Q ss_pred --CC---CCccccCCcccCeeecCCCC-cccccccccc
Q 000659 1089 --SS---PRVIHRDFKSSNILLEHDFT-PKVSDFGLAR 1120 (1368)
Q Consensus 1089 --gs---p~IVHRDIKPsNILLD~ng~-VKLsDFGLAr 1120 (1368)
-. ..|||+|+.+.|||+|.+.. +.++|||.++
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 11 12899999999999999875 8899999876
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.029 Score=65.11 Aligned_cols=94 Identities=17% Similarity=0.152 Sum_probs=56.5
Q ss_pred CCCHHHHHHHhCCccee---e-EEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccc--cceeee
Q 000659 958 TFSASEIEKATGNFDAS---R-ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR--NLVKLI 1031 (1368)
Q Consensus 958 ~fsleELe~aT~nFei~---k-lLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHP--NIVrLl 1031 (1368)
.++.+.+..+...+.+. + .+-.+....||+...++|+.+++|+.+.. .....++..|++++..|... .++..+
T Consensus 10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~ 88 (325)
T PRK11768 10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPL 88 (325)
T ss_pred CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence 34555555554444331 1 22245567899999888889999988532 23445677888888877422 222211
Q ss_pred ---e--eeeeccceEEEEeecCCCCh
Q 000659 1032 ---G--ICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 1032 ---G--~~~d~~~~~LVmEYm~gGSL 1052 (1368)
| +...++..+.|+++++|..+
T Consensus 89 ~~~G~~~~~~~g~~~~l~~~~~G~~~ 114 (325)
T PRK11768 89 AFNGQTLHEHQGFRFALFPRRGGRAP 114 (325)
T ss_pred cCCCCEEEEECCEEEEEEeeeCCCCC
Confidence 2 12224567889999987654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.031 Score=66.51 Aligned_cols=73 Identities=18% Similarity=0.162 Sum_probs=47.9
Q ss_pred EEeecCcEEEEEEEecCC-CEEEEEEeec----c---cchhhHHHHHHHHHHhhcc--ccc-ceeeeeeeeeccceEEEE
Q 000659 976 ILGEGGFGLVYSGVLDDG-TKVAVKVLKR----V---DQQGGREFLAEVEMLSRLH--HRN-LVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 976 lLGeGgFGtVYKAvlkdG-r~VAVKvLk~----~---d~~~~keFlrEIeILsrLr--HPN-IVrLlG~~~d~~~~~LVm 1044 (1368)
.||.|-...||++...+| +.|+||.-.. . -.-..++...|.+.|+... -|. +.+++. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999997755 6899997521 1 1223445567888887663 343 333433 3345667999
Q ss_pred eecCCC
Q 000659 1045 ELIPNG 1050 (1368)
Q Consensus 1045 EYm~gG 1050 (1368)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PHA03247 large tegument protein UL36; Provisional | Back alignment and domain information |
|---|
Probab=96.50 E-value=8.4 Score=55.28 Aligned_cols=27 Identities=33% Similarity=0.523 Sum_probs=13.0
Q ss_pred CCCCCCCCCc------CCCCCCCCCCccCCCCC
Q 000659 68 LPTHSAPPPV------NIPSFSPSTPAVSAPFD 94 (1368)
Q Consensus 68 ~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 94 (1368)
+|++-++++. .-|-.+|+-+++-+.++
T Consensus 2555 lPp~~~p~~pd~~~PPp~pAp~P~~PA~~~~~~ 2587 (3151)
T PHA03247 2555 LPPAAPPAAPDRSVPPPRPAPRPSEPAVTSRAR 2587 (3151)
T ss_pred CCCCCCCCCCccCCCCCCCCCCCCCCCCCCCCC
Confidence 6665444332 22334666666644333
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.31 E-value=0.0025 Score=80.04 Aligned_cols=44 Identities=14% Similarity=0.078 Sum_probs=40.2
Q ss_pred HHHHhhhhccCcccccccCCCCCceEEEeeCCCCCCCCCCCCCC
Q 000659 799 TAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSS 842 (1368)
Q Consensus 799 EaldLssnlLsGeIP~qls~LgrL~vLNVS~N~LsGpIPs~lq~ 842 (1368)
+.++|+.|.|+|.||..++.|.+|+.|++++|+|+|.+|..+..
T Consensus 445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~ 488 (623)
T PLN03150 445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488 (623)
T ss_pred CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhc
Confidence 45678999999999999999999999999999999999987655
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.034 Score=66.92 Aligned_cols=75 Identities=16% Similarity=0.242 Sum_probs=50.1
Q ss_pred eeEEeecCcEEEEEEEecC-CCEEEEEEeec---cc---chhhHHHHHHHHHHhhcc--ccc-ceeeeeeeeeccceEEE
Q 000659 974 SRILGEGGFGLVYSGVLDD-GTKVAVKVLKR---VD---QQGGREFLAEVEMLSRLH--HRN-LVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkd-Gr~VAVKvLk~---~d---~~~~keFlrEIeILsrLr--HPN-IVrLlG~~~d~~~~~LV 1043 (1368)
.+.||.|--..||++.+.+ ++.|+||.-.. .. .-..++...|.+.|+.+. -|. +.+++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4678999999999999753 56899997521 11 223456677888888764 343 4444433 34566789
Q ss_pred EeecCCC
Q 000659 1044 YELIPNG 1050 (1368)
Q Consensus 1044 mEYm~gG 1050 (1368)
||+++..
T Consensus 112 MEdL~~~ 118 (409)
T PRK12396 112 MEDLSDH 118 (409)
T ss_pred HHhCccc
Confidence 9998553
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.12 E-value=0.02 Score=66.53 Aligned_cols=141 Identities=17% Similarity=0.231 Sum_probs=81.8
Q ss_pred eEEeecCcEEEEEEEecC----CCEEEEEEeecccchhhHHHHHHHHHHhhcccccce-eeeeeeeeccceEEEEeecCC
Q 000659 975 RILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 klLGeGgFGtVYKAvlkd----Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIV-rLlG~~~d~~~~~LVmEYm~g 1049 (1368)
+.|..|-...+|+....+ +..|++|+....... .-+..+|+.+++.+..-++. ++++++. +. +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~--~G--~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG--NG--MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC--Cc--EeehhhcC
Confidence 345557788999987543 247999988654332 22346799999999765554 5555542 22 58999977
Q ss_pred CChhh-----------------cccccccC--CCCCChHHHHHHHHHH----------------------HHHHh----h
Q 000659 1050 GSVES-----------------HLHGVDKE--SAPLGWDARLKIALGA----------------------ARALA----Y 1084 (1368)
Q Consensus 1050 GSL~d-----------------~L~~~~~~--~~pLsw~erlkIA~QI----------------------A~GLa----Y 1084 (1368)
..|.. .||..... ...--|..+.++..++ .+-+. +
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 76532 12222111 1111233333222221 11111 1
Q ss_pred hhccC-CCCccccCCcccCeeecC-CCCcccccccccc
Q 000659 1085 LHEDS-SPRVIHRDFKSSNILLEH-DFTPKVSDFGLAR 1120 (1368)
Q Consensus 1085 LHs~g-sp~IVHRDIKPsNILLD~-ng~VKLsDFGLAr 1120 (1368)
+...+ ...++|.|+.+.|||+++ ++.++++||..|.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 21111 123789999999999975 5789999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.022 Score=65.23 Aligned_cols=30 Identities=17% Similarity=0.179 Sum_probs=27.6
Q ss_pred CccccCCcccCeeecCCCCccccccccccc
Q 000659 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1092 ~IVHRDIKPsNILLD~ng~VKLsDFGLArl 1121 (1368)
.++|+|+..+|||+++++.+.|+||..++.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 599999999999999999999999998864
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.011 Score=63.84 Aligned_cols=124 Identities=25% Similarity=0.232 Sum_probs=61.8
Q ss_pred CCEEEEEEeecccchhhHHHHHHHHHHhhcccccc-eeeeeeeeeccceEEEEeecCCCChhhc----------------
Q 000659 993 GTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL-VKLIGICIEEQARCLVYELIPNGSVESH---------------- 1055 (1368)
Q Consensus 993 Gr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNI-VrLlG~~~d~~~~~LVmEYm~gGSL~d~---------------- 1055 (1368)
++.|+||+...... ..-+..+|.++++.+..-++ .++++++.+ .+|+||+++..|...
T Consensus 2 ~~~~~~Ri~g~~t~-~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEGTE-NFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESCGC-SHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCCcc-cccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 56789999876533 33456789999999875555 445554422 267799977665331
Q ss_pred -cccccc---CCCCCChHHHHHH----------------------HHHHHHHHhhhh----ccCC-CCccccCCcccCee
Q 000659 1056 -LHGVDK---ESAPLGWDARLKI----------------------ALGAARALAYLH----EDSS-PRVIHRDFKSSNIL 1104 (1368)
Q Consensus 1056 -L~~~~~---~~~pLsw~erlkI----------------------A~QIA~GLaYLH----s~gs-p~IVHRDIKPsNIL 1104 (1368)
||.... .....-|+...++ +..+..-+..+. ..+. ..++|+||.+.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 111111 1111112222222 011111222221 1111 23789999999999
Q ss_pred e-cCCCCccccccccccc
Q 000659 1105 L-EHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1105 L-D~ng~VKLsDFGLArl 1121 (1368)
+ +.+++++|+||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999998863
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.93 E-value=0.072 Score=70.85 Aligned_cols=159 Identities=21% Similarity=0.274 Sum_probs=87.2
Q ss_pred CCHHHHHH-HhCCcce---eeEEeecCcEEEEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcc-------cccc
Q 000659 959 FSASEIEK-ATGNFDA---SRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-------HRNL 1027 (1368)
Q Consensus 959 fsleELe~-aT~nFei---~klLGeGgFGtVYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLr-------HPNI 1027 (1368)
++.++++. +.+.|.+ .+.|+ |.+-.+|+....+|+.+++|+.+.... ..+...|.++|..|. -+.+
T Consensus 11 ~s~~~~~~~~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~--~~~~~~q~~~L~hL~~~~~glpvP~~ 87 (1013)
T PRK06148 11 FTTKDAEALLAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEP--RVESDFQTAALDHLAAVAPDLPVPRL 87 (1013)
T ss_pred CCHHHHHHHHHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccc--hhHHHHHHHHHHHHHhhCCCCCcCee
Confidence 45555432 2334443 24554 556889999988888999999975322 233444555665553 2233
Q ss_pred eeee-e----eeee-cc--ceEEEEeecCCCChhhcc-----------------c----cccc--CCCCCChHH------
Q 000659 1028 VKLI-G----ICIE-EQ--ARCLVYELIPNGSVESHL-----------------H----GVDK--ESAPLGWDA------ 1070 (1368)
Q Consensus 1028 VrLl-G----~~~d-~~--~~~LVmEYm~gGSL~d~L-----------------~----~~~~--~~~pLsw~e------ 1070 (1368)
++.. | .... ++ ..+.+|+|++|..|.+.. | ++.. ....+.|+.
T Consensus 88 i~t~~G~~~~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l 167 (1013)
T PRK06148 88 IPSLSGASLASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRA 167 (1013)
T ss_pred eecCCCCeEEEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhh
Confidence 3322 1 1111 22 456789999998776511 1 0110 112244432
Q ss_pred -----------HHHHHHHHHHHHh-----hhhccCCCCccccCCcccCeeecCCC--Ccc-ccccccccc
Q 000659 1071 -----------RLKIALGAARALA-----YLHEDSSPRVIHRDFKSSNILLEHDF--TPK-VSDFGLARS 1121 (1368)
Q Consensus 1071 -----------rlkIA~QIA~GLa-----YLHs~gsp~IVHRDIKPsNILLD~ng--~VK-LsDFGLArl 1121 (1368)
+..++.++.+.++ .|.+. ...+||+|+...|||++.++ ++. |+|||.+..
T Consensus 168 ~~~l~~i~d~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 168 RDRLHFIDDPEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred hhhhhhcCCHHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 1122222222221 12211 23499999999999999875 565 999998763
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.80 E-value=0.075 Score=64.29 Aligned_cols=73 Identities=11% Similarity=0.116 Sum_probs=50.6
Q ss_pred eeEEeecCcEEEEEEEecCCCEEEEEEeec----ccc---hhhHHHHHHHHHHhhcc---cccceeeeeeeeeccceEEE
Q 000659 974 SRILGEGGFGLVYSGVLDDGTKVAVKVLKR----VDQ---QGGREFLAEVEMLSRLH---HRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 974 ~klLGeGgFGtVYKAvlkdGr~VAVKvLk~----~d~---~~~keFlrEIeILsrLr---HPNIVrLlG~~~d~~~~~LV 1043 (1368)
.+.||.|....||+.... +..|+||+-.. ... ....+-..|.+.|+.+. -.++.+++.+|. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 568899999999998865 56799998531 111 12334445677776664 247788888887 456789
Q ss_pred EeecCC
Q 000659 1044 YELIPN 1049 (1368)
Q Consensus 1044 mEYm~g 1049 (1368)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.019 Score=68.10 Aligned_cols=74 Identities=18% Similarity=0.175 Sum_probs=56.8
Q ss_pred cceEEEEeecCCCChhhcccccccCCCCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCccccccc
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1038 ~~~~LVmEYm~gGSL~d~L~~~~~~~~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFG 1117 (1368)
...|++|++. |+.|... ....|++.+.|+.+.+..+.-|..+ ..+-|||+.-.||||| +|+|.|+||-
T Consensus 299 ~y~yl~~kdh-gt~is~i--------k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfk 366 (488)
T COG5072 299 LYLYLHFKDH-GTPISII--------KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFK 366 (488)
T ss_pred eEEEEEEecC-Cceeeee--------ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEee
Confidence 3446667765 4444322 1357899999999988888777654 3689999999999999 9999999999
Q ss_pred cccccc
Q 000659 1118 LARSAM 1123 (1368)
Q Consensus 1118 LArll~ 1123 (1368)
|+|...
T Consensus 367 lsRl~~ 372 (488)
T COG5072 367 LSRLSY 372 (488)
T ss_pred eeeccc
Confidence 999543
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.65 E-value=0.007 Score=73.94 Aligned_cols=187 Identities=22% Similarity=0.215 Sum_probs=100.4
Q ss_pred EEEEEecCCCEEEEEEeecccchhhHHHHHHHHHHhhcccccceeeeeeeeecc-ceEEEEeecCCCChhhcccccccCC
Q 000659 985 VYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKES 1063 (1368)
Q Consensus 985 VYKAvlkdGr~VAVKvLk~~d~~~~keFlrEIeILsrLrHPNIVrLlG~~~d~~-~~~LVmEYm~gGSL~d~L~~~~~~~ 1063 (1368)
.+.|...+|+.+ .--+-- .....+++-...+++.+.|.|+...+++..... ...+|||++ +.+|++.+....
T Consensus 5 ~~~a~~~~~~~c-~nglpl--t~~s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~--- 77 (725)
T KOG1093|consen 5 TFFAQEKPGDVC-SNGLPL--TPNSIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN--- 77 (725)
T ss_pred EEehhcCCCccc-cCCCcC--CCcHHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc---
Confidence 455665656544 222211 122345666778889999999999999876543 367899999 789999884321
Q ss_pred CCCChHHHHHHHHHHHHHHhhhhccCCCCccccCCcccCeeecCCCCcccccccccccccccccccccccccccccccCc
Q 000659 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143 (1368)
Q Consensus 1064 ~pLsw~erlkIA~QIA~GLaYLHs~gsp~IVHRDIKPsNILLD~ng~VKLsDFGLArll~~~~~~~~st~v~GT~gYmAP 1143 (1368)
+ ++...++ | + +.|. | .++++| -++. .. ....|
T Consensus 78 --l------~~~s~~~------~--~---~~~~-----~-------~~~~td-~~~t------~~---~~~~~------- 109 (725)
T KOG1093|consen 78 --L------KDESLLA------H--G---VLHL-----N-------IIYITD-HFLT------KY---PSPIG------- 109 (725)
T ss_pred --c------chhhhcc------c--c---ccee-----h-------hhhccc-cccc------cC---CCCCC-------
Confidence 1 1111111 1 1 2221 1 233333 0100 00 00111
Q ss_pred chhccCCCCcccceeeHHHHHHHHHhCCCCCCCCCCCcchhHHHhhhhhcccccccceeecCCCCCCCChhhHHHHHHHH
Q 000659 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIA 1223 (1368)
Q Consensus 1144 EvL~~~~~T~KSDVWSLGVILyELLTGr~PFd~s~~~~~~nLv~Wa~plls~~e~L~eIvDp~L~~~~~~ee~~eLl~La 1223 (1368)
.|+|||++|.++.|+.-|..-+..... .+..+...........+..+... ..+-.++...++++.
T Consensus 110 ---------pKsdVwsl~~i~~el~L~~~l~~~~~~---s~~l~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~ 174 (725)
T KOG1093|consen 110 ---------PKSDVWSLGFIILELYLGISLEAELTE---SEYLEILLKYYTDDQELLSTAME---HLIQLLADKKRLPLL 174 (725)
T ss_pred ---------cchhhhhHHHHHHHHHHhhHHHHHHHH---HHHHHHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHh
Confidence 399999999999999998765432211 11111122222211111111100 012234456788999
Q ss_pred HHhcCcCcCCCCCHHHHH
Q 000659 1224 SMCVQPEVQHRPFMGEVV 1241 (1368)
Q Consensus 1224 ~~CL~pDPkeRPTMsEVL 1241 (1368)
..|+-..+..||...++.
T Consensus 175 ~~c~~~~~~ir~l~~~~~ 192 (725)
T KOG1093|consen 175 KKCLWLEPIIRPLPMELS 192 (725)
T ss_pred ccCCccccccccchhHHh
Confidence 999999999988765554
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 1368 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-63 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 9e-62 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-56 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-55 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-46 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-46 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-46 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-43 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-22 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-22 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-21 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-21 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-21 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-21 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-21 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-21 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 4e-21 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-21 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-21 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-21 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-21 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-21 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-21 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-21 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 8e-21 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-21 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 9e-21 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-21 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-20 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-20 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-20 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-20 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 2e-20 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-20 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-20 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-20 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-20 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-20 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-20 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-20 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-20 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-20 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-20 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-20 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-20 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-20 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-20 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-20 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-20 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-20 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-20 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-20 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-20 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 4e-20 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 4e-20 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-20 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-20 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 6e-20 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-20 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-20 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-20 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-20 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 9e-20 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 9e-20 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 9e-20 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 9e-20 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-19 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-19 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-19 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-19 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-19 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-19 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-19 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-19 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-19 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-19 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 4e-19 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-19 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-19 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-19 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 8e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 8e-19 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 8e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 8e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-18 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-18 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-18 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-18 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-18 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-18 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-18 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-18 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-18 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-18 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-18 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-18 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-18 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-18 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-18 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-18 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-18 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 4e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-18 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 4e-18 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-18 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-18 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-18 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-18 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-18 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-18 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-18 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-18 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 5e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-18 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-18 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 6e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 6e-18 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-18 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-18 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-18 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 9e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-17 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-17 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-17 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 2e-17 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-17 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-17 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-17 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 4e-17 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-17 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-16 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 4e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 5e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 7e-16 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 8e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 9e-16 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-15 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-15 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-15 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-15 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-15 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 5e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-15 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-15 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-15 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-15 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-15 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 6e-15 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-15 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 7e-15 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-15 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 8e-15 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 8e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-15 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 8e-15 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-15 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 8e-15 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 9e-15 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-14 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-14 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-14 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-14 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-14 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-14 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-14 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-14 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-14 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-14 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-14 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-14 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-14 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-14 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-14 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-14 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-14 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-14 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 5e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-14 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-14 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 6e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 7e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 8e-14 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-13 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-13 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 4e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-13 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-13 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-13 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 5e-13 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-13 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-13 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 6e-13 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 6e-13 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 6e-13 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 6e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-13 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 6e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-13 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-13 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 6e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-13 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 8e-13 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 9e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-13 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-12 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-12 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 3e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-12 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-12 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 4e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-12 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 4e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 4e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 5e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-12 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 6e-12 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 6e-12 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 7e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 9e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-12 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 9e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 9e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-11 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-11 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-11 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-11 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-11 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 1e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-11 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-11 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 2e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 3e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-11 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 3e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 4e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 4e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 4e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 4e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 4e-11 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-11 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 5e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-11 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-11 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-11 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-11 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-11 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 6e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-11 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 8e-11 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 8e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 8e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 8e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 8e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 8e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-10 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-10 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-10 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-10 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-10 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-10 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-10 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-10 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-10 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-10 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 4e-10 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-10 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 5e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 5e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 6e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 6e-10 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 7e-10 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-10 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 7e-10 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 7e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 7e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 7e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 8e-10 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 8e-10 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-10 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-10 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-10 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-10 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 9e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-10 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-09 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-09 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-09 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-09 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-09 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 2e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-09 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-09 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-09 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-09 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-09 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-09 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-09 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-09 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 4e-09 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 4e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-09 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 4e-09 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 5e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-09 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 6e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-09 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 7e-09 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 7e-09 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 9e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-09 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-08 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-08 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-08 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-08 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-08 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 2e-08 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-08 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-08 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-08 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-08 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-08 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-08 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-08 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-08 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-08 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-08 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-08 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-07 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-07 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-07 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 6e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 6e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 7e-07 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 8e-07 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-07 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-06 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-06 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-06 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-06 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-06 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-06 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-06 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 7e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 8e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-05 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-05 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-05 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 2e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-05 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-05 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 8e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-05 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-04 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-04 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-04 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 528 bits (1363), Expect = e-178
Identities = 125/315 (39%), Positives = 181/315 (57%), Gaps = 7/315 (2%)
Query: 934 VGSGLDSASLSFG---SSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL 990
+GS A+ S SS + ++E+AT NFD ++G G FG VY GVL
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 991 DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG 1050
DG KVA+K QG EF E+E LS H +LV LIG C E L+Y+ + NG
Sbjct: 61 RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENG 120
Query: 1051 SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110
+++ HL+G D + + W+ RL+I +GAAR L YLH + +IHRD KS NILL+ +F
Sbjct: 121 NLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFV 177
Query: 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG 1170
PK++DFG+++ + + H+ST V GT GY+ PEY + G L KSDVYS+GVV+ E+L
Sbjct: 178 PKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCA 237
Query: 1171 RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPE 1230
R + + P NL WA + + LE+I+DP+L + + +S+ K A C+
Sbjct: 238 RSAIVQSLPREMVNLAEWAVESHNNGQ-LEQIVDPNLADKIRPESLRKFGDTAVKCLALS 296
Query: 1231 VQHRPFMGEVVQALK 1245
+ RP MG+V+ L+
Sbjct: 297 SEDRPSMGDVLWKLE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 527 bits (1361), Expect = e-177
Identities = 130/297 (43%), Positives = 181/297 (60%), Gaps = 5/297 (1%)
Query: 952 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG-R 1010
+ G K FS E++ A+ NF ILG GGFG VY G L DGT VAVK LK QGG
Sbjct: 13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGEL 72
Query: 1011 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 1070
+F EVEM+S HRNL++L G C+ R LVY + NGSV S L + PL W
Sbjct: 73 QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 1071 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130
R +IALG+AR LAYLH+ P++IHRD K++NILL+ +F V DFGLA+ MD + H+
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK-LMDYKDTHV 191
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE--NLVAW 1188
+T V GT G++APEY TG K+DV+ YGV++LEL++G++ D+ + + L+ W
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ LL ++ LE ++D L + + V ++ +A +C Q RP M EVV+ L+
Sbjct: 252 VKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 506 bits (1305), Expect = e-169
Identities = 110/310 (35%), Positives = 174/310 (56%), Gaps = 19/310 (6%)
Query: 946 GSSIATYTGSAKTFSASEIEKATGNFD------ASRILGEGGFGLVYSGVLDDGTKVAVK 999
S+ +FS E++ T NFD +GEGGFG+VY G ++ T VAVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVK 60
Query: 1000 VLKRVD----QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESH 1055
L + ++ ++F E++++++ H NLV+L+G + CLVY +PNGS+
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 1056 LHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 1115
L +D + PL W R KIA GAA + +LHE+ IHRD KS+NILL+ FT K+SD
Sbjct: 121 LSCLDG-TPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISD 176
Query: 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
FGLAR++ +++R++GT Y+APE + G + KSD+YS+GVV+LE+++G VD
Sbjct: 177 FGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVD 235
Query: 1176 MTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1235
+ P + L+ + + +E ID + + SV + ++AS C+ + RP
Sbjct: 236 EHREP--QLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHEKKNKRP 292
Query: 1236 FMGEVVQALK 1245
+ +V Q L+
Sbjct: 293 DIKKVQQLLQ 302
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 288 bits (739), Expect = 3e-88
Identities = 71/308 (23%), Positives = 115/308 (37%), Gaps = 28/308 (9%)
Query: 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 1018
+ + + G FG V+ L VAVK+ D+Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 1019 LSRLHHRNLVKLIGICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKI 1074
L + H N+++ IG + L+ GS+ L + W+ I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-----NVVSWNELCHI 126
Query: 1075 ALGAARALAYLHED-------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127
A AR LAYLHED P + HRD KS N+LL+++ T ++DFGLA +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 1128 RHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
+ +GT Y+APE ++ D+Y+ G+V+ EL S D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 1183 ENLVAWARPLLTSRE----GLERIIDPSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFM 1237
+ + + + P L + + A + C + + R
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 1238 GEVVQALK 1245
G V + +
Sbjct: 307 GCVGERIT 314
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 227 bits (579), Expect = 3e-66
Identities = 73/339 (21%), Positives = 127/339 (37%), Gaps = 43/339 (12%)
Query: 959 FSASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM 1018
+ASE N ++G G +G VY G LD VAVKV ++Q F+ E +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANRQ---NFINEKNI 58
Query: 1019 --LSRLHHRNLVKLIGICIE-----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1071
+ + H N+ + I LV E PNGS+ +L W +
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-----LHTSDWVSS 113
Query: 1072 LKIALGAARALAYLHED------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR----- 1120
++A R LAYLH + P + HRD S N+L+++D T +SDFGL+
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173
Query: 1121 -SAMDEESRHISTRVMGTFGYVAPEYAM-------TGHLLVKSDVYSYGVVILELLSGRK 1172
E + + +GT Y+APE L + D+Y+ G++ E+
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233
Query: 1173 PVDMTQPPGQENLV-AWARPLLTSREGLERIID-----PSLGNDVPFDSVA--KVAAIAS 1224
+ + + + + E ++ ++ P +S+A +
Sbjct: 234 DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293
Query: 1225 MCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSS 1263
C + + R + + + + K V +
Sbjct: 294 DCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPTAHH 332
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 2e-64
Identities = 78/287 (27%), Positives = 139/287 (48%), Gaps = 42/287 (14%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG-------REFLAEVEMLSRLHHRN 1026
+ +G+GGFGLV+ G + D + VA+K L D +G +EF EV ++S L+H N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+VKL G+ +V E +P G + L ++ P+ W +L++ L A + Y+
Sbjct: 85 IVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---DKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 1087 EDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+ +P ++HRD +S NI L KV+DFGL++ +S H + ++G F ++
Sbjct: 140 -NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNFQWM 193
Query: 1142 APEYAMTGHLLV--KSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREG 1198
APE K+D YS+ +++ +L+G P + + + + + EG
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK-----IKFI--NMIREEG 246
Query: 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
L R P++ D P ++ + +C + + RP +V+ L
Sbjct: 247 L-R---PTIPEDCP----PRLRNVIELCWSGDPKKRPHFSYIVKELS 285
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-62
Identities = 75/273 (27%), Positives = 128/273 (46%), Gaps = 29/273 (10%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
++G G FG+V VA+K ++ ++ + F+ E+ LSR++H N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+ CLV E GS+ + LHG + + L ++ +AYLH +I
Sbjct: 71 L--NPVCLVMEYAEGGSLYNVLHG-AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 1095 HRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV 1153
HRD K N+LL K+ DFG A + + T G+ ++APE +
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEGSNYSE 182
Query: 1154 KSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVP 1212
K DV+S+G+++ E+++ RKP ++ P + + WA G R P L ++P
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFR---IMWA-----VHNGT-R---PPLIKNLP 230
Query: 1213 FDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ ++ + C + RP M E+V+ +
Sbjct: 231 ----KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-62
Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 25/274 (9%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHRNLVKLIG 1032
+G G FG V+ G+ VAVK+L D EFL EV ++ RL H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+ +V E + GS+ LH L RL +A A+ + YLH +P
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH-KSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
++HR+ KS N+L++ +T KV DFGL+R + + S GT ++APE
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR--LKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 1153 VKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1211
KSDVYS+GV++ EL + ++P ++ P Q V A R + ++
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLN--PAQ---VVAAVGFKCKR--------LEIPRNL 264
Query: 1212 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+VAAI C E RP ++ L+
Sbjct: 265 N----PQVAAIIEGCWTNEPWKRPSFATIMDLLR 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 1e-61
Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 40/284 (14%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG----REFLAEVEMLSRLHHRNLVKL 1030
I+G GGFG VY G +VAVK + + E ++ + L H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
G+C++E CLV E G + L G + D + A+ AR + YLH+++
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDEAI 126
Query: 1091 PRVIHRDFKSSNILLEHDFTP--------KVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
+IHRD KSSNIL+ K++DFGLAR E R G + ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAAGAYAWMA 182
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLER 1201
PE SDV+SYGV++ ELL+G P + VA+ +
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID--GLA---VAYGVAMNKLA----- 232
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ + P A + C P+ RP ++ L
Sbjct: 233 ---LPIPSTCP----EPFAKLMEDCWNPDPHSRPSFTNILDQLT 269
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-61
Identities = 63/287 (21%), Positives = 118/287 (41%), Gaps = 42/287 (14%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
L E G ++ G G + VKVLK + R+F E L H N++ ++G
Sbjct: 16 TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 1033 ICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
C A L+ +P GS+ + LH + + + +K AL AR +A+LH
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLH--EGTNFVVDQSQAVKFALDMARGMAFLH-TLE 131
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1144
P + S +++++ D T ++S + S S M +VAPE
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKP 184
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVAWARPLLTSREGLERII 1203
+D++S+ V++ EL++ P D++ + + + EGL R
Sbjct: 185 EDTNRR---SADMWSFAVLLWELVTREVPFADLS--NME---IGMK----VALEGL-R-- 229
Query: 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250
P++ + V+ + +C+ + RP +V L+ + ++
Sbjct: 230 -PTIPPGIS----PHVSKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 2e-60
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+LG+G FG + G + +K L R D++ R FL EV+++ L H N++K IG+
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+++ + E I G++ + + W R+ A A +AYLH S +
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIK---SMDSQYPWSQRVSFAKDIASGMAYLH---SMNI 129
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES------------RHISTRVMGTFGYV 1141
IHRD S N L+ + V+DFGLAR +DE++ R V+G ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARPLLTSREG 1198
APE K DV+S+G+V+ E++ N+ +
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR------- 242
Query: 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEVG 1258
P + I C + + RP ++ L+ + +G
Sbjct: 243 -----------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPLG 291
Query: 1259 SASSSQD 1265
D
Sbjct: 292 PQLEQLD 298
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 1e-59
Identities = 71/276 (25%), Positives = 118/276 (42%), Gaps = 26/276 (9%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
+ +G G FG VY G VAVK+L Q + F EV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
Q +V + S+ HLH + IA AR + YLH +
Sbjct: 88 YSTAPQ-LAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKS 140
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE---YAMTG 1149
+IHRD KS+NI L D T K+ DFGLA H ++ G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209
+SDVY++G+V+ EL++G+ P Q + G + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEM-----VGRGSLSPDLSKVRS 252
Query: 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ P ++ + + C++ + RP ++ ++
Sbjct: 253 NCP----KRMKRLMAECLKKKRDERPSFPRILAEIE 284
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 6e-56
Identities = 60/310 (19%), Positives = 116/310 (37%), Gaps = 49/310 (15%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
++G+G FG VY G +VA++++ R ++ + F EV + H N+V +G
Sbjct: 39 ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
C+ ++ L ++ S + L + +IA + + YLH +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGYLH---AKG 150
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM---GTFGYVAPEYAMTG 1149
++H+D KS N+ ++ ++DFGL + ++ ++ G ++APE
Sbjct: 151 ILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 1150 HLLV---------KSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWA-----RPLLTS 1195
SDV++ G + EL + P TQP + W +P L
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEA---IIWQMGTGMKPNL-- 263
Query: 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 1255
+++ I C E + RP +++ L+ +
Sbjct: 264 ---------------SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
Query: 1256 EVGSASSSQD 1265
G S +
Sbjct: 309 HPGHFWKSAE 318
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 5e-53
Identities = 65/302 (21%), Positives = 116/302 (38%), Gaps = 48/302 (15%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIG 1032
+G+G +G V+ G G VAVK+ D++ + E E+ L H N++ I
Sbjct: 14 ECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIA 69
Query: 1033 ICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+ + L+ GS+ +L L + L+I L A LA+LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIE 124
Query: 1089 -----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYV 1141
P + HRD KS NIL++ + ++D GLA S + + +GT Y+
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 184
Query: 1142 APE------YAMTGHLLVKSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARPL 1192
APE + D++++G+V+ E+ V+ +PP + +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD--------V 236
Query: 1193 LTSREGLERIID--------PSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFMGEVVQA 1243
+ + E + P++ N D +A + C R + +
Sbjct: 237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296
Query: 1244 LK 1245
L
Sbjct: 297 LT 298
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 5e-52
Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 50/310 (16%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIG 1032
+ +G+G +G V+ G G KVAVKV ++ + E E+ + H N++ I
Sbjct: 43 KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEA---SWFRETEIYQTVLMRHENILGFIA 98
Query: 1033 ICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
I+ L+ + NGS+ +L S L + LK+A + L +LH +
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLK-----STTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 1089 -----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH--ISTRVMGTFGYV 1141
P + HRD KS NIL++ + T ++D GLA + + + +GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 1142 APEYAMTGHLLV-------KSDVYSYGVVILELLSGRKP---VDMTQPPGQENLVAWARP 1191
PE + L +D+YS+G+++ E+ V+ Q P +
Sbjct: 214 PPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD-------- 264
Query: 1192 LLTSREGLERIID--------PSLGNDVPFDSV-AKVAAIASMCVQPEVQHRPFMGEVVQ 1242
L+ S E + + PS N D ++ + + C R V +
Sbjct: 265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
Query: 1243 ALKLVCNECD 1252
L + D
Sbjct: 325 TLAKMSESQD 334
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-50
Identities = 65/306 (21%), Positives = 124/306 (40%), Gaps = 44/306 (14%)
Query: 976 ILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEM--LSRLHHRNLVKLIGI 1033
+G+G FG V+ G G +VAVK+ +++ + E E+ L H N++ I
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAA 104
Query: 1034 CIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED- 1088
++ LV + +GS+ +L+ + + +K+AL A LA+LH +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 1089 ----SSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVMGTFGYVA 1142
P + HRD KS NIL++ + T ++D GLA + + +GT Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 1143 PEYAMTGHLLV-------KSDVYSYGVVILELLSGRKPVDMT---QPPGQENLVAWARPL 1192
PE + + + ++D+Y+ G+V E+ + Q P + + + P
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD--LVPSDPS 276
Query: 1193 LTS------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246
+ + L I + +++ +A I C R + + L
Sbjct: 277 VEEMRKVVCEQKLRPNIPNRWQSC---EALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333
Query: 1247 VCNECD 1252
+ +
Sbjct: 334 LSQQEG 339
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 6e-47
Identities = 79/281 (28%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
+G G FG V+SG L D T VAVK + + +FL E +L + H N+V+LIG
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+C ++Q +V EL+ G + L E A L L++ AA + YL
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---TEGARLRVKTLLQMVGDAAAGMEYLESK---C 233
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV-----APEYAM 1147
IHRD + N L+ K+SDFG++R D G V APE
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGL-RQVPVKWTAPEALN 288
Query: 1148 TGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206
G +SDV+S+G+++ E S G P P N ++ E +
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPY-----PNLSN-----------QQTREFVEK-- 330
Query: 1207 LGN--DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
G P V + C E RP + Q L+
Sbjct: 331 -GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQ 370
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-44
Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 19/205 (9%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ LG G FG+V G VAVK++K EF E + + +L H LVK G+C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E +V E I NG + ++L K L L++ +A+L S + I
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 1149
HRD + N L++ D KVSDFG+ R +D++ + T+ APE
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS------APEVFHYF 180
Query: 1150 HLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+++G+++ E+ S G+ P
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMP 205
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 3e-44
Identities = 62/205 (30%), Positives = 101/205 (49%), Gaps = 19/205 (9%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ +G G FGLV+ G + KVA+K ++ +F+ E E++ +L H LV+L G+C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E+ CLV E + +G + +L + L + L +AYL VI
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGL---FAAETLLGMCLDVCEGMAYL---EEACVI 126
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 1149
HRD + N L+ + KVSDFG+ R +D++ + T+ +PE
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA------SPEVFSFS 180
Query: 1150 HLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+GV++ E+ S G+ P
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIP 205
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 5e-43
Identities = 53/217 (24%), Positives = 95/217 (43%), Gaps = 30/217 (13%)
Query: 975 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 1026
LG+G F ++ GV T+V +KVL + + F M+S+L H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
LV G+C+ LV E + GS++++L K + +L++A A A+ +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLK---KNKNCINILWKLEVAKQLAAAMHFL- 129
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTP--------KVSDFGLARSAMDEESRHISTRVMGTF 1138
+IH + + NILL + K+SD G++ + + ++ +
Sbjct: 130 --EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV--- 184
Query: 1139 GYVAPEYAMTGHLL-VKSDVYSYGVVILELLS-GRKP 1173
PE L + +D +S+G + E+ S G KP
Sbjct: 185 ---PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 8e-43
Identities = 61/207 (29%), Positives = 99/207 (47%), Gaps = 17/207 (8%)
Query: 975 RILGEGGFGLVYSGVL---DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ LG G FG V G VAVK+LK D E LAE ++ +L + +V+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+IGIC E LV E+ G + +L +++ + +++ + + YL
Sbjct: 83 MIGICEAESW-MLVMEMAELGPLNKYL----QQNRHVKDKNIIELVHQVSMGMKYL---E 134
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAM 1147
+HRD + N+LL K+SDFGL++ A+ + + + G + + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSK-ALRADENYYKAQTHGKWPVKWYAPECIN 193
Query: 1148 TGHLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+GV++ E S G+KP
Sbjct: 194 YYKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ +G+G FG V G G KVAVK +K + FLAE ++++L H NLV+L+G+
Sbjct: 27 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 1035 IEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 138
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYAMTG 1149
+HRD + N+L+ D KVSDFGL + + S + ++ APE
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 189
Query: 1150 HLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+G+++ E+ S GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 2e-42
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 975 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
++LG G FG VY G+ VA+K L+ + +E L E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+GIC+ L+ +L+P G + ++ + +G L + A+ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
R++HRD + N+L++ K++DFGLA+ EE + + ++A E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKP 1173
+SDV+SYGV + EL++ G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-42
Identities = 65/237 (27%), Positives = 105/237 (44%), Gaps = 16/237 (6%)
Query: 975 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ LG+G FG V D G VAVK L+ ++ R+F E+E+L L H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 1030 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
G+C R L+ E +P GS+ +L K + L+ + + YL
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYL-- 130
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1145
+ R IHRD + NIL+E++ K+ DFGL + + ++ + G + APE
Sbjct: 131 -GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
V SDV+S+GVV+ EL + + + + + +E +
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 245
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 57/205 (27%), Positives = 100/205 (48%), Gaps = 19/205 (9%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ LG G FG+V G VA+K++K EF+ E +++ L H LV+L G+C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+++ ++ E + NG + ++L + L++ A+ YL S + +
Sbjct: 89 TKQRPIFIITEYMANGCLLNYLREMRHR---FQTQQLLEMCKDVCEAMEYL---ESKQFL 142
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMTG 1149
HRD + N L+ KVSDFGL+R +D+E + + ++ PE M
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS------PPEVLMYS 196
Query: 1150 HLLVKSDVYSYGVVILELLS-GRKP 1173
KSD++++GV++ E+ S G+ P
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMP 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-42
Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
LG G +G VY GV VAVK LK D EFL E ++ + H NLV+L+G+
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
C E ++ E + G++ +L +++ + L +A + A+ YL
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQE--VSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPEYAMT 1148
IHRD + N L+ + KV+DFGL+R + + H + APE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT------APESLAY 186
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKP 1173
+KSDV+++GV++ E+ + G P
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSP 212
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 5e-42
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
LG G FG V+ G + TKVAVK LK FLAE ++ +L H+ LV+L +
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E ++ E + NGS+ L L + L +A A +A++ I
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFI---EERNYI 131
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 1153
HRD +++NIL+ + K++DFGLAR D E + + + APE G +
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGTFTI 189
Query: 1154 KSDVYSYGVVILELLS-GRKP 1173
KSDV+S+G+++ E+++ GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 6e-42
Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 20/239 (8%)
Query: 975 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
R LGEG FG V D G +VAVK LK + E+E+L L+H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 1029 KLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
K GIC E+ L+ E +P+GS++ +L K + +LK A+ + + YL
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYL- 142
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPE 1144
S + +HRD + N+L+E + K+ DFGL + A++ + + + + + APE
Sbjct: 143 --GSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYYTVKDDRDSPVFWYAPE 199
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
M + SDV+S+GV + ELL+ + ++ +T + +
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTL 256
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 7e-42
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 15/204 (7%)
Query: 977 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+C E LV E+ G + L G +E + ++ + + YL
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYAMTGH 1150
+HRD + N+LL + K+SDFGL++ A+ + + + R G + + APE
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 189
Query: 1151 LLVKSDVYSYGVVILELLS-GRKP 1173
+SDV+SYGV + E LS G+KP
Sbjct: 190 FSSRSDVWSYGVTMWEALSYGQKP 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 9e-42
Identities = 68/205 (33%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ +G+G FG V G G KVAVK +K + FLAE ++++L H NLV+L+G+
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 1035 IEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 310
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV----MGTFGYVAPEYAMTG 1149
+HRD + N+L+ D KVSDFGL + + S + ++ APE
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEALREK 361
Query: 1150 HLLVKSDVYSYGVVILELLS-GRKP 1173
KSDV+S+G+++ E+ S GR P
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVP 386
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 66/238 (27%), Positives = 103/238 (43%), Gaps = 19/238 (7%)
Query: 975 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
LG+G FG V D G VAVK L+ R+F E+++L LH +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 1030 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
G+ + LV E +P+G + L + A L L + + + YL
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQ---RHRARLDASRLLLYSSQICKGMEYL-- 143
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1145
S R +HRD + NIL+E + K++DFGLA+ + + + R G + APE
Sbjct: 144 -GSRRCVHRDLAARNILVESEAHVKIADFGLAK-LLPLDKDYYVVREPGQSPIFWYAPES 201
Query: 1146 AMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
+SDV+S+GVV+ EL + K + ++ R + LE +
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELL 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-41
Identities = 69/210 (32%), Positives = 100/210 (47%), Gaps = 24/210 (11%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 1029
RILGEG FG VY GV + VAVK K+ +F++E ++ L H ++VK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
LIGI EE ++ EL P G + +L L + +L +A+AYL
Sbjct: 78 LIGIIEEEPT-WIIMELYPYGELGHYLERNKNS---LKVLTLVLYSLQICKAMAYL---E 130
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPE 1144
S +HRD NIL+ K+ DFGL+R DE+ + TR+ M +PE
Sbjct: 131 SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------SPE 184
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
SDV+ + V + E+LS G++P
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 65/237 (27%), Positives = 106/237 (44%), Gaps = 16/237 (6%)
Query: 975 RILGEGGFGLVYSGVLD-----DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ LG+G FG V D G VAVK L+ ++ R+F E+E+L L H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 1030 LIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
G+C R L+ E +P GS+ +L K + L+ + + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---KHKERIDHIKLLQYTSQICKGMEYL-- 161
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEY 1145
+ R IHRD + NIL+E++ K+ DFGL + + ++ + + G + APE
Sbjct: 162 -GTKRYIHRDLATRNILVENENRVKIGDFGLTK-VLPQDKEYYKVKEPGESPIFWYAPES 219
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
V SDV+S+GVV+ EL + + + + + +E +
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL 276
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-40
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 20/210 (9%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNL 1027
LG+G FG+V G VAVK LK + +F+ EV + L HRNL
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
++L G+ + +V EL P GS+ L K + A+ A + YL
Sbjct: 84 IRLYGVVLTPPM-KMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGMGYL-- 137
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT---FGYVAPE 1144
S R IHRD + N+LL K+ DFGL R+ + ++ F + APE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 194
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
T SD + +GV + E+ + G++P
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 1e-40
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 1029
++G G FG VY G L D AVK L R+ D +FL E ++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 1030 LIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L+GIC+ + + +V + +G + + + E+ + L A+ + YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYL--- 144
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 1146
+S + +HRD + N +L+ FT KV+DFGLAR D+E + + ++A E
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 1147 MTGHLLVKSDVYSYGVVILELLS-GRKP 1173
T KSDV+S+GV++ EL++ G P
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 62/210 (29%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 1029
R +GEG FG V+ G+ VA+K K +FL E + + H ++VK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
LIG+ E ++ EL G + S L L + + A + ALAYL
Sbjct: 81 LIGVITENPV-WIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYL---E 133
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRV----MGTFGYVAPE 1144
S R +HRD + N+L+ + K+ DFGL+R D + ++ M APE
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------APE 187
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
SDV+ +GV + E+L G KP
Sbjct: 188 SINFRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 57/220 (25%), Positives = 100/220 (45%), Gaps = 30/220 (13%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 1028
R+LG+G FG V L KVAVK+LK + EFL E + H ++
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 1029 KLIGICIEEQAR------CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAAR 1080
KL+G+ + +A+ ++ + +G + + L + + L ++ + A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV---- 1134
+ YL SS IHRD + N +L D T V+DFGL+R + + ++++
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ A E V SDV+++GV + E+++ G+ P
Sbjct: 206 L------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-40
Identities = 63/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+ LG G FG V+ + TKVAVK +K FLAE ++ L H LVKL +
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
+E ++ E + GS+ L E + + + A +A++ I
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLK--SDEGSKQPLPKLIDFSAQIAEGMAFI---EQRNYI 306
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV---APEYAMTGHL 1151
HRD +++NIL+ K++DFGLAR D E T G + APE G
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE----YTAREGAKFPIKWTAPEAINFGSF 362
Query: 1152 LVKSDVYSYGVVILELLS-GRKP 1173
+KSDV+S+G++++E+++ GR P
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIP 385
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-40
Identities = 62/208 (29%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 1029
R++G+G FG+VY G D + A+K L R+ + Q FL E ++ L+H N++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 1030 LIGICIEEQARCL-VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
LIGI + + + + +G + + + L AR + YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 1146
+ + +HRD + N +L+ FT KV+DFGLAR +D E + + A E
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESL 200
Query: 1147 MTGHLLVKSDVYSYGVVILELLS-GRKP 1173
T KSDV+S+GV++ ELL+ G P
Sbjct: 201 QTYRFTTKSDVWSFGVLLWELLTRGAPP 228
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 4e-40
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L +
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
EE +V E + GS+ L + L + +A A +AY+ +
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 302
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 1153
HRD +++NIL+ + KV+DFGLAR D E + + + APE A+ G +
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 360
Query: 1154 KSDVYSYGVVILELLS-GRKP 1173
KSDV+S+G+++ EL + GR P
Sbjct: 361 KSDVWSFGILLTELTTKGRVP 381
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-40
Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 25/212 (11%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 1029
+I+G G G V G L VA+K LK ++ R+FL+E ++ + H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+ + +V E + NGS+++ L + + G + YL S
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLR---THDGQFTIMQLVGMLRGVGAGMRYL---S 168
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-------MGTFGYVA 1142
+HRD + N+L++ + KVSDFGL+R D+ +T A
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWT------A 222
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
PE SDV+S+GVV+ E+L+ G +P
Sbjct: 223 PEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-39
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 29/219 (13%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLV 1028
+ILGEG FG V G L KVAVK +K Q+ EFL+E + H N++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 1029 KLIGICIEEQARC-----LVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1081
+L+G+CIE ++ ++ + G + ++L ++ + LK + A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV----M 1135
+ YL S+ +HRD + N +L D T V+DFGL++ + + ++ +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
A E KSDV+++GV + E+ + G P
Sbjct: 217 ------AIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 975 RILGEGGFGLVYSGVL-----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
+++G G FG VY G+L VA+K LK ++ +FL E ++ + H N++
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L G+ + + ++ E + NG+++ L D E + + G A + YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE---FSVLQLVGMLRGIAAGMKYL--- 163
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV-------MGTFGYV 1141
++ +HRD + NIL+ + KVSDFGL+R D+ +T
Sbjct: 164 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT------ 217
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
APE SDV+S+G+V+ E+++ G +P
Sbjct: 218 APEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 2e-39
Identities = 54/206 (26%), Positives = 99/206 (48%), Gaps = 14/206 (6%)
Query: 975 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
++LG G FG V+ GV V +KV++ +Q + + + L H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+G+C LV + +P GS+ H+ + LG L + A+ + YL
Sbjct: 79 RLLGLCPGSSL-QLVTQYLPLGSLLDHVR---QHRGALGPQLLLNWGVQIAKGMYYL--- 131
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
++HR+ + N+LL+ +V+DFG+A ++ + + + ++A E
Sbjct: 132 EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHF 191
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKP 1173
G +SDV+SYGV + EL++ G +P
Sbjct: 192 GKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-39
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 15/204 (7%)
Query: 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
LG G +G VY GV VAVK LK ++ + EFL E ++ + H NLV+L+
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 282
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSP 1091
G+C E ++ E + G++ +L + + L +A + A+ YL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQISSAMEYL---EKK 337
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGH 1150
IHR+ + N L+ + KV+DFGL+R + + H + + APE
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP--IKWTAPESLAYNK 395
Query: 1151 LLVKSDVYSYGVVILELLS-GRKP 1173
+KSDV+++GV++ E+ + G P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-39
Identities = 64/207 (30%), Positives = 102/207 (49%), Gaps = 15/207 (7%)
Query: 975 RILGEGGFGLVYSGVL----DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVK 1029
+++G G FG V SG L VA+K LK ++ R+FL E ++ + H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+ + + +V E + NGS++S L K A + + G A + YL S
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLR---KHDAQFTVIQLVGMLRGIASGMKYL---S 164
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAM 1147
+HRD + NIL+ + KVSDFGL R ++++ T G +PE
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGR-VLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 1148 TGHLLVKSDVYSYGVVILELLS-GRKP 1173
SDV+SYG+V+ E++S G +P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 4e-39
Identities = 64/224 (28%), Positives = 99/224 (44%), Gaps = 34/224 (15%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
R LGEG FG V+ D VAVK LK ++F E E+L+ L H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR----------LKIAL 1076
K G+C + +V+E + +G + L HG D G + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 1134
A + YL +S +HRD + N L+ + K+ DFG++R + T +
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 1135 ----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
M PE M +SDV+S+GV++ E+ + G++P
Sbjct: 198 PIRWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-39
Identities = 56/206 (27%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 975 RILGEGGFGLVYSGVLDDG-----TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
++LG G FG VY G+ VA+K L+ + +E L E +++ + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+L+GIC+ L+ +L+P G + ++ + +G L + A+ + YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVR---EHKDNIGSQYLLNWCVQIAKGMNYL--- 133
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
R++HRD + N+L++ K++DFGLA+ EE + + ++A E +
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193
Query: 1149 GHLLVKSDVYSYGVVILELLS-GRKP 1173
+SDV+SYGV + EL++ G KP
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 6e-39
Identities = 59/219 (26%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 975 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 1027
R LG+G FG+VY GV T+VA+K + + EFL E ++ + ++
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL------HGVDKESAPLGWDARLKIALGAARA 1081
V+L+G+ + Q ++ EL+ G ++S+L + AP +++A A
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV----M 1135
+AYL ++ + +HRD + N ++ DFT K+ DFG+ R + + + + M
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 207
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+PE G SDV+S+GVV+ E+ + +P
Sbjct: 208 ------SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-39
Identities = 74/239 (30%), Positives = 107/239 (44%), Gaps = 22/239 (9%)
Query: 975 RILGEGGFGLVYSGVLDD-----GTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
R LGEG FG V D G VAVK LK Q + E+++L L+H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 1029 KLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
K G C + A LV E +P GS+ +L +G L A +AYLH
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLH 151
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPE 1144
+ IHRD + N+LL++D K+ DFGLA+ A+ E + R G + APE
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVFWYAPE 207
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
SDV+S+GV + ELL+ + P L+ A+ +T E +
Sbjct: 208 CLKEYKFYYASDVWSFGVTLYELLTHCDSS--QSPPTKFLELIGIAQGQMTVLRLTELL 264
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-38
Identities = 72/293 (24%), Positives = 113/293 (38%), Gaps = 30/293 (10%)
Query: 892 VLCSAAAWVLLFKYKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIAT 951
L + A + + + +A L + + + + V D A I
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAE------IID 372
Query: 952 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVLDDG----TKVAVKVLKR-VDQ 1006
+ S + E + R +GEG FG V+ G+ VA+K K
Sbjct: 373 EEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSD 432
Query: 1007 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPL 1066
+FL E + + H ++VKLIG+ E ++ EL G + S L L
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQ---VRKFSL 488
Query: 1067 GWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126
+ + A + ALAYL S R +HRD + N+L+ + K+ DFGL+R D
Sbjct: 489 DLASLILYAYQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 545
Query: 1127 -----SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ + M APE SDV+ +GV + E+L G KP
Sbjct: 546 YYKASKGKLPIKWM------APESINFRRFTSASDVWMFGVCMWEILMHGVKP 592
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-38
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 15/208 (7%)
Query: 975 RILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVK 1029
++G G FG VY G L D AVK L R+ D +FL E ++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 1030 LIGICIEEQ-ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L+GIC+ + + +V + +G + + + E+ + L A+ + +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFL--- 208
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF--GYVAPEYA 1146
+S + +HRD + N +L+ FT KV+DFGLAR D+E + + ++A E
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 1147 MTGHLLVKSDVYSYGVVILELLS-GRKP 1173
T KSDV+S+GV++ EL++ G P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-38
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 35/225 (15%)
Query: 975 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 1027
LGE FG VY G L VA+K LK + EF E + +RL H N+
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR----------LKIA 1075
V L+G+ ++Q +++ +G + L + D + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST--- 1132
A + YL SS V+H+D + N+L+ K+SD GL R + +
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 1133 ---RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
R M APE M G + SD++SYGVV+ E+ S G +P
Sbjct: 192 LPIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-38
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 33/223 (14%)
Query: 975 RILGEGGFGLVYSGVLDDG------TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
LGEG FG V+ + VAVK LK + ++F E E+L+ L H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHL-----------HGVDKESAPLGWDARLKIALG 1077
+ G+C E + +V+E + +G + L G D PLG L +A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV--- 1134
A + YL + +HRD + N L+ K+ DFG++R + + R
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 223
Query: 1135 ---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
M PE + +SDV+S+GVV+ E+ + G++P
Sbjct: 224 IRWM------PPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-37
Identities = 62/204 (30%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 977 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+C E LV E+ G + L G +E + ++ + + YL
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY--VAPEYAMTGH 1150
+HR+ + N+LL + K+SDFGL++ A+ + + + R G + APE
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSK-ALGADDSYYTARSAGKWPLKWYAPECINFRK 515
Query: 1151 LLVKSDVYSYGVVILELLS-GRKP 1173
+SDV+SYGV + E LS G+KP
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKP 539
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 5e-37
Identities = 62/221 (28%), Positives = 98/221 (44%), Gaps = 32/221 (14%)
Query: 975 RILGEGGFGLVYSGVLDDG---TKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVK 1029
++GEG FG V + A+K +K + R+F E+E+L +L HH N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARLKIALG 1077
L+G C L E P+G++ L + ++ L L A
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV--- 1134
AR + YL S + IHRD + NIL+ ++ K++DFGL+R + + R+
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-EVYVKKTMGRLPVR 206
Query: 1135 -MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
M A E SDV+SYGV++ E++S G P
Sbjct: 207 WM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-36
Identities = 59/231 (25%), Positives = 95/231 (41%), Gaps = 24/231 (10%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
++ + LGEGGF V L DG A+K + +QQ E E +M +H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 1029 KLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+L+ C+ E+ L+ G++ + + + + L D L + LG R L
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-------GT 1137
+H + HRD K +NILL + P + D G A + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 1138 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
Y APE + + ++DV+S G V+ ++ G P DM G
Sbjct: 207 ISYRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGD 254
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-36
Identities = 62/224 (27%), Positives = 97/224 (43%), Gaps = 34/224 (15%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRL-HHRN 1026
+ LG G FG V D KVAVK+LK ++E++++S L H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHL----------HGVDKESAPLGWDARLKIAL 1076
+V L+G C ++ E G + + L ++ L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 1134
A+ +A+L +S IHRD + N+LL + K+ DFGLAR M++ + R+
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228
Query: 1135 ----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
M APE V+SDV+SYG+++ E+ S G P
Sbjct: 229 PVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 5e-36
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 1027
R LG G FG VY G + +VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAY 1084
V+ IG+ ++ R ++ EL+ G ++S L + + L L +A A Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 1085 LHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L IHRD + N LL K+ DFG+AR G +
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAML 207
Query: 1142 -----APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
PE M G K+D +S+GV++ E+ S G P
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-35
Identities = 59/233 (25%), Positives = 99/233 (42%), Gaps = 43/233 (18%)
Query: 975 RILGEGGFGLVYSGVLDDG------TKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 1027
+ LGEG FG V T VAVK+LK R+ L+E +L +++H ++
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL--------------------HGVDKESAPLG 1067
+KL G C ++ L+ E GS+ L + L
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 1068 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 1126
+ A ++ + YL + +++HRD + NIL+ K+SDFGL+R +E+
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 1127 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ R+ M A E +SDV+S+GV++ E+++ G P
Sbjct: 206 YVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 11/201 (5%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+L +
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 1035 IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVI 1094
EE +V E + GS+ L + L + +A A +AY+ +
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLK--GETGKYLRLPQLVDMAAQIASGMAYV---ERMNYV 385
Query: 1095 HRDFKSSNILLEHDFTPKVSDFGLARSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLV 1153
HRD +++NIL+ + KV+DFGLAR D E + + + APE A+ G +
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFP--IKWTAPEAALYGRFTI 443
Query: 1154 KSDVYSYGVVILELLS-GRKP 1173
KSDV+S+G+++ EL + GR P
Sbjct: 444 KSDVWSFGILLTELTTKGRVP 464
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-35
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 975 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 1024
+ LGEG FG V + VAVK+LK ++ + ++E+EM+ + H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 1072
+N++ L+G C ++ ++ E G++ +L + + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 1130
AR + YL +S + IHRD + N+L+ + K++DFGLAR + + +
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 1131 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 218 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-35
Identities = 61/228 (26%), Positives = 104/228 (45%), Gaps = 38/228 (16%)
Query: 975 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 1024
+ LGEG FG V + TKVAVK+LK ++ + ++E+EM+ + H
Sbjct: 75 KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 1072
+N++ L+G C ++ ++ E G++ +L + L +
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 1130
A AR + YL +S + IHRD + N+L+ D K++DFGLAR + +
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 251
Query: 1131 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 252 NGRLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-35
Identities = 56/228 (24%), Positives = 102/228 (44%), Gaps = 38/228 (16%)
Query: 975 RILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HH 1024
+ LGEG FG V + VAVK+LK ++ + ++E+EM+ + H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHL------------HGVDKESAPLGWDARL 1072
+N++ L+G C ++ ++ E G++ +L + + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHI 1130
AR + YL +S + IHRD + N+L+ + K++DFGLAR + + +
Sbjct: 207 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 1131 STRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ R+ M APE +SDV+S+GV++ E+ + G P
Sbjct: 264 NGRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 8e-35
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 27/218 (12%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNL 1027
R LG G FG VY G + +VAVK L +Q +FL E ++S+ +H+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAY 1084
V+ IG+ ++ R ++ EL+ G ++S L + + L L +A A Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 1085 LHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L IHRD + N LL K+ DFG+AR G +
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAML 248
Query: 1142 -----APEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
PE M G K+D +S+GV++ E+ S G P
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 8e-35
Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 38/228 (16%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 1026
+ LG G FG V D VAVK+LK ++E+++LS L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHL--------------HGVDKESAPLGWDARL 1072
+V L+G C ++ E G + + L ++ + L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+ A+ +A+L +S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 1133 ------RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ M APE +SDV+SYG+ + EL S G P
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 61/227 (26%), Positives = 95/227 (41%), Gaps = 37/227 (16%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 1026
+ LG G FG V VAVK+LK R ++E+++L + HH N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 1027 LVKLIGIC-IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR------------LK 1073
+V L+G C ++ E G++ ++L E P +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 1074 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHIS 1131
+ A+ + +L +S + IHRD + NILL K+ DFGLAR + R
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 1132 TRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
R+ M APE ++SDV+S+GV++ E+ S G P
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 3e-34
Identities = 62/233 (26%), Positives = 98/233 (42%), Gaps = 43/233 (18%)
Query: 975 RILGEGGFGLVYSGVLDDG------TKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNL 1027
R +GEG FG V+ T VAVK+LK +F E +++ + N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL--------------------HGVDKESAPLG 1067
VKL+G+C + CL++E + G + L PL
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 1068 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 1126
+L IA A +AYL S + +HRD + N L+ + K++DFGL+R+ +
Sbjct: 173 CAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 1127 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ + M PE +SDV++YGVV+ E+ S G +P
Sbjct: 230 YKADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 36/229 (15%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
+F+ +LG+G FG V D A+K ++ +++ L+EV +L+ L+H+ +V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL-STILSEVMLLASLNHQYVV 65
Query: 1029 KLIGICIEEQAR-------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1075
+ +E + + E NG++ +H E+ D ++
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH---SENLNQQRDEYWRLF 122
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-------------A 1122
AL+Y+H S +IHRD K NI ++ K+ DFGLA++
Sbjct: 123 RQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 1123 MDEESRHISTRVMGTFGYVAPE-YAMTGHLLVKSDVYSYGVVILELLSG 1170
+ S ++++ + GT YVA E TGH K D+YS G++ E++
Sbjct: 180 LPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-34
Identities = 61/233 (26%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRN 1026
++LG G FG V + +VAVK+LK D ++E++M+++L H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDAR------------- 1071
+V L+G C L++E G + ++L + ++ +
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 1072 ----LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE- 1126
L A A+ + +L +HRD + N+L+ H K+ DFGLAR M +
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 1127 -SRHISTRV----MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKP 1173
+ R+ M APE G +KSDV+SYG+++ E+ S G P
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 16/205 (7%)
Query: 975 RILGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLV 1028
LG GG VY +L+ KVA+K + R ++ + F EV S+L H+N+V
Sbjct: 17 DKLGGGGMSTVYLAEDTILN--IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+I + E+ LV E I ++ ++ PL D + + + H+
Sbjct: 75 SMIDVDEEDDCYYLVMEYIEGPTLSEYIE----SHGPLSVDTAINFTNQILDGIKHAHDM 130
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
R++HRD K NIL++ + T K+ DFG+A+ A+ E S + V+GT Y +PE A
Sbjct: 131 ---RIVHRDIKPQNILIDSNKTLKIFDFGIAK-ALSETSLTQTNHVLGTVQYFSPEQAKG 186
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKP 1173
+D+YS G+V+ E+L G P
Sbjct: 187 EATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 65/270 (24%), Positives = 109/270 (40%), Gaps = 37/270 (13%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
+G G F VY G+ + +VA +++ + + F E EML L H N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 1033 ICIEEQAR----CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLH 1086
LV EL+ +G+++++L V K W R +I G L +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW-CR-QILKG----LQFLH 146
Query: 1087 EDSSPRVIHRDFKSSNILLEH-DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
+P +IHRD K NI + + K+ D GLA + + V+GT ++APE
Sbjct: 147 T-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM 201
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
+ DVY++G+ +LE+ + P Q Q + +++ P
Sbjct: 202 YEEKYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG---VKPASFDKVAIP 257
Query: 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1235
+V I C++ R
Sbjct: 258 ------------EVKEIIEGCIRQNKDERY 275
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 58/241 (24%), Positives = 110/241 (45%), Gaps = 19/241 (7%)
Query: 948 SIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ 1006
S+ + E + +LG+G +G+VY+G L + ++A+K + D
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS 60
Query: 1007 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVES---HLHGVDKES 1063
+ + E+ + L H+N+V+ +G E + E +P GS+ + G K++
Sbjct: 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSA 1122
+I G L YLH++ +++HRD K N+L+ + K+SDFG ++
Sbjct: 121 EQTIGFYTKQILEG----LKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173
Query: 1123 MDEESRHISTRVMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP-VDMTQ 1178
+ GT Y+APE G+ +D++S G I+E+ +G+ P ++ +
Sbjct: 174 AGINPCTET--FTGTLQYMAPEIIDKGPRGYGK-AADIWSLGCTIIEMATGKPPFYELGE 230
Query: 1179 P 1179
P
Sbjct: 231 P 231
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 1026
+++ +G G +G DG + K + + + ++EV +L L H N
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66
Query: 1027 LVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+V+ I+ +V E G + S + KE L + L++ AL
Sbjct: 67 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 1085 LHE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
H D V+HRD K +N+ L+ K+ DFGLAR ++ ++ T V GT Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR-ILNHDTSFAKTFV-GTPYYMS 184
Query: 1143 PE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
PE Y KSD++S G ++ EL + P
Sbjct: 185 PEQMNRMSYNE------KSDIWSLGCLLYELCALMPP 215
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 43/228 (18%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
+F ++G GGFG V+ DG +K +K ++ + EV+ L++L H N+V
Sbjct: 12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIV 67
Query: 1029 KLIGICIEEQAR-----------------CLVYELIPNGSVESHLHGVDKESAPLGWDAR 1071
G C + + E G++E + + L
Sbjct: 68 HYNG-CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLA 124
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
L++ + + Y+H S ++I+RD K SNI L K+ DFGL S ++ R
Sbjct: 125 LELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--- 178
Query: 1132 TRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
TR GT Y++PE Y G + D+Y+ G+++ ELL
Sbjct: 179 TRSKGTLRYMSPEQISSQDY---GK---EVDLYALGLILAELLHVCDT 220
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-32
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 21/246 (8%)
Query: 938 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKV 996
+D S K NF + +G G F VY L DG V
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 997 AVKVLKRVDQQGGRE---FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVE 1053
A+K ++ D + + E+++L +L+H N++K IE+ +V EL G +
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 1054 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV 1113
+ K+ + K + AL ++H RV+HRD K +N+ + K+
Sbjct: 121 RMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKL 177
Query: 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILEL 1167
D GL R ++ + V GT Y++PE Y KSD++S G ++ E+
Sbjct: 178 GDLGLGR-FFSSKTTAAHSLV-GTPYYMSPERIHENGYNF------KSDIWSLGCLLYEM 229
Query: 1168 LSGRKP 1173
+ + P
Sbjct: 230 AALQSP 235
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-32
Identities = 49/214 (22%), Positives = 88/214 (41%), Gaps = 24/214 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRL--HHRNLVKL 1030
+ +G GG V+ + + A+K L+ D Q + E+ L++L H +++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
I +Q +V E N + S L K+ + R A+ +H+
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 127
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1144
++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 128 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 1145 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 1173
+ KSDV+S G ++ + G+ P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 961 ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEV 1016
A+ I + +F +LG+G F VY + G +VA+K++ K + + G + EV
Sbjct: 3 ATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEV 62
Query: 1017 EMLSRLHHRNLVKLIGICIEEQARC-LVYELIPNGSVESHLHGVDKESAPLG-WDARLKI 1074
++ +L H ++++L E+ LV E+ NG + +L K P +AR +
Sbjct: 63 KIHCQLKHPSILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKNRVK---PFSENEARHFM 118
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRV 1134
+ YLH S ++HRD SN+LL + K++DFGLA +H T +
Sbjct: 119 H-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-L 172
Query: 1135 MGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKP 1173
GT Y++PE A + H L +SDV+S G + LL GR P
Sbjct: 173 CGTPNYISPEIATRSAHGL-ESDVWSLGCMFYTLLIGRPP 211
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 49/214 (22%), Positives = 89/214 (41%), Gaps = 24/214 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNL--VKL 1030
+ +G GG V+ + + A+K L+ D Q + E+ L++L + ++L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
I +Q +V E N + S L K+S W+ + A+ +H+
Sbjct: 94 YDYEITDQYIYMVMEC-GNIDLNSWL--KKKKSIDP-WERK-SYWKNMLEAVHTIHQH-- 146
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1144
++H D K +N L+ D K+ DFG+A + + + +GT Y+ PE
Sbjct: 147 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 1145 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 1173
+ KSDV+S G ++ + G+ P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-32
Identities = 70/213 (32%), Positives = 95/213 (44%), Gaps = 23/213 (10%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 1024
+F+ R LG+G FG VY +A+KVL ++++ G EVE+ S L H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 1025 RNLVKLIGICIEEQARC-LVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1081
N+++L G + R L+ E P G+V L E I A A
Sbjct: 69 PNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKFDE-----QRTATYITE-LANA 121
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L+Y H S RVIHRD K N+LL K++DFG S SR GT Y+
Sbjct: 122 LSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTDL--CGTLDYL 174
Query: 1142 APEYAMT-GHLLVKSDVYSYGVVILELLSGRKP 1173
PE H K D++S GV+ E L G+ P
Sbjct: 175 PPEMIEGRMHDE-KVDLWSLGVLCYEFLVGKPP 206
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 8e-32
Identities = 57/223 (25%), Positives = 94/223 (42%), Gaps = 28/223 (12%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNL 1027
+F+ + LG GGFG+V+ D A+K ++ +++ RE + EV+ L++L H +
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 65
Query: 1028 VKLIGICIEEQAR------------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1075
V+ +E+ + +L ++ L I
Sbjct: 66 VRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHIF 124
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH------ 1129
L A A+ +LH S ++HRD K SNI D KV DFGL + +E
Sbjct: 125 LQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 1130 ----ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1168
T +GT Y++PE K D++S G+++ ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 66/240 (27%), Positives = 99/240 (41%), Gaps = 25/240 (10%)
Query: 946 GSSIATYTGSAKTFSASEIEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKV 1000
G + G + I G+ + LG G +G V + A+K+
Sbjct: 10 GRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKI 69
Query: 1001 L--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL-- 1056
+ V + L EV +L L H N++KL +++ LV E G + +
Sbjct: 70 IRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH 129
Query: 1057 HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKV 1113
E DA I + YLH ++HRD K N+LL E D K+
Sbjct: 130 RMKFNEV-----DAA-VIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKI 180
Query: 1114 SDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
DFGL SA+ E + + R+ GT Y+APE + K DV+S GV++ LL+G P
Sbjct: 181 VDFGL--SAVFENQKKMKERL-GTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 68/308 (22%), Positives = 116/308 (37%), Gaps = 45/308 (14%)
Query: 954 GSAKTFSASEIEKATG-------NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ 1006
GS+ + + ++ T +F +LG G G + + D VAVK +
Sbjct: 2 GSSPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF 61
Query: 1007 QGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAP 1065
EV++L H N+++ + Q + + EL +++ ++ K+ A
Sbjct: 62 SFADR---EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAH 115
Query: 1066 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 1120
LG + + LA+LH S ++HRD K NIL+ +SDFGL +
Sbjct: 116 LGLEPI-TLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCK 171
Query: 1121 SAMDEE-SRHISTRVMGTFGYVAPEY---AMTGHLLVKSDVYSYGVVILELLSGRKPVDM 1176
S + V GT G++APE + D++S G V ++S
Sbjct: 172 KLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--- 228
Query: 1177 TQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAA--IASMCVQPEVQHR 1234
P G+ R+ + SL P +A I M + + Q R
Sbjct: 229 --PFGKSL----------QRQANILLGACSLDCLHPEKHEDVIARELIEKM-IAMDPQKR 275
Query: 1235 PFMGEVVQ 1242
P V++
Sbjct: 276 PSAKHVLK 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-31
Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 22/229 (9%)
Query: 965 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRL 1022
+ G ++ LG GGFG V + D G +VA+K ++ RE E++++ +L
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 1023 HHRNLVKLIGICIEEQAR-------CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKI 1074
+H N+V + + + L E G + +L E+ L +
Sbjct: 70 NHPNVVSAREV-PDGLQKLAPNDLPLLAMEYCEGGDLRKYL--NQFENCCGLKEGPIRTL 126
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHIS 1131
+ AL YLHE+ R+IHRD K NI+L K+ D G A+ E +
Sbjct: 127 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCT 181
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1180
V GT Y+APE V D +S+G + E ++G +P P
Sbjct: 182 EFV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-31
Identities = 52/213 (24%), Positives = 94/213 (44%), Gaps = 22/213 (10%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRN 1026
+ + +GEG FG +DG + +K + R+ + E EV +L+ + H N
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+V+ E + +V + G + ++ ++ D L + AL ++H
Sbjct: 85 IVQYRESFEENGSLYIVMDYCEGGDLFKRIN--AQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE-- 1144
+++HRD KS NI L D T ++ DFG+AR ++ + GT Y++PE
Sbjct: 143 ---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR-VLNSTVELARACI-GTPYYLSPEIC 197
Query: 1145 ----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y KSD+++ G V+ EL + +
Sbjct: 198 ENKPYNN------KSDIWALGCVLYELCTLKHA 224
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 4e-31
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 965 EKATGN--FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLS 1020
++T N + S ILG+G V+ G G A+KV + + E E+L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 1021 RLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIAL 1076
+L+H+N+VKL I EE L+ E P GS+ + L + +A L L +
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLR 119
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEESRHIST 1132
+ +L E+ ++HR+ K NI+ + K++DFG AR D+E +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVS 174
Query: 1133 RVMGTFGYVAPEYAMTGHLLV--------KSDVYSYGVVILELLSGRKP-VDMTQPPGQE 1183
GT Y+ P+ L D++S GV +G P P +
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 1184 NL 1185
+
Sbjct: 234 EV 235
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-31
Identities = 69/223 (30%), Positives = 108/223 (48%), Gaps = 26/223 (11%)
Query: 964 IEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAE 1015
++ +T F R+LG+G FG V G + AVKV+ ++V Q+ +E L E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 1016 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLK 1073
V++L +L H N++KL ++ LV E+ G + + E DA +
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEV-----DAA-R 130
Query: 1074 IALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHI 1130
I + Y+H +++HRD K N+LL D ++ DFGL S E S+ +
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGL--STHFEASKKM 185
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
++ GT Y+APE + G K DV+S GV++ LLSG P
Sbjct: 186 KDKI-GTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 61/216 (28%), Positives = 89/216 (41%), Gaps = 23/216 (10%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 1024
+ R LG+GGF + D A K++ + + RE E+ + L H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1081
+++V G E+ +V EL S+ E +AR
Sbjct: 75 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1140
YLH RVIHRD K N+ L D K+ DFGLA + R +V+ GT Y
Sbjct: 128 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNY 181
Query: 1141 VAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVD 1175
+APE GH + DV+S G ++ LL G+ P +
Sbjct: 182 IAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFE 216
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-30
Identities = 45/231 (19%), Positives = 90/231 (38%), Gaps = 36/231 (15%)
Query: 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA-------------- 1014
++ R L +G F + D A+K ++ + R+F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 1015 ---EVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLG- 1067
E+++++ + + + GI I ++YE + N S+ V ++
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 1068 --WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125
+ I + +Y+H + + HRD K SNIL++ + K+SDFG + +D+
Sbjct: 149 PIQVIK-CIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK 205
Query: 1126 ESRHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVILELLSGRKP 1173
I GT+ ++ PE + K D++S G+ + + P
Sbjct: 206 ---KIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-30
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 20/210 (9%)
Query: 975 RILGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLV 1028
ILG GG V+ VAVKVL+ D F E + + L+H +V
Sbjct: 18 EILGFGGMSEVHLARDLRDHR--DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75
Query: 1029 KL--IGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+ G +V E + ++ +H P+ +++ A +AL +
Sbjct: 76 AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADACQALNF 131
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-RVMGTFGYVAP 1143
H++ +IHRD K +NI++ KV DFG+AR+ D + T V+GT Y++P
Sbjct: 132 SHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 188
Query: 1144 EYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
E A + +SDVYS G V+ E+L+G P
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-30
Identities = 64/233 (27%), Positives = 103/233 (44%), Gaps = 29/233 (12%)
Query: 952 YTGSAKTFSASE-IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQ 1007
++ + + ++ +LG+G FG V + AVKV+ +
Sbjct: 7 HSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 1008 GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDKES 1063
L EVE+L +L H N++KL I + + +V EL G + + ++
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLAR 1120
A + +K + Y+H ++HRD K NILL E D K+ DFGL
Sbjct: 124 ARI-----IKQVFS---GITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGL-- 170
Query: 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
S +++ + R+ GT Y+APE + G K DV+S GV++ LLSG P
Sbjct: 171 STCFQQNTKMKDRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-30
Identities = 32/279 (11%), Positives = 63/279 (22%), Gaps = 43/279 (15%)
Query: 939 DSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVA 997
+A + ++ + T S + + L G +V+ ++ A
Sbjct: 33 PAAMVEAVTATVWPQNAETTVD-SLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFA 91
Query: 998 VKVL---KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC-------------------- 1034
+KV + +RL + +
Sbjct: 92 LKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQL 151
Query: 1035 ------IEEQARCLVYELIP--NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
L+ + S L V G A + R A L
Sbjct: 152 SPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
S ++H F N+ + D + D Y E+
Sbjct: 212 ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFL 263
Query: 1147 MTGHLLV--KSDVYSYGVVILELLSGRKPVDMTQPPGQE 1183
+ + G+ I + P + P +
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 7e-30
Identities = 61/242 (25%), Positives = 99/242 (40%), Gaps = 30/242 (12%)
Query: 965 EKATGN--FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLS 1020
++T N + S ILG+G V+ G G A+KV + + E E+L
Sbjct: 3 SQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLK 62
Query: 1021 RLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHGVDKESA-PLGWDARLKIAL 1076
+L+H+N+VKL I EE L+ E P GS+ + L + +A L L +
Sbjct: 63 KLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVL--EEPSNAYGLPESEFLIVLR 119
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEESRHIST 1132
+ +L E+ ++HR+ K NI+ + K++DFG AR D+E +
Sbjct: 120 DVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE--QFVS 174
Query: 1133 RVMGTFGYVAPEYAMTGHLLV--------KSDVYSYGVVILELLSGRKP-VDMTQPPGQE 1183
GT Y+ P+ L D++S GV +G P P +
Sbjct: 175 LY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK 233
Query: 1184 NL 1185
+
Sbjct: 234 EV 235
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-30
Identities = 47/214 (21%), Positives = 86/214 (40%), Gaps = 24/214 (11%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNL--VKL 1030
+ +G GG V+ + + A+K L+ D Q + E+ L++L + ++L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
I +Q +V E N + S L K+ + R A+ +H+
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL----KKKKSIDPWERKSYWKNMLEAVHTIHQH-- 174
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE------ 1144
++H D K +N L+ D K+ DFG+A + + + +G Y+ PE
Sbjct: 175 -GIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 1145 YAMTGHLLV-----KSDVYSYGVVILELLSGRKP 1173
+ KSDV+S G ++ + G+ P
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-29
Identities = 48/285 (16%), Positives = 87/285 (30%), Gaps = 31/285 (10%)
Query: 911 QAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFS-ASEIEKATG 969
+ P + + L+ SGL +S + + +E + +
Sbjct: 9 GTVDAPNFIVGNPWDDKLIFKLL--SGLSK-PVSSYPNTFEWQCKLPAIKPKTEFQLGSK 65
Query: 970 NFDASRILGEGGFGLVYSGVLDD------GTKVAVKVLKRVDQQGGREFLAEVEMLSRL- 1022
+LGEG F VY D K +KV K + EF +++ RL
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLK 122
Query: 1023 --HHRNLVKLIGICIEEQARCLVYELIPNGSVESHL-HGVDKESAPLGWDARLKIALGAA 1079
+K + + LV EL G++ + + + + + A+
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-----------KVSDFGLARSAMDEESR 1128
+ +H +IH D K N +L + F + D G +
Sbjct: 183 YMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239
Query: 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
I T T G+ E + D + + +L G
Sbjct: 240 TIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 60/235 (25%), Positives = 97/235 (41%), Gaps = 40/235 (17%)
Query: 964 IEKATGNFDA----SRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-------------VD 1005
+ K G R LG G +G V + ++ A+KV+K+
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 1006 QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDK 1061
++ E E+ +L L H N++KL + +++ LV E G + + +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC 146
Query: 1062 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGL 1118
++A I + YLH ++HRD K NILLE+ K+ DFGL
Sbjct: 147 DAA--------NIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ + + R+ GT Y+APE + K DV+S GV++ LL G P
Sbjct: 196 SS--FFSKDYKLRDRL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-29
Identities = 53/205 (25%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 975 RILGEGGFGLVYSG---VLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLV 1028
R++G GG G VY V + VA+K++ D E RL ++V
Sbjct: 40 RLVGRGGMGDVYEAEDTVRER--IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
+ + + LI + + L + PL + I AL H
Sbjct: 98 PIHDFGEIDGQLYVDMRLINGVDLAAML----RRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
HRD K NIL+ D + DFG+A A +E +GT Y+APE
Sbjct: 154 ---GATHRDVKPENILVSADDFAYLVDFGIAS-ATTDEKLTQLGNTVGTLYYMAPERFSE 209
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKP 1173
H ++D+Y+ V+ E L+G P
Sbjct: 210 SHATYRADIYALTCVLYECLTGSPP 234
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 960 SASEIEKAT---GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFL 1013
+ +E+ K +FD R LG+G FG VY + +A+KVL + ++++G L
Sbjct: 2 ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 1014 A-EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDA 1070
E+E+ S L H N++++ + + L+ E P G + L HG E +
Sbjct: 62 RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE-----QRS 116
Query: 1071 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130
+ A AL Y H +VIHRD K N+L+ + K++DFG S R
Sbjct: 117 ATFMEE-LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRR 170
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ GT Y+ PE K D++ GV+ E L G P
Sbjct: 171 TM--CGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 7e-29
Identities = 56/205 (27%), Positives = 86/205 (41%), Gaps = 23/205 (11%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+G G FG V+ G + AVK L+ + E+ + L +V L G
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGA 118
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
E + EL+ GS+ + K+ L D L A L YLH R+
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLI----KQMGCLPEDRALYYLGQALEGLEYLHTR---RI 171
Query: 1094 IHRDFKSSNILLEHDFTP-KVSDFGLA-RSAMDEESRHISTR--VMGTFGYVAPEYAM-T 1148
+H D K+ N+LL D + + DFG A D + + T + GT ++APE M
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKP 1173
K D++S ++L +L+G P
Sbjct: 232 PCDA-KVDIWSSCCMMLHMLNGCHP 255
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 61/214 (28%), Positives = 88/214 (41%), Gaps = 23/214 (10%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE-FLAEVEMLSRLHH 1024
+ R LG+GGF + D A K++ + + RE E+ + L H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIALGAARA 1081
+++V G E+ +V EL S+ E +AR
Sbjct: 101 QHVVGFHG-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE-----PEAR-YYLRQIVLG 153
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1140
YLH RVIHRD K N+ L D K+ DFGLA + R +V+ GT Y
Sbjct: 154 CQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNY 207
Query: 1141 VAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKP 1173
+APE GH + DV+S G ++ LL G+ P
Sbjct: 208 IAPEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPP 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 55/208 (26%), Positives = 80/208 (38%), Gaps = 15/208 (7%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ--QGGREFLAEVEMLSRL-HHR 1025
+F LG G +G V+ +DG AVK + + LAEV ++ H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
V+L E L EL S++ H A L ALA+L
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCE---AWGASLPEAQVWGYLRDTLLALAHL 173
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S ++H D K +NI L K+ DFGL + + G Y+APE
Sbjct: 174 H---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE--VQE-GDPRYMAPEL 227
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ +DV+S G+ ILE+ +
Sbjct: 228 LQGSYGT-AADVFSLGLTILEVACNMEL 254
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-27
Identities = 47/238 (19%), Positives = 89/238 (37%), Gaps = 31/238 (13%)
Query: 975 RILGEGGFGLVYSGVLD---DGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRNLVKL 1030
+ GG G +Y + D +G V +K L + +AE + L+ + H ++V++
Sbjct: 86 GCIAHGGLGWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQI 144
Query: 1031 --IGICIEEQARCLVY---ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ + Y E + S++ L + L AL+YL
Sbjct: 145 FNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYL 198
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H +++ D K NI+L + K+ D G ++ + GT G+ APE
Sbjct: 199 HSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-RINSFGY-----LYGTPGFQAPEI 248
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203
V +D+Y+ G + L + G + P+L + + R++
Sbjct: 249 V-RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG----LPEDDPVLKTYDSYGRLL 301
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-27
Identities = 67/272 (24%), Positives = 107/272 (39%), Gaps = 46/272 (16%)
Query: 931 GLMVGSGLDSASLSFGSSIATYTGSAKTF-----SASEIEKATGNF----DASRILGEGG 981
+VG G L+ S IA K F + + S+ LG G
Sbjct: 89 TELVGKG-KRRPLNNNSEIALSLSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGA 147
Query: 982 FGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
G V KVA++++ + + E+E+L +L+H ++K+
Sbjct: 148 CGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKN 207
Query: 1033 ICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
+ + +V EL+ G V + KE+ + A+ YLHE
Sbjct: 208 F-FDAEDYYIVLELMEGGELFDKVVG---NKRLKEA-----TCK-LYFYQMLLAVQYLHE 257
Query: 1088 DSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
+ +IHRD K N+LL E D K++DFG ++ + E+ + T GT Y+APE
Sbjct: 258 N---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRTLC-GTPTYLAPE 311
Query: 1145 ---YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
T D +S GV++ LSG P
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 116 bits (291), Expect = 2e-27
Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 37/231 (16%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVK 1029
+ +ILG G G V G VAVK + L E+++L+ H N+++
Sbjct: 17 VVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIR 73
Query: 1030 LIGICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
++ + EL N + VES + ++ + A +A+L
Sbjct: 74 YYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPI-SLLRQIASGVAHL 131
Query: 1086 HEDSSPRVIHRDFKSSNILL-------------EHDFTPKVSDFGLARSAMDEES---RH 1129
H S ++IHRD K NIL+ + +SDFGL + +S +
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 1130 ISTRVMGTFGYVAPEYAMTGHLLV-------KSDVYSYGVVILELLSGRKP 1173
++ GT G+ APE + L D++S G V +LS K
Sbjct: 189 LNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 44/229 (19%), Positives = 75/229 (32%), Gaps = 35/229 (15%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRL-HHR 1025
F +G G FG V+ V DG A+K K+ + L EV + L H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
++V+ E+ + E GS+ + + + + L R L Y+
Sbjct: 72 HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131
Query: 1086 HEDSSPRVIHRDFKSSNILLEHD-------------------FTPKVSDFGLARSAMDEE 1126
H S ++H D K SNI + K+ D G +
Sbjct: 132 H---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ 188
Query: 1127 SRHISTRVMGTFGYVAPEYAM--TGHLLVKSDVYSYGVVILELLSGRKP 1173
G ++A E HL K+D+++ + ++
Sbjct: 189 V------EEGDSRFLANEVLQENYTHLP-KADIFALALTVVCAAGAEPL 230
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 5e-27
Identities = 39/280 (13%), Positives = 80/280 (28%), Gaps = 54/280 (19%)
Query: 938 LDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKV 996
+ SA+ S S+ TG SE+ + +LG+ + G
Sbjct: 43 MQSAADSLVSTSLWNTGQPFRV-ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESF 101
Query: 997 AVKVLKRVDQQGGRE----------------------------FLAEVEMLSRLHHRNLV 1028
V V ++ F+ +++ + ++
Sbjct: 102 EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMI 161
Query: 1029 KLIGIC--IEEQARCLVYELI--PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
++ + +R +Y + + L L ARL++ L R LA
Sbjct: 162 RVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLAS 221
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH ++H + +I+L+ ++ F + G+ PE
Sbjct: 222 LH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA------RVVSSVSRGFEPPE 272
Query: 1145 YAMTGHLLV-----------KSDVYSYGVVILELLSGRKP 1173
+ D ++ G+VI + P
Sbjct: 273 LEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 9e-27
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 29/233 (12%)
Query: 954 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGR 1010
G++ S ++ + GN+ + +G+G F V + G +VA+K++ + ++ +
Sbjct: 1 GNSIA-SCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ 59
Query: 1011 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGW 1068
+ EV ++ L+H N+VKL + E+ L+ E G V +L HG KE
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----- 114
Query: 1069 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128
+AR A+ Y H R++HRD K+ N+LL+ D K++DFG S
Sbjct: 115 EAR-SKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGF--SNEFTVGG 168
Query: 1129 HISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
+ G Y APE Y G + DV+S GV++ L+SG P D
Sbjct: 169 KLDAFC-GAPPYAAPELFQGKKYD--GP---EVDVWSLGVILYTLVSGSLPFD 215
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 54/228 (23%), Positives = 94/228 (41%), Gaps = 39/228 (17%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGREFLAEVEML 1019
G + +LGEG +G V + + + AVK+LK+ + +E +++L
Sbjct: 5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKE----IQLL 60
Query: 1020 SRLHHRNLVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 1077
RL H+N+++L+ + E+ + +V E G E +K R +
Sbjct: 61 RRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RFPVC-- 109
Query: 1078 AAR--------ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129
A L YLH S ++H+D K N+LL T K+S G+A + +
Sbjct: 110 QAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADD 166
Query: 1130 ISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKPVD 1175
G+ + PE A K D++S GV + + +G P +
Sbjct: 167 TCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE 214
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-26
Identities = 61/232 (26%), Positives = 91/232 (39%), Gaps = 27/232 (11%)
Query: 953 TGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE 1011
+G + I+ F R LG G FG V+ G + +K + + Q E
Sbjct: 9 SGRENLYFQGTIDD---LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPME 65
Query: 1012 -FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG------SVESHLHGVDKESA 1064
AE+E+L L H N++K+ + + +V E G E
Sbjct: 66 QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG- 124
Query: 1065 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARS 1121
++ ALAY H V+H+D K NIL K+ DFGLA
Sbjct: 125 ----YVA-ELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAE- 175
Query: 1122 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ + H + GT Y+APE + K D++S GVV+ LL+G P
Sbjct: 176 -LFKSDEHSTNAA-GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 3e-26
Identities = 62/225 (27%), Positives = 92/225 (40%), Gaps = 28/225 (12%)
Query: 958 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEV 1016
+ + I K F +LG G F V+ G A+K +K+ E+
Sbjct: 1 SMQTTNIRK---TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEI 57
Query: 1017 EMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDAR 1071
+L ++ H N+V L I LV +L+ G +E GV E DA
Sbjct: 58 AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILE---RGVYTEK-----DAS 109
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESR 1128
+ A+ YLH ++HRD K N+L + ++DFGL++ M++
Sbjct: 110 -LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGI 163
Query: 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ST GT GYVAPE D +S GV+ LL G P
Sbjct: 164 -MSTAC-GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-26
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 24/221 (10%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 1032
R+L EGGF VY + G + A+K L +++ R + EV + +L H N+V+
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 1033 ICI-------EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
QA L+ + G + L + + PL D LKI RA+ ++
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHM 152
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM---------- 1135
H P +IHRD K N+LL + T K+ DFG A + S +
Sbjct: 153 H-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211
Query: 1136 GTFGYVAPE-YAMTGHLLV--KSDVYSYGVVILELLSGRKP 1173
T Y PE + + + K D+++ G ++ L + P
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 63/238 (26%), Positives = 104/238 (43%), Gaps = 39/238 (16%)
Query: 952 YTGSAKTFS-ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQ 1007
++ + + ++ +LG+G FG V + AVKV+ +
Sbjct: 7 HSSGRENLYFQGTFAE---RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK 63
Query: 1008 GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKES 1063
L EVE+L +L H N++KL I + + +V EL G + + ++
Sbjct: 64 DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDA 123
Query: 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLAR 1120
A + +K + Y+H+ + ++HRD K NILLE D K+ DFGL+
Sbjct: 124 ARI-----IKQVFS---GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172
Query: 1121 SAMDEESRHISTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+++ + R+ GT Y+APE Y K DV+S GV++ LLSG P
Sbjct: 173 CF--QQNTKMKDRI-GTAYYIAPEVLRGTYDE------KCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 57/207 (27%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+G G +G V V + A K + + + F E+E++ L H N+++L
Sbjct: 15 NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74
Query: 1034 CIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+ LV EL G V + ++A + +K L A+AY H+
Sbjct: 75 FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-----MKDVLS---AVAYCHKL- 125
Query: 1090 SPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
V HRD K N L D K+ DFGLA + + + T+V GT YV+P+
Sbjct: 126 --NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA--RFKPGKMMRTKV-GTPYYVSPQ-V 179
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ G + D +S GV++ LL G P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-25
Identities = 54/235 (22%), Positives = 98/235 (41%), Gaps = 44/235 (18%)
Query: 958 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGRE 1011
T + + + + LG+G F +V V + G + A + L D Q +
Sbjct: 3 TITCTRFTE---EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---K 56
Query: 1012 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLG 1067
E + L H N+V+L EE L+++L+ G + + + + +++
Sbjct: 57 LEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC- 115
Query: 1068 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMD 1124
++ L A + + H+ V+HR+ K N+LL K++DFGLA ++
Sbjct: 116 ----IQQILEA---VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VE 164
Query: 1125 EESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
E + GT GY++PE Y D+++ GV++ LL G P
Sbjct: 165 GEQQAWFGFA-GTPGYLSPEVLRKDPYGK------PVDLWACGVILYILLVGYPP 212
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 38/239 (15%)
Query: 956 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQ 1006
+ S + N++ ILG G +V + + AVK++ +
Sbjct: 7 PGSHSTHGFYE---NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63
Query: 1007 QGGREFLA-EVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVD 1060
Q RE EV++L ++ H N+++L LV++L+ G + + +
Sbjct: 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123
Query: 1061 KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120
KE+ + ++ L + LH+ ++HRD K NILL+ D K++DFG +
Sbjct: 124 KETRKI-----MRALLEV---ICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 172
Query: 1121 SAMDEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ + GT Y+APE + D++S GV++ LL+G P
Sbjct: 173 --QLDPGEKLREVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 1e-24
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 38/225 (16%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGRE------FLAEVEMLS 1020
+ S+ LG G G V KVA+K++ ++ RE E+E+L
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIA 1075
+L+H ++K+ + + +V EL+ G V + KE+ +
Sbjct: 71 KLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVG---NKRLKEA-----TCK-LYF 120
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHIST 1132
A+ YLHE+ +IHRD K N+LL D K++DFG ++ + E+ + T
Sbjct: 121 YQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSK--ILGETSLMRT 175
Query: 1133 RVMGTFGYVAPE----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT Y+APE G+ D +S GV++ LSG P
Sbjct: 176 LC-GTPTYLAPEVLVSVGTAGYNR-AVDCWSLGVILFICLSGYPP 218
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 1e-24
Identities = 58/270 (21%), Positives = 101/270 (37%), Gaps = 65/270 (24%)
Query: 959 FSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREF 1012
F + + + +G+G +G+V + A+K+ +++++ +
Sbjct: 16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 1013 LAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS----VESHLHGVDKESAPLGW 1068
EV ++ +LHH N+ +L + +EQ CLV EL G + + + A
Sbjct: 76 KTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVV 135
Query: 1069 DARLKIALG-------------------------AAR-------ALAYLHEDSSPRVIHR 1096
++ + AL YLH + + HR
Sbjct: 136 KTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHR 192
Query: 1097 DFKSSNILLEHD--FTPKVSDFGLAR---SAMDEESRHISTRVMGTFGYVAPE------- 1144
D K N L + F K+ DFGL++ + E ++T+ GT +VAPE
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNE 251
Query: 1145 -YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y K D +S GV++ LL G P
Sbjct: 252 SYGP------KCDAWSAGVLLHLLLMGAVP 275
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 29/237 (12%), Positives = 64/237 (27%), Gaps = 42/237 (17%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE---------------------- 1011
+LG+ + G V V ++
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 1012 ------FLAEVEMLSRLHHRNLVKLI--GICIEEQARCLVYELI--PNGSVESHLHGVDK 1061
F+ +++ + ++++ + +R +Y + + L
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 1062 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121
L ARL++ L R LA LH ++H + +I+L+ ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV- 259
Query: 1122 AMDEESRHISTRVMGTFGYVAPE-----YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ R A + D ++ G+ I + P
Sbjct: 260 RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 1026
++D + LGEG +G V V VAVK++ E + E+ + L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 1027 LVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALGAA 1079
+VK G E L E G + + E DA+ +A
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---- 116
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
+ YLH + HRD K N+LL+ K+SDFGLA + ++ GT
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 1140 YVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
YVAPE + DV+S G+V+ +L+G P D
Sbjct: 173 YVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 14/209 (6%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
++ LG+G FG VY + G A KV++ ++ +++ E+E+L+ H +VK
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L+G + ++ E P G+V++ + +D+ L + AL +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNFLHSK- 136
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
R+IHRD K+ N+L+ + +++DFG++ + + S +GT ++APE M
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMCE 192
Query: 1150 HLL-----VKSDVYSYGVVILELLSGRKP 1173
+ K+D++S G+ ++E+ P
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 54/234 (23%), Positives = 87/234 (37%), Gaps = 26/234 (11%)
Query: 952 YTGSAKTFSASEIEKATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQ 1006
Y K + +E G+ D LG G FG+V+ V G K +
Sbjct: 30 YEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP 89
Query: 1007 QGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDK 1061
E+ ++++LHH L+ L ++ L+ E + G +
Sbjct: 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA 149
Query: 1062 ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLA 1119
E ++ A L ++HE ++H D K NI+ E K+ DFGLA
Sbjct: 150 EVINY-----MRQACEG---LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLA 198
Query: 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+E I T + APE + +D+++ GV+ LLSG P
Sbjct: 199 TKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 64/216 (29%), Positives = 94/216 (43%), Gaps = 28/216 (12%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGI 1033
+LGEG V + + L + AVK++++ EVEML + HRN+++LI
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF 79
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDK--ESAPLGWDARLKIALGAARALAYLHEDSSP 1091
EE LV+E + GS+ SH+H E +A + A AL +LH +
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVASALDFLH---NK 130
Query: 1092 RVIHRDFKSSNILLEH---DFTPKVSDFGLAR------SAMDEESRHISTRVMGTFGYVA 1142
+ HRD K NIL EH K+ DF L + + T G+ Y+A
Sbjct: 131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAEYMA 189
Query: 1143 PEYAMTGHLLVKS-----DVYSYGVVILELLSGRKP 1173
PE D++S GV++ LLSG P
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-24
Identities = 46/219 (21%), Positives = 82/219 (37%), Gaps = 27/219 (12%)
Query: 965 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVEMLSR 1021
++ + + LG G FG+V+ V K + K DQ E+ +L+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIAL 1076
HRN++ L + +++E I S ++E +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY-----VHQVC 112
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTRV 1134
A L +LH + + H D + NI+ + + K+ +FG AR + +
Sbjct: 113 EA---LQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQAR--QLKPGDNFRLLF 164
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
Y APE + +D++S G ++ LLSG P
Sbjct: 165 -TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-24
Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 13/204 (6%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEM-LSRLHHRNLVKLIGI 1033
LG G +G+V + G +AVK ++ V+ Q + L ++++ + + V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
E + EL+ + S++ V + + D KIA+ +AL +LH V
Sbjct: 75 LFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SV 131
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE----YAMTG 1149
IHRD K SN+L+ K+ DFG++ +D+ ++ G Y+APE
Sbjct: 132 IHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCKPYMAPERINPELNQK 188
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
VKSD++S G+ ++EL R P
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFP 212
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-24
Identities = 51/233 (21%), Positives = 102/233 (43%), Gaps = 43/233 (18%)
Query: 961 ASEIEKATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAE 1015
++ + + F + +G G + + + + AVK++ + ++ E E
Sbjct: 10 VQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTE---E 65
Query: 1016 VEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDK----ESAPLGWDA 1070
+E+L R H N++ L + + + +V EL+ G + + + + E +A
Sbjct: 66 IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKI--LRQKFFSER-----EA 118
Query: 1071 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL----EHDFTPKVSDFGLARSAMDEE 1126
+ + + YLH + V+HRD K SNIL + + ++ DFG A+ + E
Sbjct: 119 S-AVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ-LRAE 173
Query: 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVILELLSGRKP 1173
+ + T T +VAPE +L + D++S GV++ +L+G P
Sbjct: 174 NGLLMTPC-YTANFVAPE------VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-24
Identities = 56/280 (20%), Positives = 98/280 (35%), Gaps = 26/280 (9%)
Query: 906 KSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIE 965
+S C+ + G G + + K + +E
Sbjct: 90 QSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE 149
Query: 966 KATGNF----DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLS 1020
+ D LG G FG+V+ G A K + + E++ +S
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMS 209
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIA 1075
L H LV L ++ ++YE + G + H + E+ ++
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY-----MRQV 264
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTR 1133
L ++HE++ +H D K NI+ + K+ DFGL + + +
Sbjct: 265 CK---GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTA--HLDPKQSVKVT 316
Query: 1134 VMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT + APE A + +D++S GV+ LLSG P
Sbjct: 317 T-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 29/218 (13%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREFLA-EVEMLSRLH 1023
+D LG G F +V G + A K K + RE + EV +L +
Sbjct: 13 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAA 1079
H N++ L + + L+ EL+ G + ++E+ LK L
Sbjct: 73 HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF-----LKQILNG- 126
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRVM 1135
+ YLH + H D K NI+L P K+ DFGLA +D + +
Sbjct: 127 --VYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK-IDFGNEF--KNIF 178
Query: 1136 GTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 179 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 9e-24
Identities = 57/258 (22%), Positives = 107/258 (41%), Gaps = 12/258 (4%)
Query: 971 FDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLV 1028
F+ LG G G+V+ G +A K++ + + + E+++L + +V
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
G + + E + GS++ L K++ + K+++ + L YL E
Sbjct: 95 GFYGAFYSDGEISICMEHMDGGSLDQVL----KKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
+++HRD K SNIL+ K+ DFG++ +D + + V GT Y++PE
Sbjct: 151 H--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFV-GTRSYMSPERLQG 204
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208
H V+SD++S G+ ++E+ GR P+ E + +
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264
Query: 1209 NDVPFDSVAKVAAIASMC 1226
N DS +A +
Sbjct: 265 NKFGMDSRPPMAIFELLD 282
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 57/229 (24%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 961 ASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLAEVE 1017
+++ N+D LG+G F +V V G + A K++ K++ + ++ E
Sbjct: 1 STKFSD---NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR 57
Query: 1018 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLK 1073
+ +L H N+V+L EE LV++L+ G + + + +++ ++
Sbjct: 58 ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-----IQ 112
Query: 1074 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHI 1130
L + +AY H S ++HR+ K N+LL K++DFGLA D E+
Sbjct: 113 QILES---IAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA--W 164
Query: 1131 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT GY++PE Y+ D+++ GV++ LL G P
Sbjct: 165 HGFA-GTPGYLSPEVLKKDPYSK------PVDIWACGVILYILLVGYPP 206
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 59/219 (26%), Positives = 88/219 (40%), Gaps = 29/219 (13%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRL 1022
+++ LG G F +V G + A K +K+ R E EV +L +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGA 1078
H N++ L I + L+ EL+ G + + E+ LK L
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF-----LKQILDG 120
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRV 1134
+ YLH R+ H D K NI+L P K+ DFG+A E
Sbjct: 121 ---VHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 172
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-23
Identities = 47/214 (21%), Positives = 75/214 (35%), Gaps = 31/214 (14%)
Query: 978 GEGGFGLVYSGV-LDDGTKVAVKV--LKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
G V G V V+ L+ + E+ + +H N+V
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 1035 IEEQARCLVYELIPNGSV----ESHLHGVDKESAPLGWDARLKIAL---GAARALAYLHE 1087
I + +V + GS +H E A IA G +AL Y+H
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELA---------IAYILQGVLKALDYIHH 146
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH-----ISTRVMGTFGYVA 1142
+HR K+S+IL+ D +S S + R + +++
Sbjct: 147 M---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 1143 PEYAMTGHLL---VKSDVYSYGVVILELLSGRKP 1173
PE + +L KSD+YS G+ EL +G P
Sbjct: 204 PE-VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-23
Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 37/215 (17%)
Query: 974 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 1031
+ LGEG F + V AVK++ + + ++ E+ L H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72
Query: 1032 GICIEEQARCLVYELIPNGSVESHLHGVDK----ESAPLGWDARLKIALGAARALAYLHE 1087
+ ++ LV EL+ G + + K E+ +A I A++++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERI--KKKKHFSET-----EAS-YIMRKLVSAVSHMH- 123
Query: 1088 DSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
V+HRD K N+L + K+ DFG AR +++ + T T Y APE
Sbjct: 124 --DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPC-FTLHYAAPE 179
Query: 1145 YAMTGHLLVKS------DVYSYGVVILELLSGRKP 1173
LL ++ D++S GV++ +LSG+ P
Sbjct: 180 ------LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 62/249 (24%), Positives = 111/249 (44%), Gaps = 41/249 (16%)
Query: 946 GSSIATYTGSAKTFSASE-IEKATGNFDAS----RILGEGGFGLVYSGV-LDDGTKVAVK 999
G +A+ TG + SE + A+ F + LG+G F +V V G + A K
Sbjct: 1 GPHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK 60
Query: 1000 VL--KRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVE 1053
++ K++ + ++ E + +L H N+V+L EE LV++L+ G +
Sbjct: 61 IINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120
Query: 1054 SHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFT 1110
+ + +++ ++ L + +AY H + ++HR+ K N+LL
Sbjct: 121 AREFYSEADASHC-----IQQILES---IAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVI 1164
K++DFGLA +S GT GY++PE +L K D+++ GV++
Sbjct: 170 VKLADFGLAI--EVNDSEAWHGFA-GTPGYLSPE------VLKKDPYSKPVDIWACGVIL 220
Query: 1165 LELLSGRKP 1173
LL G P
Sbjct: 221 YILLVGYPP 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 2e-23
Identities = 63/238 (26%), Positives = 97/238 (40%), Gaps = 43/238 (18%)
Query: 960 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--------VDQQGGR 1010
A+ + + + LG G FG V++ V + +V VK +K+ ++
Sbjct: 15 LAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLG 74
Query: 1011 EFLAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGS------VESHLHGVDKES 1063
+ E+ +LSR+ H N++K++ I E Q LV E +G H E
Sbjct: 75 KVTLEIAILSRVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEP 130
Query: 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123
A I A+ YL +IHRD K NI++ DFT K+ DFG +A
Sbjct: 131 -----LAS-YIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGS--AAY 179
Query: 1124 DEESRHISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
E + T GT Y APE Y G + +++S GV + L+ P
Sbjct: 180 LERGKLFYTFC-GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEENPFC 231
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-23
Identities = 61/222 (27%), Positives = 90/222 (40%), Gaps = 34/222 (15%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA-EVEMLSRLHHRN 1026
++D + LGEG +G V V VAVK++ E + E+ + L+H N
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 66
Query: 1027 LVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALGAA 1079
+VK G E L E G + + E DA+ +A
Sbjct: 67 VVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPEP-----DAQRFFHQLMA---- 116
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFG 1139
+ YLH + HRD K N+LL+ K+SDFGLA + ++ GT
Sbjct: 117 -GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLP 172
Query: 1140 YVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
YVAPE + DV+S G+V+ +L+G P D
Sbjct: 173 YVAPELLKRREFH--AE---PVDVWSCGIVLTAMLAGELPWD 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 2e-23
Identities = 58/232 (25%), Positives = 95/232 (40%), Gaps = 32/232 (13%)
Query: 957 KTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGR 1010
+ F ++E +D LG G F +V G + A K + + R
Sbjct: 3 EPFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSR 59
Query: 1011 EFLA-EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAP 1065
E + EV +L ++ H N++ L + L+ EL+ G + ++E+
Sbjct: 60 EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 1066 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARS 1121
+K L + YLH + H D K NI+L P K+ DFGLA
Sbjct: 120 F-----IKQILDG---VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168
Query: 1122 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+++ + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 169 -IEDGVEF--KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 65/233 (27%), Positives = 97/233 (41%), Gaps = 21/233 (9%)
Query: 954 GSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF 1012
S S + G F+ ++G G +G VY G + G A+KV+ V E
Sbjct: 9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEI 67
Query: 1013 LAEVEMLSRL-HHRNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAP 1065
E+ ML + HHRN+ G I++ LV E GSV + +
Sbjct: 68 KQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLK 127
Query: 1066 LGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125
W A I R L++LH +VIHRD K N+LL + K+ DFG++
Sbjct: 128 EEWIA--YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT 182
Query: 1126 ESRHISTRVMGTFGYVAPEYAMTGHLL-----VKSDVYSYGVVILELLSGRKP 1173
R + +GT ++APE KSD++S G+ +E+ G P
Sbjct: 183 VGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 51/204 (25%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ +G+G G VY+ + + G +VA++ + Q + E+ ++ + N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+ + +V E + GS+ + + + +AL +LH
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLH--- 133
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
S +VIHRD KS NILL D + K++DFG E+S+ + ++GT ++APE
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAPEVVTRK 191
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
K D++S G++ +E++ G P
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 36/233 (15%)
Query: 958 TFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGRE 1011
TF ++E +D LG G F +V G + A K + + RE
Sbjct: 4 TFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCRE 60
Query: 1012 FL-AEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSV------ESHLHGVDKESA 1064
+ EV +L ++ H N++ L + L+ EL+ G + + L ++E+
Sbjct: 61 EIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLS--EEEAT 118
Query: 1065 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLAR 1120
+K L + YLH + H D K NI+L P K+ DFGLA
Sbjct: 119 SF-----IKQILDG---VNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167
Query: 1121 SAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
E + GT +VAPE L +++D++S GV+ LLSG P
Sbjct: 168 E---IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 5e-23
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 23/215 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLK--RVDQQGGREF-LAEVEMLSRLHHR 1025
F R+LG GGFG V++ + K+ A K L R+ ++ G + + E ++L+++H R
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 1026 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWD-ARL---KIALGAAR 1080
+V L E + CLV ++ G + H++ VD+++ A +I
Sbjct: 246 FIVSLAY-AFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVS---- 300
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L +LH+ +I+RD K N+LL+ D ++SD GLA +++ GT G+
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYA-GTPGF 355
Query: 1141 VAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
+APE + S D ++ GV + E+++ R P
Sbjct: 356 MAPELLLGEEY--DFSVDYFALGVTLYEMIAARGP 388
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 5e-23
Identities = 64/294 (21%), Positives = 108/294 (36%), Gaps = 36/294 (12%)
Query: 905 YKSHACQAEEVPQSLQTSHVKPSGA--------------AGLMVGSGLDSASLSFGSSIA 950
+ H+ + ++L +K SG + + + S +
Sbjct: 5 HHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAV 64
Query: 951 TYTGSAKTFSASEIEKATGNF------DASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR 1003
F + G + ILG G FG V+ G K+A K++K
Sbjct: 65 DIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKT 124
Query: 1004 VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES 1063
+ E E+ ++++L H NL++L + LV E + G E +D+
Sbjct: 125 RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG--ELFDRIIDESY 182
Query: 1064 APLGWDAR--LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLA 1119
D +K + ++H ++H D K NIL + K+ DFGLA
Sbjct: 183 NLTELDTILFMKQICE---GIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLA 236
Query: 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
R E + GT ++APE + +D++S GV+ LLSG P
Sbjct: 237 RRYKPREK--LKVNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 66/224 (29%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 1024
G++ LG G FG V G G KVAVK+L R + + E++ L H
Sbjct: 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH 70
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 1077
+++KL + I +V E + G + ++ HG +E +AR ++
Sbjct: 71 PHIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM-----EARRLFQQILS-- 122
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
A+ Y H V+HRD K N+LL+ K++DFGL S M + + T G+
Sbjct: 123 ---AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSC-GS 173
Query: 1138 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
Y APE YA G + D++S GV++ LL G P D
Sbjct: 174 PNYAAPEVISGRLYA--GP---EVDIWSCGVILYALLCGTLPFD 212
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-23
Identities = 55/204 (26%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
D+ +GEG G+V G +VAVK++ QQ EV ++ H N+V+
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+ + + ++ E + G++ + L + + +ALAYLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLH--- 158
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
+ VIHRD KS +ILL D K+SDFG + + S ++GT ++APE
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGTPYWMAPEVISRS 216
Query: 1150 HLLVKSDVYSYGVVILELLSGRKP 1173
+ D++S G++++E++ G P
Sbjct: 217 LYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-23
Identities = 53/223 (23%), Positives = 90/223 (40%), Gaps = 36/223 (16%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKV-----LKRVDQQGGREFLAEVEMLSRLHH 1024
++ ++G+G F +V + + G + AVK+ + E + L H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNG------SVESHLHGVDKESAPLGWDAR--LKIAL 1076
++V+L+ + +V+E + + V E+ A ++ L
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA-----VASHYMRQIL 140
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTR 1133
AL Y H++ +IHRD K +LL E+ K+ FG+A + E R
Sbjct: 141 E---ALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ-LGESGLVAGGR 193
Query: 1134 VMGTFGYVAPE---YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
V GT ++APE G DV+ GV++ LLSG P
Sbjct: 194 V-GTPHFMAPEVVKREPYGK---PVDVWGCGVILFILLSGCLP 232
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-23
Identities = 67/209 (32%), Positives = 93/209 (44%), Gaps = 28/209 (13%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
LG G +VY A+KVL K VD++ R E+ +L RL H N++KL
Sbjct: 59 SELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRT---EIGVLLRLSHPNIIKLKE 115
Query: 1033 ICIEEQARCLVYELIPNGS-----VESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
I LV EL+ G VE G E DA A+AYLHE
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVE---KGYYSER-----DAA-DAVKQILEAVAYLHE 166
Query: 1088 DSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
+ ++HRD K N+L D K++DFGL++ + E + T GT GY APE
Sbjct: 167 N---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK--IVEHQVLMKTVC-GTPGYCAPE 220
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ D++S G++ LL G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-22
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRN 1026
FD LGEG +G VY + + G VA+K + +E + E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL--QEIIKEISIMQQCDSPH 85
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+VK G + +V E GSV + +K L D I + L YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLH 142
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
R IHRD K+ NILL + K++DFG+A D ++ + V+GT ++APE
Sbjct: 143 ---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVI 197
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
+D++S G+ +E+ G+ P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 1e-22
Identities = 54/237 (22%), Positives = 92/237 (38%), Gaps = 32/237 (13%)
Query: 955 SAKTFSASEIEKATGNFD-----ASRILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQ 1007
+ + ++ NF+ S+ LG G F +V + G + A K L KR Q
Sbjct: 10 GVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ 69
Query: 1008 GGRE-FLAEVEMLSRL-HHRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDK 1061
R L E+ +L ++ L + L+ E G L +
Sbjct: 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVS 129
Query: 1062 ESAPLGWDAR--LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDF 1116
E+ D +K L + YLH++ ++H D K NILL K+ DF
Sbjct: 130 EN-----DVIRLIKQILEG---VYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
G++R + + + GT Y+APE + +D+++ G++ LL+ P
Sbjct: 179 GMSR--KIGHACELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 24/211 (11%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR--EFLAEVEMLSRLHHRNL 1027
F +G+G FG V+ G+ VA+K++ +++ + E+ +LS+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID-LEEAEDEIEDIQQEITVLSQCDSPYV 82
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL---GAARAL 1082
K G +++ ++ E + GS L G E+ +IA + L
Sbjct: 83 TKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPGPLDET---------QIATILREILKGL 132
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
YLH + + IHRD K++N+LL K++DFG+A D + + + +GT ++A
Sbjct: 133 DYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMA 187
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
PE K+D++S G+ +EL G P
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 43/231 (18%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEM 1018
I + +D + +G G FG+ VAVK ++R +D+ RE +
Sbjct: 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IIN 69
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLK--- 1073
L H N+V+ + + ++ E G + + G E +AR
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-----EARFFFQQ 124
Query: 1074 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHI 1130
++ ++Y H S ++ HRD K N LL+ P K+ DFG ++S++
Sbjct: 125 LLS-----GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 175
Query: 1131 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
+ V GT Y+APE Y G +DV+S GV + +L G P +
Sbjct: 176 -STV-GTPAYIAPEVLLRQEYD--GK---IADVWSCGVTLYVMLVGAYPFE 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 58/248 (23%), Positives = 103/248 (41%), Gaps = 60/248 (24%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVL--KRVDQQGGREFLA----------- 1014
+ +G+G +G+V +D T A+KVL K++ +Q G
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 1015 -------------EVEMLSRLHHRNLVKLIGICIEEQAR---CLVYELIPNGSVESHLHG 1058
E+ +L +L H N+VKL+ + +++ +V+EL+ G V
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPV------ 125
Query: 1059 VDKESAPLGWDARLKIALGAAR--------ALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110
++ + L AR + YLH ++IHRD K SN+L+ D
Sbjct: 126 MEVPTLK-----PLSEDQ--ARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGH 175
Query: 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV---KSDVYSYGVVILEL 1167
K++DFG+ S + S + + +GT ++APE + DV++ GV +
Sbjct: 176 IKIADFGV--SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 1168 LSGRKPVD 1175
+ G+ P
Sbjct: 234 VFGQCPFM 241
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-21
Identities = 67/218 (30%), Positives = 97/218 (44%), Gaps = 31/218 (14%)
Query: 970 NFDASRILGEGGFGLVYSG-VLDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH-- 1023
+F RI+G GGFG VY D G A+K L + +QG L E MLS +
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 1024 -HRNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIAL 1076
+V + + + +L+ G + HL HGV E+ D R +I L
Sbjct: 250 DCPFIVCMSY-AFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-----DMRFYAAEIIL 303
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1136
L ++H V++RD K +NILL+ ++SD GLA ++ V G
Sbjct: 304 ----GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASV-G 352
Query: 1137 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
T GY+APE G S D +S G ++ +LL G P
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-21
Identities = 61/224 (27%), Positives = 95/224 (42%), Gaps = 40/224 (17%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 1024
G + LGEG FG V KVA+K + R + + + E+ L L H
Sbjct: 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH 68
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 1077
+++KL + I +V E G + ++ E + R I
Sbjct: 69 PHIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED-----EGRRFFQQIIC-- 119
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
A+ Y H +++HRD K N+LL+ + K++DFGL S + + + T G+
Sbjct: 120 ---AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGL--SNIMTDGNFLKTSC-GS 170
Query: 1138 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
Y APE YA G + DV+S G+V+ +L GR P D
Sbjct: 171 PNYAAPEVINGKLYA--GP---EVDVWSCGIVLYVMLVGRLPFD 209
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 2e-21
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 12/211 (5%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRL-HHRNLVKLIGI 1033
+G G +G V V G +AVK ++ VD++ ++ L +++++ R +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
E + EL+ + + + + + KI L +AL +L E+ ++
Sbjct: 90 LFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KI 147
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1152
IHRD K SNILL+ K+ DFG++ +D ++ TR G Y+APE
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSASRQ 204
Query: 1153 ---VKSDVYSYGVVILELLSGRKPVDMTQPP 1180
V+SDV+S G+ + EL +GR P
Sbjct: 205 GYDVRSDVWSLGITLYELATGRFPYPKWNSV 235
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 53/217 (24%), Positives = 86/217 (39%), Gaps = 33/217 (15%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGG--REF---------LAEVEMLSRLH 1023
R + G +G V +GV +G VA+K + G L E+ +L+ H
Sbjct: 28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87
Query: 1024 HRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALG 1077
H N++ L I + + LV EL+ + L V + + ++
Sbjct: 88 HPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYH 142
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRVM 1135
L LH V+HRD NILL + + DF LAR + + +++ R
Sbjct: 143 ILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW- 198
Query: 1136 GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
Y APE M K D++S G V+ E+ + +
Sbjct: 199 ----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 4e-21
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLA-EVEMLSRLHH 1024
G++ LG G FG V G G KVAVK+L R + + E++ L H
Sbjct: 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH 75
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHL--HGVDKESAPLGWDARLK----IALG 1077
+++KL + I + +V E + G + ++ +G E ++R ++
Sbjct: 76 PHIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK-----ESRRLFQQILS-- 127
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
+ Y H V+HRD K N+LL+ K++DFGL S M + + T G+
Sbjct: 128 ---GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGL--SNMMSDGEFLRTSC-GS 178
Query: 1138 FGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
Y APE YA G + D++S GV++ LL G P D
Sbjct: 179 PNYAAPEVISGRLYA--G---PEVDIWSSGVILYALLCGTLPFD 217
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 6e-21
Identities = 61/286 (21%), Positives = 116/286 (40%), Gaps = 37/286 (12%)
Query: 911 QAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATG- 969
E+ +++ PS +A L+ + + + G+ + + A
Sbjct: 33 NREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEF 92
Query: 970 --NFDASRILGEGGFGLVYSGV-LDDGTKVAVKV-------LKRVDQQGGREFLA-EVEM 1018
+D ++G G +V V G + AVK+ L + RE E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 1019 LSRLH-HRNLVKLIGICIEEQARCLVYELIPNG----SVESHLHGVDKESAPLGWDARLK 1073
L ++ H +++ LI LV++L+ G + + +KE+ + ++
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSI-----MR 207
Query: 1074 IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR 1133
L A +++LH + ++HRD K NILL+ + ++SDFG + E +
Sbjct: 208 SLLEA---VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSC--HLEPGEKLREL 259
Query: 1134 VMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
GT GY+APE + D+++ GV++ LL+G P
Sbjct: 260 C-GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 6e-21
Identities = 61/255 (23%), Positives = 101/255 (39%), Gaps = 38/255 (14%)
Query: 933 MVGSGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-D 991
M G+ + + A + +F +ILGEG F V
Sbjct: 1 MDGTAAEPRPGAGSLQHAQPPPQPRKKRPE-------DFKFGKILGEGSFSTVVLARELA 53
Query: 992 DGTKVAVKVLK-----RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046
+ A+K+L+ + ++ E +++SRL H VKL +++
Sbjct: 54 TSREYAIKILEKRHIIKENKV--PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 111
Query: 1047 IPNGSVESHLHGVDKESAPLGWDARL---KIALGAARALAYLHEDSSPRVIHRDFKSSNI 1103
NG + ++ + R +I AL YLH +IHRD K NI
Sbjct: 112 AKNGELLKYIRKIGSFDET---CTRFYTAEIVS----ALEYLHGKG---IIHRDLKPENI 161
Query: 1104 LLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK-----SDVY 1158
LL D +++DFG A+ E + + +GT YV+PE L K SD++
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-----LTEKSACKSSDLW 216
Query: 1159 SYGVVILELLSGRKP 1173
+ G +I +L++G P
Sbjct: 217 ALGCIIYQLVAGLPP 231
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 8e-21
Identities = 58/206 (28%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
+GEG +G+V+ D G VA+K + + +A E+ ML +L H NLV L+ +
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
++ LV+E + + D+ + I +A+ + H
Sbjct: 71 FRRKRRLHLVFEY-----CDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCH---KHN 122
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
IHRD K NIL+ K+ DFG AR + S + V T Y +PE LL
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFAR-LLTGPSDYYDDEVA-TRWYRSPE------LL 174
Query: 1153 VKSDVYSYGV-------VILELLSGR 1171
V Y V V ELLSG
Sbjct: 175 VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 9e-21
Identities = 66/256 (25%), Positives = 99/256 (38%), Gaps = 58/256 (22%)
Query: 946 GSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVK--VLK 1002
S+ + +A S K F R+ G+G FG V G G VA+K +
Sbjct: 2 PGSMMSLNAAAAADERSR--KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD 59
Query: 1003 RVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR-------CLVYELIPNGSVESH 1055
+ RE L ++ L+ LHH N+V+L R +V E +P
Sbjct: 60 PRFRN--RE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DT 111
Query: 1056 LHGVDKESAPLGWDARLKIALGAA----------RALAYLHEDSSPRVIHRDFKSSNILL 1105
LH + R ++A R++ LH S V HRD K N+L+
Sbjct: 112 LHRCCRNYY------RRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLV 164
Query: 1106 -EHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKS------- 1155
E D T K+ DFG A+ E +I +R Y APE L+ +
Sbjct: 165 NEADGTLKLCDFGSAKKLSPSEPNVAYICSRY-----YRAPE------LIFGNQHYTTAV 213
Query: 1156 DVYSYGVVILELLSGR 1171
D++S G + E++ G
Sbjct: 214 DIWSVGCIFAEMMLGE 229
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-21
Identities = 56/206 (27%), Positives = 85/206 (41%), Gaps = 27/206 (13%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
+GEG +G+V D G VA+K D + +A E+++L +L H NLV L+ +
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
C +++ LV+E V+ + + L + K + + H S
Sbjct: 93 CKKKKRWYLVFEF-----VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCH---SHN 144
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL 1152
+IHRD K NIL+ K+ DFG AR + V T Y APE LL
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFAR-TLAAPGEVYDDEVA-TRWYRAPE------LL 196
Query: 1153 VKSDVYSYGV-------VILELLSGR 1171
V Y V ++ E+ G
Sbjct: 197 VGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 57/272 (20%), Positives = 97/272 (35%), Gaps = 51/272 (18%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 1031
++G G +G VY + VA+K + R+ D + L E+ +L+RL +++L
Sbjct: 32 HLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLY 91
Query: 1032 GICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYL 1085
+ I + +V E+ +S L + K L + +K I ++
Sbjct: 92 DLIIPDDLLKFDELYIVLEI-----ADSDLKKLFKTPIFLT-EEHIKTILYNLLLGENFI 145
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H +IHRD K +N LL D + KV DFGLAR+ E+ +I +
Sbjct: 146 H---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 1146 A----MTGH----------LLVKSDVYSYGV----V--IL-ELLSGRKPVDMTQP----- 1179
+T H L++ + Y+ + I ELL+ +
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 1180 -PGQENLVAWARPLLTSREG------LERIID 1204
PG L I +
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 1e-20
Identities = 49/271 (18%), Positives = 91/271 (33%), Gaps = 79/271 (29%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVA-------------------VKVLKRVDQQG- 1008
+F+ + +G GGFG+V+ D A VK L +++ G
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGI 66
Query: 1009 --------------------------------------GREFLAEVEMLSRLHHRNLVKL 1030
++ + +N V
Sbjct: 67 VRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQ 126
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLH---GVDKESAPLGWDARLKIALGAARALAYLHE 1087
+ + + +L +++ ++ ++ + ++IA + +LH
Sbjct: 127 LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA----VEFLH- 181
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH----------ISTRVMGT 1137
S ++HRD K SNI D KV DFGL + +E T +GT
Sbjct: 182 --SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239
Query: 1138 FGYVAPEYAMTGHLLVKSDVYSYGVVILELL 1168
Y++PE + K D++S G+++ ELL
Sbjct: 240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-20
Identities = 63/211 (29%), Positives = 106/211 (50%), Gaps = 18/211 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKV-AVKVLK--RVDQQGGREF-LAEVEMLSRLHHR 1025
F R+LG+GGFG V + + K+ A K L+ R+ ++ G L E ++L +++ R
Sbjct: 185 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSR 244
Query: 1026 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+V L E + CLV L+ G ++ H++ + + P A A L
Sbjct: 245 FVVSLAY-AYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA-RAVFYAA-EICCGLED 301
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH + R+++RD K NILL+ ++SD GLA + ++ I RV GT GY+APE
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYMAPE 355
Query: 1145 -YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
+ S D ++ G ++ E+++G+ P
Sbjct: 356 VVKNERY--TFSPDWWALGCLLYEMIAGQSP 384
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 1e-20
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 27/208 (12%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+G G +G V S + G KVA+K L R + + E+ +L + H N++ L+
Sbjct: 30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLL 89
Query: 1032 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAY 1084
+ + LV + ++ L + + +++ + + L Y
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMG--LKFS-EEKIQYLVYQMLKGLKY 141
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
+H S V+HRD K N+ + D K+ DFGLAR A E + ++ TR Y APE
Sbjct: 142 IH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----YRAPE 193
Query: 1145 YAMTGHLLVKS-DVYSYGVVILELLSGR 1171
++ ++ D++S G ++ E+L+G+
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 2e-20
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 1026
++ +GEG +G V+ + VA+K ++ D G A E+ +L L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYL 1085
+V+L + ++ LV+E + L D + L + + L +
Sbjct: 63 IVRLHDVLHSDKKLTLVFEF-----CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S V+HRD K N+L+ + K+++FGLAR A R S V+ T Y P+
Sbjct: 118 H---SRNVLHRDLKPQNLLINRNGELKLANFGLAR-AFGIPVRCYSAEVV-TLWYRPPD- 171
Query: 1146 AMTGHLLVKSDVYSYGV-------VILELLSGRKP 1173
+L + +YS + + EL + +P
Sbjct: 172 -----VLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-20
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 24/207 (11%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 31 KPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLL 90
Query: 1032 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALAY 1084
+ +++ +V EL+ +++L V + L R+ L + +
Sbjct: 91 NVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQ--MEL-DHERMSYLLYQMLCGIKH 142
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH S +IHRD K SNI+++ D T K+ DFGLAR+A + T + T Y APE
Sbjct: 143 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPE 196
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGR 1171
+ D++S G ++ E++ G
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 3e-20
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHH 1024
+ + +G G +G V S V G KVA+K L R + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 1025 RNLVKLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
N++ L+ + ++ LV + + L + K LG D +
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMK-HEKLGEDRIQFLVYQM 137
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
+ L Y+H + +IHRD K N+ + D K+ DFGLAR A E + ++ TR
Sbjct: 138 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW---- 190
Query: 1139 GYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
Y APE + ++ D++S G ++ E+++G+
Sbjct: 191 -YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 91.8 bits (229), Expect = 3e-20
Identities = 55/212 (25%), Positives = 92/212 (43%), Gaps = 26/212 (12%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 1027
+ +GEG +G+VY + G A+K ++ + G E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLH 1086
VKL + ++ LV+E ++ L + D L L +AY H
Sbjct: 63 VKLYDVIHTKKRLVLVFEH-----LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
RV+HRD K N+L+ + K++DFGLAR A R + ++ T Y AP+
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLAR-AFGIPVRKYTHEIV-TLWYRAPD-- 170
Query: 1147 MTGHLLVKSDVYSYGV-------VILELLSGR 1171
+L+ S YS + + E+++G
Sbjct: 171 ----VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 29/255 (11%)
Query: 936 SGLDSASLSFGSSIATYTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGT 994
+ + K E E + +LG GGFG VYSG+ + D
Sbjct: 10 HSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL 69
Query: 995 KVAVKVL--KRVDQQGGREFLA----EVEMLSRLHHR--NLVKLIGICIEEQARCLVYEL 1046
VA+K + R+ G EV +L ++ +++L+ + L+ E
Sbjct: 70 PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 1047 I-PNGSVESHL--HGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNI 1103
P + + G +E AR A+ + H + V+HRD K NI
Sbjct: 130 PEPVQDLFDFITERGALQEE-----LAR-SFFWQVLEAVRHCH---NCGVLHRDIKDENI 180
Query: 1104 LL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSY 1160
L+ + K+ DFG A+ +++ + GT Y PE+ + H + V+S
Sbjct: 181 LIDLNRGELKLIDFGS--GALLKDT-VYTDFD-GTRVYSPPEW-IRYHRYHGRSAAVWSL 235
Query: 1161 GVVILELLSGRKPVD 1175
G+++ +++ G P +
Sbjct: 236 GILLYDMVCGDIPFE 250
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 4e-20
Identities = 51/216 (23%), Positives = 84/216 (38%), Gaps = 41/216 (18%)
Query: 976 ILGEGGFGLVYSGV-LDDGTKVAVKVL-KRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 1032
+LG G G V G K A+K+L + EV+ + ++V ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPKAR------QEVDHHWQASGGPHIVCILD 89
Query: 1033 ICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLG-WDARLKIALGAARALAYLH 1086
+ E ++ E + G + S + ++ +A +I A+ +LH
Sbjct: 90 VY-ENMHHGKRCLLIIMECMEGGELFSRI--QERGDQAFTEREAA-EIMRDIGTAIQFLH 145
Query: 1087 EDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP 1143
S + HRD K N+L D K++DFG A+ + T T YVAP
Sbjct: 146 ---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA---LQTPC-YTPYYVAP 198
Query: 1144 EYAMTGHLLVKS------DVYSYGVVILELLSGRKP 1173
E +L D++S GV++ LL G P
Sbjct: 199 E------VLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 5e-20
Identities = 62/270 (22%), Positives = 115/270 (42%), Gaps = 37/270 (13%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLH-HRNLVKLIGI 1033
+G G G V+ G +AVK ++R +++ + L +++++ + H +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
I + EL+ E + P+ K+ + +AL YL E V
Sbjct: 93 FITNTDVFIAMELM-GTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH--GV 146
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1152
IHRD K SNILL+ K+ DFG++ +D++++ R G Y+APE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTK 203
Query: 1153 ----VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID---P 1205
+++DV+S G+ ++EL +G+ P + E L +++ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTD---------------FEVLTKVLQEEPP 248
Query: 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRP 1235
L + F + + C+ + + RP
Sbjct: 249 LLPGHMGFSGDFQ--SFVKDCLTKDHRKRP 276
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 17/209 (8%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLK-RVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+G G +V + KVA+K + Q E L E++ +S+ HH N+V
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 1035 IEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARLKIAL---GAARALAYLHEDS 1089
+ + LV +L+ GSV + H V K G IA L YLH++
Sbjct: 83 VVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN- 140
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFG----LARSAMDEESRHISTRVMGTFGYVAPEY 1145
IHRD K+ NILL D + +++DFG LA ++ T V GT ++APE
Sbjct: 141 --GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFV-GTPCWMAPEV 197
Query: 1146 AMTGHLL-VKSDVYSYGVVILELLSGRKP 1173
K+D++S+G+ +EL +G P
Sbjct: 198 MEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 6e-20
Identities = 48/224 (21%), Positives = 90/224 (40%), Gaps = 60/224 (26%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 1032
R LG G + V+ + + + KV VK+LK V ++ + E+++L L N++ L
Sbjct: 42 RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLAD 98
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA------------- 1079
I + +R V H++ D K
Sbjct: 99 IVKDPVSRTPAL-------VFEHVNNTD-----------FKQLYQTLTDYDIRFYMYEIL 140
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESR--HISTRVMG 1136
+AL Y H S ++HRD K N++++H+ ++ D+GLA + +++R
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-- 195
Query: 1137 TFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGRKP 1173
+ PE LLV D++S G ++ ++ ++P
Sbjct: 196 ---FKGPE------LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 6e-20
Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 26/212 (12%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNL 1027
+ +GEG +G+VY G VA+K ++ + G A E+ +L LHH N+
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYLH 1086
V LI + E+ LV+E +E L V D+ L R +A+ H
Sbjct: 82 VSLIDVIHSERCLTLVFEF-----MEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
R++HRD K N+L+ D K++DFGLAR A R + V+ T Y AP+
Sbjct: 137 ---QHRILHRDLKPQNLLINSDGALKLADFGLAR-AFGIPVRSYTHEVV-TLWYRAPD-- 189
Query: 1147 MTGHLLVKSDVYSYGV-------VILELLSGR 1171
+L+ S YS V + E+++G+
Sbjct: 190 ----VLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 7e-20
Identities = 59/225 (26%), Positives = 94/225 (41%), Gaps = 49/225 (21%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVL---------KRVDQQGGREFLAEVEMLSRLHH 1024
+LGEG +G+V S G VA+K + R L E+++L H
Sbjct: 17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT--------LREIKILKHFKH 68
Query: 1025 RNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKI----A 1075
N++ + I + ++ EL+ ++ LH V + L D ++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVIS-TQMLS-DDHIQYFIYQT 121
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
L RA+ LH VIHRD K SN+L+ + KV DFGLAR + + +
Sbjct: 122 L---RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQ 175
Query: 1136 GTF--GYV------APEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
+ +V APE +T ++ DV+S G ++ EL R
Sbjct: 176 QSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 57/234 (24%), Positives = 98/234 (41%), Gaps = 33/234 (14%)
Query: 960 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR-------VDQQGGRE 1011
+ E + +LG+GGFG V++G L D +VA+KV+ R
Sbjct: 22 GGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTC 81
Query: 1012 FLAEVEMLSRLH----HRNLVKLIGICIEEQARCLVYEL-IPNGSVESHL--HGVDKESA 1064
L EV +L ++ H +++L+ ++ LV E +P + ++ G E
Sbjct: 82 PL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG- 139
Query: 1065 PLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM 1123
+R A+ + H S V+HRD K NIL+ K+ DFG
Sbjct: 140 ----PSR-CFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH 191
Query: 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKPVD 1175
DE + GT Y PE+ ++ H + V+S G+++ +++ G P +
Sbjct: 192 DE---PYTDFD-GTRVYSPPEW-ISRHQYHALPATVWSLGILLYDMVCGDIPFE 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 59/207 (28%), Positives = 95/207 (45%), Gaps = 24/207 (11%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+G G +G V + G +VAVK L R + E+ +L + H N++ L+
Sbjct: 35 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 94
Query: 1032 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ ++ LV L+ + L+ + K L D + R L Y+
Sbjct: 95 DVFTPARSLEEFNDVYLVTHLM-----GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYI 148
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S +IHRD K SN+ + D K+ DFGLAR DE + +++TR Y APE
Sbjct: 149 H---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW-----YRAPEI 200
Query: 1146 AMTGHLLVKS-DVYSYGVVILELLSGR 1171
+ ++ D++S G ++ ELL+GR
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 37/218 (16%)
Query: 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKL 1030
+ +++G G FG+V+ L + +VA +K+V Q + E++++ + H N+V L
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEVA---IKKVLQDKRFK-NRELQIMRIVKHPNVVDL 97
Query: 1031 IGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL-GAARALA 1083
+ LV E +P +V K + +K+ + R+LA
Sbjct: 98 KAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLA 155
Query: 1084 YLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAM-DEESRH-ISTRVMGTFGY 1140
Y+H S + HRD K N+LL K+ DFG A+ + E + I +R Y
Sbjct: 156 YIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRY-----Y 207
Query: 1141 VAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1171
APE L+ + D++S G V+ EL+ G+
Sbjct: 208 RAPE------LIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 3e-19
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 37/220 (16%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
+ LG GG GLV+S V D +VA+K + D Q + L E++++ RL H N+VK+ I
Sbjct: 17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEI 76
Query: 1034 CIEEQARC--------------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
++ +V E + E+ L V + PL +
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLE-QGPLLEEHARLFMYQLL 130
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESR------HIST 1132
R L Y+H S V+HRD K +N+ + D K+ DFGLAR S + T
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
+ Y +P ++ + K+ D+++ G + E+L+G+
Sbjct: 188 K-----WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-19
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRNLVKLIGI 1033
LG G + VY G+ G VA+K + ++D + G A E+ ++ L H N+V+L +
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYDV 71
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARALAYLHEDSSP 1091
E LV+E + N ++ ++ + P G + L + LA+ HE+
Sbjct: 72 IHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN--- 127
Query: 1092 RVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1151
+++HRD K N+L+ K+ DFGLAR A S+ V+ T Y AP+ +
Sbjct: 128 KILHRDLKPQNLLINKRGQLKLGDFGLAR-AFGIPVNTFSSEVV-TLWYRAPD------V 179
Query: 1152 LVKSDVYSYGV-------VILELLSGR 1171
L+ S YS + ++ E+++G+
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 4e-19
Identities = 61/219 (27%), Positives = 96/219 (43%), Gaps = 44/219 (20%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVL---------KRVDQQGGREFLAEVEMLSRLHH 1024
+GEG +G+V S + +VA+K + +R L E+++L R H
Sbjct: 33 SYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT--------LREIKILLRFRH 84
Query: 1025 RNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
N++ + I +V +L+ E+ L+ + K + L D
Sbjct: 85 ENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLK-TQHLSNDHICYFLYQIL 138
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR------HISTR 1133
R L Y+H S V+HRD K SN+LL K+ DFGLAR A + +++TR
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 1134 VMGTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGR 1171
Y APE + KS D++S G ++ E+LS R
Sbjct: 196 -----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-19
Identities = 53/247 (21%), Positives = 96/247 (38%), Gaps = 42/247 (17%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRN 1026
++ ++G G +G V + VA+K + RV D + L E+ +L+RL+H +
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDH 113
Query: 1027 LVKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+VK++ I I + +V E+ +S + + L +
Sbjct: 114 VVKVLDIVIPKDVEKFDELYVVLEI-----ADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+ Y+H S ++HRD K +N L+ D + KV DFGLAR+ E+ + + +
Sbjct: 169 VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 1142 APEYA---------MTGH----------LLVKSDVYSYGV------VIL-ELLSGRKPVD 1175
+TGH L++ + Y+ + I ELL+ K
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285
Query: 1176 MTQPPGQ 1182
Sbjct: 286 AYHADRG 292
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 7e-19
Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 37/221 (16%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL 1022
+F+ R +G+G FG V + D A+K + + V++ R E++++ L
Sbjct: 16 HFEILRAIGKGSFGKVC---IVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL 72
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHL--HGVDKESAPLGWDARL---KIALG 1077
H LV L +E+ +V +L+ G + HL + KE +L ++ +
Sbjct: 73 EHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-----VKLFICELVM- 126
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
AL YL + R+IHRD K NILL+ ++DF +A E T + GT
Sbjct: 127 ---ALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGT 177
Query: 1138 FGYVAPE----YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
Y+APE G+ + D +S GV ELL GR+P
Sbjct: 178 KPYMAPEMFSSRKGAGYS--FAVDWWSLGVTAYELLRGRRP 216
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 9e-19
Identities = 59/213 (27%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 970 NFDASRILGEGGFGLVYSG-VLDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 1026
+ LGEG + VY G VA+K + R++ + G A EV +L L H N
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI-RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAARALAYL 1085
+V L I E++ LV+E ++ L D + R LAY
Sbjct: 62 IVTLHDIIHTEKSLTLVFEY-----LDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC 116
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H +V+HRD K N+L+ K++DFGLAR A ++ V+ T Y P+
Sbjct: 117 H---RQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVV-TLWYRPPD- 170
Query: 1146 AMTGHLLVKSDVYSYGV-------VILELLSGR 1171
+L+ S YS + + E+ +GR
Sbjct: 171 -----ILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-18
Identities = 62/229 (27%), Positives = 99/229 (43%), Gaps = 56/229 (24%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
++ ++++G G FG+VY L D G VA +K+V Q + E++++ +L H N+V
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVA---IKKVLQDKRFK-NRELQIMRKLDHCNIV 110
Query: 1029 KLIGICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA--- 1079
+L + LV + +P ++ V + + R K L
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVYRVARHYS------RAKQTLPVIYVK 159
Query: 1080 -------RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARS-AMDEESRH- 1129
R+LAY+H S + HRD K N+LL K+ DFG A+ E +
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 216
Query: 1130 ISTRVMGTFGYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1171
I +R Y APE L+ + DV+S G V+ ELL G+
Sbjct: 217 ICSRY-----YRAPE------LIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 4e-18
Identities = 63/212 (29%), Positives = 92/212 (43%), Gaps = 24/212 (11%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRLHHRN 1026
F R +G G FG VY + + VA+K + +Q ++ + EV L +L H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
++ G + E LV E GS L K PL + GA + LAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLH 171
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR--VMGTFGYVAPE 1144
S +IHRD K+ NILL K+ DFG + ++ +GT ++APE
Sbjct: 172 ---SHNMIHRDVKAGNILLSEPGLVKLGDFGS--------ASIMAPANSFVGTPYWMAPE 220
Query: 1145 YAMTGHLL---VKSDVYSYGVVILELLSGRKP 1173
+ K DV+S G+ +EL + P
Sbjct: 221 VILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 5e-18
Identities = 52/206 (25%), Positives = 97/206 (47%), Gaps = 22/206 (10%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 68 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 127
Query: 1032 GICIEEQARC------LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ ++ LV EL+ +++L V + L + + + +L
Sbjct: 128 NVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQ--MELDHERMSYLLYQMLCGIKHL 180
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S +IHRD K SNI+++ D T K+ DFGLAR+A + + T + T Y APE
Sbjct: 181 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEV 234
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGR 1171
+ D++S G ++ E++ +
Sbjct: 235 ILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 9e-18
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 32/210 (15%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE---FLA--EVEMLSRLHHRNLVKL 1030
LGEG F VY + VA+K +K + ++ A E+++L L H N++ L
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGV-DKESAPLGWDARLK-IALGAARALAYLHED 1088
+ + LV++ +E+ L + S L + +K L + L YLH+
Sbjct: 78 LDAFGHKSNISLVFDF-----METDLEVIIKDNSLVLT-PSHIKAYMLMTLQGLEYLHQH 131
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
++HRD K +N+LL+ + K++DFGLA+ + +R + +V+ T Y APE
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAK-SFGSPNRAYTHQVV-TRWYRAPE---- 182
Query: 1149 GHLLVKSDVYSYGV-------VILELLSGR 1171
LL + +Y GV ++ ELL
Sbjct: 183 --LLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-17
Identities = 56/224 (25%), Positives = 100/224 (44%), Gaps = 37/224 (16%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLH-HRNLVKL 1030
+ LG+G +G+V+ + G VAVK + + + E+ +L+ L H N+V L
Sbjct: 15 KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 1031 IGICIEEQARC--LVYELIPNGSVESHLHGVDKESAPLGWDARLK-IALGAARALAYLHE 1087
+ + + R LV++ + E+ LH V + + L + + + + YLH
Sbjct: 75 LNVLRADNDRDVYLVFDYM-----ETDLHAVIR-ANILE-PVHKQYVVYQLIKVIKYLH- 126
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY-- 1145
S ++HRD K SNILL + KV+DFGL+RS ++ + + +
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 1146 -AMTGH----------LLVKSDVYSYGV------VIL-ELLSGR 1171
+T + +L+ S Y+ G+ IL E+L G+
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-17
Identities = 62/219 (28%), Positives = 97/219 (44%), Gaps = 38/219 (17%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 1020
FD + LG G FG V L + G A+K+L ++ Q L E +L
Sbjct: 42 QFDRIKTLGTGSFGRVM---LVKHKESGNHYAMKILDKQKVVKLKQI--EHTLNEKRILQ 96
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1077
++ LVKL + +V E + G + SHL + + S P AR +I L
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH---ARFYAAQIVL- 152
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1136
YLH +I+RD K N+L++ +V+DFG A+ T + G
Sbjct: 153 ---TFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG------RTWTLCG 200
Query: 1137 TFGYVAPEYAMT-GHLLVKS-DVYSYGVVILELLSGRKP 1173
T +APE ++ G+ K+ D ++ GV+I E+ +G P
Sbjct: 201 TPEALAPEIILSKGY--NKAVDWWALGVLIYEMAAGYPP 237
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 3e-17
Identities = 54/217 (24%), Positives = 85/217 (39%), Gaps = 31/217 (14%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLA--EVEMLSRLHHRN 1026
+ LGEG +G VY + VA+K ++ ++ G A EV +L L HRN
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRN 94
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+++L + L++E E+ L ++ + + + H
Sbjct: 95 IIELKSVIHHNHRLHLIFEY-----AENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCH 149
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTP-----KVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
S R +HRD K N+LL K+ DFGLAR A R + ++ T Y
Sbjct: 150 ---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR-AFGIPIRQFTHEII-TLWYR 204
Query: 1142 APEYAMTGHLLVKSDVYSYGV-------VILELLSGR 1171
PE +L+ S YS V + E+L
Sbjct: 205 PPE------ILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 55/219 (25%), Positives = 88/219 (40%), Gaps = 42/219 (19%)
Query: 974 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 1031
S++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIV 121
Query: 1032 GICIEEQARC----LVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
+ A +V E + G ++ E +A +I A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGEAIQ 175
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
YLH S + HRD K N+L + K++DFG A+ S ++T T Y
Sbjct: 176 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LTTPC-YTPYY 229
Query: 1141 VAPEYAMTGHLLVKS------DVYSYGVVILELLSGRKP 1173
VAPE +L D++S GV++ LL G P
Sbjct: 230 VAPE------VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 4e-16
Identities = 58/227 (25%), Positives = 99/227 (43%), Gaps = 43/227 (18%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-F----LAEVEMLSRLH 1023
++ +G+G FG V+ G KVA LK+V + +E F L E+++L L
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVA---LKKVLMENEKEGFPITALREIKILQLLK 74
Query: 1024 HRNLVKLIGICIEEQARC--------LVYELIPNGSVESHLHGV-DKESAPLGWDARLKI 1074
H N+V LI IC + + LV++ E L G+ ++
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDF-----CEHDLAGLLSNVLVKFTLSEIKRV 129
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS---AMDEESRHIS 1131
L Y+H + +++HRD K++N+L+ D K++DFGLAR+ A + + +
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 1132 TRVMGTFGYVAPEYAMTGHLLVKSDVYSYGV-------VILELLSGR 1171
RV+ T Y PE LL+ Y + ++ E+ +
Sbjct: 187 NRVV-TLWYRPPE------LLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 83.6 bits (206), Expect = 4e-16
Identities = 56/296 (18%), Positives = 98/296 (33%), Gaps = 21/296 (7%)
Query: 117 PPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSN 176
+ TP ++ + L + +PL S+ A
Sbjct: 1457 QKITEIEDGQDGGVTPYSNESGLVNADL----DVKDELMFSPLVDSGSNDAMAGGFTAYG 1512
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A S P S + P + SP P+ P S S
Sbjct: 1513 GADYG---------EATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPT---SPAYSPTS 1560
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
+ P + S T+P + SP + PS + P+ P++ + P S PS +
Sbjct: 1561 PSYSPTSPSYSPTSPSYSPTSPSYSP---TSPSYSPTSPSYSPTSPSYSPTS-PSYSPTS 1616
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPP-PASH 355
P+ P++ + P S + P S S + P + S T+P + S +P P+
Sbjct: 1617 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYS 1676
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHP 411
P++ + P S +P P S S + P + S +P ++ +
Sbjct: 1677 PTSPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 6e-16
Identities = 59/264 (22%), Positives = 95/264 (35%), Gaps = 13/264 (4%)
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPIT 140
+S + V+A D+ P S ++ + A T
Sbjct: 1472 PYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPT 1531
Query: 141 APPLVNVLPAPSLIPTTPLASPLS------SKAFPPASPPSNAARPPASHPSNTARPPAS 194
+P P S PT+P SP S S ++ P SP + P S S + P +
Sbjct: 1532 SPGFGVSSPGFS--PTSPTYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1589
Query: 195 HPSRTAPP--PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
S T+P P S + PS + SP+ P++ + P S P S S + P
Sbjct: 1590 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP 1649
Query: 253 PASHPYKTSP-LPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
+ TSP + PS + P+ P++ + P S S + P P++ + P S
Sbjct: 1650 TSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSYSPTSP-SYSPTSPNYSPTSPSYSPTS- 1707
Query: 312 PSNTAPPPASHPSNTAPPPASHPS 335
P + PA P + +
Sbjct: 1708 PGYSPGSPAYSPKQDEQKHNENEN 1731
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 82.8 bits (204), Expect = 6e-16
Identities = 60/304 (19%), Positives = 102/304 (33%), Gaps = 13/304 (4%)
Query: 93 FDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPS 152
FD+ + + P S A ++ + S
Sbjct: 1441 FDVMIDEESLVKYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGS 1500
Query: 153 LIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTAL 212
+ + A+ P A + P P P+ P S S
Sbjct: 1501 NDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPT---SPTYSPTSPAYS 1557
Query: 213 PSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTA 272
P+ + SP S PS + P+ P+ + P S S + P+ P S P S PS +
Sbjct: 1558 PTSPSYSPTS-PSYSPTSPSYSPTSPSYSPTS-PSYSPTSPSYSPTSPSYSPTS-PSYSP 1614
Query: 273 PPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP-PASHPSNTAPPPA 331
P+ P++ + P S P S S + P + S T+P + PS + P+
Sbjct: 1615 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPS 1674
Query: 332 SHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
P+ P S +S + P + + S T+ P+ P++P P S P+ + +
Sbjct: 1675 YSPT---SPSYSPTSPSYSPTSPNYSPTS--PSYSPTSPGYSPGS-PAYSPKQDEQKHNE 1728
Query: 392 TAPP 395
Sbjct: 1729 NENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 2e-15
Identities = 55/304 (18%), Positives = 88/304 (28%), Gaps = 30/304 (9%)
Query: 73 APPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTP 132
P I P+ + + +P
Sbjct: 1453 YMPEQKITEIEDGQDGGVTPYSNESGLV---------NADLDVKDELMFSPLVDSGSNDA 1503
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
+A A SP + P SP + P S P++ P
Sbjct: 1504 MAGG-----------FTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFS-PTSPTYSP 1551
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
S P S S + P+ + SP S + P S S + P + S T+P
Sbjct: 1552 TSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1611
Query: 253 PASHPYKTSPL-----PASHPSKTAPPPASHPSNTAPPPASHPSKTAPP-PASHPSNTAP 306
+ SP P S P S S + P + S T+P + PS +
Sbjct: 1612 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPT 1671
Query: 307 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASH 366
P+ P+ P S S + P + + S T+P + S +P ++ +
Sbjct: 1672 SPSYSPT---SPSYSPTSPSYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKHNE 1728
Query: 367 PSNP 370
N
Sbjct: 1729 NENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 81.3 bits (200), Expect = 2e-15
Identities = 72/313 (23%), Positives = 97/313 (30%), Gaps = 33/313 (10%)
Query: 391 NTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPR 450
P P + + + +P+ S + A T
Sbjct: 1452 KYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAY 1511
Query: 451 GNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIP 510
G G P +P +PG P SP P P
Sbjct: 1512 GGADYGEATSPFGAYGEAPT-----------SPGFGVSSPGFSP------TSPTYSPTSP 1554
Query: 511 GGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHS 570
+PT+ PS P S PSY P SPS +P++ Y S
Sbjct: 1555 AYSPTSPSYSPTSPSYSPTSPSYSPTS-----PSYSPTSPSYSPTSPSYSPTSPSYSPTS 1609
Query: 571 -NHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQG 629
++SP P SP P + +P SP + + SP S SPT+ +
Sbjct: 1610 PSYSPTSPSYSPTSPSYSPT-SPSYSPTSPSYSPTS----PSYSPT-SPSYSPTSPAYSP 1663
Query: 630 PVVPPSFIPTSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPP 689
PS+ PTS P + SPS+SP S PTSPS SPTS P P
Sbjct: 1664 --TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYS--PTSPSYSPTSPGYSPGSPAYSP 1719
Query: 690 KSSPSEPIRAFPP 702
K +
Sbjct: 1720 KQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 80.9 bits (199), Expect = 2e-15
Identities = 61/288 (21%), Positives = 105/288 (36%), Gaps = 17/288 (5%)
Query: 133 VASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPP 192
+ + P + + + L K SP ++ A TA
Sbjct: 1454 MPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGG 1513
Query: 193 ASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP 252
A + T+P A + T+ P SP P++ P S P S S + P
Sbjct: 1514 ADYGEATSPFGAYGEAPTS-PGFGVSSPGFSPTSPTYSPTS-------PAYSPTSPSYSP 1565
Query: 253 PASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
+ TSP + +P + PS + P+ P+ + P S PS + P+ P
Sbjct: 1566 TSPSYSPTSPSYSPTSPSYSP---TSPSYSPTSPSYSPTSPSYSPTS-PSYSPTSPSYSP 1621
Query: 313 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPP-PASHPSNTALPPASHPSNPA 371
++ + P S + P S S + P + S T+P + PS + P+ P++P+
Sbjct: 1622 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPS 1681
Query: 372 IPPASHPSNTAIPPASHPSNTAP-PHASHPSNTALTPASHPSNIAPPP 418
P S + P + + S T+P + P + +PA P
Sbjct: 1682 YSPTSP---SYSPTSPNYSPTSPSYSPTSPGYSPGSPAYSPKQDEQKH 1726
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 77.4 bits (190), Expect = 3e-14
Identities = 59/316 (18%), Positives = 94/316 (29%), Gaps = 34/316 (10%)
Query: 270 KTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 329
K P P + + P + +
Sbjct: 1452 KYMPEQKITEIEDGQDGGVTPYSNESGLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAY 1511
Query: 330 PASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHP 389
+ A P + P S+ P S +P P S S + P +
Sbjct: 1512 GGADYGE-ATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPSY 1570
Query: 390 SNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATP 449
S T+P ++ P++ + +P S PS P + P PS P SP P +P+ +P
Sbjct: 1571 SPTSPSYS--PTSPSYSPTS-PSYSPTSPSYSPTSPSYSP------TSPSYSPTSPSYSP 1621
Query: 450 RGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPII 509
SP+ P+ P P S +P + +P SP P
Sbjct: 1622 ------TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPT----------SPAYSPTS 1665
Query: 510 PGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRH 569
P +PT P P++P S P+Y P SP +P + Y
Sbjct: 1666 PSYSPT---SPSYSPTSPSYSPTSPSYSPT--SPNYSPTSPSYSPTSPGYSPGSPAY--- 1717
Query: 570 SNHSPLPPFSSPKPPQ 585
S + + +
Sbjct: 1718 SPKQDEQKHNENENSR 1733
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 1e-13
Identities = 59/231 (25%), Positives = 87/231 (37%), Gaps = 15/231 (6%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASP--PSITAPPPVNMAPPPS 126
A F A ++P P PT+P SP P+ + P PS
Sbjct: 1510 AYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSPTSPTYSPTSPAYSPTSPSYSPTSPS 1569
Query: 127 LIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPS 186
PT+P SP + P +PS PT+P SP +S ++ P SP + P S P+
Sbjct: 1570 YSPTSPSYSPTSPSYSP-----TSPSYSPTSPSYSP-TSPSYSPTSPSYSPTSPSYS-PT 1622
Query: 187 NTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASH---PSNTALPPASLPSKTAPPPA 243
+ + P S P S S + P+ + SP S P++ + P S P
Sbjct: 1623 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPAYSPTSPSYSPTSPSYSPTSPSY 1682
Query: 244 SHLSNTAPPPASHPYKTSPL--PASHPSKTAPPPASHPSNTAPPPASHPSK 292
S S + P + + TSP P S P + PA P + +
Sbjct: 1683 SPTSPSYSPTSPNYSPTSPSYSPTS-PGYSPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 3e-13
Identities = 70/262 (26%), Positives = 101/262 (38%), Gaps = 30/262 (11%)
Query: 26 SAGYGIPPSPAIIGGHFLLPRLPVTFTLKPHLLGGHAP-SPIELPTHSAPPPVNIPSFSP 84
S + A+ GG P G AP SP + P P++SP
Sbjct: 1493 SPLVDSGSNDAMAGGFTAYGGADYGEATSPFGAYGEAPTSPGFGVSSPGFSP-TSPTYSP 1551
Query: 85 STPAVSA--PFDMAPPPSLIPTNPVASPPSITAPP--PVNMAPPPSLIPTTPVASPPPIT 140
++PA S P PS PT+P SP S + P P PS PT+P SP
Sbjct: 1552 TSPAYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP---- 1607
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTA 200
+PS PT+P SP +S ++ P SP + P S S P+ P+ +
Sbjct: 1608 --------TSPSYSPTSPSYSP-TSPSYSPTSPSYSPTSPSYSPTS-----PSYSPTSPS 1653
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPP--PASHPY 258
P S + PS + SP+ P++ P S S + P + + S T+P P S Y
Sbjct: 1654 YSPTSPAYSPTSPSYSPTSPSYSPTS---PSYSPTSPSYSPTSPNYSPTSPSYSPTSPGY 1710
Query: 259 K-TSPLPASHPSKTAPPPASHP 279
SP + + +
Sbjct: 1711 SPGSPAYSPKQDEQKHNENENS 1732
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 7e-11
Identities = 61/245 (24%), Positives = 84/245 (34%), Gaps = 27/245 (11%)
Query: 487 PIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYD 546
+ + SP+ S G+ P +
Sbjct: 1478 GLVNADLDVKDELMFSPLVDSGSNDAMAGGFTAYGGADYGEATS-PFGAYGEAPTSPGFG 1536
Query: 547 IPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLASFPKHRDV 606
+ P SP+ +P++ Y SP P SP P + P SP +
Sbjct: 1537 VSSPGFSPTSPTYSPTSPAY------SPTSPSYSPTSPSYSPTS-PSYSPTSP---SYSP 1586
Query: 607 RNKIASSPAPSYFISPTTSIHQGPVVP------PSFIPTSRKRHYGPPPLNSVSPSHSPL 660
+ S +PSY SPT S P P PS+ PTS P + SPS+SP
Sbjct: 1587 TSPSYSPTSPSY--SPT-SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSP- 1642
Query: 661 PTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTICTEP-YT 719
T S PTSPS SPTS + P SP+ P + P + + T P Y+
Sbjct: 1643 -TSPSYSPTSPSYSPTSPAYSPT----SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPNYS 1697
Query: 720 NTPPG 724
T P
Sbjct: 1698 PTSPS 1702
|
| >1twf_A B220, DNA-directed RNA polymerase II largest subunit; transcription, mRNA, multiprotein complex; HET: UTP; 2.30A {Saccharomyces cerevisiae} SCOP: e.29.1.2 PDB: 1i3q_A 1i6h_A 1k83_A* 1nik_A 1nt9_A 1pqv_A 1r5u_A 1r9s_A* 1r9t_A* 1sfo_A* 1twa_A* 1twc_A* 1i50_A* 1twg_A* 1twh_A* 1wcm_A 1y1v_A 1y1w_A 1y1y_A 1y77_A* ... Length = 1733 | Back alignment and structure |
|---|
Score = 51.2 bits (122), Expect = 2e-06
Identities = 46/197 (23%), Positives = 56/197 (28%), Gaps = 31/197 (15%)
Query: 539 PVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSSPLA 598
E D + P N S SPL S G T
Sbjct: 1460 TEIEDGQDGGVTPYSNESGLVNADLDVKD-ELMFSPL--VDSGSNDAMAGGFTAYGGADY 1516
Query: 599 SFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIPTSRKRHYGPPPLNSVSPSHS 658
+ +P + V P F PTS P + SP++S
Sbjct: 1517 G------------EATSPFGAYGEAPTSPGFGVSSPGFSPTS-------PTYSPTSPAYS 1557
Query: 659 P-----LPTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRAFPPPPPNADCSTTI 713
P PT S PTSPS SPTS S P P S P P + T+
Sbjct: 1558 PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1617
Query: 714 CTEP----YTNTPPGSP 726
P Y+ T P
Sbjct: 1618 SYSPTSPSYSPTSPSYS 1634
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 55/222 (24%), Positives = 89/222 (40%), Gaps = 51/222 (22%)
Query: 975 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 1025
++G+G FG V D + VA+K++K Q EV +L ++
Sbjct: 60 SLIGKGSFGQVVK-AYDRVEQEWVAIKIIKNKKAFLNQA----QIEVRLLELMNKHDTEM 114
Query: 1026 --NLVKLIGICIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 1080
+V L + CLV+E++ N L+ + + + G L K A
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSYN------LYDLLRNTNFRGVSLNLTRKFAQQMCT 168
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRH---ISTRVM 1135
AL +L +IH D K NILL + K+ DFG S+ R I +R
Sbjct: 169 ALLFLA-TPELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSR-- 222
Query: 1136 GTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 1171
F Y +PE Y + D++S G +++E+ +G
Sbjct: 223 --F-YRSPEVLLGMPYDL------AIDMWSLGCILVEMHTGE 255
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 5e-16
Identities = 54/255 (21%), Positives = 98/255 (38%), Gaps = 66/255 (25%)
Query: 965 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH 1023
E ++ + + LG G FG+V ++ G + A+K +V Q + E++++ L
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYK-NRELDIMKVLD 58
Query: 1024 HRNLVKLIGI----CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD---------- 1069
H N++KL+ EE + +++ +S +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 1070 -------------ARLKIALGAA----------RALAYLHEDSSPRVIHRDFKSSNILL- 1105
R ++ RA+ ++H S + HRD K N+L+
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175
Query: 1106 EHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAPEYAMTGHLLVKS-------D 1156
D T K+ DFG A+ + E +I +R Y APE L++ + D
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPE------LMLGATEYTPSID 224
Query: 1157 VYSYGVVILELLSGR 1171
++S G V EL+ G+
Sbjct: 225 LWSIGCVFGELILGK 239
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 7e-16
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 24/214 (11%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 1025
F+ ++LG+G FG V G A+K+LK+ V + L E +L H
Sbjct: 149 EFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 1026 NLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAARA 1081
L L + R C V E G + HL S AR +I A
Sbjct: 209 FLTALKY-SFQTHDRLCFVMEYANGGELFFHLSRERVFSED---RARFYGAEIVS----A 260
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGY 1140
L YLH + + V++RD K N++L+ D K++DFGL + + + + + GT Y
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEY 315
Query: 1141 VAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
+APE + + ++ D + GVV+ E++ GR P
Sbjct: 316 LAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 8e-16
Identities = 61/217 (28%), Positives = 106/217 (48%), Gaps = 29/217 (13%)
Query: 970 NFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLH 1023
F+ ++LG+G FG V+ D A+KVLK + + E ++L ++
Sbjct: 25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN 84
Query: 1024 HRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGAA 1079
H +VKL + + + L+ + + G + + L + D + ++AL
Sbjct: 85 HPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE---DVKFYLAELAL--- 137
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTF 1138
AL +LH +I+RD K NILL+ + K++DFGL++ ++D E + GT
Sbjct: 138 -ALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTV 190
Query: 1139 GYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
Y+APE GH +S D +S+GV++ E+L+G P
Sbjct: 191 EYMAPEVVNRRGH--TQSADWWSFGVLMFEMLTGTLP 225
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 67/219 (30%), Positives = 103/219 (47%), Gaps = 38/219 (17%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 1020
+F R LG G FG V+ L +G A+KVLK R+ Q E MLS
Sbjct: 7 DFQILRTLGTGSFGRVH---LIRSRHNGRYYAMKVLKKEIVVRLKQV--EHTNDERLMLS 61
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1077
+ H ++++ G + Q ++ + I G + S L + P A+ ++ L
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNP---VAKFYAAEVCL- 117
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1136
AL YLH +I+RD K NILL+ + K++DFG A+ D T + G
Sbjct: 118 ---ALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD------VTYTLCG 165
Query: 1137 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
T Y+APE + + KS D +S+G++I E+L+G P
Sbjct: 166 TPDYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTP 202
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-15
Identities = 59/248 (23%), Positives = 106/248 (42%), Gaps = 20/248 (8%)
Query: 938 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 995
+++ L +I Y AK F++ + +F+ +++G G FG V L + K
Sbjct: 41 CNNSPLRREKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADK 100
Query: 996 V-AVKVLKRVD--QQGGRE-FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 1051
V A+K+L + + ++ F E ++L + + L ++ LV + G
Sbjct: 101 VFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGD 160
Query: 1052 VESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFT 1110
+ + L K L + AR +A A+ +H +HRD K NIL++ +
Sbjct: 161 LLTLL---SKFEDRLPEEMARFYLA-EMVIAIDSVH---QLHYVHRDIKPDNILMDMNGH 213
Query: 1111 PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKS-----DVYSYGVVIL 1165
+++DFG M++ + S V GT Y++PE D +S GV +
Sbjct: 214 IRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMY 272
Query: 1166 ELLSGRKP 1173
E+L G P
Sbjct: 273 EMLYGETP 280
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 3e-15
Identities = 70/326 (21%), Positives = 113/326 (34%), Gaps = 54/326 (16%)
Query: 55 PHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPS----LIPTNPVASP 110
L A +P E V P + +P V + L +P
Sbjct: 1475 TSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGV 1534
Query: 111 PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPP 170
S P + A P T+P SP +P+ +P++P SP S P
Sbjct: 1535 QSPGYTSPFSSAMSPGYGLTSPSYSPSSPGYST------SPAYMPSSPSYSPTS----PS 1584
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
SP S + P + S T+ P+ + + P S + PS + SP+ P++ +
Sbjct: 1585 YSPTSPSYSPTSPSYSPTS--PSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYS 1642
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
P S P S S P+ P+ + P S + P S P
Sbjct: 1643 PTS-------PSYSPTS----------------PSYSPTSPSYSPTSPSYSPTSPSYS-P 1678
Query: 291 SKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAP 350
+ + P S + P S S + P + S T+ P+ P++ + P S
Sbjct: 1679 TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSPTS------- 1729
Query: 351 PPASHPSNTALPPASHPSNPAIPPAS 376
PS + P+ P++P+ P S
Sbjct: 1730 -----PSYSPTSPSYSPTSPSYSPTS 1750
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 78.2 bits (192), Expect = 1e-14
Identities = 61/304 (20%), Positives = 109/304 (35%), Gaps = 20/304 (6%)
Query: 94 DMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSL 153
D + V + + +P+ + +P P
Sbjct: 1452 DQDMLMNYSLGTAVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQG 1511
Query: 154 IPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALP 213
ASP P + P ++A P + + P+S P + P
Sbjct: 1512 GSEGREGFGDYG-LLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSS-PGYSTSP 1569
Query: 214 SKTAPSPASHPSNTALPPAS-LPSKTAPPPASHLSNTAPPPASHPYKTSPL-PASHPSKT 271
+ SP+ P++ + P S S T+P S T+P ++ SP P+ P+
Sbjct: 1570 AYMPSSPSYSPTSPSYSPTSPSYSPTSPSY----SPTSPSYSATSPSYSPTSPSYSPT-- 1623
Query: 272 APPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPP-----PASHPSNT 326
P+ P++ + P S P S S + P + S T+P P+ P++
Sbjct: 1624 --SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1681
Query: 327 APPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPA 386
+ P S + P S +S + P + S T+ P+ P++P+ P S PS + P+
Sbjct: 1682 SYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSPTS-PSYSPTSPS 1738
Query: 387 SHPS 390
P+
Sbjct: 1739 YSPT 1742
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 1e-12
Identities = 68/338 (20%), Positives = 114/338 (33%), Gaps = 52/338 (15%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
+ + + P P SP P A+ S P +
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPY--ERSPMVDSGFVGSPDAAAFS-----PLVQGGSEGR 1516
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP--PA 309
++ P + P ++A P + + P+S +T+P P+
Sbjct: 1517 EGFGDYGLLGAASPYKGVQS--PGYTSPFSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPS 1574
Query: 310 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSN 369
S + P S S + P + S T+P ++ S + P S PS + P+ P++
Sbjct: 1575 SPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATS--PSYSPTS-PSYSPTSPSYSPTS 1631
Query: 370 PAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALP 429
P+ P S + P S S + P + S T+ P+ P++ + P
Sbjct: 1632 PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS--PSYSPTSPSYSP----------- 1678
Query: 430 GKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIA 489
SP P +P+ +P SP+ P+ P P S P P +
Sbjct: 1679 ------TSPSYSPTSPSYSPT------SPSYSPTSPSYSPTSPSYSPTS----PSYSPTS 1722
Query: 490 PGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTP 527
P P SP P P +PT+ P P++P
Sbjct: 1723 PSYSP------TSPSYSPTSPSYSPTS---PSYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 72.4 bits (177), Expect = 1e-12
Identities = 82/311 (26%), Positives = 114/311 (36%), Gaps = 38/311 (12%)
Query: 404 ALTPASHPSNIAPPPLFVPVLPSA-LPGKAPVSQSPI---SLPDAPAATPRGNFHRHSPA 459
+ + P P P++ S + + SP+ G SP
Sbjct: 1472 GMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPY 1531
Query: 460 IHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPD 519
PG P S+ +P +P P SP P P +PT+
Sbjct: 1532 KGVQSPGYTSP------FSSAMSPGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTS--- 1582
Query: 520 PDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHSN-HSPLPPF 578
P P++P S P + PSY P SPS +P++ Y S +SP P
Sbjct: 1583 PSYSPTSPSYS--------PTS-PSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPS 1633
Query: 579 SSPKPPQNNGNDTPVSSPLASFPKHRDVRNKIASSPAPSYFISPTTSIHQGPVVPPSFIP 638
SP P + P S + + S +PSY SPT+ + PS+ P
Sbjct: 1634 YSPTSPSYS----PTSPSYSPTSPSYSPTSPSYSPTSPSY--SPTSPSYSPT--SPSYSP 1685
Query: 639 TSRKRHYGPPPLNSVSPSHSPLPTPVSRVPTSPSPSPTSASGQTELPLLPPKS---SPSE 695
TS P + SPS+SP S PTSPS SPTS S P P S SP+
Sbjct: 1686 TSPSYSPTSPSYSPTSPSYSPTSPSYS--PTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS 1743
Query: 696 PIRAFPPPPPN 706
P ++ P P+
Sbjct: 1744 P--SYSPTSPS 1752
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 72.0 bits (176), Expect = 1e-12
Identities = 83/351 (23%), Positives = 124/351 (35%), Gaps = 65/351 (18%)
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAP 295
+ + ++ P A PY+ SP+ S + A P
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEG-----REG 1518
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
A P S P + P ++A P + P S SS P ++
Sbjct: 1519 FGDYGLLGAASPYKGVQS----PGYTSPFSSAMSPGYGLT---SPSYSPSS---PGYSTS 1568
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAP-PHASHPSNTALTPASHPSNI 414
P+ P+ P++P+ P S PS + P + S T+P A+ PS + +P+ P+
Sbjct: 1569 PAYMPSSPSYSPTSPSYSPTS-PSYS--PTSPSYSPTSPSYSATSPSYSPTSPSYSPT-- 1623
Query: 415 APPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQK 474
P + P PS P SP P +P+ +P SP+ P+ P P
Sbjct: 1624 --SPSYSPTSPSYSP------TSPSYSPTSPSYSPT------SPSYSPTSPSYSPT---- 1665
Query: 475 RNASNREAPIAEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLSVDGK 534
+P P +P P SP P P +PT+ PS P S
Sbjct: 1666 -------SPSYSPTSPSYSPT------SPSYSPTSPSYSPTSPSYSPTSPSYSPTS---- 1708
Query: 535 RVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKYMRHS-NHSPLPPFSSPKPP 584
PSY P SPS +P++ Y S ++SP P SP P
Sbjct: 1709 --------PSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 5e-12
Identities = 64/248 (25%), Positives = 93/248 (37%), Gaps = 14/248 (5%)
Query: 34 SPAIIGGHFLLPRLPVTFTLKPHLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPF 93
SP + GG L SP S+ SPS S +
Sbjct: 1506 SPLVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMSPGYGLTSPSYSPSSPGY 1565
Query: 94 DMAPPPSLIPTNPVASP--PSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAP 151
+P P++P SP PS + P PS PT+P S + P +P
Sbjct: 1566 STSPAYM--PSSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPT-----SP 1618
Query: 152 SLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTA 211
S PT+P SP +S ++ P SP + P S P++ + P S P S S +
Sbjct: 1619 SYSPTSPSYSP-TSPSYSPTSPSYSPTSPSYS-PTSPSYSPTSPSYSPTSPSYSPTSPSY 1676
Query: 212 LPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP--PPASHPYKTSPLPASHPS 269
P+ + SP S + P S S + P + S T+P P S Y + P+ P+
Sbjct: 1677 SPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTS-PSYSPT 1735
Query: 270 KTAPPPAS 277
+ P S
Sbjct: 1736 SPSYSPTS 1743
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 70.1 bits (171), Expect = 5e-12
Identities = 60/300 (20%), Positives = 105/300 (35%), Gaps = 16/300 (5%)
Query: 170 PASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTAL 229
+ + + P P P + S + P S
Sbjct: 1464 AVPTLAGSGMGTSQLPEGAGTPYERSPMVDSGFVGSPDAAAFSPLVQGGSEGREGFGDYG 1523
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPP--PA 287
+ + S + + P P+ PS + ++P P
Sbjct: 1524 LLGAASPYKGVQSPGYTSPFSSAMS--PGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPT 1581
Query: 288 SHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSK 347
S PS + P+ P++ + P S + P S S + P + S T+P + S
Sbjct: 1582 S-PSYSPTSPSYSPTSPSYSPTSPSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPS 1640
Query: 348 TAP-PPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALT 406
+P P+ P++ + P S +P P S S + P + S T+P + P++ + +
Sbjct: 1641 YSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP--SYSPTSPSYS 1698
Query: 407 PASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRG-NFHRHSPAIHPSMP 465
P S PS P + P PS P SP P +P+ +P ++ SP+ P+ P
Sbjct: 1699 PTS-PSYSPTSPSYSPTSPSYSP------TSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1751
|
| >3h0g_A DNA-directed RNA polymerase II subunit RPB1; transcription, multi-protein complex, DNA- binding, magnesium; 3.65A {Schizosaccharomyces pombe} Length = 1752 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 3e-09
Identities = 51/208 (24%), Positives = 72/208 (34%), Gaps = 29/208 (13%)
Query: 539 PVAEPSYDIPMPPPVNHSP---SKAPSTHKYMRHSNHSPLPPFSSPKPPQNNGNDTPVSS 595
P+ + + + P SP + + + P+ + P + S
Sbjct: 1490 PMVDSGF-VGSPDAAAFSPLVQGGSEGREGFGDYGLLGAASPYKGVQSPGYTSPFSSAMS 1548
Query: 596 PLASFPKHRDVRNKIASSPAPSY-----FISPT------TSIHQGPVVPPSFIPTSRKRH 644
P + S +P+Y SPT TS P PS+ PTS
Sbjct: 1549 PGYGLTSPSYSPSSPGYSTSPAYMPSSPSYSPTSPSYSPTSPSYSPT-SPSYSPTS---- 1603
Query: 645 YGPPPLNSVSPSHSPL-----PTPVSRVPTSPSPSPTSASGQTELPLLPPKSSPSEPIRA 699
P ++ SPS+SP PT S PTSPS SPTS S P P S P
Sbjct: 1604 ---PSYSATSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSPSYSPTSP 1660
Query: 700 FPPPPPNADCSTTICTEPYTNTP-PGSP 726
P + T+ P + + P SP
Sbjct: 1661 SYSPTSPSYSPTSPSYSPTSPSYSPTSP 1688
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 60/217 (27%), Positives = 97/217 (44%), Gaps = 39/217 (17%)
Query: 977 LGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF-----LAEVEMLSRLH---HRNL 1027
+G G +G VY G VA+K ++ + GG + EV +L RL H N+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76
Query: 1028 VKLIGICIEEQARC-----LVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 1080
V+L+ +C + LV+E V+ L ++ P G A + R
Sbjct: 77 VRLMDVCATSRTDREIKVTLVFEH-----VDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L +LH + ++HRD K NIL+ T K++DFGLAR + ++ V+ T Y
Sbjct: 132 GLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLAR-IYSYQMA-LTPVVV-TLWY 185
Query: 1141 VAPEYAMTGHLLVKS------DVYSYGVVILELLSGR 1171
APE +L++S D++S G + E+ +
Sbjct: 186 RAPE------VLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 5e-15
Identities = 52/220 (23%), Positives = 90/220 (40%), Gaps = 40/220 (18%)
Query: 977 LGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQG-GREFLAEVEMLSRLHHRNLVKLIGICI 1035
+G G +G VY DG LK+++ G E+ +L L H N++ L + +
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88
Query: 1036 EEQARC--LVYELIPNGSVESHLHGV-DKESAPLGWDARLKIALGAA--------RALAY 1084
R L+++ E L + A +++ G + Y
Sbjct: 89 SHADRKVWLLFDY-----AEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 143
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLAR--SAMDEESRHISTRVMGTF 1138
LH + V+HRD K +NIL+ + K++D G AR ++ + + V+ TF
Sbjct: 144 LH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199
Query: 1139 GYVAPEYAMTGHLLVKS-------DVYSYGVVILELLSGR 1171
Y APE LL+ + D+++ G + ELL+
Sbjct: 200 WYRAPE------LLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 6e-15
Identities = 70/286 (24%), Positives = 121/286 (42%), Gaps = 44/286 (15%)
Query: 905 YKSHACQAEEVPQSLQTSHVKPSGAAGLMVGSGLDSASLSFGSSIATYTGSAKTFSASEI 964
+ H + E G G ++ A TG A+
Sbjct: 3 HHHHHHEEEGGSSGGAAGTSADGG------DGGEQLLTVKHELRTANLTGHAEKVGIE-- 54
Query: 965 EKATGNFDASRILGEGGFGLVY----SGVLDDGTKVAVKVLKR---VDQQGGREF-LAEV 1016
NF+ ++LG G +G V+ D G A+KVLK+ V + E E
Sbjct: 55 -----NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTER 109
Query: 1017 EMLSRL-HHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL-- 1072
++L + LV L + + + L+ + I G + +HL ++ + + ++
Sbjct: 110 QVLEHIRQSPFLVTLHY-AFQTETKLHLILDYINGGELFTHLSQRERFTEH---EVQIYV 165
Query: 1073 -KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
+I L AL +LH+ +I+RD K NILL+ + ++DFGL++ + +E+
Sbjct: 166 GEIVL----ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218
Query: 1132 TRVMGTFGYVAPE---YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
GT Y+AP+ +GH K+ D +S GV++ ELL+G P
Sbjct: 219 DFC-GTIEYMAPDIVRGGDSGH--DKAVDWWSLGVLMYELLTGASP 261
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 76.4 bits (189), Expect = 7e-15
Identities = 64/236 (27%), Positives = 110/236 (46%), Gaps = 32/236 (13%)
Query: 954 GSAKTFSASEIEKAT-GNFDASRILGEGGFGLVY----SGVLDDGTKVAVKVL-KRVDQQ 1007
GS++T EK F+ R+LG+GG+G V+ + G A+KVL K + +
Sbjct: 1 GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60
Query: 1008 GGREF---LAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKES 1063
++ AE +L + H +V LI + + L+ E + G + L
Sbjct: 61 NAKDTAHTKAERNILEEVKHPFIVDLIY-AFQTGGKLYLILEYLSGGELFMQLEREGIFM 119
Query: 1064 APLGWDARL---KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120
A +I++ AL +LH+ +I+RD K NI+L H K++DFGL +
Sbjct: 120 ED---TACFYLAEISM----ALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 1121 SAMDEESRHISTRVM-GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
++ + + T GT Y+APE +GH ++ D +S G ++ ++L+G P
Sbjct: 170 ESIHDGTV---THTFCGTIEYMAPEILMRSGH--NRAVDWWSLGALMYDMLTGAPP 220
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 2e-14
Identities = 60/246 (24%), Positives = 101/246 (41%), Gaps = 19/246 (7%)
Query: 938 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 995
LD +L +I + K + +++ +++G G FG V K
Sbjct: 36 LDFPALRKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRK 95
Query: 996 V-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGS 1051
V A+K+L + + + F E ++++ + +V+L +++ +V E +P G
Sbjct: 96 VYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 155
Query: 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111
+ + + P W AR A AL +H S IHRD K N+LL+
Sbjct: 156 LVNLM---SNYDVPEKW-ARFYTAEVVL-ALDAIH---SMGFIHRDVKPDNMLLDKSGHL 207
Query: 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVK----SDVYSYGVVILEL 1167
K++DFG E T V GT Y++PE + D +S GV + E+
Sbjct: 208 KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266
Query: 1168 LSGRKP 1173
L G P
Sbjct: 267 LVGDTP 272
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 2e-14
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 33/218 (15%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSRL 1022
+FD ++LG+G FG V L G A+K+L++ E + E +L
Sbjct: 6 DFDYLKLLGKGTFGKVI---LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT 62
Query: 1023 HHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALGA 1078
H L L + R C V E G + HL + AR +I
Sbjct: 63 RHPFLTALKY-AFQTHDRLCFVMEYANGGELFFHLSRERVFTEE---RARFYGAEIVS-- 116
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GT 1137
AL YLH V++RD K N++L+ D K++DFGL + + + + + GT
Sbjct: 117 --ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGT 168
Query: 1138 FGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
Y+APE + ++ D + GVV+ E++ GR P
Sbjct: 169 PEYLAPEVLEDNDY--GRAVDWWGLGVVMYEMMCGRLP 204
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 47/227 (20%), Positives = 90/227 (39%), Gaps = 49/227 (21%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH---------- 1023
R LG G F V+ + + T VA+K+++ D+ E+++L R++
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 1024 -HRNLVKLIG----ICIEEQARCLVYELIPNGSVESHLHGVDKES--APLGWDARLKIAL 1076
+++KL+ +V+E++ +L + K+ + +I+
Sbjct: 84 GANHILKLLDHFNHKGPNGVHVVMVFEVL-----GENLLALIKKYEHRGIPLIYVKQISK 138
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEH------DFTPKVSDFGLARSAMDEESRHI 1130
L Y+H +IH D K N+L+E K++D G A + + I
Sbjct: 139 QLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 196
Query: 1131 STRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 1171
TR Y +PE + +D++S +I EL++G
Sbjct: 197 QTRE-----YRSPEVLLGAPWGC------GADIWSTACLIFELITGD 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 75.4 bits (185), Expect = 2e-14
Identities = 35/123 (28%), Positives = 55/123 (44%), Gaps = 4/123 (3%)
Query: 1052 VESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111
VE D L + + + A+ + +L +S + IHRD + NILL
Sbjct: 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVV 232
Query: 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-G 1170
K+ DFGLAR + ++APE ++SDV+S+GV++ E+ S G
Sbjct: 233 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292
Query: 1171 RKP 1173
P
Sbjct: 293 ASP 295
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 3e-10
Identities = 34/163 (20%), Positives = 57/163 (34%), Gaps = 20/163 (12%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRN 1026
+ LG G FG V VAVK+LK R ++E+++L + HH N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 1027 LVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+V L+G C + ++ E G++ ++L R + + +
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR-----------SKRNEFVPYKTKGARFR 136
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128
I D K + + S F +S D E
Sbjct: 137 QGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 3e-14
Identities = 46/213 (21%), Positives = 76/213 (35%), Gaps = 53/213 (24%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIG 1032
++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 24 QVLGLGINGKVLQIFNKRTQEKFALKMLQDCP-----KARREVELHWRASQCPHIVRIVD 78
Query: 1033 ICIEEQARC-----LVYELIPNG----SVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
+ E +V E + G ++ E +A +I A+
Sbjct: 79 VY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTER-----EAS-EIMKSIGEAIQ 131
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
YLH S + HRD K N+L + K++DFG
Sbjct: 132 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
A E + D++S GV++ LL G P
Sbjct: 167 -AKETTGEKYDK-SCDMWSLGVIMYILLCGYPP 197
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 4e-14
Identities = 52/251 (20%), Positives = 98/251 (39%), Gaps = 24/251 (9%)
Query: 938 LDSASLSFGSSIATYTGSAKTFSASEIEKATG--NFDASRILGEGGFGLVYSGVLDDGTK 995
L ++ L+ +A + A+ E +F+ +++G G F V + +
Sbjct: 28 LGASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQ 87
Query: 996 V-AVKVLKR---VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNG 1050
V A+K++ + + + F E ++L R + +L +++ LV E G
Sbjct: 88 VYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF-AFQDENYLYLVMEYYVGG 146
Query: 1051 SVESHLHGVDKESAPLGWD-ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1109
+ + L K + + AR +A A+ +H +HRD K NILL+
Sbjct: 147 DLLTLL---SKFGERIPAEMARFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCG 199
Query: 1110 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVY-------SYGV 1162
+++DFG + + V GT Y++PE + Y + GV
Sbjct: 200 HIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258
Query: 1163 VILELLSGRKP 1173
E+ G+ P
Sbjct: 259 FAYEMFYGQTP 269
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 73.8 bits (180), Expect = 6e-14
Identities = 39/254 (15%), Positives = 70/254 (27%), Gaps = 68/254 (26%)
Query: 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVD--------QQGGREFLAEVEM 1018
T +GEG FG V+ + D T VA+K++ Q+ E L E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 1019 LSRLH---------HRNLVKLIGICI------------------------------EEQA 1039
L + L + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1099
+V E G + + I +LA S R HRD
Sbjct: 137 LFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLH 189
Query: 1100 SSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAP--EYAMTGHLLVKSDV 1157
N+LL+ K+ +S+ + + G +Y ++ V
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSST-----------IPSCGLQVSIIDYTLSRLERDGIVV 238
Query: 1158 YSYGVVILELLSGR 1171
+ + +L +G
Sbjct: 239 FCDVSMDEDLFTGD 252
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 2e-13
Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 51/221 (23%)
Query: 975 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 1025
+++G+G FG V D VA+K+++ +Q E+ +L L +
Sbjct: 103 KVIGKGSFGQVVK-AYDHKVHQHVALKMVRNEKRFHRQA----AEEIRILEHLRKQDKDN 157
Query: 1026 --NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARL--KIALGAARA 1081
N++ ++ C+ +EL+ +L+ + K++ G+ L K A +
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELL-----SMNLYELIKKNKFQGFSLPLVRKFAHSILQC 212
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRH---ISTRVMG 1136
L LH R+IH D K NILL+ KV DFG S+ E R I +R
Sbjct: 213 LDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSR--- 263
Query: 1137 TFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSGR 1171
F Y APE Y M D++S G ++ ELL+G
Sbjct: 264 -F-YRAPEVILGARYGM------PIDMWSLGCILAELLTGY 296
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 3e-13
Identities = 61/225 (27%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 970 NFDASRILGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGG------RE--FLAEVEML 1019
++ +GEG +G V+ + + G VA+K ++ + G RE L L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH---L 68
Query: 1020 SRLHHRNLVKLIGICIEEQARC-----LVYELIPNGSVESHLHGV-DKESAPLGWDARLK 1073
H N+V+L +C + LV+E V+ L DK P +K
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-----VDQDLTTYLDKVPEPGVPTETIK 123
Query: 1074 -IALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+ R L +LH S RV+HRD K NIL+ K++DFGLAR + +++
Sbjct: 124 DMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLAR-IYSFQMA-LTS 178
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKS------DVYSYGVVILELLSGR 1171
V+ T Y APE +L++S D++S G + E+ +
Sbjct: 179 VVV-TLWYRAPE------VLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 5e-13
Identities = 58/218 (26%), Positives = 95/218 (43%), Gaps = 32/218 (14%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSR- 1021
+F ++LG+G FG V+ L A+K LK+ + + E +LS
Sbjct: 18 DFILHKMLGKGSFGKVF---LAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA 74
Query: 1022 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1077
H L + + + V E + G + H+ K A +I L
Sbjct: 75 WEHPFLTHMFC-TFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFYAAEIIL- 129
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1136
L +LH +++RD K NILL+ D K++DFG+ + M +++ T G
Sbjct: 130 ---GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180
Query: 1137 TFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
T Y+APE + G S D +S+GV++ E+L G+ P
Sbjct: 181 TPDYIAPE-ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 7e-13
Identities = 57/219 (26%), Positives = 99/219 (45%), Gaps = 34/219 (15%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR- 1021
+F+ +LG+G FG V L AVK+LK+ + + E +L+
Sbjct: 21 DFNFLMVLGKGSFGKVM---LSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP 77
Query: 1022 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1077
L +L C + R V E + G + H+ V + P A +IA+
Sbjct: 78 GKPPFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAI- 132
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1136
L +L +I+RD K N++L+ + K++DFG+ + + + T+ G
Sbjct: 133 ---GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 183
Query: 1137 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
T Y+APE A + KS D +++GV++ E+L+G+ P
Sbjct: 184 TPDYIAPEIIAYQPY--GKSVDWWAFGVLLYEMLAGQAP 220
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 8e-13
Identities = 57/250 (22%), Positives = 92/250 (36%), Gaps = 89/250 (35%)
Query: 975 RILGEGGFGLVYSGVLDDGTK--VAVKVLKRVD---QQGGREFLAEVEMLSRL-----HH 1024
R +G+G FG V K AVKV++ + + E ++L ++ ++
Sbjct: 41 RKMGDGTFGRVLL-CQHIDNKKYYAVKVVRNIKKYTRSA----KIEADILKKIQNDDINN 95
Query: 1025 RNLVKLIG-------ICI--EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARLKI 1074
N+VK G +C+ E L YE+I N H+ + +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSL-YEIITRNNYNGFHIEDI-----------K-LY 142
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP----------------------- 1111
+ +AL YL + + H D K NILL+ +
Sbjct: 143 CIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 1112 --KVSDFGLARSAMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSY 1160
K+ DFG A + H I+TR Y APE + + SD++S+
Sbjct: 200 GIKLIDFG---CATFKSDYHGSIINTR----Q-YRAPEVILNLGWDV------SSDMWSF 245
Query: 1161 GVVILELLSG 1170
G V+ EL +G
Sbjct: 246 GCVLAELYTG 255
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 9e-13
Identities = 40/266 (15%), Positives = 77/266 (28%), Gaps = 59/266 (22%)
Query: 977 LGEGGFGLVYSG---VLDDGTKVAVKVLK---RVDQQGGREFLAEVEMLSRLHHRNLVKL 1030
G + LD +VA+ + + +E L+ LSR+ + ++
Sbjct: 39 HGGVPPLQFWQALDTALDR--QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 1031 IGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSS 1090
+ + +V E I GS++ ++ A A H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHRAG- 149
Query: 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGH 1150
V S + + D G V+ +
Sbjct: 150 --VALSIDHPSRVRVSID--------GDV--------------VLAYPATMPDANP---- 181
Query: 1151 LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS-LGN 1209
+ D+ G + LL R P+ R+ + I+P+ +
Sbjct: 182 ---QDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADIDR 230
Query: 1210 DVPFDSVAKVAAIASMCVQPEVQHRP 1235
D+PF ++A+A+ VQ + R
Sbjct: 231 DIPFQ----ISAVAARSVQGDGGIRS 252
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 2e-12
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 20/212 (9%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 1024
+F+ +LG+G FG V AVK+LK+ + + E +L+
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 1025 RNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
L +L C + R V E + G + H+ V + P A A A L
Sbjct: 402 PFLTQLHS-CFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAA-EIAIGLF 456
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-GTFGYVA 1142
+L +I+RD K N++L+ + K++DFG+ + + + T+ GT Y+A
Sbjct: 457 FLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIA 510
Query: 1143 PEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
PE + KS D +++GV++ E+L+G+ P
Sbjct: 511 PE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 2e-12
Identities = 60/223 (26%), Positives = 98/223 (43%), Gaps = 42/223 (18%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK--------RVDQ-QGGREFLAEV 1016
+FD R++G G + V L A+KV+K +D Q + +
Sbjct: 10 DFDLLRVIGRGSYAKVL---LVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA 66
Query: 1017 EMLSRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL--- 1072
+H LV L C + ++R V E + G + H+ K AR
Sbjct: 67 -----SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSA 117
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+I+L AL YLHE +I+RD K N+LL+ + K++D+G+ + + T
Sbjct: 118 EISL----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---T 167
Query: 1133 RVM-GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
GT Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 168 STFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 50/227 (22%), Positives = 85/227 (37%), Gaps = 41/227 (18%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 1026
NF + +G G FG + G L VA+K+ + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDG 66
Query: 1027 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDK----ESAPLGWDARLKIALGAARA 1081
+ ++ + +V EL+ G S+E D+ ++ L IA+
Sbjct: 67 IPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDRTFSLKTV-------LMIAIQLISR 117
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS-----DFGLARSAMDEES-RHISTR-- 1133
+ Y+H + +I+RD K N L+ DF LA+ +D E+ +HI R
Sbjct: 118 MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREH 174
Query: 1134 --VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
+ GT Y + HL + D+ + G + + L G P
Sbjct: 175 KSLTGT-----ARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 5e-12
Identities = 62/219 (28%), Positives = 98/219 (44%), Gaps = 34/219 (15%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGREF---LAEVEMLSR- 1021
NF+ R+LG+G FG V L + G AVKVLK+ + + E +LS
Sbjct: 24 NFEFIRVLGKGSFGKVM---LARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLA 80
Query: 1022 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIALG 1077
+H L +L C + R V E + G + H+ + AR +I
Sbjct: 81 RNHPFLTQLFC-CFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEIIS- 135
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM-G 1136
AL +LH+ +I+RD K N+LL+H+ K++DFG+ + + T G
Sbjct: 136 ---ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCG 186
Query: 1137 TFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
T Y+APE + + D ++ GV++ E+L G P
Sbjct: 187 TPDYIAPEILQEMLY--GPAVDWWAMGVLLYEMLCGHAP 223
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 5e-12
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 36/220 (16%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLK--------RVDQ-QGGREFLAEVEML 1019
+FD R++G G + V L A++V+K +D Q + +
Sbjct: 53 DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA--- 109
Query: 1020 SRLHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIA 1075
+H LV L C + ++R V E + G + H+ K AR +I+
Sbjct: 110 --SNHPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEIS 163
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
L AL YLHE +I+RD K N+LL+ + K++D+G+ + + T
Sbjct: 164 L----ALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTF 213
Query: 1136 -GTFGYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
GT Y+APE + G S D ++ GV++ E+++GR P
Sbjct: 214 CGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 5e-12
Identities = 51/238 (21%), Positives = 84/238 (35%), Gaps = 69/238 (28%)
Query: 975 RILGEGGFGLVYSGV--LDDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHR---- 1025
LGEG FG V + ++VA+K+++ V + E+ +L ++ +
Sbjct: 25 GNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA----RLEINVLKKIKEKDKEN 80
Query: 1026 --NLVKLIGICIEEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL--KIALGAAR 1080
V + C+ +EL+ N KE+ + +A
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLGKN------TFEFLKENNFQPYPLPHVRHMAYQLCH 134
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-------------------KVSDFGLARS 1121
AL +LHE ++ H D K NIL + +V+DFG S
Sbjct: 135 ALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---S 188
Query: 1122 AMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVILELLSG 1170
A + H ++TR Y PE +A DV+S G ++ E G
Sbjct: 189 ATFDHEHHTTIVATRH-----YRPPEVILELGWAQ------PCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 6e-12
Identities = 60/246 (24%), Positives = 91/246 (36%), Gaps = 85/246 (34%)
Query: 975 RILGEGGFGLVYSGVLDDGTK---VAVKVLKRVD---QQGGREFLAEVEMLSRLHHR--- 1025
LGEG FG V +D VAVK++K VD + +E+++L L+
Sbjct: 20 DTLGEGAFGKVVE-CIDHKAGGRHVAVKIVKNVDRYCEAA----RSEIQVLEHLNTTDPN 74
Query: 1026 ---NLVKLIG-------ICI--EEQARCLVYELI-PNGSVESHLHGVDKESAPLGWDARL 1072
V+++ ICI E Y+ I NG + L + R
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGLST-YDFIKENGFLPFRLDHI-----------R- 121
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP-------------------KV 1113
K+A +++ +LH ++ H D K NIL KV
Sbjct: 122 KMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 1114 SDFGLARSAMDEESRH---ISTRVMGTFGYVAPE------YAMTGHLLVKSDVYSYGVVI 1164
DFG SA ++ H +STR Y APE ++ DV+S G ++
Sbjct: 179 VDFG---SATYDDEHHSTLVSTRH-----YRAPEVILALGWSQ------PCDVWSIGCIL 224
Query: 1165 LELLSG 1170
+E G
Sbjct: 225 IEYYLG 230
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 52/221 (23%), Positives = 86/221 (38%), Gaps = 31/221 (14%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 1026
+ R +G G FG +Y G + G +VA+K+ + + E ++ +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 1027 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ + E +V EL+ G S+E + ++ L +A + Y+
Sbjct: 67 IPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYI 121
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPK---VSDFGLARSAMDEESR-HISTR----VMGT 1137
H S IHRD K N L+ + DFGLA+ D + HI R + GT
Sbjct: 122 H---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 178
Query: 1138 FGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
YA + HL + + D+ S G V++ G P
Sbjct: 179 -----ARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-12
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLK-----RVDQQGGREFLAEVEMLS 1020
+F +++G+G FG V L + AVKVL+ + ++ + ++E +L
Sbjct: 39 DFHFLKVIGKGSFGKVL---LARHKAEEVFYAVKVLQKKAILKKKEE--KHIMSERNVLL 93
Query: 1021 R-LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARL---KIA 1075
+ + H LV L + + V + I G + HL P AR +IA
Sbjct: 94 KNVKHPFLVGLHF-SFQTADKLYFVLDYINGGELFYHLQRERCFLEP---RARFYAAEIA 149
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVM 1135
AL YLH + +++RD K NILL+ ++DFGL + ++ S T
Sbjct: 150 S----ALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTF 199
Query: 1136 -GTFGYVAPE-YAMTGHLLVKS-DVYSYGVVILELLSGRKP 1173
GT Y+APE + ++ D + G V+ E+L G P
Sbjct: 200 CGTPEYLAPEVLHKQPY--DRTVDWWCLGAVLYEMLYGLPP 238
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 9e-12
Identities = 50/227 (22%), Positives = 86/227 (37%), Gaps = 41/227 (18%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RN 1026
++ R +GEG FG+++ G L + +VA+K R + + E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 1027 LVKLIGICIEEQARCLVYELIPNG-SVESHLHGVDK----ESAPLGWDARLKIALGAARA 1081
+ + E LV +L+ G S+E L + ++ A
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTV-------AMAAKQMLAR 118
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPK-----VSDFGLARSAMDEES-RHISTR-- 1133
+ +HE S +++RD K N L+ + V DFG+ + D + +HI R
Sbjct: 119 VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175
Query: 1134 --VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
+ GT Y + HL + D+ + G V + L G P
Sbjct: 176 KNLSGT-----ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 1e-11
Identities = 45/233 (19%), Positives = 85/233 (36%), Gaps = 47/233 (20%)
Query: 975 RILGEGGFGLVYSGVLDDGT------KVAVKVLKRVDQQGGREF-----LAEVEMLSRLH 1023
+G+GGFG +Y ++ VKV + E A+ E + +
Sbjct: 41 LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWI 100
Query: 1024 HRNLVKLIGIC----------IEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARL 1072
+K +G+ + R ++ + G ++ + + L
Sbjct: 101 RTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQKIY---EANAKRFSRKTVL 155
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEES-RH 1129
+++L L Y+HE +H D K+SN+LL + +V D+GLA E +
Sbjct: 156 QLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKA 212
Query: 1130 ISTR----VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
+ GT E+ + H V + D+ G +++ L+G P
Sbjct: 213 YAADPKRCHDGT-----IEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 2e-11
Identities = 38/232 (16%), Positives = 54/232 (23%), Gaps = 12/232 (5%)
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
SH + P A P+ P + A S PP + P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGA-----VPSM 56
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
+ T H + + + P P+ A P P
Sbjct: 57 GQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPN--AYMQPQVPVQMGTPLQQQQQ 114
Query: 314 NTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP 373
A P PS + P T PP PP P +
Sbjct: 115 PMAAPAYGQPSAAMGQNMRPMNQLYPIDLL----TELPPPITDLTLPPPPLVIPPERMLV 170
Query: 374 PASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLP 425
P S SN + N P ++S + L + P
Sbjct: 171 P-SELSNASPDYIRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPP 221
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 67.5 bits (164), Expect = 3e-11
Identities = 31/209 (14%), Positives = 49/209 (23%), Gaps = 3/209 (1%)
Query: 266 SHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP-PASHPSNTAPPPASHPS 324
SH K P A P P++ PP + + P P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 325 NTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIP 384
T H + + P P+ A P P A P
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPN--AYMQPQVPVQMGTPLQQQQQPMAAP 119
Query: 385 PASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDA 444
PS + + L +P P +P + + S +S
Sbjct: 120 AYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASP 179
Query: 445 PAATPRGNFHRHSPAIHPSMPGPLPPVAQ 473
N + ++ P V +
Sbjct: 180 DYIRSTLNAVPKNSSLLKKSKLPFGLVIR 208
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 66.8 bits (162), Expect = 4e-11
Identities = 32/196 (16%), Positives = 53/196 (27%), Gaps = 1/196 (0%)
Query: 167 AFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSN 226
+P A P P+ P + + P A+PS + P+
Sbjct: 8 VYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLT-PAQ 66
Query: 227 TALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPP 286
L + T+ + P ++ P+ P + P + P+ P
Sbjct: 67 EQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSA 126
Query: 287 ASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSS 346
A + P T PPP S SN +P +
Sbjct: 127 AMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTL 186
Query: 347 KTAPPPASHPSNTALP 362
P +S + LP
Sbjct: 187 NAVPKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 64.8 bits (157), Expect = 2e-10
Identities = 31/218 (14%), Positives = 46/218 (21%), Gaps = 6/218 (2%)
Query: 222 SHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSN 281
SH P A L P + PP S P + A P
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 282 TAPPPASHPSKTAPPPAS------HPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
P + S H P A + P A+
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAY 121
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
+ + T LPP PP P + P+ + +
Sbjct: 122 GQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDY 181
Query: 396 HASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAP 433
S + + + P L + P
Sbjct: 182 IRSTLNAVPKNSSLLKKSKLPFGLVIRPYQHLYDDIDP 219
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 64.1 bits (155), Expect = 3e-10
Identities = 33/217 (15%), Positives = 54/217 (24%), Gaps = 1/217 (0%)
Query: 158 PLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTA 217
P A + P P+ P + + P + A P P++
Sbjct: 10 PQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLT-PAQEQ 68
Query: 218 PSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPAS 277
+ T++ L + P +++ P P + P + P+ P A
Sbjct: 69 LHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
Query: 278 HPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNT 337
+ P T PPP S SN +P N
Sbjct: 129 GQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNA 188
Query: 338 APPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
P +S K+ P P
Sbjct: 189 VPKNSSLLKKSKLPFGLVIRPYQHLYDDIDPPPLNED 225
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 58.7 bits (141), Expect = 1e-08
Identities = 24/185 (12%), Positives = 43/185 (23%), Gaps = 8/185 (4%)
Query: 299 SHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSN 358
SH P A P P+ PP + + PP +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQ------MGMPPQGAVPS 55
Query: 359 TALPPASHPSNPAIPPASHPSNTAIPPASHPSN--TAPPHASHPSNTALTPASHPSNIAP 416
P+ + + T++ + P P P
Sbjct: 56 MGQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQP 115
Query: 417 PPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRN 476
PSA G+ + + D P P +P V + +
Sbjct: 116 MAAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELS 175
Query: 477 ASNRE 481
++ +
Sbjct: 176 NASPD 180
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 57.5 bits (138), Expect = 3e-08
Identities = 30/165 (18%), Positives = 42/165 (25%), Gaps = 2/165 (1%)
Query: 343 SHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSN 402
SH K P A P P+ P + + P A P S
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVP--SMGQQ 59
Query: 403 TALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHP 462
LTPA + + L V + P P + P P
Sbjct: 60 QFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAP 119
Query: 463 SMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVARP 507
+ P + Q N+ PI P + P+ P
Sbjct: 120 AYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIP 164
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 2e-07
Identities = 27/206 (13%), Positives = 40/206 (19%), Gaps = 2/206 (0%)
Query: 114 TAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASP 173
A P P + P A + P +
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 174 PSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPAS 233
+ + + P P+ P T L + P A +
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 234 LPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKT 293
L PPP + T P P S SN +P
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDL--TLPPPPLVIPPERMLVPSELSNASPDYIRSTLNA 188
Query: 294 APPPASHPSNTAPPPASHPSNTAPPP 319
P +S + P
Sbjct: 189 VPKNSSLLKKSKLPFGLVIRPYQHLY 214
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 54.1 bits (129), Expect = 3e-07
Identities = 33/206 (16%), Positives = 46/206 (22%), Gaps = 2/206 (0%)
Query: 103 PTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASP 162
+ P PP P S + PP V TP
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQD--PAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQ 68
Query: 163 LSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPAS 222
L + + ++ A P + P A P+ PS A
Sbjct: 69 LHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAM 128
Query: 223 HPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNT 282
+ + P T PPP L S S +P N
Sbjct: 129 GQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNA 188
Query: 283 APPPASHPSKTAPPPASHPSNTAPPP 308
P +S K+ P
Sbjct: 189 VPKNSSLLKKSKLPFGLVIRPYQHLY 214
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.8 bits (123), Expect = 2e-06
Identities = 30/193 (15%), Positives = 45/193 (23%), Gaps = 7/193 (3%)
Query: 60 GHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPV 119
G +P++ P PP + P P A
Sbjct: 17 GQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLHQQIDQA 76
Query: 120 NMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAAR 179
+ + P+ P P + + P P+A+P +
Sbjct: 77 TTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQNMRPMN 136
Query: 180 PPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTA 239
T PP PPP P L S SN +
Sbjct: 137 QLYPIDLLTELPPPITDLTLPPPPLVIPPERML-------VPSELSNASPDYIRSTLNAV 189
Query: 240 PPPASHLSNTAPP 252
P +S L + P
Sbjct: 190 PKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 2e-06
Identities = 29/204 (14%), Positives = 45/204 (22%), Gaps = 1/204 (0%)
Query: 83 SPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAP 142
+ +A P + P +P A+ S PS+ +P
Sbjct: 12 AQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSM-GQQQFLTPAQEQLH 70
Query: 143 PLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPP 202
++ + A+ P P A P PS
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 203 PASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSP 262
+ P T PP + S LSN +P P
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAVP 190
Query: 263 LPASHPSKTAPPPASHPSNTAPPP 286
+S K+ P
Sbjct: 191 KNSSLLKKSKLPFGLVIRPYQHLY 214
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 4e-05
Identities = 31/193 (16%), Positives = 49/193 (25%), Gaps = 4/193 (2%)
Query: 24 QGSAGYGIPPSPAIIGGHFLLPRLPVTFTLKPHLLGG---HAPSPIELPTHSAPPPVNIP 80
Q YG +P F+ P+ P + +G A + P +
Sbjct: 11 QAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQFLTPAQEQLH 70
Query: 81 SFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPIT 140
+ P + P + + P+ P P S
Sbjct: 71 QQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPMAAPAYGQPSAAMGQ 130
Query: 141 APPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTA 200
+N L L+ P + PP P P S SN +
Sbjct: 131 NMRPMNQLYPIDLLTELPPPITDLTLPPPPLVIPPERMLVP-SELSNASPDYIRSTLNAV 189
Query: 201 PPPASHPSNTALP 213
P +S + LP
Sbjct: 190 PKNSSLLKKSKLP 202
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 46.4 bits (109), Expect = 6e-05
Identities = 30/166 (18%), Positives = 43/166 (25%), Gaps = 5/166 (3%)
Query: 365 SHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVL 424
SH P A P P+ PP + S+ PP VP +
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAA-----GMSYGQMGMPPQGAVPSM 56
Query: 425 PSALPGKAPVSQSPISLPDAPAATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPI 484
Q + A + + H + P PV ++ P+
Sbjct: 57 GQQQFLTPAQEQLHQQIDQATTSMNDMHLHNVPLVDPNAYMQPQVPVQMGTPLQQQQQPM 116
Query: 485 AEPIAPGPFPPGNSRQKSPVARPIIPGGTPTASPDPDVPPSTPPLS 530
A P P + I T P D+ PPL
Sbjct: 117 AAPAYGQPSAAMGQNMRPMNQLYPIDLLTELPPPITDLTLPPPPLV 162
|
| >1m2v_B SEC24, protein transport protein SEC24, SEC24P, SEC24 protein, abnormal nuclear; zinc-finger, beta barrel, VWA domain, gelsolin domain,; 2.75A {Saccharomyces cerevisiae} SCOP: a.71.2.1 b.2.8.1 c.62.1.2 d.109.2.1 g.41.10.1 Length = 926 | Back alignment and structure |
|---|
Score = 44.4 bits (104), Expect = 3e-04
Identities = 33/224 (14%), Positives = 53/224 (23%), Gaps = 28/224 (12%)
Query: 387 SHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPA 446
SH P A TP P+ PP S P + S+
Sbjct: 2 SHHKKRVYPQAQLQYGQNATPLQQPAQFMPPQDPAAAGMSYGQMGMPPQGAVPSMGQQQF 61
Query: 447 ATPRGNFHRHSPAIHPSMPGPLPPVAQKRNASNREAPIAEPIAPGPFPPGNSRQKSPVAR 506
TP + + P P + + PV
Sbjct: 62 LTPAQEQLHQQIDQATTSMNDMHL----------------HNVPLVDPNAYMQPQVPVQ- 104
Query: 507 PIIPGGTPTASPDPDVPPSTPPLSVDGKRVGKPVAEPSYDIPMPPPVNHSPSKAPSTHKY 566
G P P+ S + + + P++ P
Sbjct: 105 ---MGTPLQQQQQPMAAPAYGQPSA-------AMGQNMRPMNQLYPIDLLTELPPPITDL 154
Query: 567 MRHSNHSPLPPFSSPKP-PQNNGNDTPVSSPLASFPKHRDVRNK 609
+PP P +N + + S L + PK+ + K
Sbjct: 155 TLPPPPLVIPPERMLVPSELSNASPDYIRSTLNAVPKNSSLLKK 198
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 50/231 (21%), Positives = 88/231 (38%), Gaps = 46/231 (19%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREF--------LAEVEMLSRLHHR 1025
+ +G GGFGL+Y + K A V+K Q+ G F +A+ + + + R
Sbjct: 43 KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIER 102
Query: 1026 NLVKLIGI----------CIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKI 1074
+ +GI R +V E + G ++ L++
Sbjct: 103 KQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTV----LQL 156
Query: 1075 ALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEES-RHIS 1131
+ L Y+HE+ +H D K++N+LL + +V +D+GL+ + +
Sbjct: 157 GIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213
Query: 1132 TRV----MGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
GT E+ + H V +SDV G +L L G+ P
Sbjct: 214 ENPRKGHNGT-----IEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 61.7 bits (150), Expect = 7e-10
Identities = 43/234 (18%), Positives = 83/234 (35%), Gaps = 49/234 (20%)
Query: 975 RILGEGGFGLVYSGV---------LDDGTKVAVKVLKRVDQQGGREF-----LAEVEMLS 1020
G++Y K ++K+ + D + E A+ ++
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAK-DGRLFNEQNFFQRAAKPLQVN 106
Query: 1021 RLHHRNLVKLIGI-------CIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARL 1072
+ L+ I +++ R LV + G S++S L K + L
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLSER--SVL 162
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKV--SDFGLARSAMDEESRHI 1130
++A AL +LHE+ +H + + NI ++ + +V + +G A +H+
Sbjct: 163 QVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP-SGKHV 218
Query: 1131 STR------VMGTFGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
+ G E+ M H +SD+ S G +L+ L G P
Sbjct: 219 AYVEGSRSPHEGD-----LEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 54/269 (20%), Positives = 82/269 (30%), Gaps = 79/269 (29%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH--- 1023
G + R LG G F V+ + VA+KV+K + L E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS-AEHYTETALDEIRLLKSVRNSD 94
Query: 1024 -----HRNLVKLIGICIEEQA-----RCLVYELIPNGSVESHLHGVDKESAPLGWDARL- 1072
+V+L+ + C+V+E G HL +S G
Sbjct: 95 PNDPNREMVVQLLD-DFKISGVNGTHICMVFE--VLGH---HLLKWIIKSNYQGLPLPCV 148
Query: 1073 -KIALGAARALAYLHEDSSPRVIHRDFKSSNILLE------------------------- 1106
KI + L YLH R+IH D K NILL
Sbjct: 149 KKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 1107 ------------------------HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
K++D G A + I TR Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-----YRS 261
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGR 1171
E + +D++S + EL +G
Sbjct: 262 LEVLIGSGYNTPADIWSTACMAFELATGD 290
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 1e-07
Identities = 63/448 (14%), Positives = 123/448 (27%), Gaps = 143/448 (31%)
Query: 978 GEGGFG---LVYSGVLDDGTKVAVKVLKRVDQQG-----GREFLAE--VEMLSRLHHRNL 1027
G G G + L KV ++D + E +EML +L ++
Sbjct: 157 GVLGSGKTWVALDVCLSY------KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-- 208
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
+ PN + S D S +L+I A L
Sbjct: 209 ------------------IDPNWTSRS-----DHSSNI-----KLRIHSIQAELRRLLKS 240
Query: 1088 DSSPR--VIHRDFKSSNILLEHDFTPKV----SDFGLARSAMDEESRHIS---------- 1131
++ + +++ + + K+ + + HIS
Sbjct: 241 KPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP 300
Query: 1132 TRVMGTFGYVA-------PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN 1184
V P +T + S +I E + ++
Sbjct: 301 DEVKSLLLKYLDCRPQDLPREVLTTNPRRLS-------IIAESI-------------RDG 340
Query: 1185 LVAWARPLLTSREGLERIIDPSLGNDVP------------F-DSV---AKVAAIASMCV- 1227
L W + + L II+ SL P F S + + +
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTIL-----LSLI 395
Query: 1228 --QPEVQHRPFMGEVVQALKLVCNECDEAKEVGSASSSQDDMSIDLDSKVSTGSGQLPDP 1285
+V+ + + K+ ++ S + ++L K+ L
Sbjct: 396 WFDVIKS------DVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLE-NEYALHRS 448
Query: 1286 LQRHYSVP-NYDLGLDTGRRLSLSYLFS------SSARSGKEESELFRR-YSSSGPLRTG 1337
+ HY++P +D D Y +S + E LFR + R
Sbjct: 449 IVDHYNIPKTFDSD-DLIPPYLDQYFYSHIGHHLKNIEHP-ERMTLFRMVFLD---FR-- 501
Query: 1338 RGRQFW--QRIRRLVGGSDSEHGAVFSL 1363
+ Q+IR + + G++ +
Sbjct: 502 -----FLEQKIRH-DSTAWNASGSILNT 523
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.0 bits (132), Expect = 1e-07
Identities = 55/221 (24%), Positives = 89/221 (40%), Gaps = 31/221 (14%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL 1027
F R +G G FG +Y G + +VA+K+ + + L E ++ L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 1028 V-KLIGICIEEQARCLVYELIPNG-SVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ + +E LV +L+ G S+E + S L L +A + ++
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLL--GPSLEDLF---NFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPK---VSDFGLARSAMDEES-RHISTR----VMGT 1137
H S +HRD K N L+ + DFGLA+ D + +HI R + GT
Sbjct: 120 HSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGT 176
Query: 1138 FGYVAPEYA-MTGHLLV----KSDVYSYGVVILELLSGRKP 1173
YA + HL + + D+ S G V++ L G P
Sbjct: 177 -----ARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 54.4 bits (129), Expect = 2e-07
Identities = 29/173 (16%), Positives = 44/173 (25%)
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
P + PSPA S K A PPA+ + A PPA +
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPA 320
S S PS P + PP + + S
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 321 SHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIP 373
A ++ + + P + P P+ + P P +
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.8 bits (125), Expect = 6e-07
Identities = 30/173 (17%), Positives = 41/173 (23%)
Query: 140 TAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRT 199
P + P T A P S ARPPA+ + ARPPA R
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYK 259
+ S PS P A + P A P + +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHP 312
+ + S P + AP + P
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 52.8 bits (125), Expect = 7e-07
Identities = 29/169 (17%), Positives = 44/169 (26%)
Query: 155 PTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPS 214
P L+ + PA P A S ARPPA+ A PPA ++
Sbjct: 17 PPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDE 76
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
++PS P A P K + P A + +
Sbjct: 77 VSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGAR 136
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
+ ++ S + P AP + P
Sbjct: 137 VRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 51.7 bits (122), Expect = 1e-06
Identities = 30/172 (17%), Positives = 48/172 (27%), Gaps = 3/172 (1%)
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTA 294
P + APP + P PA + S K A PPA+ + A PPA + +
Sbjct: 17 PPRIAPPKLACR---TPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
S PS P + PP + + +S
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 355 HPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALT 406
AL ++ + + P + P+ + P L
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 49.7 bits (117), Expect = 6e-06
Identities = 28/180 (15%), Positives = 43/180 (23%), Gaps = 5/180 (2%)
Query: 177 AARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPS 236
A R P + PS P + S T+ K A PA+ + A PPA
Sbjct: 11 ARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRL 70
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPP 296
+ + S +P P + K + P A P +
Sbjct: 71 RLSVDEVS-----SPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELAS 125
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
+ ++ S P AP + P
Sbjct: 126 CLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 49.3 bits (116), Expect = 8e-06
Identities = 26/173 (15%), Positives = 37/173 (21%)
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
P P+L S +A PPA+P + ARPPA
Sbjct: 13 RRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRL 72
Query: 189 ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSN 248
+ S PS P + K + A P +
Sbjct: 73 SVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARE 132
Query: 249 TAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
+ S + P AP + P
Sbjct: 133 LGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLV 185
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 48.6 bits (114), Expect = 1e-05
Identities = 22/162 (13%), Positives = 37/162 (22%)
Query: 230 PPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASH 289
+ P PA S K + PA+ A PPA + S
Sbjct: 20 IAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSS 79
Query: 290 PSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTA 349
PS P + PP + + S + A
Sbjct: 80 PSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRA 139
Query: 350 PPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSN 391
++ + + P + P+ + P
Sbjct: 140 LKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGL 181
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 48.6 bits (114), Expect = 1e-05
Identities = 27/170 (15%), Positives = 38/170 (22%), Gaps = 2/170 (1%)
Query: 268 PSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 327
PP P PA + S A PPA+ + A PPA +
Sbjct: 16 GPPRIAPPKLAC--RTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 328 PPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
S PS P PP + + S
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 388 HPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQS 437
A ++ + + TP + P P P
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 47.4 bits (111), Expect = 3e-05
Identities = 26/163 (15%), Positives = 41/163 (25%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
+ P PA S K A PPA+ + A PPA + S P
Sbjct: 21 APPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSP 80
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
S P + + PP + + S A+
Sbjct: 81 STPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRAL 140
Query: 384 PPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPS 426
++ + + + P+ L P LP
Sbjct: 141 KASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPG 183
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 44.0 bits (102), Expect = 4e-04
Identities = 24/163 (14%), Positives = 35/163 (21%)
Query: 69 PTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLI 128
P APP + + SP+ PA+ AP P A PP
Sbjct: 17 PPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDE 76
Query: 129 PTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNT 188
++P P P L+S + A
Sbjct: 77 VSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGAR 136
Query: 189 ARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPP 231
R + +PA + P
Sbjct: 137 VRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQP 179
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 43.6 bits (101), Expect = 4e-04
Identities = 27/161 (16%), Positives = 40/161 (24%), Gaps = 2/161 (1%)
Query: 286 PASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHS 345
P P + P PA S A PPA+ + A PPA
Sbjct: 11 ARRRPGPPRIAPPK-LACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRR 69
Query: 346 SKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTAL 405
+ + S PS P +P + A P S S ++
Sbjct: 70 LRLSVDEVSSPSTPEAPDIPACPSPG-QKIKKSTPAAGQPPHLTSAQDQDTISELASCLQ 128
Query: 406 TPASHPSNIAPPPLFVPVLPSALPGKAPVSQSPISLPDAPA 446
+ + + +A APA
Sbjct: 129 RARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPA 169
|
| >2wvr_C DNA replication factor CDT1; DNA replication license, DNA replication inhibitor, phosphoprotein, UBL conjugation, DNA-binding, polymorphism; HET: DNA; 3.30A {Homo sapiens} PDB: 2klo_A* Length = 546 | Back alignment and structure |
|---|
Score = 43.6 bits (101), Expect = 4e-04
Identities = 27/168 (16%), Positives = 45/168 (26%), Gaps = 4/168 (2%)
Query: 247 SNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAP-PPASHPSNTA 305
PP SP + P+ AP A+ S P + P + PPA +
Sbjct: 17 PPRIAPPKLACRTPSP---ARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLS 73
Query: 306 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPAS 365
S PS P + PP S++ + S
Sbjct: 74 VDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRAREL 133
Query: 366 HPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSN 413
A+ ++ + + P + P P+ + P
Sbjct: 134 GARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGL 181
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 26/138 (18%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 241 PPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASH 300
H+ + ++ + P S AP P S S
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHS--PISTLSS 61
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
P N PP S S+ P + T S S P + S + N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 361 LPPASHPSNPAIPPASHP 378
L +HPS H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 23/139 (16%), Positives = 35/139 (25%), Gaps = 6/139 (4%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
H ++ +++ P S AP P S S P
Sbjct: 5 HHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPI--STLSSP 62
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAI 383
N PP S S P S + P + +T P S P NP +
Sbjct: 63 INGMGPPFSVIS----SPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 384 PPASHPSNTAPPHASHPSN 402
+ + +
Sbjct: 119 NGVLKVPAHPSGNMASFTK 137
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 5e-06
Identities = 26/138 (18%), Positives = 37/138 (26%), Gaps = 2/138 (1%)
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPP--PASH 311
A H + S + P+ A + P P P S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 312 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPA 371
P N PP S S+ P + T S S P + S++ N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 372 IPPASHPSNTAIPPASHP 389
+ +HPS H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 26/138 (18%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP--PASH 333
A H + S + P+ A + P P P S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 334 PSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
P N PP S S P + T S S P + S++ N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 394 PPHASHPSNTALTPASHP 411
+HPS + H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.6 bits (115), Expect = 1e-05
Identities = 26/138 (18%), Positives = 39/138 (28%), Gaps = 5/138 (3%)
Query: 296 PPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASH 355
H + ++ +++ P S AP P S S
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHS--PISTLSS 61
Query: 356 PSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIA 415
P N PP S S+ P H + P S +P +S + + + P
Sbjct: 62 PINGMGPPFSVISS---PMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 416 PPPLFVPVLPSALPGKAP 433
L VP PS
Sbjct: 119 NGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 2e-05
Identities = 22/135 (16%), Positives = 36/135 (26%), Gaps = 3/135 (2%)
Query: 287 ASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSS 346
A H S + P+ A + P P P ++ SS
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 347 ---KTAPPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNT 403
PP + S S P+ P + ++ + P S+ +
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 404 ALTPASHPSNIAPPP 418
PA N+A
Sbjct: 122 LKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 23/138 (16%), Positives = 36/138 (26%), Gaps = 3/138 (2%)
Query: 182 ASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPP 241
A H + S + P+ + APS P L S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMA--APSLHPSLGPGIGSPGQLHS-PIST 58
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
+S ++ PP + P S P+ ++ + P S P
Sbjct: 59 LSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGL 118
Query: 302 SNTAPPPASHPSNTAPPP 319
+ PA N A
Sbjct: 119 NGVLKVPAHPSGNMASFT 136
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 3e-05
Identities = 23/138 (16%), Positives = 36/138 (26%), Gaps = 2/138 (1%)
Query: 221 ASHPSNTALPPASLPSKTAPPPASHLSNTAPP--PASHPYKTSPLPASHPSKTAPPPASH 278
A H + + S + + P+ HP + + + S
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSS 61
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
P N PP S S P + T S S P + S++ N
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGV 121
Query: 339 PPPASHSSKTAPPPASHP 356
+H S H
Sbjct: 122 LKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 7e-05
Identities = 26/132 (19%), Positives = 38/132 (28%), Gaps = 3/132 (2%)
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASH 377
H + ++ +++ P S AP P S I S
Sbjct: 4 HHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSP--ISTLSS 61
Query: 378 PSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKAPVSQS 437
P N PP S S+ PH+ T S S P+ PV S
Sbjct: 62 PINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPM-NPVSSSEDIKPPLGLNG 120
Query: 438 PISLPDAPAATP 449
+ +P P+
Sbjct: 121 VLKVPAHPSGNM 132
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 25/142 (17%), Positives = 37/142 (26%), Gaps = 4/142 (2%)
Query: 171 ASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALP 230
A + S + P+ A + P SP S +
Sbjct: 2 AHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGPG--IGSPGQLHSP--IS 57
Query: 231 PASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHP 290
S P PP S +S+ P + T L S S P + S++
Sbjct: 58 TLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLG 117
Query: 291 SKTAPPPASHPSNTAPPPASHP 312
+HPS H
Sbjct: 118 LNGVLKVPAHPSGNMASFTKHI 139
|
| >3dzy_A Retinoic acid receptor RXR-alpha; DNA-binding, HOST-virus interaction, metal-binding, nucleus, receptor, transcription, transcription regulation, zinc-FIN activator; HET: DNA REA BRL; 3.10A {Homo sapiens} PDB: 3dzu_A* 3e00_A* Length = 467 | Back alignment and structure |
|---|
Score = 42.4 bits (99), Expect = 8e-04
Identities = 25/142 (17%), Positives = 43/142 (30%), Gaps = 5/142 (3%)
Query: 58 LGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPP 117
+ H ++ VN SP+ A + P + SP + +P
Sbjct: 1 MAHHHHHHVDDDDKMFSTQVNSSLTSPTGRGSMAAPSLHPSLGP----GIGSPGQLHSPI 56
Query: 118 PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTP-LASPLSSKAFPPASPPSN 176
+P + P V S P V P +P L+SP++ + P
Sbjct: 57 STLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPL 116
Query: 177 AARPPASHPSNTARPPASHPSR 198
P++ + AS
Sbjct: 117 GLNGVLKVPAHPSGNMASFTKH 138
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.8 bits (121), Expect = 2e-06
Identities = 16/150 (10%), Positives = 31/150 (20%)
Query: 194 SHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPP 253
+ P+ ++A+ + + S ++ ALPP ++
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 254 ASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPS 313
P+ P P + + + S PAS P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 314 NTAPPPASHPSNTAPPPASHPSNTAPPPAS 343
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 20/152 (13%), Positives = 30/152 (19%), Gaps = 2/152 (1%)
Query: 250 APPPASHPYKTSPLPASHPSKTAPPPASHPSNTA--PPPASHPSKTAPPPASHPSNTAPP 307
A + +S P N A PP S P S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
+ + P + S P S P + S +T+ P + L
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASH 399
S +
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGLMC 157
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 45.0 bits (106), Expect = 1e-04
Identities = 15/150 (10%), Positives = 32/150 (21%), Gaps = 1/150 (0%)
Query: 216 TAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPP 275
+ + PS+ +++ + + L++ A PP + +
Sbjct: 7 MSQVIQAMPSDLT-ISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMPPHGS 65
Query: 276 ASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 335
P+ P P + + + S PAS P P
Sbjct: 66 LQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLKCEPD 125
Query: 336 NTAPPPASHSSKTAPPPASHPSNTALPPAS 365
+
Sbjct: 126 EPQVQAKIMAYLQQEQANRSKHEKLSTFGL 155
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 3e-04
Identities = 19/156 (12%), Positives = 32/156 (20%), Gaps = 7/156 (4%)
Query: 84 PSTPAVSAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPP 143
+ V P I + + P + A PP+ +P + P P
Sbjct: 5 EAMSQVIQA---MPSDLTISSAIQNIHSASKGLPLNHAALPPTDYDRSPFVTSPISMTMP 61
Query: 144 LVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPS----RT 199
L P + S P S P + T+ P +
Sbjct: 62 PHGSLQGYQTYGHFPSRAIKSEYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELLK 121
Query: 200 APPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
P + +
Sbjct: 122 CEPDEPQVQAKIMAYLQQEQANRSKHEKLSTFGLMC 157
|
| >3tx7_B Nuclear receptor subfamily 5 group A member 2; LRH-1, beta-catenin, armadillo repeat, nuclear receptor LIGA binding domain, protein binding; HET: P6L; 2.76A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 42.3 bits (99), Expect = 8e-04
Identities = 26/169 (15%), Positives = 42/169 (24%), Gaps = 6/169 (3%)
Query: 255 SHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSN 314
+ +P+ +A S P PP S P S
Sbjct: 6 AMSQVIQAMPSDLTISSAIQNIHSASKGLPLN----HAALPPTDYDRSPFVTSPISMTMP 61
Query: 315 TAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
+ + P + S P P + S ++ + S PAS P
Sbjct: 62 PHGSLQGYQTYGHFPSRAIKS-EYPDPYTSSPESIMGYSYMDSYQTSSPASIPHLILELL 120
Query: 375 ASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPV 423
P + A+ + L+ +A LF V
Sbjct: 121 KCEPDEPQVQAKIMAY-LQQEQANRSKHEKLSTFGLMCKMADQTLFSIV 168
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 49.8 bits (118), Expect = 5e-06
Identities = 24/133 (18%), Positives = 39/133 (29%), Gaps = 8/133 (6%)
Query: 253 PASHPYKTSPLP----ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPP 308
H + + +P PS + AS PP + P APPP P+ PP
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPD-PAPPPPPAPAAGNPPD 63
Query: 309 ASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTAL--PPASH 366
++ + P+ + + PPA+ + L P
Sbjct: 64 TV-TGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPVPE 122
Query: 367 PSNPAIPPASHPS 379
P + S
Sbjct: 123 PDPVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 49.0 bits (116), Expect = 9e-06
Identities = 26/147 (17%), Positives = 40/147 (27%), Gaps = 14/147 (9%)
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPP 319
+S H S P P + + + A HP T P P APPP
Sbjct: 3 SSHHHHHHSSGLVPRG---SHMVIPSASVTSAASDFLAALHPPVTVPDP-------APPP 52
Query: 320 ASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPPASHPS 379
P+ PP ++ + P+ + + PPA+
Sbjct: 53 PPAPAAGNPPDTV-TGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGR- 110
Query: 380 NTAIPPASHPSNTAPPHASHPSNTALT 406
A+P H P +
Sbjct: 111 --AVPGLYHHPVPEPDPVRVEEVSRRI 135
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 1e-05
Identities = 21/137 (15%), Positives = 29/137 (21%), Gaps = 10/137 (7%)
Query: 175 SNAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASL 234
S+ S PS + AS P T P PA PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAP-------PPPPA 55
Query: 235 PSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTA 294
P+ PP + P + + + +
Sbjct: 56 PAAGNPPDTVTGDSVLQRILRGP---TGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAV 112
Query: 295 PPPASHPSNTAPPPASH 311
P HP P
Sbjct: 113 PGLYHHPVPEPDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.4 bits (112), Expect = 2e-05
Identities = 21/143 (14%), Positives = 30/143 (20%), Gaps = 13/143 (9%)
Query: 205 SHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLP 264
S + S P +PS + AS PP + P P P
Sbjct: 3 SSHHHHHHSSGLVPRG---------SHMVIPSASVTSAASDFLAALHPPVTVPDPAPP-P 52
Query: 265 ASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPS 324
P+ PP + P+ P + +
Sbjct: 53 PPAPAAGNPPDTVTGDSVLQRILRGPTG---PGTTSLAPAVRYGRQPGPEAPASAPPAAG 109
Query: 325 NTAPPPASHPSNTAPPPASHSSK 347
P HP P
Sbjct: 110 RAVPGLYHHPVPEPDPVRVEEVS 132
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 3e-05
Identities = 19/134 (14%), Positives = 31/134 (23%), Gaps = 4/134 (2%)
Query: 304 TAPPPASHPSNTAPP-PASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
++ H S P + + A+ A P APPP P+ P
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVP 422
+ ++ T S + + P P
Sbjct: 63 DT--VTGDSVLQRILRGPTGPGTTS-LAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
Query: 423 VLPSALPGKAPVSQ 436
V VS+
Sbjct: 120 VPEPDPVRVEEVSR 133
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 3e-05
Identities = 23/119 (19%), Positives = 33/119 (27%), Gaps = 3/119 (2%)
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSL-IPTTPVASPPPITAPPLVNVL 148
S+ L+P PS + + T P +PPP AP N
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGN-- 60
Query: 149 PAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
P ++ + L L P + + A R R P HP
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHP 119
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 47.1 bits (111), Expect = 4e-05
Identities = 24/131 (18%), Positives = 32/131 (24%), Gaps = 6/131 (4%)
Query: 192 PASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAP 251
H + P PS + S AS PP ++P PPP + + P
Sbjct: 5 HHHHHHSSGLVPRGSHMVI--PSASVTSAASDFLAALHPPVTVPDPAPPPPPAPAAGNPP 62
Query: 252 PPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASH 311
+ + T P S P A P P H
Sbjct: 63 DTVTGDSVLQRIL---RGPTGPGTTSLAPAVRYGRQPGPEAPASAP-PAAGRAVPGLYHH 118
Query: 312 PSNTAPPPASH 322
P P
Sbjct: 119 PVPEPDPVRVE 129
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.7 bits (105), Expect = 1e-04
Identities = 15/143 (10%), Positives = 28/143 (19%), Gaps = 15/143 (10%)
Query: 130 TTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTA 189
++ P ++ + + +S PP P A
Sbjct: 3 SSHHHHHHSSGLVP-----RGSHMVIPSASVTSAASDFLAALHPPVTVPDP--------A 49
Query: 190 RPPASHPSRTAPPPASHPSNTALPSKTAPS--PASHPSNTALPPASLPSKTAPPPASHLS 247
PP P+ PP + P+ + + +
Sbjct: 50 PPPPPAPAAGNPPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAG 109
Query: 248 NTAPPPASHPYKTSPLPASHPSK 270
P HP
Sbjct: 110 RAVPGLYHHPVPEPDPVRVEEVS 132
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 44.0 bits (103), Expect = 3e-04
Identities = 19/126 (15%), Positives = 32/126 (25%), Gaps = 4/126 (3%)
Query: 315 TAPPPASHPSNTAP--PPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAI 372
++ H S P PS + AS PP + P PP
Sbjct: 3 SSHHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAALHPPVTVPD--PAPPPPPAPAAGN 60
Query: 373 PPASHPSNTAIPPASHPSNTAPPHASHPSNTALTPASHPSNIAPPPLFVPVLPSALPGKA 432
PP + ++ + + P+ + + PP +P
Sbjct: 61 PPDTVTGDSVLQRILRGPTGPGTTSLAPAVRYGRQPGPEAPASAPPAAGRAVPGLYHHPV 120
Query: 433 PVSQSP 438
P
Sbjct: 121 PEPDPV 126
|
| >3v1v_A 2-MIB synthase, 2-methylisoborneol synthase; class I terpenoid cyclase fold, DDXXXXD motif, NDXXSXXXE MOT methylisoborneol biosynthesis; HET: GST; 1.80A {Streptomyces coelicolor} PDB: 3v1x_A* Length = 433 | Back alignment and structure |
|---|
Score = 43.6 bits (102), Expect = 4e-04
Identities = 21/128 (16%), Positives = 30/128 (23%), Gaps = 3/128 (2%)
Query: 118 PVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPSNA 177
+ L+P P + + A L P + P PA+
Sbjct: 5 HHHHHHSSGLVPRGSHMVIPSASVTSAASDFLAA-LHPPVTVPDPAPPPPPAPAAGNPPD 63
Query: 178 ARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSK 237
S R P + P T+ PA P A +P P
Sbjct: 64 TVTGDSVLQRILRGP-TGPGTTSLAPAVRYGRQPGPEAPASAP-PAAGRAVPGLYHHPVP 121
Query: 238 TAPPPASH 245
P
Sbjct: 122 EPDPVRVE 129
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 28/117 (23%), Positives = 37/117 (31%), Gaps = 8/117 (6%)
Query: 215 KTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPP 274
+T P + PA S+ AP ++ + + A
Sbjct: 328 QTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAP--SADAAQMKEMMAMMQKMQQQQ 385
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 331
A P APPP +P + PP PP P PPP P APP A
Sbjct: 386 AAYPPQGYAPPPQGYPPQGYPPQG------YPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 3e-05
Identities = 24/109 (22%), Positives = 30/109 (27%), Gaps = 3/109 (2%)
Query: 237 KTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTA---PPPASHPSKT 293
+T P + + +PA S AP +
Sbjct: 328 QTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAA 387
Query: 294 APPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPA 342
PP P PP +P PP P PPP P APP A
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 46.5 bits (110), Expect = 4e-05
Identities = 23/112 (20%), Positives = 31/112 (27%), Gaps = 6/112 (5%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
P + K + + P++ + A A P
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPP 390
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPA 353
APPP PP +P PP P PPP + APP A
Sbjct: 391 QGYAPPP------QGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 8e-05
Identities = 27/117 (23%), Positives = 35/117 (29%), Gaps = 5/117 (4%)
Query: 258 YKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
+T P + PA S AP ++ + A
Sbjct: 327 SQTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAP--SADAAQMKEMMAMMQKMQQQ 384
Query: 318 PPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHPSNPAIPP 374
A P APPP +P PP + + PP P PP P PA PP
Sbjct: 385 QAAYPPQGYAPPPQGYPPQG-YPPQGYPPQGYPPQGYPPPPQGAPPQGAP--PAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 18/98 (18%), Positives = 27/98 (27%)
Query: 201 PPPASHPSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKT 260
+ ++ +S + +A PP P
Sbjct: 339 FDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAAYPPQGYAPPPQ 398
Query: 261 SPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPA 298
P +P + PP P PPP P + APP A
Sbjct: 399 GYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 6e-04
Identities = 22/111 (19%), Positives = 29/111 (26%), Gaps = 3/111 (2%)
Query: 207 PSNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPAS 266
P PA S AP S + + K A+
Sbjct: 331 PWVLTCCQFDDKETEDDKDAETEIPAGESSDAAP---SADAAQMKEMMAMMQKMQQQQAA 387
Query: 267 HPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAP 317
+P + PP PP +P + PP P PP P P
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAAPP 438
|
| >2z73_A Rhodopsin; visual pigment, GQ-type, G-protein coupled receptor, chromophore, glycoprotein, lipoprotein, membrane, palmitate phosphorylation; HET: BOG RET PLM TWT PC1; 2.50A {Todarodes pacificus} PDB: 3aym_A* 3ayn_A* 2ziy_A* Length = 448 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 22/109 (20%), Positives = 27/109 (24%), Gaps = 3/109 (2%)
Query: 292 KTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA---PPPASHSSKT 348
+T P + PA S+ AP +
Sbjct: 328 QTFPWVLTCCQFDDKETEDDKDAETEIPAGESSDAAPSADAAQMKEMMAMMQKMQQQQAA 387
Query: 349 APPPASHPSNTALPPASHPSNPAIPPASHPSNTAIPPASHPSNTAPPHA 397
PP P PP +P P P PP P APP A
Sbjct: 388 YPPQGYAPPPQGYPPQGYPPQGYPPQGYPPQGYPPPPQGAPPQGAPPAA 436
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-05
Identities = 19/96 (19%), Positives = 29/96 (30%)
Query: 281 NTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPP 340
N P PPP++ P A+ + A A S AP P S
Sbjct: 20 NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFS 79
Query: 341 PASHSSKTAPPPASHPSNTALPPASHPSNPAIPPAS 376
S++ K A+ + + S + A
Sbjct: 80 SLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.9 bits (100), Expect = 6e-04
Identities = 17/93 (18%), Positives = 26/93 (27%)
Query: 295 PPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPAS 354
P PPP++ P A+ + A A S AP P S S
Sbjct: 23 MTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFSSLS 82
Query: 355 HPSNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
+ A+ + + S + A
Sbjct: 83 NAVKQTTAAAAATFSEQVGGGSGGAGRGGAAAR 115
|
| >1pk8_A RAT synapsin I; ATP binding, ATP grAsp, calcium (II) ION, membrane protein; HET: ATP; 2.10A {Rattus norvegicus} SCOP: c.30.1.5 d.142.1.3 PDB: 1px2_A* Length = 422 | Back alignment and structure |
|---|
Score = 42.5 bits (99), Expect = 9e-04
Identities = 17/93 (18%), Positives = 27/93 (29%)
Query: 303 NTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALP 362
N P PPP++ P A+ + A A +S AP P S
Sbjct: 20 NGYMTDLQRPQPPPPPPSAASPGATPGSAAASAERASTAAPVASPAAPSPGSSGGGGFFS 79
Query: 363 PASHPSNPAIPPASHPSNTAIPPASHPSNTAPP 395
S+ A+ + + S +
Sbjct: 80 SLSNAVKQTTAAAAATFSEQVGGGSGGAGRGGA 112
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 46.9 bits (111), Expect = 5e-05
Identities = 16/97 (16%), Positives = 23/97 (23%), Gaps = 3/97 (3%)
Query: 264 PASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHP 323
PA+ S P A+ PA+ P + P+ P + PP
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATP---APPALGAAPTGDPKPKKNKKPKNPTPPRPAG 58
Query: 324 SNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
N + A P A
Sbjct: 59 DNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 15/85 (17%), Positives = 22/85 (25%)
Query: 279 PSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTA 338
P+ P + P+ APP P P + P P + A
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 339 PPPASHSSKTAPPPASHPSNTALPP 363
A H++ NT
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANF 86
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 13/91 (14%), Positives = 22/91 (24%), Gaps = 4/91 (4%)
Query: 260 TSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPP 319
TSP + T + P + P+ P + PP N
Sbjct: 6 TSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVAA 65
Query: 320 ASHPSNTAPPPASHPSNTAP----PPASHSS 346
+ A PP + ++
Sbjct: 66 GHATLREHLRDIKAENTDANFYVCPPPTGAT 96
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 2e-04
Identities = 17/93 (18%), Positives = 23/93 (24%)
Query: 301 PSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTA 360
P+ P + P+ APP P P + P P + A
Sbjct: 2 PAAPTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNA 61
Query: 361 LPPASHPSNPAIPPASHPSNTAIPPASHPSNTA 393
A H + NT P T
Sbjct: 62 TVAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 15/91 (16%), Positives = 22/91 (24%)
Query: 242 PASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSNTAPPPASHPSKTAPPPASHP 301
P S + PA AP P P P + A A+
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 302 SNTAPPPASHPSNTAPPPASHPSNTAPPPAS 332
+ A A ++ PP +
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 4e-04
Identities = 12/92 (13%), Positives = 21/92 (22%), Gaps = 2/92 (2%)
Query: 275 PASHPSNTAPPPASHPSKTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHP 334
P S + + PA AP P P +P+ P +
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKP--KNPTPPRPAGDNAT 62
Query: 335 SNTAPPPASHSSKTAPPPASHPSNTALPPASH 366
+ + + PP +
Sbjct: 63 VAAGHATLREHLRDIKAENTDANFYVCPPPTG 94
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 5e-04
Identities = 11/97 (11%), Positives = 20/97 (20%), Gaps = 6/97 (6%)
Query: 308 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHPSNTALPPASHP 367
P S + + P P + + P + PP
Sbjct: 5 PTSPGTPGVAAATQAANGGPATP------APPALGAAPTGDPKPKKNKKPKNPTPPRPAG 58
Query: 368 SNPAIPPASHPSNTAIPPASHPSNTAPPHASHPSNTA 404
N + + + A + P A
Sbjct: 59 DNATVAAGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3nwa_A GB, GB-1, GB1, envelope glycoprotein B; coiled-coil, membrane fusion, viral P glycoprotein B, HSV-1, membrane; HET: NAG; 2.26A {Human herpesvirus 1} PDB: 3nwf_A* 3nw8_A* 3nwd_A* Length = 703 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 7e-04
Identities = 13/91 (14%), Positives = 21/91 (23%)
Query: 297 PASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHPSNTAPPPASHSSKTAPPPASHP 356
P S + + PA AP P P + A A+
Sbjct: 5 PTSPGTPGVAAATQAANGGPATPAPPALGAAPTGDPKPKKNKKPKNPTPPRPAGDNATVA 64
Query: 357 SNTALPPASHPSNPAIPPASHPSNTAIPPAS 387
+ A A ++ P +
Sbjct: 65 AGHATLREHLRDIKAENTDANFYVCPPPTGA 95
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 46.5 bits (109), Expect = 6e-05
Identities = 25/217 (11%), Positives = 47/217 (21%), Gaps = 3/217 (1%)
Query: 90 SAPFDMAPPPSLIPTNPVASPPSITAPPPVNMAPPPSLIPTTPVASPPPITAPPLVNVL- 148
+ F + S + N A + +
Sbjct: 16 NLYFQGEETAVPENSGANTELVSGESEHSTNEADKQNEGEHARENKLEKAEGVATASETA 75
Query: 149 -PAPSLIPTTPLASPLSSKAFPPASPPSNAARPPASHPSNTARPPASHPSRTAPPPASHP 207
PA + TT A S+ + A P A + + + P T S P
Sbjct: 76 SPASNEAATTETAEAASAAKPEEKASEVVAETPSAEAKPKSDKETEAKPEATNQGDESKP 135
Query: 208 SNTALPSKTAPSPASHPSNTALPPASLPSKTAPPPASHLSNTAPPPASHPYKTSPLPASH 267
+ A ++ P + + A + + L +
Sbjct: 136 AAEANKTEKEVQPDVPKNTEKTLKPKEIKFNSWEELLKWEPGAREDDAINRGSVVLASRR 195
Query: 268 PSKTAPPPASHPSNT-APPPASHPSKTAPPPASHPSN 303
AS + A + +K
Sbjct: 196 TGHLVNEKASKEAKVQALSNTNSKAKDHASVGGEEFK 232
|
| >3gdb_A Endo-D, putative uncharacterized protein SPR0440; alpha-beta-barrels, cell WALL, peptidoglycan-anchor, secreted, hydrolase; HET: PGE; 1.87A {Streptococcus pneumoniae} PDB: 2xqx_A Length = 937 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 2e-04
Identities = 32/226 (14%), Positives = 52/226 (23%), Gaps = 13/226 (5%)
Query: 56 HLLGGHAPSPIELPTHSAPPPVNIPSFSPSTPAVSAPFDMAPPPSLIPTNPVASPPSITA 115
H GH L V S +T VS + + + + +
Sbjct: 5 HHHHGHHHQLENLYFQGEETAVPENS-GANTELVSGESEHSTNEADKQNEGEHARENKLE 63
Query: 116 PPPVNMAPPPSLIPTTPVASPPPITAPPLVNVLPAPSLIPTTPLASPLSSKAFPPASPPS 175
+P ++ T A S AS + ++ P A
Sbjct: 64 KAEGVATASE---TASPASNEAATTETA-----EAASAAKPEEKASEVVAET-PSAEAKP 114
Query: 176 NAARPPASHPSNTARPPASHPSRTAPPPASHPSNTALPSKTAPSPASHPSNTALPPASLP 235
+ + + P T + S P+ A P
Sbjct: 115 KSDKETEAKPEATNQGDESKPAAEANKT---EKEVQPDVPKNTEKTLKPKEIKFNSWEEL 171
Query: 236 SKTAPPPASHLSNTAPPPASHPYKTSPLPASHPSKTAPPPASHPSN 281
K P + +T L SK A A +N
Sbjct: 172 LKWEPGAREDDAINRGSVVLASRRTGHLVNEKASKEAKVQALSNTN 217
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 1368 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-68 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-66 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-66 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 8e-66 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-65 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-65 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-64 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-64 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-64 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-63 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-61 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-59 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-58 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-58 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 7e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-57 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-57 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-55 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-53 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-49 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-48 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 8e-47 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-46 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-45 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-45 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-42 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-42 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-40 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-39 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-34 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 9e-33 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-30 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-30 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (621), Expect = 3e-73
Identities = 73/288 (25%), Positives = 121/288 (42%), Gaps = 26/288 (9%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLS 1020
+ E G + +G G FG VY G VAVK+L Q + F EV +L
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
+ H N++ +G Q +V + S+ HLH + IA A+
Sbjct: 60 KTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQ 115
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
+ YLH +IHRD KS+NI L D T K+ DFGLA H ++ G+ +
Sbjct: 116 GMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 1141 VAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1197
+APE +SDVY++G+V+ EL++G+ P Q +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG--------- 223
Query: 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ P L + V + + + + C++ + RP +++ +++
Sbjct: 224 --RGYLSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (589), Expect = 4e-69
Identities = 68/278 (24%), Positives = 120/278 (43%), Gaps = 28/278 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
LG G FG V+ G + TKVAVK LK+ FLAE ++ +L H+ LV+
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L + +E ++ E + NGS+ L L + L +A A +A++
Sbjct: 73 LYAVVTQEP-IYIITEYMENGSLVDFLK--TPSGIKLTINKLLDMAAQIAEGMAFIE--- 126
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
IHRD +++NIL+ + K++DFGLAR +++ + APE G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYG 185
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ--ENLVAWARPLLTSREGLERIIDPSL 1207
+KSDV+S+G+++ E+++ + + +NL R +
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------- 231
Query: 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P + ++ + +C + + RP + L+
Sbjct: 232 ----PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (583), Expect = 2e-68
Identities = 72/276 (26%), Positives = 123/276 (44%), Gaps = 24/276 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ +G G FGLV+ G + KVA+K ++ +F+ E E++ +L H LV+
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+C+E+ CLV+E + +G + +L + + L + L +AYL E
Sbjct: 65 LYGVCLEQAPICLVFEFMEHGCLSDYLR---TQRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
VIHRD + N L+ + KVSDFG+ R +D++ ST + +PE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFS 177
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209
KSDV+S+GV++ E+ S K + + ++ R+ P L +
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRLAS 228
Query: 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
V I + C + + RP +++ L
Sbjct: 229 T-------HVYQIMNHCWKERPEDRPAFSRLLRQLA 257
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 223 bits (570), Expect = 4e-66
Identities = 75/305 (24%), Positives = 127/305 (41%), Gaps = 39/305 (12%)
Query: 958 TFSASEIEKATGNFDAS---------RILGEGGFGLVYSGVL----DDGTKVAVKVLKR- 1003
F+ + +A F +++G G FG V SG L VA+K LK
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 1004 VDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES 1063
++ R+FL+E ++ + H N++ L G+ + ++ E + NGS++S L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR---QND 122
Query: 1064 APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123
+ + G A + YL + +HRD + NIL+ + KVSDFGL+R
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 1124 DEESRHISTRV---MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPP 1180
D+ S T + APE SDV+SYG+V+ E++S + P
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE------RP 233
Query: 1181 GQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEV 1240
+ + + + I+ P D + + + C Q + HRP G++
Sbjct: 234 YWDM----------TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQI 283
Query: 1241 VQALK 1245
V L
Sbjct: 284 VNTLD 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 222 bits (566), Expect = 4e-66
Identities = 74/277 (26%), Positives = 121/277 (43%), Gaps = 30/277 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ +G+G FG V G G KVAVK +K + + FLAE ++++L H NLV+
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQ 64
Query: 1030 LIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L+G+ +EE+ +V E + GS+ +L + + LG D LK +L A+ YL
Sbjct: 65 LLGVIVEEKGGLYIVTEYMAKGSLVDYLR--SRGRSVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
+HRD + N+L+ D KVSDFGL + A + + APE
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALRE 174
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208
KSDV+S+G+++ E+ S + P + L +E+
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGRV-----PYPRIPLKDVV-------PRVEKGYKMDAP 222
Query: 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ P V + C + RP ++ + L+
Sbjct: 223 DGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLE 255
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (570), Expect = 5e-66
Identities = 65/293 (22%), Positives = 117/293 (39%), Gaps = 30/293 (10%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGIC 1034
+G+G FG V+ G G +VAVK+ +++ AE+ L H N++ I
Sbjct: 9 ESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAAD 66
Query: 1035 IEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-- 1088
++ LV + +GS+ +L+ + + +K+AL A LA+LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 1089 ---SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES--RHISTRVMGTFGYVAP 1143
P + HRD KS NIL++ + T ++D GLA +GT Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 1144 EYAMTGHLL------VKSDVYSYGVVILELLSGRKP----VDMTQPPGQENLVAWARPLL 1193
E + ++D+Y+ G+V E+ D P + +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241
Query: 1194 TSREGLERIIDPSLGNDV-PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ E+ + P++ N +++ +A I C R + + L
Sbjct: 242 R-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 8e-66
Identities = 72/293 (24%), Positives = 117/293 (39%), Gaps = 40/293 (13%)
Query: 975 RILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRL-HHRN 1026
+ LG G FG V D VAVK+LK RE ++E+++LS L +H N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHG--------------VDKESAPLGWDARL 1072
+V L+G C ++ E G + + L ++ + L + L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
+ A+ +A+L S IHRD + NILL H K+ DFGLAR ++ + +
Sbjct: 149 SFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
++APE +SDV+SYG+ + EL S P +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--------- 256
Query: 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
++I P + A++ I C + RP ++VQ ++
Sbjct: 257 ------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (568), Expect = 2e-65
Identities = 51/214 (23%), Positives = 99/214 (46%), Gaps = 12/214 (5%)
Query: 964 IEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSR 1021
+E +F+ LG G G+V+ G +A K++ + R + E+++L
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+ +V G + + E + GS++ L ++ + K+++ +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKG 116
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
L YL +++HRD K SNIL+ K+ DFG++ +D ++ +GT Y+
Sbjct: 117 LTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTRSYM 170
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD 1175
+PE H V+SD++S G+ ++E+ GR P+
Sbjct: 171 SPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIP 204
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-65
Identities = 65/276 (23%), Positives = 111/276 (40%), Gaps = 24/276 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ + LG G FG+V G VA+K++K EF+ E +++ L H LV+
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQ 63
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L G+C +++ ++ E + NG + ++L + L++ A+ YL
Sbjct: 64 LYGVCTKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES-- 118
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
+ +HRD + N L+ KVSDFGL+R +D+E S + PE M
Sbjct: 119 -KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYS 176
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209
KSD++++GV++ E+ S K + I L
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRL 220
Query: 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P + KV I C + RP ++ +
Sbjct: 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 219 bits (558), Expect = 1e-64
Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 26/296 (8%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSR 1021
E+E+ + LG G +G VY GV VAVK LK D EFL E ++
Sbjct: 13 EMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 1022 LHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARA 1081
+ H NLV+L+G+C E ++ E + G++ +L +++ + L +A + A
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ--EVSAVVLLYMATQISSA 127
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
+ YL IHRD + N L+ + KV+DFGL+R M ++ +
Sbjct: 128 MEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWT 183
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201
APE +KSDV+++GV++ E+ + Q +
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYE 227
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKEV 1257
+++ + P KV + C Q RP E+ QA + + E + EV
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 219 bits (559), Expect = 1e-64
Identities = 68/314 (21%), Positives = 121/314 (38%), Gaps = 46/314 (14%)
Query: 962 SEIEKATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKR-VDQQGGREFLA 1014
+E N + R +GEG FG V+ + T VAVK+LK +F
Sbjct: 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65
Query: 1015 EVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKES----------- 1063
E +++ + N+VKL+G+C + CL++E + G + L + +
Sbjct: 66 EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125
Query: 1064 ---------APLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVS 1114
PL +L IA A +AYL + +HRD + N L+ + K++
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182
Query: 1115 DFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPV 1174
DFGL+R+ + ++ PE +SDV++YGVV+ E+ S
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242
Query: 1175 DMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHR 1234
E + + D ++ P + ++ + +C R
Sbjct: 243 YYGMAH---------------EEVIYYVRDGNI-LACPENCPLELYNLMRLCWSKLPADR 286
Query: 1235 PFMGEVVQALKLVC 1248
P + + L+ +C
Sbjct: 287 PSFCSIHRILQRMC 300
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 2e-64
Identities = 70/303 (23%), Positives = 122/303 (40%), Gaps = 45/303 (14%)
Query: 970 NFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRL 1022
N + ++LG G FG V + +VAVK+LK RE ++E++M+++L
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97
Query: 1023 -HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHG-------------------VDKE 1062
H N+V L+G C L++E G + ++L +++
Sbjct: 98 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 157
Query: 1063 SAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122
L ++ L A A+ + +L +HRD + N+L+ H K+ DFGLAR
Sbjct: 158 LNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDI 214
Query: 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ 1182
M + + + ++APE G +KSDV+SYG+++ E+ S P
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 274
Query: 1183 ENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
++I D PF + ++ I C + + RP +
Sbjct: 275 N---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
Query: 1243 ALK 1245
L
Sbjct: 320 FLG 322
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (557), Expect = 3e-64
Identities = 78/291 (26%), Positives = 125/291 (42%), Gaps = 32/291 (10%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVDQQGG-REFLAEVE 1017
+F+ ++G G FG VY G L D AVK L R+ G +FL E
Sbjct: 23 GPSSLIVHFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 80
Query: 1018 MLSRLHHRNLVKLIGICIE-EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL 1076
++ H N++ L+GIC+ E + +V + +G + + + E+ + L
Sbjct: 81 IMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGL 137
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE--SRHISTRV 1134
A+ + +L + +HRD + N +L+ FT KV+DFGLAR D+E S H T
Sbjct: 138 QVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 194
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194
++A E T KSDV+S+GV++ EL++ P P N LL
Sbjct: 195 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQ 249
Query: 1195 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
R R++ P + + C P+ + RP E+V +
Sbjct: 250 GR----RLLQPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 1e-63
Identities = 67/291 (23%), Positives = 124/291 (42%), Gaps = 31/291 (10%)
Query: 962 SEIEKATGNFDASRILGEGGFGLVYSGVLDDGT-----KVAVKVLKRVDQQGGR-EFLAE 1015
+EI +++G G FG VY G+L + VA+K LK + R +FL E
Sbjct: 2 TEIH--PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGE 59
Query: 1016 VEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIA 1075
++ + H N+++L G+ + + ++ E + NG+++ L ++ + +
Sbjct: 60 AGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGML 116
Query: 1076 LGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM-DEESRHISTRV 1134
G A + YL + +HRD + NIL+ + KVSDFGL+R D E+ + ++
Sbjct: 117 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173
Query: 1135 MGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT 1194
+ APE SDV+S+G+V+ E+++ + +
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221
Query: 1195 SREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ + I+ P D + + + C Q E RP ++V L
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILD 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (539), Expect = 3e-62
Identities = 63/280 (22%), Positives = 113/280 (40%), Gaps = 26/280 (9%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 1026
+++ +G G +G DG + K L + + + ++EV +L L H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 1027 LVKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
+V+ I+ +V E G + S + KE L + L++ AL
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 1085 LHE--DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
H D V+HRD K +N+ L+ K+ DFGLAR + S + +GT Y++
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKAFVGTPYYMS 182
Query: 1143 PEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202
PE KSD++S G ++ EL + P +E +I
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ----------------KELAGKI 226
Query: 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ +P+ ++ I + + + HRP + E+++
Sbjct: 227 REGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 1e-61
Identities = 70/275 (25%), Positives = 121/275 (44%), Gaps = 30/275 (10%)
Query: 977 LGEGGFGLVYSGVL---DDGTKVAVKVLKR-VDQQGGREFLAEVEMLSRLHHRNLVKLIG 1032
LG G FG V GV VA+KVLK+ ++ E + E +++ +L + +V+LIG
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 76
Query: 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPR 1092
+C + +A LV E+ G + L G + + ++ + + YL E
Sbjct: 77 VC-QAEALMLVMEMAGGGPLHKFLVGKRE---EIPVSNVAELLHQVSMGMKYLEE---KN 129
Query: 1093 VIHRDFKSSNILLEHDFTPKVSDFGLARSA-MDEESRHISTRVMGTFGYVAPEYAMTGHL 1151
+HRD + N+LL + K+SDFGL+++ D+ + + APE
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189
Query: 1152 LVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGND 1210
+SDV+SYGV + E LS G+KP + P + + + +
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----------------E 232
Query: 1211 VPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P + ++ A+ S C + + RP V Q ++
Sbjct: 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (531), Expect = 4e-61
Identities = 67/277 (24%), Positives = 114/277 (41%), Gaps = 30/277 (10%)
Query: 975 RILGEGGFGLVYSGVLDD---GTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ LG G FG V G VAVK+LK D E LAE ++ +L + +V+
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
+IGIC E LV E+ G + +L ++ + +++ + + YL E
Sbjct: 73 MIGICEAES-WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE-- 125
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS-AMDEESRHISTRVMGTFGYVAPEYAMT 1148
+HRD + N+LL K+SDFGL+++ DE T + APE
Sbjct: 126 -SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 1149 GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208
KSDV+S+GV++ E S + + + +++
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER 228
Query: 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P ++ + ++C +V++RP V L+
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-60
Identities = 67/276 (24%), Positives = 118/276 (42%), Gaps = 24/276 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVK 1029
+ LG+G FG V+ G + T+VA+K LK FL E +++ +L H LV+
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQEAQVMKKLRHEKLVQ 76
Query: 1030 LIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS 1089
L + EE +V E + GS+ L G + L + +A A +AY+
Sbjct: 77 LYAVVSEEP-IYIVTEYMSKGSLLDFLKG--ETGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTG 1149
+HRD +++NIL+ + KV+DFGLAR +++ + APE A+ G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYG 189
Query: 1150 HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGN 1209
+KSDV+S+G+++ EL + + + + ++
Sbjct: 190 RFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYRM 233
Query: 1210 DVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P + + + C + E + RP + L+
Sbjct: 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 1e-59
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 34/299 (11%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRVDQQGGRE-FLAEVE 1017
EI++ + R +GEG FG V+ G+ + VA+K K RE FL E
Sbjct: 3 EIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 1018 MLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 1077
+ + H ++VKLIG+ E ++ EL G + S L L + + A
Sbjct: 61 TMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQ 116
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGT 1137
+ ALAYL R +HRD + N+L+ + K+ DFGL+R M++ + + +++
Sbjct: 117 LSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLP 172
Query: 1138 FGYVAPEYAMTGHLLVKSDVYSYGVVILELL-SGRKPVDMTQPPGQENLVAWARPLLTSR 1196
++APE SDV+ +GV + E+L G KP + + L
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---- 228
Query: 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAK 1255
+P + + ++ + C + RP E+ L + E ++A+
Sbjct: 229 -------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE-EKAQ 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (518), Expect = 1e-59
Identities = 68/277 (24%), Positives = 105/277 (37%), Gaps = 33/277 (11%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHR 1025
+F+ R LG+G FG VY +A+KVL + + EVE+ S L H
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N+++L G + L+ E P G+V L + + A AL+Y
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 122
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S RVIHRD K N+LL K++DFG + A + GT Y+ PE
Sbjct: 123 H---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT----LCGTLDYLPPEM 175
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
K D++S GV+ E L G+ P + ++ +
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF------VTE 229
Query: 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ S ++ RP + EV++
Sbjct: 230 GA------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 2e-59
Identities = 72/284 (25%), Positives = 108/284 (38%), Gaps = 30/284 (10%)
Query: 970 NFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKR---VDQQGGREFLAEVEMLSRL 1022
+ LG+G FG+V G D VAVK LK + +F+ EV + L
Sbjct: 9 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68
Query: 1023 HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
HRNL++L G+ + +V EL P GS+ L K + A+ A +
Sbjct: 69 DHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLR---KHQGHFLLGTLSRYAVQVAEGM 124
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI-STRVMGTFGYV 1141
YL S R IHRD + N+LL K+ DFGL R+ + ++ F +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201
APE T SD + +GV + E+ + + P N + E L R
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGERLPR 236
Query: 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
P D + + C + + RP + L
Sbjct: 237 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 203 bits (517), Expect = 6e-59
Identities = 67/293 (22%), Positives = 116/293 (39%), Gaps = 39/293 (13%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTK--VAVKVLKRV-DQQGGREFLAEVEMLSRL-HH 1024
+ ++GEG FG V + DG + A+K +K + R+F E+E+L +L HH
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHG------------VDKESAPLGWDARL 1072
N++ L+G C L E P+G++ L + ++ L L
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 1073 KIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST 1132
A AR + YL + IHRD + NIL+ ++ K++DFGL+R + T
Sbjct: 131 HFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---T 184
Query: 1133 RVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
++A E SDV+SYGV++ E++S P
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY--- 236
Query: 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ + P + +V + C + + RP +++ +L
Sbjct: 237 --------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 2e-58
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 33/276 (11%)
Query: 975 RILGEGGFGLVYSGVL-DDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+G G F VY G+ + +VA L+ ++ + + F E EML L H N+V+
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 1032 GICIE----EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
++ LV EL+ +G+++++L + + L +LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 1088 DSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+P +IHRD K NI + + K+ D GLA + + V+GT ++APE
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAPEM- 184
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206
DVY++G+ +LE+ + P Q Q R+
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------YRRVTSGV 229
Query: 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
++ +V I C++ R + +++
Sbjct: 230 KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (511), Expect = 2e-58
Identities = 66/274 (24%), Positives = 115/274 (41%), Gaps = 29/274 (10%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
LG+G FG VY + A KV+ ++ +++ E+++L+ H N+VKL+
Sbjct: 18 GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
E ++ E G+V++ + +++ PL + AL YLH ++
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELER---PLTESQIQVVCKQTLDALNYLH---DNKI 131
Query: 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLL- 1152
IHRD K+ NIL D K++DFG++ R +GT ++APE M
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKD 189
Query: 1153 ----VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLG 1208
K+DV+S G+ ++E+ P P +A + P P+L
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEP-------------PTLA 236
Query: 1209 NDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ S K C++ V R +++Q
Sbjct: 237 QPSRWSSNFK--DFLKKCLEKNVDARWTTSQLLQ 268
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 4e-58
Identities = 62/278 (22%), Positives = 100/278 (35%), Gaps = 27/278 (9%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHRN 1026
++D + LGEG +G V V VAVK++ E E+ + L+H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+VK G E + L E G + + + + + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+ HRD K N+LL+ K+SDFGLA + ++ GT YVAPE
Sbjct: 121 ---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 1147 MTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205
DV+S G+V+ +L+G P D QE + +
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN---------- 227
Query: 1206 SLGNDVPFDSVAKVA-AIASMCVQPEVQHRPFMGEVVQ 1242
P+ + A+ + R + ++ +
Sbjct: 228 ------PWKKIDSAPLALLHKILVENPSARITIPDIKK 259
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (510), Expect = 7e-58
Identities = 69/289 (23%), Positives = 123/289 (42%), Gaps = 30/289 (10%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGT----KVAVKVLKR-VDQQGGREFLAEV 1016
I K T F ++LG G FG VY G+ + +G VA+K L+ + +E L E
Sbjct: 4 RILKET-EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62
Query: 1017 EMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIAL 1076
+++ + + ++ +L+GIC+ L+ +L+P G L V + +G L +
Sbjct: 63 YVMASVDNPHVCRLLGICLTST-VQLITQLMPFGC---LLDYVREHKDNIGSQYLLNWCV 118
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1136
A+ + YL + R++HRD + N+L++ K++DFGLA+ EE + +
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196
++A E + +SDV+SYGV + EL++ P +
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------------- 221
Query: 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
+ I++ P V I C + RP E++
Sbjct: 222 --ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS 268
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 199 bits (507), Expect = 2e-57
Identities = 75/295 (25%), Positives = 114/295 (38%), Gaps = 41/295 (13%)
Query: 956 AKTFSASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG---RE 1011
A+ F + EK F R +G G FG VY + + VA+K + +Q ++
Sbjct: 5 AELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD 61
Query: 1012 FLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDAR 1071
+ EV L +L H N ++ G + E LV E + + PL
Sbjct: 62 IIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEI 117
Query: 1072 LKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIS 1131
+ GA + LAYLH S +IHRD K+ NILL K+ DFG A +
Sbjct: 118 AAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A 168
Query: 1132 TRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKP-VDMTQPPGQENLVA 1187
+GT ++APE + G K DV+S G+ +EL + P +M ++
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
Query: 1188 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
P L S E + C+Q Q RP +++
Sbjct: 229 NESPALQSGHWSEYFRN-----------------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 9e-57
Identities = 76/307 (24%), Positives = 140/307 (45%), Gaps = 32/307 (10%)
Query: 952 YTGSAKTFSASEIEKATGNFDASRILGEGGFGLVYSGVL------DDGTKVAVKVLKRVD 1005
Y +A + E E A SR LG+G FG+VY GV + T+VA+K +
Sbjct: 3 YFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA 62
Query: 1006 QQGGR-EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH------G 1058
R EFL E ++ + ++V+L+G+ + Q ++ EL+ G ++S+L
Sbjct: 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMA 122
Query: 1059 VDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118
+ AP +++A A +AYL+ + + +HRD + N ++ DFT K+ DFG+
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQ 1178
R + + + + +++PE G SDV+S+GVV+ E+ + +
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ----- 234
Query: 1179 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG 1238
L++ + L +++ L D P + + + MC Q + RP
Sbjct: 235 ----------PYQGLSNEQVLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFL 283
Query: 1239 EVVQALK 1245
E++ ++K
Sbjct: 284 EIISSIK 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 7e-55
Identities = 67/297 (22%), Positives = 109/297 (36%), Gaps = 39/297 (13%)
Query: 970 NFDASRILGEGGFGLVYSGV------LDDGTKVAVKVLKR-VDQQGGREFLAEVEMLSR- 1021
+ LG G FG V VAVK+LK R ++E+++L
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73
Query: 1022 LHHRNLVKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAP------------LGW 1068
HH N+V L+G C + ++ E G++ ++L E P L
Sbjct: 74 GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 1069 DARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128
+ + + A+ + +L S + IHRD + NILL K+ DFGLAR +
Sbjct: 134 EHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 190
Query: 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1188
++APE ++SDV+S+GV++ E+ S P +
Sbjct: 191 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKIDEE 245
Query: 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
R + P + ++ C E RP E+V+ L
Sbjct: 246 ----------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 2e-54
Identities = 67/298 (22%), Positives = 119/298 (39%), Gaps = 41/298 (13%)
Query: 970 NFDASRILGEGGFGLVYSGVL--------DDGTKVAVKVLKR-VDQQGGREFLAEVEMLS 1020
+ LGEG FG V + TKVAVK+LK ++ + ++E+EM+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMK 73
Query: 1021 RL-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLH------------GVDKESAPLG 1067
+ H+N++ L+G C ++ ++ E G++ +L L
Sbjct: 74 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLS 133
Query: 1068 WDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127
+ A AR + YL S + IHRD + N+L+ D K++DFGLAR +
Sbjct: 134 SKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY 190
Query: 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVA 1187
+T ++APE +SDV+S+GV++ E+ + P +
Sbjct: 191 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----- 245
Query: 1188 WARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
L +++ D P + ++ + C RP ++V+ L
Sbjct: 246 -----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 2e-53
Identities = 62/284 (21%), Positives = 119/284 (41%), Gaps = 26/284 (9%)
Query: 960 SASEIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEM 1018
S + + +G+G G VY+ + + G +VA++ + Q + E+ +
Sbjct: 11 SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILV 70
Query: 1019 LSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
+ + N+V + + +V E + GS+ + + +
Sbjct: 71 MRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCREC 125
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
+AL +LH S +VIHRD KS NILL D + K++DFG E+S+ + ++GT
Sbjct: 126 LQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTP 180
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198
++APE K D++S G++ +E++ G P P L+A G
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--------TNG 232
Query: 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ +P ++ + + C+ +V+ R E++Q
Sbjct: 233 TPELQNPE-----KLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-49
Identities = 56/213 (26%), Positives = 92/213 (43%), Gaps = 11/213 (5%)
Query: 965 EKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLS 1020
+K +F +ILGEG F V L + A+K+L++ + + E +++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
RL H VKL +++ NG + ++ +
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVS 119
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
AL YLH +IHRD K NILL D +++DFG A+ E + + +GT Y
Sbjct: 120 ALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
V+PE SD+++ G +I +L++G P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 209
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (443), Expect = 2e-49
Identities = 72/292 (24%), Positives = 116/292 (39%), Gaps = 31/292 (10%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH 1023
+ ++ ILG GG V+ L VAVKVL+ D F E + + L+
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 1024 HRNLVKLIGICIEEQAR----CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
H +V + E +V E + ++ +H P+ +++ A
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHIST-RVMGTF 1138
+AL + H +IHRD K +NI++ KV DFG+AR+ D + T V+GT
Sbjct: 122 QALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198
Y++PE A + +SDVYS G V+ E+L+G P P P
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP------- 231
Query: 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVCN 1249
I + + A + A+ + ++R E+ L V N
Sbjct: 232 ---IPPSARHEGLS----ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 173 bits (439), Expect = 7e-49
Identities = 64/290 (22%), Positives = 107/290 (36%), Gaps = 41/290 (14%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLK---------RVDQQGGREFLAEVEML 1019
N++ ILG G +V + + AVK++ Q+ L EV++L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 1020 SRLH-HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGA 1078
++ H N+++L LV++L+ G + +L E L KI
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119
Query: 1079 ARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
+ LH ++HRD K NILL+ D K++DFG + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL---DPGEKLREVCGTP 173
Query: 1139 GYVAPEYAMTGHLL------VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL 1192
Y+APE + D++S GV++ LL+G P + ++
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ 233
Query: 1193 LTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
S E +D V + S + + Q R E +
Sbjct: 234 FGSPE----------WDDYSDT----VKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 173 bits (440), Expect = 9e-49
Identities = 53/287 (18%), Positives = 92/287 (32%), Gaps = 29/287 (10%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNL 1027
+ R +G G FG +Y G + G +VA+K+ + + E ++ +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 1028 VKLIGICIEEQAR-CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+ I C E +V EL+ + S L +A + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPS----LEDLFNFCSRKFSLKTVLLLADQMISRIEYIH 120
Query: 1087 EDSSPRVIHRDFKSSNIL---LEHDFTPKVSDFGLARSAMDEES-----RHISTRVMGTF 1138
S IHRD K N L + + DFGLA+ D + + + GT
Sbjct: 121 ---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 1139 GYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198
Y + + + D+ S G V++ G P + + E
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER------ISEK 231
Query: 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
L P ++ A + C +P + Q +
Sbjct: 232 KMSTPIEVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 174 bits (441), Expect = 3e-48
Identities = 55/271 (20%), Positives = 93/271 (34%), Gaps = 26/271 (9%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
LG G FG+V+ V G K + E+ ++++LHH L+ L
Sbjct: 35 EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
++ L+ E + G + + E + + A L ++H +
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMH---EHSI 148
Query: 1094 IHRDFKSSNILLEHDFTP--KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1151
+H D K NI+ E K+ DFGLA +E T + APE +
Sbjct: 149 VHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK---VTTATAEFAAPEIVDREPV 205
Query: 1152 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1211
+D+++ GV+ LLSG P E L R E + P
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFSSVSPEA---- 259
Query: 1212 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+Q E + R + + ++
Sbjct: 260 --------KDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 4e-48
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 26/276 (9%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
++D LG G FG+V+ G A K + + E++ +S L H LV
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L ++ ++YE + G + + E + D ++ + L ++HE
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHE- 142
Query: 1089 SSPRVIHRDFKSSNILL--EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
+H D K NI+ + K+ DFGL ++S GT + APE A
Sbjct: 143 --NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK---VTTGTAEFAAPEVA 197
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206
+ +D++S GV+ LLSG P V +D S
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW----------NMDDS 247
Query: 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ + D + + R + + ++
Sbjct: 248 AFSGISED----GKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 171 bits (434), Expect = 5e-48
Identities = 45/289 (15%), Positives = 86/289 (29%), Gaps = 31/289 (10%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRN 1026
++ R +GEG FG+++ G L + +VA+K R + + E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+ + E LV +L+ S +D A + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH 118
Query: 1087 EDSSPRVIHRDFKSSNILL-----EHDFTPKVSDFGLARSAMDEESR-----HISTRVMG 1136
+++RD K N L+ ++ V DFG+ + D ++ + G
Sbjct: 119 ---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSR 1196
T Y++ + + D+ + G V + L G P + +
Sbjct: 176 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------G 229
Query: 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245
E + L P + P +
Sbjct: 230 EKKQSTPLRELCAGFP----EEFYKYMHYARNLAFDATPDYDYLQGLFS 274
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 171 bits (435), Expect = 3e-47
Identities = 58/227 (25%), Positives = 92/227 (40%), Gaps = 19/227 (8%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLH-- 1023
+F RI+G GGFG VY D G A+K L + +QG L E MLS +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 1024 -HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
+V + + +L+ G + HL + A L
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIILGL 120
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVA 1142
++H + V++RD K +NILL+ ++SD GLA ++ +GT GY+A
Sbjct: 121 EHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGYMA 173
Query: 1143 PEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW 1188
PE G +D +S G ++ +LL G P + + +
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 220
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 8e-47
Identities = 55/282 (19%), Positives = 95/282 (33%), Gaps = 23/282 (8%)
Query: 963 EIEKATGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLS 1020
+ E +D +LG G F V VA+K + + +G E+ +L
Sbjct: 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62
Query: 1021 RLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
++ H N+V L I L+ +L+ G + + E ++
Sbjct: 63 KIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQVLD 118
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
A+ YLH+ + L+ D +SDFGL++ E+ + + GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGY 175
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200
VAPE D +S GV+ LL G P + A
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--------- 226
Query: 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
D +D+ ++ + + R + +Q
Sbjct: 227 -EFDSPYWDDIS----DSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 165 bits (419), Expect = 4e-46
Identities = 54/286 (18%), Positives = 107/286 (37%), Gaps = 21/286 (7%)
Query: 970 NFDASRILGEGGFGLVYSGVLDDGTKVAVKVLK--RVDQQGGREFLAEVEMLSRLHHRNL 1027
+ +GEG +G+VY + G A+K ++ + D+ + E+ +L L H N+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62
Query: 1028 VKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
VKL + ++ LV+E + +D L L +AY H
Sbjct: 63 VKLYDVIHTKKRLVLVFEHLDQDL----KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 1088 DSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAM 1147
RV+HRD K N+L+ + K++DFGLAR+ R + ++ +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARA-FGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 1148 TGHLLVKSDVYSYGVVILELLSGRKPVD----------MTQPPGQENLVAWARPLLTSRE 1197
+ D++S G + E+++G + + G N W +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 1198 GLERIIDPSLGNDVPFDSVAKVAA-IASMCVQPEVQHRPFMGEVVQ 1242
+ L + + + + S ++ + R + ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-45
Identities = 72/324 (22%), Positives = 125/324 (38%), Gaps = 25/324 (7%)
Query: 968 TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-FLAEVEMLSRLHHR 1025
+ +GEG +G+V S + +VA+K + + Q + L E+++L R H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
N++ + I + + + + L+ + K L D R L Y+
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 125
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA-MDEESRHISTRVMGTFGYVAPE 1144
H S V+HRD K SN+LL K+ DFGLAR A D + T + T Y APE
Sbjct: 126 H---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182
Query: 1145 YAMTGHLLVKS-DVYSYGVVILELLSGRKP-------------VDMTQPPGQENLVAWAR 1190
+ KS D++S G ++ E+LS R + + P QE+L
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA--LKLVC 1248
+ + N + ++ +K + + R + + + L+
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
Query: 1249 NECDE--AKEVGSASSSQDDMSID 1270
+ DE A+ DD+ +
Sbjct: 303 DPSDEPIAEAPFKFDMELDDLPKE 326
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 2e-45
Identities = 52/227 (22%), Positives = 90/227 (39%), Gaps = 14/227 (6%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSR-LHH 1024
+F ++LG+G FG V+ A+K LK+ + + E +LS H
Sbjct: 3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
L + ++ V E + G + H+ A L +
Sbjct: 63 PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQF 118
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
LH +++RD K NILL+ D K++DFG+ + M +++ GT Y+APE
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPE 173
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191
+ D +S+GV++ E+L G+ P + + P
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNP 220
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 6e-45
Identities = 62/297 (20%), Positives = 108/297 (36%), Gaps = 28/297 (9%)
Query: 966 KATGNFDASRILGEGGFGLVYSG--VLDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSR 1021
+A ++ +GEG +G V+ + + G VA+K ++ + G + EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 1022 L---HHRNLVKLIGICIEEQARCLVYELIPNGSV--ESHLHGVDKESAPLGWDARLKIAL 1076
L H N+V+L +C + + V + + + + +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 1077 GAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMG 1136
R L +LH S RV+HRD K NIL+ K++DFGLAR + T V+
Sbjct: 124 QLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVV 177
Query: 1137 TFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV---------- 1186
T Y APE + D++S G + E+ + + Q +
Sbjct: 178 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 237
Query: 1187 AWARPLLTSREGLERIIDPSLGNDVP-FDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
W R + R+ + V D + K + C+ R +
Sbjct: 238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISAYSALS 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 7e-45
Identities = 52/271 (19%), Positives = 92/271 (33%), Gaps = 27/271 (9%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
LG G FG+V+ V K +K V E+ +L+ HRN++ L
Sbjct: 11 EDLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 1034 CIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093
+ +++E I + ++ + L + AL +LH S +
Sbjct: 70 FESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH---SHNI 123
Query: 1094 IHRDFKSSNILL--EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL 1151
H D + NI+ T K+ +FG AR ++ + + Y APE +
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAPEYYAPEVHQHDVV 180
Query: 1152 LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDV 1211
+D++S G ++ LLSG P + A D ++
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEY----------TFDEEAFKEI 230
Query: 1212 PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ + E + R E +Q
Sbjct: 231 S----IEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 6e-43
Identities = 60/208 (28%), Positives = 93/208 (44%), Gaps = 16/208 (7%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 1025
+F R LG G FG V+ +G A+KVLK+ V + E MLS + H
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
++++ G + Q ++ + I L + ++S A AL YL
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEG----GELFSLLRKSQRFPNPVAKFYAAEVCLALEYL 120
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H +I+RD K NILL+ + K++DFG A+ D + GT Y+APE
Sbjct: 121 HS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEV 172
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
T D +S+G++I E+L+G P
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTP 200
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 62/283 (21%), Positives = 100/283 (35%), Gaps = 35/283 (12%)
Query: 971 FDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGR------EFLAEVEMLSRLH 1023
+D LG G F +V G + A K +K+ + R + EV +L +
Sbjct: 12 YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 1024 HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALA 1083
H N++ L + + L+ EL+ G L E L + + +
Sbjct: 72 HPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKESLTEEEATEFLKQILNGVY 127
Query: 1084 YLHEDSSPRVIHRDFKSSNILLEHDFTP----KVSDFGLARSAMDEESRHISTRVMGTFG 1139
YLH S ++ H D K NI+L P K+ DFGLA + GT
Sbjct: 128 YLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF---KNIFGTPE 181
Query: 1140 YVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199
+VAPE L +++D++S GV+ LLSG P QE L + +
Sbjct: 182 FVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK--QETLANVSAVNYEFEDEY 239
Query: 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
+ + + R + + +Q
Sbjct: 240 FSNTSALA------------KDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 8e-42
Identities = 50/207 (24%), Positives = 87/207 (42%), Gaps = 10/207 (4%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 1026
NF +GEG +G+VY G VA+K ++ + + E+ +L L+H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+VKL+ + E LV+E + + + + LA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCH 119
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
S RV+HRD K N+L+ + K++DFGLAR+ R + V+ +
Sbjct: 120 ---SHRVLHRDLKPQNLLINTEGAIKLADFGLARA-FGVPVRTYTHEVVTLWYRAPEILL 175
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ D++S G + E+++ R
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-41
Identities = 60/278 (21%), Positives = 97/278 (34%), Gaps = 32/278 (11%)
Query: 974 SRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLI 1031
S++LG G G V K A+K+L+ + EVE+ R ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71
Query: 1032 GIC----IEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE 1087
+ + +V E + G + S + D+ +I A+ YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH- 128
Query: 1088 DSSPRVIHRDFKSSNILL---EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
S + HRD K N+L + K++DFG A+ S T YVAPE
Sbjct: 129 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYTPYYVAPE 183
Query: 1145 YAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204
D++S GV++ LL G P L R G +
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPP-----FYSNHGLAISPGMKTRIRMGQYEFPN 238
Query: 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
P K + ++ E R + E +
Sbjct: 239 PEWSE---VSEEVK--MLIRNLLKTEPTQRMTITEFMN 271
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 9e-40
Identities = 54/212 (25%), Positives = 88/212 (41%), Gaps = 18/212 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV 1028
++ ++++G G FG+VY L D G VA+K + Q R E++++ +L H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIV 76
Query: 1029 KLIGICIEEQAR------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARAL 1082
+L + LV + +P H + L R+L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY-SRAKQTLPVIYVKLYMYQLFRSL 135
Query: 1083 AYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDFGLARSAMDEESRHISTRVMGTFGYV 1141
AY+H S + HRD K N+LL+ D K+ DFG A+ + E + + +
Sbjct: 136 AYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRA 190
Query: 1142 APEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
DV+S G V+ ELL G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGRE-----FLAEVEMLSRLHHRNLV 1028
LGEG F VY + VA+K +K + ++ L E+++L L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 1029 KLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED 1088
L+ + LV++ + + S L L + L YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH-- 117
Query: 1089 SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMT 1148
++HRD K +N+LL+ + K++DFGLA+S + T + T Y APE
Sbjct: 118 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY--THQVVTRWYRAPELLFG 174
Query: 1149 GHLL-VKSDVYSYGVVILELLSGRKP 1173
+ V D+++ G ++ ELL
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPF 200
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 7e-39
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 45/285 (15%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR------VDQQGGREFLAEVEMLSR 1021
+ +LG GGFG VYSG+ + D VA+K +++ + G EV +L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 1022 LH--HRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAA 1079
+ +++L+ + L+ E E L +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI---TERGALQEELARSFFWQVL 120
Query: 1080 RALAYLHEDSSPRVIHRDFKSSNILL-EHDFTPKVSDFGLARSAMDEESRHISTRVMGTF 1138
A+ + H V+HRD K NIL+ + K+ DFG D + T GT
Sbjct: 121 EAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYTDFDGTR 173
Query: 1139 GYVAPEYAMTGHLLVKS-DVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1197
Y PE+ +S V+S G+++ +++ G P E
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP----------------------FE 211
Query: 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQ 1242
E II + S + + C+ RP E+
Sbjct: 212 HDEEIIRGQVFFRQRVSSECQ--HLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 9e-39
Identities = 54/208 (25%), Positives = 84/208 (40%), Gaps = 13/208 (6%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 1025
+FD ++LG+G FG V G A+K+L++ + + + E +L H
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
L L C V E G + HL + AL YL
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H V++RD K N++L+ D K++DFGL + + + + GT Y+APE
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK--TFCGTPEYLAPEV 176
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKP 1173
D + GVV+ E++ GR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 2e-38
Identities = 53/232 (22%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 969 GNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--REFLAEVEMLSRLHHR 1025
++ +G+G FG V+ G KVA+K + +++ G L E+++L L H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 1026 NLVKLIGICIEEQAR--------CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALG 1077
N+V LI IC + + LV++ + + + K ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK----FTLSEIKRVMQM 125
Query: 1078 AARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR--SAMDEESRHISTRVM 1135
L Y+H +++HRD K++N+L+ D K++DFGLAR S + T +
Sbjct: 126 LLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 182
Query: 1136 GTFGYVAPEYAMTGHLL-VKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1186
T Y PE + D++ G ++ E+ + + Q L+
Sbjct: 183 VTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 234
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (365), Expect = 3e-38
Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 14/237 (5%)
Query: 957 KTFSASEIEKATGNFDAS----RILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGG 1009
F E+ K A + +G G +G V S V G KVA+K L R +
Sbjct: 2 SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 61
Query: 1010 REFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWD 1069
+ E+ +L + H N++ L+ + ++ + G + LG D
Sbjct: 62 KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 121
Query: 1070 ARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRH 1129
+ + L Y+H + +IHRD K N+ + D K+ DFGLAR +
Sbjct: 122 RIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QADSE 174
Query: 1130 ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV 1186
++ V+ + D++S G ++ E+++G+ + Q +
Sbjct: 175 MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEI 231
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 1e-37
Identities = 46/207 (22%), Positives = 84/207 (40%), Gaps = 11/207 (5%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRN 1026
++ +GEG +G V+ + VA+K ++ D+ L E+ +L L H+N
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 62
Query: 1027 LVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLH 1086
+V+L + ++ LV+E D + L + + L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 1087 EDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYA 1146
V+HRD K N+L+ + K+++FGLAR+ R S V+ +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARA-FGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 1147 MTGHLLVKSDVYSYGVVILELLSGRKP 1173
D++S G + EL + +P
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 139 bits (352), Expect = 1e-36
Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 16/226 (7%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKR---VDQQGGREFLAEVEMLSRLHHR 1025
FD + LG G FG V + G A+K+L + V + L E +L ++
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 1026 NLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
LVKL + +V E + G + SHL A YL
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S +I+RD K N+L++ +V+DFG A+ + GT +APE
Sbjct: 158 H---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEI 209
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP 1191
++ D ++ GV+I E+ +G P QP + +
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-34
Identities = 62/301 (20%), Positives = 115/301 (38%), Gaps = 46/301 (15%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKR--VDQQGGREFLAEVEMLSRLHHRNLVKLI 1031
+ +G G G+V + VA+K L R +Q + E+ ++ ++H+N++ L+
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 1032 GICI------EEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ E Q LV EL+ + +D + + + +L
Sbjct: 83 NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-------HERMSYLLYQMLCGIKHL 135
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEY 1145
H S +IHRD K SNI+++ D T K+ DFGLAR+A T + T Y APE
Sbjct: 136 H---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEV 189
Query: 1146 AMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQ----------------ENLVAWA 1189
+ D++S G ++ E++ + Q + L
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 1190 RPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASM--------CVQPEVQHRPFMGEVV 1241
R + +R + P L D F + ++ + + + + R + + +
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 1242 Q 1242
Q
Sbjct: 310 Q 310
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 132 bits (332), Expect = 4e-34
Identities = 45/210 (21%), Positives = 91/210 (43%), Gaps = 22/210 (10%)
Query: 970 NFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNL 1027
++ R LG G + V+ + + + KV VK+LK V ++ + E+++L L N+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNI 92
Query: 1028 VKLIGICIEEQAR--CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYL 1085
+ L I + +R LV+E + N + L +AL Y
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYC 145
Query: 1086 HEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPE 1144
H S ++HRD K N++++H+ ++ D+GLA + + + + PE
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYFKGPE 199
Query: 1145 YAMTGHLL-VKSDVYSYGVVILELLSGRKP 1173
+ + D++S G ++ ++ ++P
Sbjct: 200 LLVDYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 9e-33
Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 19/215 (8%)
Query: 970 NFDASRILGEGGFGLVYSGVL----DDGTKVAVKVLKRV----DQQGGREFLAEVEMLSR 1021
NF+ ++LG G +G V+ D G A+KVLK+ + E ++L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 1022 L-HHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAAR 1080
+ LV L E L+ + I G + +HL ++ + +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQ-------IYVGE 137
Query: 1081 ALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
+ L +I+RD K NILL+ + ++DFGL++ + +E+ + GT Y
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-ERAYDFCGTIEY 196
Query: 1141 VAPEYAMTGHLLV--KSDVYSYGVVILELLSGRKP 1173
+AP+ G D +S GV++ ELL+G P
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 117 bits (293), Expect = 2e-30
Identities = 35/203 (17%), Positives = 65/203 (32%), Gaps = 28/203 (13%)
Query: 975 RILGEGGFGLVYSGVLDDGTKVAVKVLK----------RVDQQGGREFLAEVEMLSRLHH 1024
+++GEG V++ + + VK K G F +R
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 1025 RNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAY 1084
R L KL G+ + + Y N + + + + + +A
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118
Query: 1085 LHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTR-VMGTFGYVAP 1143
+ ++H D N+L+ + + DF + +E R I R V Y +
Sbjct: 119 FY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174
Query: 1144 EYAMTGHLLVKSDVYSYGVVILE 1166
Y + D+ S IL+
Sbjct: 175 TYRT------EKDINSAIDRILQ 191
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (302), Expect = 4e-30
Identities = 53/223 (23%), Positives = 87/223 (39%), Gaps = 14/223 (6%)
Query: 958 TFSASEIEKA----TGNFDASRILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGG--R 1010
TF E+ K + +G G +G V + G +VAVK L R Q +
Sbjct: 3 TFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62
Query: 1011 EFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDA 1070
E+ +L + H N++ L+ + ++ ++ + + L D
Sbjct: 63 RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH 122
Query: 1071 RLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHI 1130
+ R L Y+H S +IHRD K SN+ + D K+ DFGLAR +
Sbjct: 123 VQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEM 175
Query: 1131 STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKP 1173
+ V + H D++S G ++ ELL+GR
Sbjct: 176 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (292), Expect = 1e-28
Identities = 54/297 (18%), Positives = 106/297 (35%), Gaps = 24/297 (8%)
Query: 975 RILGEGGFGLVYSGV-LDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI 1033
R LG G F V+ + + T VA+K+++ D+ E+++L R++ + K +
Sbjct: 19 RKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 1034 CIEEQARCLVY--ELIPNGSVESHLHGVD----------KESAPLGWDARLKIALGAARA 1081
+ L + PNG + V E + +I+
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 1082 LAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSAMDEESRHISTRVMGTFGY 1140
L Y+H +IH D K N+L+E D + +A T + T Y
Sbjct: 138 LDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 1141 VAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVD-MTQPPGQENLVAWARPLLTSREGL 1199
+PE + +D++S +I EL++G + ++ A+ + E
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECDEAKE 1256
++ F+S + I +++ P + + K +E E +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNI------SKLKFWPLEDVLTEKYKFSKDEAKEISD 306
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 1368 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.09 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.57 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.41 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.1 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.09 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 97.8 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 83.55 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 83.47 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.92 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=213.0
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECC
Q ss_conf 99215467710483799999952897899999102352236999999998762144661125413430363589995248
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEYi~ 1048 (1368)
++|++.+.||+|+||.||+|.+.+++.||||+++.. ....++|.+|++++++++|+|||+++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 995888898208882999999889999999998788-6768999999999996689975653524315993379998369
Q ss_pred CCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99810002366567888876799999999999984321069997323577666812137887401166631002332243
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~~ 1128 (1368)
+|+|.+++.. ....++|..+++|+.|++.||.|||+.+ |+|||||++|||||.++.+||+|||+++.......
T Consensus 84 ~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~- 156 (263)
T d1sm2a_ 84 HGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY- 156 (263)
T ss_dssp TCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC-
T ss_conf 9918997520---1347889999999999999877653164---31044315326666887768655321002368873-
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHC-CCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCCC
Q ss_conf 432221255566673100149887212050079999999709-9999999998503478854200145346522104888
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTG-r~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~L 1207 (1368)
.......|+..|+|||++.+..++.++|||||||+||||+|+ +.+|.... ...+...... ..
T Consensus 157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~---~~~~~~~i~~--------------~~ 219 (263)
T d1sm2a_ 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS---NSEVVEDIST--------------GF 219 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCC---HHHHHHHHHH--------------TC
T ss_pred EEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCC---HHHHHHHHHH--------------CC
T ss_conf 350430017666785786079998403321059999999878988877899---9999999980--------------68
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999913599999999981596968999989999999999975
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1208 ~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e 1250 (1368)
+...+..+..++.+|+.+||+.+|++||+|+||++.|+.+.+.
T Consensus 220 ~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 220 RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 8899543679999999997657976891999999999999857
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=388.61 Aligned_cols=260 Identities=28% Similarity=0.455 Sum_probs=213.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CC---CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99215467710483799999952-89---78999991023-522369999999987621446611254134303635899
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DG---TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lk-dG---k~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LV 1043 (1368)
++|++.++||+|+||+||+|.+. ++ ..||||++... .....++|.+|+++|++++|+|||+++|+|.+.+..++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 95248998100023665678888767999999999999843210699973235776668121378874011666310023
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~ 1123 (1368)
|||+++|+|.+++.. ....++|.++++|+.|+++||.|||+.+ |+|||||++||||+.++.+||+|||+++...
T Consensus 106 ~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCEEEECC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECC
T ss_conf 972279853002104---5679999999999999999889885279---8357615044898899919988844315756
Q ss_pred CCCCCCC---CCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 3224343---222125556667310014988721205007999999970-999999999985034788542001453465
Q 000659 1124 DEESRHI---STRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1124 ~~~~~~~---st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L 1199 (1368)
....... .....|+..|||||++.++.++.++|||||||+||||+| |+.||..... ..+...+.
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~---~~~~~~i~--------- 247 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN---QDVINAIE--------- 247 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHH---------
T ss_pred CCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHH---------
T ss_conf 777765365025666883003878883699786121445357899998679999999999---99999997---------
Q ss_pred CEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 2210488899999135999999999815969689999899999999999750
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1200 ~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
...+...+.++...+.+|+.+||+.+|++||+|.||++.|+.+.+..
T Consensus 248 -----~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~p 294 (299)
T d1jpaa_ 248 -----QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294 (299)
T ss_dssp -----TTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred -----CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCH
T ss_conf -----37889997422699999999975879768929999999999984186
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=388.13 Aligned_cols=264 Identities=27% Similarity=0.456 Sum_probs=212.7
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 80992154677104837999999528978999991023--5223699999999876214466112541343036358999
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
..++|++.+.||+|+||.||+|.++ ..||||+++.. +....+.|.+|+++|++++|+|||+++|++.+ ...++||
T Consensus 6 ~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 6 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp CTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 5451899889830788589999999--989999997346998999999999999984799878645679715-5899999
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
||+++|+|.++|+.. ...+++.++++|+.|+++||+|||+.+ |+|||||++||||+.++.+||+|||+|+....
T Consensus 83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred ECCCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCC
T ss_conf 658998889998523---578999999999999999988875099---95161478997981899788750022133355
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCE
Q ss_conf 224343222125556667310014---98872120500799999997099999999998503478854200145346522
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~---~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~e 1201 (1368)
...........||..|||||++.+ ..++.++|||||||+||||+||+.||....... .+......... ...+
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~--~~~~~~~~~~~-~p~~-- 231 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIFMVGRGYL-SPDL-- 231 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--HHHHHHHHTSC-CCCG--
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHCCCC-CCCC--
T ss_conf 677631256655743179999950568999953151635999999997889989989699--99999965888-9860--
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 10488899999135999999999815969689999899999999999750
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1202 IIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
......+..++.+|+.+||+.+|++||||.||++.|+.+.+..
T Consensus 232 -------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 232 -------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp -------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred -------HHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf -------0036555499999999975889768929999999999999709
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=385.80 Aligned_cols=261 Identities=28% Similarity=0.473 Sum_probs=214.3
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEECC-C-----CEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEECC
Q ss_conf 80992154677104837999999528-9-----78999991023-522369999999987621-4466112541343036
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDD-G-----TKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lkd-G-----k~VAVKvLk~~-s~~~~keFlrEIeILkrL-rHPNIVkLiGv~~e~~ 1038 (1368)
-.++|++.+.||+|+||+||+|++.. + ..||+|++... +....+.|.+|+.+|+++ +|+|||+++|++.+.+
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECC
T ss_conf 78993970198307881999999857885542049999996633587899999999999997158996868778886299
Q ss_pred CEEEEEEECCCCCHHHCCCCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 35899952489981000236656-------------------78888767999999999999843210699973235776
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDK-------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFK 1099 (1368)
Q Consensus 1039 ~l~LVmEYi~gGSL~dlL~~~~~-------------------~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIK 1099 (1368)
..++||||+++|+|.++|+.... ....++|.+++.|+.|++.||+|||+++ |+|||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCC
T ss_conf 5899997279995999998625777510221000012220012577899999999999999999997399---0505270
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCC
Q ss_conf 6681213788740116663100233224343222125556667310014988721205007999999970-999999999
Q 000659 1100 SSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQ 1178 (1368)
Q Consensus 1100 PsNILLDedg~VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~ 1178 (1368)
++|||++.++.+||+|||+|+...............||..|||||++.++.++.++|||||||+||||++ |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred HHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 32144345982898514222204577861562343578765783887279999633030003999999838999999989
Q ss_pred CCCCHHHHHHHHHHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 98503478854200145346522104888999991359999999998159696899998999999999
Q 000659 1179 PPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1179 ~~d~~nLv~Wa~plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~ 1246 (1368)
... .+... +....+...+..+..++.+|+.+||+.+|++||||+||++.|..
T Consensus 272 ~~~--~~~~~--------------~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 272 VDA--NFYKL--------------IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp CSH--HHHHH--------------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHH--HHHHH--------------HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 899--99999--------------85699899887678999999999758896689399999999748
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=390.29 Aligned_cols=262 Identities=26% Similarity=0.389 Sum_probs=215.1
Q ss_pred HHHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 88099215467710483799999952-89789999910235223699999999876214466112541343036358999
Q 000659 966 KATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 966 ~at~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
...++|++.+.||+|+||.||+|.+. +++.||||+++.. ....++|++|+++|++++|+|||+++|+|.+.+..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 4579939865982088808999999999969999997776-103999999999998679998826775274578547876
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
||+++|+|.++|... ....+++..+++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+|+....
T Consensus 93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (287)
T d1opja_ 93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 167 (287)
T ss_dssp ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred ECCCCCCHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 314676067775303--5541579999999999999788898789---30576045768998999289832445465378
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
.. ........|+..|+|||++.++.++.++|||||||+||||++|..|+..... ...+.+. +.
T Consensus 168 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~--~~~~~~~--------------i~ 230 (287)
T d1opja_ 168 DT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID--LSQVYEL--------------LE 230 (287)
T ss_dssp SS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCC--HHHHHHH--------------HH
T ss_pred CC-CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHH--------------HH
T ss_conf 87-2210355665466692787279998104302178999999867998877425--9999999--------------85
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 8889999913599999999981596968999989999999999975
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e 1250 (1368)
...+...+.....++.+|+.+||+.+|++||||.||++.|+.+.++
T Consensus 231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 5888888743309999999997577976893999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.83 Aligned_cols=259 Identities=26% Similarity=0.406 Sum_probs=210.5
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 80992154677104837999999528978999991023522369999999987621446611254134303635899952
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEY 1046 (1368)
..++|++.+.||+|+||.||+|.+++++.||||+++.. ....++|.+|++++++++|+|||+++|++.+ +..++||||
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey 88 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEY 88 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEE
T ss_conf 88993886798107982899999999999999998647-6888999999999986799988578731045-976999995
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 48998100023665678888767999999999999843210699973235776668121378874011666310023322
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 i~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~ 1126 (1368)
+++|+|.+++.... ...++|.++++|+.|+++||.|||+.+ |+|||||++||||+.++.+||+|||+|+......
T Consensus 89 ~~~g~L~~~~~~~~--~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 89 MENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp CTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCC
T ss_conf 78982888875147--898878899999999999999997489---5467564225156202440423410147735886
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCC
Q ss_conf 43432221255566673100149887212050079999999709999999999850347885420014534652210488
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPS 1206 (1368)
Q Consensus 1127 ~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~ 1206 (1368)
........|+..|+|||++.++.++.++|||||||+||||+||..|+..... ...+..... ..
T Consensus 164 -~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~--~~~~~~~i~--------------~~ 226 (272)
T d1qpca_ 164 -YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMT--NPEVIQNLE--------------RG 226 (272)
T ss_dssp -EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHH--------------TT
T ss_pred -CCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHH--------------HC
T ss_conf -4420356774444582898379998245645257999999968988888889--999999997--------------06
Q ss_pred CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8999991359999999998159696899998999999999997
Q 000659 1207 LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1207 L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~ 1249 (1368)
.+...+.....++.+|+.+||+.+|++||||.||++.|+.+..
T Consensus 227 ~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 227 YRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 8888965571999999999758897689399999998611321
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=381.99 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=209.3
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 09921546771048379999995-289789999910235-2236999999998762144661125413430363589995
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s-~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmE 1045 (1368)
.++|++.+.||+|+||.||+|.. .+++.||||+++... ....+++.+|+++|++++|+|||++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 24899810002366567888876799999999999984321069997323577666812137887401166631002332
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~ 1125 (1368)
|+++|+|.++|.. ...+++.+++.|+.|++.||.|||+++ |+|||||++||||+.++++||+|||+|+.....
T Consensus 84 y~~gg~L~~~l~~----~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~ 156 (271)
T d1nvra_ 84 YCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 156 (271)
T ss_dssp CCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred CCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 4589808999753----799999999999999999999999759---835754689978878998798323142240468
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 24343222125556667310014988-72120500799999997099999999998503478854200145346522104
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1126 ~~~~~st~vvGT~gYmAPEvL~~~~~-T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
.........+||+.|||||++.+..+ +.++|||||||+||||++|+.||+........ ...+...
T Consensus 157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~------------- 222 (271)
T d1nvra_ 157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK------------- 222 (271)
T ss_dssp TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTT-------------
T ss_pred CCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH-HHHHHCC-------------
T ss_conf 86531113255747428728618999997101617379999998299788889859999-9998638-------------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 888999991359999999998159696899998999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
............++.+|+.+||+.+|++|||+.|+++.
T Consensus 223 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 260 (271)
T d1nvra_ 223 -KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 260 (271)
T ss_dssp -CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred -CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -88788644699999999999767996689099999619
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=377.72 Aligned_cols=263 Identities=24% Similarity=0.413 Sum_probs=213.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCC-----CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 09921546771048379999995289-----78999991023-5223699999999876214466112541343036358
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDG-----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lkdG-----k~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~ 1041 (1368)
...|+..++||+|+||.||+|.+++. ..||||+++.. .....++|++|++++++++|+|||+++|+|.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEE
T ss_conf 89968615981177909999999689987879999999884459689999999999998568987832367783388038
Q ss_pred EEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 99952489981000236656788887679999999999998432106999732357766681213788740116663100
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
+||||+.+|++.+++.. ....++|.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++.
T Consensus 86 ~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 159 (283)
T d1mqba_ 86 IITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 159 (283)
T ss_dssp EEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEECCCCCCHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHC
T ss_conf 99972135740222102---3454208999999999998541212123---42576564427888998499845510300
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 233224-3432221255566673100149887212050079999999709999999999850347885420014534652
Q 000659 1122 AMDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1122 i~~~~~-~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~ 1200 (1368)
...... ........||..|+|||++.++.++.++|||||||+||||++|..++..... ...+...+
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~--~~~~~~~i----------- 226 (283)
T d1mqba_ 160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS--NHEVMKAI----------- 226 (283)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHH-----------
T ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC--HHHHHHHH-----------
T ss_conf 35787652674267777343488887049999735563448989999967988655689--99999998-----------
Q ss_pred EEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 2104888999991359999999998159696899998999999999997501
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1201 eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~~ 1252 (1368)
....+...+.++..++.+|+.+||+.+|++||+|.||++.|+.+.+..+
T Consensus 227 ---~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p~ 275 (283)
T d1mqba_ 227 ---NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275 (283)
T ss_dssp ---HTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred ---HCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf ---6357899850457999999999776797689399999999999866956
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=379.49 Aligned_cols=261 Identities=28% Similarity=0.442 Sum_probs=211.6
Q ss_pred HCCCCEEEE-EEECCCEEEEEEEEC---CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 099215467-710483799999952---8978999991023-52236999999998762144661125413430363589
Q 000659 968 TGNFDASRI-LGEGGFGLVYSGVLD---DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 968 t~nFei~ei-LGkGaFGtVYKA~lk---dGk~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~L 1042 (1368)
.++|.+.++ ||+|+||.||+|.+. ++..||||+++.. .....++|.+|+++|++++|+|||+++|+|.+ +..|+
T Consensus 7 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 44718878487306080999999960897689999998820397899999999999986799888068656036-80799
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99524899810002366567888876799999999999984321069997323577666812137887401166631002
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i 1122 (1368)
||||+++|+|.+++.. .+..+++.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++..
T Consensus 86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~ 159 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKAL 159 (285)
T ss_dssp EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCC
T ss_conf 9980789968997521---2569999999999999999878998688---105767646604546885420331342115
Q ss_pred CCCCC-CCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 33224-343222125556667310014988721205007999999970-9999999999850347885420014534652
Q 000659 1123 MDEES-RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLE 1200 (1368)
Q Consensus 1123 ~~~~~-~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L~ 1200 (1368)
..... ........|+..|+|||++.++.++.++|||||||+||||+| |+.||...... .+.....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~---~~~~~i~---------- 226 (285)
T d1u59a_ 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP---EVMAFIE---------- 226 (285)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH---HHHHHHH----------
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH---HHHHHHH----------
T ss_conf 543432113562113743358688727999954123220178999993899999997999---9999998----------
Q ss_pred EEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 2104888999991359999999998159696899998999999999997501
Q 000659 1201 RIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1201 eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~~ 1252 (1368)
...+...+..+..++.+|+.+||+.+|++||+|.+|++.|+....+..
T Consensus 227 ----~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~ 274 (285)
T d1u59a_ 227 ----QGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 274 (285)
T ss_dssp ----TTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHH
T ss_conf ----189999997678999999999757797689099999999999999854
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=384.13 Aligned_cols=269 Identities=21% Similarity=0.328 Sum_probs=209.9
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 809921546771048379999995-28978999991023-5223699999999876214466112541343036358999
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
..++|++.+.||+|+||+||+|.. .+++.||+|+++.. +....+++.+|+.+|++++|+|||++++++.+.+..|+||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106-99973235776668121378874011666310023
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~-Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~ 1123 (1368)
||+++|+|.+++.+ ...+++.++++++.|++.||.|||+. + |+||||||+||||+.++++||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 76799868998742----4999999999999999999999998599---9714457799468789989995487762567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHH-HHHHCCC-------
Q ss_conf 32243432221255566673100149887212050079999999709999999999850347885-4200145-------
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAW-ARPLLTS------- 1195 (1368)
Q Consensus 1124 ~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~W-a~plls~------- 1195 (1368)
.. .....+||..|+|||++.+..|+.++|||||||+||||++|+.||...+.......... .......
T Consensus 157 ~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (322)
T d1s9ja_ 157 DS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232 (322)
T ss_dssp HH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred CC----CCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC
T ss_conf 88----62111377141194687589989488899899999999988899899887899999988751775457742123
Q ss_pred --C----------------CCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf --3----------------46522104888999991359999999998159696899998999999999
Q 000659 1196 --R----------------EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1196 --~----------------e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~ 1246 (1368)
. +.+..+...............++.+++.+||..||++|||+.|+++.-+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~ 301 (322)
T d1s9ja_ 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301 (322)
T ss_dssp -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHH
T ss_conf 332211112223541347788766502687667644489999999999868994679089999609864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=374.35 Aligned_cols=260 Identities=25% Similarity=0.432 Sum_probs=213.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCC----EEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 99215467710483799999952-897----8999991023-52236999999998762144661125413430363589
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGT----KVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lk-dGk----~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~L 1042 (1368)
.+|++.++||+|+||.||+|.+. +|+ .||+|+++.. +....++|.+|++++++++|+|||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99524899810002366567888876799999999999984321069997323577666812137887401166631002
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i 1122 (1368)
++||+.+|+|.+++.. ....+++..+++|+.|++.||.|||+++ |+|||||++||||+.++.+||+|||+++..
T Consensus 88 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEECCCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 9984268740101113---3457999999999999999999998769---504762120311679987586025522233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCE
Q ss_conf 33224343222125556667310014988721205007999999970-99999999998503478854200145346522
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L~e 1201 (1368)
.............||..|+|||++.++.++.++|||||||+||||+| |+.||+...... +....
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~~i------------ 226 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL------------ 226 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHHHH------------
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH------------
T ss_conf 544453223651058644670887469998356544079999999977999999999899---99999------------
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 104888999991359999999998159696899998999999999997501
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNECD 1252 (1368)
Q Consensus 1202 IIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~~ 1252 (1368)
....+...+..+..++.+|+.+||+.+|++||++.||++.|+.+.++..
T Consensus 227 --~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~~~ 275 (317)
T d1xkka_ 227 --EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQ 275 (317)
T ss_dssp --HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSHH
T ss_pred --HCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCHH
T ss_conf --7599899985568999999998478993469199999999999875868
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=379.56 Aligned_cols=268 Identities=26% Similarity=0.449 Sum_probs=218.7
Q ss_pred HHHHHHHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEE
Q ss_conf 7899988099215467710483799999952------89789999910235-2236999999998762144661125413
Q 000659 961 ASEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGI 1033 (1368)
Q Consensus 961 ~eELe~at~nFei~eiLGkGaFGtVYKA~lk------dGk~VAVKvLk~~s-~~~~keFlrEIeILkrLrHPNIVkLiGv 1033 (1368)
+.+++...++|++.+.||+|+||.||+|.+. +++.||||+++... ....++|.+|+++|++++|+||++++++
T Consensus 5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 84 (301)
T d1lufa_ 5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV 84 (301)
T ss_dssp HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred HHHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEE
T ss_conf 33113898893886798207883999999888765778829999998821085799999999999996689976552466
Q ss_pred EEECCCEEEEEEECCCCCHHHCCCCCCC--------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 4303635899952489981000236656--------------------78888767999999999999843210699973
Q 000659 1034 CIEEQARCLVYELIPNGSVESHLHGVDK--------------------ESAPLGWDARLKIALGAARALAYLHEDSSPRV 1093 (1368)
Q Consensus 1034 ~~e~~~l~LVmEYi~gGSL~dlL~~~~~--------------------~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~I 1093 (1368)
|.+.+..++||||+.+|+|.++|+.... ....+++.++++|+.|++.||+|||+.+ |
T Consensus 85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---i 161 (301)
T d1lufa_ 85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---F 161 (301)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred ECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---E
T ss_conf 6059803899981589929999985275542100001110012103467889899999999999999855413578---6
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCC-C
Q ss_conf 235776668121378874011666310023322434322212555666731001498872120500799999997099-9
Q 000659 1094 IHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-K 1172 (1368)
Q Consensus 1094 VHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr-~ 1172 (1368)
+|||||++|||||.++.+||+|||+++...............|+..|+|||++.+..++.++|||||||+||||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999999850347885420014534652210488899999135999999999815969689999899999999999
Q 000659 1173 PVDMTQPPGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1173 PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il 1248 (1368)
||..... ..+...+.. .. ....+..+..++.+|+.+||+.+|++||||.||++.|++++
T Consensus 242 p~~~~~~---~e~~~~v~~-----~~---------~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 242 PYYGMAH---EEVIYYVRD-----GN---------ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTTTSCH---HHHHHHHHT-----TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCCCH---HHHHHHHHC-----CC---------CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHC
T ss_conf 9999899---999999973-----99---------78887325299999999974889657939999999999842
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.79 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=212.0
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECC
Q ss_conf 99215467710483799999952897899999102352236999999998762144661125413430363589995248
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIP 1048 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEYi~ 1048 (1368)
++|++.+.||+|+||+||+|.+++++.||||+++.. ....++|++|++++++++|+||++++|+|.+++..++||||+.
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 997996898207883999999889989999998747-5778999999999996689860158899850781699997048
Q ss_pred CCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99810002366567888876799999999999984321069997323577666812137887401166631002332243
Q 000659 1049 NGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR 1128 (1368)
Q Consensus 1049 gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~~ 1128 (1368)
+|+|.+++.. ....+.+..+++|+.|+++||.|||+.+ |+|||||++||||+.++.+||+|||+++.......
T Consensus 83 ~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~- 155 (258)
T d1k2pa_ 83 NGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY- 155 (258)
T ss_dssp TEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-
T ss_pred CCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC-
T ss_conf 9938886410---2467768999999999999999875468---43466541358876998479886144202357872-
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCCC
Q ss_conf 43222125556667310014988721205007999999970-99999999998503478854200145346522104888
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~L 1207 (1368)
.......|+..|+|||++.+..++.++||||||+++|||+| |+.||+..... .+..... ...
T Consensus 156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~---~~~~~i~--------------~~~ 218 (258)
T d1k2pa_ 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS---ETAEHIA--------------QGL 218 (258)
T ss_dssp CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH---HHHHHHH--------------TTC
T ss_pred EEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH---HHHHHHH--------------HCC
T ss_conf 25246578877578078637998852103364324673975599998899999---9999998--------------079
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999991359999999998159696899998999999999
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKL 1246 (1368)
Q Consensus 1208 ~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~ 1246 (1368)
+...+.....++.+|+.+||+.+|++||||.||++.|.+
T Consensus 219 ~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 219 RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 789965465999999999766897689399999987418
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.35 Aligned_cols=250 Identities=24% Similarity=0.355 Sum_probs=208.5
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 9921546771048379999995-289789999910235223699999999876214466112541343036358999524
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEYi 1047 (1368)
++|++.+.||+|+||+||+|.. .+|+.||||+++.......+.+.+|+++|++++|+|||++++++.+.+..|+||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89981000236656788887679999999999998432106999732357766681213788740116663100233224
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~ 1127 (1368)
++|+|.+++.. ..+++.+++.|+.|++.||.|||+++ |+|||||++||||+.++++||+|||+|+......
T Consensus 100 ~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 100 AGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp TTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred CCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC-
T ss_conf 79808988641-----59999999999999999999999879---7226776888688789968642515641321366-
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCCC
Q ss_conf 34322212555666731001498872120500799999997099999999998503478854200145346522104888
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~L 1207 (1368)
......+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. ..+...... . ..
T Consensus 171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~~~~~-----~--------~~ 234 (293)
T d1yhwa1 171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYLIATN-----G--------TP 234 (293)
T ss_dssp -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHHHHH-----C--------SC
T ss_pred -CCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHC-----C--------CC
T ss_conf -6444444477736826644799880120313729999980488998997999--999999857-----9--------99
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 999991359999999998159696899998999999
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1208 ~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
....+......+.+|+.+||+.||++||++.|+++.
T Consensus 235 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H 270 (293)
T d1yhwa1 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (293)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 888855379999999999866996689099999649
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=373.42 Aligned_cols=253 Identities=20% Similarity=0.286 Sum_probs=208.0
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 09921546771048379999995-28978999991023522369999999987621446611254134303635899952
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEY 1046 (1368)
.++|++.+.||+|+||.||+|.. .+|+.||||++........+.+.+|+.+|++++|+|||++++++.+++..|+||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECC--CCCCCCCCCCCCCCCCC
Q ss_conf 4899810002366567888876799999999999984321069997323577666812137--88740116663100233
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH--DFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1047 i~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDe--dg~VKIsDFGLAr~i~~ 1124 (1368)
|++|+|.+++.. ....+++.+++.|+.||+.||.|||+.+ |+|||||++||||+. ++.+||+|||+++....
T Consensus 105 ~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 105 MSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred CCCCCHHHHHHH---HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 799889999976---2378999999999999999999997569---7600015467364168898699954521044256
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
. .......||..|||||++.+..++.++|||||||+||||++|+.||...+.. .+.... ......
T Consensus 179 ~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~~~~~------ 243 (350)
T d1koaa2 179 K---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD---ETLRNV---KSCDWN------ 243 (350)
T ss_dssp T---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH---HHTCCC------
T ss_pred C---CCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HHCCCC------
T ss_conf 5---4320006862421889975899872676554659999998598998997999---999999---847889------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 888999991359999999998159696899998999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
+..........++.+|+.+||..||++|||+.|+++.
T Consensus 244 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 244 --MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp --SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred --CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --8942235899999999999756896679089998629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=380.28 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=208.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--CCCEEEE
Q ss_conf 9921546771048379999995-28978999991023--52236999999998762144661125413430--3635899
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE--EQARCLV 1043 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e--~~~l~LV 1043 (1368)
++|++.+.||+|+||.||+|.. .+|+.||+|+++.. +....+.+.+|+++|++++|+|||++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 9524899810002366567888876799999999999984321069--99732357766681213788740116663100
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS--SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~G--sp~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
|||+++|+|.+++.........+++.+++.|+.|++.||.|||+.+ ..+|+||||||+||||+.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCE
Q ss_conf 23322434322212555666731001498872120500799999997099999999998503478854200145346522
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1122 i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~e 1201 (1368)
..... ......+||+.|||||++.+..++.++|||||||+||||++|+.||...+. ..+..... . ...
T Consensus 164 ~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~---~~~~~~i~---~--~~~-- 231 (269)
T d2java1 164 LNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ---KELAGKIR---E--GKF-- 231 (269)
T ss_dssp C-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH---H--TCC--
T ss_pred CCCCC--CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH---HHHHHHHH---C--CCC--
T ss_conf 24577--755667788232799998399999389887527899998018899899899---99999997---1--899--
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 104888999991359999999998159696899998999999
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 IIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
...+.....++.+|+.+||+.||++||++.|+++.
T Consensus 232 -------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h 266 (269)
T d2java1 232 -------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266 (269)
T ss_dssp -------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred -------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf -------88974359999999999767995579189999729
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.50 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=204.3
Q ss_pred EEEEECCCEEEEEEEECC---CCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEECCC
Q ss_conf 677104837999999528---978999991023--522369999999987621446611254134303635899952489
Q 000659 975 RILGEGGFGLVYSGVLDD---GTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELIPN 1049 (1368)
Q Consensus 975 eiLGkGaFGtVYKA~lkd---Gk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEYi~g 1049 (1368)
+.||+|+||.||+|.+++ ++.||||+++.. +....++|.+|+++|++++|+|||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC-
Q ss_conf 9810002366567888876799999999999984321069997323577666812137887401166631002332243-
Q 000659 1050 GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEESR- 1128 (1368)
Q Consensus 1050 GSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~~- 1128 (1368)
|+|.++++. ...++|.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++........
T Consensus 92 g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~ 164 (277)
T d1xbba_ 92 GPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164 (277)
T ss_dssp EEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred CCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCC
T ss_conf 968999752----257899999999999999976687479---5567776113102356751234134533134323443
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCCC
Q ss_conf 43222125556667310014988721205007999999970-99999999998503478854200145346522104888
Q 000659 1129 HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1129 ~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~L 1207 (1368)
.......||..|+|||++.+..++.++|||||||+||||++ |+.||..... ..+..... ...
T Consensus 165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~---~~~~~~i~--------------~~~ 227 (277)
T d1xbba_ 165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG---SEVTAMLE--------------KGE 227 (277)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH---HHHHHHHH--------------TTC
T ss_pred CCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH---HHHHHHHH--------------CCC
T ss_conf 2244567784203916653799984344303403132896589999999899---99999998--------------289
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 9999913599999999981596968999989999999999975
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1208 ~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e 1250 (1368)
+...+..+..++.+|+.+||+.+|++||+|.+|++.|+....+
T Consensus 228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHHHH
T ss_conf 9999865679999999997588976890989999985288750
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=370.90 Aligned_cols=253 Identities=21% Similarity=0.289 Sum_probs=208.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 09921546771048379999995-28978999991023522369999999987621446611254134303635899952
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEY 1046 (1368)
.++|++.+.||+|+||.||+|.. .+|+.||||+++.......+.+.+|+++|++++|+|||++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEEC--CCCCCCCCCCCCCCCCCC
Q ss_conf 489981000236656788887679999999999998432106999732357766681213--788740116663100233
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE--HDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1047 i~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLD--edg~VKIsDFGLAr~i~~ 1124 (1368)
|++|+|.+++.. ....+++.+++.|+.|++.||.|||+.+ |+|||||++||||+ .++.+||+|||+|+....
T Consensus 108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred CCCCHHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 899808888986---3899899999999999999999999779---2651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
. .......|+..|+|||++.+..++.++|||||||+||||++|+.||..... ..+..... ...
T Consensus 182 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~---~~~~~~i~---~~~-------- 244 (352)
T d1koba_ 182 D---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD---LETLQNVK---RCD-------- 244 (352)
T ss_dssp T---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH---HHHHHHHH---HCC--------
T ss_pred C---CCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---HCC--------
T ss_conf 8---720100476453489997479989763338989999999968899899799---99999998---478--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 888999991359999999998159696899998999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
..+..........++.+|+.+||+.||++|||+.|+++.
T Consensus 245 ~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 245 WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 898930024799999999999756996689189999609
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.67 Aligned_cols=252 Identities=25% Similarity=0.380 Sum_probs=207.4
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 9921546771048379999995-289789999910235223699999999876214466112541343036358999524
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEYi 1047 (1368)
+.|++.+.||+|+||.||+|.. .+++.||||+++.......+.|.+|+++|++++|+|||++++++.+++..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89981000236656788887679999999999998432106999732357766681213788740116663100233224
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~ 1127 (1368)
++|+|.+++... ...+++.++..|+.|++.||.|||+++ |+|||||++||||+.++++||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI- 164 (288)
T ss_dssp TTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-
T ss_pred CCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC-
T ss_conf 998188999862---899999999999999999999999889---8871407003148789998997161230357786-
Q ss_pred CCCCCCCCCCCCCCCCCHHC-----CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEE
Q ss_conf 34322212555666731001-----4988721205007999999970999999999985034788542001453465221
Q 000659 1128 RHISTRVMGTFGYVAPEYAM-----TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1128 ~~~st~vvGT~gYmAPEvL~-----~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eI 1202 (1368)
......+||..|+|||++. ...|+.++|||||||+||||++|+.||...+... .+....... ..
T Consensus 165 -~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~i~~~~------~~-- 233 (288)
T d2jfla1 165 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLKIAKSE------PP-- 233 (288)
T ss_dssp -HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHHHHHSC------CC--
T ss_pred -CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHCCC------CC--
T ss_conf -4100102562647999983202578888806657878999999820889999989999--999997079------98--
Q ss_pred ECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 04888999991359999999998159696899998999999
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1203 IDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
....+.....++.+|+.+||+.||++|||+.|+++.
T Consensus 234 -----~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h 269 (288)
T d2jfla1 234 -----TLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH 269 (288)
T ss_dssp -----CCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----777656699999999999766996689199999629
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.08 Aligned_cols=257 Identities=26% Similarity=0.404 Sum_probs=210.3
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEEC
Q ss_conf 09921546771048379999995289789999910235223699999999876214466112541343036358999524
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYELI 1047 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEYi 1047 (1368)
.++|++.+.||+|+||.||+|.+++++.||||+++.. ....+.|.+|+.++++++|+|||+++|+|.+ +..++||||+
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~ 93 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 93 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEEC
T ss_conf 7997984699307980999999999999999998804-4888999999999986666788689999823-9759999944
Q ss_pred CCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89981000236656788887679999999999998432106999732357766681213788740116663100233224
Q 000659 1048 PNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEES 1127 (1368)
Q Consensus 1048 ~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~~ 1127 (1368)
++|+|.+++... ....++|.++++|+.|++.||+|||+.+ |+|||||++|||||.++.+||+|||+++.......
T Consensus 94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 799435420000--3553059999999999999999875411---43353123079998999299844255542568873
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECCCC
Q ss_conf 34322212555666731001498872120500799999997099999999998503478854200145346522104888
Q 000659 1128 RHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDPSL 1207 (1368)
Q Consensus 1128 ~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp~L 1207 (1368)
.......|+..|+|||++..+.++.++|||||||+||||++|..|+..... ...+..++.. ..
T Consensus 169 -~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~--~~~~~~~i~~--------------~~ 231 (285)
T d1fmka3 169 -TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV--NREVLDQVER--------------GY 231 (285)
T ss_dssp --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC--HHHHHHHHHT--------------TC
T ss_pred -EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCC--HHHHHHHHHH--------------CC
T ss_conf -352454556654580898379989177413235899999868999998888--9999999982--------------68
Q ss_pred CCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99999135999999999815969689999899999999999
Q 000659 1208 GNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVC 1248 (1368)
Q Consensus 1208 ~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il 1248 (1368)
+......+..++.+++.+||+.+|++||+|.+|++.|+...
T Consensus 232 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 232 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99998323799999999975669758919999999876662
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.02 Aligned_cols=248 Identities=27% Similarity=0.366 Sum_probs=207.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 99215467710483799999952-8978999991023---5223699999999876214466112541343036358999
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
++|++.+.||+|+||.||+|... +++.||+|++... +....+.+.+|++++++++|+|||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
||+++|+|.+++.. ...+++.+++.|+.|++.||.|||+++ |+||||||+||||+.++++||+|||+|+....
T Consensus 86 Ey~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~ 158 (263)
T d2j4za1 86 EYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS 158 (263)
T ss_dssp ECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred EECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCC
T ss_conf 50479858988750----489999999999999999999999889---46522023441466899871155563354488
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
. .....+||..|||||++.+..++.++|||||||+||||++|+.||+..+.. .+.... ....
T Consensus 159 ~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~---~~~~~i---~~~~-------- 220 (263)
T d2j4za1 159 S----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ---ETYKRI---SRVE-------- 220 (263)
T ss_dssp C----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---HTTC--------
T ss_pred C----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHH---HCCC--------
T ss_conf 8----523557887634999975899893144046759999983299998889999---999999---7189--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 88899999135999999999815969689999899999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk 1245 (1368)
..++.....++.+|+.+||+.||++|||+.|+++.-+
T Consensus 221 ----~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~ 257 (263)
T d2j4za1 221 ----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW 257 (263)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf ----9998668999999999976479768909999971907
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.07 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=210.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771048379999995-28978999991023---5223699999999876214466112541343036358999
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
++|++.+.||+|+||.||+|.. .+++.||||+++.. .....+.+.+|+++|++++|+||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
||+++|+|.+++.. ...+++.+++.++.|++.||.|||+.+ |+|||||++||||++++.+||+|||+|+....
T Consensus 88 Ey~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~ 160 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160 (288)
T ss_dssp CCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCC
T ss_conf 70489877776531----599999999999999999997621650---88476774123668885388603210242256
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
..........+||..|+|||++.+..++.++|||||||+||||++|+.||...+. ..+.... ....
T Consensus 161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i---~~~~-------- 226 (288)
T d1uu3a_ 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE---YLIFQKI---IKLE-------- 226 (288)
T ss_dssp ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HTTC--------
T ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HCCC--------
T ss_conf 7764333555677552584400268989666230456999998038899899599---9999999---7189--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 88899999135999999999815969689999899999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk 1245 (1368)
..++.....++.+|+.+||+.||++|+|+.|+++..+
T Consensus 227 ----~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 227 ----YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp ----CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred ----CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf ----9998547999999999985579768919789737789
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.11 Aligned_cols=270 Identities=24% Similarity=0.356 Sum_probs=214.1
Q ss_pred HHHHHHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEEEE
Q ss_conf 899988099215467710483799999952------8978999991023-522369999999987621-44661125413
Q 000659 962 SEIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGI 1033 (1368)
Q Consensus 962 eELe~at~nFei~eiLGkGaFGtVYKA~lk------dGk~VAVKvLk~~-s~~~~keFlrEIeILkrL-rHPNIVkLiGv 1033 (1368)
.+.+...++|++.+.||+|+||.||+|.+. +++.||||+++.. .....+.+.+|+.++.++ +|+||+.++++
T Consensus 6 ~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~ 85 (299)
T d1ywna1 6 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85 (299)
T ss_dssp HHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEE
T ss_conf 25261679979844984167839999998677755578399999986001717899999999998861499849974115
Q ss_pred EEEC-CCEEEEEEECCCCCHHHCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 4303-635899952489981000236656------------788887679999999999998432106999732357766
Q 000659 1034 CIEE-QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKS 1100 (1368)
Q Consensus 1034 ~~e~-~~l~LVmEYi~gGSL~dlL~~~~~------------~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKP 1100 (1368)
+.+. ...++|||||++|+|.++|+.... ....+++.++++|+.|+++||.|||+++ |+|||||+
T Consensus 86 ~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp 162 (299)
T d1ywna1 86 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAA 162 (299)
T ss_dssp ECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCG
T ss_pred ECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCC
T ss_conf 404797579999845899299999853666665322202332146899999999999999999887379---71786773
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCC
Q ss_conf 68121378874011666310023322434322212555666731001498872120500799999997099-99999999
Q 000659 1101 SNILLEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMTQP 1179 (1368)
Q Consensus 1101 sNILLDedg~VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr-~PFd~s~~ 1179 (1368)
+||||+.++.+||+|||+|+...............||..|+|||++.+..++.++|||||||++|||++|. .||.....
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred CCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCH
T ss_conf 10657799828984575200113566522247516672102036864688996632213678999998688999989998
Q ss_pred CCCHHHHHHHHHHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 85034788542001453465221048889999913599999999981596968999989999999999975
Q 000659 1180 PGQENLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1180 ~d~~nLv~Wa~plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e 1250 (1368)
.. .+..... ...+...+.....++.+++.+||+.+|++|||+.||+++|+.+++.
T Consensus 243 ~~--~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 243 DE--EFCRRLK--------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp SH--HHHHHHH--------------HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HH--HHHHHHH--------------CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 99--9999996--------------3898888865789999999997677966791999999999799867
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.68 Aligned_cols=257 Identities=27% Similarity=0.446 Sum_probs=206.9
Q ss_pred EEEEEEECCCEEEEEEEECCC----CEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-CCCEEEEEEE
Q ss_conf 546771048379999995289----78999991023-52236999999998762144661125413430-3635899952
Q 000659 973 ASRILGEGGFGLVYSGVLDDG----TKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYEL 1046 (1368)
Q Consensus 973 i~eiLGkGaFGtVYKA~lkdG----k~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e-~~~l~LVmEY 1046 (1368)
..++||+|+||+||+|.+.++ ..||||+++.. +....++|.+|+++|++++|+||++++|+|.+ +...++||||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 66698136880999999977998799999999884369789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 48998100023665678888767999999999999843210699973235776668121378874011666310023322
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 i~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~ 1126 (1368)
+++|+|.++++. ....+.+..+++|+.|++.||.|||+.+ |+|||||++|||||+++.+||+|||+++......
T Consensus 111 ~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 111 MKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp CTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred EECCCHHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCC
T ss_conf 406741442101---3454048999999999887652003367---6257766875767799988991065232255665
Q ss_pred CC--CCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 43--4322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1127 SR--HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1127 ~~--~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
.. .......|+..|+|||++..+.++.++||||||++||||++|+.||...... ..+..+.. ..
T Consensus 185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~---~g--------- 250 (311)
T d1r0pa_ 185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL---QG--------- 250 (311)
T ss_dssp CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TT---------
T ss_pred CCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHH---CC---------
T ss_conf 55310025655564556768874379997457466199999999789999888999--99999998---08---------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 88899999135999999999815969689999899999999999750
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
.+...+..+..++.+|+.+||+.||++||+|.||++.|+.+.+..
T Consensus 251 --~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 251 --RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred --CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf --988996447599999999976889768939999999999999752
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=369.58 Aligned_cols=247 Identities=26% Similarity=0.333 Sum_probs=200.6
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771048379999995-289789999910235---223699999999876214466112541343036358999
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD---QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s---~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
+.|+..+.||+|+||.||+|.. .+++.||||+++... ....+++.+|+++|++++|+|||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
|||.+|+|..++. ....+++.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~----~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEV----HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp ECCSEEHHHHHHH----HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EECCCCCHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC
T ss_conf 8069994578997----3799999999999999999999998689---76667884217987999789844365334677
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCC---CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCE
Q ss_conf 224343222125556667310014---98872120500799999997099999999998503478854200145346522
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMT---GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~---~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~e 1201 (1368)
. ...+||+.|||||++.+ +.|+.++|||||||+||||++|+.||...... ..+..- ..
T Consensus 168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~~i----~~------- 228 (309)
T d1u5ra_ 168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALYHI----AQ------- 228 (309)
T ss_dssp B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHHH----HH-------
T ss_pred C------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHH----HH-------
T ss_conf 8------7313476636889983467888672145455899999998788999997999--999999----82-------
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
Q ss_conf 1048889999913599999999981596968999989999999
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQAL 1244 (1368)
Q Consensus 1202 IIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~L 1244 (1368)
..............+.+|+.+||+.||++|||+.|+++.-
T Consensus 229 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp 268 (309)
T d1u5ra_ 229 ---NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (309)
T ss_dssp ---SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCH
T ss_conf ---8999888788899999999997737965791899997199
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.09 Aligned_cols=265 Identities=26% Similarity=0.399 Sum_probs=215.6
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEECC
Q ss_conf 8099215467710483799999952------89789999910235-22369999999987621-4466112541343036
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lk------dGk~VAVKvLk~~s-~~~~keFlrEIeILkrL-rHPNIVkLiGv~~e~~ 1038 (1368)
-.++|++.+.||+|+||.||+|.+. +++.||||+++... .....+|.+|+.+++++ +|+|||+++|+|.+.+
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
T ss_conf 78996985498206882999999806644778869999998742487799999999999876269998878998983199
Q ss_pred CEEEEEEECCCCCHHHCCCCCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEE
Q ss_conf 35899952489981000236656--------------7888876799999999999984321069997323577666812
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDK--------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNIL 1104 (1368)
Q Consensus 1039 ~l~LVmEYi~gGSL~dlL~~~~~--------------~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNIL 1104 (1368)
..++||||+++|+|.++|+.... ....+++.++++|+.|+++||+|||+++ |+|||||++|||
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred EEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCC
T ss_conf 78999973799879999985356654444453322233458899999999999999999887579---266624102100
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHC-CCCCCCCCCCCCH
Q ss_conf 137887401166631002332243432221255566673100149887212050079999999709-9999999998503
Q 000659 1105 LEHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSG-RKPVDMTQPPGQE 1183 (1368)
Q Consensus 1105 LDedg~VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTG-r~PFd~s~~~d~~ 1183 (1368)
++.++.+||+|||+++..............+|+..|+|||++.++.++.++|||||||+||||+|+ ..+|.......
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-- 255 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-- 255 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH--
T ss_pred CCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHH--
T ss_conf 002575210234010233678861586201359687677886179999740010258999999858998877899899--
Q ss_pred HHHHHHHHHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 4788542001453465221048889999913599999999981596968999989999999999975
Q 000659 1184 NLVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1184 nLv~Wa~plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e 1250 (1368)
.+... ++...+...+......+.+|+.+||+.+|++||+|.||+++|+.++.+
T Consensus 256 ~~~~~--------------i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 256 KFYKM--------------IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp HHHHH--------------HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH--------------HHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 99999--------------866898898543659999999997577965792999999999876534
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.94 Aligned_cols=260 Identities=27% Similarity=0.425 Sum_probs=211.4
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCC--EEEEEEEECC-CCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEECCCEEEE
Q ss_conf 99215467710483799999952-897--8999991023-522369999999987621-446611254134303635899
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGT--KVAVKVLKRV-DQQGGREFLAEVEMLSRL-HHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lk-dGk--~VAVKvLk~~-s~~~~keFlrEIeILkrL-rHPNIVkLiGv~~e~~~l~LV 1043 (1368)
++|++.+.||+|+||.||+|.+. ++. .||||+++.. .....++|.+|+++|+++ +|+|||+++|+|.+++..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHCCCCCC------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 95248998100023665------------678888767999999999999843210699973235776668121378874
Q 000659 1044 YELIPNGSVESHLHGVD------------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTP 1111 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~------------~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~V 1111 (1368)
|||+++|+|.++|+... .....++|.++++++.|++.||.|||+.+ |+|||||++|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHH
Q ss_conf 0116663100233224343222125556667310014988721205007999999970999-999999985034788542
Q 000659 1112 KVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRK-PVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1112 KIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~-PFd~s~~~d~~nLv~Wa~ 1190 (1368)
||+|||+++...... ......|+..|+|||.+.++.++.++|||||||+||||++|.. ||...+ ...+...+.
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~---~~~~~~~i~ 240 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT---CAELYEKLP 240 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---HHHHHHHGG
T ss_pred EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC---HHHHHHHHH
T ss_conf 874344322444223---45530137755553875269999622153138899999836899999999---999999998
Q ss_pred HHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 0014534652210488899999135999999999815969689999899999999999750
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1191 plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
. ..+...+.....++.+|+.+||+.+|++||+|.||++.|+.+.++.
T Consensus 241 ~--------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 241 Q--------------GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp G--------------TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred H--------------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 2--------------6888887667899999999976789668949999999999998618
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.87 Aligned_cols=253 Identities=22% Similarity=0.284 Sum_probs=206.6
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 8099215467710483799999952-89789999910235-223699999999876214466112541343036358999
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~s-~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
..+.|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+++|++++|+|||++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEEC---CCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213---788740116663100
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLD---edg~VKIsDFGLAr~ 1121 (1368)
||++||+|.++|.. ...+++.++..|+.|++.||.|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 87 E~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~ 159 (307)
T d1a06a_ 87 QLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159 (307)
T ss_dssp CCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred ECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEE
T ss_conf 52689848886530----367887899999999999987524130---55687046300110468882499831543587
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCE
Q ss_conf 23322434322212555666731001498872120500799999997099999999998503478854200145346522
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1122 i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~e 1201 (1368)
.... ......+||..|||||++.+..++.++|||||||+||||++|+.||..... ..+..... ...
T Consensus 160 ~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---~~~~~~i~---~~~----- 225 (307)
T d1a06a_ 160 EDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND---AKLFEQIL---KAE----- 225 (307)
T ss_dssp ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH---HHHHHHHH---TTC-----
T ss_pred CCCC---CEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---CCC-----
T ss_conf 2589---704400328422591887379998078734515999999859799999899---99999986---168-----
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 104888999991359999999998159696899998999999
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 IIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
..+..........++.+|+.+||+.||++|||+.|+++.
T Consensus 226 ---~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 226 ---YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp ---CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred ---CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf ---777876666789999999999760897579189998629
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.49 Aligned_cols=248 Identities=23% Similarity=0.361 Sum_probs=196.4
Q ss_pred CCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE----CCCEEEE
Q ss_conf 215467710483799999952-8978999991023--52236999999998762144661125413430----3635899
Q 000659 971 FDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE----EQARCLV 1043 (1368)
Q Consensus 971 Fei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e----~~~l~LV 1043 (1368)
|+..+.||+|+||+||+|... +++.||+|++... .....++|.+|+++|++++|+|||++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEEC-CCCCCCCCCCCCCCCC
Q ss_conf 952489981000236656788887679999999999998432106999732357766681213-7887401166631002
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE-HDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLD-edg~VKIsDFGLAr~i 1122 (1368)
|||+++|+|.+++.. ...+++.+++.|+.|++.||.|||+++ ++|+|||||++||||+ +++.+||+|||+++..
T Consensus 91 mE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEEC
T ss_conf 957898948999751----355469999999999999999999789-979968767435116679998898005765423
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEE
Q ss_conf 33224343222125556667310014988721205007999999970999999999985034788542001453465221
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERI 1202 (1368)
Q Consensus 1123 ~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eI 1202 (1368)
.. ......+||+.|||||++.+ .++.++|||||||+||||++|+.||..... ...+.........
T Consensus 166 ~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~--~~~~~~~i~~~~~-------- 230 (270)
T d1t4ha_ 166 RA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQN--AAQIYRRVTSGVK-------- 230 (270)
T ss_dssp CT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSS--HHHHHHHHTTTCC--------
T ss_pred CC----CCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHCCCC--------
T ss_conf 68----76677553813008988478-999867110079999999878899987655--9999999973899--------
Q ss_pred ECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 04888999991359999999998159696899998999999
Q 000659 1203 IDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1203 IDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
...+......++.+|+.+||+.+|++|||+.|+++.
T Consensus 231 -----~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H 266 (270)
T d1t4ha_ 231 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH 266 (270)
T ss_dssp -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred -----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf -----865675578999999999763797589299999677
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.25 Aligned_cols=259 Identities=25% Similarity=0.385 Sum_probs=211.1
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECC----CCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
Q ss_conf 0992154677104837999999528----9789999910235-2236999999998762144661125413430363589
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDD----GTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lkd----Gk~VAVKvLk~~s-~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~L 1042 (1368)
.++|++.+.||+|+||.||+|.+.. +..||||+++... ....+.|.+|+++|++++|+|||+++|++. ++..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 99524899810002366567888876799999999999984321069997323577666812137887401166631002
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1043 VmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i 1122 (1368)
||||+.+|+|.+++.. ....+++.+++.++.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++..
T Consensus 85 v~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEECCCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 9984069807765422---4789999999999999987752302267---441410265532067896787650342133
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCE
Q ss_conf 33224343222125556667310014988721205007999999970-99999999998503478854200145346522
Q 000659 1123 MDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLER 1201 (1368)
Q Consensus 1123 ~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L~e 1201 (1368)
... .........||..|+|||++.+..++.++|||||||+||||++ |+.||...... .+...+.. .
T Consensus 159 ~~~-~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~---~~~~~i~~----~----- 225 (273)
T d1mp8a_ 159 EDS-TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIEN----G----- 225 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHT----T-----
T ss_pred CCC-CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH---HHHHHHHC----C-----
T ss_conf 677-6233054005831032667516998874524442478999982699998889999---99999981----8-----
Q ss_pred EECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 10488899999135999999999815969689999899999999999750
Q 000659 1202 IIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1202 IIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
.....+..+..++.+|+.+||..+|++|||+.||++.|+.++++.
T Consensus 226 -----~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 270 (273)
T d1mp8a_ 226 -----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270 (273)
T ss_dssp -----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf -----999898777999999999976879768929999999999997786
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.43 Aligned_cols=267 Identities=27% Similarity=0.455 Sum_probs=215.0
Q ss_pred HHHHHHCCCCEEEEEEECCCEEEEEEEEC------CCCEEEEEEEECC-CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
Q ss_conf 99988099215467710483799999952------8978999991023-5223699999999876214466112541343
Q 000659 963 EIEKATGNFDASRILGEGGFGLVYSGVLD------DGTKVAVKVLKRV-DQQGGREFLAEVEMLSRLHHRNLVKLIGICI 1035 (1368)
Q Consensus 963 ELe~at~nFei~eiLGkGaFGtVYKA~lk------dGk~VAVKvLk~~-s~~~~keFlrEIeILkrLrHPNIVkLiGv~~ 1035 (1368)
+++...++|++.+.||+|+||.||+|.+. +++.||||+++.. .......|.+|++++++++|+|||+++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred CEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 00426899188359820788189999987864477896899999870128689999999999999769998841254784
Q ss_pred ECCCEEEEEEECCCCCHHHCCCCCC------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 0363589995248998100023665------6788887679999999999998432106999732357766681213788
Q 000659 1036 EEQARCLVYELIPNGSVESHLHGVD------KESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF 1109 (1368)
Q Consensus 1036 e~~~l~LVmEYi~gGSL~dlL~~~~------~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg 1109 (1368)
.+...++||||+.+|+|.++++... .....+++..+++|+.|+++||.|||+.+ |+|||||++|||||.++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF 170 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCC
T ss_conf 288106777604899889998750332113444688799999999999999999876479---65432867754035996
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCC-CCCCCCCCCCCHHHHHH
Q ss_conf 74011666310023322434322212555666731001498872120500799999997099-99999999850347885
Q 000659 1110 TPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGR-KPVDMTQPPGQENLVAW 1188 (1368)
Q Consensus 1110 ~VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr-~PFd~s~~~d~~nLv~W 1188 (1368)
++||+|||+++...............|+..|+|||.+.+..++.++||||||++||||+||+ .||..... ......
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~---~~~~~~ 247 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN---EQVLRF 247 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH---HHHHHH
T ss_pred EEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCH---HHHHHH
T ss_conf 49994245420235776303134023163237888873699883334443789999999689999999899---999999
Q ss_pred HHHHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 4200145346522104888999991359999999998159696899998999999999997
Q 000659 1189 ARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1189 a~plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~ 1249 (1368)
+. +.. ....+..+...+.+++.+||+.+|++||+|.||++.|+...+
T Consensus 248 i~-------------~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 VM-------------EGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp HH-------------TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred HH-------------HCC-CCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 98-------------088-888863353999999999757796589399999999787617
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.13 Aligned_cols=262 Identities=26% Similarity=0.412 Sum_probs=215.9
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECC--------CCEEEEEEEECCC-CHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEEC
Q ss_conf 0992154677104837999999528--------9789999910235-22369999999987621-446611254134303
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDD--------GTKVAVKVLKRVD-QQGGREFLAEVEMLSRL-HHRNLVKLIGICIEE 1037 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lkd--------Gk~VAVKvLk~~s-~~~~keFlrEIeILkrL-rHPNIVkLiGv~~e~ 1037 (1368)
.++|++.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+.++ +|+|||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CCEEEEEEECCCCCHHHCCCCCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEE
Q ss_conf 635899952489981000236656------------78888767999999999999843210699973235776668121
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDK------------ESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILL 1105 (1368)
Q Consensus 1038 ~~l~LVmEYi~gGSL~dlL~~~~~------------~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILL 1105 (1368)
+..++||||+++|+|.++|..... ....+++.++++|+.|++.||.|||+.+ |+|||||++|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHH
Q ss_conf 3788740116663100233224343222125556667310014988721205007999999970-999999999985034
Q 000659 1106 EHDFTPKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQEN 1184 (1368)
Q Consensus 1106 Dedg~VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~n 1184 (1368)
+.++.+||+|||+++...............|+..|+|||++.++.|+.++||||||++||||++ |+.||..... ..
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~---~~ 245 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV---EE 245 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH---HH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH---HH
T ss_conf 478976762211101135555543146678884663266751798882555477588888740179898999999---99
Q ss_pred HHHHHHHHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78854200145346522104888999991359999999998159696899998999999999997
Q 000659 1185 LVAWARPLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1185 Lv~Wa~plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~ 1249 (1368)
+..++. ...+...+.....++.+|+.+||+.+|++|||+.||++.|+.+..
T Consensus 246 ~~~~i~--------------~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLK--------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHHH--------------TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHH--------------CCCCCCCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999997--------------288889874352999999999766797679399999999988860
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.03 Aligned_cols=252 Identities=30% Similarity=0.471 Sum_probs=209.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-CCCEEEEEEE
Q ss_conf 099215467710483799999952897899999102352236999999998762144661125413430-3635899952
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-EQARCLVYEL 1046 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e-~~~l~LVmEY 1046 (1368)
.++|++.+.||+|+||.||+|.++ |+.||||+++.. ...++|.+|++++++++|+||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-909999998857--77999999999998678989854987887238928999963
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 48998100023665678888767999999999999843210699973235776668121378874011666310023322
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 i~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~ 1126 (1368)
+++|+|.++|+... ...++|..+++|+.|++.||.|||+.+ |+|||||++|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred CCCCCHHHHHHHCC--CCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC-
T ss_conf 69998999987457--888899999999999985232113376---553666567601468997763245600344787-
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEECC
Q ss_conf 4343222125556667310014988721205007999999970-999999999985034788542001453465221048
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGLERIIDP 1205 (1368)
Q Consensus 1127 ~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIIDp 1205 (1368)
.....++..|+|||++.++.++.++||||||+++|||+| |+.||..... ..+..+...
T Consensus 157 ----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~---~~~~~~i~~-------------- 215 (262)
T d1byga_ 157 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK-------------- 215 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTT--------------
T ss_pred ----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHC--------------
T ss_conf ----76556664677817872798885887775799999999789999999999---999999980--------------
Q ss_pred CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 88999991359999999998159696899998999999999997
Q 000659 1206 SLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCN 1249 (1368)
Q Consensus 1206 ~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~ 1249 (1368)
..+...+.....++.+|+.+||+.||++||+|.|+++.|+.+..
T Consensus 216 ~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 216 GYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 89999976579999999999756697689399999999999986
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.85 Aligned_cols=249 Identities=24% Similarity=0.325 Sum_probs=207.1
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 09921546771048379999995-28978999991023---522369999999987621446611254134303635899
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LV 1043 (1368)
.++|++.+.||+|+||.||+|.. .+++.||||++++. .....+++.+|+.+|++++|+||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 95248998100023665678888767999999999999843210699973235776668121378874011666310023
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~ 1123 (1368)
|||+.+|+|.+++.. ...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp EECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred EECCCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCC
T ss_conf 003579860555532----567759999999999965211343159---6224647778476589988882056520035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEE
Q ss_conf 32243432221255566673100149887212050079999999709999999999850347885420014534652210
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eII 1203 (1368)
... ......+||+.|+|||++.+..|+.++|||||||+||||++|+.||...+. ..+..... ...
T Consensus 157 ~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~---~~~~~~i~---~~~------- 221 (337)
T d1o6la_ 157 SDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELIL---MEE------- 221 (337)
T ss_dssp CTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHH---HCC-------
T ss_pred CCC--CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH---HHHHHHHH---CCC-------
T ss_conf 678--620551008899666650489888333102230678899878999999699---99999985---289-------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 488899999135999999999815969689999-----8999999
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPT-----MsEILq~ 1243 (1368)
..++.....++.+|+.+||+.||++|++ +.|+++.
T Consensus 222 -----~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H 261 (337)
T d1o6la_ 222 -----IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH 261 (337)
T ss_dssp -----CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred -----CCCCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCC
T ss_conf -----9898668999999998666389344225652349999729
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=358.79 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=200.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCC---CHHHHHHHHH---HHHHHHCCCCCCEEEEEEEEECCCE
Q ss_conf 099215467710483799999952-89789999910235---2236999999---9987621446611254134303635
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVD---QQGGREFLAE---VEMLSRLHHRNLVKLIGICIEEQAR 1040 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~s---~~~~keFlrE---IeILkrLrHPNIVkLiGv~~e~~~l 1040 (1368)
.++|++.+.||+|+||.||+|... +|+.||||++.... ......+.+| +.+++.++|+|||++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 89995248998100023665678888767999999999999843210699973235776668121378874011666310
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr 1120 (1368)
|+||||+++|+|.++|.. ...+.+.+++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+
T Consensus 83 ~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEEECCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEE
T ss_conf 999991489838999873----255327899999999999999999779---6220444221678588967982201023
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 0233224343222125556667310014-988721205007999999970999999999985034788542001453465
Q 000659 1121 SAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1121 ~i~~~~~~~~st~vvGT~gYmAPEvL~~-~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L 1199 (1368)
..... .....+||..|+|||++.. ..++.++|||||||+||||++|+.||......+...+..... ..
T Consensus 156 ~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~---~~---- 224 (364)
T d1omwa3 156 DFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---TM---- 224 (364)
T ss_dssp ECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS---SC----
T ss_pred ECCCC----CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCC---CC----
T ss_conf 33788----64331134554216876038999844104677899999985999888899899999998604---68----
Q ss_pred CEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 2210488899999135999999999815969689999-----8999999
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1200 ~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPT-----MsEILq~ 1243 (1368)
....+.....++.+|+.+||+.||++|++ +.|+++.
T Consensus 225 --------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H 265 (364)
T d1omwa3 225 --------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES 265 (364)
T ss_dssp --------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred --------CCCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCC
T ss_conf --------88788778999999999985669888088743579999749
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.30 Aligned_cols=253 Identities=23% Similarity=0.297 Sum_probs=205.1
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC------CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC
Q ss_conf 809921546771048379999995-289789999910235------2236999999998762144661125413430363
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD------QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s------~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~ 1039 (1368)
..++|++.+.||+|+||.||+|.. .+|+.||||+++... ....+.|.+|+++|++++|+|||++++++.+.+.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred EEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCC----CCCCCC
Q ss_conf 5899952489981000236656788887679999999999998432106999732357766681213788----740116
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF----TPKVSD 1115 (1368)
Q Consensus 1040 l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg----~VKIsD 1115 (1368)
.|+|||||++|+|.++|.. ...+++.+++.|+.|++.||.|||+.+ |+|||||++|||++.++ .+||+|
T Consensus 88 ~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~D 160 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIID 160 (293)
T ss_dssp EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred EEEEEECCCCCCCCCHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECC
T ss_conf 9999986778643100103----564215578999999999987666254---221133301279825898666469643
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 66310023322434322212555666731001498872120500799999997099999999998503478854200145
Q 000659 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1116 FGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~ 1195 (1368)
||+++..... .......|+..|+|||++.+..++.++|||||||+||||++|+.||...+.. ....... ..
T Consensus 161 fG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~---~~~~~i~---~~ 231 (293)
T d1jksa_ 161 FGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ---ETLANVS---AV 231 (293)
T ss_dssp CTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---TT
T ss_pred HHHHHHCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHH---HC
T ss_conf 3442105777---6312247777430999981899997665221409999997088998899999---9999998---16
Q ss_pred CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 346522104888999991359999999998159696899998999999
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 ~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
..... ..........+.+|+.+||+.||++||++.|+++.
T Consensus 232 ~~~~~--------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 271 (293)
T d1jksa_ 232 NYEFE--------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 271 (293)
T ss_dssp CCCCC--------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred CCCCC--------CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88887--------01047889999999999863896689199999619
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=356.92 Aligned_cols=245 Identities=27% Similarity=0.341 Sum_probs=204.5
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771048379999995-28978999991023---5223699999999876214466112541343036358999
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
++|++.+.||+|+||.||+|.. .+|+.||||+++.. .....+.+.+|+.+|++++|+|||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
||+.||+|.+++.. ...+.+.++..++.|++.||.|||+++ |+|||||++||||+.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~ 156 (316)
T d1fota_ 84 DYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 156 (316)
T ss_dssp CCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EECCCCCCCCCCCC----CCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECC
T ss_conf 50378632234322----221110079999999987655412476---77055681050386899889831752167124
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
. ....+||..|||||++.+..++.++|||||||+||||++|+.||...+.. .+.. ......
T Consensus 157 ~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~---~~~~---~i~~~~-------- 217 (316)
T d1fota_ 157 V-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM---KTYE---KILNAE-------- 217 (316)
T ss_dssp C-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHH---HHHHCC--------
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHH---HHHH---HHHCCC--------
T ss_conf 5-----64345763435999983899980430465333689997598999996999---9999---997089--------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 8889999913599999999981596968999-----98999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRP-----TMsEILq~ 1243 (1368)
..++.....++.+++.+||..+|.+|+ +++|+++.
T Consensus 218 ----~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H 257 (316)
T d1fota_ 218 ----LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH 257 (316)
T ss_dssp ----CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred ----CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCC
T ss_conf ----8899778999999999995449976664310219999819
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.77 Aligned_cols=276 Identities=22% Similarity=0.282 Sum_probs=203.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CEEEE
Q ss_conf 09921546771048379999995289789999910235223699999999876214466112541343036----35899
Q 000659 968 TGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----ARCLV 1043 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~----~l~LV 1043 (1368)
.++|.+.+.||+|+||.||+|++. |+.||||+++... .....+.+|+..+++++|+|||+++|+|.+++ ..++|
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC-HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 868999889820788199999999-9899999987200-46799999999996279986832688998379860489999
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 9524899810002366567888876799999999999984321069-----99732357766681213788740116663
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDS-----SPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~G-----sp~IVHRDIKPsNILLDedg~VKIsDFGL 1118 (1368)
|||+.+|+|.++|++ ..++|.++++++.|++.||.|||..+ .++|+|||||++||||+.++.+||+|||+
T Consensus 80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EECCCCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 964669898999865-----899989999999999999999887665204689866153173135786887768876386
Q ss_pred CCCCCCCCCC--CCCCCCCCCCCCCCCCHHCCCC------CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 1002332243--4322212555666731001498------8721205007999999970999999999985034788542
Q 000659 1119 ARSAMDEESR--HISTRVMGTFGYVAPEYAMTGH------LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1119 Ar~i~~~~~~--~~st~vvGT~gYmAPEvL~~~~------~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~ 1190 (1368)
++........ ......+||..|+|||++.+.. ++.++|||||||+||||+||..+|.......... .....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~-~~~~~ 233 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVP 233 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSC
T ss_pred CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCH-HHCCC
T ss_conf 62346777620013552503547678221056545467776750122015999999962899887663112410-12255
Q ss_pred HHCCCCCCCCEEECCCCCCCC-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 001453465221048889999-----9135999999999815969689999899999999999750
Q 000659 1191 PLLTSREGLERIIDPSLGNDV-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1191 plls~~e~L~eIIDp~L~~~~-----~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
...........+.+..++... ..+....+.+|+.+||+.||++||+|.||++.|+++.++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHC
T ss_conf 643099999987502468887765577689999999999976069858959999999999888865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.90 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=207.8
Q ss_pred CCCCEEEEEEECCCEEEEEEEECC--C--CEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEE
Q ss_conf 992154677104837999999528--9--78999991023---5223699999999876214466112541343036358
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDD--G--TKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARC 1041 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lkd--G--k~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~ 1041 (1368)
++|++.+.||+|+||.||+|.+.. + ..||||+++.. .....++|.+|+++|++++|+|||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 99952489981000236656788887679999999999998432106999732357766681213788740116663100
Q 000659 1042 LVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1042 LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
+||||+++|+|.+++.. ....+++..+++++.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++.
T Consensus 87 lv~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK---HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEECCTTCBHHHHHHH---HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEECCCCHHHHHHC---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHH
T ss_conf 14654238612544421---2689999999999999999998752178---75205668881565565433256115553
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 23322434-3222125556667310014988721205007999999970-999999999985034788542001453465
Q 000659 1122 AMDEESRH-ISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLS-GRKPVDMTQPPGQENLVAWARPLLTSREGL 1199 (1368)
Q Consensus 1122 i~~~~~~~-~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLT-Gr~PFd~s~~~d~~nLv~Wa~plls~~e~L 1199 (1368)
........ ......|+..|+|||++.+..++.++||||||+++|||+| |+.||...+. .....++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~---~~~~~~i~~-------- 229 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---SQILHKIDK-------- 229 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH---HHHHHHHHT--------
T ss_pred CCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHH--------
T ss_conf 035887526547632573107999983799994215661489999999689999999699---999999984--------
Q ss_pred CEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 221048889999913599999999981596968999989999999999
Q 000659 1200 ERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLV 1247 (1368)
Q Consensus 1200 ~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~I 1247 (1368)
...+..........+.+|+.+||+.+|++||||.||++.|++.
T Consensus 230 -----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 230 -----EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp -----SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf -----7999998544539999999997688966792999999999964
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=357.06 Aligned_cols=245 Identities=23% Similarity=0.303 Sum_probs=204.5
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
Q ss_conf 9921546771048379999995-28978999991023---5223699999999876214466112541343036358999
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVm 1044 (1368)
++|++.+.||+|+||.||+|.. .+|+.||||++... +....+.+.+|+++|+.++|+|||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788740116663100233
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMD 1124 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~ 1124 (1368)
||+.+|+|.+++.. ...+++.+++.|+.|++.||.|||+++ ||||||||+||||+.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~ 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred CCCCCCCHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCC
T ss_conf 23346622666751----589899999999999999899998599---86176799993607789788610103332256
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEEC
Q ss_conf 22434322212555666731001498872120500799999997099999999998503478854200145346522104
Q 000659 1125 EESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERIID 1204 (1368)
Q Consensus 1125 ~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eIID 1204 (1368)
. ....+||..|||||++.+..++.++|||||||+||||++|+.||...+. ..+.... ..
T Consensus 194 ~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~---~~~~~~i---~~---------- 252 (350)
T d1rdqe_ 194 R-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP---IQIYEKI---VS---------- 252 (350)
T ss_dssp C-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHH---HH----------
T ss_pred C-----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCH---HHHHHHH---HC----------
T ss_conf 6-----6433676356788997179988533114500789999758899899599---9999998---61----------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHHH
Q ss_conf 8889999913599999999981596968999-----98999999
Q 000659 1205 PSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-----FMGEVVQA 1243 (1368)
Q Consensus 1205 p~L~~~~~~ee~~eLlkLI~~CLspDPkeRP-----TMsEILq~ 1243 (1368)
.. ...+.....++.+++.+||..||.+|+ ++.|+++.
T Consensus 253 ~~--~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H 294 (350)
T d1rdqe_ 253 GK--VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH 294 (350)
T ss_dssp CC--CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred CC--CCCCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCC
T ss_conf 79--8897668999999999983409986065534549999719
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=353.44 Aligned_cols=260 Identities=26% Similarity=0.338 Sum_probs=209.6
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC---CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCC----
Q ss_conf 09921546771048379999995-28978999991023---52236999999998762144661125413430363----
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV---DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQA---- 1039 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~---s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~---- 1039 (1368)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. +....++|.+|++++++++|+|||++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 58999524899810002366567888876799999999999984321069997323577666812137887401166631
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLA 1119 (1368)
.|+||||++||+|.+++.. ...+++.+++.|+.|++.||.|||+.+ |+||||||+||||+.++..+|+|||++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~ 158 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 158 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTC
T ss_pred EEEEEECCCCCEEHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHH
T ss_conf 9999977889871011203----589999999999999999999998579---527634675566575432010034443
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCC
Q ss_conf 0023322-434322212555666731001498872120500799999997099999999998503478854200145346
Q 000659 1120 RSAMDEE-SRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREG 1198 (1368)
Q Consensus 1120 r~i~~~~-~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~ 1198 (1368)
+...... ........+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. ..+... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~~----~~~~~~ 232 (277)
T d1o6ya_ 159 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV--SVAYQH----VREDPI 232 (277)
T ss_dssp EECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH----HHCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHH--HHHHHH----HHCCCC
T ss_conf 22123544333346425762436999983999996632026528999997697998996999--999999----846999
Q ss_pred CCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHHHH
Q ss_conf 5221048889999913599999999981596968999-9899999999999
Q 000659 1199 LERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRP-FMGEVVQALKLVC 1248 (1368)
Q Consensus 1199 L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRP-TMsEILq~Lk~Il 1248 (1368)
. ..........++.+++.+||+.||++|| +++++++.|.++.
T Consensus 233 ~--------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 P--------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp C--------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred C--------CCHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 9--------710034789999999999866797677739999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.10 Aligned_cols=255 Identities=19% Similarity=0.235 Sum_probs=206.1
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 8099215467710483799999952-897899999102352236999999998762144661125413430363589995
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmE 1045 (1368)
..++|++.+.||+|+||.||+|... +++.||||+++.. ......+.+|+++|++++|+|||++++++.+++..|+|||
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 701058878983177839999999899969999997578-6659999999999985799798909899988998899995
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCC--CCCCCCCCCCCCCCC
Q ss_conf 248998100023665678888767999999999999843210699973235776668121378--874011666310023
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD--FTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDed--g~VKIsDFGLAr~i~ 1123 (1368)
||+||+|.+++.. ....+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.+ ..+||+|||+++...
T Consensus 82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~ 155 (321)
T d1tkia_ 82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK 155 (321)
T ss_dssp CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred CCCCCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC
T ss_conf 3899808899875---3899999999999999999999998769---975135544434437885189976441110034
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEE
Q ss_conf 32243432221255566673100149887212050079999999709999999999850347885420014534652210
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eII 1203 (1368)
.. .......|+..|+|||.+.+..++.++|||||||+||||++|+.||...+.. .+.... ......+..
T Consensus 156 ~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~---~~~~~i---~~~~~~~~~-- 224 (321)
T d1tkia_ 156 PG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ---QIIENI---MNAEYTFDE-- 224 (321)
T ss_dssp TT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH---HHHHHH---HHTCCCCCH--
T ss_pred CC---CCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHH---HHHHHH---HHCCCCCCH--
T ss_conf 67---7532122332223402104877784011302799999998289999998999---999999---838999880--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 488899999135999999999815969689999899999999
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk 1245 (1368)
........++.+|+.+||..||++|+++.|+++.-+
T Consensus 225 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 225 ------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp ------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred ------HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf ------223678999999999986699668909999963996
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.83 Aligned_cols=253 Identities=22% Similarity=0.256 Sum_probs=199.4
Q ss_pred HCCCCEE-EEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHC-CCCCCEEEEEEEEE----CCCE
Q ss_conf 0992154-6771048379999995-28978999991023522369999999987621-44661125413430----3635
Q 000659 968 TGNFDAS-RILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRL-HHRNLVKLIGICIE----EQAR 1040 (1368)
Q Consensus 968 t~nFei~-eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrL-rHPNIVkLiGv~~e----~~~l 1040 (1368)
.++|++. ++||+|+||.||+|.. .+++.||||+++.. +.+.+|++++.++ +|+|||++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 148798107965454869999998899989999998974-----779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECC---CCCCCCCCCC
Q ss_conf 8999524899810002366567888876799999999999984321069997323577666812137---8874011666
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH---DFTPKVSDFG 1117 (1368)
Q Consensus 1041 ~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDe---dg~VKIsDFG 1117 (1368)
|+|||||+||+|.++|... ....+++.+++.|+.|++.||.|||+.+ |+|||||++|||++. ++.+||+|||
T Consensus 85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEECCCCCCHHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 9999778998499999862--7877579999999999999999999769---8644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 31002332243432221255566673100149887212050079999999709999999999850347885420014534
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1197 (1368)
Q Consensus 1118 LAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e 1197 (1368)
+|+...... .....+||..|+|||++.+..|+.++|||||||+||||++|+.||...+...... ..
T Consensus 160 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~-------- 225 (335)
T d2ozaa1 160 FAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GM-------- 225 (335)
T ss_dssp TCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred EEEECCCCC---CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HH--------
T ss_conf 123336888---6432267756379277748988888888764516778865889988988778899---99--------
Q ss_pred CCCEEECCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 652210488--899999135999999999815969689999899999999
Q 000659 1198 GLERIIDPS--LGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1198 ~L~eIIDp~--L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk 1245 (1368)
...+.... +..........++.+|+.+||+.+|++||++.|+++.-+
T Consensus 226 -~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 274 (335)
T d2ozaa1 226 -KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW 274 (335)
T ss_dssp ---CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHH
T ss_pred -HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf -9998538888898543469999999999975699657909999970987
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.66 Aligned_cols=248 Identities=23% Similarity=0.321 Sum_probs=202.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC---CCHHHHHHHHHHHHHH-HCCCCCCEEEEEEEEECCCEEEE
Q ss_conf 99215467710483799999952-8978999991023---5223699999999876-21446611254134303635899
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV---DQQGGREFLAEVEMLS-RLHHRNLVKLIGICIEEQARCLV 1043 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~---s~~~~keFlrEIeILk-rLrHPNIVkLiGv~~e~~~l~LV 1043 (1368)
++|++.+.||+|+||+||+|... +++.||||++++. .....+.+.+|+.++. .++|+|||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC
Q ss_conf 95248998100023665678888767999999999999843210699973235776668121378874011666310023
Q 000659 1044 YELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAM 1123 (1368)
Q Consensus 1044 mEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~ 1123 (1368)
|||+++|+|.+++.. ...+++.+++.++.|++.||.|||+++ |+|||||++|||++.++++||+|||+++...
T Consensus 82 mEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~ 154 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM 154 (320)
T ss_dssp EECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred EEECCCCCHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCC
T ss_conf 750379808998640----478999999999999999999998689---3403476540444489963015553023235
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCEEE
Q ss_conf 32243432221255566673100149887212050079999999709999999999850347885420014534652210
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSREGLERII 1203 (1368)
Q Consensus 1124 ~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e~L~eII 1203 (1368)
.. .......+||..|+|||++.+..++.++|||||||+||||++|+.||...+.. .+..-.. ..
T Consensus 155 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~---~~-------- 218 (320)
T d1xjda_ 155 LG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHSIR---MD-------- 218 (320)
T ss_dssp CT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH---HC--------
T ss_pred CC--CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH---CC--------
T ss_conf 66--53345457877768999982799883232011227898987388999998999---9999997---18--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHH
Q ss_conf 48889999913599999999981596968999989-99999
Q 000659 1204 DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMG-EVVQA 1243 (1368)
Q Consensus 1204 Dp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMs-EILq~ 1243 (1368)
. ..++.....++.+|+.+||..+|++|+++. |+++.
T Consensus 219 ~----~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h 255 (320)
T d1xjda_ 219 N----PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH 255 (320)
T ss_dssp C----CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred C----CCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHC
T ss_conf 9----989756799999999996544898783889999809
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.99 Aligned_cols=261 Identities=23% Similarity=0.243 Sum_probs=198.2
Q ss_pred CEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCH-----HHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 1546771048379999995-28978999991023522-----36999999998762144661125413430363589995
Q 000659 972 DASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQ-----GGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 972 ei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~-----~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmE 1045 (1368)
+..++||+|+||+||+|.. .+|+.||||+++..... ..+.+.+|+++|++++|+|||++++++.+++..|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CCCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHH
T ss_conf 95638512728299999999999699999984202124567999999999999986799998689854225874022045
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 24899810002366567888876799999999999984321069997323577666812137887401166631002332
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~ 1125 (1368)
|+.++++..++. ....+++.++..|+.|++.||.|||+++ |+|||||++|||++.++.+||+|||+++.....
T Consensus 81 ~~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 81 FMETDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CCSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred HHCCHHHHHHHH----CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC
T ss_conf 534507765541----2667789999999999999998863163---550357762588537784114657610005787
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCC-------CCC
Q ss_conf 24343222125556667310014-9887212050079999999709999999999850347885420014-------534
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT-------SRE 1197 (1368)
Q Consensus 1126 ~~~~~st~vvGT~gYmAPEvL~~-~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls-------~~e 1197 (1368)
.. .....+||..|+|||++.. ..++.++|||||||+||||++|+.||......+. +......... ...
T Consensus 154 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~--l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 154 NR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--LTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCTTTSSSTT
T ss_pred CC--CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHH--HHHHHHHCCCCCHHHCCCHH
T ss_conf 55--433020473336399972677888056436304289999859699999999999--99999851899725452100
Q ss_pred CCCEEECCCCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 652210488899999-----1359999999998159696899998999999
Q 000659 1198 GLERIIDPSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1198 ~L~eIIDp~L~~~~~-----~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
............... .....++.+|+.+||+.||++|+|+.|+++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 021344303478988678565689999999999763894569089999679
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=347.08 Aligned_cols=252 Identities=25% Similarity=0.322 Sum_probs=204.3
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCC---------HHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE
Q ss_conf 09921546771048379999995-2897899999102352---------23699999999876214-4661125413430
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ---------QGGREFLAEVEMLSRLH-HRNLVKLIGICIE 1036 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~---------~~~keFlrEIeILkrLr-HPNIVkLiGv~~e 1036 (1368)
.++|++.+.||+|+||+||+|+. .+++.||||+++.... ...+.+.+|+.++++++ |+||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 36358999524899810002366567888876799999999999984321069997323577666812137887401166
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDF 1116 (1368)
++..|+||||+++|+|.++|.. ...+++.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DF 154 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 154 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred CCCEEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCC
T ss_conf 7605999976898668999986----599999999999999999999998759---943234625489868998387124
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCC------CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 63100233224343222125556667310014------988721205007999999970999999999985034788542
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMT------GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWAR 1190 (1368)
Q Consensus 1117 GLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~------~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~ 1190 (1368)
|+++...... .....+||..|++||++.+ ..++.++||||+||+||||++|+.||...+... .....
T Consensus 155 G~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~---~~~~i- 227 (277)
T d1phka_ 155 GFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRMI- 227 (277)
T ss_dssp TTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH-
T ss_pred HHEEECCCCC---CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHH---HHHHH-
T ss_conf 0316726887---2134524678889888605344567889923318565602310322888988999999---99999-
Q ss_pred HHCCCCCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 00145346522104888999991359999999998159696899998999999
Q 000659 1191 PLLTSREGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1191 plls~~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
..... .+..........++.+|+.+||+.+|++||++.|+++.
T Consensus 228 --~~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 228 --MSGNY--------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --HHTCC--------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --HHCCC--------CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --81898--------88985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.56 Aligned_cols=265 Identities=24% Similarity=0.316 Sum_probs=201.2
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC--CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 9921546771048379999995-289789999910235--2236999999998762144661125413430363589995
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD--QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s--~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmE 1045 (1368)
++|++.+.||+|+||.||+|.. .+++.||||+++... ....+++.+|+++|++++|+|||++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 24899810002366567888876799999999999984321069997323577666812137887401166631002332
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~ 1125 (1368)
|+.++ +.+++.. .....+++.+++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~-~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQD-LKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEE-HHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ECCCC-HHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCC
T ss_conf 23774-4555442--02568888999999999999999865288---992135711401134676210357861343688
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC----CCC
Q ss_conf 2434322212555666731001498-87212050079999999709999999999850347885420014534----652
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE----GLE 1200 (1368)
Q Consensus 1126 ~~~~~st~vvGT~gYmAPEvL~~~~-~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e----~L~ 1200 (1368)
. .......|+..|+|||++.... ++.++|||||||+||||++|+.||...+..+ .+...........+ ...
T Consensus 156 ~--~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 156 V--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp S--BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGG
T ss_pred C--CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHH--HHHHHHHHCCCCCHHHCCCCC
T ss_conf 6--410010365215411221366577742210333313427966879989889999--999999832898333144422
Q ss_pred EEEC--CCCCCC--C-----CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 2104--888999--9-----91359999999998159696899998999999
Q 000659 1201 RIID--PSLGND--V-----PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1201 eIID--p~L~~~--~-----~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
.+.+ ...... . ......++.+|+.+||..||++|||+.|+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2421243454322220444166789999999999763995579189999678
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=338.01 Aligned_cols=266 Identities=21% Similarity=0.254 Sum_probs=204.8
Q ss_pred CCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
Q ss_conf 992154677104837999999528978999991023--522369999999987621446611254134303635899952
Q 000659 969 GNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYEL 1046 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmEY 1046 (1368)
++|++.+.||+|+||+||+|...+++.||||+++.. +....+++.+|+.+|++++|+|||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 48998100023665678888767999999999999843210699973235776668121378874011666310023322
Q 000659 1047 IPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDEE 1126 (1368)
Q Consensus 1047 i~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~~ 1126 (1368)
+.++.+..+.. ....+++.++++|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||++.......
T Consensus 82 ~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~ 154 (286)
T d1ob3a_ 82 LDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV 154 (286)
T ss_dssp CSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred EHHHHHHHHHH----HCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 00456789986----0477514456899999999999860574---8826787750568689978732366430114676
Q ss_pred CCCCCCCCCCCCCCCCCCHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH-----CCCCCCCC
Q ss_conf 4343222125556667310014-98872120500799999997099999999998503478854200-----14534652
Q 000659 1127 SRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL-----LTSREGLE 1200 (1368)
Q Consensus 1127 ~~~~st~vvGT~gYmAPEvL~~-~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~pl-----ls~~e~L~ 1200 (1368)
. ......|+..|++||.+.. ..++.++|||||||+||||++|+.||...+..+........... ......+.
T Consensus 155 ~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 155 R--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred C--CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 5--41010243110137887178888841002111758999977979989889899999999863899711042123332
Q ss_pred EEE------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 210------4888999991359999999998159696899998999999
Q 000659 1201 RII------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1201 eII------Dp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
+.. ...............+.+++.+||+.||++|+|+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H 281 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH 281 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2143333356764666512589999999999866896689099998569
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.88 Aligned_cols=267 Identities=22% Similarity=0.270 Sum_probs=198.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CC-CCEEEEEEEECC--CCHHHHHHHHHHHHHHHC---CCCCCEEEEEEEEE----
Q ss_conf 09921546771048379999995-28-978999991023--522369999999987621---44661125413430----
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DD-GTKVAVKVLKRV--DQQGGREFLAEVEMLSRL---HHRNLVKLIGICIE---- 1036 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kd-Gk~VAVKvLk~~--s~~~~keFlrEIeILkrL---rHPNIVkLiGv~~e---- 1036 (1368)
.++|++.+.||+|+||+||+|.. ++ ++.||||+++.. .......+.+|+.+|+.| +|+||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf -3635899952489981000236656788887679999999999998432106999732357766681213788740116
Q 000659 1037 -EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSD 1115 (1368)
Q Consensus 1037 -~~~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsD 1115 (1368)
....+++|||+.+|.+..... .....+++..++.|+.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~---~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDK---VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHH---SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCEEEEEEEECCCCCHHHHHH---CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECC
T ss_conf 6746999997405871444443---03789998999999999999999997588---98357986278985899754210
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHH-HHHHHH--
Q ss_conf 66310023322434322212555666731001498872120500799999997099999999998503478-854200--
Q 000659 1116 FGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARPL-- 1192 (1368)
Q Consensus 1116 FGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv-~Wa~pl-- 1192 (1368)
||+++..... ......+||..|+|||++.+..++.++|||||||+||||++|+.||...+..+..... ......
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCG
T ss_pred HHHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCH
T ss_conf 0010110023---4577765485114831001798881110003289999998787998998989999999984079961
Q ss_pred --CCCCCCCCE-EEC---CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --145346522-104---888999991359999999998159696899998999999
Q 000659 1193 --LTSREGLER-IID---PSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1193 --ls~~e~L~e-IID---p~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
+........ ... ......+.......+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 105321111033302234564544044589999999999874896679189999669
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.49 Aligned_cols=261 Identities=23% Similarity=0.276 Sum_probs=194.3
Q ss_pred CCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEC------CCEEE
Q ss_conf 9215467710483799999952-8978999991023522369999999987621446611254134303------63589
Q 000659 970 NFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGICIEE------QARCL 1042 (1368)
Q Consensus 970 nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~------~~l~L 1042 (1368)
+|+..++||+|+||+||+|... +++.||||+++.... .+.+|+++|++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCC
Q ss_conf 9952489981000236656788887679999999999998432106999732357766681213788-740116663100
Q 000659 1043 VYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARS 1121 (1368)
Q Consensus 1043 VmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg-~VKIsDFGLAr~ 1121 (1368)
||||+++|.+. .+.........+++.+++.|+.|++.||.|||+++ |+|||||++||||+.++ .+||+|||+++.
T Consensus 97 v~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 97 VLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEECCCCCCHH-HHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHH
T ss_conf 98416886078-88863103689999999999999999999998668---764578860378735897116733660544
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH---------
Q ss_conf 233224343222125556667310014-9887212050079999999709999999999850347885420---------
Q 000659 1122 AMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARP--------- 1191 (1368)
Q Consensus 1122 i~~~~~~~~st~vvGT~gYmAPEvL~~-~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~p--------- 1191 (1368)
..... .....+|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. +....+.
T Consensus 173 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 173 LVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTREQI 247 (350)
T ss_dssp CCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHHHH
T ss_pred CCCCC---CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHH--HHHHHHHHCCCHHHHH
T ss_conf 04776---532002555556827764046888210002465277855028799898799999--9999997489817765
Q ss_pred --HCCC--CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf --0145--346522104888999991359999999998159696899998999999
Q 000659 1192 --LLTS--REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 --lls~--~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
.... ...+.......+..........++.+|+.+||..||++|+|+.|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43062101103554456744443156899999999999765895579299999669
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.42 Aligned_cols=241 Identities=22% Similarity=0.347 Sum_probs=195.8
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCC------HHHHHHHHHHHHHHHCC--CCCCEEEEEEEEECC
Q ss_conf 09921546771048379999995-2897899999102352------23699999999876214--466112541343036
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQ------QGGREFLAEVEMLSRLH--HRNLVKLIGICIEEQ 1038 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~------~~~keFlrEIeILkrLr--HPNIVkLiGv~~e~~ 1038 (1368)
.++|++.+.||+|+||.||+|+. .+++.||||+++.... ...+++.+|+.+|++++ |+|||++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CEEEEEEECCC-CCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCC-CCCCCCCC
Q ss_conf 35899952489-98100023665678888767999999999999843210699973235776668121378-87401166
Q 000659 1039 ARCLVYELIPN-GSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHD-FTPKVSDF 1116 (1368)
Q Consensus 1039 ~l~LVmEYi~g-GSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDed-g~VKIsDF 1116 (1368)
..++||||+.+ +++.+++.. ...+++.+++.|+.|++.||.|||+.+ |+|||||++|||++.+ +.+||+||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DF 155 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDF 155 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred EEEEEEEECCCCCHHHHHHHC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 689999833686228999861----589999999999999999999998779---7556676111477447884897754
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCC-CCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 63100233224343222125556667310014988-72120500799999997099999999998503478854200145
Q 000659 1117 GLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHL-LVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1117 GLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~-T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~ 1195 (1368)
|+|+..... ..+..+||..|+|||++.+..+ +.++|||||||+||||++|+.||... ......
T Consensus 156 G~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----~~i~~~------- 219 (273)
T d1xwsa_ 156 GSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----EEIIRG------- 219 (273)
T ss_dssp TTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HHHHHC-------
T ss_pred CCCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC-----HHHHHC-------
T ss_conf 653532444----5566565877479999848997886533255403453675688998873-----677615-------
Q ss_pred CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 346522104888999991359999999998159696899998999999
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1196 ~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
. . .+......++.+|+.+||..||++|||+.|+++.
T Consensus 220 ~--------~----~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h 255 (273)
T d1xwsa_ 220 Q--------V----FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH 255 (273)
T ss_dssp C--------C----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred C--------C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4--------4----7787799999999999760897589399998539
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.12 Aligned_cols=271 Identities=20% Similarity=0.251 Sum_probs=201.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE--------
Q ss_conf 09921546771048379999995-28978999991023--52236999999998762144661125413430--------
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-------- 1036 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e-------- 1036 (1368)
.++|++.+.||+|+||+||+|.. .+|+.||||++... .....+++.+|+++|++++|+||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 36358999524899810002366567888876799999999999984321069997323577666812137887401166
Q 000659 1037 EQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDF 1116 (1368)
Q Consensus 1037 ~~~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDF 1116 (1368)
++..++||||+.++.+..... ....+.+.+++.|+.|++.||.|||+.+ |+|||||++||||+.++.+||+||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~----~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTC----TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCC
T ss_pred CCEEEEEEECCCCCCCCHHHH----CCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEEC
T ss_conf 763899985357874101222----0344330899999999999998852299---885676722203668996876313
Q ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 631002332243--432221255566673100149-88721205007999999970999999999985034788542001
Q 000659 1117 GLARSAMDEESR--HISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLL 1193 (1368)
Q Consensus 1117 GLAr~i~~~~~~--~~st~vvGT~gYmAPEvL~~~-~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~pll 1193 (1368)
|+++........ ......+||..|+|||++.+. .++.++|||||||++|||++|+.||+..................
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 50022355444321135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred CCC-------CCCCEEECCCCCCCCCH-------HHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 453-------46522104888999991-------35999999999815969689999899999999
Q 000659 1194 TSR-------EGLERIIDPSLGNDVPF-------DSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1194 s~~-------e~L~eIIDp~L~~~~~~-------ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk 1245 (1368)
... ......+.......... .....+.+|+.+||+.||++|+|+.|+++.-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpf 307 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDF 307 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGG
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 825534432034443320133445550334044459989999999987389658909999974950
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.66 Aligned_cols=269 Identities=23% Similarity=0.287 Sum_probs=201.9
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC----CE
Q ss_conf 809921546771048379999995-289789999910235-223699999999876214466112541343036----35
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVD-QQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----AR 1040 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s-~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~----~l 1040 (1368)
...+|++.+.||+|+||+||+|.. .+++.||||+++... ....+++++|+++|++++|+||+++++++.... ..
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 38985997899406480999999999994999999803109589999999999999768989885888995056455414
Q ss_pred EEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 89995248998100023665678888767999999999999843210699973235776668121378874011666310
Q 000659 1041 CLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLAR 1120 (1368)
Q Consensus 1041 ~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr 1120 (1368)
+++++|+.+|+|.+++.. ..+++..++.|+.|++.||.|||+.+ |+|||||++||||+.++.+||+|||+++
T Consensus 86 ~~l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp EEEEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCHHHHHHC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEE
T ss_conf 999996259865664405-----89999999999999999999999789---8677787643788799977875457056
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCHHC-CCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC-
Q ss_conf 02332243-4322212555666731001-49887212050079999999709999999999850347885420014534-
Q 000659 1121 SAMDEESR-HISTRVMGTFGYVAPEYAM-TGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE- 1197 (1368)
Q Consensus 1121 ~i~~~~~~-~~st~vvGT~gYmAPEvL~-~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e- 1197 (1368)
........ ......+|+..|+|||++. ...++.++||||+||++|||++|+.||......+................
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 237 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHH
T ss_conf 50477764101011026520003878604788874101004670133776697997888889999987652069975664
Q ss_pred ------CCCEEEC-CCCCCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ------6522104-88899999-----1359999999998159696899998999999
Q 000659 1198 ------GLERIID-PSLGNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1198 ------~L~eIID-p~L~~~~~-----~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
....... ........ .....++.+|+.+||..||++||++.|+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2343322220244677557787778378999999999999764895679089998619
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.63 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=199.9
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECC-----
Q ss_conf 809921546771048379999995-28978999991023--5223699999999876214466112541343036-----
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQ----- 1038 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~----- 1038 (1368)
..++|++.+.||+|+||.||+|.. .+|+.||||+++.. +....+.+.+|+++|++++|+|||++++++...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -CEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf -3589995248998100023665678888767999999999999843210699973235776668121378874011666
Q 000659 1039 -ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1039 -~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFG 1117 (1368)
..|+||||+ +++|..+++ ...+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCT
T ss_pred CEEEEEEECC-CCCHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCC
T ss_conf 1599998405-521899987-----402269999999999999999987378---7645668511112100122113431
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCC-CCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH----
Q ss_conf 3100233224343222125556667310014-98872120500799999997099999999998503478854200----
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMT-GHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPL---- 1192 (1368)
Q Consensus 1118 LAr~i~~~~~~~~st~vvGT~gYmAPEvL~~-~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~pl---- 1192 (1368)
+++.... ..+...|+..|+|||++.+ ..++.++||||+||+||||++|+.||...+..+...........
T Consensus 167 ~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 241 (346)
T d1cm8a_ 167 LARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241 (346)
T ss_dssp TCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CEECCCC-----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCCHH
T ss_conf 0220687-----63102455333588998178789965010300389999997869988897689999998503788488
Q ss_pred ----CCC------CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ----145------346522104888999991359999999998159696899998999999
Q 000659 1193 ----LTS------REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1193 ----ls~------~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
... ...+.++....+. .........+.+|+.+||..||++|||+.|+++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 242 FVQRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHHTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCCHHHHHHHCCCCCCCCCCHH-HHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 88653000344331157866655667-7556899999999999772995579299999639
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=324.20 Aligned_cols=259 Identities=18% Similarity=0.282 Sum_probs=197.9
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE--CCCEEEEE
Q ss_conf 9921546771048379999995-289789999910235223699999999876214-4661125413430--36358999
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIE--EQARCLVY 1044 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLr-HPNIVkLiGv~~e--~~~l~LVm 1044 (1368)
++|++.+.||+|+||+||+|+. .+++.||||+++... .+++.+|+++|+.++ |+||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 67189789831748199999988999799999988899---999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCC
Q ss_conf 52489981000236656788887679999999999998432106999732357766681213788-74011666310023
Q 000659 1045 ELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDF-TPKVSDFGLARSAM 1123 (1368)
Q Consensus 1045 EYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg-~VKIsDFGLAr~i~ 1123 (1368)
||+.+|+|..+.. .+++.+++.|+.|++.||.|||+++ |+|||||++||||+.++ .+||+|||+|+...
T Consensus 112 e~~~~~~L~~~~~-------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~ 181 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181 (328)
T ss_dssp ECCCSCBGGGTTT-------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECC
T ss_pred EECCCCCHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECC
T ss_conf 6317985899746-------8999999999999999998876433---44345644123774899836641565426646
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHH--H---------HHHHHH
Q ss_conf 32243432221255566673100149-88721205007999999970999999999985034--7---------885420
Q 000659 1124 DEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQEN--L---------VAWARP 1191 (1368)
Q Consensus 1124 ~~~~~~~st~vvGT~gYmAPEvL~~~-~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~n--L---------v~Wa~p 1191 (1368)
... .....+||..|+|||.+.+. .++.++||||+||++|||++|+.||.......... + ..|...
T Consensus 182 ~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 182 PGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHH
T ss_conf 887---44432248642476102688888845232335455587604889998876018999999998788415555542
Q ss_pred H-CCCCCCCCEEE--------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 0-14534652210--------4888999991359999999998159696899998999999
Q 000659 1192 L-LTSREGLERII--------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1192 l-ls~~e~L~eII--------Dp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
. .........+. ..............++.+|+.+||..||++|+|++|+++.
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H 319 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred CCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 2544474300000333433112115521124489999999999866995689089999649
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=326.85 Aligned_cols=263 Identities=19% Similarity=0.255 Sum_probs=201.4
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCEEEEEE-EEECCCEEEEEE
Q ss_conf 09921546771048379999995-2897899999102352236999999998762144661125413-430363589995
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLVKLIGI-CIEEQARCLVYE 1045 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIVkLiGv-~~e~~~l~LVmE 1045 (1368)
.++|++.+.||+|+||.||+|.+ .+++.||||++.... ..+++.+|++++++++|.|++.+++. ..+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 888999689850788099999998899899999972100--588899999999970389960179999951987789998
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEEC---CCCCCCCCCCCCCCCC
Q ss_conf 2489981000236656788887679999999999998432106999732357766681213---7887401166631002
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLE---HDFTPKVSDFGLARSA 1122 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLD---edg~VKIsDFGLAr~i 1122 (1368)
|+ +|+|.+.+.. ....+++.+++.++.|++.||+|||+.+ |+||||||+|||++ .+..+||+|||+|+..
T Consensus 84 ~~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 84 LL-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp CC-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EC-CCCHHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 73-8713332443---0688768999999999999999999799---442667876606433577761565046751342
Q ss_pred CCCCCC-----CCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHH-HHHHHHCCCC
Q ss_conf 332243-----4322212555666731001498872120500799999997099999999998503478-8542001453
Q 000659 1123 MDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV-AWARPLLTSR 1196 (1368)
Q Consensus 1123 ~~~~~~-----~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv-~Wa~plls~~ 1196 (1368)
...... ......+||..|+|||++.+..++.++|||||||++|||++|+.||............ .+.......
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~- 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST- 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC-
T ss_conf 5544554100013577678735329999918998983218861778999984987665530577999999852356789-
Q ss_pred CCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHH
Q ss_conf 465221048889999913599999999981596968999989999999999975
Q 000659 1197 EGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNE 1250 (1368)
Q Consensus 1197 e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e 1250 (1368)
.... .......++.+++..||..+|++||++.++.+.|+.+...
T Consensus 236 -~~~~---------~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 -PIEV---------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp -CHHH---------HTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred -CHHH---------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -8357---------5347889999999998439955791999999999999997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=323.52 Aligned_cols=265 Identities=17% Similarity=0.199 Sum_probs=208.7
Q ss_pred HCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCCEEEEEE
Q ss_conf 09921546771048379999995-2897899999102352236999999998762144-661125413430363589995
Q 000659 968 TGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 968 t~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrH-PNIVkLiGv~~e~~~l~LVmE 1045 (1368)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECC-----CCCCCCCCCCCCC
Q ss_conf 24899810002366567888876799999999999984321069997323577666812137-----8874011666310
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEH-----DFTPKVSDFGLAR 1120 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDe-----dg~VKIsDFGLAr 1120 (1368)
|+ +|+|.+++... ...+++.++.+|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+
T Consensus 82 ~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 82 LL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EC-CCCHHHHHHHH---CCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 64-88879999752---031106899999999999999999779---662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 02332243-----4322212555666731001498872120500799999997099999999998503478854200145
Q 000659 1121 SAMDEESR-----HISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTS 1195 (1368)
Q Consensus 1121 ~i~~~~~~-----~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~ 1195 (1368)
........ ......+||..|||||++.+..++.++||||||+++|||++|+.||....................
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~- 233 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ- 233 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCC-
T ss_conf 7146766541110246762775102679896488888699989831999999869876788530219999999970567-
Q ss_pred CCCCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHHHH
Q ss_conf 34652210488899999135999999999815969689999899999999999750
Q 000659 1196 REGLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALKLVCNEC 1251 (1368)
Q Consensus 1196 ~e~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk~Il~e~ 1251 (1368)
.....++ .. ....++.+++..|+..++++||++..+.+.|+.+++..
T Consensus 234 ~~~~~~l-----~~----~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 234 STPLREL-----CA----GFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HSCHHHH-----TT----TSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CCCHHHH-----CC----CCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHC
T ss_conf 9995896-----57----99899999999984399300859999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.01 Aligned_cols=253 Identities=25% Similarity=0.320 Sum_probs=202.1
Q ss_pred CCCCEEEEEEECCCEEEEEEEEC----CCCEEEEEEEECC----CCHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEECCC
Q ss_conf 99215467710483799999952----8978999991023----52236999999998762144-661125413430363
Q 000659 969 GNFDASRILGEGGFGLVYSGVLD----DGTKVAVKVLKRV----DQQGGREFLAEVEMLSRLHH-RNLVKLIGICIEEQA 1039 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~lk----dGk~VAVKvLk~~----s~~~~keFlrEIeILkrLrH-PNIVkLiGv~~e~~~ 1039 (1368)
++|++.+.||+|+||+||+|... +|+.||||+++.. +....+.+.+|+++|++++| +||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 58999524899810002366567888876799999999999984321069997323577666812137887401166631
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLA 1119 (1368)
Q Consensus 1040 l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLA 1119 (1368)
.+++|||+.+|+|.+++.. ...+.+...+.++.|++.||.|||+.+ |+|||||++||||+.++.+||+|||++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred EEEEEECCCCCHHHHHHHH----CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 0012312341179999873----045437888888999999998851499---896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHCCC--CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 002332243432221255566673100149--887212050079999999709999999999850347885420014534
Q 000659 1120 RSAMDEESRHISTRVMGTFGYVAPEYAMTG--HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLTSRE 1197 (1368)
Q Consensus 1120 r~i~~~~~~~~st~vvGT~gYmAPEvL~~~--~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls~~e 1197 (1368)
+........ ......|+..|++||.+... .++.++|||||||+||||++|+.||...+..+........ ....
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--~~~~-- 251 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--ILKS-- 251 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--HHHC--
T ss_pred HHHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH--CCCC--
T ss_conf 220344443-22122233333106876057768871325177779999997689998888777799999983--3568--
Q ss_pred CCCEEECCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHHH
Q ss_conf 652210488899999135999999999815969689999-----8999999
Q 000659 1198 GLERIIDPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPF-----MGEVVQA 1243 (1368)
Q Consensus 1198 ~L~eIIDp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPT-----MsEILq~ 1243 (1368)
...++.....++.+++.+||+.+|++|++ ++|+++.
T Consensus 252 ----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H 292 (322)
T d1vzoa_ 252 ----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 292 (322)
T ss_dssp ----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred ----------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCC
T ss_conf ----------99886547999999999974458988199974509999749
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.32 Aligned_cols=266 Identities=19% Similarity=0.244 Sum_probs=203.3
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEE
Q ss_conf 9921546771048379999995-28978999991023--52236999999998762144661125413430363589995
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIEEQARCLVYE 1045 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e~~~l~LVmE 1045 (1368)
++|++.+.||+|+||+||+|+. .+++.||||+++.. .....+++.+|+.+|+.++|+||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 24899810002366567888876799999999999984321069997323577666812137887401166631002332
Q 000659 1046 LIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGLARSAMDE 1125 (1368)
Q Consensus 1046 Yi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~i~~~ 1125 (1368)
++.+++|..++.. ...+.+.+++.++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ECCCCCCCCCCCC----CCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCC
T ss_conf 0233222112123----565403678999999999987743399---860014676121133782665204601104688
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCH-H-HHHHHHHHCC-CCCCCCE
Q ss_conf 2434322212555666731001498-872120500799999997099999999998503-4-7885420014-5346522
Q 000659 1126 ESRHISTRVMGTFGYVAPEYAMTGH-LLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE-N-LVAWARPLLT-SREGLER 1201 (1368)
Q Consensus 1126 ~~~~~st~vvGT~gYmAPEvL~~~~-~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~-n-Lv~Wa~plls-~~e~L~e 1201 (1368)
.. ......++..|++||++.... ++.++|||||||++|||++|+.||......... . +......... .......
T Consensus 155 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 155 VR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp CS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred CC--CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 75--1001034431014667506988880444026541889985189999889999999999986118997355134432
Q ss_pred EE---------CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 10---------4888999991359999999998159696899998999999
Q 000659 1202 II---------DPSLGNDVPFDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1202 II---------Dp~L~~~~~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
.. ...............+.+|+.+|++.||++|+|+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H 283 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 221133444544310433065689999999999864996689099999649
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.79 Aligned_cols=266 Identities=23% Similarity=0.267 Sum_probs=201.2
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEEC-CCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE------C
Q ss_conf 8099215467710483799999952-8978999991023--52236999999998762144661125413430------3
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVLD-DGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE------E 1037 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~lk-dGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e------~ 1037 (1368)
+.++|++.+.||+|+||+||+|.+. +|+.||||+++.. +....+++.+|+.+|++++|+|||++++++.. .
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~ 94 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 94 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ECCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCC
T ss_conf 33775998896217585999999999998999999882336979999999999999864898764899897025643457
Q ss_pred CCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 63589995248998100023665678888767999999999999843210699973235776668121378874011666
Q 000659 1038 QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFG 1117 (1368)
Q Consensus 1038 ~~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFG 1117 (1368)
...|+||||+.++. .+.++ ..+++.+++.++.|++.||.|||+.| |+||||||+|||++.++.+|++|||
T Consensus 95 ~~~~iv~Ey~~~~l-~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~ 164 (355)
T d2b1pa1 95 QDVYLVMELMDANL-CQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_dssp CEEEEEEECCSEEH-HHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred CEEEEEEECCCHHH-HHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHH
T ss_conf 62699984144677-87650------38999999999999999998865221---1245677632113654431320102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHH---------HH
Q ss_conf 310023322434322212555666731001498872120500799999997099999999998503478---------85
Q 000659 1118 LARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLV---------AW 1188 (1368)
Q Consensus 1118 LAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv---------~W 1188 (1368)
+++..... ......+||..|+|||++.+..++.++||||+||++|||++|+.||...+........ ++
T Consensus 165 ~~~~~~~~---~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 165 LARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp C------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HHHCCCCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 32114666---553322146555581331477778774333566257898659899888977889999997205898799
Q ss_pred HHHHC-------CCC-----CCCCEEECCCCCCCC---CHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 42001-------453-----465221048889999---9135999999999815969689999899999999
Q 000659 1189 ARPLL-------TSR-----EGLERIIDPSLGNDV---PFDSVAKVAAIASMCVQPEVQHRPFMGEVVQALK 1245 (1368)
Q Consensus 1189 a~pll-------s~~-----e~L~eIIDp~L~~~~---~~ee~~eLlkLI~~CLspDPkeRPTMsEILq~Lk 1245 (1368)
..... ... .....++........ .......+.+|+.+|+..||++|||++|+++.-+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw 313 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPY 313 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTT
T ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf 987656677776417543566642126433354321013337999999999987699457908999966942
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.86 Aligned_cols=264 Identities=23% Similarity=0.303 Sum_probs=199.0
Q ss_pred HHCCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECC--CCHHHHHHHHHHHHHHHCCCCCCEEEEEEEEE-----CC
Q ss_conf 809921546771048379999995-28978999991023--52236999999998762144661125413430-----36
Q 000659 967 ATGNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRV--DQQGGREFLAEVEMLSRLHHRNLVKLIGICIE-----EQ 1038 (1368)
Q Consensus 967 at~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~--s~~~~keFlrEIeILkrLrHPNIVkLiGv~~e-----~~ 1038 (1368)
..++|++.+.||+|+||+||+|.. .+|+.||||+++.. +....+++.+|+++|++++|+|||++++++.. ..
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred CEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCC
Q ss_conf 35899952489981000236656788887679999999999998432106999732357766681213788740116663
Q 000659 1039 ARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPKVSDFGL 1118 (1368)
Q Consensus 1039 ~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VKIsDFGL 1118 (1368)
..+++++|+.+|+|.+++.. ..+++.+++.|+.|++.||+|||+++ |+|||||++|||++.++.+|++|||+
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC--
T ss_pred CEEEEEEEECCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCH
T ss_conf 64999996258862320022-----45309999999999999999997388---76516677633455432200132100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC-CCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCC---
Q ss_conf 1002332243432221255566673100149-887212050079999999709999999999850347885420014---
Q 000659 1119 ARSAMDEESRHISTRVMGTFGYVAPEYAMTG-HLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQENLVAWARPLLT--- 1194 (1368)
Q Consensus 1119 Ar~i~~~~~~~~st~vvGT~gYmAPEvL~~~-~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~nLv~Wa~plls--- 1194 (1368)
+..... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||...+................
T Consensus 168 a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 242 (348)
T d2gfsa1 168 ARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 242 (348)
T ss_dssp --CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred HCCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 012575-----444434543555835533775678551243205899999768899788988999999997307997577
Q ss_pred ----CCCCCCEEECCCC-CCCCC-----HHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf ----5346522104888-99999-----1359999999998159696899998999999
Q 000659 1195 ----SREGLERIIDPSL-GNDVP-----FDSVAKVAAIASMCVQPEVQHRPFMGEVVQA 1243 (1368)
Q Consensus 1195 ----~~e~L~eIIDp~L-~~~~~-----~ee~~eLlkLI~~CLspDPkeRPTMsEILq~ 1243 (1368)
............. ..... .....++.+|+.+||..||++|+|+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H 301 (348)
T d2gfsa1 243 LKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 301 (348)
T ss_dssp HTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 32001024454443035578755566267899999999999775883459389998559
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.5e-44 Score=292.17 Aligned_cols=265 Identities=21% Similarity=0.214 Sum_probs=192.7
Q ss_pred CCCCEEEEEEECCCEEEEEEEE-CCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-----------CCCCEEEEEEEEE
Q ss_conf 9921546771048379999995-289789999910235223699999999876214-----------4661125413430
Q 000659 969 GNFDASRILGEGGFGLVYSGVL-DDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-----------HRNLVKLIGICIE 1036 (1368)
Q Consensus 969 ~nFei~eiLGkGaFGtVYKA~l-kdGk~VAVKvLk~~s~~~~keFlrEIeILkrLr-----------HPNIVkLiGv~~e 1036 (1368)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECC-CCCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 8579989975077818999999999979999998343-133689999999999840145555542276764789987631
Q ss_pred C--CCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCCCCCCCCCCCEEECCCCC---
Q ss_conf 3--63589995248998100023665678888767999999999999843210-69997323577666812137887---
Q 000659 1037 E--QARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHE-DSSPRVIHRDFKSSNILLEHDFT--- 1110 (1368)
Q Consensus 1037 ~--~~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs-~Gsp~IVHRDIKPsNILLDedg~--- 1110 (1368)
. ...+++++++..+........ ......+.+..+..++.|++.||.|||+ .+ |+|||||++||||+.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIK-KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHH-HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTT
T ss_pred CCCCCEEEEEEECCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCC
T ss_conf 256520234320003542000001-2234678689999999999999888764058---646567705705630576564
Q ss_pred ---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCCCCH----
Q ss_conf ---4011666310023322434322212555666731001498872120500799999997099999999998503----
Q 000659 1111 ---PKVSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVILELLSGRKPVDMTQPPGQE---- 1183 (1368)
Q Consensus 1111 ---VKIsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILlELLTGr~PFd~s~~~d~~---- 1183 (1368)
++++|||.++.... .....+|+..|+|||++....++.++||||+||+++||++|+.||.........
T Consensus 168 ~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred CCEEEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHH
T ss_conf 43056753144212344-----5422366521057132146677764320123789999987889989875543210268
Q ss_pred HHHHHHHHHC-----------------CCCCCCCEEECCC---------CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 4788542001-----------------4534652210488---------8999991359999999998159696899998
Q 000659 1184 NLVAWARPLL-----------------TSREGLERIIDPS---------LGNDVPFDSVAKVAAIASMCVQPEVQHRPFM 1237 (1368)
Q Consensus 1184 nLv~Wa~pll-----------------s~~e~L~eIIDp~---------L~~~~~~ee~~eLlkLI~~CLspDPkeRPTM 1237 (1368)
.+...+..+. ........+.... ...........++.+|+.+|+..||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999998379987886245322000132012202432357764442100015674358999999999877994579089
Q ss_pred HHHHHH
Q ss_conf 999999
Q 000659 1238 GEVVQA 1243 (1368)
Q Consensus 1238 sEILq~ 1243 (1368)
+|+++.
T Consensus 323 ~e~L~H 328 (362)
T d1q8ya_ 323 GGLVNH 328 (362)
T ss_dssp HHHHTC
T ss_pred HHHHCC
T ss_conf 999669
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=4.8e-26 Score=176.77 Aligned_cols=171 Identities=18% Similarity=0.166 Sum_probs=120.9
Q ss_pred CCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC------------------HHHHHHHHHHHHHHHCCCCCCEEEEE
Q ss_conf 215467710483799999952897899999102352------------------23699999999876214466112541
Q 000659 971 FDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQ------------------QGGREFLAEVEMLSRLHHRNLVKLIG 1032 (1368)
Q Consensus 971 Fei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~------------------~~~keFlrEIeILkrLrHPNIVkLiG 1032 (1368)
+.+.+.||+|+||.||+|...+|+.||||+++.... .....+.+|...+.++.|.+++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred EEEECCCEEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 34303635899952489981000236656788887679999999999998432106999732357766681213788740
Q 000659 1033 ICIEEQARCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHEDSSPRVIHRDFKSSNILLEHDFTPK 1112 (1368)
Q Consensus 1033 v~~e~~~l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~Gsp~IVHRDIKPsNILLDedg~VK 1112 (1368)
+. ..+++|||+.++.+.+ +.+....+++.|++.+|+|||+.+ |+||||||+|||++++ .++
T Consensus 82 ~~----~~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEE
T ss_pred EC----CCEEEEEEECCCCCCC-----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEE
T ss_conf 62----8889999504565420-----------015789999999999999982688---8983689036114289-899
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCEEEHHHHHH
Q ss_conf 11666310023322434322212555666731001498872120500799999
Q 000659 1113 VSDFGLARSAMDEESRHISTRVMGTFGYVAPEYAMTGHLLVKSDVYSYGVVIL 1165 (1368)
Q Consensus 1113 IsDFGLAr~i~~~~~~~~st~vvGT~gYmAPEvL~~~~~T~KSDVWSLGVILl 1165 (1368)
|+|||+|+..............+.. --|+ ..+.|..++|+||+.--++
T Consensus 143 liDFG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp ECCCTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred EEECCCCCCCCCCCCHHHHHHHHHH----HHHH-HCCCCCCCCCHHHHHHHHH
T ss_conf 9877884308998709999877999----9999-7578998446899999874
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.09 E-value=9e-10 Score=75.15 Aligned_cols=151 Identities=15% Similarity=0.094 Sum_probs=100.0
Q ss_pred HHHHHHHHCCCCEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEECCC
Q ss_conf 789998809921546771048379999995289789999910235223699999999876214-4661125413430363
Q 000659 961 ASEIEKATGNFDASRILGEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLH-HRNLVKLIGICIEEQA 1039 (1368)
Q Consensus 961 ~eELe~at~nFei~eiLGkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLr-HPNIVkLiGv~~e~~~ 1039 (1368)
..++.+....|+..+..+.+..+.||+...+ +..+++|+...........+.+|..+++.+. +--+.+++.++.+.+.
T Consensus 6 ~~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 6 SPELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp CHHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred CHHHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 7999975135279976789987718999908-986999984887653255699999999987606998728999750896
Q ss_pred EEEEEEECCCCCHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-------------------------------
Q ss_conf 5899952489981000236656788887679999999999998432106-------------------------------
Q 000659 1040 RCLVYELIPNGSVESHLHGVDKESAPLGWDARLKIALGAARALAYLHED------------------------------- 1088 (1368)
Q Consensus 1040 l~LVmEYi~gGSL~dlL~~~~~~~~~Lsw~erlkIA~QIA~ALaYLHs~------------------------------- 1088 (1368)
.++||++++|..+.+.... ......++.++++.++.||+.
T Consensus 85 ~~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred EEEEEEECCCCCCCCCCCC---------CCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHH
T ss_conf 4999986043343543344---------0269999998999999985568421435764465655577899877655554
Q ss_pred -------------------------CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf -------------------------999732357766681213788740116663100
Q 000659 1089 -------------------------SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1089 -------------------------Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
....++|+|+.+.|||++++..+.|+||+.+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HCCCCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3033232005799999999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.57 E-value=1.3e-07 Score=61.58 Aligned_cols=143 Identities=21% Similarity=0.174 Sum_probs=85.1
Q ss_pred EEEECCC-EEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCC--CCEEEEEEEEECCCEEEEEEECCCCCH
Q ss_conf 7710483-7999999528978999991023522369999999987621446--611254134303635899952489981
Q 000659 976 ILGEGGF-GLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHR--NLVKLIGICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 976 iLGkGaF-GtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHP--NIVkLiGv~~e~~~l~LVmEYi~gGSL 1052 (1368)
.+..|.. +.||+....++..+++|...... ...+.+|+..++.+... .+.++++++.+.+..++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HHCC-----------------CCCCCCCCCCCHHH--HHHHHH--------------------HHHHHHHHHHC----CC
Q ss_conf 0002-----------------36656788887679--999999--------------------99999843210----69
Q 000659 1053 ESHL-----------------HGVDKESAPLGWDA--RLKIAL--------------------GAARALAYLHE----DS 1089 (1368)
Q Consensus 1053 ~dlL-----------------~~~~~~~~~Lsw~e--rlkIA~--------------------QIA~ALaYLHs----~G 1089 (1368)
.+.. |........+.+.. ...... .....+..+.+ ..
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 173 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGE 173 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379999999987187657
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 99732357766681213788740116663100
Q 000659 1090 SPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1090 sp~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
...++|+|+.+.|||++++..+.|+||+.+..
T Consensus 174 ~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 174 DLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp CEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 95678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.41 E-value=2e-06 Score=54.30 Aligned_cols=77 Identities=14% Similarity=0.118 Sum_probs=50.0
Q ss_pred EEEEEECCCEEEEEEEECC-CCEEEEEEEEC----C---CCHHHHHHHHHHHHHHHCC-C--CCCEEEEEEEEECCCEEE
Q ss_conf 4677104837999999528-97899999102----3---5223699999999876214-4--661125413430363589
Q 000659 974 SRILGEGGFGLVYSGVLDD-GTKVAVKVLKR----V---DQQGGREFLAEVEMLSRLH-H--RNLVKLIGICIEEQARCL 1042 (1368)
Q Consensus 974 ~eiLGkGaFGtVYKA~lkd-Gk~VAVKvLk~----~---s~~~~keFlrEIeILkrLr-H--PNIVkLiGv~~e~~~l~L 1042 (1368)
.+.||.|....||++...+ ++.|++|.-.. . ......+...|.+.|+.+. + ..+.+++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9952489981
Q 000659 1043 VYELIPNGSV 1052 (1368)
Q Consensus 1043 VmEYi~gGSL 1052 (1368)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.10 E-value=2.1e-05 Score=47.85 Aligned_cols=139 Identities=19% Similarity=0.191 Sum_probs=79.0
Q ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCE--EEEE-----EEEECCCEEEEEEECCCCCH
Q ss_conf 4837999999528978999991023522369999999987621446611--2541-----34303635899952489981
Q 000659 980 GGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KLIG-----ICIEEQARCLVYELIPNGSV 1052 (1368)
Q Consensus 980 GaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIV--kLiG-----v~~e~~~l~LVmEYi~gGSL 1052 (1368)
+....||++..++|+.|++|+.+.. ....+++..|...+..|...++. ..+. .....+..+.+++++.|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 6120269998389997999984787-788999999999999998559987875206898056653479999865277688
Q ss_pred HHC--------------CCC----CCC-CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HCCCC
Q ss_conf 000--------------236----656-78888767----------------------9999999999998432-10699
Q 000659 1053 ESH--------------LHG----VDK-ESAPLGWD----------------------ARLKIALGAARALAYL-HEDSS 1090 (1368)
Q Consensus 1053 ~dl--------------L~~----~~~-~~~~Lsw~----------------------erlkIA~QIA~ALaYL-Hs~Gs 1090 (1368)
... +|. ... ....+++. ....++..+...+.-+ .....
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 9732357766681213788740116663100
Q 000659 1091 PRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1091 p~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
..+||+|+.+.|||++++ ..++||+-++.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 120247888042878389--35886520146
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.10 E-value=2.6e-05 Score=47.32 Aligned_cols=160 Identities=12% Similarity=0.066 Sum_probs=87.8
Q ss_pred CCHHHHHHHHCCCCEEEEE-----EECCCEEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCE--EEE
Q ss_conf 8978999880992154677-----104837999999528978999991023522369999999987621446611--254
Q 000659 959 FSASEIEKATGNFDASRIL-----GEGGFGLVYSGVLDDGTKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV--KLI 1031 (1368)
Q Consensus 959 fs~eELe~at~nFei~eiL-----GkGaFGtVYKA~lkdGk~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIV--kLi 1031 (1368)
.+.++++....+|.++++. ..|--.+.|+....+|+ +++|++.... ..+++..|++++..|...++. ..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCC-EEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 89999999998679998568523788852673899978972-8999807899--98899999999875430255545564
Q ss_pred ----E--EEEECCCEEEEEEECCCCCHHHCCC--------------C----C--CCCCCC-----------------CCH
Q ss_conf ----1--3430363589995248998100023--------------6----6--567888-----------------876
Q 000659 1032 ----G--ICIEEQARCLVYELIPNGSVESHLH--------------G----V--DKESAP-----------------LGW 1068 (1368)
Q Consensus 1032 ----G--v~~e~~~l~LVmEYi~gGSL~dlL~--------------~----~--~~~~~~-----------------Lsw 1068 (1368)
| +.........++.++.+........ . . ...... ...
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120024567777653114
Q ss_pred HHHHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCC
Q ss_conf 79999999999998432106-999732357766681213788740116663100
Q 000659 1069 DARLKIALGAARALAYLHED-SSPRVIHRDFKSSNILLEHDFTPKVSDFGLARS 1121 (1368)
Q Consensus 1069 ~erlkIA~QIA~ALaYLHs~-Gsp~IVHRDIKPsNILLDedg~VKIsDFGLAr~ 1121 (1368)
......+..+...+...... -..++||+|+..+|||++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 127999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.09 E-value=3.8e-05 Score=46.28 Aligned_cols=76 Identities=22% Similarity=0.289 Sum_probs=51.3
Q ss_pred CCEEEEEEECCCEEEEEEEECCC--------CEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCCE-EEEEEEEECCCEE
Q ss_conf 21546771048379999995289--------78999991023522369999999987621446611-2541343036358
Q 000659 971 FDASRILGEGGFGLVYSGVLDDG--------TKVAVKVLKRVDQQGGREFLAEVEMLSRLHHRNLV-KLIGICIEEQARC 1041 (1368)
Q Consensus 971 Fei~eiLGkGaFGtVYKA~lkdG--------k~VAVKvLk~~s~~~~keFlrEIeILkrLrHPNIV-kLiGv~~e~~~l~ 1041 (1368)
+++ +.|+.|-.-.+|++...++ +.|.+++... .....+..+|..+++.+.-.+++ ++++++.+ .
T Consensus 45 l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 45 LRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEE-EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----C
T ss_conf 699-9917853343489996887754457898179996599--61165899999999999757999808998189----5
Q ss_pred EEEEECCCCCHH
Q ss_conf 999524899810
Q 000659 1042 LVYELIPNGSVE 1053 (1368)
Q Consensus 1042 LVmEYi~gGSL~ 1053 (1368)
+|+||++|..|.
T Consensus 118 ~I~efi~g~~l~ 129 (395)
T d1nw1a_ 118 RLEEYIPSRPLS 129 (395)
T ss_dssp EEECCCCEEECC
T ss_pred EEEEEECCCCCC
T ss_conf 699973455488
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=97.80 E-value=5.6e-07 Score=57.67 Aligned_cols=38 Identities=8% Similarity=0.058 Sum_probs=19.2
Q ss_pred HHHHH-HCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCC
Q ss_conf 97642-013862233567888830899318999999999
Q 000659 801 FLTYQ-RFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPS 838 (1368)
Q Consensus 801 ldLss-nlLsGeIP~qls~LgrL~vLNVS~N~LsGsIPs 838 (1368)
++|+. |.++|+||..++.|..|+.|++++|++.+.++.
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~ 119 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPD 119 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 020265433300243114542001102035643443322
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=83.55 E-value=0.38 Score=21.32 Aligned_cols=39 Identities=10% Similarity=0.031 Sum_probs=23.7
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEECCCCCC
Q ss_conf 846799764201386223356788883089931899999
Q 000659 796 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPP 834 (1368)
Q Consensus 796 ~~sEaldLssnlLsGeIP~qls~LgrL~vLNVS~N~LsG 834 (1368)
...+.++|+.|.+++-.+..+..+.+|+.|++++|+|+.
T Consensus 31 ~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~ 69 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK 69 (266)
T ss_dssp TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCC
T ss_conf 688989884992898597786345655221356654444
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=83.47 E-value=0.086 Score=25.31 Aligned_cols=67 Identities=13% Similarity=0.073 Sum_probs=42.2
Q ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 84679976420138622335678888308993189999999999987776799999889998999986
Q 000659 796 DNTTAFLTYQRFWHKQVVIKSSYFGDYEVLYVRYPGLPPSPPSASSSIGIIDDGPYSGNNGRATKPEG 863 (1368)
Q Consensus 796 ~~sEaldLssnlLsGeIP~qls~LgrL~vLNVS~N~LsGsIPssls~~stf~assFsGN~GLCG~PLs 863 (1368)
..-+.++|+.|.++|.||..+..+..|+.|++++|+|+|.||.... ...+....+.||..+||.|+.
T Consensus 244 ~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~-L~~L~~l~l~~N~~l~g~plp 310 (313)
T d1ogqa_ 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN-LQRFDVSAYANNKCLCGSPLP 310 (313)
T ss_dssp TTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTT-GGGSCGGGTCSSSEEESTTSS
T ss_pred CCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCCC-CCCCCHHHHCCCCCCCCCCCC
T ss_conf 5444444765706660876884799999897958835166898666-799897886889500198988
|